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LETTERS TO THE EDITOR 
YSM in W.W. II 
To the editor: 
I enjoyed reading Dr. Fred Collier's 
humorous account in the Summer 1990 
Yale Medicine of the change in the 
Yale medical students’ education 
during World War 11. I would like to 
mention another change that was 
effected by the war: the composition of 
classes at the Yale School of Medicine. 
During these years, the percentage of 
women rose dramatically from about 6 
percent to over 11 percent. In fact, in 
1948, 15 percent of the entering class 
were women, but this figure dropped to 
5 percent two years later. It was not 
until 1971 that the number of women at 
the School of Medicine reached the 
same proportion. These trends are also 
reflected in national statistics on the 
admission of women to medical 
schools. 
Susan Baserga, M.D., Ph.D. '88 
Lecturer, MB&B 
Yale School of Medicine 
To the editor: 
Dr. Collier’s article, “Yale Medical 
Students March to War,’’ was on target 
even if we student-soliders rarely were. 
The war changed all American 
communities, but the Yale School of 
Medicine was changed in special ways. 
Medical students were allowed to 
continue their studies, but most went off 
to the military. They were replaced by 
all sorts of trainees from the armed 
services, American and otherwise. My 
roommate, a public health student 
named Ray Chan, organized a big 
dance for a contingent from Chiang 
Kai-shek’s air force, busing in Chinese 
girls from nearby colleges. 
We lost faculty to the regular 
services and to the Yale unit. We gained 
faculty in the form of refugees from 
Hitler and Mussolini. We learned to 
pronounce “necrosis” with a rolled “R” 
and a “Z” sound. Arturo Castiglioni, 
who had just published his History of 
Medicine, gave an elective to a small 
group before the big fireplace in the 
historical library. The setting, plus the 
intensity and passion of his 
presentations, rose above our 
differences in language. Other refugee 
physicians were not as fortunate and 
worked in the area at menial jobs. 
I can still find the little scar on my 
arm where Professor Harold S. Burr 
burned me with mustard gas. While 
studying the toxic effects of the 
mustards, faculty of the department of 
pharmacology discovered the anti¬ 
tumor activities of these compounds. As 
a part-time worker in that department, I 
witnessed Dr. Burr’s research, which 
included measuring the electrical 
potential across a blister raised by 
liquefied mustard gas. He had no 
trouble recruiting volunteers; long 
before institutional review boards, we 
just walked in and rolled up our sleeves. 
Far more unpleasant, hazardous — 
and ultimately important to science — 
were the studies on conscientious 
objectors. Then as later there was a 
strong virology unit at Yale. Hepatitis 
A, then called catarrhal jaundice, was 
prevalent among the troops, and an 
outbreak of hepatitis B followed the 
introduction of a yellow fever vaccine. 
With transmission modes unknown, 
potentially infectious materials were 
administered to the volunteers through 
several routes. I don’t recall any deaths, 
but these young men who were often 
scorned because they were unwilling to 
“risk their livers” in war certainly risked 
them in another way. 
Charles A. Hall, M.D. ’44 
Veterans Affairs Medical Center 
Albany, New York 
Insurance Benefits 
To the editor: 
Though not a School of Medicine 
alumnus, I did graduate from another 
Yale professional school, and that 
occasionally brings me into contact 
with Yale Medicine. 
As a consultant to large employers 
regarding their employee health 
insurance benefits, I found the Spring 
1990 issue of Yale Medicine to be 
especially helpful. The question of solid 
organ transplantation is one of vital 
interest to the nation’s employers who 
are paying the bulk of the cost for these 
procedures. Gregory R. Huth’s 
interview with Dr. Levine regarding the 
ethical challenges of transplantation 
was well done and proved of interest to 
one of our clients who is considering 
whether or not her company should pay 
for certain types of solid organ 
transpkints. 
Keep up the good work and please 
understand that your impact extends 
well beyond the medical community. 
Tho.se of us in the health care financing 
area also profit from what we learn in 
Yale Medicine. 
Scott J. Fruchter, M.Div. '76 





To the editor: 
I read with interest and not a little 
disappointment the recent article by 
Susan Okula in the Spring 1990 Yale 
Medicine. While page 16 gave good 
general coverage to the fetal neural 
transplant program, it failed to reflect 
the singular efforts of the department of 
obstetrics and gynecology and Drs. 
Richard Robbins and Csaba Leranth, 
without whom the project would never 
have progressed. Of course, I know that 
this was an innocent error. It does not 
detract from my appreciation of the 
general excellence and style of the 
Bulletin. However, it is sad that those 
who have worked so hard on behalf of 
the program should have missed their 
chance to be included in this exposure 
to the Yale audience. 
Frederick Naftolin, M.D., D.Phil. 
Professor and Chairman, OBIGYN 
Yale School of Medicine 
Clarification 
In a photo caption on page 39 of the 
Summer 1990 Yale Medicine, 
Matthew F. Lopes Jr., M.P.H. ’77, was 
listed as director of the medical school’s 
Health Careers Opportunity Program 
(HCOP). More precisely, HCOP is a 
program of the department of 
epidemiology and public health. 
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THE CREATIVE LEAP 
hy Dr. Allen C. Steere, Post-doctoral fellow '75-’77 
Members of the Yale medical school Class of 1990, I have 
decided to speak today about artistic qualities in medicine, 
about the importance of intuitive, creative thinking, and about 
feeling and empathy for patients. We generally devote little 
time to thinking or teaching about such things, but 1 believe 
that they form an important framework for our lives in 
medicine. Besides, today is a day for reflection, and more 
importantly, a day of dreaming about what is to come, so it 
seems appropriate to think about and highlight the importance 
of intuitive thinking. 
Let me state emphatically that I am in no way 
downgrading the importance of science or the scientific 
method. This is an age of incredible, unbelievable scientific 
accomplishment of which we are all in awe. It still amazes me 
to think that DNA was described only in the 1950s. I was in 
high school. We are the first generation ever to know that the 
same four nucleic acids — adenine, thymidine, guanine and 
cytosine — code for all life fomis, for all the diversity around 
us. It is almost unfathomable how much this discovery has 
changed medicine and medical research in only 30 years. This 
is the molecular biologic revolution. It is an incredibly 
exciting time to be involved with the biologic sciences. 
However, it is important for us to recognize that intuitive 
thinking and dreaming, what 1 am calling today a part of the 
art of medicine, had to come first. There were people 
previously who knew or felt that all life was interrelated. 
Charles Darwin theorized that all life had evolved from the 
simplest to the most complex fomis. This kind of thinking had 
to come first and had to guide the scientific accomplishment. 
In the same way, dreaming about your future career in 
medicine, as we do today, has to come first, and these dreams 
will play a role in shaping your career. To say it in another 
way, both the right and left brain must work together to get a 
creative result; both creative and analytical thought are 
necessary. To say it more metaphorically, both masculine and 
teminine qualities are important in creativity; to have a baby, 
both a man and a women are necessary. Whether man or 
woman is more important is an absurd question. Neither can 
do it alone. 
Lessons from Ixodes dammini Ticks 
■As a way of illustrating these points, 1 would like to share 
with you a story about ticks. Back a few years ago, we were 
trying to find the agent of Lyme disease in ticks. Each 
summer. 1 hired two students, often from the forestry school, 
to collect ticks for study. 
On several occasions, to show solidarity, 1 went with them. 
I'lagging lor ticks involves dressing up in a white jump suit 
and dragging a blanket through the forest. On an average day, 
you may collect a couple of ticks per hour. It is one of the 
Dr. .Alien ( '. Steere. professor of medicine at Tufts Universitx 
Si hoot oj .Medicine, and chief, rheumatolot’ylimnuinoloyx at 
New T.n^land Medical Center, delivered the first School of 
MediiHie Class Day address on Max 27. This article is ati 
' lilted version of that address. 
more tedious things that I have done. However, the people 
that you are with make a big difference. I particularly enjoyed 
one student from the forestry school who had a tremendous 
respect and reverence for nature. Reuben spoke at length 
about how the entire system in the forest was delicately 
balanced and every life forni had its role. 
Well, what good are ticks, I thought. Andy Speilman, an 
entomologist at Harvard who is always a provocative thinker, 
has subsequently told me that the purpose of ticks is to keep 
the visitors out. The animals that have lived with the ticks for 
eons, like mice and deer, are completely tolerant to infection 
with the tick-transmitted spirochete that causes Lyme disease. 
These animals do not become sick when infected. In contrast, 
the strangers in the forest, the new predator or you and I, do 
become ill when exposed to the tick-transmitted spirochete. 
At the time, 1 had no such insight and instead thought 
about how ironic it was that my life’s journey had taken me 
down this road where my life had become inextricably linked 
with ticks, detestable creatures about which I had no previous 
interest whatsoever. I was trying to learn about and 
understand the complex life cycle of Ixodes dammini ticks. 
These insects feed only three times in their usual two-year 
life cycle. A larval tick climbs a blade of grass or a twig in the 
morning or evening during summer and waits for a host, 
preferably a mouse. If none comes by, the tick drops back 
down to the ground. This process is repeated over and over. 
Many larval ticks never find a suitable host and die. Others 
may find the wrong host, such as my blanket, and end up 
being dissected in the laboratory. 
However, if an appropriate animal brushes by, preferably a 
mouse, the tick leaps and attaches, sucking blood for three to 
four days. The tick then falls to the ground, so engorged that it 
is unable to move. The blood meal is then processed and 
eventually the tick molts to the next stage, a nymph. The next 
summer, the nymphal tick goes through this same process, 
and that fall, the adult ticks must go through the process 
again. While feeding as adults, the ticks mate, and then the 
male tick falls off and dies. The female tick falls to the 
ground, lays thousands of eggs and then dies. What a life, I 
thought. What a useless life. 
Then 1 realized to my amazement, to my horror, that my 
life was like that of the ticks. I suppose now you may be 
wondering what kind of life I’ve had. Let me tell you 
something about it. My DNA is lined up in such a way that I 
am very interested in music. Before medicine, I played the 
violin; I practiced hours each day. When it was time to go to 
college, I went to New York. I was a student at Columbia and 
took private lessons from Ivan Galamian, who was head of 
the violin department at Juilliard. Important qualities that 
were stressed included the communication of feeling through 
music, listening carefully, and practicing long hours in an 
attempt to refine and perfect one’s message. 
It is the same person who now does medical research on 
Lyme disease. 1 consider myself to be an artist within the 
scientific field of medical research. The feeling person in 
music has become the intuitive thinker and listener in my 
current life, and long hours of practicing violin have become 
the persistent effort over a period of years to determine 
whether one’s intuitive ideas are correct. 
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Pfizer Pharmaceuticals 
Tick Ixodes Dammini 
Let me explain more of what I mean by the intuitive, 
creative leap. One of the most famous examples of this sort of 
thinking was manifested by the observation of Sir Alexander 
Fleming, the father of the antibiotic age. You know the story. 
He noticed that bread mold, a fungus, which had fallen onto a 
culture plate, inhibited the growth of bacteria near the fungus. 
With this seemingly simple and obvious observation, he saw 
the world in a completely new way; he saw with clarity what 
others had not seen. As you know, this observation led to the 
development of penicillin, which remains the wonder drug of 
our century. 
Although creative leaps of genius are rare, all of us must 
make several creative leaps in the course of our lives. Such an 
event happened in my life several months after beginning a 
rheumatology fellowship at Yale in 1975. I learned of a 
cluster of children in Lyme, Connecticut, who were thought to 
have juvenile rheumatoid arthritis, a puzzling illness of 
unknown cause. Soon after beginning work on this problem, 
there was the intuitive realization that this illness was 
something new, something different, and that it was probably 
a tick-transmitted infection. 
Our thinking is often formed or at least influenced by 
listening to others and hearing what they have to say. In this 
particular case, it was two mothers from Lyme who brought 
this situation to my attention. Both suspected that the children 
with apparent juvenile rheumatoid arthritis had an infection 
because so many children that they knew were affected. 
Because of the tremendous explosion of ticks in the area, both 
had even wondered if ticks were transmitting the illness. 
Many subsequent experiences have reinforced for me that 
reasonable patients often have an intuitive sense of what is 
happening to them, and being able to listen and hear what 
they .say is an important part of the art of medicine. Even if 
we do not understand the disease process, the sense that you 
have listened, and stood with the patient, can influence the 
healing process. 
The Long Run 
Of course, if one stops here, one is left only with intuition, a 
guess, and empathy. It is here that science steps in to test the 
reality of the intuition, and to go, step by step, through the 
laborious process of determining whether the intuitive idea is 
correct. For me, the Yale medical school environment was a 
place where such work could flourish; I was fortunate to be in 
the fellowship program directed at that time by Dr. Stephen 
Malawista, who was a supportive mentor. 
Still, it often requires one's intuitive vision to help one stay 
the course through all of the negative experiments. Over the 
next several years, we were able to put together clinical and 
epidemiologic evidence that strongly implicated a particular 
Ixodes tick in transmitting the disease. We also learned that 
the illness responded to penicillin therapy, which suggested 
that a bacterial agent was the cause. However, all of our 
efforts to find an infectious agent in ticks were negative. 
The actual causative agent, a spirochete, was not found 
until seven years after the initial observation in Lyme, 
Connecticut. People have subsequently told me that seven 
years is no time at all to wait for a major breakthrough. And, 
as you may know, we were not the ones who made the 
breakthrough. We did not have the special expertise required; 
Willy Burgdorfer at the Rocky Mountain Laboratory did. 
Burgdorfer, an entomologist, had spent years dissecting ticks 
and working with a type of tick-transmitted spirochete called 
Borrelia. 
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Dr. Allen C. Steere, Postdoc ’75-’77: 
Lyme Disease Pioneer 
Before Dr. Allen C. Steere came to Yale in 1975 for a two- 
year post-doctoral fellowship in rheumatology, he had spent 
eight years in and around Columbia University gamering his 
undergraduate degree and medical education; a 1965 B.A. 
degree from Columbia College was followed by an M.D. 
degree in 1969 from the College of Physicians and Surgeons. 
The next four years featured internship and residency in 
medicine at St. Luke’s Hospital in New York City, including 
a year as chief resident in medicine. From 1973 to 1975, he 
served in Atlanta at the Centers for Disease Control as an 
epidemiologist for the U.S. Public Health Service. 
It was Dr. Steere’s subsequent work at Yale, however, that 
established him as one the nation’s preeminent medical 
researchers. As a fellow in the rheumatology program then 
directed by Dr. Stephen E. Malawista, professor of medicine, 
Dr. Steere played a leading role on the team of biomedical 
.scientists that identified Lyme disease. The researchers did so 
by studying a group of children from Lyme, Connecticut, who 
had arthritis. With the help of colleagues at the department of 
epidemiology and public health, the researchers also 
implicated the tick Ixodes dammini as the Lyme disease 
vector. 
Dr. Steere continued his investigations into the disease as 
an assistant and associate professor at the medical school 
from 1977 to 1987. His contributions to the study and 
treatment of Lyme di.sea.se have won him numerous citations 
and awards, including the Ciba-Geiga Rheumatology Prize, 
which he shared with Dr. Malawista in 1985. Most recently, 
he received the Zucker Prize from Tufts University School of 
Medicine, where he has served since 1987 as professor of 
medicine and chief, rheumatology/immunology at New 
England Medical Center. 
.•\t times, it was difficult for him to get support for this 
work since its purpose seemed obscure. But then the day 
came for his creative leap, the day when his special expertise 
allowed him to see what no one else had seen, a previously 
unrccogni/ed spirochete, now called Bonelia burgdorferi, in 
the midgut of an Ixodes daniniini tick. My role, as it turned 
out. was to help articulate a vision that this tick carried an 
infectious agent which caused Lyme disease. To articulate a 
vision is one of the roles of the artist in medical research or in 
any other field. 
.So how is my life like the ticks? While they climb a blade 
of grass each day, I come to work, take out my papers, or set 
up my test tubes, or perhaps even drag a blanket through the 
lorest. At the end of the average day, I clo.se up and go home; 
nothing too enlightening has happened. However, at the 
appropriate time, a time of searching, I must be poised and 
reatly for the intuitive leap. 
< >ne cannot decide to make a scientific discovery any more 
than a tick can make a mouse come by its blade of grass. 
Rather, wc- must dream about what we want first, prepare 
I'urselves lor those dreams, position ourselves appropriately, 
and wait, rtien. when the opportunity presents itself, we must 
lake .an mtuitise leap, just as the tick leaps to its host, ’fhough 
do not know at the time where our leaps will take us, a 
Dr. Allen C. Steere 
successful intuitive leap will introduce us to new realms that 
will make possible the next stage of our lives. 
You are about to enter into a new period in your life. For 
most of you, the demanding years of internship and residency 
training will still be a period of putting in place the 
knowledge that will allow you to make creative leaps in 
medicine. Some of you will make important scientific 
discoveries; some of you will be exceptional healers; some of 
you will be gifted leaders; and some of you will be 
extraordinary teachers. We know that all of you have been 
given exceptional talents and abilities, and therefore you will 
have much to give in these roles. 
Along the way, it is likely that you, like the ticks, will take 
several creative leaps which will take you into new realms 
that are difficult to imagine today. You will see incredible 
new discoveries and treatments, and because of this, learning 
will be a part of your everyday life. As graduating medical 
students, you carry our hopes and aspirations for progress in 
medicine and for making this a better world. You are both the 
greatest resource of the Yale School of Medicine and its most 
important accomplishment. Congratulations and may God 
bless you in your journey and give you courage in your 
creative leaps. YM 
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PUBLIC POLICY IN THE AGE OF AIDS 
by Stephen C. Joseph, M.D. ’63, M.P.H. 
All major public health issues have significant social and 
political parameters. AIDS represents the first major public 
health issue, at least in modem times, in which the political 
and social contexts have been defined (one might even say 
“fixed”) before the critical elements of clinical and 
biomedical knowledge were available. “And that,” as the poet 
said, “has made all the difference.” 
All through this first decade of the epidemic, we have been 
playing catch-up defense: charting the epidemic by cases of 
illness rather than by rates of infection — working with a 
snapshot in time, five years or more delayed. Thus, we have 
been identifying new risk groups and foci of infection years 
too late to be able to cut the virus off before it gained a solid 
foothold. 
The human immunodeficiency virus is extraordinarily 
well-adapted for survival; its epidemic will smolder on for 
decades even after the explosive outbreaks of the 1980s and 
early 1990s are behind us. Transmitted by sexual, blood- 
borne, or materno-fetal routes, the virus turns the DNA of 
infected cells into factories to produce more virus. 
In adults, it then, with no specific clinical signs at the time 
of infection, enters a long (usually three-to-five year) period 
of clinical latency. During the months of the so-called 
“window period” between infection and first appearance of 
HIV-antibodies, no currently applicable technology can 
diagnose the infected individual. 
Once infected, a person becomes infectious to others and 
remains so for life. With a median time from infection to full¬ 
blown AIDS of some eight-to-10 years, and a post-diagnosis 
survival period of more than two years, that leaves a very long 
interval for continued transmission and infection of others. 
Moreover, with rapid advances in treating opportunistic 
infections and palliating viral replication, it may soon be 
possible to characterize AIDS as a “chronic treatable disease, 
though incurable.” 
In New York City, we have had approximately 26,000 
cases of AIDS to date as defined by the Centers for Disease 
Control (CDC). An estimated three-to-four times that many 
people are affected by HIV-related illness, and some 200,000 
persons in the city are infected with the virus. 
To understand where the epidemic is going, and what 
would constitute appropriate public policy to combat it, one 
needs to look at three major trends that constitute the present 
and future course of the epidemic in New York. These trends 
will also be increasingly reflected nationwide, especially in 
the other cities of high-prevalence HIV infection. 
The Imploding Epidemic 
The first trend is what I call the “Great Epidemiologic Shift.” 
AIDS is increasingly a family, neighborhood, poverty, 
minority, drug-abuse associated epidemic. In 1988, the 
This article was adapted from an address, “Public Health and 
Public Policy in the Age of AIDS," which Dr. Joseph 
delivered at Medical Alumni Weekend on Friday, June 8. 
number of newly diagnosed AIDS cases in New York among 
intravenous drug users surpassed cases newly diagnosed 
among men who have sex with men. Substance abusers 
continue to account for an increasing proportion of HIV 
transmission, to each other through the use of contaminated 
injection equipment, and to their sexual partners and unborn 
children through heterosexual transmission. 
Women, who comprised less than 11 percent of AIDS 
cases in New York during the first five years of the epidemic, 
now account for over 15 percent of the cases occurring 
annually; we expect this to rise to 20 percent in the next year 
or two. Two-thirds of these women have been infected by 
their own drug use. But increasingly, heterosexual 
transmission from an infected drug-using sex partner is the 
route of infection to non-drug injecting women. Often these 
women are unaware of the risk posed by current or past 
partners. 
We have had almost 3,500 cases of AIDS among females 
in New York City, and there is little doubt that there are 
thousands of asymptomatic infected women and women in 
early stages of clinical immuno-incompetence as yet 
undiagnosed. State health department surveys have shown 
that one in 61 women giving birth in New York City is HIV- 
infected, compared to one in 489 in the rest of the state. 
The association with drug abuse has meant that AIDS is 
increasingly concentrated in minority and poverty 
populations, and this trend is accentuated as drug use becomes 
a gateway to heterosexual transmission. Of the more than 600 
cases of children with AIDS diagnosed in New York, over 90 
percent have been black or Hispanic. In short, the epidemic is 
not “exploding” across the entire landscape; there is no reason 
to predict the formerly feared “heterosexual break-out” in 
epidemic proportions across white middle-class America. 
Rather, the virus is imploding, in poverty and minority 
neighborhoods, where rates of intravenous transmission have 
been high and unmodified since the beginning of the 
epidemic, and where heterosexual transmission is 
accelerating. These localized pockets of high endemicity are 
the future of the epidemic, as the virus adds to the burdens of 
social and health problems — not to mention the 
discrimination — that these poverty and minority 
communities already bear. 
A recent CDC study showed at one sentinel hospital in the 
Bronx, almost one in four emergency room patients are HIV- 
infected, the great majority unaware of their infection. It is 
reasonable to assume that in some parts of New York City, 
five-to-10 percent of childbearing-age women are currently 
infected. 
Intravenous drug use has been the common denominator of 
this penetration of the virus into poverty and minority 
communities, but it is no longer the only drug-AIDS 
connection. Increasingly, the crack epidemic is a powerful 
channel for the virus. The reasons are multiple: 
• the increase in cocaine injectors, who “shoot up” more 
frequently and share more needles than heroin injectors; 
• the hypersexual behavior associated with cocaine, and 
especially crack addiction; 
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• the vast increase in sex-for-drugs transactions among 
crack-addicted women; 
• the greater proportion of women and young persons in 
general addicted to crack as compared to heroin; 
• the phenomenon of the “crack house,” which plays a 
role in rapid multiple partner transmission comparable 
to the gay bath house/sex club and the heroin shooting 
gallery; 
• the very probable association of sexually transmitted 
diseases, especially genital ulcer disease, with 
potentiation of HIV transmission. 
The incidence of primary and .secondary syphilis doubled 
in New York between 1988 and 1989, and more new cases 
were reported among women than among men, a distinctly 
unusual trend. In a recent study of men attending a sexually 
transmitted disease clinic in the Bronx, all of whom were 
heavy crack users, and all of whom denied intravenous drug 
injection and sex with other men, 30 percent tested HIV 
positive. 
Among gay men in New York and San Francisco, where 
educational levels are high and where outstanding community 
action and rnobili/ation took place, risk-avoiding behavior 
was mirrored by rates of decrease in sexually transmitted 
diseases and reduced rates of new HIV infections. By 
contrast, there is little rea.son to hope that similar phenomena 
will take place in the “imploding” communities. Both 
minority leadership and the rank-and-file have to date been 
more notably focused on denying the problem rather than on 
rnobili/ing against it, though this has started to change, 
especially in New York's black community. 
Kducational efforts and other preventive programs aimed at 
drug injectors have shown no outstanding success. Infection 
rates among intravenous drug users in New York City are 
reliably estimated at between 50 and 60 percent, much higher 
if one focuses on those who frequent the shooting galleries, 
and are probably reaching functional saturation. And 
increasingly, onwards hetero.sexual transmission to black and 
Hispanic women and their children cannot be predicted by the 
standard categories of risk groups or risk behavior; The virus 
has dived below the surface of our scanning categories. 
Palliation, Not Cure 
The second major trend of critical importance to the future of 
the epidemic is the rapidly broadening treatment horizon, 
riiough v\e can offer neither a long-term effective 
chemotherapeutic agent nor chemoprophylaxis, we can 
palliate with anti-virals on a rapidly increasing scale. 
Our ability to combat the sequelae of immunodeficiency 
— the opportunistic and other infections — has increased 
even more dramatically, and here we already have solid 
instances of chemoprophylaxis that can bring proven survival 
benetits to asymptomatic and early-stage HIV-ill patients as 
well as to those with categorical AIDS. 
I hese advances, extraordinary as to how much has been 
learned ami applied to a new disease process in less than a 
decade, have important itnplications for patient care, for 
^iirvi\al and quality of life. They also have daunting 
implications tor access, availability atid costs of tnedical care. 
But I wisli to locus here oti their implications for public health 
pi'lies. 
N"v., lur the first time, early identification of the HIV- 
■ ' . i individual is in the clear best interests of that 
individual, as well as in the interests of society. Medical 
benefits of early identification of the asymptomatic individual 
mean that greatly expanded efforts need to be placed upon 
identifying and alerting that individual, and on making 
accessible an appropriate system of care. There is no longer 
any credibility to the old argument, “Why be tested? They 
can’t do anything about it anyway....” Nor can it be said that 
widespread antibody testing would serve more as a tool of 
social repression than of public health and individual 
protection. 
I predict that history will view our collective failure to use 
the HIV-antibody test more vigorously as one of the major 
missed opportunities of the AIDS tragedy. We have displayed 
an unwillingness to rapidly expand counseling and testing. 
We have not matched the technical power of the testing 
instrument with strong protective legislation and practice to 
preserve voluntary consent and confidentiality. 
Thus, we have lost an opportunity to develop timely 
understanding of the patterns of infection within populations; 
neither have we developed effective systems of partner 
notification that would have warned many thousands of 
unsuspecting partners-at-risk. As a result, we have failed in 
our medical responsibilities to provide asymptomatic infected 
individuals with early access to clinical support and, 
increasingly, effective disease management. 
The strident politics of AIDS has led to a view of the 
antibody test as a “necessary evil” only to be employed within 
the narrowest of conditions, rather than as a significant public 
health tool. With careful safeguards against potential abuse, 
wider use of this test could have given us a much more 
effective approach to both the prevention and treatment 
dilemmas of the epidemic. 
Strident Voices 
The third major trend, along with the epidemiologic shift and 
the broadening treatment horizon, has been the growth of the 
politics of conflict. AIDS, being about sex and about drugs, is 
impossible to address without engendering controversy and 
social conflict. 
From the earliest issues of homophobia and stigmatism, 
through the current bitter struggle over providing clean 
needles and syringes to drug addicts, the history of the 
epidemic has been one of harsh criticism and counter¬ 
criticism, of conflicts over social policy that sometimes led to 
threats and violence. The politics of sexual and racial conflict 
have influenced, and at times dominated, the scientific as well 
as the social response to the epidemic. 
More recently, the rise of militant AIDS activism, 
especially on the part of gay advocacy groups such as ACT- 
UP, has taken the controversies over public health policy, the 
availability of care, and the appropriate course of drug 
research, development and distribution to new heights of 
visibility — and to new depths of rancor. 
In the early years of the epidemic, most of the threats to 
reasoned debate and unbiased development of public health 
policy came from the right. Conservative religious and 
political groups sought to bar explicit health education, 
condom availability and needle exchange. These days, the 
clamor comes more from the left, as protesters demand that 
only their perspective be considered, and that something, 
everything, be done immediately, successfully, and no matter 
what the feasibility, cost or competing priority. 
My chief concern is that both the scientific community and 
the public will grow tired of the shrill demands, and move on 
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Dr. Stephen C. Joseph, ^63: 
Battling the Dragon 
Before assuming the office of New York City Commissioner 
of Health in 1986, Dr. Stephen C. Joseph’s public health 
career had taken him around the world, from the developing 
nations of Nepal and Cameroon to the wilds of Wyoming and 
Newfoundland. 
A New York City native. Dr. Joseph earned his degree 
from Harvard before entering the School of Medicine in 
1959. He received an M.P.H. degree from the Johns Hopkins 
University in 1968, and did his internship and residency in 
pediatrics at Boston Children’s Hospital. 
He was the special coordinator for Child Health and 
Survival for the United Nations Children’s Fund (UNICEF) 
in New York from 1983 until 1986. During a five-year term 
as a commissioned officer in the U.S. Public Health Service 
in the mid-1960s, he served as a Peace Corps physician in 
Nepal. 
Dr. Joseph has worked at the Children’s Hospital Center of 
the District of Columbia and was chief of pediatrics at 
Grenfell Regional Health Services in Newfoundland. He has 
taught at Harvard University, the University for Health 
Sciences in Cameroon and Memorial University of 
Newfoundland. He prepared a plan for a community-based 
medical school for the University of Wyoming. 
During two stints with the Agency for International 
Development, Dr. Joseph worked in Cameroon helping 
establish a medical school and in Washington, D.C., 
overseeing health, population and education programs. He 
has also served as special assistant to the assistant secretary 
for health and scientific affairs of the U.S. Department of 
Health, Education and Welfare and as director of the 
Neighborhood Health Centers Program of the Office of 
Economic Opportunity. 
to other concerns, leaving us less with which to combat the 
very real and growing needs of the epidemic than we might 
otherwise have had. To scream “genocide” at the Centers for 
Disease Control or the National Institutes of Health, the only 
two federal agencies that have met their responsibilities — 
and met them with excellence in this epidemic — is not likely 
to generate additional political, scientific, medical or popular 
support. 
It would be foolish to think that the politics of conflict will 
lessen as we move into the second decade of the epidemic. 
We are witnessing a tightening knot composed of a worsening 
fiscal situation and a rapidly expanding need for ever more 
expensive care. 
The increasingly ugly racial climate of the 1990s and the 
epidemiologic shift of AIDS will exacerbate each other. Our 
best measures as health professionals for meeting these 
conflicts will be the ones that have always served us well: 
working from our best current data, not being afraid to change 
our positions as the data give us new insights; providing the 
public with a full and honest account of what the science 
reveals, not being afraid to convey either bad news or good; 
and seeking a balance between the rights of the individual and 
the protection of society. 
Dr. Joseph is a member of the Institute of Medicine, a 
fellow and former chairman of the executive board of the 
American Public Health Association, and a fellow of the 
American Academy of Pediatrics. 
Currently, he is writing a book about his experiences 
confronting the AIDS epidemic while New York City’s top 
health official from 1986 until 1990. The working title is 
Dragon Within the Gates: The Once and Future AIDS 
Epidemic. 
Dr. Stephen C. Joseph 
New Initiatives 
As the great epidemiologic shift, the broadening therapeutic 
horizon and the politics of conflict form the future of the 
epidemic, how should public policy respond? Let me suggest 
an outline of four principles: 
• continued maximal efforts in biomedical and socio¬ 
medical research; 
• rapid expansion of clinical and social services; 
• a serious approach to the national drug abuse epidemic; 
and 
• a mobilization of effective public health action. 
I can’t imagine that anyone can be found who is opposed 
to continued investment at the highest feasible level in HIV 
biomedical research. Since HIV infection represents the 
convergence of two critical facets of contemporary 
biomedicine, immunology and virology, the long-term 
benefits of AIDS research will include an immense payoff for 
a wide spectrum of diseases. 
We have been fortunate in one sense; Had the AIDS 
epidemic burst upon us even a decade earlier, we would not 
have possessed the basic tools with which to define and study 
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the virus as we have. Nevertheless, we have barely tapped the 
knowledge we need to gain from AIDS regarding the 
behavioral, social and cultural aspects of epidemic infectious 
disease. 
The critical importance of both areas, biomedical and 
sociomedical research, transcends this epidemic, for if AIDS 
has taught us anything, it should be that we are not, as we had 
mistakenly thought, immune from mass infectious disease. 
There will be a next time, and perhaps this next virus to come 
out of the forest and catch hold will be one that is more 
casually transmissible. 
With regard to expanding clinical and social services for 
people with MIV illness, there is an urgent need for a federal 
strategy to support high-prevalence areas. New York City is 
spending more than $400 million dollars annually on the 
epidemic, half of that from the city tax levy. Over the first 
five years of this decade the direct costs of the epidemic in the 
city will be $7 billion, and we cannot continue to bear so 
much of the costs with only moderate state support. The same 
phenomenon is occurring in San Francisco and in other high- 
prevalence areas. 
There are many more service delivery issues that are not 
being adequately addressed, too many to mention here. The 
major problems in HIV clinical care are the same as those that 
plague our entire health care system: access, equity, quality 
and quality assurance, evaluation and cost. It may just be that 
if we find .some roads to improvement with AIDS, we may 
find some answers applicable on a wider scale. 
fhere will be no effective prevention of AIDS until or 
unless we solve the primary problems of the substance abuse 
epidemic. Our prevention and treatment efforts to date, 
beyond sloganeering, have been half-hearted, our law 
enforcement efforts have been inadequate. Clearly neither 
approach by itself provides the answer. 
We need much broader sanctions on the enforcement side, 
especially measures that will provide a credible deterrent to 
street dealers. Only this will provide a buffer within which 
vastly expanded education and treatment can work. We need 
to understand much more about why people use drugs, and 
especially about the pharmacology and sociology of what is 
clearly the future of drug abuse: smokable purified 
derivatives, of which crack is only the harbinger. 
Instead of decriminalizing hard drugs, we need to 
effectively criminalize the supply side with harsh and 
believable sanctions, while at the same time providing 
preventive education and accessible treatment. All this will be 
incredibly expensive on a national .scale, perhaps $4 billion a 
year on education and treatment, perhaps another billion or 
more annually for research — and who can estimate? — $10 
billion or more in military, local law enforcement. Judicial 
and corrections systems costs. 
Are we willing to pay for it? Tm not optimistic, but I can 
see no order-of-magnitude progress on either epidemic front 
without that kind of commitment. 
Public Health Planning 
I w'ant to close by focusing briefly on specific public health 
initiatives that are necessary at this stage of the epidemic, and 
that have so far not been adequately taken in New York or 
■ ■F.lw here, 
Thr first has to do with providing clean injection 
equip; i‘ III to intravenous drug users. It is in my view 
' ■ ’ ..ble that w'c would withhold this measure on the 
r: and unproven platitudes of “encouraging drug 
I'ding mixed messages." These same tired 
arguments have been used to oppose family planning — with 
just as little supporting data. 
On the contrary, the data, including those from our own 
constrained program in New York, all point to the same 
conclusion: no evidence of harm and many indicators of 
benefit. This is one of the very few direct measures of primary 
prevention we can take to slow HIV transmission, not only 
among intravenous drug users, but also to their (largely 
female and largely minority) sexual partners and children. 
Simply changing state laws to permit needle possession 
without prescription is not enough. Proactive public health 
programs of needle exchange should be vigorously 
undertaken so that other prevention and treatment initiatives 
can be coupled with them. 
We must have many-fold expansion of counseling and 
HIV antibody testing programs, with voluntary confidential 
testing available and aggressively pursued at every clinical 
point of contact. Anonymous testing must be preserved as an 
option for those who will refuse under any other 
circumstances, but voluntary confidential testing in a medical 
and health service context is the key to massive expansion. 
Even in New York City, where the resistance to testing has 
been greatest, and where we have opened eight city-funded 
and -operated anonymous counseling and testing sites, the 
volume of confidential testing outweighs anonymous testing 
by more than two to one. Expanded testing must, of course, be 
buttressed by strong legal protection of confidentiality and 
anti-discrimination measures, as well as by maximal efforts to 
expand services. 
More extensive efforts in contact tracing and partner 
notification are essential, especially now that the virus has 
“submerged” in minority communities and risk cannot be 
correlated with traditional risk groups. Obviously, partner 
notification must remain voluntary and be focused where it 
will be most effective. Arguments that “tracing everyone’s 
sex partners for the past 10 years would be expensive and 
futile” are spurious diversions from what is both a medical 
and a public health obligation: the duty to warn where 
possible the unsuspecting person of the risk of a fatal and 
sexually transmissible disease. 
The effective implementation of both expanded testing and 
partner notification requires that all states should have 
mandatory confidential public health reporting of HIV 
infection. Physicians and hospitals should be required to 
report, under strict conditions of confidentiality, the names of 
infected persons, as is currently the case in 32 (mostly low- 
prevalence) states. 
We have an excellent record in public health of using this 
kind of information well and sensitively. In New York City, 
where AIDS but not HIV infection has been reportable since 
the beginning of the epidemic, we now have a list of 26,000 
names which has been invaluable in tracking the epidemic. 
Guarded with the utmost care, there has never been a leak 
from this list, even when we were threatened with legal 
action. 
Particularly because of the epidemiologic shift and the 
broadening therapeutic horizon, there is an urgent need now 
to employ the traditional tools of prevention and disease 
control. The hour is late, and the largest opportunities for 
stopping transmission are long behind us. But there is much 
that we can still salvage for the welfare of individuals at risk, 
for those already infected and for the welfare of the entire 
community. I believe that future generations of medicine and 
public health will look back with a measure of contempt for 
tho.se who understood this equation but failed to act. YM 
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EPH CELEBRATES 
ITS FIRST 75 YEARS 
Photos bv Harry Bishop 
by Gregory R. Hath, M.P.H. ’84 ^ 
I 
In the winter of 1915, as the cannons of 
World War I roared an ocean away, a little 
known singer named A1 Jolson faced a far 
friendlier din in downtown New Haven. 
Applause thundered in Jolson’s ears as he 
concluded his performance in “Sinbad,” a 
musical at the newly opened Shubert 
Theater. In that same city, 1915 would 
prove auspicious for another young man 
who would touch many lives — though in a 
field that would offer far less fame, fortune 
and applause — Charles-Edward Amory 
Winslow, one of the first biomedical 
scientists with training in public health. 
Winslow had earned his M.S. degree 
from M.I.T., where he had been a student, 
and later a colleague, of William T. 
Sedgwick. Sedgwick, 1877S, had left a 
teaching position at Yale Medical School to 
found the nation’s first department of public 
health at M.I.T. C.-E.A. Winslow, bearing 
the torch that his mentor had lighted, was 
bringing it to Yale, inaugurating a 
professorship in public health endowed by 
the estate of Anna M.R. Lauder, an heiress 
to the Andrew Carnegie fortune. Thus 
Yale’s department of public health was bom. 
Three-quarters of century later, the 
department, known as epidemiology and 
public health (EPH) since 1960, has 
emerged from a recent time of uncertainty. 
This period ended in the summer of 1989, when a University 
committee headed by Provost Frank M. Turner affirmed 
Yale’s commitment to the program, while recommending 
some key changes. University President Benno C. Schmidt Jr. 
and medical school Dean Leon E. Rosenberg endorsed the 
Turner report without amendment. 
At that time, the dean commented, “Our country must see a 
closer bond forged between those scientists, educators, care 
givers and administrators concerned with the health of groups 
and those concerned with the health of individuals.’’ He 
added, “The ties between our School of Medicine and its 
department of public health must be stronger. I will do all I 
can to see that Yale’s educational, service and research 
activities aimed at improving the health of the public will 
continue to be strengthened.” 
This support, along with the take-charge style of the 
department’s new chairman and associate dean. Burton H. 
Singer, Ph.D., has helped renew EPH’s sense of purpose. 
Gregory R. Huth is publications editor at the Yale University 
School of Medicine Office of Public Information. 
\ 
Comments today’s Lauder professor, 22-year faculty member 
Adrian M. Ostfeld, M.D.: “A feeling of optimism has arisen 
in this department since the Turner report was released, and 
much of that feeling is directly attributable to Burt Singer’s 
leadership.” 
After only a year with Dr. Singer at the helm, the results go 
far beyond boosting faculty and staff morale. For example, 
the incoming M.P.H. Class of 1992 comprises 66 students, a 
third smaller than previous classes due to tighter screening of 
applicants. And these students have begun the fall semester 
challenged by a new, more rigorous curriculum. 
In one way, EPH’s renaissance represents the department’s 
coming full circle, a return to its founder’s emphasis on how 
medicine and public health must work together. Even as 
Winslow required the department’s first public health students 
to study biochemistry, he also taught medical students about 
the public health perspective. Similarly, this year’s incoming 
M.P.H. students will be encouraged (and next year’s class 
required) to take a course covering the basic ideas of 
molecular biology and its implications for epidemiology and 
health policy. In addition, more classes will be offered jointly 
between the medical school and EPH. 
) 
1 
Dr. Burton H. Singer 
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Taking this a step further. Dr. Singer has begun to build 
bridges between his department and those with a primary 
focus other than health care, especially Yale’s forestry and 
law schools. In addition to fostering ties with other fields and 
modernizing the curriculum, the plan to strengthen EPH 
includes: 
• recruiting eight more faculty members, in accordance 
with the Turner report; 
• bolstering the environmental health division by 
recruiting some of these full-time faculty members for 
primary appointment with the division; 
• putting a greater emphasis on international health; 
• repairing and modernizing the Laboratory of 
Epidemiology and Public Health (LEPH), the 
department’s headquarters and primary research facility. 
Toward a 21st-century M.P.H. Curriculum 
EPH was undergoing a thorough self-examination even as the 
Turner committee convened. In July 1989, as the provost’s 
committee concluded its work, an EPH faculty and staff 
committee also issued a report, about how to strengthen the 
M.P.H. curriculum. This panel was chaired by Michael B. 
Bracken. M.P.H., Ph.D., professor of research in 
epidemiology and obstetrics and gynecology. 
Perhaps the most dramatic changes to grow out of the 
Bracken report have to do with the “core curriculum,” the 
series of lectures and discussions designed to provide M.P.H. 
students with an overview of the most serious public health 
problems — and w ith approaches for dealing with them. Until 
this year, lectures would feature faculty members from each 
division giving one or more presentations as part of a single, 
massive overview course. 
/ ’; \//i htif! H Hrnckcn 
Observes Dr. Singer: “We came to the conclusion that by 
attempting to offer so much breadth, we erred on the side of 
not offering enough depth.” 
To remedy the situation, key faculty from each division 
have been more involved in planning and teaching core 
courses than ever before. Just as importantly, the format of the 
courses has changed, with each now taught as a discrete, 
separately graded class, or module, lasting several weeks, 
similar to medical students’ rotations. Reflecting the increased 
rigor of the courses and the addition of a second required 
biostatistics course, credit for the core curriculum has been 
increased by several credit hours, to a total of 30. 
The final three semesters of the master’s core program 
resemble those of previous years. The community project is 
still required in the second .semester, and the praxis (renamed 
“internship”) and master’s essay (now called the “master’s 
thesis”) round out the third and fourth semesters, along with 
divisional requirements and electives. 
Eor many M.P.H. graduates, the most intriguing core 
curriculum addition may be the new course, “Concepts of 
Molecular Biology in Public Health.” What does the 
submicroscopic focus of molecular biology have to offer 
tomorrow’s public health professionals? 
Dr. Singer replies: “The tools of tomorrow’s epidemiology 
will be molecular diagnostic tools. These will serve as a kind 
of early warning system, making it possible to assess who is 
susceptible to the onset of any number of chronic diseases. If 
our students are unfamiliar with these technologies, they will 
be basically illiterate as public health professionals.” 
His words echo those of the Bracken report: “The 
development of AIDS policy cannot be understood without an 
appreciation of the molecular behavior and microbiology of 
the virus, or the epidemiology of viral transmission. Similarly, 
the impact of genetic engineering, DNA probes and other new 
technologies on the health care system cannot be assessed 
without understanding [these] fundamental concepts.” 
Hands-on Education Continues 
Dr. Bracken’s committee strongly endorsed the community 
project requirement in which teams of students undertake 
health care research and evaluation projects for a wide range 
of organizations, most of them within the state. The 
community project concept represents one of EPH’s great 
contributions to the training of public health professionals in 
this country. Pioneered at Yale in the 1950s by the late Ira 
Hiscock, M.P.H., community projects have received national 
recognition for combining community service, practical 
experience and the application of academic techniques. [See 
“Community Projects at Yale: Central to an M.P.H. 
Education.”] 
Yet even this part of the core program has undergone fine 
tuning: 
• Like all parts of the master’s program, community 
projects are now overseen by Lorraine V. Klerman, 
Dr.P.H., professor of public health, in her new role as 
M.P.H. program director. 
• After the traditional review process by faculty and 
students, final review of projects will be made by the 
newly fonned EPH curriculum committee. 
• Each project will involve smaller groups of students — 
numbering four or five. In recent years, some projects 
included up to seven students. 
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Community Projects at Yale: 
Central to an M.P.H. Education 
By offering students hands-on experience in doing research 
and evaluation for health care and social service 
organizations, community projects have played a major role 
in the M.P.H. program for more than 40 years. Community 
projects are among the most acclaimed facets of the M.P.H. 
curriculum at Yale. In fact, a recent report on graduate level 
public health education by the National Academy of Sciences’ 
Institute of Medicine cited EPH’s community projects as a 
model. 
Since 1980, community projects have been coordinated by 
Elaine Anderson, M.P.H. ’76, director of the EPH resource 
center. She can present a litany of projects that have had a 
lasting impact locally, some even nationally. For instance, a 
1974 community project focused on the dangers of second¬ 
hand smoking to non-smokers. It resulted in the commuter 
railroad between New Haven and New York limiting smoking 
passengers to designated cars. This set a national precedent 
that helped launch the increasingly successful movement to 
ban smoking on public transportation. 
• Projects will be graded with a full range of grades and 
not on a pass/fail basis as in recent years. 
• Public and non-profit sector projects will be encouraged 
even more strongly than in the past. 
The Bracken committee also made suggestions regarding 
the final two requirements of the core program, now known as 
the internship and the master’s thesis. Like the community 
project, the internship allows students to gain work or 
research experience in their area of interest. The internship, 
however, involves the placement of a single student in a 
sponsoring organization that may be located locally or 
anywhere in the world. 
In the past, students were encouraged to begin their praxis 
in the summer after their first year and if possible to continue 
their work through the third semester. The department even 
offered the incentive of up to 13 or 14 extra credits for some 
praxis experiences. 
The rationale behind encouraging an extended praxis was 
dual: The added experience one gained from a longer 
placement, the thinking went, would make the praxis more 
valuable as a job reference. An extended placement might 
also increase the chances for students finding full-time work 
at their sponsoring agency after graduation. 
Now the emphasis has shifted to maximizing M.P.H. 
students’ exposure to Yale’s academic resources during their 
concentrated, two-year training period. Comments Dr. 
Bracken, “While the internship is very important, this 
experience does not make up for the knowledge students gain 
in their third semester courses.” 
Beginning this year, students are being encouraged to 
pursue internship placements that last only the summer. As 
part of this revised approach, one of the incentives for 
undertaking an extended internship has been removed; a 
maximum three credit hours can be accrued for the internship. 
Moreover, to increase the opportunities for students 
looking for experience using statistics, epidemiology and data 
management, faculty members who are pursuing research that 
A more recent community project conducted a survey of 
New Haven neighborhoods in an effort to help the Hill Health 
Center plan for expanding its services; another provided the 
city of West Haven with data about infant mortality rates in 
various neighborhoods. An evaluation of the LIFESTAR 
emergency services program of Hartford Hospital helped 
administrators decide to continue the program, which they 
had considered closing. And this year a team of M.P.H. 
students will continue a project that is assisting New Haven 
department of health Director William P. Quinn, M.P.H. ’75, 
determine how well the city is meeting its health goals for the 
year 2000. 
Almost every year some of the written reports that 
conclude community projects lead to articles that are 
published in scholarly journals. Such was the case of a recent 
project that documented the misconceptions many 
Connecticut secondary school school students hold regarding 
transmission of the AIDS virus. This project, advised by 
Steven D. Helgerson, M.D., M.P.H., a former faculty 
member, was published in the journal Pediatrics, and was 
presented at the 1990 national meeting of the American 
Public Health Association in Washington, D.C. 
involves these disciplines are being asked to consider 
sponsoring an internship. 
Rounding out its review of the core program for the 
M.P.H. degree, the Bracken committee strongly endorsed 
continuing the master’s thesis requirement. As before, two 
readers will review each thesis, with one reader coming from 
a division other than the student’s concentration. 
In addition to these core program changes, beginning this 
year, M.P.H. candidates will be given the opportunity to 
graduate with honors. Students will be so rewarded if they 
receive an honors grade from both their readers on the 
master’s essay and if their course work ranks within the top 
20 percent of their class. 
Faculty Mobilizes 
EPH’s reorganization will have a marked effect on the 
department’s faculty, as well. To start. Chairman Singer 
expects that the eight additional faculty members called for in 
the Turner report should be in place within five years. 
Currently EPH is recruiting for two professors at the 
assistant or associate level in health economics and in 
outcome and technology assessment. Another two junior 
faculty members will be hired to bolster environmental health, 
and soon the department will begin a search for a senior 
person to serve as this division’s director. 
Finally, EPH has advertised for a senior level faculty 
person for the Harold H. Hines Jr. Professor of Health Care 
Management, a position that is moving to the department 
from the School of Organization and Management (SOM). 
(The professorship is filled alternately by the YSM and SOM.) 
The promise of reinforcements, however, has not kept the 
work load of many current faculty members from 
intensifying. Dr. Singer has undertaken the EPH 
reorganization in close consultation with the faculty; this has 
translated into hundreds of hours spent on myriad committees. 
Moreover, institution of the core course modules has 
demanded more teaching time. 
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Dr. Lorraine \ '. Klernian 
Neither is this heightened faculty involvement a temporary 
state of affairs. Take for example the new M.P.H. curriculum 
committee chaired by Dr. Lorraine V. Klemian. She leads the 
committee by virtue of her role as director of the M.P.H. 
program, a newly created position assumed in addition to her 
other responsibilities. 
Other committee members include eight lead faculty from 
the core courses, the community project coordinator and a 
member each from the M.P.H. admissions and academic 
progress committees; three second-year M.P.H. candidates 
will represent students. 
.‘\ look at the steering committee charged with 
strengthening the environmental health division illustrates 
how liPH is working closer with other departments and Yale 
protessional schools. In fact, the steering committee is led by 
someone from outside the medical school, Garry D. Brewer, 
Ph.I)., a professor with joint appointments at SOM and the 
forestry school. 
('ommittee member Dr. Mark R. Cullen, associate 
prolessor ol medicine and epidemiology, points out that “in 
aildition to recruiting new faculty members and a division 
head, we have been charged with strengthening El^H’s 
alliances with other Yale professional schools, the Pierce 
Laboratory and the occupational and environmental health 
program m internal medicine." The John B. Pierce 
Laboratory, alliliated with the medical school, conducts basic 
rt-search into environmental effects on the human body. 
Stutlenis already are taking advantage of these new links; 
ihi-. V'.-ar. Id’ll has ofiered several new environmental health 
; uiist V thanks 1(1 cross-listings with forestry, law' and internal 
Mj.-dk IIUV 
I ' ' '.v spirit of inter-departmental and inter-school 
' (i I may also help lead the way to a deeper 
; It in the New Haven community. In July, the W.K. 
s u aii'in ol Battle Creek, Michigan, announced 
that Yale was one of 15 institutions which had received grants 
to submit a plan for developing a community-based center for 
education, research and service in primary health care. The 
University’s partner in this endeavor is the nearby Hill Health 
Center, which has had a close working relationship with the 
School of Medicine since its founding in 1968. 
Heading up this effort is Dr. Ralph 1. Horwitz, professor of 
medicine and epidemiology. He has assembled a team of 
faculty members from EPH and other medical school 
departments, the School of Nursing, and staff members from 
the Hill Health Center. The proposal they will submit will 
allow for health professionals in training to increase the care 
offered to the most underserved people of greater New Haven. 
In the summer of 1992, the foundation will announce which 
of a maximum of six institutions will receive funding to 
establish such a program. Grants will range from $4 million to 
$6 million. 
Foreign Attachments 
To complement the department’s efforts to help its neighbors, 
EPH has gotten the backing to expand its service to the 
international community. Since the early 1960s the 
department has provided a home for the Yale-World Health 
Organization (WHO) Collaborating Centre for Arbovirus 
Research and Reference. [See “EPH Scientists Lead in Wide 
Range of Research.’’] 
In November, the department’s expertise in policy 
planning and evaluation will be spotlighted as the medical 
school dedicates the Yale-WHO Collaborating Centre for 
Health Promotion, Policy and Research. Center Director 
Lowell S. Levin, Ed.D., M.P.H., professor of public health, 
explains that the new program will use a space-age computer 
network to make sophisticated data bases available to improve 
the health of even the poorest countries. He says that the 
system “is designed to allow practitioners, scholars, and 
policy makers and analysts worldwide develop and evaluate 
public policies and health promotion programs.” Beginning in 
1991, scholars from around the world will visit EPH to learn 
continued on page 14 
EPH Divisions and Division Heads 
Biostatistics 
Theodore R. Holford, Ph.D., professor of public health 
Chronic Disease Epidemiology 
Adrian M. Ostfeld, M.D., the Anna M.R. Lauder 
Professor of Epidemiology and Public Health 
Environmental Health 
Burton H. Singer, Ph.D., associate dean, chairman and 
professor of public health and statistics (acting head) 
Health Policy and Resources 
Lisa E. Berkman, Ph.D., associate professor of 
epidemiology 
Infectious Disease Epidemiology 
Robert E. Shope, Ph.D., professor of epidemiology 
Microbiology* 
Nancy H. Ruddle, Ph.D., associate professor of 
epidemiology and biology 
*Division introduced in fall 1990 
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EPH Scientists Lead in 
Wide Array of Research 
Dr. Robert B. Tesh 
Throughout the discussions about EPH’s future, the 
excellence of one major aspect of the department was 
underscored: its research program. Currently, 25 faculty 
scientists serve as principal investigators of projects supported 
by $7.5 million in grants and contracts. Their studies range 
from molecular science and “wet” laboratory research to 
demographic, epidemiological and other social studies. 
The researchers whose work is briefly described here 
undertake their investigations in such fields as tropical 
diseases, nutrition, genetic disorders and environmental 
health. They represent but a small sampling of the cornucopia 
of interests pursued by EPH scientists. 
One of the oldest research groups at EPH is the world- 
renowned Yale Arbovirus Research Unit (YARU), which is 
directed by Robert E. Shope, M.D., professor of 
epidemiology. YARU was originally established by the 
Rockefeller Foundation to study diseases which are 
transmitted by biting insects and ticks and which affect people 
and their domestic animals throughout the world. The unit 
also serves as the World Health Organization Reference 
Center for Arboviruses. 
Dr. Shope and other researchers at YARU study how 
diseases such as dengue, yellow fever, eastern equine 
encephalomyelitis and leishmaniasis are transmitted by 
insects to people. The arbovirus unit. Dr. Shope explains, is 
devoted to studying how the infectious agents which cause 
these diseases are maintained in nature, usually through a 
cycle of biting insects and wild animals. “Man is sort of an 
incidental host,” he explains. “If we can better understand this 
cycle of the disease, then we can better figure out where the 
cycle can be best interrupted.” 
One of Dr. Shope’s colleagues, Robert B. Tesh, M.D., 
professor of epidemiology, has traveled to tropical regions 
around the globe to collect the mosquitoes, sand flies and 
triatomines (“kissing bugs”) that he breeds in the warm, most 
chambers of the YARU insectary on the 6th floor of LEPH. 
Dr. Tesh is particularly interested in the epidemiology of 
leishmaniasis, a sometimes fatal parasitic disease which can 
also cause ulcerations of the skin and mucous membranes. For 
the past seven years, he has captured sand flies and other 
potential insect vectors of the disease in the coffee fields and 
jungles of Colombia, where leishmaniasis is highly endemic. 
Also collaborating with Dr. Tesh is Diane McMahon-Pratt, 
Ph.D., associate professor of epidemiology. She studies more 
basic questions such as the molecular mechanisms by which 
the leishmania develop in the sand fly’s gut and the immune 
response of animals and people to infection with these 
parasites. A better understanding of these questions, she says, 
may enable researchers to develop vaccines or to genetically 
engineer antibodies that would protect people from infection. 
While tropical diseases as a rule do not plague Western 
nations, the First World faces its own set of health problems, 
many associated with the unsound eating habits of affluence, 
such as a high-fat, low-vegetable diet. Evidence that beta 
carotene, a vitamin A precursor, may prevent lung cancer has 
influenced the research of Susan T. Mayne, Ph.D., assistant 
professor of epidemiology and public health. She is exploring 
whether the diets of non-smoking lung cancer patients lack 
this nutrient. Dr. Mayne also has begun enrolling head and 
neck cancer patients in a seven-year clinical study to test 
whether beta-carotene — found in carrots and other leafy 
vegetables — can prevent second primary tumors and local 
recurrences. 
Our modern way of living also presents its share of 
environmental hazards. This reminder comes from Brian P. 
Leaderer, M.P.H. ’71, Ph.D. ’75, associate professor of 
epidemiology, head of the division of environmental health 
sciences at EPH and associate fellow at the John B. Pierce 
Laboratory. He specializes in indoor air quality, passive 
smoking and environmental risk assessment. 
Dr. Leaderer’s research indicates that even staying indoors 
doesn’t necessarily help in eluding air pollution. Chemical 
solvents, air fresheners, new carpets, cleaning fluids and 
foundation soils release fumes or gases that can cause “sick 
building syndrome,” a chronic case of unhealthy indoor air. 
Dr. Leaderer also has documented how other people’s 
cigarette smoke can affect non-smokers’ health. In one study 
he and colleagues found that in buildings where smoking is 
permitted, three to five times greater ventilation is needed to 
maintain healthy air quality than in smoke-free buildings. 
Neil Risch, Ph.D., associate professor of public health and 
human genetics, thinks many common chronic disorders may 
be due to a complex combination of genes and environmental 
influences. He looking for possible genetic links to illnesses 
such as schizophrenia and depression. 
Dr. Risch devises mathematical strategies in efforts to 
detect and map genes associated with such disorders, which 
tend to run in families. In addition to the diseases mentioned 
above, he studies breast, ovarian and endometrial cancers, 
autoimmune diseases such as insulin-dependent diabetes 
mellitus and multiple sclerosis, psychiatric disorders, 
cardiovascular disease, epilepsy and dystonia, a neurological 
disorder prevalent in Ashkenazi Jews. 
Recently, Dr. Risch and colleagues studied a controversial 
aspect of genetic screening: DNA fingerprinting. This 
technique attempts to single out individuals by identifying 
gene segments extracted from samples of blood, hair, semen 
and other tissue. The Risch team found that one problem 
attributed to DNA fingerprinting resulted from technicians 
misinterpreting the DNA pattern rather than unexpected 
genetic similarity among unrelated individuals due to 
population subgrouping. 
“The objections that some people raised to DNA 
fingerprinting aren’t valid reasons for excluding these 
techniques from the forensic setting,” Dr. Risch concludes. 
— Diane Loupe and Gregory R. Hath 
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how they can apply the system in their home countries. 
Dr. Singer adds that many of the center’s environmental 
policy efforts will focus on Eastern Europe, where the 
democracy movement has brought to light some ot the most 
severe pollution problems ever documented. An economist 
with expertise in the epidemiology of malaria. Dr. Singer has 
promoted even further EPH involvement in developing lands. 
Under his leadership, the infectious diseases division is 
forging new ties with the forestry school’s Tropical Resource 
Institute. Dr. Singer himself is participating in 
epidemiological studies of malaria in Brazil and Chagas’ 
disease in Argentina. 
Renovating LEPH: .A $.VIulti-million Challenge 
In addition to restructuring the department. Dr. Singer also 
has initiated an ambitious plan to rebuild LEPH, located at 60 
College St. Years of neglect to the building had passed due to 
a combination of circumstances. As a result ot ditticult 
financial times in the 197()s. Yale pursued a University-wide 
policy of deferring maintenance on its physical plant. Later, 
when the medical school undertook its capital campaign, 
EPlEs uncertain tuture further delayed renovation plans. 
Now, given the long-term commitment of the University 
and medical school to EPH, Dr. Singer has submitted a multi- 
million dollar plan for inclusion in the University’s upcoming 
capital campaign. His plans detail the need for a 
comprehensive fix-up. 
LEPH, designed by noted architect Phillip Johnson, is 
widely regarded as one of the jewels in the medical school’s 
architectural crown. Still, the edifice has not aged gracefully, 
requiring a “face-lift” after only 26 years. For some months 
now, those entering or leaving through the main entrance have 
done so under the protection of scaffolding, lest one of the 
limestone slabs that makes up the outer walls succumbs to 
gravity. The building’s foundation needs work as well. 
Inside, the original ventilation system has to be 
modernized to meet new building codes, and to more easily 
accommodate increasing numbers of “P-3” laboratories, those 
equipped for the most noxious or infectious agents. Such 
laboratories must adhere to the strictest federal ventilation 
standards. 
A Healthy Future 
EPH’s renaissance, as reflected in its building plans, 
program improvements and expanding faculty, is based on a 
proud heritage. In the spirit of the public health ethos, over 
the years EPH has made its mark through the dramatic 
contributions of basic researchers such as Drs. Dorothy 
Horstmann and John Rodman Paul, whose work paved the 
way for the polio vaccine. Its policy experts, such as John 
Thompson, have revolutionized the health care field with such 
cost-control measures as DRGs, or diagnostic-related groups, 
even as current faculty members such as Drs. Ostfeld and 
Berkman, along with Stanislav Kastl, Ph.D., are exploring 
new vistas in the study of aging. Moreover, EPH’s graduates 
are serving in key health care positions from Washington, 
D.C., to some of the most remote areas of the world. 
From these many contributions emerges a picture of a 
medical school department which for 75 years has fulfilled its 
mission of education, research and public service by helping 
to improve the health of people worldwide. Yale’s efforts to 
strengthen EPH too reaffirm a tradition: the University’s 
commitment to academic excellence and to serving its local, 
national and international communities. 
When asked about the time and effort it has taken to 
implement the new EPH program. Dr. Singer replies at first 
with only a smile and a shrug. Then he concludes with 
characteristic aplomb, “Of course, it’s a lot of work, but that’s 
what it takes to make exciting things happen.” YM 
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REFLECTIONS ON PUBLIC HEALTH 
As part of the 75th anniversary celebration of the medical 
school's department of epidemiology and public health, Yale 
Medicine prondlv presents the essays of nine distinguished 
EPH graduates who have agreed to reflect on their 
professional education and to share their thoughts about the 
many public health challenges facing humanity today. 
Frederick G. 
Adams 
D.D.S., M.P.H. ’70 
Health Services 
Commissioner 
State of Connecticut 
Hartford, Conn. 
In my travels around the country I meet with people from all 
segments of society. 1 have found, to my dismay, that 
Americans in general are more aware of and concerned about 
public health concerns than their leaders, especially their 
elected officials. This is particularly true of officials at the 
highest levels of national government. Although America’s 
leaders express concern in speeches and other forms of public 
communication, a national policy on public health has yet to 
be articulated. 
To be sure, certain issues have captured the national 
attention — for example, AIDS, abortion and drug abuse — 
but the broader aspects of public health have not. My sense is 
that we as a nation still regard health care as primarily 
reactive or “curative” rather than comprehensive and 
preventive; concentration is on the individual rather than on 
the community. 
One distressing result of this approach: Although the 
United States spends more per capita on health care than other 
industrialized countries, we seem to benefit less from these 
services. Our infant mortality rate is higher than that of all but 
a handful of Western European nations and our life 
expectancy statistics are not much better. Even more 
deplorable, America’s health care shortcomings affect 
minority peoples disproportionately. 
If the public health approach of prevention, education and 
empowerment represents what is needed to address the health 
crisis of developing nations, it also offers the United States’ 
best hope for improving the health of its poor and minority 
communities — the burgeoning Third World within our own 
borders. 
Shan Cretin 
Ph.D., M.RH. ’70 
Professor 
UCLA department of 
health services 
Los Angeles, Calif. 
During the past decade the most urgent public policy 
questions have involved public health. AIDS and the 
environment have become front-page news, along with the 
problems of drug addiction, health care financing and 
abortion. Despite the demonstrable importance of public 
health education and research, Yale’s department of 
epidemiology and public health and other schools of public 
health have recently had their position in the academic milieu 
questioned. What explains the uneasy relationship between 
public health and the rest of academia? 
Public health offers a shared, societal perspective, in 
contrast to the majority of more parochial academic 
disciplines. Eaculty in schools of public health come from a 
variety of backgrounds, including social sciences, biological 
sciences and physical sciences, and address a wide range of 
problems, from health financing to toxic waste. What unifies 
this apparently disparate field is an interest in applying 
disciplinary training to the solution of health problems at a 
population, rather than at an individual level. This unifying 
principle is, unfortunately, also the source of the friction 
between public health and other faculties of the university. 
The focus on applications leads colleagues from the “pure” 
disciplines to view public health research with suspicion. We 
do not work at the “cutting edge” of theory, but rather see 
whether established theory can lead to better solutions for 
practical problems. In this sense, we are engineers more than 
scientists. When our work is judged by academics from such 
fields as economics or biochemistry, it may be dismissed as 
“too applied” to qualify as “real” research. 
Public health differs with medicine, as well, over its 
emphasis on the health of populations rather than individuals. 
What is good for the health of one individual may benefit the 
entire community, as in the case of immunizations against 
infectious diseases. However, costly life support for a 
terminally ill patient may contribute less to the community’s 
health than such non-medical approaches as subsidized school 
lunches or better occupational safety standards. Advances in 
medical technology have improved our collective health, but 
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have also complicated the delivery and financing of medical 
care. The United States spends 12 percent of its gross national 
product on medical care, yet our health as a nation lags behind 
that of countries spending far less. We clearly need to 
complement our biomedical research with health policy 
research focusing on the health of the society. 
In the dialogue between advocates for individual patients 
and advocates for society, there are no “good guys” or “bad 
guys.” A fundamental problem for a free society is balancing 
the rights of the individual and the needs of society. This 
same balance is needed in developing national health policies. 
It is important for there to be both schools of medicine, with 
physicians who are working to improve the diagnosis and 
treatment of diseases for individual patients, and schools of 
public health, with economists, sociologists, behavioral 
scientists, environmental scientists and epidemiologists 
working to improve the health of populations. 
In providing a home for public health, the university 
fulfills its obligation to address societal as well as intellectual 
problems. As an alumna. 1 am pleased and proud that the 
tradition of public health education will continue at Yale. 
Debra W. Haffner 
M.RH. ’79 
Executive director 
Sex Information and 
Education Council 
of the United States 
New York, N.Y. 
fhough I received my degree from the department of 
epidemiology and public health 11 years ago, to this day I 
often use information from my epidemiology, management, 
and maternal and child health courses. My work has been 
particularly influenced by the principles 1 learned from Jim 
Jekel. Lorraine Klerman and Lowell Levin. But 1 also daily 
call upon a set of skills which were not addressed during my 
student days at LBII: the political skills that we as leaders in 
public health require to educate others as to the need for 
public health programs. 
.•\s the executive director of SIECUS, the Sex Information 
anil liducation Council of the United States, 1 lead an 
organi/ation dedicated to affirm sexuality as a natural and 
healthy part of living and to advocate for the right of 
individuals to make responsible sexual choices. Sexuality is 
clearly a public health issue, although 1 do not remember it 
b. mg addressed in any of my classes. 
I' ah the sexual diseases (sexually transmitted diseases, 
III' ' ction, infertility, etc.) and the rampant sexual “dis- 
■ ur culture (as reflected in sexism, homophobia, 
c, etc.) require public health approaches to reduce 
their prevalence. Many of today’s public health problems are 
rooted in the culture's lack of understanding about — and 
acceptance of — sexuality. 
Nowhere is this more evident than in the response to the 
HIV epidemic, where moralism is being presented by some 
political leaders as a public health imperative. Much of the 
funding for HIV prevention has been used to promote efforts 
to restrict sexual behaviors and lifestyles. 
For example, almost all HIV education programs for teen¬ 
agers concentrate on abstinence, while ignoring the needs of 
millions of teen-agers for “safer sex” education. Regulations 
promulgated by the Centers for Disease Control at the 
directive of Congress forbid the use of public monies to 
produce explicit materials on heterosexual and homosexual 
safer sex practices. Many of us have worked vigorously to 
blunt the effects of these misguided political/moral agendas 
that have dominated public health practice. 
Almost all of us in public health need to work in a political 
context; political decisions affect public health priorities. 
During the last decade, political considerations have affected 
regulations and funding for maternal and child health 
programs, community health centers, abortion, family 
planning, fetal research, environmental health and 
occupational health, to name only a few. The acceptance of a 
national health service or insurance program, first proposed 
by Yale professors more than 50 years ago, is clearly 
dependent on building political support. 
1 believe that it is vital to prepare public health students for 
their role in the political arena. We need to teach these new 
professionals how to lobby, work with the media and 
articulate their vision. Understanding and developing these 
skills are as important as developing those in research, 
administration and fund-raising. It is incumbent on all of us in 
public health to provide the leadership to assure that everyone 
has the right to affordable and quality health care services and 
education. 
William L. Kissick 
M.D. ’57 
Dr.P.H. ’61 
G.S. Pepper Professor 
of Public Health 
and Preventive 
Medicine 
University of Pennsylvania 
Philadelphia, Pa. 
When I left the wards of Yale-New Haven Hospital in the 
summer of 1958 to matriculate for the study of public health, 1 
cros.sed the Rubicon of health affairs. Visits as a fourth-year 
clinical clerk to chronically ill patients in their homes with my 
wife, a staff nurse with the New Haven Visiting Nurse 
Association, had convinced me that the School of Public 
Health needed the School of Medicine. Three decades later, 1 
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recognize the reverse as imperative. Society spent 
approximately $600 billion for health and medical care last 
year, almost 12 percent of the gross national product. That is 
twice the defense budget and two-and-one-half times the 
revenues of America’s automotive industry. Some claim the 
United States has thus bought the finest health services in the 
world. This statement is true, if you mean that our finest is 
unexcelled. If one includes the dimension of equity and the 
highest health status, the claim is not valid. 
The U.S. Health Care Financing Administration forecasts 
medical expenditures reaching 15 percent of GNP in the year 
2000. Some economists reason that the health care sector’s 
marginal growth will balance out at 18 percent of GNP; an 
extrapolation of growth over the past three decades, however, 
would carry it to 100 percent of GNP in 2057. 
Kissick’s Second Law states, “No society has sufficient 
resources to provide all of the health services its population 
would utilize.” I am convinced that this law would be valid at 
100 percent GNP. This frames the dilemma for medicine in 
the 21st century. Enter public health. 
Public health is based on principles that can be 
incorporated into medicine in a variety of ways. Medical 
practice is predominantly reactive; the physician stands ready 
to provide the fullest spectrum of quality care. By contrast, 
public health is anticipatory, proactively identifying and 
targeting opportunities for health promotion, disease 
prevention and comprehensive care. Medicine, quite properly, 
focuses on advocacy for the individual patient; public health 
has a population priority. The golden age of American 
medicine was fueled by fee-for-service, with the physician 
determining both price and volume. Retrospective cost-based 
reimbursement financed hospitals and added to an open-ended 
philosophy. Public health, by contrast, requires resource 
allocation in closed budgets. 
Population basis, closed budgets and anticipatory strategies 
help determine our priorities. Who Shall Live? asks Victor 
Fuchs, the distinguished economist. The derivative question is 
“Who shall decide?” We in medicine are uncomfortable with 
these decisions and often make them almost by default. 
Though we may decline to address priorities in medicine, rest 
assured, the decisions will be made, explicitly or implicitly, 
overtly or covertly, with or without medicine’s participation. 
The main lesson of public health is accountability. As 
physicians we are accountable to the individual patient. Public 
health is accountable to society through its representatives. 
As I view the evolution of health affairs over the past three 
decades, it is my conviction that medicine in collaboration 
with public health can achieve excellence as well as equity for 
250 million Americans. The department of epidemiology and 
public health in its 75 years stands ready for the joint venture. 
Peter J. Levin 
M.RH. ’65, Sc.D. 
Dean, College of 
Public Health 
University of South 
Florida 
Tampa, Fla. 
In 1963, jobs in hospital administration were not yet the high- 
prestige executive positions that they sometimes are today. 
These were the pre-Medicare days, just before a flood of 
federal funds would transform the health care system. I was 
attracted to Yale because it offered the master of public health 
degree, not a master's in business administration. I viewed 
hospital care as part of a much wider public health system. 
Happily, EPH saw it this way, too, which led to my most 
exciting academic years being spent under John Thompson’s 
tutelage. 
The old building on Cedar Street smelled of formaldehyde 
from the pathology laboratories with which we shared a floor. 
Smoke from cigars and pipes — then an acceptable part of the 
academic scene — also made their atmospheric contribution. 
As they do today, M.P.H. students attended core course 
lectures together and represented a wide variety of points of 
view and academic and ethnic backgrounds. What made EPH 
exceptional for me, however, was the overall positive outlook 
of the faculty; along with knowledge, they transmitted hope to 
their students. They believed that what they were doing was 
important and what we would do in our careers in public 
health would be important. 
Society as a whole certainly was not impressed with our 
importance. People did not go into public health to become 
rich. HMOs, disease prevention and health promotion were 
not yet accepted as replicable concepts. We were people who 
were prepared to accept modest material success in exchange 
for knowing that we were doing good for society. We were 
the inheritors of the expertise and, hopefully, the values of C.- 
E.A. Winslow. 
In the case of hospital administration, we had John D. 
Thompson leading the way, prodding and pushing, to have us 
embrace scientific methods to analyze situations and develop 
methods for change. He was constantly experimenting with 
hospital data to improve care through management. He 
believed that the administrator could make a difference even 
if the doctors and the trustees did not think so. He taught us to 
keep one eye on the big picture while you “got the laundry 
sorted out.” Politics as well as statistics were part of the game, 
and you had better be sure that you had the votes, as well as 
the numbers, all added up ahead of time. 
Another appealing feature of EPH was its future 
orientation. We were all working to make a better world for 
everyone. We believed that things would change. My M.P.H. 
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graduation year, 1965, saw the passage of Medicare and 
Medicaid. Since then, massive infusions of money have gone 
into health care delivery, and there is now much wider 
government involvement in all aspects of health care and the 
environment. Unfortunately, we have not seen improvement 
in health status for all of the population that we might have 
hoped for, given the amount of money we have invested. 
The belief that components of health care delivery can be 
analyzed, studied and integrated into a measurably better 
system still is not widely accepted. This approach is 
sometimes threatening to medical schools, physicians, 
hospitals and those who do not believe that we are our 
brothers’ and sisters' keepers. Yale EPH gave me more than 
tools; it provided me with a framework to approach and solve 
problems, and supported my conviction that we can and 
should make a difference. 
^ I V 
Capt. Patricia D. 








What, you might ask, do the following have in common: the 
U.S. Surgeon General, medicine men, puberty ceremonies, 
alcoholism prevention and treatment, food handlers' courses, 
project officers, clinic managers, HIV services, coalition 
building, community outreach workers, health manpower 
shortage areas, and military protocol. These are but a few of 
the strands that have been woven into the colorful tapestry of 
my career in the U.S. Public Health Service. 
A combination of field placement with a Western Apache 
tribe coupled with a request to develop a community drinking 
profile led to a career in public health which has spanned the 
continent and provided significant opportunities for 
professional growth and contribution. The core curriculum 
required during my Yale training laid the foundation for 
multidisciplinary activities with an emphasis on the 
importance of wider professional affiliation with peers and 
colleagues. 
My thesis research in alcoholism began a lifelong interest 
and resulted in the publication of an annotated bibliography 
on North American Intlian alcohol use and abuse (1980), to 
say nothing about a basement full of reference material 
collected over 20 years. 
OI greatest value in my professional preparation was the 
emphasis on ileveloping an appreciation of other public health 
disi iplines. I'roin statistics and epidemiology through 
b I Mistration and basic research, to disease prevention and 
'^e.ilth services in the community, my Yale education 
provided a coordinated overview that enabled me to approach 
all my professional activities as parts of a single discipline. 
My greatest concern is that public health is being 
increasingly fragmented, destroying the community and 
professional integration so important to the delivery and 
maintenance of public health services. I have found that 
professionals lack a generic frame of reference. Even that 
frontline provider, the public health nurse, has disappeared 
into the linguistic limbo of “community health nursing.” The 
basic environmental health sciences so artfully integrated into 
the disease-prevention model seem to have shifted toward 
public works and land conservation, and away from simply 
protecting people’s health. And health promotion seems more 
closely associated with aerobic exercise than with personal 
responsibility for positive health behavior. 
The finest training in public health was mine in the 1960s. 
I do not see this same meaningful integration in the 1990s. 
Education for public health practice seems to have shifted 
from a community-based model to a more fragmented, single¬ 
issue approach characteristic of the “congressional disease 
syndrome” in which health care priorities are too often set in 
reaction to the most vocal or most inOuential special interest 
groups. 
Public health — as distinct from medical care — is the one 
system equipped to address the nation’s health at its core: the 
family, community and culture, where health and disease have 
their origins. Moreover, public health works with and 
understands the needs of the nation’s indigent peoples. My 
professional preparation readied me to work in the front lines 
of health service delivery. I hope that those of us trained in 
the 196()s do not represent the last of the generic public health 
professionals. 
Michael H. Owens 
M.D., M.P.H. ’78 
Executive vice president 
and chief health officer 
Watts Health Foundation 
Los Angeles, Calif. 
The shadow of 21st-century health care challenges is already 
casting a nebulous cloak about us. Our health care system is 
undergoing nothing short of a revolution in its definition, 
control and economy. Advancing technology is outpacing our 
grasp of its liabilities, raising questions of our ability to 
incorporate modern medicine into society within ethical let 
alone rational constraints. We are concomitantly faced with 
the reality that much of the United States’ minority population 
is confronting a health care crisis rivaling that of so-called 
“Third-World” countries, as evidenced by the current measles 
outbreak and by minority infant mortality rates. 
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The perverse interplay of new technology and the life 
challenges of the poor is evidenced when we view the 
problem of runaway teenage pregnancy in terms of the debate 
about fetal research; poor minority women produce ample 
potential raw material for such research. Similar parallels can 
be seen between the potential linkages between homicide as 
the number one cause of mortality in inner-city youth and the 
coincidental location of many large teaching hospitals with 
organ transplant centers for everything from cornea to heart- 
lung transplants. 
The failure of leadership and communication from the 
cognoscente to the ever-burgeoning numbers of functionally 
illiterate in our society does not argue well for a true national 
resolve to understand — let alone address — the problems of 
a society in decay. Our schools of public health must move 
beyond their current status as bastions of training researchers 
and bureaucratic information gatherers and users, to become 
institutions of creative learning, outreach and 
experimentation. The World Health Organization includes the 
psychological and spiritual along with the physical as 
principal tenets of health. 
Schools such as Yale must focus more outwardly for the 
common good. They must aggressively network with minority 
and non-traditional institutions of higher learning; they must 
forge links with health care organizations and civic 
organizations that reflect our poly-cultural and poly-ethnic 
citizenry. The social responsibilities of our premier schools of 
public health of course do not stop at our shores. International 
health needs are also ever-increasing. How better to begin 
meeting our global responsibility than by rededicating 
ourselves to creatively bringing forth the potential of our own 
multicultural/multiethnic population as the cultural bridge 
between ourselves and those on distant shores. The mission is 
the same, the timing not yet impossible, the imperative 
compelling, the risk of avoidance incontrovertibly evident in 
human misery and suffering. The indefatigable spirit of 
humanity will prevail only if we get out of our own way. 
Karl A. Smith 
M.D., Dr.P.H. ’71 
Deputy director, division 




knowledge was important in my subsequent work for the 
Dr.P.H., which, in turn, added greater depth to my teaching, 
research and service activities back at the University of the 
West Indies. Some of my former students now bear witness to 
the indirect influence EPH has exerted on their own career 
choices, especially those who embraced the once new and 
suspect discipline of epidemiology. My Yale exposure also 
convinced me that my own career choice in public health was 
the correct one. 
I was later drawn to international health as a second career; 
for more than a decade I have worked for an organization that 
encourages and supports research in the developing world. In 
this role I have discovered that every country needs a rational 
mix of personal and community health services; that health 
status results from the interplay of many factors, including 
genetics, environment, economics, health systems and 
services, personal and community behavior — and public 
policies. 
There is a tendency in many developed countries to regard 
basic research and the provision of biomedical and clinical 
high-technology packages as the answer to health problems. 
Public health receives little attention. Yet, while many 
developing countries for reasons of prestige will try to follow 
this high-technology model, most of them will find it an 
unaffordable and inappropriate use of scarce resources. 
Greater emphasis must be placed on “the public health,” 
including preventive measures and health promotion. 
Learning institutions like Yale, with their tremendous 
prestige, must assume even greater leadership in assisting the 
developing world meet its public health challenges. The world 
is increasingly becoming a global village with shared needs, 
concerns and consequences for each other’s actions. In this 
context, Yale has an obligation to make major contributions 
as one of the world’s leaders in medical and public health 
education and research. 
How many developing country scientists are being trained 
in public health at Yale? Do they return to their own countries 
to work? What continuing support do they receive? Are there 
ongoing networks with Yale faculty? 
Yale must exercise greater influence, nationally and 
internationally, in culturally sensitive ways, in research, 
training and advocacy regarding the public health. While, for 
example, the EPH chairman’s advisory role to WHO is 
laudable, and other professors engage in international 
activities, will EPH enhance its corporate international 
stature? Let me close by quoting the late Arthur J. Viseltear, 
Ph.D., from his graduation address to the EPH Class of 1989; 
“The world is changing rapidly; will you do your share to 
influence the future? Will you remember and hold dear the 
public health ethos?” 
In studying for my M.P.H. at Yale, while the tools of 
epidemiology and biostatistics and the know-how to 
administer health services were imperatives, equally exciting 
were the qualitative approaches and methodologies for 
understanding people’s motivation and behavior. I remain 
grateful to all my teachers in these various domains.This 






Professor in the 
Social Sciences 
Uni versify of Pennsylvania 
Philadelphia, Pa. 
In 1961, the year I entered EPH as a student, the department 
was housed on Cedar Street. Public health was a collection of 
disciplines which were assumed to fit naturally together as 
they had done in the days, not too far distant, when the field 
was a matter of controlling infectious diseases and was 
concerned with measurement, sanitation, education, 
progressive social policies and the stark realities of practical 
politics. Federal funding for public health was in its prime, 
both for education and research — I was one of the fortunate 
recipients. 
Medical care and hospital administration, then two 
separate fields, were taught within this framework, although it 
was not always clear how the newer problems of institutional 
management, private health insurance arrangements and 
proposals for government intervention (this was before 
Medicare) meshed with some of the other fields. Eric Mood’s 
lecture on how to build a rural sanitation system for a 
dwelling, made graphic by the large model of a privy he 
hefted to class, contrasted with Isidore Falk’s discussions of 
w ho was backing what major piece of health legislation in the 
L'..S. Congress, or John Thompson’s concerns about hospital- 
hospital and hospital-medical staff relations. 
1 was fortunate to be able to combine hospital 
administration and medical care in the M.P.H. curriculum and 
then to go on for a Ph.D. in epidemiology, focusing my 
dissertation on specialization in medicine with Dr. Falk as my 
advisor. My dissertation fields, epidemiology, sociology, 
health administration, have stood me in good stead over the 
\ears. How much more versatile than doing three fields of 
management! 
Being a student of health care institutions within a public 
health conte.xt also has been of continuing practical value. Dr. 
i-alk. like others of his generation of activists, saw 
government involvement in medical care as the next logical 
step in the broad history of public health. John Thompson, 
presenting the hospital as a force for potential good in the 
community, expected the administrator to do more than keep 
the institution going along established lines. Managers were 
agents ol change, with the opportunity to create better 
services to local communities through cooperation across 
institutions. 
1 n. .ili/e no" how much I have internalized these views. I 
b i" . ■ li'o l\ accepted the public health perspective — 
' I'js io d in the 199()s as the “new way” to look 
i n < - ilv.ilth is a collective concern, whether 
one is talking about Medicare costs, AIDS, pollution, or the 
absence of health insurance. Managers of health care 
institutions need to have a strong background in epidemiology 
and social statistics as well as in the arcane details of capital 
finance; they certainly need an appreciation of history and 
politics. As I write about the history and policies of health 
care, I feel particularly grateful for my background in health 
statistics. (Thank you, Colin White!) 
And yes, the lecture on privies has proved useful on at 
least three occasions. 
Preventive medicine must come through a fundamental 
change in the attitude of the physician and in the attitude of 
the medical school where he is trained. It is to a new 
generation of medical students, imbued with a new spirit of 
prevention, that we look forward with hope. At Yale, it is our 
special duty and opportunity to make this new spirit prevail; 
and we believe that in the working of such a revolution our 
medical school can make its most unique contribution to 
human progress. 
To state that the death rate of New York City has been 
reduced from 25 per 1,000 in 1890 to 13 per 1,000 in 1920 
may perhaps leave one unmoved; but think for a moment 
what such statistics mean in temis of human life and human 
happiness. Today (1923) in that great city, there are 201 
deaths every 24 hours. If the death rate of 30 years ago were 
still in force there would be 384 — a saving of 183 lives with 
each revolution of the Earth. If death be the wage of sanitary 
sin, nearly one-half the debt has been remitted in a period of 
30 years. 
If we had but the gift of second sight to transmute abstract 
figures into tlesh and blood, so that as we walk along the 
street we could say, “That man would be dead of typhoid 
fever,” “That woman would have succumbed to tuberculosis,” 
“That rosy infant would be in its coffin” — then only should 
we have a faint conception of the silent victories of public 
health. For such achievements we may thank God and take 
courage for the future, bearing on our banners that eternal 
phrase of Cicero: “In no single thing do men approach the 
gods more nearly than in the giving of safety to mankind.” 
The Evolution and Significance of the Modern Public Health 
Campaign, C.-E.A. Winslow. Yale University Press, 1984, 
pp. 64-65. YM 
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THE CHANGING FACE 
OF PUBLIC HEALTH 
by Dr. Myron E. Wegman, ’32, ’32-’36 HS 
From the perspective of 1990, the status of public health in 
1915 appears not very different from the turn of the century. 
By the time Yale established its department of public health, 
life expectancy in the United States had improved to age 52, 
from 47 in 1900; figures as low as these are seen today only 
in a few developing countries. Yet profound changes in 
thinking were taking place. Understanding of infectious 
diseases was expanding rapidly, even though newly 
developed specific treatments, like serotherapy, were not 
terribly effective. 
This concern with contagion may have influenced the 
choice of Charles-Edward Amory Winslow as the first EPH 
department head; his own studies with William T. Sedgwick 
at MIT had been in sanitary science and biology. Two earlier 
efforts to develop a broadly based. University-wide 
department at Yale had been shelved, which may have moved 
Winslow to focus on teaching prevention to undergraduate 
medical students and “to capture a few for public health.” In 
his comprehensive 1988 article in the Yale Journal of Biology 
and Medicine, the late Arthur J. Viseltear reports that 
Winslow failed in the latter goal; a parallel effort to develop 
an Institute of Human Relations to bring medicine into closer 
relationship with non-medical aspects of health and disease 
also failed, “as the medical curriculum returned to traditional 
concerns” with the patient, sickness and cure. 
Since my own medical school education overlapped some 
of these developments, I propose to comment on the history 
from both a personal and conceptual point of view. How a 
person such as myself — focused on a clinical area in student 
and residency days — wound up in public health, may be 
instructive for others. Moreover, a look at how public health 
has changed in 75 years may help achieve a better perspective 
on today’s problems. 
Illustrious Professors 
As I think back to 1928-1932, Winslow was hardly a failure. 
His lectures, and those of Professor Ira Hiscock, were great 
intellectual exercises for us medical students, even though 
they did not lead me or, as I recall, any of my classmates 
directly to a public health career. More importantly, there 
must have been considerable influence on faculty members 
like Leo Rettger and George Smith in bacteriology and the 
Yale greats in infectious diseases — Francis Blake and John 
Paul in medicine and James Trask in pediatrics. We certainly 
learned from them of the community implications of the 
spread of disease. 
Winslow’s regard for medical students was revealed 
outside the classroom as well as inside it. Once each year he 
invited the entire senior class for dinner at his home after 
which, with most of us sitting on the floor, he talked of the 
social function of medicine, reading to us selections from 
medical, public health and English literature. I remember it as 
an inspiring evening although, again, it did little for 
recruitment to public health. 
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Dr. Myron E. Wegman 
Dr. Myron Wegman ^32, ’32-’36 HS: 
A Half-century in Public Health 
After completing his residency in pediatrics at New Haven 
Hospital in 1936, Dr. Myron Wegman headed South to 
become a pediatric consultant in the Maryland 
Department of Health. At the urging of Dr. Grover Powers 
and another of his former professors at Yale, Dr. Martha 
Eliot, he also completed an M.P.H. degree at the Johns 
Hopkins School of Public Health. The advice of these two 
great teachers had a profound effect on his professional life. 
Dr. Wegman’s subsequent career in public health led 
him to Puerto Rico for a teaching post at the School of 
Tropical Medicine, to New York City and work with the 
bureau of child hygiene, and to medical school teaching 
positions at Cornell, Columbia and Johns Hopkins. 
In 1946, he returned to his original field, becoming 
professor and head of pediatrics at Louisiana State 
University Medical School in New Orleans. Here Dr. 
Wegman maintained his involvement in public health 
through volunteer work and by chairing the city’s health 
council. A series of international consultancies for the 
World Health Organization led him to join the Pan 
American Health Organization (the WHO Regional Office 
for the Americas) in Washington, D.C.; for his last four 
years there, he served as its secretary-general. 
In 1960, Dr. Wegman returned to academe as dean and 
professor of public health at the University of Michigan 
School of Public Health and Searle Professor of Pediatrics 
in the medical school. He was named dean emeritus in 
1974 and Searle Professor emeritus in 1978. 
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My own path to a career in public health was anything but 
straight and narrow. After a three-week substitute internship 
in surger) demonstrated to my discomfiture that technical 
de.xterit) was not my forte. 1 became more and more attracted 
to pediatrics, chiefly through increasing admiration for Grover 
Powers and his colleagues. Internship and residency in 
pediatrics v\ere glorious years; when 1 became chief residenf, 
I had reached the top. In fact, although 1 have since held high 
administratise and academic positions. 1 have never felt so 
important as 1 did in 19.15-19.16. 
Pediatrics is in many ways public health in action, so upon 
finishing my residency. 1 jumped at the opportunity to work 
as a pediatric consultant in the Maryland Department of 
Health. I here I helped educate rural practitioners in better 
care of children. Not surprisingly. Dr. Powers’ urging that 1 
become involved in the community was crucial to my 
decision. I also benefited from knowing another faculty 
member, Martha liliot, whose sophisticated research on 
\itamin D and rickets led her almost inevitably to child 
health. Later, as associate chief and chief of the U.S. 
Children's Bureau, she had a lasting impact on public health 
in the United .States. 
Martha Idiot urged me not only to accept the Maryland 
post but to insist that 1 do my .Master's in Public Health at 
Johns Hopkins at the same time. At first 1 resisted the latter 
suggestion, largely out of a Yale-induced conceit. After four 
years of medical school and four years of pediatric residency 
at d ale, I didn’t see how Johns Hopkins could teach me 
an>thing! This attitude was shattered quickly as I sat in 
Lowell Reed’s exciting clas.ses in biostatistics and had contact 
with public health giants like Wade Hampton Frost and Abel 
Wolman. Being a graduate student in public health proved to 
be an intellectually stimulating and rewarding experience. 
At the same time, as 1 tried to teach modem pediatrics to 
rural Maryland practitioners — some the product of the pre- 
Flexner diploma mills — I encountered public health “in the 
raw.” In addition to primitive environmental conditions and 
dreadful maternal and infant mortality rates, I had to deal with 
a variety of infectious diseases. This included a family 
outbreak of tularemia, diagnosed not by my clinical acumen 
but through the astuteness of the state bacteriology laboratory. 
It was a powerful exposure and a great learning experience, 
even though there were times when I wondered whether my 
training on a sophisticated clinical and research service was 
being frittered away. 
Then came a major break; I was asked to teach the six- 
week maternal and child health course at Hopkins. I accepted 
and continued at this position as a commuter during my next 
two jobs. In the second of these, incidentally, I had the good 
luck to work under another remarkable Yalie, Leona 
Baumgartner, then head of the Bureau of Child Hygiene; her 
extraordinary career included eight years as one of New York 
City’s greatest health commissioners. Subsequently, my 
various posts have given me opportunity to take part in city, 
state and international public health activities, as well as 
teaching and academic administration in two large state 
universities. 
Table 1. .\ge-adjusted death rates. United States, selected causes, three five-year periods. 
1 
Age-adjusted death rate per 100,000 
2 3 
1900-04 1940-44 1980-84 
.Ml causes 1698.1 1017.1 560.8 
Selected infectious diseases 
Tuberculosis 188.5 43.0 0.6 
Innuen/a and pneumonia 190.9 60.3 12.0 
Measles 8.1 1.1 
Whooping cough 8.0 2.0 
Typhoid fever 26.8 0.7 
Gastritis and enteritis 91.6 8.9 
Syphilis 16.6 12.3 
Selected chronic diseases 
Major cardiova.scular disease 437.2 469.1 240.7 
M.iligntint net)plasms 83.9 118.4 132.6 
\ iolence 
,\ccidcnls 83.1 71.6 37.8 
(Motor vehicle) - 22.6 20.3 
(All v)ther) 83.1 49.0 17.5 
Suicide 12.1 11.7 9.3 
1 himieide 1.2 5.7 9.6 
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Figure 1. Trends in neonataS and total infant mortality rates, United States, 1915-1987. 
Public Health Then and Now 
I have gone on at some length about my personal history to 
set the stage for contrasting the state of public health 75 years 
ago with today. How to measure the change? Since “health” 
can’t be quantified and morbidity data are incomplete, we 
often look at absence of mortality as an indicator of health. 
We certainly live longer — life expectancy in the United 
States has increased since 1915 to almost 75, a gain of almost 
50 percent. 
One way to look at the components of this improvement is 
to study age-adjusted mortality rates for various disease 
groups. Age-adjustment is a standard technique that 
compensates for the inevitably higher mortality rates in older 
people. By applying actual age-specific rates at different 
times or in different communities to a single standard 
population, one can calculate a hypothetical total rate that is 
more meaningful for comparative purposes. 
In Table 1, age-adjusted death rates from major cause 
groups are shown for three five-year periods, 1900-1904, 
1940-1944 and 1980-1984. The decline in deaths from 
communicable diseases has been little short of spectacular. In 
our present, well-justified concern over the physical and 
chemical pollution of our environment, it is easy to forget the 
lethal biological pollution that was so pervasive in the early 
decades of this century. 
Tuberculosis was everywhere — three-quarters of my 
medical school class tested positive when we entered, and all 
of us were positive when we graduated. At least two of my 
classmates had to drop out of medical school because of 
tuberculosis. Typhoid fever was so prevalent that in 1920 the 
Boy Scout’s handbook advised: “Scouts must be careful when 
out in the country never to drink water from a stream just 
because it looks clean and pure; it may well be contaminated 
with typhoid bacilli.” 
Most of the decline in infectious disease deaths, however, 
took place prior to 1940. During this period there had been 
considerable expansion of public health activities, particularly 
as to the environment, as well as great improvement in 
general clinical management of the ill, especially regarding 
their fluids and electrolytes. Since 1940, of course, the 
influence of specific therapy has been substantial; for 
example, deaths from tuberculosis have declined more rapidly 
since 1940 than before. 
Syphilis is a striking exception to this infectious disease 
trend; almost no change in death rates took place in the pre- 
1940 era, when therapy was ineffective and public health 
focus on venereal diseases was just beginning. It was a 
curious coincidence that the discovery of penicillin as 
effective therapy for syphilis came only after the 1936 
appointment of an innovative surgeon general, Thomas 
Parran, who had made an attack on syphilis one of his 
priorities. 
Among chronic diseases, the remarkable decline in deaths 
from cardiovascular disease since 1940 is more likely 
attributable to improvements in therapy than to effectiveness 
of prevention. By contrast, the steady increase in deaths from 
malignant neoplasms is dire evidence of the gaps in our 
knowledge as well as our failure to apply what we do know 
about prevention and therapy. We are doing better with some 
cancers, but the seemingly inexorable increase in cancer of 
the lung in women is disheartening. 
One explanation is failure to combat the advertising skills 
of the tobacco companies, who while claiming piously that 
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their only goal is to get people to change brands, nevertheless 
target the young. Yet it seems obvious that as older smokers 
die oft' the young must be recruited it sales are to be 
maintained. 
■American tobacco's other market, of course, is outside our 
borders. Here the situation is a national disgrace. While the 
Public Health Service has made a decrease in smoking a 
national priority, the President's trade representative promotes 
the sale of American cigarettes abroad. It seems to me 
obscene to threaten Thailand — in the midst of its national 
anti-smoking campaign — with U.S. trade sanctions it it 
resists importation of American cigarettes and won't allow 
American cigarette advertising. 
Death rates from non-motor vehicle accidents have 
declined by almost 80 percent, but we can glean only small 
satisfaction from the stabilization of motor vehicle death 
rates. There is still a long way to go. 
Curiously, the age-adjusted rate of deaths from suicide has 
shown little variation throughout the century although there 
have been changes in the rates for individual age groups. A 
recent increase in suicide among teen-agers and young adults 
has been paralleled by declines in older age groups. One 
might hypothesize some genetic predisposition to suicide 
which becomes manifest at different ages, depending upon the 
social stress of particular time periods. Finally, the awful 
increase in deaths from homicide reflects deep-rooted social 
and economic ills in our society not easily susceptible to 
public health interventions. 
Let me supplement the data on the general population with 
two selected observations on infant mortality, a subject I have 
worked on for 60 years. Figure 1, taken from an annual paper 
I do on vital statistics for the journal Pediatrics, illustrates a 
pervasive problem in our society; far poorer health status in 
some population groups. The widening discrepancy between 
white and black infant mortality rates runs counter to the 
e.xpectation that, other things being equal, higher rates ought 
to come down more rapidly than rates that have already 
reached lower levels. But all things are not equal. Differences 
in environmental conditions and access to quality health care 
for .Afro-Americans persist, and the results are obvious. 
Infant mortality is also a useful measure of our status 
internationally. Figure 2 compares the U.S. with four other 
countries, reasonably representative of the rest of the 
developed world. The scale is logarithmic, permitting direct 
comparison of speed of decline, irrespective of absolute 
differences in rates. 
Relative slowing of the U.S. decline has been a cause for 
serious national concern and can by no means be explained by 
the size ol our minority problem. It seems intolerable that the 
richest and most powerful nation in the world should have 
slipped from having the sixth lowest rate in 19.^0, when we 
were bettered by only a few small countries, to being 22nd in 
l‘‘H/. And the total population of the countries with rates 
better than ours now exceeds 500 million. 
Remaining \ igilant 
I his briel re\iew ol the past leads me now to speculate on 
luture public health priorities. Since I cannot hope to be 
exhaustive. I shall limit m\self to three general areas: 
• atteiitiiiii to the traditional aspects of public health; 
• publk health ellorts in ileveloping countries; 
• medu.il e.ire in the United States. 
First off, all the evidence indicates that concern with the 
more traditional aspects of public health must not slacken. 
Infectious diseases have not gone away. True, the World 
Health Organization (WHO) had unique success in 
eradicating smallpox, a disease with a centuries-long legacy 
of cutting down “princes and peasants.” But the microbial 
world is resourceful. The appearance of AIDS as a worldwide 
phenomenon of devastating proportions is but one example. 
The size of the problem and the way this disease has robbed 
us of some of our brightest minds worldwide illustrate why 
we must make a concerted and adequately financed attack an 
urgent priority. 
Thinking in quantitative terms, however, diseases of longer 
standing must not be forgotten. Measles and tuberculosis also 
are on the rise, though still on a relatively minor scale. These 
are portents; maintenance of adequate immunization levels in 
all sectors of the population must be a national priority. 
Targeting immunization programs for budget cutting is highly 
misguided. 
Having controlled bacterial and parasitic “pollution,” the 
developed countries must now turn to problems in the 
chemical and physical environment; such dangers occupy 
enough space in the media to obviate discussion here. But the 
media seem to pay less attention to the health danger of 
ionizing radiation. There is now general recognition that 
whoever starts a nuclear war signals the suicide of mankind. 
How then can anyone justify continuing testing of nuclear 
weapons and the resultant increase in environmental danger? 
Secondly, the vast majority of the world’s 5,000 million 
people live in countries with what we would consider 
unacceptable health resources and environmental conditions. 
It is naive to assume that in the 20th, let alone the 21st 
century, we in the West can isolate ourselves and not be 
affected by health conditions abroad. Nor is this a question 
solely of infectious diseases. The cycle of ill health and 
poverty exaggerates international tensions, threatening the 
“haves” as well as the “have-nots” and leading too often to 
armed conflicts that may spread like any other epidemic. 
Our country has been a leader in international health 
cooperation. The Agency for International Development, 
within its limits as an arm of our State Department, has a 
distinguished history in helping many countries in crucial 
health areas. Furthermore, the United States took the lead in 
establishing and supporting the Pan American Health 
Organization in 1902 and was a potent force in later starting 
the World Health Organization and encouraging its growth. 
Yet WHO’s accomplishments, while considerable, are far less 
than its potential. 
Is it not a national scandal that our country is crippling 
WHO’s programs by being in serious arrears since 1985, in 
effect welshing on the dues we accepted as a formal 
obligation? As of this writing, WHO puts the sum of our 
arrears and current assessment at $111.2 million. Yet this is 
not because of any disagreement with WHO health policies; 
the United States has, in fact, praised WHO fiscal 
management. Even countries as poor as Haiti and Bangladesh 
pay their dues regularly! 
Finally, I come to medical care. Although I believe that 
continued attention to preventive activities must be a priority, 
the data 1 have shown emphasize that high quality medical 
care is central to better health for all. Inequities and 
unevenness in medical care must be overcome if the United 
States is to reach its national potential and catch up to the rest 
of the world. It is simply not enough to say that the United 
States provides the finest care available anywhere—if one can 
afford it. 










Figure 2. Trends in infant mortality rates, five countries, 1930-1987. 
During my early years in public health, many of my 
colleagues believed that medical care should not be a concern 
of government. In 1948, the American Public Health 
Association almost split before adopting a mild statement 
supporting the principle of health insurance for all Americans. 
Now, at least, there is growing consensus that assurance of 
available, accessible and acceptable medical care to 
everybody is a national responsibility. Many argue that a 
national plan would be too expensive, yet with our current, 
chaotic approach, few can suggest that we are getting our 
money’s worth. 
It is a bit sad that warnings from decades ago about 
escalating medical costs are just now hitting home. Secretary 
of Health and Human Services Louis J. Sullivan predicts that 
our health care costs will reach $1.5 trillion by the year 2000. 
Personally, that figure, incomprehensible as it is, doesn’t 
frighten me. We could afford it — if only we were to receive 
the full value of every dollar we shall spend. As it stands, 
absurd fragmentation has led to huge waste and billions of 
dollars squandered in needless duplication and administrative 
complexity. Individuals have their costs paid by multiple 
units, some public and some private. Highly trained 
physicians waste increasing amounts of time in paperwork 
instead of caring for patients; doctors are very expensive 
clerks. 
More than 20 years ago, I chaired the Comprehensive 
Health Planning Council of Southeast Michigan, seeking 
public and private cooperation for an area of 5 million people. 
Interestingly, the push to do something about rational 
planning came primarily from the big auto companies and the 
unions, working together. Objections and foot-dragging came 
from the organized medical profession. In the end, the 
initiative failed. Now, as evidence of waste and unnecessary 
expense mounts, business and labor are bringing renewed 
pressure. 
Canada, our neighbor, with better health indices and lower 
costs, presents an example that merits serious study. But 
Canada does not have all the answers. Persistence of fee-for- 
service remuneration reflects serious problems. Industry long 
ago demonstrated that productivity does not depend on piece 
work. 
Yale people were early leaders in trying to reform medical 
care. In the 1930s, during my house staff years. Dr. John 
Punnett Peters, the John Slade Ely Professor of Internal 
Medicine, formed the “Committee of 430,’’ one of the earliest 
groups from within the medical profession that called for 
reform in health care organization. It is no reflection on Dr. 
Peters or his many successors among medical leaders that a 
rational plan has not yet been achieved. 
Yale’s EPH department has a distinguished record in 
health services research over the years, as well. There is 
plenty of “room at the top” for Yale once again to take a 
national leadership role; the department’s current 
reorganization appears to be a major step toward achieving 
this end. 
I’d like to close on an aspect of public health I have 
referred to only indirectly thus far — the quality of life. It is 
easy in the desire to quantify health status and progress to 
concentrate too much on just reducing mortality rates. But 
clearly, keeping people alive is not enough. One pundit put it 
well: “The basic objective of public health is to help everyone 
die young — as late as possible.” Society needs to provide the 
environment, in the broadest sense, that permits every person 
to enjoy life to the extent of his or her capacity. That’s a goal 
every health worker can accept gladly. YM 
Yale Medicine FallAVinter 1990-91 25 
STUDENT RESEARCH DAY 1990 
At the poster session. Dr. Robert //. Gifford confers with Sonya Ei 
Opening Remarks 
The tradition of inedical student research at Yale goes back 
about ]s() years. We remain one of the few, if not the only 
medical school that requires a completed, bound thesis as a 
requirement for graduation. Thus, the thesis project stands as 
one of the cornerstones of the Yale System of medical 
education. 
'fhis important exercise graphically illustrates to each 
student how difficult it is to implement and to write up quality 
research. It fosters an appreciation of the scientific literature 
and a more critical appraisal of published results. It often, but 
not always, leads to new infomiation. 
However, in many ways, the student research process is 
more important than the results, especially the experience 
uith sophisticated research techniques and the one-on-one 
relationship uith a faculty advisor. Many students become so 
engrossed in their projects that they decide to spend an 
aiklitional year in medical school to pursue their investigation 
111 greater depth. 
In nH-ent \ears, thanks to the efforts of the office of student 
ri-si-areh anti its tlirector. Dr. John N. Forrest Jr., a number of 
• m. M t-r lellowships have been made available to support 
* l Uerestetl m a fifth year devoted to research. Many of 
ih:-s. [-r..;:Tts liave been tir will be published in the near 
iUiie si man\ have been presented at national meetings. 
■ ; s' ulents sDinmence their thesis work in the summer 
s■■ eu ir first year of medical school. They choose a 
ickson, '90. about her historical research. 
thesis advisor and a topic that interests them. The topic does 
not have to involve “wet bench” research. Some students 
select clinical projects involving patients or chart reviews. 
Some opt for projects in public health. Some tackle subjects 
in medical ethics or medical history. Whatever the subject, it 
is essential that there be a hypothesis; the student must ask a 
question and figure out how best to answer it or to prove the 
hypothesis using the scientific method. 
During that first summer, many choose a faculty sponsor 
and begin a long, close student-faculty collaboration that 
extends into the senior year. The final written thesis must be 
approved by the sponsor and read and approved by a 
departmental thesis committee. Some theses are later 
designated by the various departments for honors and these 
are forwarded to members of the Medical School Thesis 
Committee where they are read and discussed. That group 
decides on the five theses that merit presentation here and 
identifies those to be awarded prizes at graduation. 
I would like to express my appreciation to all who worked 
so hard to make Student Research Day a success, especially 
the students who have participated, their faculty sponsors, 
Mrs. Virginia Simon and biomedical communications. 
Assistant Dean Betsy Winters and Ms. Nancy Dometios in the 
office of student research. 
Dr. Robert //. Gifford 
Associate dean for education and student affairs 
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Abstracts 
Identification for RNA splicing errors resulting in human 
ornithine transcarbamylase deficiency 
Russ P. Carstens 
Faculty advisor: Lean E. Rosenberg, M.D., the C.N.H. Long 
Professor of Human Genetics, Medicine and Pediatrics 
Ornithine transcarbamylase (OTC) is an X-linked, liver 
specific enzyme which catalyzes the second step of the urea 
cycle. In humans, inherited deficiency of OTC in hemizygous 
affected males usually results in severe ammonia intoxication 
and early death. In order to characterize mutations responsible 
for OTC deficiency, we used the polymerase chain reaction to 
amplify cDNAs prepared from patient livers, obtained at 
autopsy, which demonstrated no OTC enzyme activity. Of 11 
livers tested, it was possible to produce amplifiable cDNA 
from seven. In three of these seven cases, smaller than normal 
products were observed. Sequencing of the cDNAs revealed 
that two were missing exon 7 of the OTC gene and that the 
other was missing the first 12 base pairs of exon 5. 
Sequencing of genomic DNA from these patients revealed 
that one mutant missing exon 7 had a point mutation causing 
a T to C substitution in the 5’ splice donor site of intron 7. 
The other mutant missing exon 7 had an A to G change in the 
third position of intron 7. Interestingly, both of these 
mutations resulted in skipping the preceeding exon, rather 
than inclusion of some or all of the affected intron 4. Here, the 
cryptic splice acceptor site within exon 5 was used. Although 
each of the deletions was in frame. Western blotting of liver 
homogenates from these patients with anti-OTC antiserum 
showed no immunoreactive material. Northern blotting of 
liver RNA from these patients demonstrated reduced but 
significant amounts of OTC mRNA in one of the patients with 
a deleted exon, but dramatic reduction in OTC mRNA in the 
other two. We propose that these point mutations, which 
result in abberant splicing of the OTC pre-mRNAs, lead to 
OTC deficiency through either decreased efficiency of mRNA 
export from the nucleus to the cytosol or synthesis of enzyme 
subunits that are unstable and rapidly degraded. These are the 
first examples of human OTC deficiency resulting from 
mutations that cause production of abnormally spliced 
mRNAs and may represent a common mechanism involved in 
the pathogenesis of this disease. 
Dean Leon E. Rosenberg congratulates those who made oral thesis presentations: (from left) Sanjoy 
Sundaresan, Russ P. Carstens, Mark A. Dettelbach, Guy M. McKhann and Beverly J. Stoute. 
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Intraperitoneal delivery of free fatty acids induces severe 
h\pocalcemia in rats; a model for hypocalcemia of 
pancreatitis 
Mark Dettelharfi 
f ill i(lt\ advisor: Andrew F. Stewart. M.D.. associate 
professor oj me die me 
Hypocalcemia is a regular feature of severe pancreatitis. 
Indirect evidence suggests a causative role for intraperitoneal 
free fatty acids generated by the action of pancreatic lipase on 
peritoneal and retroperitoneal fat. We therefore examined the 
effects of direct intraperitoneal injections of free fatty acids 
on serum calcium in rats. Four free fatty acids were selected 
based on their natural abundance in animal fat. Two saturated 
free fatty acids, stearate and palmitate, induced little or no 
hypocalcemia. In contrast, the two unsaturated free fatty 
acids, oleate and linoleate, which together account for the 
majority of free fatty acids in animal fat, caused dramatic 
hypocalcemia in treated versus control rats (6.3 ± 1.4 and 5.3 
± 0.7 mg/dl, respectively, versus 10.1 ± 0.5). Dose-response 
studies demonstrated that even minute quantities of oleate 
(3(K) and KM) p per 250 gm rat) caused marked hypocalcemia 
(7.2 ± O.S and 7.2 ± 0.3 mg/dl, respectively). Studies of 
treated versus control rats also revealed a decrease in ionized 
calcium (3.15 ± 0.2 versus 5.6 ± 0.05. p < .001) and 
magnesium (1.4 ± 0.15 versus 2.0 ± 0.10, p < .001), an 
appropriate increase in PTll levels (1670 ± 451 versus 296 ± 
142 pg/dl, p < .001), and a fall in calcitonin levels (70.4 ± 
16.4 pg/ml, p < .002) but no change in albumin or phosphate 
levels. In vitro, the Ksp of calcium dioleate was shown to be 
5.3 X 10 -S M 3/L 3: thus at physiologic levels of calcium and 
free fatty acid. 100 p of oleate binds 7.2 mg of calcium, or 
approximately twice the total ECF ionized calcium in the rat. 
.Amounts of intraperitoneal free fatty acids which can 
easily be achieved in pancreatitis find pathophysiologically 
significant amounts of calcium and can lead to severe 
hy pocalcemia. This model strongly suggests a role for free 
fatty acids in the etiology of pancreatitis-associated 
h\ pocalcemia. 
Neurochemical changes in the hippocampus in human 
temporal lobe epilepsy 
Sanjoy Sundaresan 
Faculty advisor: Nahal DeLenerolle, D.Phil., associate 
professor of surgery (neurosurgery) 
Medically intractable temporal lobe epilepsy (TLE) is 
commonly treated surgically by antero-medical temporal 
lobectomy, which includes removal of the hippocampus. In 
patients with temporal lobe epilepsy of unknown etiology 
(CTLE), such surgery results in seizure control, implying the 
presence of a seizure focus within this tissue. The hippocampi 
from such patients; from patients with TLE resulting from a 
lesion (TTLE); and from autopsy controls were examined by 
autoradiographic techniques for the localization of receptors 
(glutamate, GABA A, adenosine Al, muscarinic, NPY, 
opiate); second messengers (adenylate cyclase, protein kinase 
C); and sodium-potassium ATPase. The distribution of the 
opioid peptide dynorphin was studied by 
immunocytochemistry and in situ hybridization. These studies 
show that TTLE hippocampi are similar to those of autopsy 
controls. The CTLE hippocampi displayed changes in the 
above substances which are consistent with mechanisms that 
may increase the excitability of hippocampal principal 
neurons. The pattern of distribution of glutamate receptor 
subtypes provides insight as to the selective vulnerability of 
neurons in the hippocampus due to excitotoxic injury: CAl 
and CA4 neurons which show upregulation of NMDA and 
QA receptors are in areas most affected, while granule cells 
which do not show these changes are least affected. The 
development of a seizure focus and hippocampal injury in 
epilepsy thus seems to be related to cellular and biochemical 
reorganization of the hippocampus. 
Robin Hornung's research into 
AIDS prevalence among 
pregnant women and their 
children in Tanzania attracted 
the attention of Dr. Anthony S. 
Fauci, who delivered the third 
annual Lee E. Farr, M.D., 
Lecture. Dr. Fauci is director of 
the National Institute of Allergy 
and Infectious Diseases. 
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Russ Carstens and Beverly Stoute 
share a lighter moment with 
Dr. Farr, ’33, and his wife Miriam. 
Effect of low temperature on the trafficking of 215 kD 
mannose-6-phosphate/IGF-ll receptors in rat clone 9 
hepatocytes 
Beverly J. Stoute 
Faculty advisor: Marilyn Farquhar, Ph.D., Sterling Professor 
of Cell Biology and Pathology 
Reduction in temperature has been used extensively as a tool 
for disrupting membrane and intracellular protein traffic at 
defined stations along both the endocytic and exocytic 
pathways. In the present study, the effect of low temperature 
on the intracellular trafficking of mannose-6-phosphate 
(Man6P) receptors in rat Clone 9 hepatocytes was 
investigrced using indirect immunofluorescence (IF) and 
immunoperoxidase (IP) localization of receptors at the 
electron microscopic level. Clone 9 hepatocytes were treated 
with ammonium chloride (NH 4 Cl) or chloroquine for 1 hour, 
2 hours, and 3 hours at 37°C and at 20°C to follow receptors 
as they became progressively trapped in endosomes. The 
percentage of cells with “Golgi,” “Mixed Endosomal-Golgi,” 
and pure “Endosomal” immunofluorescence signals was 
determined at each time point. The presence of 
immunodetectable Man6P receptor in each intracellular locale 
at the IE level was confirmed by diaminobenzidine 
localization at the electron microscopic level. To follow 
receptors as they recycled back to the Golgi complex. Clone 9 
hepatocytes were first treated with NH 4 Cl or chloroquine for 
3.5 hours at 37°C to trap receptors in endosomes, then 
incubated in weak base-free media at 37°C and at 20°C to 
allow receptors to travel back to the Golgi complex. Results 
reported in this study demonstrate that the trafficking of 
Man6P receptors from the Golgi complex (receptor sorting 
site) to endosomes (receptor delivery site) proceeds at a 
slower rate, but is not disrupted at 20°C. The results obtained 
using NH 4 Cl and chloroquine are identical except that the 
recycling of Man6P receptors back to the Golgi complex after 
chloroquine removal is slower than recycling after NH 4 Cl 
removal. We conclude that movement of intracellular Man6P 
receptors from the Golgi complex to endosomes and recycling 
from endosomes back to the Golgi complex proceeds at 20°C, 
indicating that Man6P receptor traffic is not sensitive at this 
temperature. 
Isolation and characterization of human T-cell 
lymphotropic virus type-1 from patients with tropical 
spastic paraparesis 
Guy M. McKhann II 
Faculty advisor: Gueh-Djen Edith Hsiung, Ph.D., professor 
emeritus of laboratory medicine 
Endemic tropical spastic paraparesis/HTLV-1 associated 
myelopathy (TSP/HAM) is a slowly progressive chronic 
neurological disorder that is manifested clinically by spastic 
paraparesis frequently in association with bowel and bladder 
dysfunction. It is one of the most common chronic neurologic 
disorders in many endemic foci around the world. Human T- 
lymphotropic virus type 1 (HTLV-1) has been etiologically 
associated with TSP/HAM based primarily on the high 
prevalence of antibodies to HTLV-1 in the serum and CSF of 
affected patients. We report here the isolation of HTLV-1 
from peripheral blood lymphocytes and cerebrospinal fluid 
derived mononuclear cells of TSP/HAM patients by 
stimulation with interleukin-2 and cocultivation with 
umbilical cord blood mononuclear cells. Established cell lines 
contained HTLV-1 antigen as demonstrated by 
immunofluorescence and cell-associated virus particles as 
observed by electron microscopy; low-level reverse 
transcriptase activity was detected in cultures expressing viral 
antigens. Virus infected cultures were transformed in vitro as 
determined by their loss of contact inhibition and their 
continuous growth in the absence of exogenous IL-2. Of 
particular significance was our isolation of HTLV-1 from 
three family members with TSP/HAM of varying duration 
and clinical severity. 
This study resulted in the first isolation of virus from a 
cluster of TSP/HAM patients within the same family, the first 
isolation of virus from a childhood case of TSP/HAM, and the 
first in vitro transfromed HTLV-l-infected cells from 
TSP/HAM patients. In addition, the methodology applied in 
this investigation subsequently has been used to consistently 
isolate virus from HTLV-1 infected persons from widely 
separated geographic locations. This work supports a 
causative role from HTLV-1 in the pathogenesis of 
TSP/HAM and helps to extend the spectrum of disease that 
may result from HTLV-1 infection. 
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GALLERY 
''Portrait of Bernardino RamazzinV^ by Johann Georg Seilla 
This benevolent portrait of Ramazzini appears in his 
posthumous Opera Omnia (Geneva, 1717) as the 
frontispiece. The print is a copper plate engraving with its 
characteristic sharply cut lines, which is the most common 
fomi of book illustration at the time. Johann Georg Seiller 
of Schaffhausen was a painter and engraver primarily of 
portraits, including one in 1705, of Joseph I, Emperor of 
the Holy Roman Empire, and another with the tantalizing 
title, “A monk attempting to kiss a girl.” 
Janice Braun 
Medical Historical Library 
Bernardino Ramazzini (1633-1714) 
ua.s born in Carpi, a town in north 
central Italy a few miles north of 
Modena. He studied both medicine 
and law at Pamia and received his 
doctorate in medicine in 1959. 
In 17()(). Ramazzini's work 
entitled De morhis artificum 
diatriha was published; five years 
later, the Latin work was translated 
into English (although not 
adequately until 1940) as Diseases 
of Tradesmen. This was the first 
treatise to address comprehensively 
the infirmities provoked by the 
hazards of one's livelihood, that is, 
occupational health. 
Ramazzini deals with a variety 
of trades people, such as miners of 
metals, wet-nurses, corpse-bearers 
and fishermen. He also offers 
advice for workers who stand, 
sedentary workers and those who 
strain their eyes over fine work. A 
dissertation on "Diseases of 
Learned Men" is included as well, 
lest it be thought that only those 
involved with physical labor were 
subject to health hazards. 
Ramazzini discusses 
occupational health and hygiene in 
a practical yet poetic manner, 
combining quotations from 
classical verse with his own erudite 
prose. In the 1713 supplement, 
vshich augments the original edition 
by 12 entries. Ramazzini muses on 
the nature of weaving; 
How useful or rather how’ necessary is the 
w eaver's art we can decide from the fact that 
every livini; soul covers his nakedness with some 
sort oj woven stuff. Nor should we j’rumhle at 
Nature for having bestowed plumage on birds and 
on every animal a hairy coverini>, while man 
(do/ie she has left naked. Lor man has inventive 
lalent.s and hands with which to weave for himself 
many difjerent kinds of clothin}’. not merelv as a 
(in crim; but also to adorn and beautify himself. 
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SCOPE 
Joining in Yale-New Haven Hospital’s groundbreaking (from left): Deputy Dean 
Donald M. Donaldson; Dr. Gary Friedlaender, chairman and chief, orthopaedics 
and rehabilitation: Dr. Paul G. Barash, chairman and chief, anesthesiology; 
M. Patricia Gibbons, R.N., YNHH’s vice president of nursing: and Dr. Joseph 
Warshaw, chairman and chief, pediatrics. 
YNHH Breaks Ground 
For New Building 
After months of preparations, on 
Sept. 26, Yale-New Haven Hospital 
(YNHH) broke ground for an 11-story 
building — which includes a 
children’s hospital — and the 
renovation of its Memorial Unit. In 
August, YNHH received approval 
from the state Commission on 
Hospitals and Health Care (CHHC) 
for the construction, which is 
scheduled for completion in 1993. 
Key points of the facilities renewal 
project include: construction of the new 
patient care building with all private 
rooms; renovation of the Memorial Unit 
and elimination of three- and four-bed 
rooms; expansion of emergency room, 
operating room, diagnostic imaging and 
radiation therapy facilities. 
The CHHC granted a bed increase of 
25, bringing the hospital’s licensed bed 
capacity up to 900; this will allow 
YNHH to increase its number of beds 
and bassinets by 68. The total capital 
expenditure approved was $153 million 
for 445,0(X) square feet of new 
constmction and 300,0(X) square feet of 
renovation. 
In anticipation of the YNHH 
building project, the nursing school has 
moved into temporary quarters in the 
Grace Building. The University has 
commissioned the New York 
architectural firm of Williams and Tsien 
to design and oversee the constmction 
of a new School of Nursing on the 
medical center campus. 
Maternal HIV 
Transmission 
Less than 20 Percent 
More than 80 percent of babies bom to 
women infected with the AIDS vims 
are free from infection and symptoms 
three years after birth, according to a 
study by School of Medicine 
researchers. 
Dr. Warren A. Andiman, associate 
professor of pediatrics and epidemi¬ 
ology and medical director of the AIDS 
Care Program at Yale-New Haven 
Hospital (YNHH), directed the study 
which examined 116 babies bom to 
women infected with the Human 
Immunodeficiency Vims, or HIV, the 
vims responsible for AIDS. The 
researchers reported their results in the 
July issue of the American Journal of 
Diseases of Children. 
Since babies acquire antibodies to 
many diseases from their mothers, 
infants of HIV-infected mothers will 
test positive for HIV antibodies at birth, 
says Dr. Andiman. But most infants 
lose their HIV antibodies after birth and 
will not exhibit signs of infection during 
the first years of life. Other studies have 
estimated the matemo-fetal 
transmission rate at 24 to 33 percent. 
Co-authors of the article are B. Joyce 
Simpson, R.N., YNHH; Betty Olson, 
A.A.S., research associate, Yale; Dr. 
Laura Dember, ’88, the Hospital of the 
University of Pennsylvania; Dr. 
Thomas J. Silva, ’90, Children’s 
Hospital, Boston; and Dr. George 
Miller, the John F. Enders Professor of 
Pediatrics and professor of 
epidemiology and of molecular 
biophysics and biochemistry. Dr. Miller 
is also chief of the section of pediatric 
infectious diseases at YNHH. 
Secondhand Smoke 
Puts Youth at Risk 
Nearly 17 percent of lung cancer deaths 
among nonsmokers can be traced to 
secondhand cigarette smoke they 
inhaled as children or adolescents from 
their smoking parents. A Yale research 
team led by Dr. Dwight T. Janerich, 
professor of epidemiology and in the 
Cancer Center, reported the findings in 
the Sept. 5 edition of the New England 
Journal of Medicine. 
The study involved almost 400 
pieople throughout upstate New York. It 
found that the risk of lung cancer was 
double that of other nonsmokers. If 
these figures are confirmed, annually 
1,7(X) deaths in the United States are 
caused by childhood exposure to other 
people’s cigarette smoke. 
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Researchers Join 
National Infant Study 
I'he Sch(K)l of Medicine, Yale-New 
Haven Hospital (YNHH) and 
Quinnipiac College collaborated with 
resetirchers at seven other sites across 
the country in the Infant Health and 
Development Program, a national study 
of u hether intervention programs 
improve the development of premature, 
low-birth-weight infants. 
David T. .Scott, Ph.D., an associate 
professor of pediatrics and a 
developmental psychologist at YNHH 
directed the New Haven segment of the 
study. Results for the national study, 
which involved more than 1,(KK) 
infants, uere reported in the June 13 
issue of the Journal ofllic American 
Medical Association. 
'Hie Neu 1 laven researchers studied 
126 premature babies, most from New 
Haven County. 'I’he babies, weighing 
5.3 pounds or less, were bom at YNHH 
in 19X4 and I9S5, and were cared for at 
the Newborn Special Care Unit. 
"All t)f the children in the trials 
received high quality follow-up services 
that included physical examinations, 
developmental evaluations and referral 
sen. ices," notes Dr. .Scott. 
Researchers randomly chose which 
babies would receive extra sen ices. 
including weekly home visits during 
their first three years of life. During 
their second and third years, these 
children also attended a special child 
development program h)r premature 
babies run by the Quinnipiac College 
Day-Care Center. 
bivalualions at age three showed 
significant IQ score improvements for 
children who received the extra 
educational sen ices. In a second phase 
of the study, researchers are tracking the 
children's progress after completing the 
specitil intenention program. 
Hoys Often Mistaken 
For Reading Disabled 
fhe "snips and snails and puppy dog 
tails" little boys are made of may result 
in their teachers misclassifying them as 
reading disabled, as revealed by a study 
led by Dr, .Sally If Shaywit/, asscK’iate 
.irolessoi of (v.xiiatrics and in the Child 
: :dy ^ ^-liter. 
I" : !‘neral, 'i-aehers rate Niys as 
: . lnil•^ more aetive, more 
inattentive and less dextrous and as 
having more problems in behavior, 
kinguage and academics than their 
female peers,” reports Dr. Shay witz and 
colleagues in the August 22 Journal of 
the American Medical Association. Yet, 
despite teacher reports of difficulties in 
the classroom, the researchers’ 
measures of the overall ability and 
achievement of boys turned out to be 
comparable to that of girls. 
The authors studied reading levels in 
445 children from six geographic 
regions in Connecticut. The 235 girls 
and 210 boys were followed from 
kindergarten through the third grade. 
Co-authors on the study include: 
Bennett A. Shaywitz, M.D., professor 
of pediatrics, neurology and in the Child 
Study Center; Jack M. Fletcher, Ph.D., 
department of ptediatrics, the University 
of Texas, and Michael D. Escobar, 
Ph.D., associate research scientist in 
public health (biostatistics). 
Foundation Funds 
Sexual Abuse Program 
The New Haven Foundation has 
awarded a $.54,(KX) grant to the 
depiulment of pediatrics to expand its 
Sexual Abu.se Evaluation Program and 
enhance the program’s affiliations with 
local organizations concerned with 
children at risk.“We want to make sure 
that a child with a complicated case 
doesn’t get lost between the cracks in 
the system,” says Dr. John M. 
Leventhal, medical director of the 
program and associate professor of 
pediatrics. “The grant will enable us to 
follow through more thoroughly with 
such cases.” 
The funding also will help establish 
outreach with hard-to-contact families 
in which children have been suspected 
of being sexually abused and with 
sexually abu.sed children who are more 
comfortable talking about their situation 
in their own home. 
Julia P. Hamilton, M.S.W., the 
program’s co-director, adds, “We also 
hojx’ to start a one-day training program 
for members of the state Department of 
Children and Youth Services, along 
with members of community and health 
care agencies, to better educate them 
about the problem of sexual abuse.” 
Ms. Hamiliton also is chief social 
worker for ambulatory care at Yale- 
New 1 laven 1 lospital and assistant 
clinical professor of pediatrics. 
The program began in 1985 in 
response to a dramatic increase in 
reports of sexual abuse among children. 
Dr. Leventhal reports: “We see between 
180 and 200 children per year suspected 
of being sexually abused, with an 
average age of 7.” 
Tlie program is a collaborative effort 
of the School of Medicine’s department 
of pediatrics, the YNHH department of 
.social work, the School of Nursing 
Pediatric Nurse Practitioner Program 
and YNHH Primary Care Center. The 
evaluation team includes a medical 
director, co-director, two nurse 
practitioners and two social workers. 
Gene Mutation Linked 
To SIDS Symptoms 
An enzyme deficiency that sometimes 
masquerades as sudden infant death 
syndrome (SIDS) can be traced to a 
single genetic mutation in most cases, 
paving the way for genetic screening 
for the disorder, report researchers at 
Yale and the University of 
Pennsylvania. 
The disorder results from a 
deficiency of the enzyme MCAD, or 
medium chain acyl-CoA dehydro¬ 
genase. MCAD helps the body use its 
stored fat to generate energy. People 
who lack a normally functioning 
MCAD gene have a problem breaking 
down fatty acids and are susceptible 
to sudden drops in blood glucose levels, 
leading to lethargy, vomiting and coma. 
Babies and children who lack the 
enzyme can suddenly lapse into a 
coma and die, says Dr. Kay Tanaka, 
professor of human genetics at Yale. 
Since such symptoms occur in SIDS, 
researchers think some babies who 
apparently died of SIDS probably had 
MCAD deficiency, he adds. 
The disease appears to be most 
common among people of northern 
European descent. Studies done in 
England have estimated that as many 
as one in 100 people carry the gene, 
meaning that approximately one in 
10,000 people will have the di.sorder. 
Dr. 'Tanaka, Paul M. Coates, Ph.D., 
professor of pediatrics at the 
University of Pennsylvania and a 
researcher at the Children’s Hospital 
of Philadelphia, and their colleagues 
report in the September issue of the 
Journal of Clinical Investigation that 
MCAD deficiency is apparently due 
to a single genetic mutation in 8 out 
of 9 cases. 
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In his commencement address to the EPH Class of 1990, Dr. Benjamin Spock said, “The major problems facing our 
children today include over-competitiveness; physical punishment; violence on television.... The problems are a lack of 
daycare and the need for more inspiring schools.” He added, “There’s no reason why we in the United States shouldn’t 
have a good health care system. . . It’s horrible, it’s indecent, it’s immoral that people by the hundreds of thousands are 
wandering the streets without any place to live in the richest country the world has ever known, even as trillions of dollars 
are being wasted adding to our nuclear arsenal despite the improvement in our relationship with the Soviet Union.” 
Protein May Lead 
To Diabetes Test 
A protein that plays a key role in the 
development of insulin-dependent 
diabetes has been identified by a team 
of researchers from Yale and 
University of California at San 
Francisco (UCSF) medical schools. 
The finding could lead to a test to 
screen for people likely to develop 
insulin-dependent, or Type I, diabetes 
mellitus. Often called juvenile-onset 
diabetes, it is the most severe form of 
diabetes, afflicting nearly a million 
Americans who come to require daily 
insulin injections. 
The discovery may make it 
possible to diagnose those prone to 
developing Type I diabetes as early as 
eight years before symptoms appear, 
and could lead to preventive therapy. 
The researchers report their findings 
in the Sept. 13 issue of Nature. 
Pietro De Camilli, M.D., associate 
professor of cell biology at Yale, 
Steinunn Baekkeskov, Ph.D., assistant 
professor of microbiology/immunology 
and medicine at UCSF, and their 
colleagues established that the 
enzyme glutamic acid decarboxylase 
(GAD), is the protein that stimulates 
the production of antibodies in the 
blood of many people who eventually 
develop diabetes — often years 
before symptoms appear. These 
antibodies were first discovered in 
diabetics eight years ago, but the 
identity of the protein that stimulated 
them remained a mystery. GAD is 
found in insulin-secreting cells of the 
pancreas and in many neurons. 
Medical Education 
Project to Begin 
Yale University is one of 12 U.S. 
medical schools selected to participate 
in the Robert Wood Johnson 
Foundation’s major initiative to reform 
medical education. The foundation’s 
planning grant of up to $150,(XX) will 
enable the school to “chart a strategy for 
adapting its educational programs to 
prepare students to become physicians 
able to serve the health care needs of 
both the individual and the public.’’ 
Medical school Dean Leon E. 
Rosenberg comments: “These national 
foundation funds will help support the 
school’s efforts to review our 
curriculum and to implement 
recommendations made in 1988 by a 
special task force that evaluated our 
curriculum. Since then, we have been 
moving in directions parallel to the 
foundation’s initiative.” 
A year ago. Dean Rosenberg 
appointed Dr. Emile L. Boulpaep, 
former chairman of the cellular and 
molecular physiology department, as 
the first chairman of a 12-member 
Educational Policy and Curriculum 
Committee to carry out its broad 
mandate to change, integrate or manage 
the curriculum to adapt it to emerging 
needs. 
Three main program areas that 
complement the foundation’s objectives 
were identified. They include: 
• Finding new sites for clinical 
education, especially ambulatory, 
out-patient care settings such as 
health maintenance organizations. 
These settings reflect current shifts 
in the modes of delivering health 
care services. 
• Better integrating the teaching of 
basic sciences into clinical medicine 
programs, taking a physiological 
system- or disease-related approach. 
In addition, the school will 
encourage integrated programs 
between medical students and other 
health professional students through 
new curriculum initiatives, including 
shared teaching experiences. 
• Centralizing educational policy and 
curriculum governance. 
A cornerstone of the curriculum 
review is that the unique “Yale System” 
of medical education shall be preserved. 
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Cocaine Withdrawal Tied 
To Dopamine Metabolism 
School ot Medicine researchers report 
that the brain chemical responsible for 
cocaine's euphoria may also contribute 
to the intense craving addicts feel w hen 
they stop taking the drug. 
.A month-long study of six ccx'aine- 
addicted men. most of v\ horn smoked 
freebase ccxaine, revealed that after 
they stopped using the drug, their brains 
prtxessed less dopamine, a 
neurotransmitter responsible for the 
cwaine high. That craving helps keep 
addicts kxked in ctxaine’s potentially 
deadl) embrace. 
Researchers at the Clinical 
Neuroscience Research Lhiit of the 
Connecticut .Mental Health Center 
noted that during their subjects’ early 
withdrawal stage, the men exhibited 
increased dopamine metabolism, a 
development vv hich nomialized later in 
the stud)'. 
Dr. Christopher McDougle, a 
postd(K'toral research fellow in 
psychiatn,. presented his findings May 
16 at the annual meeting of the 
.American Psychiatric .Association. 
(i)ther authors include Drs. Lawrence H. 
Price, asscx'iate professor of psychiatry; 
Joseph Palumbo, fomierly a 
postdtx'toral fellow in psychiatry and 
now in private practice; Thomas R. 
Kosten, asscxiate professor of 
psychiatry; and Herbert D. Kleber and 
Ceorge R. Heninger, both professors of 
psychiatry. Dr. Kleber is on leave from 
'I'ale to sen. e as deputy director for 
demand reduction for the Office of 
National Drug Control Policy. 
C^)caine Prices Parallel 
Those of 1908 Epidemic 
Ixgali/ing dmgs won't necessarily 
remove profits from dmg trafficking, 
accortling to a comparison of cxxaine 
pricing undertaken by a School of 
Medicine physician-historian. 
('omparing prices to average wages, 
the current street price of ctxaine is 
similar to or even lower than cixaine's 
price during an epidemic of drug abuse 
that empted after the turn of the century 
I hen.: i raine was legally available in 
till- I s xplains Dr, David F, Musto. 
' • ■■ ■ >i psychiatry and the history 
' 1 >r. Musto compared the 
price of cocaine during two periods of 
drug abuse: 1908 to 1914 and 1982 
to 1989. 
“In terms of buying power, the cost 
of illicit cocaine in the early and the 
recent eras studied was similar,” notes 
Dr. Musto. 
His findings, published in the June 
issue of Connecticut Medicine, seem to 
negate the argument that drug 
legalization would reduce the crime 
associated with drug sales by 
undercutting black market profits. 
“Today’s advocates of the 
legalization of cocaine may be surprised 
to find out that the United States was 
the only major Western nation to allow 
unlimited distribution, sale and 
promotion of narcotics during the 19th 
century," says Dr. Musto. 
Anti-drug laws were passed in 
reaction to public experience with legal 
drugs. Dr. Musto adds. 
Lyme Organism Present 
A Half-century Ago 
Sophisticated genetic tests indicate 
that ticks carried the organism 
responsible for Lyme disease as long 
as 44 years ago. three decades before 
the disease was identified. 
The finding suggests that Lyme 
disease could have appeared in the 
1940s in eastern Long Island, where it 
may have been diagnosed as 
“Montauk knee" or “Montauk spider 
bite," says David Persing. M.D.. 
Ph.D., who directed the study while a 
researcher at the School of Medicine. 
Dr. Persing. now a staff clinical 
pathologist at the Mayo Foundation, 
and colleagues describe their research 
in the Sept. 21 issue of Science. Dr. 
Persing's Yale co-authors are Stephen 
E. Malawista, M.D., professor of 
medicine, and Paul N. Rys. a 
laboratory research scientist. 
Lyme disease, named for the 
Connecticut town where it was first 
identified in 1975 by Yale 
rheumatologists including Dr. 
Malawista, is caused by a spiral¬ 
shaped bacterium, or spirochete, 
called Borrelia burgdorferi. It is 
transmitted by the tick Ixodes 
dammini. In their research, the 
scientists employed an advanced 
genetic procedure called polymerase 
chain reaction, or PCR. The PCR test 
permitted them to look for the Lyme 
organism in museum tick specimens, 
often dried or preserv ed in alcohol. 
Traumatic Stress Causes 
Brain Chemistry Changes 
Traumatic events may substantially 
alter the chemistry of the brain, 
sensitizing victims to adrenaline surges 
decades later. This may account for 
symptoms of post-traumatic stress 
disorder (PTSD) and panic disorder, say 
researchers at the Department of 
Veterans Affairs Medical Center in 
West Haven and at the School of 
Medicine. Dr. Dennis S. Chamey, 
associate professor of psychiatry and 
director of the National Center for 
PTSD neuroscience division, presented 
the findings at a May 19 symposium at 
the annual meeting of the American 
Psychiatric Association in New York. 
People with PTSD typically have 
endured severe trauma such as military 
combat, child abuse, rape, torture or a 
natural disaster. Years later PTSD 
sufferers can exhibit “fight or flight” 
reactions in the absence of real danger. 
Other symptoms include flashbacks of 
the traumatic event, jumpiness, 
irritability, disturbed sleep, depression 
or feelings of guilt. 
Researchers at the National PTSD 
Center at West Haven have found that 
yohimbine — a drug commonly used to 
elevate blood pressure and treat 
impotence — triggers panic attacks and 
flashbacks in PTSD patients. On two 
occasions, the researchers administered 
either the drug or a placebo to 15 PTSD 
patients who are Vietnam veterans. 
Yohimbine induced panic attacks in 
60 percent of the subjects and triggered 
flashbacks in about half of them. In 
earlier studies, the drug brought about 
panic attacks in about 60 percent of 
more than 100 patients with panic 
disorder. 
Because yohimbine blocks the 
action of the alpha 2 receptor, a protein 
that stimulates the sympathetic nerv'ous 
system, the results support the 
hypothesis that trauma may alter brain 
chemistry in PTSD patients, sensitizing 
them to adrenaline surges. 
Dr. Chamey's co-authors include Dr. 
Steven M. Southw ick, director of FTSD 
programs at West Haven, and Dr. John 
H. Kry'sUil. chief of the center's 
Laboratory of Clinical Psychopharma¬ 
cology. Drs. Krystal and Southwick are 
assistant professors of psychiatry. 
The West Haven center is the only 
U.S. institution devoted to studying the 
biology iind psychopharmacology 
of PTSD. 
Yai.e Medicine Fall/Winter 1990-91 
Fetal Neural Cells 
Survive Transplantation 
Cryopreserved fetal brain cells 
implanted into the brain of a human 
patient have survived transplantation, 
report members of the Yale 
University Neural Transplant 
Program in the Sept. 29 issue of 
Lancet. 
Comments D. Eugene Redmond 
Jr., M.D., professor of psychiatry, 
“The grafted tissue demonstrated the 
capacity to survive, adapt, develop 
and mature in the adult human brain, 
as well as in the brains of monkeys. 
Grafts were recovered after the 
patient died of continuing 
complications of Parkinsonism which 
the team believes were unrelated to 
the transplant procedure. 
“Although this patient did not 
appear to benefit from the graft, the 
team remains optimistic about the 
success of the procedure and looks 
forward to determining the outcome 
from a current study involving 20 
patients,” Dr. Redmond adds. 
The clinical research procedure is 
based on fundamental scientific work 
and laboratory animal studies 
conducted for many years by School 
of Medicine biomedical scientists, in 
conjunction with colleagues at the 
University of Rochester. Private funds 
support this clinical research study. 
Study Offers Clues 
To OCD Physiology 
Researchers at the School of Medicine 
and at Brown University have found 
that fluvoxamine, an antidepressant, 
effectively relieves symptoms of 
obsessive compulsive disorder (OCD) 
in many patients. Besides providing 
doctors with another dmg to treat OCD, 
the research findings, described in the 
June Archives of General Psychiatry, 
strongly suggest that serotonin, a brain 
chemical important in transmitting 
nerve impulses between nerve cells, 
plays a major role in the disorder. 
Simple tasks often tyrannize people 
suffering from OCD. Some are 
obsessed with recurring and disturbing 
thoughts, ideas or images. Others feel 
compelled to perform repetitive tasks, 
such as washing their hands. Some 
At a reception following the Yale physician associates’ commencement on 
Aug. 28, graduates Jeffrey R. Smith and B. Sarah Schiefer converse with state 
Rep. Benjamin V. DeZinno Jr. Mr. DeZinno wrote a recently passed law 
allowing Connecticut P.A.s to write prescriptions, given a physician's approval 
within 24 hours. 
people have both obsessions and 
compulsions. An estimated 1 to 3 
percent of Americans will suffer from 
some form of OCD during their 
lifetime. 
“Our findings indicate that only 
those antidepressants which possess the 
ability to inhibit the transport of 
serotonin into nerve terminals are also 
effective against OCD,” says Dr. 
Goodman, assistant professor of 
psychiatry and director of the study. 
Serotonin is a multipurpose protein 
found in many places in the body, and 
is thought to be involved in controlling 
states of consciousness and mood. 
Dr. Goodman also chairs the 
Scientific Advisory Board to the New 
Haven-based Obsessive Compulsive 
Foundation, Inc., an organization that 
he co-founded with an OCD patient. 
Study co-authors from Yale include; 
Drs. Lawrence H. Price and Dennis S. 
Chamey, associate professors of 
psychiatry; Pedro L. Delgado, John H. 
Krystal and Linda Nagy, all assistant 
professors of psychiatry; Joseph 
Palumbo, a former postdoctoral fellow 
at Yale; and George R. Heninger, 
professor of psychiatry. Co-author 
Steven A. Rasmussen is with the Brown 
University School of Medicine. 
NEW BOOKS 
Diagnostic Dysmorphology, by Dr. Jon 
M. Aase ’62. Plenum Publishing (New 
York) 1990. 
Spinal Cord Compression: Diagnosis 
and Principles of Management, by Drs. 
Thomas N. Byrne, associate clinical 
professor of neurology, and Stephen G. 
Waxman, professor and chairman of 
neurology. F.A. Davis Co. 
(Philadelphia) 1990. 
Scientific Foundations of Sports 
Medicine, ed. by Dr. Carol C. Teitz, 
’74. B.C. Decker (Toronto) 1989. 
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HARVEY CUSHING/JOHN HAY WHITNEY 
MEDICAL LIBRARY 
(Left) A new information room is included in 
35,000 square feet of additional medical library 
space. This augments the previously available 
50,000 square feet, much of which was renovated. 
Total cost of the project: $10 million. 
(Right) At the dedication ceremony held on .lune 
7, Yale President Benno C. Schmidt ,lr. presents a 
framed architectural rendering of the medical 
library addition to Betsey Cushing Whitney as 
daughter Kate \\ hitney looks on. Mrs. Whitney 
and her family donated $S million to the project. 
/\.v a tribute to their generosity, the medical 
library has been renamed to honor two illustrious 
Yale College graduates. Mrs. Whitney's father. 
Dr. Harvey Cushing. IS91, and her husband, the 
laie.lohn Hay Whitney. 192b. 
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I 
t) Daylight streams into the information 
Architect Alexander Piirves, associate 
:sor of architectural design at Yale, 
led the renovated and expanded areas with 
Dehar Associates of New Haven. 
(Right) Renovation of the periodical room was 
made possible by a $1 million gift by Mrs. Belle 
Morse. The space was renamed the Morse 
Periodical Room to honor the memory of Mrs. 
Morse's husband, Stephen I. Morse, a 1925 
Sheffield Scientific School graduate, and her son, 
Stephen /. Morse, '51 M.D., Ph.D. 
(Left) Students prepare for classes in one of the 
libraiy's new study areas. Also included in the 
e.xpanded space is a computer system which 
connects to the University's fiber optics computer 
netvi’ork and which makes available more than 
400 electronic databases. 
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FACULTY NEWS 
Dr. Stephen Aryian, professor of 
surgerv', was recognized with a 
Distinguished Service Auard from the 
Society ot } lead tind Neck Surgeons for 
his outstanding contributions to the 
educational activities of the society. 
Mark D. Biggin, Ph.D., assistant 
professor ol molecular biophysics and 
bicKhemistry, was named a Pew 
Scholar in the Biomedical Sciences by 
the Pew Chiiritable Trusts of 
Philadelphia. He will receive a 
S2(K).(K)0 aw ard during the next four 
years to help support his research on 
detennining how proteins control the 
complex patterns of gene expression in 
tin orgtuiism. 
Dr. .Arthur E. Broadus, professor 
of medicine and head of the division of 
endcK'rinology, was awarded the annual 
Prederic C. FTirtter Award from the 
American StK'iety for Bone tind Mineral 
Research. I'he international award 
recognizes Dr. Broadus leading work 
on disorders asscK'iated with 
hypercalcemia, abnonnally high levels 
of bkxKl calcium. 
Dr. Lawrence S. Cohen, the 
Ebenezer K. Hunt Professor of 
Medicine, is president-elect of the 
■AsscK'iation of University Cardiologists. 
He will assume the presidency of the 
national orgtuiization in January 1991. 
Dr. Michael L. Dewar, assistant 
professor of cardiothoracic surgery, and 
Dr. .lohn A. Klefteriades, asstxtiate 
professor of surgery', have received a 
S16,9(X) grant from the American Heart 
.Ass(x'iation, Connecticut affiliate, to 
support an ex{x;rimental surgery project 
that uses skeletal muscle in an attempt 
to assist a failing heart. 
Dr. Rocko M. Fasanella, associate 
clinical professor of ophthalmology and 
visual science, received tin honorary 
degree from Sacred 1 leart University 
lor his research into eye surgery' and his 
pioneering Easanella-Sers at Operation, 
vshich corrects dnxrping eyelids. 
Oene K. (Jindi, Ph D., assixiate 
prolessor of ditignosiic radiology, has 
tx-en awtirdeil a ,^-year, $3.J5,(KK) grant 
from the Air 1-orce Office of Scientific 
Resetirch for basic research in the 
.ipplicalion of neural networks to image 
prik Ning and analysis. 
The 1990 Francis Gilman Blake Award for the most outstanding teacher in the 
medical arts was shared by G. Morris Dillard, M.D., Ph.D., associate professor 
of medicine (left), and Peter A. Grannnm, M.B.B.S., associate professor of 
obstetrics and gynecology. 
Susan Hockfield, Ph D., associate 
professor of neuroanatomy, has been 
named by Yale President Benno C. 
Schmidt Jr. to the University-wide 
faculty committee instituted to monitor 
the University's affinnative action 
efforts concerning faculty recruitment 
and retention of women, members of 
minority groups and handicapped 
IKTsons. 
Dr. Dorothy M. Horstmann, the 
John R. Paul Professor Emeritus of 
Epidemiology and Pediatrics and senior 
research scientist, received the 1990 
Alumnus of the Year Award for 
outstanding achievement from the 
Alumni-Eaculty Association of the 
University of California San Francisco 
School of Medicine. 
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Dr. Robert A. King, assistant 
professor in the Child Study Center, 
was the first recipient of the B’nai 
B’rith Women’s National Scholars 
Award for his contributions toward 
advances in children’s emotional health. 
He received the award in April during a 
special session of the organization’s 
biannual convention. 
Dr. Michael Lerner, associate 
professor of internal medicine, was 
awarded the Burroughs Wellcome 
Fund’s 1990 George Herbert Hitchings 
Award for Innovative Methods in Dmg 
Design for his research endeavors to 
harness the chemical reactions that 
enable frogs to change from green to 
brown. The $300,000 gift will support 
Dr. Lemer’s studies for five years, 
which he hopes will lead to a way for 
drug developers to rapidly screen 
experimental drugs for their potential 
efficacy. 
Drs. Robert A. Levine and Stephen 
C. Wardlaw, both clinical professors of 
laboratory medicine, received the “R & 
D 100” award, recognizing their design 
of the QBC Malaria Test as one of the 
most significant technical products of 
the past year. The QBC Malaria Test, 
which represents the most advanced 
malaria diagnostic method, was a joint 
effort with Becton Dickinson Tropical 
Disease Diagnostics. Also recognized 
was Dr. R. Rodion Rathbone, director 
of biomedical instrumentation and 
assistant clinieal professor of laboratory 
medicine, for the development of the 
light beam-splitting microscope adapter. 
Dr. Richard A. Matthay, professor 
of medicine, has been elected chairman 
of the Medical School Council for a 
two-year term beginning Sept. 1, 1990. 
Dr. Leonard M. Milstone, associate 
professor of dermatology, was the 
Dozor Visiting Professor at the Ben 
Gurion University Medical School in 
Beer Sheva, Israel, during the month of 
June. 
Dr. Eva-Pia Reich, associate 
research scientist in immunobiology, 
received the Juvenile Diabetes 
Foundation International Career 
Development Award and the Greenwall 
Foundation Award for her research on 
insulin-dependent diabetes mellitus. 
Judith S. Rodin, Ph.D., chairman 
and the Philip R. Allen Professor of 
Psychology, and Thomas A. Steitz, 
Ph.D., professor of molecular 
biophysics and biochemistry, have been 
elected fellows of the American 
Academy of Arts and Sciences. 
Professor Rodin is chairman of the John 
D. and Catherine T. MacArthur 
Foundation Research Network on 
Health-Promoting and Health- 
Damaging Behavior. Professor Steitz’s 
research involves the use of X-ray 
crystallography to determine the three- 
dimensional molecular stmcture of 
proteins and nucleic acids. 
Dr. Eva-Pia Reich 
Dr. John M. Sedivy, assistant 
professor of molecular biophysics and 
biochemistry, received a Presidential 
Young Investigator Award from the 
National Science Foundation to support 
his research on the normal functions of 
genes that control cell growth and 
development. He studies ways to halt 
mutant cancer genes without upsetting 
normal body function. 
Dr. Robert E. Shope, professor of 
epidemiology, has been appointed 
chairman of the steering committee of 
Dengue and Japanese Encephalitis 
Vaccine Development of the World 
Health Organization “Programme for 
Vaccine Development and Transdisease 
Vaccinology.” 
Dr. Norman J. Siegel, professor of 
pediatrics and medicine and director of 
pediatric nephrology, was appointed in 
April to the National Board of Medical 
Examiners Part II Pediatrics Test 
Committee. 
Dr. Stephanie S. Spangler, 
assistant clinical professor of obstetrics 
and gynecology, has been named 
director of the University Health 
Services Center (UHSC). The five-year 
appointment, announced by Yale 
President Benno C. Schmidt in May, 
took effect July 1. Dr. Spangler had 
been serving as acting medical director 
of UHSC since 1989. 
Dr. John S. Strauss, profes.sor of 
psychiatry, participated in Clark 
University’s conference entitled “What 
is Schizophrenia?” The conference, 
held in Worcester, Mass., brought 
together scholars and clinicians from all 
over the world to discuss questions 
relating to the identification and 
treatment of the debilitating mental 
illness. 
Dr. Joseph B. Warshaw, chairman 
and professor of pediatrics, has been 
elected to the Institute of Medicine. Dr. 
Warshaw’s research has led to a better 
understanding of normal fetal 
development, how babies adapt 
biologically to life after birth and other 
problems newborns have in an intensive 
care unit. He has also been a leading 
proponent for the development of a 
children’s hospital at Yale-New Haven 
Hospital. 
In November 1991, Dr. Barry L. 
Zaret, the Robert W. Berliner Professor 
of Medicine and Diagnostic Radiology, 
will assume the presidency of the newly 
formed Association of Professors of 
Cardiology. The organization of 
directors comprises cardiology sections 
at U.S. medical schools. 
Several faculty members have been 
named fellows of the American 
Association for the Advancement of 
Science: Lawrence B. Cohen, Ph.D., 
professor of cellular and molecular 
biology; Michael Davis, Ph.D., 
professor of psychiatry and psychology; 
Alan C. Sartorelli, Ph.D., director of 
the Comprehensive Cancer Center and 
the Alfred Gilman Professor of 
Pharmacology; and Dieter Gerhard 
Soil, Ph.D., professor of molecuku 
biophysics and biochemistry. 
Five members of the School of 
Medicine have been designated 
“Emeritus” by the Yale Corporation: 
Franklin Hutchinson, Ph.D., professor 
of molecular biophysics and 
biochemistry; William H. Prusoff, 
Ph.D., professor of pharmacology; 
Morton F. Reiser, M.D., the Albert E. 
Kent Professor of Psychiatry; Daniel S. 
Rowe, M.D., professor of pediatrics and 
public health; and Albert J. Solnit, 
M.D., Sterling Professor in the Child 
Study Center, Pediatrics and Psychiatry. 
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ALUMNI REPORT 
My asscK'iation with the School of 
Medicine began when 1 enrolled as a 
freshman in 1950. My classmates and 1 
were enthusiastic but concerned about 
u hat w as ahead of us. Our journey 
through medical school was guided by a 
superb faculty who taught us to be 
ctiring physicitms in the broadest sense 
of the temi. My training sustained me 
through my years of clinical practice in 
urology. 
Now, 40 years later. 1 am once again 
a freshman of sorts. I am honored to 
accept this appointment as director of 
alumni affairs and eager to represent the 
alumni/ae of our school. My new 
journey w ill be guided by Nick Spinelli, 
w ho has given new life to alumni affairs 
vsith his enthusiasm and perception. He 
w ill be a hard act to follow but has 
agreed to serve as a consultant for as 
long as necessar)'. 
Physically, the medical center has 
changed dramatically from the time I 
was a student. 'Hie Memorial Unit has 
been e.xpanded to iticlude the sites of 
the fomier church, convent and the 
How ard .Avenue donnitories. Plans call 
for a new children's hospital to replace 
the old .St. John's parochial school, 
vshich later housed the School of 
Nursing. The old dental building has 
been converted into lecture halls with 
direct access to the anatomy w ing and 
renamed the Jane Ellen Hope Building. 
The driveway at the Howard Avenue 
entrance to the New Haven unit was 
removed to e.xpand the hospital to the 
sidewalk on 1 loward Avenue, and the 
Yale Physicians Building replaced part 
ol the parking lot and residents' housing 
across the street. 
The new '^'ale Psychiatric Institute 
now operates ticross from the I lope 
Building, and our new Center for 
Molecular Medicine on College Street 
and Congress Avenue is nearing 
completion. Phis beautiful facility is 
architecturally striking and will 
contribute profoundly to the medical 
sch(H)l research mission. The library' too 
has undergone a major renovation; the 
llar\e\ Cushing/John Hay Whitney 
Mvdical Library' offers much expanded 
Stacks, exciting new computer 
ctipahilitii's ;ind other improvements 
well li' l:i\ ing altered the beauty of the 
re I. ing riKim or the reference 
Remarkable progress has occurred 
since many of us left New Haven. But 
with all the change, the sense of 
continuity remains. The students I have 
met are intelligent, eager and appear 
happy. The Yale System — including 
the thesis requirement — remains in 
place and is endorsed by the students 
and faculty. A major concern is the 
current cost of attending medical school 
and the severe debt burden a large 
percentage of the students must assume. 
It is hoped that we can find means to 
support these future Yale graduates 
with increasing alumni support. The 
students are very much part of the 
medical school family and continue to 
represent our legacy. 
Alumni Weekend in June was once 
again well planned and executed. 
Stephen C. Joseph, M.D. '63, M.P.H., 
was the keynote speaker and presented 
an excellent address titled “Public 
Health and Public Policy in the Age of 
AIDS.” Dr. Joseph also participated in a 
symposium moderated by William L. 
Kissick, M.D. '57, M.P.H. '59, Dr.P.H. 
'61, which discussed the weekend's 
theme, the “Ethos of Public Health: A 
Challenge for Medicine in the Twenty- 
First Century.” Susan Addiss, M.P.H. 
'69, and Lawrence Crowley, M.D. '44, 
added significantly to the panel. 
Dr. Thomas Kugelman, '60, 
president of the Ass(x:iation of Yale 
Alumni in Medicine (AYAM), presided 
at the annual meeting. A plaque for 
record alumni giving to the medical 
school campaign was accepted on 
behalf of alumni donors by Dr. John 
Ogilvie, '34, chairman. Medical School 
Alumni Campaign. A special 
presentation to Jack was made by Dean 
Leon E. Rosenberg. The AYAM by¬ 
laws amendments were approved. 
Nominees for the AYAM executive 
committee for 1990 included Drs. 
Sanfurd G. Bluestein, '46, (renominated 
for a second temi); Bennett L. Blitzer, 
'73; Harold D. Bomstein, '53; Michael 
Kashgarian, ’5S; Forrester A. Lee, '79; 
and William A. Whalen Jr., '53. 
Class reunion seminars were again 
well attended and provcKative. Tlie 
Class of 1965 discussion, “Twenty-Five 
Years l^ater: Yale and Beyond,” was 
chaired and nKxierated by Dr. John 
Seashore; the Class of 1960 presented 
“Medicine in the Public Arena,” 
moderated by Dr. Jerrold R. Post. The 
Class of 1945 appointed Dr. Richard 
Breck to lead a discussion of “Wine, 
Women and War.” Class dinners 
arranged by individual classes offered 
the opportunity to renew old 
friendships, reminisce about old times 
and plan for future meetings. A dinner 
at the Graduates Club honoring the 
Classes of 1940, 1935 and 1985 
climaxed a busy and stimulating 
weekend. 
Dr. Kugelman will continue to serve 
as president of our alumni association. 
He has been an active and assertive 
leader of our executive committee. It 
will be a privilege to work with him. 
Students and residency candidates 
have been welcomed and hosted by 
alumni during their out-of-state 
interviews. We keep a 'host' list of 
those of you who can help. Let us know 
if you are available. We will continue to 
support Dr. Leonard Kemler, alumni 
fund chairman, and Dr. Samuel 
Kushlan, co-chairman, bequests and 
endowments, in their efforts. Student 
loan funds must be increa.sed to 
encourage a continuing active alumni 
association. 
The office of alumni affairs 
represents all Yale medical school 
alumni. We welcome your suggestions, 
concurrence and criticism. Please 
communicate your ideas to us, 
especially regarding alumni weekend, 
regarding both format and scheduling. 
While our office is based in New 
Haven, we hope to involve alumni from 
beyond the Connecticut, New York and 
Massachusetts areas. 
I look forward to assuming my 
responsibility as director of alumni 
affairs. 
Dr. Arthur C. Crovatto, '54 
Director of Alumni Affairs 
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ALUMNI NEWS 
During Alumni Weekend 1990, John B. Ogilvie, M.D. ’34, received a 
framed drawing of the Sterling Hall of Medicine and the thanks of Dean 
Leon E. Rosenberg for serving as medical alumni chairman of the school’s 
successful capita! campaign. 
Dr. Alice Whittier, ’25, of Portland, 
Maine, retired from pediatric practice in 
1978 at the age of 80. She is a past 
president of the New England Pediatric 
Society and served through the 1950s as 
Maine Medical Center’s chief of 
pediatrics. 
Dr. Samuel Albert, ’30, has been 
practicing medicine for the past 45 
years for Americans who have served in 
the armed services. He has an outpatient 
practice in Manhattan where he is 
affiliated with the U.S. Department of 
Veterans Affairs. 
Dr. Arnold S. Reiman, ’46-’49 HS, 
editor-in-chief of the New England 
Journal of Medicine, will retire in June 
1991. Dr. Reiman was appointed editor 
in 1977 and became editor-in-chief in 
1988. He plans to devote more time to 
writing, teaching and public policy 
debates on American health care. 
Dr. Cecil G. Sheps, ’47 M.P.H, 
professor emeritus at the schools of 
medicine and public health at the 
University of North Carolina at Chapel 
Hill, was awarded the American Public 
Health Association’s 1990 Sedgwick 
Memorial Medal for Distinguished 
Service in Public Health. 
Dr. James M.A. Weiss, ’51 M.P.H, 
’50-’53 HS, the first professor of 
psychiatry at the University of Missouri 
and founding chairman of the 
department at the University Health 
Sciences Center in Columbia, will retire 
Dec. 31, 1990. He will continue as a 
full-time research professor at Missouri 
in the medical school. 
Drs. Paul Calabresi, ’55, physician- 
in-chief in the department of medicine 
at Brown University, and David J. 
Kupfer ’65, professor and chairman of 
psychiatry at the University of 
Pittsburgh Medical School, are newly 
elected members to the Institute of 
Medicine. 
Dr. Eiji Yanagisawa, ’56-’59 HS, 
clinical professor of otolaryngology at 
Yale, won the World Festival of 
Cinematography and Videography 
Silver Medal at the September meeting 
of the 14th World Congress of Oto- 
Rhino-Laryngology and Head and Neck 
Surgery held in Madrid, Spain. His 
winning videotape demonstrated the 
contribution of aryepiglottic 
constriction to ringing voice quality 
using videolaryngoscopic 
documentation with acoustic analysis. 
Dr. Robert W. Wroblewski, ’58, 
after serving as director of oncology at 
Akron General Center and Medina 
General Hospital in Ohio, is now 
director of medical oncology at Good 
Samaritan Hospital in Vincennes, Ind. 
Dr. Robert C. Wallach, ’60, has 
left his position as departmental director 
of obstetrics and gynecology at the Beth 
Israel Medical Center to become the 
director of gynecologic oncology at the 
New York University School of 
Medicine. He also is a professorial 
lecturer at the University of Puerto Rico 
School of Medicine. 
Dr. Thomas B. Kirsch, ’61, clinical 
associate professor of psychiatry at 
Stanford University, is president of the 
International Association for Analytical 
Psychology, the professional 
organization of Jungian psychoanalysis. 
Dr. Robert L. Johnson, ’63-’64 
HS, associate clinical professor at the 
University of California San Francisco 
and chief of otolaryngology at the 
Children’s Hospital, is a lieutenant 
colonel in the U.S. Army Reserve and a 
consultant at Fetterman Hospital in San 
Francisco. He also guest lectures at the 
University at Jodpur in Rajaston, India. 
Dr. Anthony Robbins, ’66, 
professor of public health at Boston 
University, directs the International 
Commission of Physicians and 
Environmentalists to Investigate the 
Health and Environmental 
Consequences of Nuclear Weapons 
Production. The commission plans a 
comprehensive review of the 1957 
Kyshtym accident in the Soviet Union, 
where a high-level waste storage tank 
exploded. He also is treasurer of the 
International Physicians for the 
Prevention of Nuclear War. 
Dr. Joan L. Venes, ’67 HS, 
professor of surgery (neurosurgery) and 
pediatrics at the University of 
Michigan, was awarded a 1990-1991 
Robert Wood Johnson Foundation 
Fellowship in Health Policy to serve as 
part of a one-year orientation and work 
experience program in Washington, 
D.C. 
Dr. John J. Kelly Jr., ’69, ’69-’70 
HS, professor of neurology at Tufts 
Medical School, is senior neurologist 
and director of neuromuscular service 
and the electromyography laboratory at 
New England Medical Center in 
Boston. 
Frederick G. Adams, D.D.S., ’70 
M.P.H, Connecticut state health 
commissioner, has been chosen to 
advise federal expenditures in dental 
research. He serves on the 17-member 
panel of the National Institute of Dental 
Research’s National Advisory Dental 
Research Council. 
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Ur. .John C. Lee, ’70-’72 HS. has 
been appointed associate dean for 
research and graduate studies at the 
Virginia-Mar>'land Regional College of 
VeterintuA' Medicine. 
Ur. .John A. Daelev, '71 
retired from the federal .seiA'ice in 
JanuaiA 1990 to Arlington, Te.x.. after 
42 years of combined military and civil 
service. He .served as director for Region 
VI, department of health and human 
seiA'ices since 1981. Dr. Daeley received 
the Federal Emergency Management 
Agency’s Outstanding Public Service 
Award in recognition of exemplary 
serv ice as a regional emergency 
management team director. 
Ur. .John P. Fulkerson, '72, 
professor of orthopaedic surgery' at the 
University of Connecticut School of 
Medicine, was named director of sports 
medicine at the UConn Health Center 
and as a physician for the Hartford 
Whalers litK'key team. He is secretary- 
elect of the Arthroscopy Association of 
North America, and is a member of the 
American Orthopaedic Srx'iety of Sports 
Medicine and the Sports Medicine 
Committee of the American Academy 
of Orthpaedic Surgeons. He received the 
Bantam Award of Trinity College in 
1 lartford for his care of athletes. 
Matthew A. Kurs, 75 M.P.H., 
received the American Medical 
International (AMI) 1989 Special 
Achievement .Award. He is president 
and chief executive officer of AMI St. 
Joseph Hospital at Creighton University 
in Omaha, Neb. He was previously 
chief operating officer of AMFs Florida 
region and AMFs central region in 
Denver. 
Ur. Mary I.ake Polan, '75, fomier 
asscK'iate professor of obstetrics and 
gynecology at Yale, has been appointed 
chair of the department of gynecology 
and obstetrics at Stanford University 
Sch(H)l of Medicine and as chief of 
gynecology and obstetrics services at 
Stanford University Hospital. 
Ur. (’arol I>. Kpstein, '76, was 
appointed vice president of medical 
affairs and chief medical officer of 
ImmunoCien. Inc., a biotechnology 
company based in Cambridge, Mass., 
s[X‘c'iali/ing in the treatment of cancer. 
Prior to this ap|X)inlment, Dr. Epstein 
'.' is vice president and director of 
■ linicui affairs for Imnuinex Corp. and 
■s c .(ant clirectDr of anti-inflammatory 
' i.'l'niism and cardiovascular 
' Ayersi Laboratories. 
Dr. O’dell M. Owens, '16, a 
member of the University of Cincinnati 
board of trustees, visited hospitals in 
Moscow, Leningrad, Kharkov and 
TTilisi during two weeks in July and 
August in a program to evaluate laser 
surgery in the Soviet Union. 
Dr. Dennis U’Arcy Banks, 'll, 
teaches freshman composition at the 
University of Arizona while pursuing a 
Ph.D. in English, with a concentration 
in Native American Indian literature 
and poetry. He also has received a law 
degree and was a visiting scholar at 
Harvard Law School. 
Dr. Stephen E. Levick, ’77-’82 HS, 
began full-time private practice in 
August 1989 at the Institute of 
Pennsylvania Hospital where he also is 
medical director of outpatient 
evaluation services. 
Dr, Richard D. Bey, '19, clinical 
assistant professor of neurology at 
Bowman Gray School of Medicine and 
managing partner of Southeastern 
Medical Imaging, has a private neurol¬ 
ogy practice in Winston-Salem, N.C. 
Robert V. Levine, '80 M.P.H, has 
been appointed a member of the board 
of directors of the Queens, New York, 
chapter of the American Lung 
Association. 
Dr. David S. Weiss, '81, has been 
named orthopaedic consultant to the 
Juilliard School dance division. In 
April, he delivered Grand Rounds at 
Yale to the department of orthopaedics 
and rehabilitation entitled “Scientific 
and Practical Aspects of Knee 
Rehabilitation Following Anterior 
Cruciate Ligament Reconstruction." 
Dr. David P. Norton, '83, is part of 
a pediatrics group practice in Marin 
County, Calif., and attends and teaches 
at San Franci.sco General Hospital. He 
also is a clinical faculty member at the 
University of California San Francisco. 
.leannee P. Martin, '83 M.P.H, is 
the executive director of the Hospice 
Programs of Visiting Nurses and 
Hospice of San Francisco, which have 
been widely recognized for their cost- 
effective and innovative care to persons 
with HIV disea.se. 
(Jary F. Spinner, '83 PA, physician 
assistant at the Hill Health Center in 
New Haven, received the American 
Academy of Physician Assistants' 
Outstanding Physician Assistant of the 
Year Award at its June annual 
conference in New Orleans. 
Dr. Edwin Trevathan, ’82-’84 HS, 
recently left his position at the Centers 
for Disease Control to become medical 
director for the department of 
neurophysiology and director of the 
pediatric epilepsy program at Scottish 
Rite Children’s Medical Center in 
Atlanta. 
Dr. Duncan K. Fischer 
Dr, Charles M. Zacks, '84, has an 
ophthalmology practice with a sub¬ 
specialty in cornea and external disease 
at the Maine Eye Center in Portland. 
Dr. Greg A. Sachs, '85, is assistant 
professor of medicine at the University 
of Chicago after finishing fellowships in 
geriatrics and medical ethics. 
Dr. Duncan K. Fischer, '86, a 
neurosurgery resident at Baylor College 
of Medicine, has won a $30,0(X) 
American College of Surgeons 
Scholarship for his research on human 
brain tumor antigens and the production 
of monoclonal antibodies. 
Michael P. Krusch, '86 PA, is 
pursuing an M.D. degree at the 
University of Chicago Medical School. 
Dr. Glenn Isaacson, '88, has been 
appointed director of pediatric 
otolaryngology at St. Christopher’s 
Hospital for Children in Philadelphia 
and assistant professor of 
otolaryngology and pediatrics at 
Temple University School of Medicine. 
Drs. .loni Hansson, '89, an intern in 
the department of medicine, and 
Kathleen Stewart, '88-'90 HS, junior 
assistant resident in the department of 
medicine, received Samuel D. Kushlan 
Awards for their contributions to patient 
care during rotation through the 
community medical .service. 
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STUDENT NEWS 
Second-year students May Chen and 
Marlene Corujo were selected by their 
classmates to receive the CIBA-GEIGY 
Award for outstanding community 
service. The students co-direct the Yale 
chapter of Students Teaching AIDS to 
Students, a national group of medical 
students who teach high school pupils 
about preventing the disease. 
Sonya Erickson, a fifth-year 
medical student, has been selected as 
the student member of the American 
Association of Medical Colleges’ 
Liaison Committee on Medical 
Education for the 1990-1991 academic 
year. As a member of the committee, 
Ms. Erickson will participate in the 
review and discussion of medical 
school accreditation survey reports and 
will take part in survey visits to medical 
schools each year. 
Terence L, Geiger, an M.D., Ph.D. 
graduate student in the section of 
immunobiology, has been named the 
second recipient of the Miles Scholar 
Award. Dr. Geiger’s research centers on 
how the immune system learns to 
distinguish foreign bodies, such as 
bacteria and viruses, from its own 
organism. The award covers tuition, 




The Howard Hughes Medical Institute 
^ (HHMI) has awarded nearly $400,000 
to the School of Medicine for graduate 
training in the biomedical sciences. The 
school will distribute money from the 
grant, determined by the excellence of 
graduate students working with HHMI- 
supported researchers, into three 
programs to nature graduate research. 
The HHMI grant will contribute 
$122,400 to establish six new graduate 
student fellowships, including three for 
the new Neuroscience Graduate 
Program; $265,400 will go to raising 
biomedical graduate student stipends to 
$12,900; and approximately $10,000 
will help develop and support 
computer-based facilities to promote 
communication among graduate 
students at scattered campus locations. 
(Above, from left) Madeline Cordero, Amy Freeman and Marisol Pagan were 
among 16 minority high school students from New Haven who spent most of July 
and August doing laboratory research at the side of some of the nation’s leading 
scientists. The School of Medicine’s 11th annual Summer Research Apprenticeship 
Program offered stipends to 13 students thanks to the National Institutes of 
Health! Public Health Service Division of Research Resources: the medical school 
itself funded three stipends. Researchers from the School of Medicine, epidemiology 
and public health, and the John B. Pierce Laboratory took part in the program. 
Class of 1992 medical students William Rodriguez and Adetokunbo “Toki” 
Ayelese coordinated the weekly lecture series attended by the high school students. 
(Below) Matthew Lemer, ’91, was one of eight Wilbur G. Downs Fellows from the 
medical school and EPH to pursue research outside the United States during 1990. 
Mr. Lemer gathered data on the relationship between malaria and anemia in a 
pediatric population in Kenya, the subject of his M.D. thesis. 
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COMMENCEMENT 1990 
Four generations husk in the joy of Mark Miller's graduation. 
.lennifer Mark and her proud father. 
Richard Mark. 
Dr. Charles A. Jane way Jr., professor of 
inununohiology, biology and in the 
Cancer Center, received the 1990 
Bohmfalk Prize for teaching basic 
science; Dr. Margaret J. Bia, associate 
professor of medicine, won the Bohmfalk 
Prize for clinical instruction. 
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Stacy Wills (left) and Christina 
Wypijewski share in the anticipation of 
receiving their M.P.H. degrees. 
M.D. graduate Ron Ennis poses with his 
son, Ariel, a candidate for the School of 
Medicine Class of 2013. 
AH Uhmed Ajani leads a contingent of graduating EPH students up the stairs of the Yale Repertory 
Theater. Mohammad Zahid Ansari follows a step behind. 
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DEVELOPMENT REPORT 
The Kresge Foundation 
Challenges YSM Alumns 
rtic Kresge Foundation of Troy, 
Mich., has awarded a $1 million 
challenge grant to the School of 
Medicine to support construction of 
the Center for Molecular Medicine 
(CMM). The award is contingent on 
1) "b ale’s ability to raise the 
remaining S5.45 million needed to 
complete the S35.4 million project; 2) 
an increase in the percentage of YSM 
alumni/ae donors to the School of 
Medicine Alumni Fund to 55 percent, 
from the current 43 percent. 
When the CMM opens next year, it 
will represent (me of Yale's most 
significant investments in basic 
scientific research. More than 40 
laboratories will help sustain 
leadership in molecular genetics and 
expand the scientific horizons in such 
fields as neurobiology, oncology and 
cardiovascular research. Biomedical 
scientists at the center w ill explore 
new directions in research outlined in 
the work of Drs. Leon F. Rosenberg, 
(ieorge Iftlade and other pioneers in 
molecular and cell biology. 
file School of Medicine has 
launched a campaign of intensive 
fundraising to meet the goals .set by 
the foundation's grant. Over the next 
year, the school will seek the support 
from its alumni and friends, as well as 
from corporations and foundations in 
an effort to complete funding for the 
( \FVL Already, progress has been 
made toward increasing the 
percentage of contributions from 
alumni/ae; at least 50 corporations 
and foundations have been contacted 
as potential donors, as well. 
I'he Kresge l-'oundation joins an 
arra\ ol (irgani/ations which have 
supported Yale in this venture. The 
W .\f Keck Foundation, the Ira W. 
DeCamp Foundation, the Lucille B. 
Markey Charitable 'I'rust and the 
Ihw-ard Hughes Medical Institute 
h.i\e (ommitled funds for the center's 
coiisiMkiiDn and its research programs. 
I ' :i iishcd in 1024, the foundation 
' [ident, private foundation 
• personal gifts of 
Sebastian S. Kresge. The foundation 
supports institutions of higher 
education, health and long-term care, 
arts and humanities, social service, 
science and environment, and public 
affairs. Its grants fund projects 
involving construction or renovation 
of facilities and purchase of major 
capital equipment or real estate. 
The Gesell Institute 
Endows Professorship 
Dr. Arnold Gesell, founder of child 
development at Yale and the creator 
of the institution which became the 
Child Study Center, has been honored 
by the creation of the Arnold Gesell 
endowed professorship for an 
assistant or associate professor in the 
Child Study Center. The chair is made 
possible by a major gift from the 
Gesell Institute and marks the 
reintegration of the work of Arnold 
Gesell and his collaborators into the 
Child Study Center and Yale 
University. 
Arnold Gesell came to Yale in 
1911 after earning his Ph.D. degree at 
Clark University and starting medical 
school at the University of Wisconsin. 
His first appointment was as assistant 
professor of education. In 1915 he 
earned his M.D. degree from Yale and 
was rapidly launched on creating a 
new discipline, spanning the 
emerging fields of child psychology, 
pediatrics and mental hygiene. 
For the next four decades, he and 
his closest collaborators, including 
Frances L. Ilg, M.D., and Louise 
Bates Ames, Ph.D.. laid the 
foundations for the scientific study of 
the maturation of behavior, through 
their rigorous testing of normal and 
developmentally impaired infants and 
children. Their pathbreaking work 
was reported in a series of books and 
reports translated into many 
languages for professionals, parents 
and social policy planners. The Gesell 
method became the framework for all 
subsequent approaches to 
developmental assessments. 
Dr. Gesell and his collaborators 
left Yale at the time of his retirement 
in 1948 and organized the Gesell 
Institute for Human Development in 
New Haven. The Gesell Institute 
began providing a range of services, 
primarily for younger children, 
including a nursery school and 
developmental clinics. In addition, the 
institute offered a national lecture 
series and psychological consultation 
to schools throughout the United 
States. This work continued after Dr. 
GeselFs death in 1961. 
Over the last two years, the board 
of the Gesell Institute, chaired by 
Howard Kahn, Ph.D., and with the 
scientific guidance of Dr. Louise 
Bates Ames, conducted a review of 
the institute's policy. This led to the 
decision to emphasize the national 
lecture series, and to scale back 
clinical programs in New Haven. 
Toward these ends, the Gesell 
Institute has sold its two buildings to 
Yale, where the institute retains 
offices. Some proceeds from the sale 
have gone to create the Gesell 
professorship, to assure the long-term 
continuation of the academic and 
clinical work in the spirit of Dr. 
Arnold Gesell. 
Fulton Book Fund 
Established at Yale 
The Lucia P. Fulton Book Fund, an 
endowed book fund in memory of Mrs. 
John F. Fulton, has recently been 
established at the Harvey Cushing/John 
Hay Whitney Medical Library. Mrs. 
Fulton, who died in April 1989, was the 
widow of Dr. John F. Fulton. She was a 
devoted supporter of the Medical 
Library and the History of Medicine at 
Yale. 
Following Dr. Fulton’s death in 1960, 
she continued for three decades to 
extend her hospitality to faculty and 
students at Mill Rock, her home in 
Hamden. Contributions to this book 
fund may be send to Ms. Bella Berson, 
director, Harvey Cushing/John Hay 
Whitney Medical Library, 333 Cedar 
St., P.O. Box 3333, New Haven, CT 
06510. 
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Samuel P.W. Black 
Samuel P.W. Black, M.D., one of the 
founders of the University of Missouri 
Medical School, died of a heart attack 
on June 9 at his home in Cornwall, 
Conn. He was 73. 
Dr. Black, professor of neurosurgery 
at the University of Michigan from 
1955 until his retirement in 1982, 
continued his research and writing 
about aneurysms as professor emeritus. 
A native of Barbourville, Ky., Dr. 
Black graduated from Choate School in 
1936, Yale University in 1940 and 
Johns Hopkins School of Medicine in 
1943. After active duty in the Pacific 
during World War II, he returned to 
Yale for his residency in neurosurgery 
and joined the Yale faculty in 1950. 
Five years later he helped found the 
University of Missouri Medical School. 
He authored and co-authored more 
than 40 journal articles and was a past 
president of the Missouri State 
Neurological Society. Among his 
medical society memberships were the 
American College of Surgeons and the 
American Association of Neurological 
Surgeons. 
A skillful mountaineer, Dr. Black 
had been on climbing expeditions all 
over the world. 
He is predeceased by his wife, Betty 
Lohman Black. He leaves two 
daughters, Susan Norling and Nancy 
Montgomery; two sons, John and 
Samuel; and six grandchildren. 
Contributions may be sent to the 
University of Missouri Medical School, 
1 Hospital Dr., Columbia, MO 65212. 
Henry Brill 
Henry Brill, M.D., former director of 
the Pilgrim State Psychiatric Center in 
West Brentwood, Long Island, died of 
cancer on June 17 at the Good 
Samaritan Hospital in West Islip, Long 
Island. He was 83. 
A psychiatrist and authority on drug 
addiction. Dr. Bril! helped introduce the 
use of tranquilizers in New York State 
mental hospitals to foster the early 
release of patients. He was the first 
deputy commissioner of the state’s 
Department of Mental Hygiene, its 
regional commissioner for Long Island 
and later a consultant. 
He was a clinical professor at the 
Downstate Medical Center in Stony 
Brook, Long Island, and for decades 
served as a drug consultant for many 
state and federal agencies, including the 
American Medical Association, the 
OBITUARIES 
National Academy of Sciences and the 
World Health Organization. 
During his career he served as 
chairman of the New York State Drug 
Abuse Advisory Commission and 
president of the American College of 
Neuropsychopharmacology. Dr. Brill 
repeatedly warned of the hazards of 
marijuana and opposed its legalization. 
A native of Bridgeport, Conn., Dr. 
Brill earned his bachelor’s and medical 
degrees at Yale, in 1928 and 1932. He 
interned at Pilgrim State Mental 
Institution and was its clinical director 
for eight years before his promotion to 
director. 
He is survived by his wife, Wenonah 
Beale Brill; a son, Michael; two 
daughters, Helen Broxmeyer and Jean 
Hough; and four grandchildren. 
Dr. Fred Collier 
Fred Collier 
Fred Collier, M.D., died April 19 at the 
age of 66. 
A native of Topeka, Kan., Dr. 
Collier earned a B.S. degree from 
Sheffield Scientific School of Yale 
University in 1944 and an M.D. degree 
from Yale School of Medicine in 1946. 
He interned at the Medical College of 
Virginia and served pathology 
residencies at Yale, New Britain 
General Hospital and the Cleveland 
Clinic. He was a private first class in the 
medical administrative corps during 
World War II. 
In 1956, he was associate pathologist 
at the Hospital of the University of 
Pennsylvania and from 1957 to 1961 
served as professor of surgical 
pathology at the University of Alabama 
Medical Center. He went on to become 
a clinical professor of pathology at New 
York Medical College; director of 
clinical laboratories in Ramsey, N.J.; 
corporate medical director of Becton 
Dickinson and Co. in Rutherford, N.J.; 
and adjunct professor of pathology at 
Farleigh Dickin.son University in 
Teaneck, N.J. 
Dr. Collier was a member of the 
American Association of Pathologists 
and Bacteriologists, the International 
Academy of Pathology, American 
Society of Clinical Pathologists, and the 
United States and Canadian Academy 
of Pathology, Inc. He also was a 
member of the Pathology Advisory 
Committee of the Southeastern Cancer 
Chemotherapy Study Group; the board 
of directors for the Harkins Medical 
Research Foundation and the 
subcommittee on neonatal 
hypothyroidism of the National 
Committee for Clinical Laboratory 
Standards. 
Dr. Collier retired in July 1989 to 
pursue his interests in writing, sailing 
and traveling. 
He is survived by his wife, Rosalie; 
two sons, Wade and Fred; and one 
daughter, R. Samantha Collier. 
Ward J. McFarland 
Ward J. McFarland, M.D., an 
orthopaedic surgeon, died April 6 at 
Lawrence and Memorial Hospital in 
New London, Conn. He was 75. 
A native of Caspian, Mich., Dr. 
McFarland graduated from Yale 
College in 1936 and from the School of 
Medicine in 1939. He interned at New 
Haven Hospital and served residencies 
at Newington Children’s Hospital and 
Grace-New Haven Hospital. He was a 
captain in the Army Air Force during 
World Wai- II. 
Dr. McFarland was chief of the 
medical staff and orthopedic surgery at 
Lawrence and Memorial Hospital in 
New London for more than 20 years 
and was in private practice from 1949 
until his death. He also was a consultant 
for Uncas-on-Thames Hospital in 
Norwich, Conn., and the U.S. Coast 
Guard Academy Hospital in New 
London. 
A diplomate of the American Board 
of Orthopaedic Surgery and a fellow of 
the American Academy of Orthopaedic 
Surgery, Dr. McFarland was honored 
with the American Medical 
Association’s Physician’s Recognition 
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Award in 1973 and 1976. He wa.s a 
member of the .American Medical 
A.ssociation and the Alumni 
.Asstx;ialion of Newington Children's 
Hospital. 
1 le was predecea.sed by his wife, 
.Mar\ Luise Heniy', iind is surv ived by a 
son. Dr. Ward J. .McFarland Jr.; a 
daughter. Natalie .M. Black; and three 
grandchildren. 
.Memorial contributions may be 
made to 1 lospice of Southeastern 
Connecticut, c/o Utwrence and 
Memorial Hospital, 325 Montauk Ave., 
New London, CT 06320. 
Arnold B. Rilance 
.Arnold B. Rilance, M.D., died of ciuicer 
on .May 13 at the Potomac Valley 
Nursing Home in Main land. He was 82. 
.-\ native of Montreal, Dr. Rilance 
became a U.S. citizen in 1942 and was 
a practicing physician in New Haven 
from 1944 until his retirement in 1986. 
1 le also was an attending physician at 
Yale-New Haven Hospital and the 
Hospital of St. Raphael. .A 1931 
graduate of McGill University Medical 
Sclux)l, Dr. Rilance worked as an 
assistant resident at Trudeau Sanitarium 
and as a senior physician at Laurel 
Heights Sanitarium until 19-44. 
During his career. Dr. Rilance served 
as asscK'iate clinical professor of 
metlicine at Yale University luid acting 
director at the Bureau of Tuberculosis 
Control. Department of Health, New 
1 Liven. 1 le was a fellow and governor 
for Connecticut’s American College of 
Chest Ph> sicians; past president of the 
.American Trudeau ScK'iety; and a 
member of the American, New Haven 
and Connecticut medical siK'ieties. In 
1963, he w as the first recipient of the 
David Russell Lyman Memorial 
frophy. presented annually by the 
fuberculosis and Health Association of 
the New 1 Liven Area Inc. 
1 le was predeceased by his wife, 
Ldith Marshall Rilance. He leaves three 
daughtcl^. Jane Keefer. Nancy Rilance 
and Janet Rilance; anti a granddaughter. 
Lewis A. Scheuer 
Lew is A. Scheuer. M.D.. tiled of colon 
cancer May 26. 1 le was 87. 
I )r. Scheuer. a 1928 graduate of the 
.St hix)l ot Metlicine. completed an 
inlemship at (irace 1 lospital and a 
[vtlialric resitlency at the New York 
I'oundling Hospital, where he remained 
as a staff memlvr. I le maintaineti a 




Dr. Milton J.E. Senn 
Milton J.E. Senn 
Milton J.E. Senn, M.D., an expert in 
child psychiatry, died on June 8 of 
bladder cancer at the Connecticut 
Hospice. He was 88. 
Dr. Senn was chainnan of the Yale 
pediatrics department from 1951 to 
1964 and director of the Child Study 
Center from 1948 to 1966. After 
retiretiient in 1970, he remained as 
Sterling Professor Emeritus of 
Pediatrics and Psychiatry at Yale and 
became vice president for child studies 
of the Eield Eoundation of New York 
City. 
An activist for children’s issues, he 
helped found the Children’s Defense 
Eund and traveled extensively to gather 
firsthand evidence of child hunger and 
ill health for Congress and compiled an 
oral history of the child development 
movement for the National Library of 
Medicine. 
A native of Milwaukee, Wis., Dr. 
Senn was a 1925 B.A. degree graduate 
of the University of Wisconsin and a 
1927 graduate of its medical school. He 
became a fellow in pediatrics at 
Washington University in St. Louis luid 
in 1939 was named professor of 
pediatrics and psychiatry at Cornell 
University Medical College and 
director of the Institute for Child 
Development at New York Hospital. 
Eight years later he became attending 
[K'diatrician at New York Hospital and 
the follow ing year became attending 
physician at Grace-New Haven 
Community Hospital, where he served 
as f)ediatrician-in-chief for nine years. 
He was the author of more than 70 
scientific publications and two books. 
In 1964, the American Academy of 
Pediatrics bestowed on Dr. Senn the 
first C. Anderson Aldrich Award in 
Child Development and in 1970 the 
American Psychiatric Association 
honored him with its Agnes Purcell 
McGavin Award for his outstanding 
contributions to the prevention of 
emotional disorders in children. 
He is survived by a daughter, the 
Rev. Corelyn Senn, and two 
grandchildren. 
Contributions may be made to the 
Children’s Defense Fund, the Nature 
Conservancy or Connecticut Hospice. 
Rudolph E. Vandeveer 
Rudolph E. Vandeveer, M.D., died June 
25, 1989, in the Health Science Center 
in Syracuse, N.Y. Dr. Vandeveer, who 
died of injuries suffered in an 
automobile accident, was 83. 
A native of Detroit, Mich., and 
resident of Winter Park, Ela., Dr. 
Vandeveer was a graduate of Staunton 
Military Academy, the University of 
Michigan and a 1932 graduate of the 
Yale School of Medicine. He served his 
internship at Haiper and Children’s 
Hospital in Detroit, pediatric residence 
at Eord Hospital and Keifer Contagious 
Children’s Hospital and his allergy 
residency at New York Ho.spital of 
Cornell University. He became a fellow 
of the American Academy of Pediatrics 
in 1943 and of the American College of 
Allergists in 1944. 
Prior to his retirement in 1981, Dr. 
Vandeveer was a pediatrician/allergist 
associated with Dr. John Hoes in Rome, 
N.J. He was affiliated with Rome 
Hospital, past president of the Oneida 
County Medical Society and the Central 
New York Academy of Medicine, and a 
member of the Central New York 
Pediatric Club and the America Medical 
Association. Dr. Vandeveer also was a 
member of the Rome Board of 
Education, on which he served as 
president for two years. 
He is predeceased by his wife, Ellen. 
He leaves three sons, Lauren, Peter and 
James; luid eight grandchildren. 
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Memorials Harold T. Vogel 
Harold T. Vogel, M.D., a retired 
pediatrician from Queens, N.Y., died 
May 19 of a heart attack at South 
Nassau Community Hospital in 
Rockville Centre, Long Island. He was 
90 years old. 
Dr. Vogel graduated from Yale 
School of Medicine in 1924 and was a 
charter member of the Queens Medical 
Society. He joined the Flushing 
Hospital staff in 1930 and served as 
director of pediatrics from 1946 to 
1966. He also was a board member of 
the hospital. He retired at 78. 
He was predeceased by his wife, 
Madeleine Bauer. He leaves two 
daughters, Karen Vorhees and Carla 
Leon; seven grandchildren, and a great¬ 
grandchild. 
John J. Wolfe 
John J. Wolfe, M.D., died April 21 at 
the age of 86. 
A native of Dublin, Ireland, Dr. 
Wolfe practiced in Louisville, Ky., as a 
maxillofacial plastic surgeon from 1946 
until his retirement. A graduate of the 
Royal Dental Academy in London, he 
also attended Columbia Lfniversity 
Dental School and taught at New York 
University Dental School. He graduated 
from Yale School of Medicine in 1933. 
In 1933, Dr. Wolfe began work for 
the Rockefeller Foundation’s School of 
Medical Nursing and Research and in 
1939, practiced and taught in 
missionary hospitals throughout South 
India and served on the staff of the 
BiJay Singh Hospital in Bikaner, 
Rajasthan. During World War II, Dr. 
Wolfe joined the 10th Air Force and 
was instrumental in bringing Chinese 
troops to India. Upon his discharge as a 
colonel, he was awarded U.S. 
citizenship. 
He served as head of the department 
of plastic surgery at the University of 
Louisville Medical School, and was a 
member of the American Board of 
Plastic Surgery, the American College 
of Surgeons, the American Society of 
Maxillofacial Surgeons, the American 
Society of Plastic and Reconstructive 
Surgery and the Kentucky Medical 
Association. 
He is survived by his wife, Jill, and a 
daughter, Julia. 
Memorial contributions may be 
made to the Yale University School of 
Medicine, Office of Development, 
Parkinson’s Disease Research, P.O. 
Box 3333, 350 Congress Ave., New 
Haven, CT06519. 
Grillwork at the Yale Medical 
Historical Library 
IN MEMORIAM 
Howard A. Wood ’25 M.D. 
November 22, 1989 
Samuel J. Stabins ’26 HS 
January 27, 1989 
Robert I. Rubinstein ’28 M.D. 
May 1, 1990 
Lewis A. Scheuer ’28 M.D. 
May 26, 1990 
Harold E. Harrison ’31 M.D. 
October 2, 1989 
Paul E. Huston ’39 M.D. 
November 21, 1988 
Ward J. McFarland ’39 M.D., ’49 HS 
April 6, 1990 
Lawrence P. Shea ’47 M.D. 
February 13, 1990 
Ame G. Haavik ’56 M.D. 
January 1, 1990 
Douglas W. Johnston ’64 M.D., ’66 HS 
November 30, 1989 
Deceased medical alumni and friends 
may be memorialized by a gift to the 
School of Medicine Alumni Fund 
endowment in the name and class of 
the person so honored. The next-of- 
kin of a deceased medical alumnus/a 
is advised about this In Memoriam 
Program by mail sometime after the 
School of Medicine receives 
notification of the death. The letter of 
information includes a copy of the 
Testament of Remembrance in which 
the names of all persons so 
memorialized are listed in the medical 
section by class, thus establishing a 
lasting memorial. Donors receive a 
personally penned note of 
appreciation from the In Memoriam 
Program director. 
Deceased alumni and friends so 
honored in 1989-1990 were: 
Donato Anthony D’Esopo, ’24 
Albert Jablonsky, ’27 
Robert I. Rubinstein, ’28 
Vincent A. Doroszka, ’30 
Robert Watkinson Huntington Jr., ’33 
Francis P. Guida, ’34 
Ward J. McFarland, ’39 
Arthur S. Tucker, ’39 
Joseph P. Kriss, ’43 
Paul E. Molumphy, ’44 
Charles Sheldon Judd Jr., ’46 
Richard G. Britton, ’47 
Edward Foord, ’47 
Lawrence C. Perry, ’47 
Russell J. Barmett, ’48 
Boy Frame, ’48 
Class of 1950 Scholarship Fund 
John Currier Gallagher, ’58 
Robert Joseph Polackwich, ’73 
David J. Kreis Jr., ’77 
Hans Graichen (faculty) 
Mrs. Bieggi (friend) 
Richard G.Jordan 
Director, In Memoriam Program 
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ALUMNI WEEKEND 
An Alumni Weekend panel on the "Ethos of Public Health" included (from left} Drs. 
Burton //. Singer. Lawrence Crowley, Stephen Joseph, and Susan Addiss. M.P.H. 
This )ear Medical Alumni Weekend 
attracted nearly 4(X) alumni/ae. A most 
extraordinary dedication ceremony of 
the new Harvey Cushing/John Hay 
Whitney Medical Library ushered in the 
weekend on Tliursday afternoon. June 
7. The ingeniously expanded space 
contains the technology for the most 
sophisticated computer systems for 
medical infomiatics. It deserxes 
inspection by everx' alumnus/a. 
The reunion ke) note speaker. Dr. 
Stephen C. Joseph. '63, commissioner 
of health for New York City from 1986 
to Hf-X), drew a record attendance on 
I riday. fhe detailed description of his 
attempts to moxe public policy to 
control the rapidly proliferating AIDS 
epidemic in New '^'ork City provoked 
lively audience questions and dialogue. 
I le explained the shifting character of 
the epidemic, which is affecting more 
women and children as a consequence 
of increasing dmg abuse. [See "Public 
Policy in the Age of AIDS," page 5| 
Reunion 1990 celebrated the 75th 
litniversarx of the .Sch(X)l of Medicine's 
di ■ irtment of epidemiology and public 
h-'.ilt! 1 PPl I) and saluted the Univer- 
■ i '. ; oinmitment to strengthening 
io.i in tills field. Dr. Joseph's talk 
■ d ihe political, economic and 
hich are crucial to 
function in the field, and are thereby 
required as elements in the curriculum. 
Dr. Joseph joined the panel on the 
follow ing morning to discuss the theme: 
"The Ethos of Public Health: A 
Challenge for Medicine in the 21st 
Century.” Also on the panel was Dr. 
Burton H. Singer, recently appointed 
EPH chainnan, who described newly 
articulated plans for broadening and 
integrating training in medicine, nursing 
and public health to meet the challenges 
of a new centurv'. 
Dr. William L. Kissick '57, as 
moderator, presented the dramatic 
history of his three decades as a 
physician in public health. The revival 
of the ethos of public health is crucial if 
medicine is to fulfill its promise as a 
profession. 
Ms. Susan Addiss. M.P.H. '69. 
reviewed the distinguished history of 
public health at Yale. As a working 
professional in the field, she described 
her own role as "continuously defining 
the unacceptable"; she added that her 
hofie for the years ahead in community 
health, was to be able to conquer the 
“unacceptable." 
Dr. Joseph, in de.scribing the 
harrow ing "second epidemic" of drug 
abuse complicating HIV infection, 
detailed the politics of poverty, w ith 
special emphasis on women and 
children. He painted an intriguing 
picture of public health challenges 
which are global and ecological, 
including not only infections (HIV, 
malaria) but also environmental 
pollution (global warming), problems 
which require professionals whose 
vision has no boundaries. 
Dr. Lawrence Crowley, '44, former 
chancellor and dean of medicine at 
Stanford University, outlined the 
emerging need for settings other than 
tertiary care hospitals for training 
tomorrow's physician. Ambulatory 
settings of varied character are needed 
to address many of the issues posed by 
the other speakers, and in a setting 
where nurses, public health workers, as 
well as physicians, work together in 
improving the health of patients. He 
presented as examples the University of 
Washington School of Medicine and 
the pediatrics program at North 
Carolina at Chapel Hill. This was a 
sobering and thought-provoking hour. 
The faculty lectures on Saturday 
morning presented varied subject 
matter. Best attended was the seminar 
in psychiatry. Dr. Eric J. Nestler 
described the ways in which molecular 
chemistry and physics are entering the 
arena of clinical medicine and 
psychiatry', including treatment for drug 
addiction. Dr. Robert B. Innis also gave 
a fascinating presentation about how 
new imaging techniques are helping 
redefine the function and malfunction 
of the living brain. His laboratory team 
is paying special attention to the 
molecular chemistry' and genetics of 
schizophrenia. 
Presentations by Drs. Henry R. 
Black and Barry L. Zaret outlined major 
research in the treatment and prevention 
of heart disease. Dr. Black summarized 
the identification and modification of 
cardiovascular risk factors; his talk 
featured investigations of hypertension 
and hyperlipidemias w hich have led to 
effective preventive measures. 
Dr. Zaret described a projected 
cardiovascular rehabilitation hotel, with 
construction planned to begin in 1991. 
This 4(X)-unit facility, known as the 
Vivatat Pavilion, should provide 
scientifically based behavior 
modification programs with attention to 
both nutrition and exercise. This center 
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will combine the medical center’s 
scientific expertise with private 
enterprise resources to offer preventive 
measures to individuals who manifest 
risk factors for future disease. 
The session moderated by Ms. Merle 
Waxman, director of the Office for 
Women in Medicine, was attended by a 
capacity audience. Alumnae who spoke 
included: Drs. Alice Shepard Cary, '43, 
(35 years of primary care practice in 
Kyoto, Japan); Margretta Seashore, ’65, 
(20 years in academic practice of 
pediatrics and genetics at Yale); and 
Jane Carter, ’85, assistant professor, 
department of anesthesiology. 
Reflections on their medical education 
and subsequent careers provoked lively 
dialogue among members of the 
audience. The issue of integrating 
successful marriage and parenting with 
practice and teaching dominated the 
discussion. The problem of ascending 
the promotional ladder in academic 
medicine was also a major topic. Susan 
Baserga, M.D., Ph.D., ’88, presented a 
history of coeducation at the medical 
school. The popularity of this 
presentation suggests it might warrant 
repetition at future reunions. 
Dean Rosenberg’s “State of the 
School” report at the A YAM annual 
meeting on Saturday described the 
spiectacular and moving dedication of 
the recently completed Harvey 
Cushing/John Hay Whitney Medical 
Library. Dedication of the Yale 
Psychiatric Institute took place this past 
winter; and progress on construction of 
the Center for Molecular Medicine 
continues, with its dedication scheduled 
for June 6, immediately prior to next 
year’s reunion. The architects 
responsible for each of these three 
facilities are of international renown, 
and the buildings will become 
landmarks in American architecture. 
Major expansion of Yale-New 
Haven Hospital is planned and will 
include a new children’s hospital 
facility. The involvement of a 
distinguished commercial urban 
developer in the community contiguous 
to our medical center promises to 
change the face of our campus and to 
provide an attractive, unified 
architectural plan. 
Recent ambitious and crucial 
investments in the future of the School 
of Medicine have required the support 
of its friends and family as never before. 
To date it has received such assistance 
in record fashion. Dr. John B. Ogilvie, 
’34, chairman of alumni contributions 
for the Campaign for the Yale School of 
Medicine, reported that 65 percent of 
our graduates contributed, providing 
more than $15 million of the total $155 
million raised. Dr. Ogilvie unveiled a 
bronze plaque recording names of 
major alumni donors; this will be placed 
at the entrance of the newly completed 
medical library. For his dedicated 
perfomiance as chairman. Dr. Ogilvie 
was presented a framed painting of the 
Sterling Hall of Medicine. 
Dr. Martin Gordon, chairman of the 
nominating committee, presented the 
nominees for appointment to the 
executive committee of A YAM, and as 
delegates to AYA. They were 
unanimously elected by the assembly 
and include: Executive committee: 
Bennett L. Blitzer, M.D., ’73; Harold D. 
Bomstein, M.D., ’53; Michael 
Kashgarian, M.D., ’58; Forrester A. 
Lee, M.D., ’79, HS ’81; William A. 
Whalen Jr., M.D., ’53, HS ’59; AYA: 
Martin E. Gordon, M.D., ’46; Marie- 
Louise T. Johnson, M.D., ’56. 
The second annual reunion dialogue 
and tea held in the historical library was 
particularly engaging this year. The 
speakers, Drs. Howard Spiro and 
Shirley McCarthy, with Dr. Arthur 
Ebbert as moderator, skillfully 
established the intended dialogue and 
engaged the audience in discussion. The 
topic, “Humanism in an Era of High 
Technology,” evoked wide-ranging 
comments about the apparent erosion of 
the doctor-patient relationship in an age 
of increasingly complex knowledge. 
The difficulties in teaching “humanism” 
in any era were also discussed. 
The reunion dinners, in various 
locations, were well received, 
particularly the Eriends of the 50th 
dinner for the Class of 1940; the classes 
of 1935, 1930 and 1985 were honored 
at this party as well. With more than 
100 guests at the Graduates Club, the 
group was greeted by Dean Rosenberg. 
A record 12 members of the 50th 
reunion class attended. Also present 
were Dr. John Mendillo and Dr. Knox 
Einley, celebrating their 60th reunion; 
and Dr. Samuel Kushlan, celebrating 
his 55th. Toastmaster Lawrence Pickett, 
’44, paid special tribute to Dr. Lee 
Sannella of the 50th-reunion class, 
whose family had presented a 
scholarship fund honoring his late 
father. Dr. Salvatore Sannella, of 
Springfield, Mass. Dr. Lee Sannella’s 
mother, Mrs. Susan Sannella, age 94, 
was present and was saluted by all those 
assembled. Representing his Class of 
1985, Dr. Ered Santoro, the class agent, 
extended greetings from the 30 guests 
assembled at their fifth reunion. 
While overall attendance this year 
averaged that of 1989, attendance at 
each scheduled event was nearly double 
that of past years. The reunion class 
programs were exceptionally well 
structured and the panel discussions 
superlative. Efforts to improve certain 
factors, such as faculty attendance, will 
continue to be pursued. Eoremost, 
because almost all participants seemed 
to enjoy basking in nostalgic 
reminiscence, the primary goal of the 
weekend was achieved. 
Dr. Nicholas P.R. Spinelli, '44 
Former Director, Alumni Affairs 
Association of 
Yale Alumni in Medicine 
Thomas P. Kugelman, M.D. ’60, 
President 
Muriel D. Wolf, M.D. ’59, 
Vice President 
Gilbert E. Hogan, M.D. ’57, 
Secretary 
Dwight E. Miller, M.D. ’56, 
Past President 
Executive Committee 
Bennett L. Blitzer, M.D. ’73 
Sharon L. Bonney, M.D. ’76 
Harold D. Bomstein, M.D. ’53 
Jay H. Hoofnagle, M.D. ’70 
Michael Kashgarian, M.D. ’58, 
HS ’63 
Forrester A. Lee, M.D. ’79, HS 
’81 
Nicholas M. Passarelli, M.D. ’59 
Dorothea R. Peck, M.D. ’43 
William A. Whalen Jr., M.D. 
’53, HS ’59 
Representatives to the 
Association of Yale Alumni 
Fredric K. Cantor, M.D. ’62 
Lycurgus M. Davey, M.D. ’43 
Martin E. Gordon, M.D. ’46 
Marie-Louise Johnson, M.D. ’56 
Kristaps J. Keggi, M.D. ’59 
Gioacchino S. Parrella, M.D. ’41 
R. Leonard Kemler, M.D. ’43 
Chairman 
Medical School Alumni Fund 
Yale Medicine FallAVinter 1990-91 51 
DISTINGUISHED SERVICE AWARDS 
Dr. A. John Anlxan 
A. John Anlyan, M.D. 
Class of 1945 
Ir is 50 years since you were transplanted fron] Ale.xandria, 
liyypt. to Yale and to its medical school for your education. 
You have been a devoted alumnus of Yale for half a century. 
You graced the medical Class of 1945 with your 
individualistic and continental wit and manner for which you 
were famous on campus. Completing medical school as an 
AOA graduate, you commenced practice as a thoracic 
surgeon in San Francisco after educational pauses at the 
Memorial Sloan-Kettering Institute in New York. Ohio State 
University and the U.S. Navy. 
W ith your beloved wife. Betty Ann. you have been active 
among our California alumni contingent since the 1950s. 
Your loyalty and generosity to our school has been constant 
and e.xtraordinary. The Aniyans have repeatedly hosted social 
rvi-nts in the Bay area of California as gracious ambassadors 
■ the Yale School of Medicine. You have been a role model of 
th di'.tant alumnus leader who provides a regional and 
naii.iiud identity for our medical center. 
It i - inr your unwavering and always positive response to 
/ •“ your school has made of you. and for your wise 
//■ • ounsri (o leaders of the School of Medicine, that 
aion honors you. 
Louis J. Kaplan 
The faithful and dedicated service you rendered to the 
graduates of the School of Medicine as associate dean for 
alumni affairs during the years 1971 through 1985 is warmly 
and gratefully remembered today. 
You skillfully and wisely guided the leadership of our 
Association and helped to build an organization which has 
become an important source of support for the school, its 
students, and alumni/ae. In a brief decade, you earned the 
affection and respect of our alumni throughout the country. 
Many came to know you especially well at their annual 
reunions. They responded in 1985 by electing you an 
honorary member of the Association of Yale Alumni in 
Medicine for your lifetime. 
With the passage of time, the value of your directorship 
grows ever more apparent as our Association continues to 
mature. For your enduring counsel and contributions to this 
process we honor you. 
Harry M. Zimmerman, M.D. 
Class of 1927 
Drs. Harvey Cushing and Milton Winternitz were your 
teachers and mentors at Yale over 60 years ago, and you 
proceeded to forge a brilliant career as a pioneer in the field 
of neuropathology. Your extraordinary talent as a teacher of 
pathology was to make you a legend among the graduates of 
Yale Medical School during the two decades you seiwed as a 
faculty member. Although your career brought you 
distinguished posts at tw'o prestigious medical schools 
thereafter, the affection and respect of your Yale students has 
brought you back to New Haven and to your students’ 
reunions almost annually as their guest. You have continued 
to be our teacher and school historian. 
As you approach your ninth decade of life, you continue to 
teach with the same energy, charisma and wonder of your 
youth. Your former students now number in the thousands 
throughout the world. September 1990 will find you lecturing 
to some of them in Kyoto, Japan. 
For your abiding love and service to Yale and her alumni 
we thank you. 
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Louis J. Kaplan (left) with Dr. Nicholas P.R. Spinelli, a 1988 Distinguished Service Award recipient. 
Dr. Spinelli received a plaque at this year s award ceremony, citing his service as YSM director of 
alumni affairs. He retired in October. 
Dr. Harry M. Zimmerman (center) flanked by his wife, Miriam, and Dr. Kno.x H. Finley, '30. 
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REUNION REPORTS 
Photos by Harry Bishop 
Dr. Ia’c Sunnclla.'4(), (center) pauses from his conversation with classmates Richard 
Durmont and John Halew 
1940 
5()th-year reunion 
hy Dr. Donald C. Johnson 
It is a great pleasure to have the 
opportunity to report to you all on the 
5()th reunion of our class. In spite of the 
losses in our class roster, illness, and 
other reasons for not attending, there 
were 16 menibers of our class who 
w ere able to make it. Of these, 14 came 
to the "Friends of the .“iOth” dinner held 
at the Graduates Club on Elm .Street in 
New Haven. 
It was awesome to see how New 
I laven has grown — not always as 
some might have liked it to — but grow 
it has. And so has the medical school 
area. It was a thrill to see the new 
CushingAVhitney labrary', which was 
dedicated on I'hursday, June 7th. 
'I'wo individuals in our class came to 
a reunion for the first time — Dick 
Dormont, recently retired, from Minot, 
N.D.. and Ike Eefevre, who left his 
general medicine practice in Coeymans, 
N.Y.. Just outside Albany. It w'as good 
til see them both after .SO years. Ike's 
channing w ife. Helen, came with him. 
The dinner the medical school gave 
111 luir honor also was attended by 
I'lMiii trom classes before us — and I 
I. .. to >how what .SO years w ill do for 
and to you — the Class of 198S was 
also in attendance. How young they 
seem! The highlight of the evening was 
the recognition of Lee Sannella's 
family for their contribution of $S0.(XX). 
Lee, of course, was present and so was 
his 92-year-old mother, who seemed to 
be having a ball! It is a great thing that 
the Sannella family has done, and I am 
sure the entire class joins me in 
expressing our gratitude. 
The following came to the dinner on 
Saturday evening: Ron Beckett, still 
active at Hartford Hospital, brought 
Eunie Wells, who reports on Jack in a 
nursing home with Alzheimer’s. Dick 
Domiont also attended. Jack and 
Rosemary Haley, who now live in 
Wallingford, Conn., semi-retired (Jack 
does some office gynecology); both 
look great and have changed ever so 
little since our last encounter. Hank and 
Ellen Humphrey are just fine; he loves 
retirement, both have time to do what 
they want, which includes visiting 
grandchildren. Henry is better since 
surgery for the spinal problem. Stu 
Irons came from Florida. He’s doing 
well in retirement; his wife died some 
time back. 
It was good to see Bill Lee again, 
who has retired to Bath, Maine. He still 
plays a mean game of tennis. I’m told. 
Ike Lefevre has not as yet completely 
retired but is heading rapidly in that 
direction, he says. Jack MacAllister 
came, and it was good to renew contact 
with him. He and I drove back to 
Portsmouth, N.H., where he now lives 
in the Strawberry Banke area in a 
charming old restored house. Pat 
Emerson is now remarried to a Yale 
graduate, Sheffield, and medical school 
Class of 1943. Pat and Wes now live in 
Cotuit on Capte Cod. It was just great to 
see Helen Haury Woods again. Dick 
has been laid low with his chronic 
hepatitis and seems a bit frail. Helen 
also has been having trouble with the 
spinal stenosis problem. Although Dick 
didn’t make the dinner, both came to 
Jim’s brunch on Sunday. 
It was great to see Eddie and Martie 
Martin. Eddie is still practicing in New 
Britain. Both look wonderful and have 
changed little, if at all, in the past 10 
years. Jim and Iz Ferguson, both their 
usual selves, were hosts for the Sunday 
quiche brunch, and delicious it was. We 
all had a marvelous time. “Old Ferg” 
seems to be doing well, although his 
back is a bit troublesome and he has had 
to curtail his strenuous athletic 
endeavors. The honorary member of 
our class, (ilene Fitzpatrick, and his 
wife came to the brunch and it was 
great to see them both again. 
As for me, your class amanuensis, I 
continue my volunteer jobs with the 
Red Cross, with local AIDS education 
endeavors, and have finished a tour of 
duty on a committee to advise the 
commissioner of human services in 
Maine regarding AIDS. Despite some 
prostatic surgery, I manage to get 
around, bogged down by excess weight 
and the attendant dietary indiscretions. 
1 am planning to send to all members 
of the Class of 1940 an update of things 
I could not include in this column 
because of lack of space; so bear with 
me. Best Wishes. 
1945 
45th-year reunion 
by Dr. Frederic M. Blodgett 
The School of Medicine held its 45th 
reunion June 8th and 9th. We began on 
Friday, the 8th by attending the class 
seminar in the Beaumont Room. There 
we heard from Drs. Atwood. Breck, 
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Class of 1950 graduates reminisce (from left): Drs. William Bucher, Margaret Lyman 
and Claude Delia. 
Gardam, Reiner, Laupus and Alice 
Shepard Cary, and were reminded that 
our class has come to play a significant 
role in today’s world-wide medical care 
system. We toured the fine, amply 
expanded Cushing/Whitney Library. 
We sat in on many other seminars and 
grand rounds in the Hope Building and 
the hospital. A highlight was the alumni 
association meeting, where John 
Aniyan was awarded a Distinguished 
Service Award for his generous support 
of the school. Making this meeting all 
the more special was the same award 
for Professor Harry Zimmerman, one 
of our most respected teachers. 
Our banquet was held at the Colony 
Inn. Topped off with John Anlyan’s 
keen humor and enriched by George 
Naumburg’s gift of Seyval Blanc table 
wine from his Hudson River region 
vineyard. George was unanimously 
voted Honored Vintner of the Yale 
School of Medicine. The deaths of 
John Flynn and Ray Lesser were 
recognized and deeply regretted. Bobbi 
Morin, widow of Larry Morin, was 
the guest of Dick and Natalie Dyer and 
made the reunion more complete. 
Some of the class were absent 
because of prior commitments, but sent 
regards. Mark and Margaret Lindsey 
were traveling in Europe. Ken and 
Nicki Steele were at Dartmouth for 
Ken's 50th-year reunion; Bob and 
Rutbie Easton were in California for 
grandchildren’s celebration and other 
reasons. All of our absent classmates 
were missed. Those who did attend 
were: John and Betty Aniyan; Fred 
and Phyllis Blodgett; Louise Burr; 
Sandy and Claudene Cockerell; Dick 
and Natalie Dyer; Alice Dershimer 
and Joseph; Jim and Dorothy 
Gardam; Herb and Jean Harned Jr,; 
Bill and Majorie Jenny; Mike Lau; 
George and Michelle Naumburg Jr.; 
Sam May; Joe and Mary Stanton; AI 
Atwood; Dick Breck; Alice Shepard 
Cary; Edward and Hadassah Daniels; 
Sid Feuerstein; Ray and Pat 
Gagliardi; Phil Good; Roger (Tex) 
Hollan; Lee and Barbara Jones; Bill 
Laupus; Tim Reiner; and Chick 
Sherwood. 
Don’t forget about the Big 50, 1995! 
Put it on the calendar now. 
1950 
40th-year reunion 
hy Dr. Claude W. Delia 
I am very pleased to report the activities 
of the Class of 1950 at the alumni 
reunion in New Haven in this our 40th 
year. There was a remarkable turnout 
for this occasion despite the fact that we 
are spread out from coast to coast. Our 
class has 43 members, and 23 were 
present at the 4 p.m. welcoming 
speeches. In all, 53 percent of our class 
attended the reunion. 
In addition to the scheduled events, 
there were several impromptu dinners 
on Thursday evening which ended in 
the early morning hours in our class 
hospitality suite in the Colony Inn. Our 
dinner on Saturday night was preceded 
by a reception in the same suite. Here 
the classmates came together with 
spouses and friends to renew old 
acquaintances and forge new 
friendships. 
Our dinner at Paolo’s restaurant was 
made very enjoyable by the good food 
and wine, the efficient service, the large 
attendance, and the presence of our 
special guest from the faculty. Dr. 
Rocko Fasanella. There were 42 of us 
who sat at six round tables, an 
arrangement that allowed family-style 
service and conversation. 
Those present were: Russell and 
Joan Anderson; Lyal and Bonnie 
Asay; Jane (Baldwin) and Clare 
Shumway; Bill and Ida Bucher; Bill 
and Jeanne Delia; Kent Ellis; Lloyd 
and Peg Felmly; Daniel and Anita 
Fine; Lawrence and Rina Friedman; 
Carl and Marjorie Gagliardi; Naomi 
and Sara (iolden; Sidney and Karen 
(Pat) and Amy Lee; John Leroy; 
Sylvia (Levine) and Robert Axelrod; 
Margaret Lyman; Harold and Julia 
March; Orlando and Dorothy Miller; 
Harry and Sheila McClelland; 
Charles and Margaret Nugent; 
Robert and Ruth Sturman; Robert 
and Phoebe Sceery; and Myra Tyler. 
The banquet lasted four hours, 
during which time there was a serious 
interlude when we remembered our 
deceased classmates. Sid Lee reminded 
us of our class commitment to the 
memorial fund as well as our needed 
support of the Yale endowment. Many 
of those who were not present sent 
messages by mail, telephone and we 
were even “faxed” once. In fact, there 
were only five classmates whom we did 
not hear from. Finally, Jane Baldwin 
Shumway was elected by acclamation 
as class secretary and correspondent for 
the next five years. 
We trooped back across the street to 
our hospitality suite to regroup and plan 
for the final event, which was a 
delightful Sunday brunch at Margaret 
Lyman’s brand new country home in 
Middlefield. Here many of us bid 
farewell to our best reunion so far. 
On our way back to South Carolina, 
Jeanne and I learned that we were the 
grandparents of an 8 pound, 9 ounce 
girl — Carson Mackenzie Diltz, bom 
early evening on the 11th of June. She 
is our reunion baby! 
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1955 
35th-year reunion 
h\' Dr. William E. Lattanzi 
The medical school Class ot 1955 held 
a class dinner at the Quinnipiack Club 
in New Haven on June 9. To those of 
you who did not attend, I extend my 
condolences; a marvelous time was had 
by all. 
A few of us have now retired and 
those in that category who attended 
were the Petersons (Florida), Dave 
Kessler (S;ui Francisco) and the 
Atwaters (Michigan). The 
Bravermans, the Landaus, the 
Camilleris, the Peters and the 
Lattanzis are all .still in New Haven. 
Paul (lOnick is still in practice of 
urology but spends time being a part- 
time bicycle tourist. Ed Brennan 
practices psychiatry in Greenwich when 
he is not scuba-diving. Bob Kramer 
has left the medical directorship of the 
Newington Children's Hospital and is 
now a fund-raiser for the proposed 
Children’s Hospital in Hartford. Paddy 
Burns is practicing psychiatry in 
Boston. .Jay Bobruff is in 
gastrcKmterology, practicing in New 
l.ondon and announced his upcoming 
marriage to his channing fiancee. Dave 
Nelligan is also in New London in the 
pathology department at Lawrence and 
Memorial Hospital. At this 35th class 
reunion, conversation has changed from 
what we are all doing in our busy 
careers to the status of our 
grandchildren. 
It was sadly noted that four of our 
class members are deceased: Bill 
Powell, (lill Leib, Ed Coppola and 
.lim Miles. After this wonderful 




by Dr. .lerrold M. Post 
fhe 3()th reunion of the Cla.ss of 1960 
w as a splendid affair. The troika of Vic 
Altsbul, l orn Kugelman and Jerry 
Post planned a very full weekend, and 
some 34 classmates and significant 
others were in attendance. On Friday 
our class sponsored a reunion seminar 
;)n "Medicine in the Public Arena.” 
1 iT\ I'ost presented a paper on “The 
ii' 1' King: Filfects of 111 Health and 
! >e ibih:' on Political Leadership,” and 
: ' ei 'lman addressed “Is The 
i I null Degrading Because of 
a Decline in Research Ethics?” In 
addition to Class of '60 attendees there 
were a large number of attendees from 
other classes. 
On Friday evening, there was a 
lovely supper at Vic Altshufs graceful 
Victorian home, which the class was 
reluctant to leave. After the traditional 
Saturday reunion seminars and 
luncheon, Saturday evening the class 
continued their celebration at the New 
Haven Lawn Club, with a cocktail 
reception and dinner. Songs from our 
1958 class skit were resurrected by Vic 
and Jerry, and as has become their 
tradition. Bob Wallach and Al Ross 
once again regaled us with their off-beat 
senses of humor. Several members of 
the class have retired or are 
contemplating retirement in the near 
future, a staggering concept. 
In attendance were: Vic and Laura 
Altsbul, Donna and (Jerry (recently 
retired) Cimmino, Paul and Clare 
Friedman, Gene Gaenslen, Jim 
(lilman, Dan (recently retired from the 
military) and Carolyn Jones, Rick and 
Marilyn Kindwall, Sue Kleeman, 
Tom and Alice Kugelman, Al and 
Barbara New-comb, Fred and Ruth 
Palace, Jerry and Carolyn Post, 
Nancy Rolick Pow'er and Orlo Power, 
Al Ross, Dan Rubin and Lina 
Swisher, John and Ann Schrogie, 
Fred and Ann Stargardter, Gus 
Voyagis and Bob Wallach. 
1965 
25th-year reunion 
by Dr. John El. Seashore 
Believe it or not, our class celebrated its 
25th reunion. Since Phil Manfredi was 
unable to attend, he asked me to write a 
summary of this historic occasion. We 
gathered on Friday afternoon for the 
class seminar to hear talks by 
Mohandas Kini, John Parrish, Dave 
Williams, Carl Hunt, Greta Reed 
Seashore and John Seashore. That 
evening we had dinner at the Seashores’ 
and on Saturday night the class dinner 
was held at the New Haven Medical 
Association building. Twenty-four 
classmates (about one-third of the class) 
attended one or both dinners: John and 
Nancy Austin, Phil Askenase, Paul 
and Susan Balter, Phyllis Hurwitz 
Duvdevani and Ban, Bob Finkel, 
Frank and Donna (Jrady, Gary and 
Betsy Gross, Bob (Jryboski, Reid and 
Ellie Heftner, Dave and Gretchen 
Hill, Carl Hunt, Ginny Burnham 
Johnson, Ron and Jane Karpick, 
Mohandas and Joanne Kini, Walter 
and Joyce Noll, Larry and Linda 
Ossias, John and Joan Parrish, Bob 
and Mary Pickens, John and Greta 
Seashore, Alan and Jeri Stone, John 
Titus, Bob and Sue Weiner, and Dave 
and Carol Williams. 
For entertainment on Saturday we 
enjoyed (or suffered through) a tape and 
slides of that timeless classic, our senior 
show, thanks to the foresight of John 
Austin, who has saved these 
Dr. Paul Eriedman and I960 classmates celebrate 30 years in the healing arts. 
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memorabilia all these years. Everyone 
agreed that we all look exactly the 
same! We all had a grand time 
renewing friendships and recalling our 
glory days at 333 Cedar St. I think we 
would have had even a bigger turnout 
except that many of our classmates had 
children graduating from high school or 
college that weekend. A good many 
also live in California and apparently 
felt it was too long a trip, but they were 
put to shame by Dave Williams who 
came all the way from Alaska, mainly, I 
think, to play a round at the Yale golf 
course with Alan Stone. Frank Grady 
won the prize for the youngest child — 
his wife Donna arrived with their 5- 
month-old in arms. Frank must still be 
searching for the fountain of youth. 
All in all it was a great weekend. We 
missed those of you who couldn’t come 
and hope to see you all at our 30th. 
1970 
20th-year reunion 
by Dr. Robert M. Rosa 
Our 20th reunion was held at Mory’s 
and was a delightful evening of 
conversation and reminiscence. In 
addition to spouses and guests, those 
present included Scott Peterson, who 
made the dinner arrangements and who 
directs a large private practice of 
ophthalmology out of Waterbury, 
Conn.; Anne Curtis, chief of chest 
radiology at Yale and professor of 
radiology; Rick Edelson, recently 
appointed chairman of dermatology at 
Yale; Jay Hoofnagle, who is at the 
NIH and directs the division of 
digestive diseases; Norm Coleman, 
professor and chairman of the joint 
center for radiation therapy at Harvard; 
Jonathan Katz, who practices 
anesthesia in Bridgeport, Conn.; 
Michael Danzig, a cardiologist in Fort 
Meyers, Fla.; Jim O’Brien, a plastic 
surgeon in Norwood, Mass.; Karl 
Wustrack, who came all the way from 
Oregon where he is engaged in plastic 
surgery; John Blanton, still in New 
Haven, where he is a pediatrician; Rick 
Solomon, who is moving to the New 
England Deaconess Hospital as chief of 
clinical nephrology; Jonathan Ecker, a 
psychiatrist in Syracuse; Lynn 
Whisnant Reiser, a psychiatrist in New 
Haven; Paul Hessler, a radiologist in 
Rhode Island; Mark Korsten, who is at 
Mt. Sinai in New York and is also an 
accomplished guitarist and sailor; Meg 
DeLano, now a stepgrandmother; and 
Bob Rosa, your class secretary, who is 
Graduates of the decades meet: Dr. Margaret Delano. '70, (left) converses with Dr. 
Leon Sweer, '80, and his wife Karen Sweer. 
at the Harvard Medical School, where 
he is associate director of the clinical 
research center at the Beth Israel 
Hospital. 
During the evening, letters were read 
from Bob Janco (Vanderbilt), Dave 
Dueker (University of Missouri- 
Columbia), Bill Mueller (Ohio), Ken 
Khoury (California), Phil Steeves 
(Massachusetts), Joe Chosid 
(Milwaukee), Henry Chessin 
(Wisconsin), and Stuart Shorr 
(Washington). In addition, Harvey 
Fernbach called during the dinner to 
extend his best to everyone and to 
apologize for his absence, which was 
unavoidable. We sincerely hope that 




by Dr. Mary Jane Minkin 
Our 15th reunion may not have been the 
best attended, but we all did have fun. It 
was wonderful seeing Vivian Reznick, 
and her husband Andy Ries, ’74 — 
Andy was able to pass on lots of gossip 
about his class, too. Vivian is on the 
faculty in pediatric nephrology at UC 
San Diego (Andy is there in adult 
pulmonary medicine). They were also 
able to share exploits of their three kids 
with Henry Cabin and Florence 
Comite, ’76, who have two kids in the 
same age group. Henry is still an adult 
cardiologist at Yale, and Florence holds 
a joint appointment in pediatrics, ob- 
gyn and medicine. Your reporter is still 
in private practice, ob-gyn, in New 
Haven, and on the clinical faculty for 
the medical school (and eagerly await¬ 
ing the birtli of her and mathematician 
husband Steve’s second kid). 
We did receive a few updates from 
class members in the mail. Lana 
Holstein and Dave Taylor are in 
Arizona, doing family practice and 
caring for their family of two kids. 
Dave London is in San Francisco, 
enjoying private practice radiology. 
Doug Zusman is in California as well, 
as a cardiac surgeon. Fred Rosenfelt is 
an oncologist in Los Angeles, and 
unfortunately couldn’t make the 
reunion because of an adventure travel 
trip. 
All of us at the reunion were sorry 
that more of our classmates didn’t 
attend. Vivian and I had a particularly 
good time laughing at our first-year 
pictures outside the pathology offices (a 
good locale) in Brady. Hopefully, you 
all will try for the 20th. 
Yale Medicine Fall/Winter 1990-91 57 
Classmates catch up on each other's news from the five short years since graduation. 
1980 
lOth-year reunion 
hy Dr. Patricia C. Brown 
The YSM Class ot 1980 enjoyed its 
iOth reunion with good food and cheer 
at Bruxelles restaurant in the heart of 
downtown New Haven. ITie turnout 
was good with a tr)tal of 29 attending, 
including 17 classmates and 12 spouses 
and companions. A summary of their 
activities follows. 
Claudia Dinan is practicing 
pulmonary' medicine and living in 
Orange, Conn., with her husband 
.\ttilio (iranata, '77, and their son, 
V ince. Larry Young, cardiology 
faculty at Yale, is married to Lynn 
Tanoue, '82. Kric Nestler, Yale faculty 
in psychiatr>’ and phamiacology, and 
his w ife Sue have two children, David 
and Matthew, and are expecting a third. 
.-\lso kK'al arc Deborah Desir, 
rheumatologist at the Community 
I lealth Care Plan, and (lary Desir, 
nephrologist at Yale. They have three 
sons: Carl, Matthew and Christopher. 
Nearly liK'al are Mare (iliekstein, 
director of MRI at Hartford Hospital, 
and wife, Sylvie, w'ho live in 
(ilastonbur)’. Conn., and have a baby 
bt)'., Sam, 
\ numt-HT of [X'ople drop;x'd in from 
'\ev, York City, including Carl .SchifT 
! :d ' iara, C 'arl practices 
' T Brooklyn. .Alan 
■ ' I : . director of 
s .ilogy at St. Vincent's 
Hospital, joined the reunion with 
girlfriend Jill Nathanson. John 
Jacobs, Cornell faculty and medical 
director of their clinical AIDS program, 
is married to Carolyn Douglas and 
they are expecting in August. Also from 
New York, but the other end of the 
state, is Patricia Brown, who has 
finished a residency in dermatology 
after training in pathology. 
Massachusetts is home to many 
attendees including David Adelberg, 
married to Linda Britto and busily 
engaged in private practice orthopedics 
in South Dartmouth. Judy Garber, 
cancer epidemiologist and clinical 
oncologist at Dana Farber, is married to 
Myles Brown with whom she has a 
girl, Jenifer. Marty Silverstein, 
business consultant in health care, is 
married to Andy Haas with whom he 
has a baby girl, Amy. Etban Lerner, 
dennatology faculty at Brighimi and 
Women's, and wife Lisa have a baby 
boy. Max. 
Leon Sweer arrived from Hershey. 
Penn., where he is finishing a 
pulmonary fellowship. Leon is married 
to Karen and they have two children, 
Ryan and Kevin. Steve Rosenfeld raid 
wife Lisa fiew in from Boca Raton, 
Fla., where he practices ophthalmology. 
They have two children, Michael and 
.lulie. Todd (larvin, urology faculty at 
University of New Mexico, travelled 
farthest, from Albuquerque, where he 
lives w ith wife Dianne and their three 




hy Dr. Fred E. Santoro 
Members of the Class of 1985 attended 
the “Friends of the 5()th’’ dinner hosted 
by the Class of 1940 at the Graduates 
Club. Michael Gilbert and Susan 
McClintic came to New Haven 
accompanied by their children, Megan 
and Kevin. Mike is a family practice 
physician in Irvine, Calif. Brian 
Lombardo, whose wife Tracy was 
unable to attend, took some time off 
from his busy family practice clinic in 
Minneapolis. Guy Fish, along with his 
wife Kim and children Nicole and 
James came from Delaware, where 
Guy is in solo practice in internal 
medicine. JoAnne Burger has 
continued her training at Yale where 
she is a developmental pediatrics 
fellow. Her husband, Michael Kaplan, 
and daughter, Rebecca, also 
participated in the weekend activities. 
Ted and Joyce Love drove down from 
Boston, where Ted is a cardiology 
fellow at the Massachusetts General 
Hospital. Carol Farver, now a 
pathology fellow at Brigham and 
Women's Hospital, and Robert 
Neediman, who is developmental 
pediatrics fellow at Boston City 
Hospital, also made the trip down the 
coast. They are the proud parents of a 
daughter, Grace. 
Peter Rubin is completing an 
ophthalmology fellowship and will be 
joining the staff at the Massachusetts 
Eye and Ear Hospital. Fred Santoro, 
after completing a one-year fellowship 
in adolescent medicine, joined another 
pediatrician in private practice in 
Groton, Conn. His wife. Anne, and son. 
Thomas, have settled down in East 
Lyme. Also in Connecticut are Susan 
Moore and Albert Gobel and their son 
Wade. Susan has been continuing her 
training, now with the department of 
laboratory medicine at Yale. Kimball 
and Janet Woodward have settled in 
Westport where they have a one-year 
old .son, Richmond. Kim is just 
completing a one-year fellowship in 
vitreo-retinal surgery at Manhattan Eye, 
Ear and Throat Hospital, where he plans 
on staying as a resident instructor and to 
work in the private practice of retinal 
surgery. Marnin Merrick joined us 
from Philadelphia where he is a 
hematology-oncology fellow at the 
University of Pennsylvania. 
We are all looking forward to the 
lOth, where hopefully more of us can 
catch up with each other. 
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1989-1990 ALUMNI FUND REPORT 
Message from the Dean 
Today’s students become tomorrow’s 
alumni/ae; no one understands this 
better than Dr. Nicholas P.R. Spinelli, 
’44, the school’s immediate past 
director of alumni affairs. During the 
past five years, he has worked closely 
with our students, encouraging them 
to recognize just how vital they are to 
the future of their alma mater. 
As a tribute to Dr. Spinelli’s 
success, many of these students and 
recent graduates have displayed their 
dedication to Yale in charitable 
giving. By doing so, these new and 
future physicians, biomedical 
scientists and public health 
professionals — most of them of 
modest means — have provided much 
needed financial support to Yale 
medical and public health students as 
the cost of higher education continues 
to climb. 
The medical school Class of 1990 
provides a good example of this spirit 
of generosity. More than 90 percent 
contributed to the School of Medicine 
Alumni Fund. Class members also 
conceived of, and provided initial 
funding for, the new student lounge in 
Edward S. Flarkness Hall. At their 
request, we have dedicated this 
handsome space to Dr. Spinelli. 
The spirit of generosity also 
manifests itself as your school gives 
of itself as an institution. We continue 
to give the highest quality education 
to our students; our students, faculty 
and staff still volunteer countless 
hours to support the New Haven 
community, including many not-for- 
profit organizations that require our 
help more than ever during these 
unsettled economic times. 
Last year, the School of Medicine 
received richly, too, including major 
gifts from Belle Morse, the Mathers 
Foundation, the Sanella family and 
the Kresge Foundation challenge. 
Finally, we are most grateful for the 
record donations of $656,000 from 
medical alumni/ae and $135,500 from 
our EPH graduates. 
I urge you as medical and EPH 
alumni/ae to continue in this great 
Yale heritage of generosity. Your 
gifts support the education of a 
generation of young people who 
through their scholarship, idealism 
and dedication to community service 
are already helping to build a 
healthier future for humanity. 
Leon E. Rosenberg, M.D. 
Dean 
Dr. Leonard Kemler, ’43, addresses 
the 1990 AYAM assembly. 
From the YSM 
Alumni Fund Chairman 
The train of alumni giving is back on 
track. We had set a goal of $650,000 
for the academic year 1989-1990. 
Thanks to the efforts of our loyal 
class agents and to Drs. Sam Kushlan 
and William Collins (representing 
house staff and bequest and 
endowments), we not only achieved 
our goal, but surpassed it. A record 
$656,000 was pledged or given to the 
School of Medicine Alumni Fund this 
past academic year. We congratulate 
our class agents and thank all our 
alumni donors. 
During the 1989-1990 fiscal year, 
our percentage of participation 
remained the same—43 percent—but 
this will have to increase during the 
current year if we are to meet a 
challenge from the Kresge 
Foundation. If we raise our 
percentage of participation to 55 
percent, the foundation has agreed to 
donate $1 million toward the 
completion of the Center for 
Molecular Medicine. If those of you 
who have not given recently make 
even a small contribution this year, 
the School of Medicine will benefit 
forever. The size of your contribution 
is not as important as you 
participation. All gifts, large or small, 
will be gratefully accepted. We can 
do it. 
We are also planning special 
programs for reunion classes 
beginning this year. Dean Rosenberg 
is particularly interested in this 
project. Those of you who will have a 
1991 reunion will hear from your 
reunion chairperson during the course 
of the year. Any suggestions or ideas 
will be welcomed by the reunion 
committee, and volunteers to work on 
this nostalgic event are encouraged to 
come forth. 
No report would be complete 
without heartfelt thanks to our alumni 
fund Director, Monica Robinson, and 
her staff. This year’s success would 
not have been possible without their 
consistent efforts and help. Also, 
special thanks to those agents whose 
classes achieved a 75 percent or 
greater alumni fund participation, as 
listed below. 
We look forward with enthusiasm 
to our coming campaign. Best wishes 
for a happy and healthy year. 
Dr. R. Leonard Kemler, '43 
Chairman 
% CLASS CLASS AtJENT 
100 1923 William Cohen 
100 1924 David Raskind 
91 1931 Michael D’Amico 
75 1934 John Ogilvie 
76 1941 Charles Cheney 
75 1946 Thomas Whelan 
78 1947 George Barnes 
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School of Medicine Alumni Fund Class Participation 
1988-1989 1989-1990 
CLASS ACENT TOTAL % PART. TOTAL % PART. 
1922 and prior $ 1.811 100 2,011 100 
1923 William Cohen 642 100 686 100 
1924 David Raskind 10,284 100 11,334 100 
1925 Alice Whittier 531 56 5,473 50 
1926 Maxwell Bogin 542 60 1,720 60 
1927 Harry' Zimmerman 1,038 67 1,136 63 
1928 Lewis Scheuer 53,518 60 3,580 60 
1929 Paul McAlenney 1,358 67 1,376 67 
1930 12,957 53 147,690 71 
1931 Michael D'Amico 4.494 79 3,426 91 
1932 5,865 63 2,339 50 
1933 Franklin Foote 1,607 57 2,103 69 
1934 John Ogilvie 4,389 62 4,652 75 
1935 James Haralambie 6,454 57 6,780 52 
1936 23,677 23 3,991 34 
1937 Wilbur Johnston 1,904 50 2.289 64 
1938 Nelson Ordway 2,136 56 1,346 72 
1939 Rebecca Solomon 19,301 71 4,131 69 
1940 James Ferguson 9,178 58 16,441 65 
1941 Charles Cheney 4,702 66 4,593 76 
1942 Walter Burdette 3,829 56 3,600 64 
1943A Dorothea Peck 4,232 67 6,743 74 
1943B S. Brownlee Brinkley 3.399 5 5.930 54 
7,631 59 12.673 64 
1944 Nicholas Spinelli 46,770 73 10,131 65 
1945 Richard Breck 3,850 53 10.573 67 
1946 Thomas Whelan 9,196 52 8,800 70 
1947A George Barnes 6,834 78 
1947B W. Roy Breg 7.764 57 2.653 64 
9,487 71 
1948 Paul Koehler 7,288 46 7,675 56 
1949 Daniel Elliot 5.951 70 3,930 60 
1950 Margaret Lyman 12,523 64 74,952 71 
1951 Lowell Goodman 8,479 45 10,581 59 
1952 Harvey Young 5,770 40 4,275 42 
1953 Vincent Gott 6,355 51 8,710 55 
1954 John Rose 8,237 70 6,034 60 
1955 Robert Kramer 6,405 63 6.932 58 
1956A John Gardner 10..346 54 4,862 47 
1956B Donald Dalessio 3.235 53 
8,097 50 
1957A Harry Briggs 2,975 59 3,575 57 
1957B Howard Minners 3,515 61 4.575 64 
6,490 60 8,150 61 
1958A Andrew McGowan 7,414 68 9.702 53 
1958B Paul Rudnick 3.985 58 4.820 52 
11.399 63 14.522 53 
1959 A Asa Barnes 7,094 64 7,222 61 
1959B Muriel Wolf 5,798 59 4.474 57 
12,892 62 11.696 59 
1960A Eugene Gaenslen 3,536 50 5.333 57 
1960B Thomas Kugelman 4.275 52 6.500 57 
7,811 51 11.833 57 
1961A Robert S. Briggs 3,575 54 3,305 51 
1961 B Warren Widmann 3,925 54 4.610 57 
7,500 54 7.915 54 
1962 A A.R. Pschirrer 1,580 34 4,090 60 
1962B Frederic Cantor 2,527 38 3.051 39 
4.107 36 7,141 50 
l'»(:3 Craig Llewellyn 7,971 35 6,984 32 
I'lWA William J. Houghton 4,360 51 2.185 41 
H Robert Lyons 9,800 71 10.6.50 68 
14,160 61 12.835 55 
i v-r. David Hill 5.544 47 13,299 50 
\ Mary Alice Houghton 2,775 51 2.975 57 
Gar- I'ownsend 1.885 42 3,400 52 
4.660 47 6,375 55 
J. i -. Dowaliby 4,204 57 3,428 54 
nth 'O', Lo\ell 5,935 76 5.715 74 
10,139 67 9,143 64 
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1988-1989 1989-1990 
CLASS AGENT TOTAL % PART. TOTAL % PART. 
1968A Frank Lucente 3,627 43 9,053 45 
1968B Donald Lyman 3.852 64 4.830 58 
7,480 53 13,883 52 
1969 Adrian Schnall 11,088 63 7,602 52 
1970 James Missett 4,922 38 5,823 46 
I971A John Cieply 3,438 52 3,468 43 
1971B Barbara Kinder 4,175 57 5.725 44 
7,613 44 9,193 44 
1972 Harry Malech 10,108 47 9,835 47 
1973A Lee Goldman 1,425 39 1,766 48 
1973B John McQuade 3,740 39 2,015 39 
1973C Jerrold Rosenbaum 1.725 46 1.691 43 
6,890 40 5,472 43 
1974A Amy Schechter 1.955 49 1,755 49 
1974B Robert Schechter 1.385 32 3.800 37 
3,340 40 5,555 43 
1975A Daniel Passed 1,410 23 1,570 31 
1975B Mary Jane Minkin 1.304 18 1.179 20 
2,714 20 2,749 26 
I976A William Levy 2,540 32 3,000 35 
1976B Glenn Gorlitsky 2.275 46 1.260 36 
4,815 36 4,260 36 
1977A Attilio Granata 610 24 2,420 24 
1977B Ronald Vender 1.205 44 2.527 47 
1,815 34 4,947 36 
1978A Duke Cameron 2,325 26 1,770 22 
1978B Seth Powsner 415 33 325 27 
1978C Thomas Smith 280 50 115 25 
3,020 30 2.210 25 
1979A Jeffrey Kaine 1,190 40 685 34 
1979B Cynthia Sherman 1.245 31 1.900 24 
2,435 35 2,585 29 
1980A Eduardo Alfonso 1,020 29 2,375 35 
1980B Steven Rosenfeld 725 30 1.056 27 
1,745 30 3,431 31 
1981 Anthony Urbano 1,125 23 1,645 20 
1982A Muriel Cyrus 95 7 650 12 
1982B Jed Gorlin 330 44 300 35 
1982C S. Wolf-Rosenblum 335 29 470 38 
760 23 1.420 28 
1983A Michael Tom 324 16 276 9 
1983B David Schwartz 205 26 330 30 
529 20 606 20 
1984A Hingge Hsu 675 32 485 26 
1984B Jay Kostman 385 18 500 19 
1,060 25 985 23 
1985A Greg Sachs 695 26 
1985B Fred Santoro 786 32 190 23 
786 32 885 25 
1986A Eric Bernstein 95 7 230 16 
1986B Clinton Lindo 220 7 95 11 
1986C Eric Suan 60 14 35 7 
375 9 360 12 
1987A Barry Weinstock 237 26 261 20 
1987B Subba Gollamudi 2,070 22 50 17 
1987C Mindy Schuster 175 23 100 14 
1987D Mark Widmann 70 11 
2,552 21 411 17 
1988A Michael Mockovak 59 26 57 19 
1988B Susan Valley 90 17 145 17 
1988C Hedi Zaghi 149 16 20 8 
298 20 222 15 
1989A Stephen Bharucha 110 20 110 13 
1989B Lewis Lipsey 245 20 245 24 
1989C Melissa Myers 50 10 50 11 
1989D Roger Widmann 10 35 13 
440 15 440 15 
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CONTRIBUTORS 1990-1991 
The names and data included on the following pages were provided by the 
Yale School of Medicine Alumni Fund and reflect contributions made 
between Julx 1. 1989 and June 30. 1990. 
MKDK Al. SCHOOL 
AIT MM 
1906 
Charles R. Mitchell* 
1908 
Michael A. Parlalo* 
1912 
Waller Clark Tiklen* 
1913 









Chester E. Hurwit/* 
Helen P, Langner 
1923 
William Cohen 
lulius Anthony Olean* 
Hyman W. Weinstein* 
1924 
John J. Batchelor 
Donato Anthony D'Esopo' 
David M. Raskind 
Myron A. Sallick* 
Harold 1'. Vogel* 
1925 
Dorence S. Cowles 
Waldo F. Desmond* 
Wdliam E. Hall 
Samuel Reback 
Eli Hyman Rubin* 
Alice A. S. Whittier 
Howard Asa Wood* 
1926 
Stanton T. Allison* 
Louise Baker 
Maxwell Bogin 
Wdliam 11 Hahn* 
Joseph L. 1 let/el* 
Joseph 1'. Matteis 
1927 
\S’allace Robert Boslssick" 
llenrs Irwin l ineberg 
John Martin I reiheil' 
I ;-'nald F t nbson 
AM rt Jablonsky 
'' i' I i-\, v' 
‘ - i‘ I ■ Meredith 
■ I i - I ;■ 
■ ^ ' ;iC 
' ' Vi - iiKin 
1928 
Max Alpert* 
Sheldon A. Jacobson 
Edw ard P J Kearney 
Ralph E. Knutti 
R. Harold Lockhan 
Edward W. Ludw ig* 
Nathan E. Ross 
Robert 1. Rubinstein* 
John M. Russell* 
Alvin A. Schaye* 
Lew is A. Scheuer* 
1929 
James Rae Ameill Jr.* 
John M. Bailey* 
John W. Cass Jr. 
Olive Gates 
George S. Goldman 
Alexander O. Half* 
John A. Hangen 
Paul F. .McAlenney 
Tony Liebman Rakieten* 
William Frederick Roth Jr.* 








Daniel N. Beers* 
Frederick Fit/herbert Boyce 
Charles A. Breck* 
Lewis Dickar* 
Vincent A. Doroszka* 
Knox H. Finley 
J. Roswell Gallagher 
Leonard Greenburg 
Amy H. Hunter-Wilson 
Edmund L. Kitzmeyer 
Paul H. Lavietes 
Moses D. Lischner* 
James Merriman Lynch* 
John C. Mendillo 
Paul Watson* 
Charles L. Wood 
1931 
Henry H. Briggs Jr. 
Benjamin Castleman* 
.Michael D'Amico 
Helen R. Gilmore 
Paul A. Harper 
Morris Heller* 
Thomas C. Jaleski 
Rhoda M. Mickey 
Nelson Newmark 
Abraham J. Schechter 
James .A. Stringham 
Max Tal'I'el 
1932 
Louis K. Alpert 
Reginald V. Berry 
Frank Carroll 
Clement C. Clarke 
Hester B. Curtis 
Joseph P. Donnelly 
Lee E. Farr 
Thomas FI. Farthing* 
Conrad R. Lam 
Elizabeth M. Ramsey 
Benjamin N. Tager 
Myron E. Wegman 
Roland T. Wehger* 
1933 
Myron J. Adams* 
Fred W. Buse 
Warren P. Cordes 
Franklin M. Foote 
Jack Greenberg 
Daniel Foster Harvey* 
George K. Hirst 
Robert Watkinson 
Huntington Jr.* 
John G. Martin 
Raymond E. Miller 
Ashley Pond 111* 
Edwin B. Seelye* 
Sidney Stringer* 
John J. Wolfe 




Francis P. Guida* 
Derick Algernon January* 
Knowles B. Lawrence 
Herbert C. Miller 
Edward Thomas O'Donnell* 
John B. Ogilvie 
Lucien M. Pascucci 
Harry Sherman 
Wedgwood P. Webber 
William R. Willard 
George Zalkan* 
1935 
Walter E. Barney 
George A. Carden Jr. 
Edgar S. Childs 
H. Hoffman Groskloss 
James Quintin Haralambie 
W. Howard Homer 
Mildred Hartshorn January 
Samuel D. Kushlan 
Donald P. Morris* 
Norman E. Peatfield 
Milton Rose* 
Clark P. Searle 
Walter A.L. Thompson 
1935 Classmates 
1936 
Lester W. Burket 
Albert W. Diddle 
Margaret C. L. Gildea 
George A. Hahn* 
Louise G. Hutchins 
Philip M. LeCompte 
Donald F. Marshall 
Stephen F. Nagyfy 




Edmund R. Blower 
William G. Cooper Jr. 
David A. Dolowitz 
D. Crosby Greene 
Wilbur D. Johnston 
Alfred E. King 
Dunham Kirkham 
Julia Mehlman 
James P. Morrill 
T. Dennie Pratt 
Alan A. Rozen 
Morgan Sargent 
Edward J. Shaw 
Albert D. Spicer 
John M. Thomas 
Jean Wells 
1938 
Roy N. Barnett 
Henry L. Carideo 
S. Charles Kasdon 
Benjamin E. Lyons 
John J. McGillicuddy 
Edward Nichols 
Nelson K. Ordway 
Charles J. Petrillo 
Edward W. Pinkham Jr. 
James Radcliffe Jr. 
George E. Roberge 
Theodore W. Steege 
Lester J. Wallman 
1939 
Stephen W. Collins Jr.* 
Harold H. Coppersmith 
Noiman L. Cressy 
William H. Druckemiller 
Robert Goodfellow Ernst* 
John P. Ferguson Jr. 
S. Jerome Greenfield 
Arthur E. Laidlaw 
Margaret A. Lennox 
Ward J. McFarland* 
James Peter Murphy 
Russell Nahigian* 
Douglas S. Riggs 
Roger N. Ryley 
Ernest L. Sarason 
Rebecca Z. Solomon 
John D. Tobin 
Darrell G. Voorhees 
Douglass W. Walker 
John H. Wentworth 
Malvin F. White 
SCHOOL OF MEDICINE 
ALUMNI EUND BOARD 
David Raskind, M.D. '24 
J. Roswell Gallagher, M.D. '30 
Franklin M. Foote, M.D. '33 
Samuel D. Kushlan, M.D. '35 
Malvin White, M.D. '39 
R. Leonard Kemler, M.D. '43 
Nicholas P.R. Spinelli, M.D. '44 
William McClelland, M.D. '47 
Paul Koehler, M.D. '48 
Lowell I. Goodman, M.D. '51 
Harold Bomstein Jr., M.D. '53 
Herbert Hurwitz, M.D. '54 
Robert Kramer, M.D. '55 
Robert Donahue, M.D. '58 
William Waskowitz, M.D. '57 
Nicholas Passarelli, M.D. '59 
David Hill, M.D. '65 
John Foster, M.D. '71 
Sharon Bonney, M.D. '76 
FUND OFFICERS 1989-1990 
Medical School Alumni Fund 
R. Leonard Kemler, M.D. '43 
Chairman 
J. Roswell Gallagher, M.D. '30 
Bequest & Endowment Co-chairman 
Samuel D. Kushlan, M.D. '35 
Bequest & Endowment Co-chairman 
Former House Staff Chairman 
EPH Alumni Fund 
Stephen Skorcz, M.P.H. '70 
Chairman 
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1940 
Theodore E. Allen 
Joseph V. Baldwin 
Ronald S. Beckett 
Jack S. Blaisdell 
Philip S. Brezina 
David Crocker* 
Wynant Dean 
Richard E. Dormont 
Robert M. Dunlap 
James E. Eerguson Jr. 
Eugene J. Fitzpatrick Jr. 
Henry D. Humphrey 
H. Stuart Irons 
Donald G. Johnson 
Ira D. LeFevre Jr. 
John D. MacAllister 
Paul D. MacLean 
Edward Martin 
Maurice Ross* 
W. Norman Sears* 
Joseph E. Sokal* 
J. Champneys Taylor 
Patricia E. Wanning 
Helen H. Woods 
1941 
Robert H. Alway 
Robert H. Areson 
W. Randal Bell 
Knute E. Berger 
William A. Carey 
Joseph P. Carson Jr. 
Charles B. Cheney 
Herbert W. Diefendorf 
Robert F. Dine* 
Peter A. Duncan 
Lloyd D. Flint 
John Franklin 
Robert L. Gilbert 
Frederick P. Glike 
Sidney L. Lasell 
William Lee 
Bjorn Lih 
F. Eugene Martin 
John R. McDermott* 
Willys M. Monroe 
Malcolm C. Murfitt 
Jean E. Neighbor 
Edward B. O’Connell 
Robert W. Ollayos 
Gioacchino S. Parrella 
David V. Pecora 
Edwin D. Rogers 
Leslie Simmonds 
1942 
William E. Bloomer 
James M. Bunce 
Walter J. Burdette 
Robert E. Carroll 
Donald S. Childs Jr. 
Vincent J. Collins 
Eugene M. de Hostos 




Allan V.N. Goodyer* 
William Harrison Jr. 
Wilson E. Hughes 
Leo Kellerman 
John R. Lincoln 
Patrick S. Mullins* 
Dean Nichols* 
Charles F. Scholhamer 
Richmond W. Smith Jr. 
Carter Stilson 
Edgar B. Taft, 
Maurice Tulin 
Francis P. Vose* 
Irving Norman Wolfson 
1942 Classmates* 
Roy B. Sauberman celebrates his graduation with grandfather Nathan 
Sauberman, a retired engineer. (Commencement photographs throughout 
this section offer a reminder that contributions to the School of Medicine 
and EPH alumni funds, unless otherwise directed by the donor, support 
student financial aid. 
1943A 
Ralph D. Alley 
John R. Brobeck 
Lycurgus M. Davey 
Donal L. Dunphy 
R. M. Fasanella 
Gerard Fountain 
Edward Douglas Homing* 
R. Leonard Kemler 
Jonathan Trumbull Lanman* 
Douglas Lindsey 
J. Philip Loge 
Henry E. Markley 
Walter J.J. Nero 
Dorothea R. Peck 
Earl J. Rhoades 
Henry A. Riedel 
Bernard R. Rowen 
Marcus E. Sanford 
Robert A. Sears* 
Edward Hersey Soule 
Hilliard Spitz 
Nicholas M. Stahl 
Robert J. Staub 
Sophie Trent Stevens 
Oliver G. Stonington 
Frederick A. Waldron 
John J. Weber 
Robert H. Wyatt 
1943B 
Richard N. Abbott 
John R. Almklov 
David G. Borden 
James L. Bradley* 
S. Brownlee Brinkley 
Henry B. Bruyn Jr. 
Thomas L. Bucky 
Jane B. Cadbury 
Philip B. Chase 
Hunter H. Comly 
Norman I. Condit 
Ronald W. Cooke 
Joseph I. Epstein 
Robert H. Furman 
Victor C. Hackney 
Frank R. Hurlbutt Jr. 
Henry H. Jones 
Joseph F. Kell 
Sawyer E. Medbury 
Hoyt B. Miles Jr. 
Benjamin R. Robinson Jr. 
Donald W. Seldin 
Francis A. Spellman* 
1944 
Carl E. Andrews 
Joseph Ciola* 
Edward J. Conway 
John C. Coolidge 
George B. Corcoran Jr. 
Frank W. Countryman 
Charles H. Crothers 
Lawrence G. Crowley 
John H. Doherty 
Robert W. Frelick 
Carol Goldenthal 
Charles A. Hall 
Howard B. Hamilton 
Robert I. Hinkiey 
Ward S. Jenkins 
Edith M. Jurka 
John Weaver King 
Frederick F. Krauskopf 
Elias J. Marsh 
Katharine Hawley Martin 
Joseph Massaro 
A. Reese Matteson 
Paul E. Molumphy* 
Russell R. Monroe 
Lawrence K. Pickett 
Haynes W. Sheppard 
Sarah P. Sherwood 
Nicholas P.R. Spinelli 
Mrs. Gertrude Spinelli* 
Priscilla Dienes Taft 
Anthony Varjabedian 
Calvin Watts Woodruff* 
Reuben Zucker* 
1945 
George Howard Allison 
Albert S. Atwood 
Frederic M. Blodgett 
Richard W. Breck 
Louise H. Burr 
Alice Shepard Cary 
Sanford F. Cockerell 
Jay B. Cohn 
Thomas P. Cotter 
Edward M. Daniels 
Richard R. Dyer 
Robert S. Easton 
Sidney S. Feuerstein 
Alice Dershimer Friedman 
Raymond A. Gagliardi 
Philip S. Good 
Herbert S. Hamed Jr. 
Paul W. Hoffert 
O. Roger Hollan 
Hans R. Huessy 
Leland W. Jones 
Michael W. Lau 
William E. Laupus 
Raymond E. Lesser* 
Mark McD Lindsey 
} 
James R. Mason 
Charles E. McLean 
George W. Naumburg Jr. 
Fitzhugh C. Pannill 
Richard M. Peters 
Elliot R. Reiner 
Charles E. Sherwood 
Joseph R. Stanton 
1946 
Margaret J. Albrink 
William G. Banfield Jr. 
Franklin C. Behrle 
Sanfurd G. Bluestein 
Linus W. Cave 
'Thomas J. Coleman 
James F. Cooney* 
George C. Cusick 
Thomas A. Doe 
Edward F. Edinger 
Gregory E. Flynn 
Martin E. Gordon 
Charles Sheldon Judd Jr.* 
Ruth S. Kempe 
Benjamin F. Kitchen Jr. 
James A. Kleeman 
Vincent J. Longo 
Richard Hess Mann* 
Thomas J. Mathieu 
Hugh J. McLane 
Joe D. Morris 
John H. Morton 
John F. Neville Jr. 
Laura W. Neville 
Harry Dickson Patton 
Vincent Pepe 
Francis G. Reilly* 
David H. Riege 
Phillips E. Roth 
Julian A. Sachs 
Donald P. Shedd 
Richard G. Sisson 
Colby S. Steams 
Robert R. Wagner 
William J. Wedemeyer Jr. 
Thomas J. Whelan Jr. 
Hugh R. Williams* 
Elihu S. Wing Jr. 
1947 
George R. Barnes Jr. 
Albert W. Bostrom Jr. 
John E. Bowers 
W. Roy Breg Jr. 
Richard G. Britton* 
David L. Brook 
Rocco A. Calandruccio 
John C. Carpenter 
Charles R. Cavanagh Jr. 
Roland G. Chambers 
Arthur Harry Chapman 
Robert A. Chase 
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(From left) Beverly Stoiite enjoys the afternoon with Tracy Nelson and Laurie-Ann Nesseralla. 
1947 (cont.) 
Amo/, I. ChemofT 
William r. Collins Jr. 
Bradford S. Colwell 
Robert P. Darrow 
Archie L. Dean Jr. 
Jean H. Dougherty 
Owen W. Doyle 
Franklin Harold Epstein 
Edward Eoord* 
Richard K. Friedlander 
Frank L. Golbranson 
Frank 11. Horton 
Robert J. Kerin 
Don F. Kimmerling 
Richard P. Levy 
Brock Lynch 
Victor A. .Machcinski 
Charles L. .Mache Jr. 
William K. .McClelland 
Robert F. Newton 
Myron K. Nobil 
Lawrence C. Perry* 
Philip H. Philbin 
Olive E. Pitkin 
Irv ing Rudman 
■Alvin Somberg 
Igor Tamm 
Patricia B. Fudbury 
Fdlis J. Van Slyck 
M. Henry Williams Jr. 
I94H 
Russell J. Barmelt 
■ leorge F Batten 
F.dith M Beck 
Jonathan S. Bishop 
Allyn (i. Bridge 
Rithard Steele Buker Jr, 
Aiiliui 1. Coleman Jr. 
Ruth F . Corlell 
■-1 Robi-rl Downie 
Victor A Drill 
Fli/aFcih Fuller Fdsner 
■ tv n A l isi^ 
Frame 
1 
Emil Frei III 
Julian Frieden 
Paul S. Goldstein 
Allan Green* 
B. Herold Griffith 
Sylvia Preston Griffiths 
Richard M. Hannah 
Ross R. Harcus 
Paul B. Koehler 
Patrick J. McLaughlin Jr, 
C. Arden Miller 
Lewis P. Rowland 
Benjamin F. Rush Jr. 
Gabriel A. Saviano* 
Jerome H. Shapiro 
Jessie Parkinson Spear 
Anne G. St. Goar 
Paul Talalay 
Wallace W. Turner 
Paul Woodbury Weld 
1949 
William G. Aniyan 
Jonathan S. Bishop 
Mary Pucci Couchman 
Phillip G. Couchman 
N. Joel Ehrenkran/ 
Daniel W. Elliott 
Gunnar O. Eng 
Albert A. Fisk 
Eleanora C. Gordon 
Frederic W. Gray 
Jackson Harris 
Frederick R. Hine 
Halsted R. Holman 
Benjamin A. Johnson 
Orval 1, McKay 
Timothy F. Nolan Jr. 
Julian I. Pichel 
Edmund L. Piper 
Charles L. Rennell Jr. 
Murray /.. Rosenberg 
Daniel Rudman 
Lawrence E. Shulman 
Martha Vaughan 
Vernon T. Watley 
Mary-Agnes P. Wine 
1950 
Russell N. Anderson 
Sylvia L. Axelrod 
Malcolm A. Bagshaw 
John E. Borowy 
William H. Bucher 
Alvin Davis 
Claude W. Delia 
Marie C. Duncan 
Kent Ellis 
Thomas J. Ferraro Jr. 
Daniel Fine 
Lawrence R. Freedman 
Carl A. Gagliardi 
Archie James Golden* 
Melvin H. Kaplan 
Sidney S. Lee 
Janus C. Lindner 
Margaret S. Lyman 
Harold March 
Harry L. McClelland 
Marina P. Meyers* 
John H. Meyers 
Robert Edward Quinn* 
Robert T. Sceery 
Cynia B. Shimm 
Jane B. Shumway 
Martin E. Smith* 
John S. Strauss 
Robert H. Sturman 
B. Lionel Truscott 
Myra D. Tyler 
Frederick Edward Vultee* 
1950 Classmates 
1951 
Karel Bedrich Absolon 
W. Robert Adams 
Frank R. Allen 
Thomas T. Amatruda Jr. 
Stanley D. Ardell 
Eleanor Clay Bigley 
John J. Egan 
Lawrence R. Freedman 
Sidney S. Furst 
Joseph M, Garland 
Lowell 1. Goodman 
John T. Groel 
Robert N. Hamburger 
Carrold K. Iverson 
William Kiekhofer 
Jocelyn S. Malkin 
Francis L. Merritt 
Paul D. Millikin 
Walter S. Morgan 
Albert R. Mowlem 
Richard S. Munford 
Ismail Nik Nevin 
Charles A. Nugent Jr. 
Gerard B. Odell 
Jose Felix Patino 
Arthur A. Pava 
Majic S. Potsaid 
Robert G. Small 
Bradley R. Straatsma 
William A. Taylor* 
1952 
Siegried A. Centerwall 
Willard R. Centerwall 
Frank R. Coughlin Jr. 
Robert P. Gerety 
Arthur P. Hustead 
James Kent Luce 
N. Karle Mottet 
Robert L. Nolan 
Sidney Nathan Paly 
Robert G. Petersdorf 
Leonard Rush 
Elizabeth M. Rush 
Mary Wheatland Schley 
Donald H. Schultz 
Robert B. Schultz 
John H. Wagner Jr. 
John L. Wolff 





Harold D. Bomstein Jr. 
William R. Chaffee 
Allen Chetrick 
Rex B. Conn 
James P. Dunn 
Donnell Dencil Etzwiler 
Vincent Lynn Gott 
A. Daniel Hauser 
George L. Hoffmann 
Peter Biggs Hukill 
Richard Robert Knowles III 
Preston Lee Leslie 
Hildegard Mueller Leslie 
John Dutch Lord 
Robert N. Melnick 
Harvey Martin Peck 
Warwick Potter Jr. 
Paul G. Quie 
Jose Ramirez-Rivera 
Irwin K. Rosenberg 
Barbara F. Rosenberg 
Virginia C. Saft 
Richard Andrew Sinnott Jr. 
Ora K. Smith 
Howard Willis Smith 
Lynn Cortland Stoker 
William Junior Vandervort 
William August Wilson 
James Frederic Young 
1954 
Frank P. Berg 
Richard J. Bouchard 
George N. Bowers Jr. 
Ralph K. Campbell 
John R. Cole 
Arthur C. Crovatto 
Donald D. Davis 
Walter J. Freeman 
John A. Gariepy 
Edward J. Gerety 
Samuel T.J. Giammona 
Frank L. Gruskay 
Robert P. Hatch 
Walker R. Heap Jr. 
Eva H. Henriksen 
Herbert S. Hurwitz 
Robert F. Hustead 
Robert J. T. Joy 
Donald S. Komfeld 
Richard Lamb 
Harry C. Miller Jr. 
Paul N. Neufeld 
James J. Nora 
Lowell E. Olson 
Anthony V. Piccirillo 
Richard D. Pullen 
Jacques M. Quen 
John Keith Rose 
Elihu M. Schimmel 
Leonard M. Silverman 
Robert L. Stein 
Martin B. Vita 
1955 
John B. Atwater 
John C. Bailar III 
George E. Becker 
E. Edward Bittar 
Joseph 1. Boylan Jr. 
Irwin M. Braverman 
Edward Noel Brennan 
Padraic Bums 
Nicholas A. Coassin 
Edward D. Coppola* 
Milton Com 
Pasquale James Costa 
Robert G. Crounse 
John G. Daley 
Fred Wendell Doyle 
Leroy Engel 
F. Robert Fekety Jr. 
Edwin G. Fernand 
Mahlon V.R. Freeman 
James Conway Garlington 
Paul Gonick 
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Ion Gresser 
John H. Hodge 
D. Franklin Johnson Jr. 
Harry O. Kendall 
David R. Kessler 
Robert A. Kramer 
James Lum 
Joseph S. McGuire Jr. 
Robert C. Nodine 
James P. Nolan Jr. 
Gloria C. Onque 
Edward J. Ottenheimer Jr. 
John C. Pace Jr. 
Robert H. Peters Jr. 
Gregory Peterson Jr. 
Robert A. Reich 
Paul J. Robinson 
F. Brantley Scott Jr. 
Clement B. Sledge 
Alan A. Stone 
1956 
Alan E. Apfel 
Peter Bios Jr. 
Levon Z. Boyajian 
Thomas M. Brown 
Rosalie A. Bums 
Donald J. Dalessio 
Chandler Dawson 
S. Evans Downing 
Gilbert M. Eisner 
Thomas F. Ferris 
John H. Gardner III 
Sumner Gochberg 
Joan Marasco Hardenbergh 
John Herd Hart 
Robert L. Hill 
William H. Hindle 
George T. Kammerer 
Jerome O. Klein 
William V. Lewit 
Preston C. Manning 
Elmer T. Mitchell Jr. 
Norman F. Moon 
Donald J. Nalebuff 
A. Frederick North Jr. 
David A. Page 
George W. Paulson 
Stewart E. Pursel 
Robert Lee Scheig 
Edward C. Senay 
Benjamin A. Shaver Jr. 
Donald William Sherrick 
Daniel R. Silbert 
Donald R. Sperling 
1957 
F. Calvin Bigler 
Jack Norman Blechner 
Richard I. Breuer 
Harry C. Briggs 
Carl A. Brinkman 
John P. Carey 
Louis Z. Cooper 
Harold Dick Cross 
Thomas H. Danaher 
James R. Dorr 
Salvatore Falbo 
Harold J. Fallon Jr. 
Robert E. Eishbein 
Ronald H. Eishbein 
James R. Eitzgerald 
Anthony L. Fons 111 
Elizabeth H. Forsyth 
Robert H. Glass 
Anne H. Good 
Jack Peter Green 
Gilbert F. Hogan 
Warren R. Johnson 
Richard Lee Kahler 
Stanley E. Kilty 
William L. Kissick 
Willard A. Krehl 
Jack Levin 
Bennett F. Markel 
Mark D. Marshall 
Howard A. Minners 
Robert K. Modlin 
George Albert Nelson Jr. 
Herbert A. Newman 
Thomas Francis O’Brien Jr. 
Raymond E. Phillips 
Clifford B. Reifler 
Melville P. Roberts Jr. 
Arnold Schoolman 
Kenneth A. Simon 
Gilbert B. Solitare 
Donald C. Stahl 
William J. Waskowitz 
Herbert Winston 
James G. Zimmer 
1958 
George K. Aghajanian 
Don P. Amren 
Joseph E. Angelo 
Gerard N. Burrow 
Benjamin Bursten 
John A. Carlston 
Robert J. Donohue Jr. 
Donald A. Duncan 
Joel C. Eberlin 
Michael E. Fishman 
John Currier Gallagher* 
Marcia Kraft Goin 
William M. Gould 
James Greenwald 
Charles A. Hall Jr. 
Stanley Harris 
Michael Kashgarian 
Haskins K. Kashima 
Jay Ward Kislak 
Theodore W. Lieberman 
Myron Lotz 
Andrew Joseph McGowan Jr. 
Richard Charles Miller 
Albert Muggia 
Robert S. Neuwirth 
Carol F. Phillips 
William B. Radcliffe 
Paul A. Rudnick 
Thomas R. Shea 
Bruce H. Sklarew 
Edward Lloyd Socolow 
Raymond W. Turner 
Margaret Smith Wenzel 
Joseph P. Wierzbinski III 
John Patrick Wood 
Pauline B. Wood 
1959 
Scott Ingram Allen 
Robert M. Amick 
Asa Barnes Jr. 
Francis A. Beer 
Jack F. Bowers 
Edwin M. Clayton 
Sidney M. Cohen 
Ronald C. De Conti 
Gerald Fenichel 
Robert L. Fisher 
Paul Jay Friedman 
Robert J. Gonyea 
Gerald B. Gordon 
W. Keith Hadley 
H. Rodney Hartmann 
William H. Heydom 
C. Richard Hinckley 
Leonard Inker 
John J. Jasaitis 
Edvardas Kaminskas 
Herbert J. Kaufmann 
David W. Kingsbury 
Myron S.S. Lee 
Kathryn Huxtable Lewis 
Brian J. McGrath 
James A. O’Neill Jr. 
Robert H. Ostberg 
Nicholas M. Passarelli 
Charles A. Phillips 
Lincoln T. Potter 
James D. Prokop 
James R. Ralph 
Joseph D. Saccio 
Constantine J. Sakles 
Marc D. Schwartz 
Richard M. Senfield 
Owen A. Shteir 
Sanford P. Solomon 
Gene W. Spector 
James J. Stagnone 
John S. Strauss 
Lois W. Tice* 
Leo H. Von Euler 
Muriel D. Wolf 
1960 
Victor Altshul 
Jack D. Barchas 
Stuart P. Bowne 
Ormond V. Brody 
Donald P. Buebendorf 
Stanley M. K. Chung 
Gerald N. Cimmino 
Jon E. Courtney 
John M. Davis 
Malin Dollinger 
David Paul Dunn* 
Caldwell B. Esselstyn Jr. 
Warren H. Eisher 
Paul Jay Friedman 
Eugene C. Gaenslen Jr. 
James I. Gilman 
Roland H. Ingram Jr. 
Daniel M. Jones 
William S. Kaden 
Eric P. Kindwall 
Frank J. Kleeman 
Susan T. Kleeman 
Thomas P. Kugelman 
Edward R. Lang 
Thomas Lau 
Eugene G. McCarthy Jr. 
Donald L. Miller 
Allan W. Newcomb 
Buford L. Nichols Jr. 
Fred Palace 
Nancy Rolick Powell 
Albert Matthew Ross 
Daniel J. Rubin 
John J. Schrogie 
Fred Stargardter 
Constantine M. Voyagis 
Robert C. Wallach 
May Yung-Fun Woo Wang 
Ronald A. Yankee 
1960 Classmates 
1961 
Kenneth A. Arndt 
Earl L. Baker 
Frank H. Baker 
Albert A. Bechtoldt Jr. 
Robert S. Briggs 
Orson R. Dee 
Paul David Deiter 
Ronald A. Dierwechter 
Jon Dudley Dorman 
T. Wayne Downey 
John E. Fenn 
Norbert Fleisig 
Edward C. Gilbert 
Robert Sterling Gillcash 
Louis D. Hunt 
Richard L. Keefe 
Robert Isaac Levy 
George M. Lordi 
Hugh James Lurie 
Joseph Richard Lusby 
Sally Lockwood Marches! 
Vincent T. Marches! 
David B. Matloff 
Joseph W. McDaniel 
Anoush Miridjanian 
Richard Allen Moore 
Norman 1. Moss 
John Curtis Parker 
Elaine Pitt 
Roy E. Ronke Jr. 
Thomas H. Sakoda 
Stanley G. Schade 
Robert N. Taub 
Hugh C. Thompson III 
Eranklin H. Top Jr. 
David E. Weaver 
Warren D. Widmann 
John R. Woodward 
1962 
Charles B. Anderson 
Frederic P. Anderson 
Spencer J. Brody 
Fredric K. Cantor 
Thomas Newell Chase 
Richard N. Collins 
Oliver Townsend Dann 
Arnold Joel Eisenfeld 
I. Bruce Elfenbein 
John W. Foreman 
Anthony V. Furano 
John N. German 
David H. Groth 
Patricia C. Hassakis 
Gary Jacobson 
Glenn L. Kelly 
David E. Knoop 
Manuel J. Lipson 
John P. Lynch 
Malcolm A. Martin 
Allan L. Mattem 
Stanley E. Matyszewski 
David J. McConnell 
William A. Miller 
Malcolm S. Mitchell 
David D. Nicholas 
A. Richard Pschirrer 
Joseph Ross 
Edward L. Spencer Jr. 
James A E Spencer 
Larry Lee Stewart 
Seth Thaler 
Sherwood Waldron Jr. 
William Eamsworth Weber 
Stewart R. Wright 
1963 
Miguel R. Alonso 
John E. Conte Jr. 
Andrew Edin 
John P. Eliopoulos 
William T. Friedewald 
Alexander R. Gaudio 
Lee D. Goldberg 
Peter B. Gregory 
Benjamin Keith Harris 
Harold P. Kaplan 
Constantine D. Kyropoulos 
William B. Lehmann 
Peter B. Livingston* 
Craig H. Llewellyn 
Herbert Meltzer 
Robert E. Mueller 
Sheldon R. Pinnell 
Jay M. Pomerantz 
Lee Bland Talner 
Peter V. Tishler 
Lawrence Tremonti 
Peter G. Weiner 
Jerome Allen Winer 
1988-1989 1989-1990 
NUMBER NUMBER PERCENT NUMBER NUMBER PERCENT 
SOLI- CONTRI- PARTICI- SOLI- CONTRI- PARTICI- 
CITED BUTED RATION TOTAL CITED BUTED RATION TOTAL 
Alumni 3,687 1,609 46 $ 484,848 3,735 1,630 44 $ 607,960 
Former House Staff 1,002 276 28 31,436 2,112 221 10 28,932 
Parents/ Friends 432 88 20 12,256 432 69 16 7,946 
Interest/Miscellaneous — — — 11,558 — — — 11,337 
TOTAL 5,121 1,973 39 $ 522,698 6,279 1,920 31 $ 656,175 
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1964 
William A. Alonso 
Benon W, Ashman 
Leland S. Berger 
Philip Blume 
Robert M. Briggs 
Thomas A. Cardella 
Joseph F.J. Curi 
Anthony Ferranle 
Norman C. Fosi 
John F.B. Haney 
Gene 1. Higashi 
l.awrence Horwiiz 
William J. Houghton 
Lewis Landsberg 
Richard V. Lee 
Thomas L. Lentz 
David B. Leof 
James S. Levine 
Richard Murray Linburg 
Robert W. Lyons 
Andrew E. MacMahon 
William F. Matchett 
Robert L. Mitchell 
Alan H. Morris 
James J. Murphy 
Donald A. O'Kieft'e Jr. 
William B. Pratt 
Jack S. Rice Jr. 
Norman Seller 
Robert L. Shelton 
Donald G. Skinner 
A. Thomas Snoke 
Lyall C. Stilp 11 





Susan A. Aoki 
Thomas T. Aoki 
John H..M. Austin 
Paul Balter 
Thomas B. Caldwell 111 
David G. Campbell 
Robert M. Cohn 
.Michael J. Cummings 
David S. Fedson 
Robert I. Finkel 
Christopher C. Gates 
Frank J. Grady 
Robert Andre Gryboski 
James K. Ciude 
Reid R. Helt'ner Jr. 
David A. Hill 
Carl E. Hunt 
Ronald J. Karpick 
Mohandas M. Kini 
Sandra Chook Levine 
Mark W. Lischner 
Philip D. .ManTredi 
Walter W. Noll 
A. Lawrence Ossias 
John .A. Parrish 
Robert L. Pickens 
William A. Renert 
Ciene A. Robinson 
George B. Row land 
John 11. Seashore 
Margretta Ann Reed 
Seashore 
David .M. Shames 
David P. Simmons 
Harlan Spitz 
Man Vk'illiam Stone 
R iS. ;i (i. Weiner 
I’. l Vuan Shu Wong 
Philip Bernstein 
James Edward Brown 
Eugene Patrick Cassidy 
Joseph A. Donadio 
Marvin A. Eisengart 
Peter M. Fitzer 
Robert N. Frank 
Robert C. George 
Peter D. Gibbons 
J. McLeod Griffiss 
Robert A. Gunn 
Stuart T. Hauser 
Jay G. Hayden 
Mary Alice Houghton 
Bruce W. Jackson 
Gordon R. Kelly 
Stuart M. Kotler 
Wilbur L. Kukes 
David C. Law 
Lynne L. Levitsky 
John Stephens Melish 
Harold Mellin 
Eli H. Newberger 
Edward J. O'Keefe 
Neil J. Peterson 
William D. Peterson 
James D. Slavin Jr. 
Parker J. Staples 
Gary L. Townsend 
Jon S. Way I and 
Joan T. Wayland 
Arne S. Youngberg 
Richard B. Yules 
1967 
Daniel L. Arons 
Arthur L. Beaudet 
Daniel J. Booser 
Gary C. Burget 
Mary Williams Clark 
Kenneth F. Crumley 
Cynthia Rapp Curry 
Marian C. Davidson 
James J. Dineen 
James M. Dowaliby II 
John A. Drews 
Peter R. Egbert 
Dennis Grant Egnatz 
Herbert W. Felsenfeld 
Richard J. Hart Jr. 
Richard L. Heppner 
George P. Herr 
David L. Ingram 
Anthony P. Lovell 
Laura Kirchman Manuelidis 
Stephen W. Miller 
William J. Mitchell 
Joseph L. Morris 
Jennifer Robinson Niebyl 
John Northup Jr. 
John O. Pastore 
William E. Perkins 
Brian F. Rigney 
Robert I. Roy 
Jonathan L. Saveli 
Alfred Q. Scheuer 
Stephen C. Schimpff 
Sidney C. Smith Jr. 
Lewis S. Solomon 
Robert S. Steinberg 
Richard B. Swett 
M. David Tilson 111 
Robert A. Vogel 
Robert A. Vollero 
Joseph F. Walter 
.Martin Wand 
Robert J. Winer 
Robert S. K. Young 
Peter M. Zeman 
1968 
Philip L. Barry 
Daniel 1. Becker 
Grace Jordison Boxer 
William Catalona 
Donald R. Coustan 
Rutledge W. Currie 
Barbara Mayer Egbert 
Alan G. Finesilver 
Richard A. Getnick 
Mark Gilbert Grand 
Leonard Grauer 
Ralph S. Greco 
Kevin N. Hennessey 
John R. Hill II 
Peter Jokl 
Jeffrey S. Lee 
Marc E. Lippman 
Frank E. Lucente 
Donald O. Lyman 
Stephen I. Marglin 
Rodrigo Martinez 
David P. Millett 
Richard P. Mills 
Richard M. Morehead Jr. 
John A. Ogden 
James W. Ogilvie 
Jackson B.E. Pickett 111 
Ralph Jerome Rauch 
Joseph L. Renda 
Gordon H. Sasaki 
Jacob J. Schlesinger 
Bruce Stuart Schoenberg* 
Frederick C. Sherman 
Elizabeth M. Short 
Howard W. Siegel 
Gerald L. Springer 
Lee H. Strohl 
Per Henrik Wickstrom 
Creed W. Wood 
1969 
Charles S. Angell 
David G. Ansel 
David W. Barry 
Robert E. Belliveau 
Donald H. Buchholz 
Richard J. Daly 
Charles A. Dinarello 
Douglass T. Domoto 
Ralph J. Falkenstein 
Gary S. Famham 
Steven A. Frankel 
William H. Frazier 
Anna S. Gail 
Royal J. Gay 
Sander G. Genser 
Robert O. Gordon 
Thomas C. Howard 
Lee M. Jampol 
Joel Mark Kaufman 
Paul H. Kelker 
Lynn G. Lagerquist Jr. 
Elliot M. Livstone 
Robert L. Marier 
Arnold F. Mazur 
Ellen B. Milstone 
Bruce K. Nagle 
Lionel M. Nelson 
Nancy Olmsted 
Deborah A. Putnam 
N. Burgess Record Jr. 
Joseph M. Rochford 
David J. Sahn 
Lutz H. Schlicke 
Adrian M. Schnall 
David J. Schulak 
Gerald J. Smallberg 
Michael S. Toren 
David L. Upton 
Robert J. Walat 
Stephen R. Webb 
1970 
Richard A. Charlat 
Henry Chessin 
Michael J. Chusid 
C. Norman Coleman 
James E. De Lano Jr. 
Margaret W. DeLano 
W. Montague Downs 
Jonathan Ecker 
Richard L. Edelson 
Robert Alan Epstein 
Bruce A. Fabric 
Thomas H. Gouge 
Paul C. Hessler 
Jay H. Hoofnagle 
Jonathan D. Katz 
Mark A. Korsten 
Thomas L. Lewis 
Robert B. Litman 
Anne W. Lucky 
Roger A. Mason 
James R. Missett 
William K. Mueller 
W. Scott Peterson 
Bruce A. Reitz 
Robert M. Rosa 
Dennis E. Shield 
Stuart S. Shorr 
Richard A. St. Onge 
Daniel A. Symonds 
Ray W. Tripp III 
Brian Weiss 
C. Bruce Wenger 
Joellen Weme 
Daniel Wuensch 
Karl O. Wustrack 
1971 
Judith L. Bader 
Laurie J. Bleicher 
Bruce Block 
Willard Cates Jr. 
John L. Cieply 
Frederick L. Cohn 
Andrew D. Cook 
Michael Cynamon 
Leonard I. Eisenfeld 
Harvey Fembach 
Fred Finkelman 
John W. Foster Jr. 
Jerold Alan Haber 
Michael J. Hart 
William W. Hay Jr. 
N. Timothy Jette 
Robert M. Kessler 
Barbara K. Kinder 
William L. Krinsky 
Gary M. Lande 
David H. Lippman 
Richard Albert Moggio 
Martin Paris 
John A. Patti 
Barry Bruce Perlman 
Michael C. Piercey 
Anthony V. Proto 
Barry S. Rand 
Irving G. Raphael 
Douglas R. Schmidt 
John Smiarowski 
James P. Southwick 
Daniel R. Synkowski 
Richard D. Travers 
Paul A. Vignola 
Robert B. Vranian 
Albert Carl Weihl 
Daniel G. Wright 
1972 
Robert D. Arbeit 
R. Michael Buckley Jr. 
Michael A. Catalano 
Leonard H. Cohen 
Philip L. Cohen 
Gloria Cummings* 
Robert F. DeBlasi 
Norman M. Dinerman 
William H. Druckemiller Jr. 
M. Felix Freshwater 
John P. Fulkerson 
Robert B. Geehr 
Robert D. Glassman 
Robert F. Goodman 
Bruce B. Haak 
Andrew E. Hoover 
Thomas L. Horn 
Vernon H. Humbert Jr. 
Fred Hyde 
Anthony H. Jackson 
Jesse B. Jupiter 
Philip W. Lebowitz 
Theodore M. Levin 
Paul A. Lucky 
Harry L. Malech 
Jeffrey S. Menkes 
David B. Moyer Jr. 
James A. Nathanson 
John P. O’Grady 
Edward J. Olinger 
William L. Risser 
David H. Romond 
Philip M. Rothfeld 
John S. Smolowe 
Frederick D. Stockwell 
Lawrence P. Temkin 
Philip J. Weyman 
Michael W. Yogman 
1973 
David A. Adler 
David Nelson Bailey 
Clement R. Boland 
Mary Ann Brunstetter- 
Shafer 
Robert W. Bucholz 
James N. Campbell 
Marvin M. Chassin 
F. Sessions Cole III 
Joseph M. Connors 
Christopher M. Doran 
Jane H. Ferguson 
Richard J. Fingeroth 
Robert A. Florin 
Lee Goldman 
Gary V. Gordon 
Gary T. Grimes 
Howard S. Honig 
Andrew G. Kadar 
Lynne M. Liptay 
Mark G.F. McCormick 
John F. McQuade III 
Jerry Nagler 
John Frederick Neil* 
Claes M. Nilsson 
David E. Peach 
David Pickar 
Robert Joseph Polackwich* 
Charles F. Reynolds 111 
James S. Robertson 
Thomas J. Romano 
Jerrold F. Rosenbaum 
Robert A. Sirota 
John R. Stratton 
James F. Sullivan 
Thomas F. Sweeney 
Robert J. Ursano 
Richard S.K. Young 
Randall M. Zusman 
1974 
Stephen B. Arnold 
Irving M. Asher 
Leonard I. Banco 
Douglas A. Berv 
Bruce David Blumberg 
Neil Blumberg 
Peter J. Buchin 
Bert D. Collier Jr. 
Paul David 
Vincent A. Di Maria 
Roger H. Emerson Jr. 
Irl L. Extein 
Allan B. Fried land 
Michael A. Gerber 
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David Grant 
Robert F. Flempton 
Robert C. Jimerson 
Ancil A. Jones 
Robert M. Kolodner 
Saul Lande 
Olusegun O. Lawoyin 
Edward L. Marut 
James R. McMonagle 
Marjorie A. S. Oda 
Richard C. Pasternak 
Andrew L. Ries 
David Z. Ritvo 
Amy S. Schechter 
Robert J. Schechter 
James A. Strom 
George H. Talbot 
Carol C. Teitz 
Edward M. Wolin 
1975 
Ralph E. Binder 
Sharon L. Bonney 
William S. Bush 
Rodney J. Butch 
James P. Grabman 
Carol L. Kandall 
Kevin Kane 
Bernhard H. Lisker* 
Richard J. Loewenstein 
Yvonne E. Lomax Burnett 
Hyman J. Milstein 
Mary Jane Minkin 
Robert G. Nankin 
Andrew B. Newman 
Edwin G. Olson 
George J. Pardos 
Vivian Reznik 
Philip J. Rich 
James E. Robertson III 
Salvatore V. Romano Jr. 
Robert S. Sandler 
Steven A. Schwartz 
Barbara J. Stoll 
David J. Taylor 
David W. Wiltse 
Douglas R. Zusman 
1976 
Sarah S. Auchincloss 
Alfredo L. Axtmayer 
John C. Bartlett 
Peter B. Bitterman 
Alan B. Bloch 
Randall D. Cebul 
Pauline Y. Chao 
Richard S. Childs Jr. 
John D. Clemens 
Kenneth J. Dobuler 
John A. Elefteriades 
Geoffrey Etherington 
Leonard Firestone 
Ira H. Gewolb 
Glenn A. Gorlitsky 
Joel Kabak 
Norman V. Kohn 
William K. Levy 
Douglas G. Mann 
Jon S. Morrow 
Daniel W. Rahn 
Paul R. Ramirez 
Susan H.K. Ryu 
Richard S. Schottenfeld 
John T. Sladky 
Bonita F. Stanton 
Charles R. Swenson 
Jacob E. Tauber 
Peter M. Ting 
John C. Wiles 
Jerome B. Zeldis 
1977 
Michael G. Adelberg 
John J. Boronow 
Stuart Brian Dubin 
Sybil E. Duchin 
Susan Firestone 
James A. Fox 
Julia B. Frank 
Robert W. Hand 
Bruce L. Innis 
Howard K. Koh 
David J. Kreis Jr.* 
Margaret S. McKenna 
Robert J. Mitchell 
R. Andrew Packard 
Alan S. Penziner 
Richard E. Peschel 
Theodore M. Pitts 
Jordan S. Pober 
Steven J. Scheinman 
Susan Bromberg Schneider 
Ricky M. Schneider 
Simeon A. Schwartz 
Ronald J. Vender 
Steven L. Warsof 
Sharon R. Weinstein 
John E. Whitcomb 
Daniel Wohlgelemter 
Richard N.W. Wohns 
1978 
Thomas T. Amatruda 
Booker T. Bush Jr. 
Duke E. Cameron 
Jesse M. Cedarbaum 
Emily A. Fine 
Stuart M. Forman 
Arthur M. Gershkoff 
Linda J. Hall 
Jeffrey Neal Hausfeld 
Alexandra N. Helper 
Robert Hershfield 
Anne A. Knowlton 
Sanford D. Markowitz 
Barbara H. Pober 
Seth M. Powsner 
Sally Rudicel 
Donald C. Simonson 
Caroline R. Taylor 
Stanley J. Tillinghast 
Marcia J. Wade 




J. Kenneth Burkus 
Jeffrey Neil Dombusch 
Joel I. Franck 
John Jay Gargus 
David E. Golan 
Bruce Halperin 
Edward C. Halperin 
Marc Hellerstein 
Heather L. Johnson 
Jeffrey L. Kaine 
Leslie Jay Katz 
Helen H. Kay 
Anne A. Knowlton 
Forrester A. Lee Jr. 
Michael K. Lindsay 
Shirley McCarthy 
David E. Ness 
Jean Rosenthal 
Lynn K. Rudich 
Gary L. Schaer 




David E. Adelberg 
Eduardo Alfonso 
Seth Leo Alper 
Frederick R. Aronson 
Alan B. Astrow 
David Allen August 
Patricia Church Brown 
Daryl F. Browne 
Michael W. Champeau 
Michael M. Chang 
Thomas F. Deering 
Forrest John Doud 
Todd J. Garvin 
Marc F. Glickstein 
David Jay Goldberg 
Gary I. Greenwald 
Maria White Greenwald 
Jonathan L. Jacobs 
Mary Polly McKinstry 
Cesar R. Molina 
Eric J. Nestler 
Mark J. Ratain 
Neal L. Rosen* 
Steven I. Rosenfeld 
John A. Selling 
Hillel D. Skoff 
Kim R. Swartz 
Marcia R. Taylor 
Lawrence H. Young 
1981 
Cynthia B. Aten 
Robert B. Bailey Jr. 
Alicia Barela 
Sherri L. Brown 
Susan Burdette 
Stephen Wilson Burgos 
Patricia A. Burke 
Marc D. Coltrera 
Paula M. Fracasso 
Laurie J. Gordon 
Neil D. Gross 
Scott A. Hundahl 
Elliot Each 
Robert M. Milstein 
Richard L. Mogemian 
David A. Paly 
Barbara A. Roach 
Dovelet Shashou 
Anthony M. Urbano 
Nancy E. Vinton 
1982 
Sylvia R. Beck 
Thomas J. Brennan 
Keith L. Gladstien 
Jed B. Gorlin 
Daphne Hsu 
Laurie B. Komreich Katz 
Michael E. Katz 
Patricia Kellner 
Kathleen Anne Nolan 
Joyce A. O’Shaughnessy 
Dan B. Odenheimer 
Carrie A. Redlich 
Robert J. Rizzo 
Lewis P. Rubin 
William M. Sikov 
Henry J. Stern 
Lynn T. Tanoue 
Patrick Toth 
Albert L. Ungricht 
David A. White 
Stephanie Wolf-Rosenblum 
1983 
John Taylor Adams* 




Lois A. Morton 
David P. Norton 
Dan A. Oren 
Harlan A. Pinto 
Augusta S. Roth 
Moshe Rubin 
Daniel Paul Sabbeth 
David E. Schwartz 
Daniel M. Sosin 
Philip M. Spiro 
Kenichi Takeshita 
1984 
Martha Ray Arden 
Robert W. Arnold 
David I. Astrachan 
John E. Babich 
Leonard Bell 
Troyen A. Brennan 
Barbara Ann Coda 
David J. Fillmore 
David A. Frank 
Kim A. Gutner 
Bruce G. Haffty 
Jeffrey N. Katz 
Jay R. Kostman 
John H. Krystal 
Richard L. Leff 
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Loretla Rubens 
Saul Sadka 
David A. Shrier 
Mark Stein 
Susan P. Tredwell 
1985 
Alice S.Y. Chi 
Guy Fried 






Stuan Neal Isaacs 
Susan Korrick 
Shirley J. Lee 
Jeffrey A. Lowell 
Gail Mattson-Gates 
Robert D. Needlman 
Anne Regenstein 
Ellen C. Rieur 
Greg A. Sachs 
Fred Santoro 
Edward B. Savage 
Gary L. Shapira 
Timothy Alan Shapiro 
Louis J. Tesoro 
1985 Classmates* 
1986 
Catharine Ann Arnold 
\V. Lee Bailey 
Eric F. Bernstein 
John A. Detre 
Jay Gates 
Michael Grossbard 
Clinton L. Lindo 
Brian P, Lombardo 
Elizabeth A. Plotkin 
Andrew W. Steele 
Steven VVaisbren 
John J. Wysolmerski 
1987 
Andrew Ba/.os 
Subba R. Gollamudi 
Amy Caroline Justice 
Rebecca E. Radish 
Joseph Thomas King Jr. 
Theresa L. McGuinness 
Seth A. Rosenthal 
Mindy G. Schuster 
Richard P. Tierney 
Robert C. Urban Jr. 






Joshua E. Freedman 
Robert Kim 
Frederick Long 
Peter .Alexander Merkel 
Theodore Miclau 
Michael Emeric Mockovak 
John Robert Nienow 
Michael A. Rothschild 
Steven Slovic 
Walter Michael Stadler 
Susan \ alley 
I ledasatollaii /.aghl 
1989 
K.itherine Ann Albert 
III t er l-ranklin Bock 
'■ ■ ; inv.cll 
■ c.iil 
Lewis Lipsey 
Melissa Terry Myers 
Lisa Ragen 
Andrew TTiomas Walker 
Roger F. Widmann 
FORMER HOUSE 
OFFICERS 
Phillip R. Aaron 
Robert A. Achtel 
William R. Adams 
N. Erick Albert 
John L. Albrigo 
Neil S. Alex 
Arthur Ames 
C. E. Anagnostopoulos 
Angela Anderson 
Renato Armas 
John P. Amst 
John M. Aversa 
Adel H. Ayoub 
Ronald J. Bailey 
Arnold M. Baskin 
Carl Bennett Bean 
Gerald A. Belkin 
Gregory Kent Bergey 
Michael Richard Berman 
Larry Berte 
Ralph Daniel Bien 
Richard A. Blasband 
Paula McFadden Bortnichak 
Christine Brahney 
Ronald W. Braun 
Steven A. Brody 
Kenneth Burke 
Dennis J. Card 
Richard S. Casden 
J. Richard Casuccio 
Whei C. Chang 
Richard Allen Chase 
Martin S. Chattman 
Ryszard Chetkowski 
Chang Song Choi 
Michael Chun 
Jane R. Clark 
Gary M. Cohen 
Ian M. Cohen 
Burton H. Cohen 
David L. Copen 
Leandro Cordero 
Susan Covey 
Sidney L. Cramer 
Robert E. Crootof 
F. Mitchell Cummins 
Michael Martin Deren 
Daniel M. Divack 
Donald S. Dock 
William R. Drucker 
Frank H. Duffy 
Edward Dunn 
Marlene R. Eckstein 
Stephen A. Edelstein 
Lawrence B. Eisenberg 
Malcolm Mitchell Ellison 
Walter Ettinger 
Richard B. Everson 
Jeffrey C. Femyhough 
Richard Webster Finner 
Bruce T. Fletcher 
John N. Forrest Jr. 
l.awrence Z. Freedman 
George J. Friou 
Norman H. Gahm 
Jose L. Garcia-Oller 
Phillip 11. Gates 
George O. Gclinas Jr. 
Jonathan Gertler 
V. Philip Glassman 
Barry Goldberg 
Nelson U. Goldberg 
Joel S. Golden 
John W. Goidkrand 
Isaac Goodrich 
Richard Reed Gramse 
Gordon W. Grundy 
Joseph Guaraldo 
Alberto R. Guinazu 
Kenneth Gwirtz 
Seymour Haber 
Hedda Ann Litowitz Haning 
Ray V. Haning Jr. 
Richard B. Harvey 
Richard U. Hausknecht 
Richard U. Hausnecht 
Michael D. Heafner 
Mary M. Herman 
William H. Heydom 
Judith Hochstadt 
Gregory L. Holmes 
David Smith Hubbell 
Eric A. Hyson 
Raymond J. Ippolito 
Henry G. Jarecki 
Robert Orville Jensen 
Rollin M. Johnson 
Clifford Joseph 
John P. Judson 
Sheila Moriber Katz 
Douglas Key 
Stephen King 
Samuel C. Klagsbrun 
Lawrence E. Klein 
Richard Knobelman 
Arthur H. Knowiton 
Thomas J. Koontz 
Boonsri Kosarussavadi 
Joseph A. Kovarik 
Eugene Kuchner 
Joel C. Labow 
W. Clark Lambert 




Douglas M. Levin 
Arthur L. Levy 
John D. Lewis 
Luke K. Licalzi 





Richard J. Maunder 
Randolph M. McConnie 
John P. McGovern 
Pamela M. McKenzie 
Janet Meegan 
Thalia Mesologites 
Anthony B. Minnefor 
George Mizner 
John H. Monroe 
Phyllis R. Monroe 
Yasmeen A. Moody 
Alan Morelli 
Patrick E. Moriarty 
L-ewis B. Morrow 
Seymour Cy Nash 
Donald Natibuff 
Gwendolyn B. Nichols 
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Mr. & Mrs. Lewis Nankin 
Elbert John Thomas Nelson 
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Arthur B. Robins 
Charles D, Spangler 
194.3 
Carolyn S. Koffler 
Eric W. Mood 
Muriel Bliss Wilbur* 
1944 
Massimo Calabresi* 
Jean F. Heston 
Jane Y, Parker 
1948 1950 James M A Weiss Laurence K. Rainsford 
1945 John B. Dibeler Dorothy Reese Bloomfild Walter Wenkert Milton H. Sisselman 
Roslyn R. Bilford Mary Margaret Filzgerald Henry G. Brickman John J. Zugich 
Naomi Barer Golden Joseph Hanford Gerber Ida M. Bucher 1954 
JiK' Bales Graber .Samuel S. Hemian Helen P. Cleary 1952 Calvin P. Hatcher 
Lois M. Jund Barbara L. Holman 
Richard E. Johnson 
Austin J. Evans 
Jerome M. Glassman 
Mary 0. Gabrielson 
Joanna Adele Henry 
Ruth M. Taber 
1946 Beatrice H. Kaasch Martha P. Jayne Malcolm C. Hope 1955 
Doroiliy B. Hamilion Dorothea S. LaBelle Frances K. Reynolds Charles Holway Lawrance Amy L. Cawley 
; Paintla Nelson 
1947 
• : hies S ( hipinan 
Xi'iic 7 -::l|on 
, . 1 ; . : j 1 1 . J , . . 1 
Hiram Sibley Nathan M. Simon Sidney S. Lee 
Helen Kardys Loria 
Evelyn S. Farnsworth 
Morris London 
1949 1951 Yolande F. Lyon Mary Me C. Mogan 
Edgar L. Geibel Clarissa E. Boyd Hannah Eileen MacHenry Helen K. Moore* 
Eleanor P. Kostant Nonon G. Chaucer Jeanne Ellen Paty Frances R. Ogasawara 
Hilda 11. Kroeger Joanne E. Finley Gerald Rosenblatt 
Christine R. Owre Homer P. Hopkins Jr. 1953 
. .1 , • 
Elizabeth D. Robinton Robert L. Johnson Jeanette Averill 
Matilda Rudnick 
l-mcst M. Sable 
Leonard F. Menezer 
Jessie Parkinson Spear 
Abraham Cutcher 
William H. Hermann 
From the Public Health Alumni Fund Chairman 
The 1989-1990 campaign has been a 
resounding success! We reached 298 
percent of our goal — raising $ 135,523 — 
the most successful public health campaign 
ever. This was made possible in no small 
measure by the impressive sum of nearly 
$101,000 raised by the Class of 1948 and its 
class agent, Sam Herman. 
Of course, 1 am pleased to acknowledge 
the contributions made by all 597 of our 
alumni/ae donors, 27 percent of those 
solicited. While proud of our 
accomplishments, I would like our percent 
of participation to increase. Almost 10 years 
Stephen Skorez, M.P.H. 
ago, we achieved a participation of 37 
percent of alumni/ae. That will be our goal 
for next year! 
The meaning is simple — we can’t rest 
on our laurels. Please try to emulate those 
classes who passed our target goal of 
$1,000 per class. Special thanks to the 
classes of ’59, ’78, ’79 and ’86, who have 
been added to this list since last year. 
Thanks again to all of our donors. 
Without you we would have no fund at all! 
Stephen Skorez, M.P.H. ’70 
Chairman 
AMOUNT CLASS AGENT(S) 
$100,885 1948 Samuel S. Herman 
1,680 1967 James M. Malloy 
1,670 1976 Elaine P. Anderson 
1,570 1979 Catherine Norton/ 
Ralph Tartaglione 
1,540 1971 John Bihldorff 
1,340 1969 Robert L. Young 
1,330 1973 Gary Dean Sax 
1,2.50 1959 Dorothy M. Wilson 
1,235 1970 Susan W. Balter 
1,210 1978 Ann T. Freedman 
1,177 1975 Linda K. Broker 
1,135 1986 Indu B. Ahluwalia/ 
Aric T. Wilt 
1,085 1968 Francis J. Greaney 
♦Deceased Yale Medicine FallAVinter 1990-1991 
1956 
David D. Boyd 
Kathleen H. Howe 
John E. Ives 
Paul C. Kaufman 
John F. Mullett 
Julia R. Nole 
Mary K. Ochiai 
Alice M. Wagner 
1957 
Janet Beach 
Lee De Cady Jr. 
William A. Clermont 
Edward R. DeLouise 
Gaston Jules Deslouches 
Sheldon Selig King 
Edna May Klutas 
Shirley T. Steidel 
Patricia A. Viscosi 
1958 
Edward Bronstein 
Helen H. Davenport 
Thomas T. Flynn 
Normand E. Girard 
Mary K. Spiker 
Thomas P. Weil 
1959 
William L. Kissick 
Marvin A. Lavenhar 
Hugh J. Maher 
Lee J. Podolin 
Ellwyn D. Spiker 
Mattie Lee D. Wade 
1960 
Gyla E. Brooks 
Kathryn L. D’Amico 
Wouter Ekker 
Maxine Geeslin 
Rose A. lannotta 
Katharine Anna Keppel 
John J. Kwasnowski 
R. John C Pearson 
Hannah Clark Russell 
1961 
Gordon R. Beem 
Martin Donabedian 
Helen M. O’Connell 
Margaret P. Parker 
Angela M. Russo 
William R. Slivka 
Harold W. Wicks 
1963 
Raul R. Cuadrado 
David Dolins 
C. DuVe Florey 
Edward M. Kenney 
Jean M. Maynard 
Samuel B. Webb Jr. 
1964 
Katherine Maria Detre 
John S. T. Gallagher 
Linda F. George 
Neal L. Maslan 
Theodore Rosenberg 
Estelle Siker 
Monroe W. Spero 
Claudewell Sidney Thomas 
1965 
Robert M. Edwards 
Edgar W. Francisco III 
H. Patterson Harris Jr. 
William C. Harvey 
James F. Jekel 
Michael E. Kove 
Peter J. Levin 
Francia M. Pagano 
Elliot A. Segal 
Viola J. Spinelli 
Sttrah L. Turner 
David S. Weiner 
1966 
Barbara L. Brody 
Allen Cohen 
Patricia R. Colenback 
Robert C. Lowrie Jr. 
Nancy Alfred Persily 
Raul Walder 
1967 
Carlos E. Alvarez Herrera 





Patricia D. Mail 
James M. Malloy 
Nancy Ruth Phillips 
Brigitte Prusoff 
Bruce J. Steinhardt 
Beth M. Whelan 
Irma Willner, R.N. 
Robert L. Woodward 
Peter T. Wotton 
1968 
Sonia M. Colon 
Joseph L. Dorsey 
Robert R. Everett 
L. Carol Femow 
Michael J. Geaney Jr. 
Francis J. Greaney 
William D. Harkins 
Chester H. Johnson 
R. Elizabeth Leif 
Jean C. MacCorison 
Robert F. Morisse 
Arnold R. Saslow 
Elizabeth Schwartz Small- 
Elliot 
Martha F. Steel 
Sheila W. Wellington 
1969 
Susan S. Addiss 
Janet A. Albrecht 
James M. Dawson Jr. 
Catherine E. Hanley 
Gerald R. Harpel 
Sylvia N. Holtzberg 
Samuel P. Korper 
Suchitra Nimmannitya 
Samuel D. Rowley 
Marva Serotkin 
Wanda Vierthaler 
Robert L. Young 
Chester W. Zamoch Jr. 
1970 
Susan W. Balter 
Arthur A. Berarducci 
Michael B. Bracken 
Ruth C. Edelson 
Walter M. Gawlak 
Robert S. Gureasko 
Martin James Kandes 
Shirley O. Labrum 
Scott W. Lite 
C. P. Noel McCarthy 
Andrea W. Nevins 
Saro Palmeri 
William L. Pedersen 
Charlotte F. Schwartz 
Stephen Skorcz 
Joseph A. Zaccagnino 
1971 
John Bihldorff 
Evelyn J. Bromet 
Willard Cates Jr. 
Katrina H. Clark 
Karen S. Cohen 
John A. Daeley 
Harvey Fembach 
Anne-Marie A. Foltz 
Wanda J. Hatmaker 
Mohamed Ismail Johnson 
William P. Koughan 
Mark J. Magenheim 
Joan L. Martinez 
Eugene S. Mayer 
Nancy P. Mogielnicki 
William C. Okulicz 
Wan Hin Ooi 
David A. Osgood 
Carol L. Paul 
Jane Silver 
Walter O. Spitzer 
Robert E. Steele 
Barbara R. Stoloff 
Judith Whitcomb 
1972 
David P. Barone 
Catherine A. Connolly 
Daphne deJ. Gemmill 
Dorothy N. Lewis 
Steven M. Lipsius 
Sergio Ruschel 
Jo Ann K. Silverstein 
Laurence A. Tanner 
Joyce R. Waksman 
1973 
Emily M. Barclay 
Eva Danielsson Cohen 
Bernice E. Coleman 
A.R. Taylor Denues 
Ellen B. Doft 
Helen B. Hubert 
James L. Mason 
Dennis P. May 
Dwight N. McNeill 
Marjorie E. Nelson 
Gary Dean Sax 
Janet B. Schoenberg 
Alice S. Stark 
Thomas J. Stranova 
Irene Trowell-Harris 
Bonnie C. Yankaskas 
Carl J. Zack 
1974 
Rose Salisbury Beer 
Thomas A. Benoit 
Ian B. Berger 
Olga Brown-Vanderpool 
Carl A. Cappello 
Beth G. Crocker 
J. Breckenridge Eagle 
Roberta Lawrence 
Evelyn B. Mostow 
Deborah Rose 
Shelley S. Shanok 
Abigail L. Smith 
Myma M. Weissman 
1975 
Edith N. Baum 
Ralph E. Binder 
Gerald E. Bisbee Jr. 
Linda K. Broker 
Linda K. Demlo 
Jack A. Eiferman 
Gerard R. Goulet 
William J. Grego Jr. 
Rosemary M. Johnson 
Barbara R. Unterman Jones 
Philip D. Kennedy 
James E. Knoben 
Stuart L. Lefkowich 
Laurence F. McMahon Jr. 
Mary W. Palshaw 
Dale P. Sandler 
Nancy E. Stroup 
Raymond Chiu-Ping Tang 
Thomas J. Trudell 
Franziska U. Ulrich 
Vera B. Walline 
Pat Boylston Whitt 
1976 
Elaine P. Anderson 
William F. Appicelli 
Frances L. de Peyster 
Joanna M. Erikson 
Paul H. Etkind 
Robert H. Frazier 
Annette B. Garofalo 
Gail lies Genvert 
Karen A. Gordon 
Janet Heinrich 
Robert T. Kauer 
Cleve Lee Killingsworth 
Instant rapport: Dr. Burton Singer welcomes home New Haven native Dr. Benjamin Spock. 
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A graduate focuses on Dr. Benjamin Spock’s 
EPH commencement address. 
Robert A. Knauf 
Janina Levy 
Robert C. Marquarclt 
Gino A. Nalli 
Janies B. Rokos 
Robert Risdon Schwarz 
Mao' Jo Shepard 
Marcia A. Testa 
Thomas S. Wingardner Jr. 
1977 
Ldward A. Bortnichak 
Richard B. Burt'ord Jr. 
Patrick i-. Carone 
Terry IJwyer 
fierard J. I'oley 
Travis K. Hedrick 
Idlen I). Jaslow 
Rh-ma Kantor Kershnar 
Ronald I-. LtilVnsee 
V‘. endv K. LelT owich 
T'. W. 




■ itT hild 
Carroll Schilling 
Gail M. Sullivan 
Virginia R. Towle 
Marian Troyer-Merkel 
1978 
Vijaya V. Bapat 
Kathleen M. Berman 
Robert J. Fensterheim 
Ann T. Freedman 
Janice F. Gold 
Cynthia R. Gross 
Jane E. Hill 
David W. Houck 
Christopher M. Maylahn 
H. James Myers 
Marguerite Nelligan 
Peter F. O'Connor 
David W. Osborne 
Ellen J. Reitler 
Ellen D. Rothberg 
Robert E. Schwartz 
Roberta Jo Shapiro 
Marie Stoeckel 
Bernadette S. Vissani 
R. Bradford Walker 
Lucy Ellen Weiger 
1986 
Indu B. Ahluwalia 
Clare F. Averbach 
Andrea Lee Boissevain 
Louise M. Brenner 
Debra Jean Brown 
Marijane L. Carey 
Marie Irene Ciacco 
Reid M. Davis 
Joe Tom Easley 
James R. Ferguson 
Nancy E. Fithian 
Stephen B. Gruber 
Roxanne Kapikian 
William J. Malone 
Catherine McQuilkin 
Daphne M. Nielsen 
Joseph M. Pajor 
Elizabeth G. Pelz 
Philip O. Renzullo 
Denise Amy Riedel 
Eric Triffin 
Tracey E. Virgin 
Virginia M. Westra 
Lynn D. Wilson 
1987 
Maureen E. Brady 
Hilda C. Chaski 
Woan-Ru Chen 
Bridgid M. Garrison 
Sara A. Holdcroft 
Timothy A. Jacobs 
Michael T. Koff Jr. 
Catherine A. Leda 
Barbara J. Moggio 
Joseph J. Napolitano 
Judith Ann Natale 
Pamela Fitzgerald 
Pomputius 
Anita A, Roth 
Mubashar R. Sheikh 
Joel A. Wasserman 
1979 
Bruce S. Anderson 
Virginia P. Bainbridge 
Gertrud S. Berkowitz 
Marianne Berwick 
Mama P. Borgstrom 
Ralph J. Cobum 
Susan De Renzo 
Frances D. Dwyer 
Elizabeth Feuer 
Lynn Fielden-Smith 
Judith B. Gancher 
Debra Haffner 
Candice C. Haslegrave 
Bruce H. Heckman 
Shelley Helfer-Amira 
Joseph D. Henn-DeMayo 
Phillip S. Katz 
Karen Kmetzo 
Paul Anthony Kowalski 
Benjamin Krevsky 
Renee S. L^ary 
Mary Elisabeth Lorenzi 
Osvaldo Marrero 
Patricia J. Moore-Pastides 
Marcia C. Richardson 
Lisa K. Rosenfeld 
George B. Rowland 
William E. Schweizer 
Ralph Tartaglione Jr. 
Elizabeth Tedder 
Ilene B. Wachs 
Jonas Zucker 
1980 
Phillip R. Aaron 
Gary J. Aboff 
Frederick R. Aronson 
Diane Denis Aye 
Antoinette M. Brooke 
Richard L. Buck 
Gary L. Busack 
Barbara H. Granger 
Ellen B. Greif 
Irwin J. Halperin 
Samuel S. Hamilton 
Virginia S. Humphrey 
Helen E. Kelly 
Yee-Lean Lee 
LeRoy F. Ludwig 
James S. Marks 
Jane Ungate O’Connor 
Ann L. Prestipino 
Nancy Maguire Rhodes 
Norman M. Schlossberger 
Lydia A. Selling 
Marsha L. Silverman 
Carolyn K. Wells 
1981 
Harold J. Burdo Jr. 
Rebecca L. Calderon 
Rollin C. Chew 
Angelo J. De Vita 
Brian J. Foley 
Richard T. Forsley 
Ellen M. Gallagher 
Peggy A. Gallup 
Marie F. Gavula 
Joan Urquhart Goodman 
Diane E. Goren 
Cindy F. Kleiman 
William J. McLaughlin 
Blackford Middleton 
Mtulee D. Mooney 
Barbara Gaugler Pennebaker 
Frederick V. Peterson Jr. 
Maureen T. Power 
Gerald W. Robinson Jr. 
Elizabeth N. Shapiro 
Susan M. Stoecker 
Karin Swanson 
Keith D. Tait 
1982 
Jamie L. Amaral 
Gretchen Dieck 
Biemesderfer 
Martha Livingston Bruce 
Francis L. Crowley 
Kathleen K. Devine 
Denise Heinemann 
Ann Storms Kloter 
Linda F. Me Caig 
William F. McKeon 
Susan G. Rice 
Lisa E. Stone 
Carol L. Vander Wal 
Nancy K. Wander 
Sandra Michaelson Warren 
Maud Helen White 
Alvin C. White 
Jill Okrent Zaheer 
1988 
Ellen Elizabeth Banach 
Elaine P. Berger 
Sylvia Hillary Blackburn 
Francesca Marie Cook 
Ellen Lucy Kraftsow 
Mark William Legnini 
Paul Alan Lindia 
Saifuddin Taiyeb Mama 
Virginia Alicia Pittman- 
Waller 
Carrie A. Redlich 
Lawrence Vincent Silvia 
Carol Ann Strycharz 
Darlene Uten Zimmermann 
1989 
Judy Gardner Audette 
Daniella Duke 
Mary Beth Durkin 
Elizabeth Harrison Hadley 
Marcella Perez Jones 
Mary Jo McGinley 
Mary D. H. Miller 
Deena Beth Myers 
David Dean Peete 
Elizabeth Ann Platz 
Marie V. Roberto 
Robert P. Sbriglio 
Joy Misako St. Germain 
Joseph Thevenin Jr. 




Barbara W. Abraham 
Dean S. Archibald 
Dalia Castillo-Aguilar 
Mark L. Dembert 
Robert A. Duncan 
Susan Paris 
James N. Gaito 
Ellen M. Ginzler 
Virginia C. Hiland 
Margaret M. Kolb 
Allen F. Levy 
Cynthia M. Meyer 
Scott K. Mock 
Shinsuke Morio 
Jeannee Parker-Martin 
Keith A. Radcliffe 
Nano G. Rush 
Paul M. Schur 
Elizabeth C.H. Stevenson 
Patricia C. Weber 
1984 
Jean L. Freeman 
Carolyn H. Grantham- 
Millman 
Penny H. Hausser 
Marcia Lipkind Hirsch 
Sarah M. Horwitz 
Gregory R. Huth 
Mehrdad Jalali 
Georgia Jennings 
Jean G. Larson 
Cathy Nager 
Grael M. O'Brien 
Julie A. Russem 
Stephen Marc Schwartz 
Dennis G. Shrauger 
Gerald L. Springer 
Marie Ann Tobin 
1985 
Rene S. Cabral 
Joan M. Cleary 
Susan M. Coakley 
Suzanne Mary Cooney 
Jerald A. Fagliano 
Katherine Santella 
Fitzpatrick 
Barbara K. Gottlieb-Ware 
Shirley J. Lee 
P. Douglas McConatha 
Rona Janis Mogil 
Adrian J. Pinsince 
Eric Scalettar 
Marcia Shapiro 
Shirley J. Tirrell 
Terry Martin Zingman 
FRIENDS 
U. Robert Merikangas 
* Deceased Yale Medicine Fall/Winter 1990-1991 
EPH Alumni Fund Class Participation 
1988-1989 1989-1990 
CLASS AGENT TOTAL % PART. TOTAL % PART. 
1941 and prior $ 1,829 2,499 62 
1942 Eric Mood 260 60 525 80 
1943 Eric Mood 396 45 301 18 
1944 Eric Mood 790 50 226 33 
1945 Stephen Skorcz 25 54 125 33 
1946 Stephen Skorcz 75 29 75 29 
1947 Stephen Skorcz 140 35 145 30 
1948 Samuel Herman 1,185 50 100,885 56 
1949 Edgar Geibel 360 25 480 35 
1950 Eric Mood 765 52 590 43 
1951 Robert Johnson 460 32 590 40 
1952 Yolande Lyon 1,010 37 445 33 
1953 Milton Sisselman 280 25 185 25 
1954 Eric Mood 50 14 45 14 
1955 Frances Ogasawara 360 50 370 47 
1956 David Boyd 365 47 520 42 
1957 Edward DeLouise 395 40 520 45 
1958 Philip Hallen 955 41 350 22 
1959 Dorothy Wilson 725 30 1,250 22 
1960 Gyla Brooks 515 39 350 39 
1961 Joseph Prekup 660 47 425 41 
1962 Thomas Mayhugh 80 20 0 0 
1963 David Dolins 795 30 650 30 
1964 Estelle Siker 590 27 760 36 
1965 780 38 725 41 
1966 Allen Cohen 145 15 135 23 
1967 James Malloy 1,545 36 1,680 38 
1968 Francis Greaney 1,505 33 1,185 36 
1969 Robert Young 1,305 38 1,340 33 
1970 Susan Balter 1,245 27 1,235 32 
1971 John Bihldorff 2,015 48 1,540 44 
1972 Dorothy Lewis 415 24 395 21 
1973 Gary Sax 1,120 25 1,330 30 
1974A Thomas Benoit 435 26 350 30 
1974B 510 32 275 20 
945 29 625 25 
1975 Linda Broker 1,952 26 1,178 27 
1976 Elaine Anderson 1,020 24 1,670 30 
1977 Dorothy Rice 735 19 740 24 
1978 Ann Freedman 815 21 1,210 24 
1979A Catherine Norton 960 28 1,010 34 
1979B Ralph Tartaglione 550 36 560 36 
1,510 32 1,570 35 
1980 Christina Quinn 830 24 820 22 
1981A Angelo DeVita 640 24 485 21 
1981B Barbara Pennebaker 260 29 255 33 
900 25 740 27 
1982A Constance Jarowey 380 22 265 12 
1982B Jean Milton 495 37 470 26 
875 28 735 19 
1983A Jeffrey Hughes 475 23 475 22 
1983B Marybeth McNemey 230 23 245 20 
705 23 720 21 
1984A Anthony Alberg 105 11 235 18 
1984B Leslie Balch 180 16 205 17 
285 13 440 18 
1985A Joan Cleary 40 5 205 13 
1985B Katherine Fitzpatrick 330 26 305 21 
3~70' 14 510 17 
1986A Indu Ahluwalia 365 14 625 25 
1986B Aric Wilt 720 33 510 24 
1,085 24 1,135 25 
1987A Hilda Chaski 620 25 458 15 
1987B Elizabeth Wennar 180 16 300 8 
800 21 758 12 
1988 Joseph Della Puca 321 22 425 15 
1989 Joy St. Germain 370 21 
1988-1989 1989-1990 
NUMBER NUMBER PERCENT NUMBER NUMBER PERCENT 
SOLI- CONTRI- PARTICI- SOLI- CONTRI- PARTICI- 
CITED BUTORS RATION TOTAL CITED BUTORS RATION TOTAL 
EPH Alumni 2,161 598 28 $36,388 2,267 597 26 $135,523 
Interest/Miscellaneous — — — 3,125 — — — 869 
TOTAL 2,161 598 28 $ 39,513 2,267 597 26 $136,392 
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THE LAST WORD 
Dr. Thomas P. OuJf\'. professor of medicine, delivered the 1990 medical school commencement address. An excerpt follows: 
"UV are now poised to unlock the mysteries of life, and as scientists, have entered a grove where it has become literally 
possible to alter the very nature of nature. No restraints will completely stifle this quest; what has been thought cannot now 
be unthought. But someone must take responsibility for the manner in which society utilizes the knowledge which will be 
uncovered. That someone includes people such as yourselves, individuals trained as physicians — scientists with knowledge 
encompassing the vast terrain of the molecular and the patient. You must be the stewards who will guarantee that science is 
applied in the service of humanity and not humanity in the service of science." 
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CONTINUING MEDICAL 
EDUCATION AT YALE 
Friday 
Nov. 9, 1990 
UPDATE IN CEREBROVASCULAR DISEASES (A) 
Director: Lawrence M. Brass. M.D. 
For practicing neurologists, internists and surgeons. Will focus on the latest advances in 
stroke diagnosis, prevention and treatment. 
Saturday 
Nov. 10, 1990 
Friday-Saturday 
Nov. 16-17, 1990 
Friday-Saturday 
Nov. 30-Dec. 1, 1990 
Wednesday 
Dec. 5, 1990 
Monday-Thursday 
Dec. 10-13,1990 
SOFT TISSUE WORKSHOP EOR THE DERMATOLOGIST (H) 
TO IMPROVE OEEICE SURGICAL SKILLS 
Director: David.J. Leff'ell, M.D. 
For the practicing physician and the dermatology resident who anticipate a surgically 
oriented practice. Designed to meet the needs of the office-based demiatologists and 
structured to address a broad range of skills and interests. 
VISITING LECTURE SERIES IN OPHTHALMOLOGY (C) 
Director: David E. Silverstone. M.D. 
Speaker: Jerry A. Shields, M.D. 
Ocular tumor update. 
VISITING LECTURE SERIES IN OPHTHALMOLOGY (D) 
Director: David E. Silverstone, M.D. 
Speaker: Marshall M. Parks, M.D. 
Pediatric ophthalmology and strabismus update. 
HOT BABIES: HOW MUCH OE A WORK-UP? (E) 
Director: John M. Leventhal. M.D. 
Recent advances in pediatries. 
DIAGNOSTIC ULTRASOUND IN OBSTETRICS (F) 
Director: John C. Hohhins, M.D. 
Didactic lectures and workshops in the morning; video pre.sentations and patient scanning 
in the afternoon. 
CIRCLE THE APPROPRIATE LETTER!S) ON THE ATTACHED POSTCARD TO OBTAIN MORE INFORMATION ON 
CONFERENCES DISCUSSED IN THIS ISSUE. PLEASE BE SURE TO INCLUDE YOUR NAME AND ADDRESS. 
Valk Mkdicink 
P.O. Box 3333 
333 Cedar Street 
New Haven, CT 06510-8011 
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Yalk Medicine Interview: Are Living Wills Necessary? 
What should physicians do to fulfill the wishes of patients regarding 
life support when patients cannot speak for themselves? For an informed 
opinion, Yale Medicine turns to Angela R. Holder, clinical professor of 
pediatrics (law). 
5 Blueprint for the ’90s: the Dean’s Address 
In his faculty address delivered on Dec. 17, Dean Leon E. Rosenberg presented 
the .School of Medicine’s academic plan and announced, among other items of 
note, that YSM will construct a clinical sciences building and a new home for 
the Yale Comprehensive Cancer Center. 
Yale Immunobiologists Get Down to Basics 
Not quite three years old, the School of Medicine's section of 
immunobiology, headed by Richard A. Flavell, Ph.D., is forging ahead 
in its quest to understand the sophisticated defenses of the human 
immune system. 
Center for Molecular Medicine: the 21st Century Debuts 
As the June 6 dedication of the $38 million Center for Molecular Medicine 
nears, the .scientists who will serve its four programs are preparing to write 
an exciting new chapter in the history of biomedical research. Discover 
how the center will be integrated into the School of Medicine. 
1 Letters 33 New Books 39 Student News 
27 Gallery 33 Faculty News 40 Obituaries 
28 M.L. King Jr. Day 36 Alumni Report 42 In Memoriam 
30 Scope 38 Alumni News 43 Development Report 
On the cover: I'rciinin^ the nuiin entrance to the Center for Molecular Medicine, twitt pillars do more than recall Ei>yptian Revival 
architecture. I'hey also serve as air shafts for the center's ventilation system. {Photo hy Harry Bishop.) 
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Office of Public Information, .^.SO Congress Ave., P.O. Box 333.^, New Haven, 
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LETTERS TO THE EDITOR 
Thanks to 
Elizabeth Morgan 
To the editor: 
This letter represents my second 
attempt to thank you for publishing Dr. 
Morgan’s article deploring the medical 
profession’s long-standing denial of the 
incidence and impact of child abuse 
(“My Perspective on Child Abuse,” 
Summer 1990). Because her article 
moved me deeply for personal reasons, 
my first attempt grew too long, too 
revealing, and perhaps too painful, for 
me to share in a professional journal. 
But I did finish that letter for myself 
because I needed to finish the work of 
my heart which Dr. Morgan’s article 
had begun within me — grieving again 
for my lost mother, once a creative and 
intelligent but unhappy young woman 
who received prescriptions for 
amphetamines and barbiturates from 
physicians rather than appropriate 
treatment for the adult sequelae of 
severe abuse she had suffered as a 
child; experiencing again the terror, 
rage and shame engendered by her 
physical and sexual abuse of me, 
abuse that was certainly exacerbated 
by the addiction physicians eased 
her toward; longing painfully again for 
the physician-father whose selfless 
dedication to his patients was 
admirable but who left his own children 
without much protection against 
violence. 
In this second letter I would like to 
emphasize that my own life has turned 
out much happier than my mother’s 
primarily because increased awareness 
of child abuse has made successful 
treatment available to me. I have not 
had to revisit my own abuse on my 
children, as my mother did; on the 
contrary, I enjoy parenting immensely 
and my children seem to be thriving 
emotionally. I also know the deep 
pleasure of a long and honest marriage 
because my husband’s love for me has 
encompassed a willingness to learn 
about child abuse since our student 
days together at Yale medical school. 
What we have learned has changed the 
way we both practice medicine and has 
definitely helped out patients. Like Dr. 
Morgan, we are convinced that child 
abuse causes or prolongs many 
r r ^ 
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illnesses later in life. Since much child 
abuse is preventable and many adult 
sequelae are now treatable, a physician 
who cannot recognize child abuse and 
its sequelae today and refer these 
problems appropriately is, in essence, 
denying treatment to patients and may 
even be exacerbating the problem, as 
happened in my own family. Dr. 
Morgan rightly insists that all 
physicians, whatever their specialties, 
need to educate themselves about child 
abuse. Thank you again for publishing 
her excellent article. 
Elizaheth Michel, M.D. ’75 
Encinitas, Calif. 
r r r 
Kudos 
To the editor: 
Congratulations on the EPH 75th 
anniversary edition of Yale Medicine 
— This is a nicely balanced and very 
readable issue. 
Patricia D. Mail, M.P.H. ’67 
Rockville, Md. 
To the editor: 
Congratulations on the Fall/Winter 
issue of Yale Medicine. The whole 
issue is excellent. 
Rosemary A. Stevens 
M.P.H. '63, Ph.D. '68 
Philadelphia, Penn. 
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Harry Bishop 
Fhilaiithropist John B. Pierce 
Winslow Inaugurated 
Pierce Laboratory 
To the editor: 
Your recent article about EPH 
celebrating its first 75 years was 
inlomiative and thorough, emphasizing 
appropriately the medical school's 
renewed attention to the integration of 
clinical medicine and public health. 
I wish to expand upon your 
description of the important role that 
the John B. Pierce Laboratory has 
played in the department since the 
founding of the laboratory in 1933. C.- 
E.A. Winslow, the father of public 
health at Yale, was also the first 
director of the Pierce laboratory. Some 
of his best known and most often cited 
research was done at the Pierce 
laboratory. Professor Winslow initiated 
at the Pierce laboratory a unique 
interdisciplinary basic science approach 
to the study of responses to different 
environmental stimuli. Pierce 
laboratory research over the years has 
provided important information on such 
public health and environmental issues 
as new means to assess indoor air 
quality and the details of biological 
responses to various airborne 
contaminants. Basic environmental 
variables currently under study at the 
Pierce laboratory include microwave 
radiation, temperature, humidity, 
oxidants in general and a number of 
air pollutants. 
Today nearly all of the Pierce 
laboratory’s scientific staff participate 
in the teaching program of the EPfTs 
division of environmental health 
science. I'hrough this symbiotic 
relationship, we are able to bring 
specialized knowledge to new 
generations of researchers and public 
health practitioners. 
The close ties that have developed 
between the Pierce laboratory and 
EPH in recent years are partly 
responsible for the renewed vitality of 
the department. The department’s vigor 
insures that it will continue to 
contribute to the field of public 
health and to the health of the School 
of Medicine. 
Ethan R. Nadel. Ph D. 
Director. John B. Pierce Laboratory 
Professor of Epidemiology 
(Environmental Health) and 
Cellular and Molecular Physiology 
RISON LIBRARY 
Harold E. Harrison 
M.D. '31. '31-'35 HS 
Harold Harrison 
Remembered 
To the editor: 
It wasn’t long after Harold Harrison 
and I first met, more than 60 years ago, 
that we learned we’d been born on the 
same day. The symbolism was right 
on target, for the friendship that 
followed had many parallels and 
many intersections. 
Harold was a year ahead of me in 
medical school, and 1 quickly learned 
to look with awe on his towering 
intellect. Like him, 1 did internship in 
pediatrics with Grover Powers, whom 
we both revered, and 1 quickly 
discovered that Harold was a tough 
taskmaster. But what I learned from 
him stuck with me. In fact, Harold’s 
extraordinary clinical acumen meant 
more to me in those years than his 
scientific and re.search brilliance that I 
later learned to appreciate. 
We did so many things together 
while we worked on the same .service: 
our first trip “abroad,” to eastern 
Canada, eating dust in an open roadster 
owned by a mutual friend; double 
dating with our future wives whom 
we’d both met at Yale. Our marriages 
took place less than a month apart, and 
we kept in touch as we went our 
separate ways. It was while I was 
staying with Harold and his wife Helen, 
when I came to New York from Puerto 
Rico during the war, that I was able to 
find the sublet that made it possible for 
me to reunite our young family. 
When, just a few years later, we 
both came to head pediatric services, 
his advice helped me over some rough 
spots. And in 1951 we had a 
memorable week in New Orleans with 
Harold as a visiting professor. There 
he showed his teaching skills to 
Louisiana practitioners and demon¬ 
strated to them and the pediatric faculty 
the logic and potential of oral 
rehydration long before it achieved 
international recognition. 
What a thrill it was to watch the 
steadily increasing recognition of 
Harold Harrison’s scientific 
preeminence and, particularly, to be 
among the cheering multitude present 
at the crowning glory of the joint 
Howland Award to Helen and Harold 
— an extraordinary couple. Despite all 
this praise and appreciation of his 
talent, Harold never lost his humility or 
his likelihood to deprecate the relative 
significance of his own contribution. 
Harold’s was a marvelously 
productive life; he was still remarkably 
active after so-called retirement, 
making it seem even more unfair that 
he was cut off prematurely. In fact, 
however, Harold’s major contribution 
has not been stopped at all. Important 
as the new knowledge, the new ideas, 
the new approaches have been, his 
major legacy is the corps of younger 
persons whom he developed and 
nurtured. It will be the succeeding 
generations that will make Harold 
Harrison’s influence truly enduring. 
I am proud to have been his friend. 
Myron E. Wegman 
M.D. '32. '32-'36 HS 
Ann Arbor. Mich. 
Correction 
The inside cover of the Eall/Winter 
1990-1991 Yale Medicine incorrectly 
listed Stephen C. Joseph M.D., M.P.H., 
as a graduate of the department of 
epidemiology and public health. While 
not an EPH graduate. Dr. Joseph did 
receive his M.D. degree from the 
School of Medicine in 1963. 
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YALE MEDICINE INTERVIEW: 
ARE LIVING WILLS NECESSARY? 
Editor’s note: Last summer, the U.S. Supreme Court issued 
one of its more controversial decisions of recent years in the 
case of Nancy Cruzan vs. William Webster. The court ruled 
that neither family nor physician could terminate life support 
for a comatose patient without written documentation of the 
patient's intent. As a result of this decision, incpdries have 
drastically increased to organizations such as Concern For 
Dying, which offers "living wills” to specify such intent. 
In a related development, administrators of hospitals, nursing 
homes and other health care institutions have welcomed a 
recently passed federal law which, as of Jan. 1, 1991, 
requires such institutions to read patients a medical 
"Miranda warning” of their right-to-die options. In response 
to these developments, Rosalind D'Eugenio, staff assistant at 
the School of Medicine Office of Public Information, 
interviewed Angela R. Holder, LL.M., clinical professor of 
pediatrics (law) at Yale and past president of the American 
Society of Law and Medicine. 
In light of the Cruzan vs. Webster decision, do you feel a 
living will is necessary to uphold a patient's wishes? 
Some form of written instruction may be required in some 
states, but a formal living will is much too complicated. You 
can’t ask somebody who’s not sick to decide under what 
circumstances he or she would not want treatment. From the 
legal perspective, two things ought to happen about advance 
directives. First, instead of having people fill out forms, 
doctors ought to realize that they have the responsibility to 
talk to patients in general terms about how they feel about 
life-saving interventions. Second, if they’re treating a person 
for a disease that’s terminal, they ought to get concrete about 
what the patient wants while the patient can still speak up. 
Is a document needed to represent a patient's intent in court? 
Not a single state in the country requires any specific form of 
documentation of somebody’s wishes. A note from a doctor’s 
office chart saying “I talked to the patient about these issues, 
and this is what the patient reported that she or he would 
want,” is good enough for the courts in any state. The other 
thing that most lawyers advise people to do is to sign a 
durable power of attorney, which appoints a given person to 
make the decision in a real situation. 
Would that be a family member? 
Or a friend. It should not ever be the doctor who’s taking care 
of the patient. States vary about how formal these have to be, 
but in all states, they need evidence of intent. Some states 
now have statutes that say that the next of kin can make these 
decisions without having to go to court. It’s just appalling that 
one of the saddest parts of a family’s life has been made into a 
.lames Anderson 
Angela R. Holder: "Talk to patients in general terms about 
how they feel about life-saving interventions.” 
legal circus. I can’t imagine anything worse than having to go 
to court to let a loved one in my family die. There may be 
times when there’s serious conflict within a family that no 
amount of negotiation can solve, and in very rare instances it 
makes sense to go to court, but I’ve never encountered one. 
Is there a living will that would apply in all states, or would it 
be different from state to state and country to country? 
From country to country there are wide variations. For 
example, there’s no such thing in France as the law of 
informed consent. You can’t sue a physician for not telling 
you something; the whole professional patient or client 
relationship is different. But within the United States, 
although each state may have a statute saying a living will or 
a durable power of attorney has to have three witnesses, you 
merely need to demonstrate the intention of the person who 
signs it. People have been dying since before lawyers were 
invented, and it’s not necessary to make a legal maneuver of 
this. Doctors and patients and families can work these things 
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out by talking before the crisis occurs. Of course, there are 
situations where that just can't happen. If I take off in my car 
and have an accident in a place where nobody’s ever seen me 
before, then you can't fault somebody for not having talked to 
me. And 1 certainly am not going to carry my living will in 
my overnight bag, either. But, if I have a relationship with a 
physician, then it strikes me that he or she has an ethical 
obligation at appropriate times to bring up this subject. 
\\ hat do von think about the new law that requires medieal 
institutions to advise prospective patients about living wills at 
or before admission? 
The law is a good idea for nursing homes, but how many 
hospital admissions clerks are capable of explaining the 
consequences of a durable power of attorney to a patient? It's 
absurd. There are probably not a lot of doctors that know 
enough about it themselves. If a state wants to do living wills 
on a mass basis, they ought to do it like they do organ 
donations, with driver's licenses. That takes it out of the 
medical context so the person who's going to the hospital to 
have a healthy baby doesn't think somebody knows 
something she doesn't when she gets a living will in the mail. 
\\ hen is the right time to write a living will? 
.\s far as 1 know, the patient can write out on a piece of 
stationery. "If 1 can't speak up. ask my friend Jane,” sign it, 
date it and give it to the doctor to put in the doctor’s office 
chart, and that will solve 99 percent of the problems that may 
come up later. The "clear and convincing evidence” a court 
requires doesn't necessarily mean a fomial legal document. 
Therefore, a durable power of attorney is more important 
than a living will? 
The most important thing is for doctors to encourage patients 
to express themselves about what they want in general, since 
no one knows about particulars. Then doctors should help 
patients figure out who they want to make the medical 
decisions and then document these wishes in some way. The 
main thing the doctor must know is exactly how the patient 
wants to be treated and if he or she isn't able to speak, who 
should speak for the patient. 
What if a relative contests the decison of the patient? 
If a daughter comes in after her mother can’t speak up and 
says, “I want my mother treated,” when the mother has made 
it clear up to this point that she doesn’t want treatment, the 
physician might feel that he has to go get a court order. But 
that’s the reason to have the patient's wishes documented. A 
doctor is perfectly legally correct in saying, “This is what 
your mother wanted. We discussed it. I have this note in my 
chart that your mother countersigned, and I’m going to do 
what my patient wants even though she can’t speak up at this 
point.” That’s absolutely legally correct. The problem is that 
the unconscious patient can't sue, and the daughter can, so 
most doctors would pay more attention to the daughter than 
they’re legally required to. 
This brings us back to the issue of a living will or some other 
document regarding the patient's wishes. 
In the best of all worlds, you go to a lawyer and either get the 
lawyer to draft a statement for you or tell you what the state’s 
requirements are so you can comply with them. A lot of bar 
associations do volunteer work in nursing homes and 
retirement homes helping people with these documents. 
Have you seen any particular outline for a living will that you 
would recommend? 
Concern for Dying, an organization in New York which 
actually started the living wills, has the best. It’s very short 
and just says "If I’m terminally ill, I don’t want heroic 
treatment.” There is a problem defining those terms though. 
What is a "terminal illness?” And I have no idea what "heroic 
treatment” is. It’s hard to say whether you want something or 
not when you don’t know in what circumstances you’ll ever 
need it. That’s why it’s better to say. "I don’t know what’s 
going to happen to me. but I trust ‘X.’ And I want ‘X’ to 
decide on the facts that occur at the time.” 
You clearly recommend assigning a power of attorney rather 
than writing a living will? 
Yes. Don’t try to figure out what you will want in a situation; 
try to figure out some person that you trust to make decisions 
for you. It’s not that your values change, it’s that your life 
changes. Some things become more important, while others 
become less important. To say that for all time you can fill out 
a form about when you want invasive diagnostic tests is just 
ludicrous. It makes the whole process too complicated. YM 
For More Information 
Information about living wills and on durable power of 
attorney may be obtained through the following: 
Concern for Dying 
250 West 57th St. 
New York. NY 10107 
(212) 246-6962 
“The Medical Directive” 
Harvard Medical School Health Letter 
164 Longwood Ave. 
Boston, MA 02115 
($5 for tvv'o; $ 10 for five; 
bulk order prices available) 
American Bar Association 
“Health Care Powers of Attorney” 
stock #D-13895 
c/o AARP Fulfillment 
1909 K St.. NW 
Washington, DC 20049 
(202) 3.31-2200. 
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BLUEPRINT FOR THE ’90S 
THE DEAN’S ADDRESS 
Editor’s note: On December 17, 1990, as he addressed 
members of the School of Medicine's faculty and 
administration. Dr. Leon E. Rosenberg commented on the 
medical school’s acadenuc plan and outlined plans for his 
second term as dean. An edited version of his address follows. 
When I last addressed you in 1984, I assessed the state of our 
school. I reminded you of our proud institutional heritage and 
of the prowess of our distinguished faculty. 1 described our 
scale and scope, speaking of such things as the size of our 
faculty, our national standing in NIH grant awards, our 
growth in clinical earnings. I forecast changes of many sorts 
and said that these changes represented a challenge we must 
accept, for in the challenge of change lies the opportunity to 
soar and to excel. I exhorted you to do more and do it better. 
You — and I genuinely mean all of you — have responded 
magnificently. You have done more of everything — 
teaching, research and service — and you’ve done it better. 
My admiration for your collective efforts is equalled only by 
my pride in your personal achievements. 
You have responded so magnificently to the call of your 
dean, your chair, your school and your profession that I have 
brought you together today to ask for still more. During the 
past three years we have responded to a request from 
President Schmidt and provosts Nordhaus and Turner to 
develop an academic plan for the School of Medicine in the 
1990s. This plan and its counterparts from the Faculty of Arts 
and Sciences and from each of the other professional schools 
are currently being molded into an academic plan for the 
entire University. In turn, this academic blueprint will serve to 
define and direct the upcoming $1.5 billion capital campaign 
for Yale. 
The School of Medicine's planning effort has been multi¬ 
focal and iterative. It has included five-year plans from all 
departments, autonomous sections and centers; digestion and 
discussion of those plans at a retreat of deans and chairs; 
further appraisal of the departmental plans and a presentation 
of a related institutional vision by the dean’s operating group, 
consisting of the school’s deans and other key administrators; 
and finally a draft text prepared by our marvelous deputy 
dean. Bob Donaldson, and myself with the valuable input of 
key faculty members. The draft was then read by the Provost, 
the President, the Yale Corporation and the chairs of the 
school. You now have the revised final plan as submitted to 
the corporation in November 1990. 
Academic Leadership 
The introduction to our school’s plan sets the tone and 
presents the vision. The words are largely those of Bob 
Donaldson. The spirit, I hope, is all of ours. 
This plan charts a strategic course for the School of 
Medicine in the 1990s: to establish Yale as the unquestioned 
academic leader in making science-based and humane 
medicine responsive to the needs of society as a whole, not 
Just the needs of individuals. 
Since World War 11, the technological advances of 
biomedical research have revolutionized the care of seriously 
ill patients. Thousands of people now survive ailments which 
in the past were uniformly fatal. At the same time, the 
vineyards of academic medicine have yielded vintage after 
vintage of highly specialized physicians skilled in the use of 
sophisticated methods for diagnosing and treating diseases. 
Despite all this success — and in some instances because 
of it — the consequences of disease and its treatment have 
come to impose a growing economic burden on the public. 
The nation finds itself confronting burgeoning epidemics of 
costly disorders rooted in substance abuse and poverty, in 
the special needs of a rapidly aging population, and in the 
major fiscal commitments required by technology-intensive 
medical care. 
Instead of the praise and appreciation it used to hear, 
medicine now finds itself the target of constant complaints: 
It's too impersonal: it’s unevenly distributed: it neglects 
minorities and the poor: it’s too concerned with dramatic, 
occasional cures and not concerned enough with prevention: 
it doesn’t worry enough about maternal and infant survival: 
and most of all, it costs too much. U.S. Sen. Albert Gore 
recently summarized the public’ a frustration as follows: “We 
are the richest nation in the world, our medical e.vpertise and 
accomplishments are the envy of the world, and yet our 
inability to meet the basic health needs of our citizens is an 
embarrassment.’’ 
Too often, medical schools and academic health centers 
have tended to set themselves apart from society’s needs and 
dissatisfactions by limiting the size of medicine’s playing 
field. Medicine, according to this argument, cannot make 
people happy, eliminate slums or feed the hungry: it can only 
apply its increasingly powerful tools to those individuals 
whose afflictions are definable in biological terms. 
This academic plan for the Yale School of Medicine asserts 
that these limits are too narrow and that the school, together 
with Yale-New Haven Hospital, West Haven Veterans Affairs 
Medical Center and its other partners, must take advantage of 
its highly developed research and educational programs, not 
only to cope with complicated illnesses in individual patients, 
hut also to address broadly the urgent health care needs of 
the public. We agree that medicine cannot keep drunks from 
driving cars, crack dealers from entering school yards, 
addicts from sharing needles or cheats from operating 
Medicare mills. 
However, academic medicine can and should assign a high 
priority to research and educational efforts directed at the 
fundamental causes, prevention and treatment of alcoholism, 
addiction, AIDS, afflictions of the elderly and other diseases 
of increasing public conceim. Moreover, academic health 
centers must increasingly bring their resources to bear upon 
pressing policy issues, including the costs of medical care, 
strategies for disease prevention, access to primary care and 
quality assurance. 
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Yale School of Medicine is ideally positioned for a leading 
role in meeting these difficult challenges this decade. It is 
situated in a city large enough to provide the variety of 
settings necessary to e.xamine the nation's complex ills, yet 
small enough not to he overwhelmed hy them. Moreover, the 
school is most fortunate in having Yale-New Haven Hospital 
as its academic partner. This modern, multi-faceted health 
care facility with its busy emergency room, trauma center and 
H25 beds not only provides dedicated and outstanding 
medical care to the community but also commits itself to 
excellence in clinical research and education. The West 
Haven V’/A Medical Center provides similar partnership 
opportunities for research and education concerned with the 
special health care needs of our rapidly aging population 
(f veterans. 
Other affiliates of the School of Medicine provide diverse 
health care "laboratories" in which Yale can develop 
innovative approaches to diseases and health issues of 
escalating national concern. These affiliates include two 
communitv-based atnbulatoiy clinics for indigent patients and 
10 community hospitals in southern Connecticut. The School 
of Medicine is able to take full advantage of these diverse 
settings, thanks to its major program in public health and a 
strong, academically oriented School of Nursing, a key 
component of Yale-New Haven Medical Center. 
Building upon the school's many strengths, this academic 
plan envisions new investigative. educational and service 
initiatives. It recognizes the social, legal, economic and 
ethic al implications of health and disease. But it goes further. 
This plan also articulates the school's unicpie opportunity at 
this point in its history to produce physicians and scientists 
who will be prepared to solve the myriad health maladies of 
our society which will only worsen without soundly conceived 
and aggressive intervention. 
To Better Serve Society 
I want to return to the first sentence which defines the 
strategic course of the plan: “to establish Yale as the 
unquestioned academic leader in making science-based and 
humane medicine responsive to the needs of society as a 
whole, not just the needs of individuals." 
1 doubt that anyone would see this vision as trivial. 1 hope 
all will mark it as bold. As importantly, I hope you agree with 
me that it is realistic for our school to aspire to be the 
unquestioned leader in the coming decades. The foundation 
for leadership is here: 
• a great university led by a president who cares deeply 
about medicine and who says repeatedly that he is 
energized by the health field because of its significance 
in today’s world; 
• a city which has. in microcosm, all of our nation’s 
social, political and health problems and which looks to 
our University for model answers to major problems; 
• excellent health care facilities in which to perfect 
our attempts to prevent, diagnose, cure and under¬ 
stand illness and. thereby, promote health and 
reduce suffering; 
• a faculty and staff of sufficient size, quality, diversity, 
energy and dedication to accomplish almost any 
reasonable goals. 
I his mission statement is worthy of all of us because we 
are worthy of it. 
The plan then expands on this vision in the form of 10 
major goals [see “Goals,” page 7] and a considerably larger 
number of specific aims. Taken together, the goals amplify 
and buttress the key words in the plan’s first sentence; 
academic, science, humane, society, individuals. Concerning 
the ordering of these goals, the plan’s first three goals are of 
the highest priority because they are the most general and, 
therefore, of the broadest significance to the plan as a whole 
and to the faculty as a group. Goals 4 through 10 are not 
arranged in any order of importance. Each is significant in its 
own right; each reflects an institutional need to build on 
strength and to correct weakness. Now, I’d like to comment in 
some detail on the first three central goals. 
Goal 1: Reaffirm our central mission as an educational 
institution. 
This goal is placed where it belongs — at the very top of 
the list. We are, first and foremost, a medical school, and our 
central mission is and must continue to be the education of 
those who will succeed us — those who will be our 
professional heirs. Parenthetically, the recent birth of my first 
grandson makes this metaphor particularly gratifying to me. 
Three years ago, I asked Dr. Edward Benz to chair a 
faculty task force that would evaluate our medical school 
curriculum. That group made many important 
recommendations which have been incorporated into the plan. 
Its central message was that we must “find ways to elevate 
the status of teaching as a treasured activity within the 
medical school.’’ We must place it higher on the marquee, the 
task force said. 
Some of you might question the validity of this conclusion 
because there is abundant evidence that we have done rather 
well as an educational institution over the years. We continue 
to attract many of the most able students in the country. They 
come here because of you, a superb faculty providing them 
with exceptional instruction, exciting research opportunities, 
personal attention and clinical excellence. They come, as 
well, because of the “Yale System” of education which holds 
that self-education is the best education when it is guided by 
small group seminars and conferences, when it allows 
progress at an individual’s own pace, when it stresses learning 
principles rather than memorization of facts, when it 
eliminates competition for grades, when examinations are 
mainly for the student’s benefit, and when close personal 
relationships between faculty and student are emphasized. 
Thanks to Bob Gifford, our splendid associate dean for 
education and student affairs, and his fine staff, the superb 
students we attract are also among the happiest and most 
satisfied in the nation. 
Rewards for Teaching 
And yet, a number of forces, some external, some internal, 
threaten our commitment and performance in medical 
education. One is the perception — the all too common 
perception — among our faculty that good teaching is not 
appropriately recognized or rewarded here, that our coin and 
kudos go to those who produce income for the school through 
research grants or clinical activities. We must rid our school 
of this perception because it threatens us at our very core. 
How to do this? 
First, we must make teaching performance a significant 
prerequisite for appointment or promotion to senior rank in 
our school. The appointments and promotions committee has 
already begun to make this point by obtaining much more 
information from candidates for promotion about teaching 
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responsibilities and by pressing department chairs for a 
detailed appraisal of teaching performance. But we need a 
more objective system of teaching performance based on 
input from students and peers, and serious efforts in this 
regard are underway. 
Second, we must convince the chairs, and they in turn 
must convince their faculties, that the institutional funds 
they receive each year recognize their teaching 
responsibilities. I have 
changed the name for this 
institutional allocation from 
“general appropriations,” or 
GA, to “educational appro¬ 
priations,” or EA, to 
emphasize this point. I urge 
and expect chairs and section 
chiefs to use these funds 
explicitly in support of the 
teaching time and respons¬ 
ibilities of their faculty 
members. 
Third, we must reward our 
truly outstanding teachers. 
Through the generosity of the 
Bohmfalk bequest, we have 
recently established two new 
teaching prizes of $5,000 
each. These are awarded 
annually to one member of 
the faculty in the basic 
science departments and 
another in the clinical 
departments whose teaching 
performance has been 
deemed stellar by a 
committee composed of 
students and faculty. More 
such accolades are needed. 
A second force which 
impinges on our educational 
purpose is the dramatic 
increase in our knowledge 
base concerning both basic 
biology and its application to 
health and disease. The 
explosion of new information 
in medical science is so great that neither our faculty nor our 
students can organize or absorb it all. Equally dramatic 
changes have occurred in clinical practice. The capacity of 
physicians and surgeons to intervene on behalf of sick people 
has burgeoned in a sometimes breathtaking way. The Benz 
task force said that we needed a new way to respond to these 
dramatic changes — that our structure for curriculum 
evaluation and modification was inadequate. 
Hence, two years ago we established the educational 
policy and curriculum committee (EPCC) as a standing 
committee of the school reporting directly to the Board of 
Permanent Officers (BPO). This committee, under the strong 
leadership of Emile Boulpaep, has already accomplished 
much, thereby convincing me and others that medical 
education is not as mired in maintaining the status quo as 
many in our country proclaim. 
Let me recount the progress; 
1. A three-week required clerkship in clinical neuroscience 
has been inserted into the curriculum for third-year 
students; 
2. All directors of required clinical clerkships must now 
provide students with a syllabus which identifies a core 
body of knowledge and skills that students are expected 
to master; 
3. In recognition of the changing demographics of clinical 
practice, each required clerkship must now contain an 
ambulatory component; 
4. Eleven interdepart¬ 
mental, systems- 
oriented faculty/student 
study groups are 
meeting regularly to 
analyze the curriculum 
of the first two years, 
to seek greater integra¬ 
tion and coordination 
and to minimize 
unwanted redundancy 
and duplication; and, 
5. Yale is one of 12 
schools in the country 
(out of more than 70 
which applied) to be 
awarded an 18-month 
planning grant from 
the Robert Wood 
Johnson Eoundation as 
part of its program to 
catalyze change in 
medical education in 
our country. We hope 
to be among the six to 
eight schools that will 
receive larger, longer- 
term support next year. 
A third powerful force 
affecting medical educa¬ 
tion concerns the shifting 
ecology and sociology of 
clinical practice and of 
health care needs. 
Medical practice is 
moving increasingly to 
ambulatory settings. 
Moreover, the locus of unmet health needs of our poor, our 
disadvantaged minorities, our homeless resides in our cities 
and our neighborhoods. The hospital, then, can no longer he 
the only — or even the preferred — site for clinical 
instruction. Yet our required clerkships are almost entirely 
inpatient-oriented, focusing on the most seriously ill patients 
who require high-technology and intensive care. It is. 
therefore, possible for a student to complete medical school 
with a distorted, myopic view of the clinical arena. 
If we are to prepare our students to grapple with the 
societal ills that are so much the antecedents of poor health; if 
we are to encourage more of our graduates to follow career 
paths in primary care; if we are to prepare our students for the 
kind of medicine they will practice after leaving us, we must 
identify and use new teaching settings and new teachers. 
Such settings must include the Yale Physicians Building, the 
Yale Health Services Center, the Hill and Eair Haven health 
centers, our affiliated community hospitals, and the offices 
of our voluntary faculty members. 
Goals of the 1990 Academic Plan 
For the Yale School of Medicine 
1. Reaffirm our central mission as an educational 
institution. 
2. Strengthen Yale’s position of leadership in basic 
biomedical research. 
3. Integrate the complementary disciplines of 
clinical medicine and public health. 
4. Lead a University-wide initiative toward 
prevention and cure of disabling diseases of the 
brain. 
5. Strengthen and broaden programs aimed at 
understanding, controlling and eradicating 
infectious diseases. 
6. Secure a leading role in the prevention, detection 
and cure of cancer by strengthening Yale’s 
Comprehensive Cancer Center. 
7. Expand academic programs devoted to maternal 
health and the well-being of children. 
8. Develop novel approaches to the prevention and 
treatment of vascular diseases affecting the heart, 
brain and kidney. 
9. Make curative transplantation strategies safer 
and more available. 
10. Integrate and strengthen programs aimed at the 
prevention, treatment and rehabilitation of 
musculoskeletal disorders. 
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This will not be easy to do. HMOs are under great 
financial pressure to be efficient, and teaching is inefficient. 
Community health centers must be responsive to the concern 
that they not be places for students to “experiment” on those 
groups who already feel discriminated against. Our practicing 
physicians feel the pinch of competition, the threat of 
litigation and the heavy hand of regulation. Nonetheless, we 
must meet this challenge, and I must ask you — full-time and 
part-time faculty alike — to recognize your responsibilities to 
take students into your clinical settings. 
Being a faculty member at this school is a privilege earned 
by individuals in recognition of their commitment to enhance 
our academic programs. It is not a right conferred by 
membership on a hospital staff, inclusion in a directory of 
alumni or alumnae, or geographic proximity to our institution. 
Willing participation in teaching is a necessary but not 
sufficient condition of achieving and retaining faculty status. 
(Joal 2: Strengthen Yale’s position of leadership in basic 
biomedical research. 
Here. 1 can be brief because none of you doubt either my 
personal or our institutional commitment to this central 
mission. This faculty excels in basic research. Very few 
institutions match either our breadth or our strength. Our 
basic science departments are second to none, but they are 
not the only sites at which outstanding fundamental 
research is conducted. Our clinical departments have superb 
programs as well. 
Further, as evidenced by our soon-to-be-completed 
Yale Center for Molecular Medicine, we are neither limited 
to departmental organization of science nor to artificial 
and often simplistic designations of research as being either 
fundamental or applied, basic or clinical. It is, in fact, from 
the purposeful blurring of these designations that exciting 
progress toward understanding disease mechanisms will 
continue to come. 
1 o retain our position as leader, we must continue to 
provide resources in the form of people, space and money. 
We can compete for the best people if we have adequate 
space and the required funds. The space must come from a 
combination of new construction and renovation. We've done 
a lot of both in the past six years, but we must do more. 
iipport for Research 
■o • .,rding new facilities, the top priority in our plan calls for 
i ' . clinical sciences building to house the fine research 
■ .o:' .i'll of our department of internal medicine, as well as 
other, interdepartmental programs. Only by doing this can we 
both expand and decompress internal medicine space and, 
thereby, the other clinical departments in which research 
aimed at ferreting out basic .secrets of pathobiology is carried 
out. Planning for this new building began in September. 
Hopefully, construction will begin in less than two years. 
Other re.search facilities needs will be noted in relationship to 
their respective goals. 
Our faculty has been very successful in competing for 
federal research funds, particularly from the National 
Institutes of Health. Your entrepreneurial spirit in this regard 
is to be applauded and appreciated. Moreover, you’ve become 
increasingly effective at securing funds from the for-profit 
sector to supplement and complement dollars from federal 
and non-federal, not-for-profit agencies. 
Our capabilities in research will be influenced by our 
national climate for research, which has been unusually 
stormy during the past year, warranting a brief digression. I 
feel compelled to clarify my own position about the current 
state of biomedical research because I’m afraid I'm being 
misunderstood. The United States has and will, for the 
foreseeable future, continue to have the pre-eminent 
biomedical research program in the world. It has achieved this 
enviable position during the past 40 years through the 
following actions: 
• a generous, sustained investment of public funds; 
• distribution of the vast majority of those funds to 
investigators at academic institutions; 
• a nationally accepted and supported mechanism for 
awarding funds through peer review; 
• appreciation of the value of a mixed support program 
composed of individual project grants, center grants and 
training funds; 
• vesting considerable leadership authority 
in the director of NIH. If we are to retain 
our position of pre-eminence, these facets 
of our system must be recognized and 
reaffirmed. Although we are currently 
experiencing serious problems in the 
leadership at the federal level and in the 
management of federal funds, I have no 
hesitation in saying to you, “Press on and 
be resolute.” 
I remain convinced that our country will 
continue to invest in health-related research 
because it is the most cost-effective 
investment in health that we have. I remain 
certain that a stable, rewarding career in 
science is achievable here and will continue to 
be. I remain committed to this School of 
Medicine retaining its unified stance in 
support of research and not succumbing to the we-they 
dissonance of scientist versus institution, or Ph.D. versus 
M.D.. or “working” scientist versus Washington-based 
organizations that has characterized recent discourse. 
(loal 3: Integrate the complementary disciplines of clinical 
medicine and public health. 
American medicine and public health are each 
experiencing fundamental pressures to change. The 
aspirations of the American people to enhance the public’s 
health and to enrich their personal lives through improved 
functioning have become compelling considerations for the 
Student Enrollment 
1983-84 1990-91 % Change 
M.D. candidates 417 478 + 15 
Ph.D. candidates 208 300 +44 
M.D., Ph.D. candidates 47 55 + 17 
M.P.H. candidates 206 149 -28 
Dr.P.H. candidates 7 18 + 157 
P.A. candidates 44 43 .2 
House officers 360 407 + 13 
Postdoctoral fellows 437 504 + 15 
Total 1,726 1,954 +13 
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health policies we develop as a nation and for the health 
practices we follow as individuals. These aspirations have 
also challenged the health professions to broaden their 
traditional biomedical paradigm by incorporating into it the 
socio-cultural and behavioral influences on health and human 
functioning. 
Although Yale has developed programs of international 
distinction in these areas, neither we nor the other great 
universities have created the interdisciplinary approaches of 
research and education that are needed. Accordingly, we 
propose the following objectives to enable Yale University to 
provide national and international leadership in crucial 
decisions concerning the health of both the public and its 
individual members: 
Objective 1. Infuse the ethos of public health into the teaching 
programs of the medical school and integrate biomedical 
knowledge into the teaching programs in the School of Public 
Health. 
This objective must be viewed as 
encompassing the full scope of medical 
education and public health. It can only be 
accomplished with the full participation of 
our clinical, basic science and public health 
faculty. Educational content must emphasize 
previously neglected areas such as nutrition, 
health promotion and disease prevention, 
screening for cancer and other chronic 
disorders, and deciding when treatment does 
more harm than good. These programs must 
be merged and fully integrated among 
participating groups throughout Yale. 
Objective 2. Acquire new knowledge about 
the bio-behavioral interactions which 
determine good health and optimal outcomes 
of illness. 
In developing this knowledge, we need to 
learn how psychosocial, economic and 
behavioral conditions, as well as large-scale 
environmental conditions, influence health. 
Much work still needs to be done in 
understanding the role these factors play in 
health outcomes. 
Objective 3. Acquire new knowledge about 
vulnerable populations. 
In bringing together the research and educational 
approaches of traditional biology and clinical medicine with 
those of public health, our focus must be on the needs of 
special groups across the life span, including not only the very 
young and the very old, but also adolescents and those who 
have reached mid-life. Studies of vulnerable populations 
cannot be complete, of course, unless we continually integrate 
the special considerations of those disadvantaged by race, 
poverty, social class or by exposure to occupational hazards. 
Objective 4. Construct interdisciplinary educational curricula 
involving students and faculty in the schools of medicine, 
nursing and public health. 
Such curricula are urgently required because we cannot 
hope to enhance the health of the public unless we broaden 
the educational scope of the conventional biomedical 
curriculum. Students in all of these disciplines need to 
understand the ethos, concepts and evidence that guide 
research and influence clinical decisions and health policy. 
Moreover, major health-related topics such as the influence 
of poverty on health, the role of genes in the expression 
of disease, the importance of nutritional principles on 
health, and the problems of substance abuse and teen-age 
pregnancy cut across the arbitrary boundaries that tend to 
separate the disciplines. 
The Kellogg Foundation has recently decided to fund a 
major program combining such health professions’ 
educational partnerships with a second partnership — namely, 
between an academic institution and a community health 
center. Yale is one of 15 institutions to have received a highly 
competitive planning grant for this endeavor. Large-scale 
funding for six or more of these institutions will be announced 
in a few months. I hope that our proposal, prepared by a team 
led by Ralph Horwitz of the department of internal medicine 
and including Burton Singer, chair of EPH, and Judy Krauss, 
dean of the School of Nursing, will be found meritorious. 
Objective 5. Provide objective foundations for policy 
decisions affecting the health of society and the individual. 
Through the forcefulness of its science and the 
persuasiveness of its faculty, Yale can achieve leadership in 
health policy by developing exciting new programs of 
research and education that become models for the nation. 
The integrated efforts of Yale’s traditional biomedical and 
public health programs must be designed to: 
• improve clinical care in all of the health services at 
Yale and throughout the country, by basing decisions 
firmly on valid scientific evidence; 
• take into account important demographic changes, 
particularly the rapid aging of the population in 
developed countries; 
• promote national health care policies which trumpet the 
crucial goal of universal access and which address 
quality and cost by providing the evidence and 
intellectual framework to guide public policy makers; 
Facilities Highlights: 1984-Present 
Research 
• 80,600 nsf of incremental laboratory space through new building 
construction (Magnetic Resonance Center, Yale Psychiatric Institute, 
Yale Center for Molecular Medicine) 
• 61,000 nsf of incremental laboratory space through renovation and 
modification of existing buildings (Fitkin, Tompkins, Winchester, 
Sterling Hall of Medicine) 
• Three-fold increase in funds expended annually for renovation and 
infrastructure improvement ($3.0 million in 1983-1984; $10.8 million 
in 1989-1990) 
Education 
• 33,000 nsf expansion/renovation of CushingAVhitney medical library 
• Renovation of Fitkin Amphitheater 
Clinical Service 
• Construction of 39,400 nsf Yale Physicians Building 
• Construction of 41,000 nsf Yale Psychiatric Institute 
• Construction/renovation of 13,000 nsf Yale Eye Center 
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• integrate into a comprehensive health policy agenda 
those elements of economic social policies that 
influence health. 
Goals 4 through 10 are. though less general than goals I 
through 3, surely no less important to the school and to groups 
among you. 1 will comment briefly on them. 
Goal 4; Lead a Lniversity-wide initiative toward 
prevention and cure of disabling diseases of the brain. 
Yale is blessed with a very large and excellent group of 
neuroscientists. Most of them are on the faculty of our school. 
Our challenge is to integrate, to coalesce, to cohere. This must 
be done in research, education and service. 
The vehicles for such integration are being put in place. 
They include: a University-wide graduate program overseen 
ably by Bill Agnew from cellular and molecular physiology 
and .Martha Baton from biology: a neuroscience steering 
committee chaired by Basko Rakic; and a commitment on the 
part of the school to erect a new facility — a Yale Brain 
Center — which will house key components of the program 
and community. Yale must respond aggressively during this 
Congressionally designated "Decade of the Brain." 
(ioal 5: Strengthen and broaden programs aimed 
at understanding, controlling and eradicating 
infectious diseases. 
Blagues continue to befall humankind. Yale scientists have 
contributed much in such areas as poliomyelitis, infectious 
mononucleosis and Lyme disease. We have not been among 
the leaders in AIDS, at least in part because of a decision 20 
years ago to dismantle the department of microbiology. We 
badly need a basic science unit in this field and have 
requested from the Yale Corporation approval to reinstitute an 
autonomous section of microbiology as of July 1991. 
.Although this is not an easy time either in terms of finances or 
of available space, to add new academic organizations, we 
must do so when necessary. A free-standing section of 
microbiology will act in synergy with our increasingly strong 
section of immunobiology and with programs in EBH, 
internal medicine, laboratory medicine and pediatrics. We 
shall all prosper as an outcome. 
Goal 6: Secure a leading role in the prevention, detection 
and cure of cancer by strengthening Yale’s 
Comprehensive Cancer Center. 
We are most fortunate to have one of 24 National Cancer 
Institute-designated comprehensive cancer centers in the 
United States. We are fortunate, too, that it is remarkably well 
led by Alan Sartorelli. It is time to take the next step and build 
a facility which will house the center’s offices, its ambulatory 
care programs and some research activities. This construction 
is necessary if we are to be an effective referral center for 
patients with malignancies still responsible for more than 
500,()0() deaths in this country annually. 
Goal 7: Expand academic programs devoted to maternal 
health and the well-being of children. 
Because children don't vote, they are regularly overlooked 
by politicians. We must be advocates for and champions of 
children and their families. Yale has a proud tradition through 
its Child Study Center, its department of pediatrics and other 
programs aimed at protecting and improving child health. As 
our partner, Yale-New Haven Hospital, erects its new 
Children’s Hospital, so we must join in promoting laboratory, 
clinical, epidemiologic and psychosocial 
research aimed at understanding the 
vulnerable child — whether that child be 
the premature infant of a drug-abusing 
teen-age mother or a baby destined to a 
life of chronic illness due to cystic 
fibrosis. 
Goal 8: Develop novel approaches to 
the prevention and treatment of 
vascular diseases affecting the heart, 
brain and kidney. 
Cardiovascular disease remains the 
number one killer of American adults. 
We are on the verge of making truly 
dramatic strides toward prevention of 
disease resulting from our identification 
of such major risk factors as smoking and 
hypercholesterolemia. We have much to 
contribute here already. We will do more 
when we initiate our cardiobiology 
program in the Center for Molecular 
Medicine and as we expand our vascular 
biology research efforts and our clinical care efforts in 
internal medicine, surgery, neurology, diagnostic radiology 
and elsewhere. 
Goal 9: Make curative transplantation strategies safer and 
more available. 
Among the clinical marvels of our age, organ and tissue 
transplantations stand out because of their proven capability 
to cure disease. Barenthetically, this essence of high- 
technology care is consonant with our emphasis on public 
health: first, because transplants are unquestionably cost- 
effective; second, because they depend on public support 
through organ and tissue donors. 
In the past decade we have assembled a superb group of 
surgeons and physicians, basic scientists and clinical 
investigators, who now enable us to offer transplants of heart, 
lungs, pancreas, liver, kidney, cornea, bone and bone marrow. 
We must provide these clinicians and scientists with the 
hospital and associated resources they need to make us a true 
center of transplant excellence. 
Faculty Profile 
Number 
Category 1983-84 1990-91 % Increase 
Full-time 
Academic track 
Tenure 171 188 10 
Temi 230 337 47 
Clinical track 
Continuing 34 60 76 
Temt 88 92 5 
Research track 169 247 46 
Total full-time 692 924 34 
Voluntary 1,492 1,672 12 
(irand total 2,184 2,596 19 
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Pencil drawing of Dean Leon E. Rosenberg composed for Yale Medicine and copyright © 1991 by Gerald York. 
Goal 10: Integrate and strengthen programs aimed 
at prevention, treatment and rehabilitation of 
musculoskeletal disorders. 
About 20 percent of all Americans have their quality 
of life impaired by significant and chronic dysfunction 
of the musculoskeletal system. As our population ages, 
lost productivity resulting from these conditions will 
increase as will monetary and human costs. Our research 
and clinical programs aimed at arthritis, metabolic bone 
disease, skeletal trauma and sports injuries are both multi- 
departmental and strong. To them must be added a focus 
on rehabilitation, which is currently underdeveloped. 
Hopefully, this can be accomplished by establishing a major 
partnership with Gaylord Hospital and by asking our 
department of orthopaedics and rehabilitation to be a lead 
agency in our programs. 
That outlines this academic vision for our school in the 
decade ahead. It cannot be accomplished unless every one 
of us plays a part in it. Consider it a working document 
which will change with time and circumstances; none of it 
is carved in stone. 
Some may wonder whether this plan is achievable and 
whether it’s realistic given today’s tough economic climate. 
Of course, it will not be easy to meet the many goals and aims 
I’ve articulated. But being a great institution is never easy. It 
requires courage, character, discipline, integrity, leadership 
and lots of good luck. Before any of you begin to worry about 
whether we’ve overreached, let me remind you that it is 
during the toughest economic times — not the easiest ones — 
that the soundest and most creative institutions outdistance the 
competition. Yale University built more buildings, added 
more endowment and launched more programs during the 
Great Depression than during any other decade in the 
University’s history. 
Recent Accomplishments 
Furthermore, our own recent history should make us 
optimistic about our future. In the short 6 1/2 years that I've 
served as dean, this institution has accomplished a great deal. 
Since 1984, more than 400 people have been added to our 
faculty, largely due to growth in the full-time ranks where 
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we’ve experienced a 34 percent increase in all components: 
tenure, continuing, term; and in all three ladders: academic, 
clinical and research. [See "Faculty Profile,” page 10,] The 
largest fractional increase has occurred among those with 
continuing appointments in the clinical track — attesting to 
our commitment to greater clinical excellence. The voluntary 
faculty has grown less. This reflects a widespread view that 
this segment of the faculty is too large, and that its very size 
tends to diminish the significance of carrying the Yale name. 
1 am particularly pleased to note that the number of tenured 
women on our faculty has more than doubled since 1984 — 
from 10 to 21. Women with term appointments have also 
increased nearly two-fold. This positive step toward equitable 
diversity among us has, disappointingly, not yet been 
achieved for members of disadvantaged minorities. They 
remain distinctly underrepresented, and there has been no 
fractional increase in their presence in our tenured or term 
faculty ranks. Clearly, there is more to be done here. 
Our student body, too, has increased significantly in size 
— now numbering 1,954. [See "Student Enrollment,” page 8.) 
We educate no fewer than eight categories of students. To 
those of you who express concern regularly about our 
numbers of graduate students and postdoctoral fellows, I ask 
you to be cognizant of the robust growth in these categories. 
Further, and of greatest importance, there is every reason to 
believe that the quality of our students in all categories has 
been sustained or even improved. 
New Facilities, Financial (Jrowth 
Next, some remarks on facilities. [See "Facilities Highlights,” 
page 9.1 We've made remarkable strides in improving the 
quality and quantity of our educational, clinical and re.search 
space: Of the now nearly 7()().()()() net square feet (nsf) 
devoted to our three missions, nearly 3()().()()() — 42 percent 
have been built since 1984. 
Highlights of this facilities expansion and improvement 
program include: 
• a 33.()()() nsf expansion and renovation of the 
Cushing/Whitney medical library; 
• construction of the 41,()()() nsf Yale Psychiatric Institute; 
• construction and renovation of the 13,()()() nsf Yale 
Fiye Center; 
• 8(),b()() nsf of incremental laboratory space through new 
building construction in the Magnetic Resonance 
Center, 't ale Psychiatrie Institute and \'ale Center for 
Molecular Medicine; 
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• 61,000 nsf of incremental laboratory space through 
renovation and modification of existing buildings 
(Fitkin, Tompkins, Winchester, Sterling Hall 
of Medicine) 
• a more than three-fold increase in funds expended 
annually for renovation and infrastructure improvement 
($3 million in 1984; $10.8 million in 1990.) These data 
clearly reflect our commitment to and capability for 
providing the physical resources commensurate with 
our missions and vision. They are a symbol of vigor. 
Fet me conclude this brief survey of resources by saying 
something about money. [See “Financial Highlights.”] Since 
1984 the total operating budget of the school has more than 
doubled in actual dollars, corresponding to a 53 percent 
increase in constant dollars. This denotes a 7.3 percent 
compounded annual real growth — a most impressive figure. 
Since nearly 90 percent of our income is earned from research 
grants and contracts and from clinical programs, it follows 
from what Fve just said that those programs would have to 
grow, and they have: 37 percent real growth in grants; 64 
percent real growth in clinical earnings. Tuition income has 
increased too, though not nearly as much. That is as it should 
be if you’re as worried as I am about the increased 
indebtedness that our M.D.s carry with them upon graduation. 
Please take note of the impressive growth in the school’s 
endowment base, from $70 million in 1984 to $194 million in 
1990. This financial underpinning is 
enormously important to us; its growth 
reflects both generous philanthropy 
and excellent management of the 
portfolio. Finally, Td like to mention 
that corporate support for our research 
programs has increased markedly. It is 
still small compared to our federally 
derived support, but it is now 
respectable. That’s a good omen. 
Finally, a word about fund-raising. 
Thanks to Sue Dorn and now Will 
Melton and an excellent staff, we’re 
raising more than twice as much 
private money each year now than we 
did in 1984. This increase has been 
seen in gifts as well as in grants. 
In this connection, I am truly 
delighted to announce a very special, 
recent financial commitment to the school: a $10 million 
naming construction gift for the Center for Molecular 
Medicine (CMM) from Professor and Mrs. Herb Boyer of $an 
Francisco. Herb was a postdoctoral fellow in Ed Adelberg’s 
laboratory many years ago. He is a member of the National 
Academy of Sciences and one of three people ever to win 
both the National Medal of Science and the National Medal of 
Technology. Many of you know him as the co-discoverer of 
recombinant DNA technology and the co-founder of 
Genentech. This magnificent gift is the largest single 
contribution by an individual in this .school’s history. 
If you believe as 1 do that the best way to project the future 
of a person, group or institution is to assess the recent past, 
then we have every right to address our future and our 
innovative academic plan with confidence; confidence 
strengthened by knowing that what we want to do is in the 
public interest. YM 
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Financial Highlights: 1983-1984 to 1989-1990 
(Dollars in millions) 
Dollars % Increase 
% Compound 
Annual Growth 
Parameter 1983-84 1989-90 Actual Real Actual Real 
Operating budget 143.6 295.6 105.8 52.8 12.8 7.3 
Grants/contracts 76.5 141.6 85.1 37.4 10.8 5.4 
Clinical programs 53.2 117.8 121.4 64.3 14.2 8.6 
Tuition 7.0 11.1 58.6 17.7 8.0 2.8 
Endowment income 2.8 6.9 146.4 82.9 16.2 10.6 
Endowment principle 69.7 194.0 178.6 106.6 18.6 12.9 
Corporate support 1.8 6.7 272.2 176.2 24.5 18.5 
YALE IMMUNOBIOLOGISTS 
GET DOWN TO BASICS 
Photographs by James Anderson 
Using a Fluorescence Activated Cell Sorter (FACS), /. Nicholas Crispe, Ph.D., can monitor 2,000 cells per second. The $200,000 
machine can sort with 99 percent accuracy using six different parameters, including four fluorescing signals and tv^'o cell sizes. 
by Diane E. Loupe and Gregory R. Hath, M.P.H. ’84 
A laser beam’s ethereal blue light cuts through what appears 
to be a strand of monofilament fishing line. A microscope, 
however, reveals the line to be a fine stream of drops 
whizzing by. 
Some of the drops contain T cells, specialized white blood 
cells that form the front line of defense in the human immune 
system. I. Nicholas Crispe, Ph.D., assistant professor of 
immunobiology, has chemically labeled some of those cells 
with fluorescing molecules and is sorting them with a 
Fluorescence Activated Cell Sorter (FACS). When the FACS 
laser beam hits a drop bearing a labeled cell, an electric 
charge deflects the cell into a test tube. Unlabeled cells drop 
into another tube. A video monitor nearby glows with a 
computer count of the labeled cells. 
This article was written by Diane E. Loupe, staff writer at the 
medical school office of public information (OPl), with the 
assistance of Gregory R. Huth, OPI publications editor. 
Using FACS, Dr. Crispe can sift through 2,000 cells a 
second with 99 percent accuracy, an impressive feat 
considering that 20,000 such cells could fit on a pinhead. 
FACS exemplifies the powerful tools of molecular, cellular 
and genetic research that Dr. Crispe and other faculty in the 
medical school's section of immunobiology use to understand 
better the human immune system. 
Ever since Louis Pasteur introduced the germ theory in the 
late 1800s, medical researchers have sought to understand 
how the body defends itself against the relentless invasion of 
microscopic agents that can cause disease. Richard A. Flavell, 
Ph.D., professor and section head of immunobiology, says that 
every day, discoveries in his field are providing more answers. 
Immunobiology, as Dr. Flavell explains with a British 
accent flattened by his years in the United States, "interfaces 
with the study of infectious diseases, autoimmunity and 
transplantation. Some of the key unsolved problems in all of 
the.se areas are related to the immune system.” 
When Dr. Flavell arrived in July 1988 to launch the 
section, he fulfilled the dream of the late Richard Gershon, 
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Richard A. FlavelL Ph D. 
M.I3.. a noted researcher in imimine response regulation. As a 
professor of pathology. Dr. Gershon's broad-based approach 
helped shape immunology research at Yale. He also 
advocated forming an autonomous .section of immunobiology. 
The fruits of Dr. Gershon's advocacy can be seen in the 
growing section's laboratory space on the fourth floor of the 
Pitkin .Memorial Building. Here immunobiology’s five 
primary faculty members work in conjunction with 
approximately 20 graduate students, 40 post-doctoral fellows, 
four faculty members with joint departmental appointments 
and other faculty collaborators. The quality of the section’s 
research attracted support from the Howard Hughes Medical 
Institute (HHMl), which largely underwrote laboratory 
renovations and the purchase of equipment. Four of the 
section’s faculty members, including Drs. Flavell, Bottomly, 
Janeway and Bothwell, share appointments with HHMl and 
the University. 
Immunobiologists study how the immune system develops 
and how it is marshalled to destroy pathogens, the viruses, 
bacteria and other microorganisms that can make us ill. Some 
of the scientists focus on why the immune system sometimes 
induces autoimmunity — an assault on the body it is supposed 
to protect — causing such diseases as diabetes, multiple 
sclerosis and lupus. 
(’onslanf Kngagement 
Key to the immune system’s ongoing vigil against 
microscopic invaders are white blood cells called 
F, mphix yies. Like immunological sentries, lymphocytes 
•J.ister in the body’s checkpoints, the lymph nodes. As lymph 
piidi -. Idter fluids flowing from the body’s tissues, white 
- 1;: :d : ells mouitor for pathogens. 
Each lymphocyte is a specialist, trained to 
recognize and kill a single infiltrator called an 
antigen — usually a protein from a pathogen, 
foreign to the body. Lymphocytes recognize 
antigens by using cell surface molecules called 
receptors that fit to an antigenic molecule like a 
key fits a lock. 
Only when a lymphocyte’s receptor key fits 
into an antigen’s lock does it swing into action to 
destroy that antigen. Since each lymphocyte reacts 
to only one kind of invader, the body develops a 
repertoire of such cells with different receptors to 
battle a wide array of antigens. 
Lymphocytes come in two varieties: T cells, so 
named because they form in the thymus, and B 
cells, which are formed in bone marrow. B cells 
are responsible for eliminating pathogens, such as 
bacteria and other microorganisms, that appear 
outside cell walls; T cells fight other pathogens, 
such as viruses, that hide inside cells. 
Like immunological arms factories, B cells 
manufacture antibodies, Y-shaped molecules that 
circulate in the blood. Antibodies are “trained” to 
kill antigen. Some attack and kill pathogens by 
binding to them and punching lethal holes in the 
invading cell’s surface. Other antibodies bind a 
pathogen and introduce it to the surface of macro¬ 
phages, large cells which then engulf and devour 
the invader. 
The mission of T cells is even more subtle than 
that of their B cell counterparts. Since T cells 
attack pathogens that lurk inside cells, these 
immunological defenders must identify infected 
cells without entering them, a process that would destroy 
healthy cells. 
Enter the “spies,” major histocompatibility complex 
(MHC) proteins, to help T cells with their task. An MHC 
molecule comprises a chain of amino acids folded into what 
in graphic renderings resembles an intricate wire sculpture. In 
one of its tangles, the MHC molecule has formed a deep cleft 
in which it can clutch a bit of antigen. 
Once it snares some antigenic prey, the MHC protein 
brings it to the cell surface, where T cells can chemically 
sense the antigen. Upon detecting antigen, T cells punch holes 
in the surface of the infected cell, causing an influx of water 
that bursts the cell, thus killing the invading pathogen. 
At the Microscopic Ramparts 
When the elaborate defenses of the immune system 
malfunction and begin attacking a person’s own, or “self,” 
cells, a wide range of autoimmune diseases can result. Yale’s 
immunobiologists are undertaking the basic research that may 
lead to better treatments for these diseases and others with 
autoimmune components, including AIDS. 
Some of the .section’s researchers are learning more about 
how cells communicate with each other to signal destruction 
of infected cells; their studies could lead to more effective 
bone marrow transplants. Still other Yale immunobiologists 
are experimenting with new recombinant — genetically 
engineered — vaccines against Lyme disease. 
The molecular research of Adrian C. Hayday, Ph.D., 
associate professor of biology and immunobiology, touches 
on one of medicine’s most debated issues; how stress may be 
related to immune response. Dr. Hayday and his team study 
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gamma delta T cells, many of which are located on the body’s 
barrier surfaces, such as the skin, intestines, mouth and genitals. 
Dr. Hayday thinks that gamma delta T cells may 
sometimes start killing self cells because of an unfortunate 
coincidence. Gamma delta T cells can respond to proteins 
switched on during physical or immunological stress, what 
Dr. Hayday calls the “molecular equivalent of cries for help.” 
These proteins include ones that resemble proteins expressed 
by mycobacteria which cause tuberculosis and other di,seases, 
a likeness which may trigger an autoimmune attack. 
“This raises the question of whether there’s a relationship 
between various types of stress and susceptibility to disease,” 
affirms Dr. Hayday. To explore this, he plans to test genet¬ 
ically whether molecules in the brain known to be affected by 
mental and emotional stress will disrupt immune function. 
Section scientists, in addition to addressing questions of 
general autoimmunity, also study individual autoimmune 
diseases. For example, the laboratory of Charles A. Janeway 
Jr., M.D., is researching the role of T cells in such diseases as 
insulin-dependent diabetes, multiple sclerosis and systemic 
lupus erythmatosus. Using strains of mice bred to exhibit 
symptoms of these diseases. Dr. Janeway, a professor of 
immunobiology and HHMI investigator, is trying to discover 
how T and B cells communicate with other cells. 
Toward this end, his laboratory was one of the first to 
clone T cells. Dr. Janeway and his colleagues are focusing on 
how these cellular soldiers recognize antigen, how they 
distinguish between self and non-self cells, and what spurs the 
T cells to action. 
Dr. Janeway’s T cell research may contribute to the fight 
against the Human Immunodeficiency Virus (HIV), the 
AIDS virus. HIV disables the immune system by infecting 
and killing T cells which bear molecules called CD4 on their 
cell surfaces. Dr. Janeway’s team discovered why T cells 
which bear CD4 molecules recognize one of two major forms 
of MHC, class 11. T cells link to an antigen-bearing 
MHC molecule through both a surface receptor and a 
CD4 molecule. 
“CD4 binding to MHC class II makes the cell a hundred to 
a thousand times more sensitive to antigen, enabling the T cell 
to respond efficiently to very low amounts of antigen,” Dr. 
Janeway explains. 
Dr. Flavell’s research team is also accumulating evidence 
that HIV infection may be linked to autoimmunity. HIV- 
infected cells may shed the protein gpl20, which binds to 
the CD4 molecule. Shedding gpl20 renders the cell a target 
for killer T cells, says Dr. Flavell, who is studying 
this interaction. 
Another aspect of Dr. Flavell’s work, his decade-long 
research into MHC genes, may help determine why some 
people are susceptible to diabetes and other autoimmune 
diseases. To pursue this question, his team fashions transgenic 
mice by inserting foreign — in this case human — genes into 
embryonic animals which then express the genes. 
“People who have a certain type of MHC II gene have a 
likelihood that they’re going to get diabetes. People who have 
a protective kind of gene, which is an MHC class II gene in 
mice, are likely not to get disease,” notes Dr. Flavell. 
There also may be an autoimmune component to Lyme 
disease. Dr. Flavell suggests. Lyme disease is caused by a 
spirochete, a spiral-shaped bacterium. Patients displaying 
neurological symptoms of the disease have antibodies in their 
cerebrospinal fluid that cross-react with an antigen of the 
spirochete. Dr. Flavell speculates that “if this antibody binds 
to neurons, that might be part of the cause of the damage.” 
Delving into Diabetes 
Four years ago. Professor of Medicine Robert S. Sherwin, 
M.D., a blood sugar metabolism researcher, took an unusual 
sabbatical. Passing up a chance to study in Denmark, he 
stayed at home to work in the laboratory of another Yale 
researcher, immunobiologist Charles A. Janeway Jr., M.D. 
Their collaboration has led to a major research project 
regarding the immunological progression of insulin- 
dependent diabetes mellitus. The $6 million project, 
supported by the National Institutes of Health, began Sept. 1. 
It involves 10 Yale 
medical school 
researchers who are 
studying the cell 
biology, immunology 
and molecular 
biology of diabetes. 
The scientists plan to 
conduct clinical 
studies, as well. 
Scientists believe 
diabetes develops after 
T cells make a serious 
mistake — they attack 
and destroy the 
insulin-producing beta 
cells of the pancreas 
until insulin 
production slows or 
stops. Researchers think this error occurs because beta cells 
cloak themselves with an antigen that T cells may mistake for 
an invading organism. 
Dr. Sherwin, together with associate research scientist Eva- 
Pia Reich, Ph.D., and Dr. Janeway, identified T cell cloned 
lines that could induce diabetes in experimental mice. With 
this discovery, the scientists had developed an animal model 
that could help them pursue answers to some of the most 
basic questions about the disease. 
For example, does MHC interact with antigens that attack 
beta cells? To find out, Dr. Richard Flavell’s laboratory 
fashioned a gene that will be inserted into diabetic mice. He 
hopes the gene will induce production of MHC II molecules 
targeted by T cells. If this gene hastens the disease’s 
progression. Dr. Flavell will have evidence that MHC II plays 
a role in diabetes etiology. 
Another question involves identifying which antigens on 
beta cell surfaces are targets of autoimmune attack. Should 
the laboratories of Drs. Janeway and Flavell succeed in 
identifying these antigens, it might lead to immunotherapies 
for diabetes. 
Do cytokines, which often initiate immune responses, play 
a role in the disease? To find out. Dr. Nancy Ruddle is 
examining the impact of cytokines on insulin-producing cells. 
And Dr. Adrian Hayday wants to elucidate the interaction 
between the T cells and the pancreatic tissues that they 
destroy. His team is trying to clone the genes for T cell 
receptors and then insert them into cells that don’t recognize 
beta cells. This will help test whether these receptors trigger 
an autoimmune attack. 
For his part. Dr. Sherwin is working to understand how T 
cell clones attack beta cells and whether beta cell activity 
influences the attack. Pleased with his ongoing collaboration 
with the immunobiologists, he calls their section “a lively, 
energetic place where there’s a lot of learning going on.” 
Robert S. Sherwin. M.D. 
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Sounding the Battle Cry 
Paula Kavathas, Fh.D., discusses with Dr. Flavell about 
recent findings from her research involving CDS molecules. 
Yale Scientists Progress 
In Cracking the Genetic Code 
Immiinobiological research at Yale reflects a growing 
emphasis on understanding genes. With ramifications for a 
wide range of biomedical issues, genetic research benefits 
from an interdisciplinary approach, as reflected in the work of 
three of the section's researchers: 
• Paula Kavathas, Ph.D., assistant professor of laboratory 
medicine, human genetics and immunobiology. She works 
with mutant CD8 molecules on the surfaces of some T 
cells. By studying the mutant CD8 cells, she hopes to learn 
how they bind to MHC class I molecules on nearby cells 
and signal T cells to destroy pathogenic cells. She also is 
studying a chemical secreted by the immune system which 
appears to interact with both immune and nervous system 
cells. This chemical interaction may be responsible in part 
for nervous system changes during illness. 
• Nancy Ruddle, Ph.D., associate professor of epidemiology, 
biology and immunobiology. She works with genes cloned 
for two related cytokines called lymphotoxin and tumor 
necrosis factor (TNF). Manufactured by T cells, cytokines 
can kill some cells while spurring replication of others. Dr. 
Ruddle thinks TNF and lymphotoxin may contribute to the 
myelin destruction and interrupted nerve transmission 
characteristic of multiple sclerosis. HIV-infected T cells 
also appear to be much more sensitive to these cytokines 
than non-infected cells. “It’s becoming more and more 
clear that TNF and lymphotoxin are important co-factors in 
AIDS, in stimulating virus replication and in killing cells," 
she says. 
• David Schat/., Ph.D., a Massachusetts Institute of 
Technology researcher who will join the section as the 
sixth primary faculty member in July. He studies two 
genes important in the assembly of T cell receptor and 
antibody genes. Dr. Schat/ cloned the genes called RAG-1 
and RAG-2 which appear to produce an enzyme that 
shuffles genes around to recombine and produce the 
body’s vast repertoire of antibodies and T cell receptors. 
But Dr. Schat/ has also found evidence that the genes 
aj')pear in the nerve cells of the brain, which may lead to 
further insights into brain function. 
As some section .scientists look into newly discovered Lyme 
disease, others' research may help manage a parasitic scourge 
known for millennia, what modern medicine calls 
leishmaniasis. This sandtJy-borne disease affects 12 million 
people worldwide. Experiments by Kim Bottomly, Ph.D., 
associate professor of immunobiology and associate 
investigator with HHMI, are focusing on how the body 
eliminates various pathogens, such as those leading to 
leishmaniasis and other diseases. 
She notes that the mode of defense the immune system 
deploys might make the difference between resistance or 
susceptibility to Leishmania. If one hand, CD4 T cells 
activate antibodies to fight the Leishmania parasite, this 
paradoxically is associated with susceptibility and leads to 
leishmaniasis, often characterized by fever, fatigue and 
secondary infections. If, on the other hand, T cells activate 
macrophages, then the body is better able to resist 
the parasite. 
Dr. Bottomly’s laboratory has identified two kinds of CD4 
T cells: helper T cells, which help B cells secrete antibody, 
and inflammatory T cells, which activate macrophages. 
Hence, the type of helper cell that responds may influence the 
severity of leprosy and other diseases. Concludes Dr. 
Bottomly: “If we understood the mechanisms that detemiine 
the type of cellular response, we might be able to switch on or 
trigger the more favorable response.” 
In their work with vaccines. Yale immunobiologists 
employ yet another strategy to strengthen immune defenses. 
Vaccines induce a protective immunity which works like the 
natural, lifetime defenses one develops after conquering such 
childhood diseases as measles or chicken pox. In effect, 
vaccines train the body to defend against a disease without 
having to suffer its effects. 
Most vaccines stimulate antibody production by using 
disease-causing agents that have been killed or greatly 
weakened. In a small number of cases, however, such 
vaccines actually cause disease. Such is the drawback of the 
currently available Lyme disease vaccine for animals, which 
uses killed bacteria. 
In an attempt to produce a safer result. Dr. Flavell’s team 
has developed an experimental recombinant vaccine using a 
mouse model developed by Stephen W. Barthold, D.V.M., 
Ph.D., professor of comparative medicine. Dr. Flavell and 
Erol Fikrig, M.D., a post-doctoral fellow in infectious 
diseases, created the vaccine in collaboration with Ered S. 
Kantor, M.D., the Paul B. Beeson Professor of Medicine, by 
splicing the gene for a protein from the surface of the Lyme 
disease bacterium into a hanniess, common bacterium. Their 
vaccine protected mice from an experimentally induced fomi 
of the disease. 
Eventually, this research may lead to a better diagnostic- 
test for Lyme disease, a more useful animal vaccine, and 
perhaps even a human vaccine. Dr. Flavell’s work also could 
help efforts to develop a vaccine for syphilis, which is caused 
by a spirochete, as well. 
Complementing such research into protective immunity, 
the scientists in Dr. Bottomly’s laboratory are helping to 
define the mechanism of immunological memory, the way 
one’s body can recognize and fight diseases which previously 
ran their course, sometimes many years earlier. In 1988, Dr. 
Bottomly’s team was the first to identify markers for naive 
cells, T cells which have not encountered antigen, and 
memory cells. T cells which have. 
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She has evidence that receptors on the surface of memory 
T cells are better organized and are located closer together 
than those on naive cells. This better organization apparently 
leads to more efficient signalling. Now Dr. Bottomly is trying 
to find out which genetic signal orders reorganization of those 
receptors. 
Knowledge of T cells is advancing as well in the 
laboratories of Alfred L. Bothwell, Ph.D., an associate 
professor and associate HHMI investigator. With Dr. 
Bothwell as his advisor, third-year graduate student Alfred 
Slanetz has developed a water soluble T cell receptor. 
Researchers hope to deduce this protein’s molecular structure 
using x-ray crystallography. 
Dr. Bothwell also is leading research into how B cell 
memory strengthens immunity after a second encounter with a 
microorganism — the effect induced by a booster vaccination. 
Dr. Bothwell and colleagues are using certain mutations in B 
cells to trace the development of immunologic memory. 
Welcoming the Ally 
Basic research by Yale immunologists may improve the 
outlook for the growing number of bone marrow transplant 
patients. In this area, the challenge is to help patients rebuild 
their compromised immune systems. 
A physician who transplants bone marrow to treat a 
leukemia patient presents two windows of opportunity for 
pathogenic invaders. The first is opened by drugs which 
suppress the immune system to counter rejection, the second 
by the destruction of the patient’s own bone marrow. Since 
marrow generates lymphocytes, its destruction leaves patients 
even more vulnerable to infection. 
Dr. Crispe's studies of stem cells may lead to better 
methods of bone marrow transplantation by offering insights 
into lymphocyte development. Adult bone marrow and the 
fetal liver produce stem cells, which eventually become T and 
B cells, red and white blood cells and macrophages. 
Preliminary work in his laboratory suggests that stem cells 
develop into T cells after they enter the thymus. 
Refining such knowledge may even allow physicians to 
develop treatments for leukemia that would obviate the need 
for marrow transplants. Observes Dr. Crispe: “Knowing how 
stem cells get their orders to become T cells may help in the 
understanding of diseases where T or B cell development 
goes wrong, such as some types of leukemia or lymphoma.” 
Given the enomious clinical implications of this and other 
research pursued by the section. Dr. Flavell sees possible 
commercial applications on the horizon. This potential will 
benefit from his experience in private industry as the former 
president and chief scientific officer of Biogen Research 
Corporation in Cambridge, Mass. 
Dr. Flavell comments: “It behooves us to make sure that 
transfers of technology occur smoothly from academia to 
industry, to make sure that our society benefits from 
innovation in basic science. This can reward the University 
financially and help the development of important new 
products in the private sector.” 
He adds, on a cautionary note: “It is, however, important to 
remember that while industry concerns itself with product 
development, our role in the University is to teach and 
advance knowledge through basic research.” YM 
Working under a sterile hood, Kim Bottomly, Ph.D., separates 
memory from virgin CD4 cells using a specific antibody 
developed in her lab. She coats a petri dish with antibodies 
that bind strongly to naive cells; memory cells do not bind 
strongly to the antibody and can be washed from the dish. 
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CENTER FOR MOLECULAR MEDICINE 
THE 21 ST CENTURY DEBUTS 
Harry Bishop 
Adding dO.OOO net square feet of laboratory space to the School of Medicine, the Center for Molecular Medicine will hear the 
family name of Herbert W. and Marigrace Boyer to recognise their $10 million gift to the center, the largest-ever family donation 
to the School of Medicine. 
by Gregory R. Hath. M.P.H. '84. and Diane E. Loupe 
From its conception seven years ago through the completion 
of its $38 million edifice this year, Yale's Center for 
Molecular Medicine (CMM) has displayed the momentum of 
an idea whose time has come. CMM’s June 6 dedication, 
scheduled to coincide with Alumni Weekend, culminates an 
effort that has transformed a vision for modern medical 
science into programs that promise to usher Yale into the next 
century at the vanguard of biomedical research. 
CM M's story begins in the summer of 1984. As Dr. Leon 
F£. Rosenberg exchanged the mantle of department chair of 
human genetics for that of medical school dean, he presented 
the CMM concept to Dean Fimeritus Robert W. Berliner and 
In this article. Gregory R. Hath, publications editor at the 
School of Medicine's office of public information (OPl). 
reported and wrote about historical and programmatic 
developments regarding the Center for Molecular Medicine: 
Diane /.. Loupe. OP! staff writer, reported and wrote about 
scientific issues. 
other respected faculty members such as Drs, George E. 
Palade and Samuel O. Thier. 
Dr. Rosenberg, the first scientist to describe patients with a 
genetic defect in vitamin B-12 metabolism, realized how the 
cooperation of colleagues from other disciplines had 
strengthened his own research. He also was aware of how the 
human genetics department speeded the delivery of scientific 
discovery to patients by encouraging its basic scientists to 
work closely with clinical researchers. 
Why not apply these principles on a grand scale, he 
reasoned, and do so employing the most advanced tools 
modern biomedical science had to offer? Notes Dr. 
Rosenberg: “As the fields of cell and molecular biology, 
genetics and immunology had burgeoned in the last decade, it 
seemed that the opportunities for understanding disease in 
molecular temis were enonnous.” 
FJis faculty advisors agreed. Enthusiastically. So the dean 
proceeded to form a planning committee comprising .some of 
the medical .school’s leading basic and clinical researchers. 
[See “Steering Committee Governs CMM,” page 23.] The 
quest had begun to transform a dream into steel, brick 
and mortar. 
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During CMM’s planning stage, a development in the 
not-for-profit sector provided an invaluable boost. In March 
1986, the Howard Hughes Medical Institute (HHMI) 
embarked on a major reorganization in which it dramatically 
increased research funding in five areas: genetics, 
immunology, cell biology and regulation, neuroscience and 
structural biology. This emphasis so closely meshed with the 
one envisioned by CMM’s planners that they wasted no time 
in contacting HHMI. 
The outcome of subsequent talks exceeded the committee’s 
hopes; HHMI committed itself to pay for the construction of 
roughly half the center’s research space. Furthermore, the 
institute agreed to appoint investigators in two of CMM’s four 
research programs, molecular neurobiology and molecular 
genetics, from among faculty nominated by the University. 
HHMI’s support initiated an avalanche of fund-raising 
success. A major gift from the Lucille P. Markey Charitable 
Trust established CMM’s third research program, molecular 
oncology and development. Molecular cardiobiology emerged 
as CMM’s fourth and final program; the medical school is 
negotiating with a major pharmaceutical company as a 
possible sole corporate sponsor for this Poor. 
Meanwhile, other organizations committed to biomedical 
research and education added major support for construction 
and program. These included the W.M. Keck Foundation, the 
Ira W. DeCamp Foundation, and the Walter J. and Lillie A. 
Berbecker Scholarship Fund. 
One potential funding source, the S.S. Kresge Foundation, 
offered a $1 million challenge grant, with the proviso that the 
medical school; 1) match this gift with $5 million in 
subsequent fund raising; and 2) increase the level of 
alumni/ae giving to the School of Medicine Alumni Fund to 
$450,000 and achieve 53 percent participation. 
At the close of 1990, in dramatic fashion, Herbert W. 
Boyer, Ph.D., and his wife, Marigrace, met the first part of the 
Kresge Foundation challenge. A 1966 post-doctoral fellow in 
the laboratory of Professor Ed Adelberg, Dr. Boyer had gone 
on to invent recombinant DNA technology and then develop 
it commercially by founding Genentech, Inc., in California. 
The magnitude of his success — and of his gratitude to Yale 
— was reflected in his family’s $10 million donation to 
CMM. In recognition of this gift, the largest ever bestowed on 
the School of Medicine by individuals, the CMM will bear the 
Boyer family name. [See the Development Report, page 43.1 
Building on Experience, Nurturing Innovation 
The medical school’s success in gamering support for CMM 
not only testifies to careful planning; it also reflects Yale’s 
strength in human genetics and in cellular and molecular 
research. Dean Rosenberg himself proved to be an important 
asset. His leadership in genetic research had earned him 
membership in the National Academy of Sciences and the 
Institute of Medicine — important credentials when seeking 
support in the tens of millions of dollars. Moreover, this 
former president of the American Society of Human Genetics 
had proven himself in molecular research through studies 
which have helped advance understanding of and treatments 
for several metabolic diseases characterized by selective 
deficiency of mitochondrial enzymes. 
Yale’s case was bolstered as well by the distinguished 
faculty members who will administer the center. In July 1989, 
the Yale Corporation named Vincent T. Marchesi, M.D. ’63, 
Ph.D., the Anthony N. Brady Professor of Pathology, Cell 
Biology and Biology, as CMM’s first director. A National 
Academy of Sciences member and former president of the 
American Association of Pathologists, Dr. Marchesi has 
conducted pathbreaking studies into the structure of 
membrane proteins in red blood cells. 
CMM’s program heads also presented impressive 
credentials. Joan A. Steitz, Ph.D., professor of molecular 
biophysics and biochemistry (MB&B), an HHMI investigator, 
had been chosen to head molecular genetics. In addition to her 
membership in the National Academy of Sciences, 
National Academy of Sciences member Vincent T. Marchesi, M.D. '63, Ph.D., serves as CMM’s director. 
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Herhert U . Boyer. Ph D., completed his post-doctoral 
fellowship at Yale in 1966 and went on to found (lenentech 
hu .. thus helping to launch the hiotechnoloyy industry. 
Dr. Steilz's laurels include the National Medal of Science 
and the Warren Prize, which more than once has presaged 
the Nobel Prize. Her basic research involving RNA function 
and her discovery of at least six new essential cellular 
components have clinical implications for the treatment 
of lupus and cancer. 
At the helm in molecular oncology and development is 
Sherman M. Weissman, M.D., Sterling Professor of Human 
Cienetics, Medicine and MB&B. Dr. Weissman also has an 
appointment in the Yale Comprehensive Cancer Center, 
bdected to the National Academy of Sciences by virtue of his 
leadership in gene structure analysis, he also has developed 
new appro’aches for studying the organization of DNA. 
Spyridon Artavanis-Tsakonas, Ph.D., at age 44, repre.sents 
the youngest of CMM’s program heads. This professor of cell 
biology and biology, an HHMI investigator, will move from 
Yale’s Science Hill to oversee molecular neurobiology. I4r. 
Artavanis-Tsakonas' research has led scientists to identify a 
key group of genes which allows embryonic tissue to 
segregate neural from epidermal cells. 
.‘Mthough a head for molecular cardiobiology — the last of 
the four programs to be identified — has not yet been 
announced, the program’s focus has been determined. 4’his 
ihi-r's researchers will study endothelial cells, which line the 
h,;i]i ud blood vessels, learning more about these cells is 
\ital to improve treatments for heart disease, stroke and other 
\ .!‘>cular diseases. 
< Jn, e the full complement of scientists is aboard, the center 
V. r! house 2.‘s to .^0 faculty researchers, with six to eight on 
' ' -'i ilN lour floors. Dr. Marchesi reports that CMM’s 
eight-member faculty steering committee, which he chairs, is 
recruiting the center’s junior faculty from candidates with 
several years of post-doctoral or residency experience. 
In addition to the Yale faculty’s leadership in genetic 
research, funding sources were attracted to CMM’s unique, 
interdepartmental approach, designed to encourage 
collaboration. Moreover, clinically oriented basic researchers 
were mandated to play key roles in each program, to speed the 
discoveries of basic science to the bedside. 
In fact, the entire CMM has been carefully integrated 
into the mainstream of medical school. As Dr. Marchesi 
explains: “The center idea outside New Haven is often one in 
which an elaborate structure is created within a medical 
center. Usually it’s isolated and reserved, a province for a 
small number of people. That’s not what we’re trying to 
achieve here. CMM researchers will be Yale faculty who 
happen to work in that location.” 
Every CMM researcher will have a primary departmental 
appointment at the School of Medicine; Dr. Marchesi says 
that he hopes to establish as wide a distribution among 
departments as possible. He emphasizes that though “the 
center is neither a department, nor a kind of ‘mega¬ 
department’, nor four departments, one for each tloor. . . its 
re.searchers are in every way members of the Yale faculty.” 
In addition to their research responsibilities, the center’s 
faculty will play an important teaching role. As in CMM 
research programs, training at the center will be designed to 
foster connections within the medical school. 
Hence, trainees will not be limited to graduate-level 
fellows assigned to the center. Intramural programs will fund 
medical students, residents and clinical fellows who may wish 
to rotate in CMM for periods ranging from three months to 
several years. Small grants also will be available to support 
collaborative research projects between CMM and University 
research groups based outside the center. 
The medical school’s emphasis on intra.school cooperation 
also is evident in the pains planners took in making CMM 
accessible. To facilitate pedestrian traffic between CMM and 
the rest of the medical school, a pedestrian bridge connects 
the center with the Jane Ellen Hope Building. Easy access 
from across Cedar Street is assured by a second bridge, which 
has been constructed between the second Boors of the Hope 
building and Brady Memorial Laboratory. 
Cracking the Code 
Walking from the Hope building into CMM. one enters the 
head space, or shared facility, where a small auditorium and a 
common room will serve the entire medical school. CMM 
administrators will occupy the first Boor. 
The top two floors of the head space will house the W.M. 
Keck Foundation Biotechnology Resource Laboratory. This 
core service will consolidate the six labs of the Yale Protein 
and Nucleic Acid Chemistry Facility, which have been 
dispersed among the departments of MB&B, human genetics, 
cell biology and in the Membrane Center. 
With a full-time staff of 12, the Keck Foundation 
laboratory will put $1.6 million worth of high-technology 
instruments to work analyzing protein and DNA samples and 
providing such sophisticated products as custom-designed 
peptides as well as DNA and RNA oligonucleotides. Kenneth 
R. Williams, Ph.D., an adjunct professor in MB&B and senior 
associate of HHMI, serves as the laboratory’s director. He 
reports. “In 1990, we .served 132 re.searchers at Yale, and I 14 
others from the National Institutes of Health and 64 
institutions around the world.” 
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Complementing the laboratory’s broad clientele is a wide 
base of support, which reflects the pervasive effect molecular 
science is having on modern medicine. In addition to the 
Keck Foundation and the departments listed above, the 
laboratory has received funds from the National Institutes of 
Health, the National Science Foundation, HHMI and the Yale 
Comprehensive Cancer Cente,r among other sources. 
Moving from CMM’s headpiece into the graceful curve of 
the building which sweeps along where Congress Avenue 
meets College Street, one encounters the laboratories for the 
center’s four programs; each program has been assigned its 
own floor. Programs will share a common interest in DNA’s 
double helix and its key component, genes. All CMM 
researchers will work on some aspect of these minute building 
blocks of life. 
In the molecular genetics program, located on CMM’s 
ground floor, scientists will study how genes produce proteins 
and how they sometimes trigger disease — knowledge 
essential to all the center’s researchers. Investigators on other 
floors will study specific gene functions. Molecular 
oncologists, for example, will study the genetics of normal 
cell development, in hopes of understanding what goes wrong 
to cause the growth and spread of cancers. Molecular 
neurobiologists will investigate how genes affect nervous 
system development, while cardiobiologists will study 
developmental aspects of the cardiovascular system. 
For faculty in the HHMI-sponsored molecular genetics 
program, research questions arise from the fundamental steps 
leading to protein synthesis; stated simply: DNA makes RNA, 
which in turn manufactures proteins. 
“These basic steps go on in every cell in order to get the 
information out of the genome and into the various proteins 
that make one kind of cell different from another,” 
comments Dr. Steitz. “Everybody who’s involved in the 
program is doing research that’s targeted at some aspect of 
this basic pathway.” 
Dr. Steitz studies an early part of the molecular path: how 
DNA assembles messenger RNA (mRNA). In gene 
expression, DNA unzips its strands and constructs a mirror 
image of itself. This copy — mRNA — directs the production 
of proteins. 
A key aspect of Dr. Steitz’s work dates back to when 
Associate Professor and Assistant HHMI Investigator Michael 
R. Lerner, M.D. ’81, Ph.D., ’81, was a graduate student doing 
research in her laboratory. It was then that she and Dr. Lerner 
di.scovered subcellular particles involved in mRNA synthesis. 
They dubbed the particles small nuclear ribonucleoproteins, 
snRNPs, and nicknamed them “snurps.” Later research 
revealed that snRNPs perform many vital cell functions; Dr. 
Steitz aims to discover the individual tasks of the 
approximately 15 snRNPs that have been identified. 
Some snRNPs appear to be crucial in rearranging the gene 
segments that make up mRNA. Dr. Steitz explains that the 
DNA of higher organisms contains large regions of “junk,” 
called introns, which do not produce proteins. Introns’ 
protein-producing counterparts are called exons. Some 
snRNPs identify boundaries between introns and exons. Other 
snRNPs then aid in chopping out the introns and reconnecting 
exons so that these protein-making genes can organize 
sequences of amino acids into mRNA. 
Once the DNA and snRNPs create mRNA, the latter leaves 
the nucleus and enters the cytoplasm. With this exodus begins 
the research of Sandra L. Wolin, M.D., Ph.D., assistant 
professor of cell biology, an associate HHMI investigator. Dr. 
Wolin works with ribosomes, complexes of RNA and protein 
in the cytoplasm that interact with mRNA to assemble amino 
acids into proteins. 
Strands of mRNA comprise sequences of three nucleotide 
bases, and each of the.se triplets codes for a particular amino 
acid. Ribosomes roll along mRNA, both decoding it and 
stringing together amino acids, which later become proteins. 
.Itimes Anderson 
Joan A. Steitz. Ph.D., and Michael R. Lerner. M.D. '81. Ph.D. '81, have been collaborating on research 
into small nuclear ribonucleoproteins — snRNPs — since Dr. Lerner was a graduate student working in 
Dr. Steitz’s laboratory. 
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Dr. Wolin studies the features of inRNA that affect 
ribosomes' ability to do this job. 
Studies led by Arthur Horwich, M.D.. begin at the home 
stretch of the pathway of protein synthesis. Dr. Horwich is 
associate professor of human genetics and pediatrics, and an 
associate HHMI investigator. He is discovering how newly 
made strings of amino acids are folded into complex three- 
dimensional structures. These structures are the functional 
forms of proteins. 
Dr. Horwich has identified a specialized protein that serves 
as a folding "machine” that can recognize the unfolded strings 
of amino acids and carry out the origami-like steps that turn 
them into folded proteins. Understanding how such machinery 
works may allow better methods of producing biologically 
important proteins, or might allow genetically altered proteins 
that don't fold properly to be corrected. 
Another aspect of Dr. Horwich's work may have 
implications for babies born with defective hearts. He is 
analyzing a strain of mice in which a defect in a single gene 
causes the visceral organs to become exactly reversed in their 
left-right position. Included is the heart, which becomes 
HHMI: Modern Medicine’s Medicis 
A Washington Post writer recently drew a parallel between 
what the Howard Hughes Medical Institute (HHMI) is doing 
for today's medical research and what the Medici family of 
Florence, Italy, did for 15th-century art. Just as the Medicis 
used their wealth to nurture the genius of Michelangelo, 
da Vinci and Botticelli, the writer suggests, HHMI is 
putting to work its $6 billion endowment to advance the 
biomedical sciences. 
Founded by the late aviator-industrialist in 1953, the 
Howard Hughes Medical Institute has become one of the 
world’s wealthiest philanthropies and the largest private 
supporter of biomedical science in the United States. It 
conducts research at some 52 medical centers, hospitals, 
universities and other research institutions around the country. 
Yale has been an HHMI beneficiary since the institute’s 
founding, and has received generous support for both capital 
and program development. Most recently, HHMI announced 
that it will help Yale construct a new molecular biology and 
biophysics building on the central campus next to Kline 
Biology Tower, where four HHMI investigators now work. 
HHMI agreed to appoint investigators in two of CMM’s 
research programs, molecular neurobiology and molecular 
genetics. This includes paying their salaries and funding the 
research in their laboratories. HHMI also supports four 
investigators in the immunobiology section [see “Yale 
Immunobiologists Get Back to Basics,” page 13|. 
Yale’s 15 HHMI researchers are among approximately 200 
HHMI investigators who work at more than 50 sites 
nationwide. Unlike many biomedical funding sources, the 
Bethesda, Md.-based institute is an independent medical 
research organization, employing scientists rather than giving 
them grants — a distinction crucial to HHMI’s organizational 
struc ture and tax status. HHMI investigators do, however, 
hold faculty posts at their universities. 
Hughes institute support at Yale extends beyond salaries 
and capital improvements. Some Yale medical students and 
graduate students in the biomedical sciences have received 
fc-llciwships through HIlMI’s grants program. And each year 
s'le v I9SX, the institute has made awards to the University to 
positioned on the right instead of the left, and is often 
abnormal in structure. This mouse model of congenital heart 
disease resembles many types of human disease, and 
understanding how this gene works may offer new avenues of 
diagnosis or treatment of the human di.seases. In addition, the 
model may help solve one of the body’s fundamental riddles 
— how it knows its right from its left. 
The research of Stephen T. Reeders, M.D., assistant 
professor of medicine and human genetics, further illustrates 
the clinical potential of CMM’s basic research. This assistant 
HHMI inv estigator seeks to pinpoint genes that cause 
inherited kidney diseases, the most common of which is 
polycystic kidney disease (PKD). One in 1,000 Americans 
suffers from PKD, in which tluid-filled cysts replace healthy 
kidney tissue, often leading to renal failure. 
Dr. Reeders and his colleagues are studying large numbers 
of patients and their families in order to track the disease- 
producing mutations. Their goal is to identify the PKD gene 
and a means to characterize and match each mutation with the 
pattern of disease it produces. 
Purnell W. Choppin, M.D. 
recognize the support HHMI investigators receive from 
graduate students working in the laboratories of the HHMI 
scientists. To link researchers and students across campus, 
HHMI underwrites a computer bulletin board, electronic mail 
and the “Bio-Med Express,” a bus that shuttles between the 
medical school and Science Hill. 
Of the CMM, HHMI President Purnell W. Choppin, M.D., 
says he is “confident that from this multidisciplinary center 
we shall see the emergence of important new insights into 
fundamental biological processes and disease mechanisms, 
and the application of that knowledge to the treatment and 
prevention of serious diseases.” He adds, “We at HHMI are 
pleased and proud to be collaborating with Yale University in 
this magnificent new endeavor.” 
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In another project. Dr. Reeders has cloned the gene for 
one of the collagen molecules that are critical structural 
components of glomerular basement membrane — an 
extracellular membrane in the kidney that divides the blood 
from the urine. This collagen molecule is frequently absent 
in the basement membranes of patients with Alport syndrome, 
a sex-linked degenerative kidney disease. The gene product 
is also the target of autoantibodies in Goodpasture’s 
syndrome, a rare autoimmune cause of acute kidney failure 
and lung hemorrhage. Dr. Reeders hopes that knowledge of 
the molecular structure of the target of Goodpasture 
antibodies will shed light on the mechanism of autoimmunity 
in this disease. 
A vital complement to the floor’s — and the center’s — 
research will be provided by Paul B. Sigler, M.D., Ph.D., 
professor of MB&B, and his skills in protein crystallography. 
In this process. Dr. Sigler, an HHMI investigator, targets a 
section of DNA, binds protein molecules to it and crystallizes 
the protein. He then creates an atomic blueprint of the 
protein’s molecular structure by interpreting how the crystal 
scatters x-rays. 
Dr. Sigler comments, “These aren’t wiring diagrams, these 
are detailed molecular structures that indicate how the 
molecule works in chemical terms. That’s exciting to me.” 
Some of Dr. Sigler’s research is based on x-ray 
crystallography analysis of the “trp” repressor-operator 
complex, which regulates the genes in bacteria that produce 
tryptophan, an amino acid essential in human nutrition. 
He’s also working to describe how DNA interacts with steroid 
hormone receptors and with the proteins of human papilloma 
virus, a virus implicated in cervical cancer. 
Cellular Communication Sans Satellite 
In neurobiology, the HHMI-sponsored program on the second 
floor. Dr. Artavanis-Tsakonas and his colleagues will work 
with genes that control the development and function of the 
nervous system. Among the issues these scientists will 
explore are those of cellular long-distance communication. 
Dr. Artavanis-Tsakonas explains; “Nerve cells have to 
communicate with other cells that are far away. One is in your 
head and the other is in your toe, and they are in constant 
communication. That poses a number of very specific 
problems that other cells may not be facing.” 
He cites, for example, the question of how nerve cells 
“wire” the body. How do embryonic nerve cells lengthen, 
follow their elaborate path and connect in a pattern that is 
virtually identical within species? Surprisingly, for answers. 
Dr. Artavanis-Tsakonas turns not to the human genome but to 
that of an insect that is barely visible to the naked eye. 
His diminutive subject is Drosophila melanogaster — the 
humble fruit fly. Scientists study fruit fly genes that affect 
nerve cell development. Because the animal kingdom displays 
dramatic similarities at the genetic level, understanding how 
nerves develop in these tiny insects may one day help 
researchers learn to regenerate nerves in human patients with 
spinal cord injuries. 
“There’s an incredible conservation of basic biological 
mechanisms that essentially transcends species barriers,” says 
Dr. Artavanis-Tsakonas. “So, there’s an enormous overlap in 
things that we’re looking at in flies or in mice or in humans.” 
These biological similarities will help CMM programs 
transcend disciplinary boundaries, both within the center and 
with the rest of the medical school. 
Continued on page 25 
Spyridon Artavanis-Tsakonas, Ph.D., joins the other program 
heads on the CMM steering committee. At full complement, 
the committee will include 10 members. 
Steering Committee Governs CMM 
Members of CMM’s steering committee serve for overlapping 
three-year terms. Current members include: 
Spyridon Artavanis-Tsakonas, Ph.D., professor of cell 
biology and biology, an HHMI investigator 
Edward J. Benz Jr., M.D., professor of medicine, human 
genetics and in the Cancer Center 
Richard A. Flavell, Ph.D. professor and chairman of 
immunobiology, an HHMI investigator 
*Gerhard H. Giebisch, Sterling Professor of Cellular 
and Molecular Physiology 
*Vincent T. Marches!, M.D., Ph.D., Anthony N. Brady 
Professor of Pathology, Cell Biology and Biology 
(committee chairman) 
*Joan A. Steitz, Ph.D., professor of molecular 
biophysics and biochemistry, an HHMI investigator 
*Joseph B. Warshaw, M.D., professor and chairman 
of pediatrics 
*Sherman M. Weissman, M.D., Sterling Professor of 
Human Genetics, Medicine, and Molecular Biology and 
Biochemistry and in the Cancer Center. 
* Asterisks denote those w’ho served on the CMM planning 
committee. Other current faculty members who worked on the 
planning committee include: 
Emile L. Boulpaep, M.D., professor of cellular and 
molecular physiology 
Edwin C. Cadman, M.D., Ensign Professor of Medicine 
and in the Cancer Center, chairman of internal medicine 
Bernard G. Forget, M.D., professor of medicine and 
human genetics. 
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CMM Design Embodies Integration 
Cesar Pelli’s Center for Molecular Medicine (CMM) joins 
Frank Gehry’s Yale Psychiatric Institute (YPI) and Philip 
Johnson’s Laboratory of Epidemiology and Public Health 
(LEPH) in the medical school’s — and the University’s — 
tradition of commissioning projects by leading architects. 
Argentine-born Pelli’s CMM design incorporates a 
dramatic curve, evident not only in the building’s exterior, but 
also inside, in its main corridors. These hallways separate 
CMM’s 40 research laboratories facing the street or “south” 
side, from the interior, which includes faculty and fellows’ 
offices, and support facilities such as controlled-temperature 
rooms and tissue culture laboratories. Each south-side 
laboratory offers 750 square feet of space. In hallways and 
stairwells, built-in oak benches invite researchers to converse 
and exchange ideas. 
A (liaiii uni of the headpiece’s second floor. CMM’s architect, 
( ■' -.ar Pelli. served as dean of the Yale School of Architecture 
h 'ini l‘)77 to I9H4. General contractor for the project is 
■ in ner i onstniction Co. of New York Cit\. 
Even as CMM’s exterior commands a dominating 
presence, the elegance and strength of its curve complements 
the center’s urban environment. By defining the intersection 
of College Street and Congress Avenue, the building’s bold 
sweep completes the gateway to the medical center heralded 
by LEPH on the Oak Street connector. 
The Center for Molecular Medicine offers a contemporary 
interpretation of the styles exhibited by two of its venerable 
neighbors — the Jane Ellen Hope Building and the Brady 
Memorial Laboratory — to which CMM is linked via 
pedestrian bridges. The center’s red brick also evokes 
industrial buildings from New Haven’s manufacturing era. 
Such considerations, too, are reflected in Mr. Pelli’s other 
recent projects: the World Einancial Center, Carnegie Hall 
Tower and the Museum of Modem Art addition, all in New 
York City. 
Because of the sophisticated, rapidly evolving research that 
Yale and HHMl scientists will conduct at the center, CMM’s 
services, including electricity, heating and cooling, plumbing 
and ventilation, have been designed with an eye to meeting 
the needs of 21st-century science. These mechanical elements 
represent approximately one third of the $38 million cost of 
the 125,000 gross-square-foot building, which itself has been 
likened to a finely tuned, high-technology instrument. 
In some instances, addressing CMM’s mechanical needs 
required form to serve function in inventive ways. For 
example, Mr. Pelli’s associate, project manager Bruce W. 
Sielaff, ’59 M.ARCH., points out that the flared, copper- 
covered pillars which frame the main entrance on Congress 
Avenue do more than support a canopy to protect the porch 
below. Though the pillars may recall Egyptian revival style, 
their hollow interiors serve as intake shafts for an advanced 
ventilation system which draws fresh air into the sub¬ 
basement for delivery throughout the building. The pillars’ 
flare is also functional: to reduce turbulence and noise. 
Walking between the pillars one enters CMM's headpiece, 
or shared facility. On the headpiece’s third and fourth floors, 
core laboratories for protein chemistry, protein synthesis, and 
DNA synthesis and sequencing will centralize facilities now 
scattered throughout the medical center. The headpiece offers 
different kinds of shared facilities on the second floor, with a 
seminar room and a comfortably furnished common room. 
Located in the headpiece and elsewhere in the center are three 
conference rooms, plus lunch/break rooms for each of the four 
program’s floors. 
A subtle emphasis on integration comes from the second- 
and third-floor outdoor terraces, from which one can view the 
weathered copper dome of Sterling Hall of Medicine and the 
new arc-shaped information room of the CushingAVhitney 
medical library. Another recent architectural project, the 
library renovation and addition, was designed by Alexander 
Purves with New Haven architect Allan Debar, who also 
collaborated on YPI. 
Finally, architect Pelli has integrated the Center for 
Molecular Medicine by including the two pedestrian bridges 
which unite CMM with teaching and research facilities 
located in the rest of the medical school. The first, a bi-level 
bridge, connects the center’s headpiece with the Hope 
building. The second, a single-story structure, overarches 
Cedar Street to link Hope and Brady. Through this bridge’s 
series of square windows, the School of Medicine unfolds 
before the observer’s eye —just as will the mysteries of DNA 
in the mind’s eye of scientists who soon will animate the 
newest addition to Yale’s architectural treasures. 
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Dr. Artavanis-Tsakonas observes: “We’re all using 
different experimental approaches, but in many ways, this is 
breaking down the traditional barriers between the various 
disciplines: molecular biology, developmental biology, 
neurobiology and cell biology. Our people in neurobiology 
will have a lot in common with the molecular genetics floor, 
with the oncology and development floor, and even with the 
cardiobiology floor.” 
He points out, for example, that cardiobiologists won’t be 
the only scientists with a stake in understanding angiogenesis, 
how cells develop into blood vessels. This process may also 
interest molecular oncologists, since a cancer can survive only 
if nourished by blood. If one could stop the blood vessel from 
reaching the cancer, the tumor should starve. 
Similarly, CMM cardiobiologists will want to know how 
cells communicate to fuse extracellular material and create a 
blood vessel. Such knowledge could help treat some forms of 
heart disease as well as aneurysm, stroke and other vascular 
diseases. 
The work of one CMM neurobiologist further illustrates 
the potential for inter-program collaboration. Building on his 
earlier work with Dr. Steitz, Dr. Michael R. Lerner, associate 
professor of molecular neurobiology and associate HHMI 
investigator, studies how scientists might employ one 
particular snRNP in splicing new forms of mRNA. 
In other research. Dr. Lerner, like his colleagues in 
neurobiology, turns to a perhaps surprising branch of the 
animal kingdom to benefit human health — in this case, 
amphibians. He uses frog pigment cells to screen new drugs 
for efficacy. 
Current screening methods lack quick, simple ways to 
evaluate chemicals that trigger production of cyclic adenosine 
monophosphate, (cAMP), which helps regulate heart rate, 
blood sugar levels and air flow in the lungs. Since cAMP also 
allows certain frogs to adapt their skin color to changing 
environments. Dr. Lerner is trying to use frog pigment cells to 
identify chemicals that trigger cAMP production. 
“The beauty of this test is that it would harness a naturally 
operating system already in place,” says Dr. Lerner. 
Genes of still other animals, including chickens, will guide 
many scientists in the molecular oncology program on the 
third floor. Dr. Weissman is recruiting researchers who will 
study the genetics of normal cellular growth and development, 
hoping that this will help explain how tumors form and grow. 
“We recognize that the genes involved in controlling 
growth during differentiation are a significant portion of the 
genes that may be involved in cancer,” reports Dr. Weissman. 
Here researchers will compare the varying effects that the 
same gene can produce in humans and other organisms. For 
example, they will study how the “rel” oncogene, which 
directs immunoglobulin production in humans, can mutate to 
cause cancer in chickens, and how this same gene controls 
body development in the fruit fly. Scientists will move even 
further down the evolutionary scale to investigate the human 
neurofibromatosis gene, an analog of a yeast gene that helps 
regulate cAMP. 
The first faculty member recruited for the floor, Michael J. 
Stern, Ph.D., currently a postdoctoral fellow at the 
Massachusetts Institute of Technology, studies the 
development of Caenorhahditis elegans, a roundwonn as tiny 
as a comma. Specifically, he studies how a pair of cells in the 
developing worm migrate to their final positions. 
Understanding this may lead to approaches to control the 
abnormal migrations of metastatic tumor cells in humans. 
To spur such research. Dr. Weissman’s laboratory is 
improving methods for mapping genomes, whether human or 
those of other organisms. Dr. Weissman already has 
introduced several such techniques, including chromosome 
jumping, in which one cuts a length of chromosome, loops it 
and joins its ends. By sequencing the ends, researchers save 
many hours in identifying genes. He and colleagues now are 
attempting to sequence large pieces of DNA by quickly 
identifying all of the mRNA that the DNA encodes. 
Dr. Weissman also studies the processes by which the 
body switches from producing fetal hemoglobin to adult 
hemoglobin. His work may advance treatments for such blood 
disorders as sickle cell anemia, thalassemia and leukemia. 
Fulfilling the Dream 
Dean Rosenberg is confident that CMM’s interdisciplinary 
structure will nurture such crucial research in all four of the 
center’s programs and throughout the medical school. He afso 
points out the CMM’s strategic importance to the School of 
Medicine’s ongoing quest to maintain a leading faculty in 
basic research. 
Comments the dean: “You can’t get the best people 
without facilities that are good enough to attract the best. Bart 
Giamatti once said that if you’re going to be the best, you 
have to be able to afford it. Part of affording the best in 
science has to do with the facilities.” 
Citing the state-of-the-art CMM laboratories which soon 
will come to life, he adds: “This is a project about which I’m 
extraordinarily excited, proud and hopeful.” YM 
Sherman M. Weissman. M.D. 
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Symposia Honoring the Dedication of the 
Boyer Center for Molecular Medicine 
June 6,1:30 p.m. 
Constructing a National Agenda for Biomedical Research 
Mary S. Harkness Memorial Auditorium 
Yale University School of Medicine 
The Honorable Lowell P. Weicker, Jr. 
Governor. State of Connecticut 
Leon E. Rosenberg, M.D. 
C.N.H. Long Professor of Human Genetics. Medicine, and Pediatrics 
Dean, Yale University School of Medicine 
P. Roy Vagelos, M.D. 
Chairman and C.E.O., Merck & Company, Inc. 
Dick Thompson 
Chief Science and Medicine Correspondent 
Washington Bureau, TIME Magazine 
June 7, 9:00 a.m. 
Perspectives in Molecular Medicine 
Commemorating the Four Programs in the 
Boyer Center for Molecular Medicine: 
Molecular Genetics, Molecular and Developmental 
Neurobiology, Molecular Oncology and Development, 
and Molecular Cardiobiology 
Mary S. Harkness Memorial Auditorium 
Yale University School of Medicine 
Introduction: Vincent T. Marchesi, M.D., Ph.D. 
Anthony N. Brady Professor of Pathology, Cell Biology, and Biology 
Director, Boyer Center for Molecular Medicine 
“Ribonucleoproteins in the Amphibian Oocyte Nucleus” 
Joseph G. Gall, Ph.D. 
Department of Embryology 
Carnegie Institution of Washington 
“The Accumulation of Chemoreceptors at Developing Synapses” 
(ierald D. Fischbach, M.D. 
Nathan Marsh Pusey Professor and Chairman of Neurobiology 
Department of Neurobiology 
Harvard Medical School 
“Regulating the Transcriptional Regulators” 
David Baltimore, Ph.D. 
President 
The Rockefeller University 
“How Cells Control Cholesterol” 
Joseph L. Goldstein, M.D. 
Professor and Chairman 
Department of Molecular Genetics 
University of Texas 
Southwestern Medical Center at Dallas 
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GALLERY 
Photograph © 1969 Irving Geis 
“Hemoglobin Molecule^’ by Irving Geis 
This graphic depiction is based on a photograph derived 
from x-ray crystallography — a technique widely used by 
Yale biomedical researchers. This technique involves 
mathematically reconstructing submicroscopic structures 
using data from x-ray diffraction — scattering x-rays off 
minute crystals and recording the resulting patterns. In this 
drawing, American artist Irving Geis uses such an image to 
create a three-dimensional tubular form with peculiar¬ 
looking bends which represents the myoglobin fold 
(hemoglobin is comprised of four myoglobins). In 1957, 
myoglobin was the first protein molecule to be visualized 
using x-ray crystallography. 
The hemoglobin molecule consists of four chains of 
amino acids and comprises 10,000 atoms. Oxygenated 
blood is red due to four iron atoms located at the center of 
a cluster of atoms called heme. These are depicted here as 
the four hovering spheres embedded in rectangular plates. 
The width of the molecule is 64 angstrom units — 100 
million angstrom units make up a centimeter. 
Irving Geis has been a scientific illustrator for more 
than five decades. He has illustrated and authored 
numerous textbooks, exhibited widely and lectured on 
molecular structure. He combines a knowledge of science 
with artistic acumen in his conception and execution of 
structures that normally elude the human eye. His 
rendering of hemoglobin exemplifies the evolving 
association between the advancements of medicine and art. 
Janice Braun, Historical Library 
Harvey CushinglJohn Hay Whitney Medical Library 




MARTIN LUTHER KING JR. DAY. 1991 
John Dow Jr., Ph.D., superintendent of the New Haven public schools (left) joins 
Warren A. Andiman, associate professor of pediatrics, epidemiology and 
laboratory medicine, and Linda Mayes, M.D., the Arnold Gesell Associate 
Professor of Child Development, in exploring “Drug Abuse as it Affects Children.” 
'a-‘It. M.P.Il. Y)(S’, director of the Hill Health Center, 
■j the afternoon’s many discussion groups. 
Maxine Whitehead, director of minority affairs, is flanked by 
Therman E. Evans, M.D.. corporate medicine director and 
vice president, CIGNA Corp., and Olivia Cole, stage, screen 
and television actor. Dr. Evans and Ms. Cole made presenta¬ 
tions that drew standing ovations at Harkness auditorium. 
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The Youth Department Connecticut Mass Choir of New Haven performs in Harkness auditorium. 
William King Jr. (left) and Dee Dockery demonstrate a role- 
playing technicjue used with New Haven public school 
students in the Adolescent Substance Abuse Prevention 
(ASAP) program. Mr. King coordinates ASAP with Joanna 
Rosen, also a second-year medical student. 
Phyllis Harris, a second-year M.P.H. student, led one of the 
discussions held in the Hope building's Ebbert lounge. 
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SCOPE 
New MB&B Building 
To (irace Science Hill 
Construction has started for a new 
building on Science Hill that will house 
the department of molecular biophysics 
and biochemistry. The four-story. 
9(),()()()-square-foot structure, scheduled 
for completion in 1993, marks the first 
new construction on Science Hill since 
I96.S. 
The estimated S22.2 million 
construction project is partially funded 
by a S4.5 million contribution from the 
Howard Hughes Medical Institute. The 
building, designed by Kallmann. 
McKinnell & Wood .Architects Inc. of 
Boston, will connect with the Sterling 
Chemistry Lab and the Josiah Williard 
Gibbs Research Laboratories, and will 
be adjacent to the Kline Biology Tower. 
Vascular Center 
Debuts at Yale 
The new \'ale Vascular Center taps into 
the medical school's knowledge in a 
variety of disciplines to provide high 
quality, convenient care targeted at 
atherosclerosis and other diseases 
affecting blood vessels. The center is 
located in the Yale Physicians Building. 
‘‘.Atherosclerotic cardiovascular 
disease and its complications will kill 
or disable the majority of our 
population." states Dr. Henry R. Black, 
professor of internal medicine, director 
of the Preventive Cardiology Program 
and co-director of the center. 
Lxplains co-director Dr. Richard J. 
Gusberg. professor and chief of vascular 
surgery. "As our aging population 
increasingly confronts the complications 
of atherosclerosis, advances in knowledge 
and technology have made the manage¬ 
ment of vascular disease both more 
effective and more complicated." 
Drs. Gusberg and Black established 
the center to keep pace with such 
medical advances and to insure that 
patients benefit from them in a 
:,-nemeni ua\. fhe center's multi- 
■ as'- iplinary team includes specialists 
lr;im internal medicine, vascular 
.me-Ty. neurosurgery, plastic surgery. 
neurology, radiology, laboratory 
medicine and anesthesiology. 
These specialists offer a wide array 
of non-invasive vascular diagnostic 
studies, sophisticated lipid profiling, 
nutrition counseling, ambulatory blood 
pressure monitoring, magnetic resonance 
imaging and complete angiographic 
capabilities. These services augment, 
and do not replace, care provided by a 
patient's personal physician. Dr. Black 
emphasizes. 
Linda Berganzi 
W HO official Ilona S. Kickhnsch. Ph.D.. 
at the coUahorating centre dedication. 
WHO Centre Focuses 
On Health Promotion 
The World Health Organization (WHO) 
has designated the department of 
epidemiology and public health as a 
WHO Collaborating Centre for Health 
Promotion Policy and Research, the 
first such WHO-sponsored organization. 
Burton H. Singer, Ph.D., professor 
and chaimian of epidemiology and 
public health, explains that the new 
centre melds research, service and 
teaching. "EPH faculty members, with 
the help of other Yale faculty, will 
foster cooperation in research between 
health policy experts, epidemiologists, 
environmentalists and biostatisticians, 
says Dr. Singer. 
Lowell S. Levin, Ed.D., M.P.H., 
professor of public health, will direct 
the new centre. He comments. "By 
collaborating with the WHO and other 
global- and country-level institutions on 
programs of education, research, 
information exchange and consultation, 
the centre will help formulate and 
implement health-promotion policies 
and research." 
Key to this effort will be establishing 
a global information/problem-solving 
netw ork, using teleconferencing to link 
23 Yale experts w ith scholars in WHO- 
member states throughout the world. 
Economists, environmentalists, 
epidemiologists and planners in fields 
as diverse as agronomy and virology 
will contribute their expertise. 
Also, through the centre, visiting 
scholars w ill collaborate in research 
w ith Yale faculty and learn how to 
apply teleconferencing methods in 
graduate education. 
Pulsed Dye Laser 
Removes Birthmarks 
Both adults and children can now be 
treated at Yale for vascular tumors of 
the skin, thanks to the new pulsed dye 
laser acquired by the School of Medicine 
and Yale-New Haven Hospital. 
This laser — the only one of its kind 
in the region — treats port-w ine stains 
as well as other blood vessel tumors 
and broken blood vessels. Port-w ine 
stains, like the purplish-red birthmark 
on the forehead of Soviet President 
Mikhail S. Gorbachev, occur in three 
out of every 1,000 new borns. 
David J. Leffell. M.D.. assistant 
professor of dermatology, explains that 
the highly sophisticated laser emits 
yellow light, a complementary color to 
the red blood vessels that make up the 
tumors. Because the laser's heat is 
absorbed only by the blood vessels, 
w hich are destroyed, and not by the 
surrounding tissue, scarring is rare. 
The laser unit, about the size of a 
small washing machine, uses fiber-optic 
cable to conduct the laser energy. 
Patients require no anesthesia for the 
treatment, which feels like the snap of 
an elastic band. In most cases. va.scular 
tumors can be permanently removed, 
although several treatments may be 
required. 
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Yale Clinic Begins 
Genetic Counseling 
For Kidney Disorders 
People with a relatively common 
hereditary disorder that fills their 
kidneys with cysts — often leading to 
kidney failure — can now receive 
genetic testing and counseling, thanks 
to a new clinic at the Yale Physicians 
Building. The Hereditary Renal Disease 
Clinic, which opened in February, is the 
first of its kind to offer genetic testing 
and coun.seling specifically for people 
with such renal diseases as polycystic 
kidney disease (PKD), notes Gregory 
G. Gemiino, M.D., instructor of 
medicine. 
Counseling helps people with a 
family history of PKD to make 
informed choices about health care, 
childbearing and the possibility of 
receiving a donated organ, explains Dr. 
Germino, who co-directs the clinic with 
Margretta R. Seashore, M.D., professor 
of human genetics and pediatrics. 
Although no therapy can prevent PKD, 
some of its symptoms, like 
hypertension and recurrent kidney 
infections, can be managed. 
Notes one of the clinic’s scientific 
advisors, Stephen T. Reeders, M.D., 
“PKD is one of the most common 
genetic diseases in Caucasians.” Dr. 
Reeders, assistant professor of medicine 
and human genetics, and an assistant 
investigator of the Howard Hughes 
Medical Institute, estimates that one in 
1,000 Americans suffers from PKD. 
Medical Informatics 
Center Opens at YSM 
To keep itself at the forefront of the 
computer age, the School of Medicine 
has established a Center for Medical 
Informatics. Perry L. Miller, M.D., 
Ph.D., associate professor of anesthesi¬ 
ology, has been named its first director. 
In announcing this new multidisci¬ 
plinary center, Dean Leon E. Rosenberg, 
states: “The center will provide 
intellectual leadership in the creative 
application of computers in biomedicine. 
Through Dr. Miller’s efforts, the center 
will focus on the emerging field of 
biomedical information technology, 
incorporating patient care, research, 
medical education, scholarly information, 
and computing and communications.” 
R. Paul Andersen 
Perry L. Miller. M.D.. Ph.D. 
Dr. Miller comments: “Medical 
knowledge is in constant flux as new 
drugs and diagnostic tests are 
developed, new studies perfonned, new 
scientific research published. The 
computer has the potential to make this 
infomiation available in an up-to-date 
fomi to practitioners, researchers and 
students anywhere.” 
From its office at 350 Congress 
Ave., the new center will: 
• Focus on basic research into the 
creative use of computers to support 
clinical medicine, molecular 
biology, biomedical research and 
medical education. 
• Support and coordinate collaborative 
research projects involving medical 
school faculty, as well as faculty in 
computer science and other 
departments at Yale. 
• Serve as a focal point for training 
the next generation of researchers in 
this field. 
New Center To Research 
Child Development 
The School of Medicine will establish a 
Child Health Research Center where 
pediatricians and scientists will advance 
the understanding of normal and 
abnormal child development. 
The Yale center is one of seven new 
Child Health Research Centers funded 
by the National Institute of Child 
Health and Human Development, part 
of the National Institutes of Health. 
Each center will receive a maximum of 
$400,000 annually for five years and 
will then compete for additional funds. 
Dr. Joseph B. Warshaw, chairman of 
the department of pediatrics, serves as 
the center’s program director. He 
explains: “Senior pediatricians, 
scientists, cellular and molecular 
biologists, neuroscientists and 
geneticists will teach basic science to 
pediatric researchers in training. These 
young scientists will bring fresh ideas 
to the technology of modern basic 
science. Their innovative thinking will 
improve our understanding of normal 
development and the abnormalities that 
result in injury, handicaps and death to 
children.” 
Eight pediatric faculty, including 
Dr. Warshaw, will train four young 
faculty researchers yet to be selected. In 
addition, Yale medical faculty members 
in several departments, including 
internal medicine, human genetics, cell 
biology, pathology, and molecular 
biophysics and biochemistry, and the 
sections of anatomy and immuno¬ 
biology, will provide support and 
resources for the young faculty. 
CMHC Celebrates 
25 Years of Service 
The Connecticut Mental Health Center, 
(CMHC) a collaborative program of the 
State Department of Mental Health and 
Yale University, will hold a 25th anni¬ 
versary celebration on Sept. 20 and 21. 
Speakers will include former and 
current faculty who will highlight the 
center’s role as a model mental health 
care system for the public and as a 
liaison in clinical programs, research 
and education. They also will discuss 
various challenges facing mental health 
professionals today. 
“We hope that all former faculty and 
staff, especially those who trained at 
CMHC, will return to New Haven to 
participate in this celebration and to see 
our growth and accomplishments in 
mental health care,” says Dr. Ezra E.H. 
Griffith, CMHC director and professor 
of psychiatry. 
Connecticut Gov. Lowell P. Weicker 
Jr. is scheduled to be the keynote speaker 
Sept. 21 in Yale Commons at a dinner 
and ball that are part of the anniversary 
events. 
For further information about the 
CMHC 25th anniversary celebration, 
call (203)789-7290. 
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Dr. (iriffith Addresses 
Transracial Adoption 
In a lecture he delivered at the 
University of Maryland Medical Center 
in Baltimore, Ezra E.H. Griffith, M,D.. 
associate professor of psychiatry and 
African and Afro-American Studies, 
presented his perspective on black 
children being adopted by white 
parents, lie noted that despite the 20- 
year stand against such transracial 
adoption taken by the National 
Association of Black Social Workers, 
"the scientific data show that black 
children involved in transracial 
adoptions generally adapt well, and do 
not have more behavioral and .school 
problems than children who are adopted 
by couples of the same race.” 
Dr. Griffith said that opponents of 
transracial adoption who are concerned 
with such issues as black children losing 
their racial identity, should acknowledge 
that their opinion is a political rather 
than a scientific judgment. Minority 
children in America have historically 
been more difficult to place in adoptive 
homes than have white children, and 
while race cannot legally be considered 
in adoptions. Dr. Griffith points out that 
white couples are often discouraged 
from adopting black children. 
I3r. Griffith is director of Connecticut 
Mental Health Center, a collaborative 
program of Yale University and the 
State of Connecticut. He delivered his 
remarks as the Dana African-American 
Visiting F^rofes.sor of Psychiatry during 
Martin l.uther King Jr. Day activities at 
the .Maryland medical center. 
Second-hand Smoke 
Tied to Infections 
Two School of Medicine pediatric 
researchers have produced evidence 
that ties cigarette smoking in the home 
with serious infections in children. 
,\nne f. Berg, Ph.D., associate re.search 
scientist, and ITigene 1). Shapiro, M.D., 
associate professor of pediatrics and 
epidemiology, re|X)rted in a January 
edition of the Anicrican Joiiniul of 
l\pi(li’niiolof>y that they were looking 
fur a possible association between 
enrullment in a ilay-care center and the 
risk of incurring a serious infection. 
I hey round none. Instead, they 
tlisi O', i-red that children e.xposed 
postiiatally to household smoke hatl 
approximately a four times-higher risk 
of being hospitalized for a bacterial or 
viral infection than youngsters who 
were not subjected to passive smoking. 
Foundation Funds 
Research Equipment 
The New Haven Eoundation has 
awarded the department of internal 
medicine, section of rheumatology, 
$37,000 to further research and treat¬ 
ment of Lyme disease and arthritis. The 
grant funds the purchase of diagnostic 
laboratory equipment to aid in the 
search of patients’ tissues and fluids for 
evidence of the bacterium that causes 
Lyme disea.se. This research will help 
scientists elucidate how the disease 
process comes about and hopefully aid 
in diagnosis. 
“Grants such as this one. to fund 
equipment, are difficult to come by, 
which makes it of special value,” states 
Dr. Stephen E. Malawista, M.D., 
professor of medicine, whose 
laboratory benefits from the grant. The 
grant comes from the foundation’s 
Josephine Burgess Fund, which 
supports arthritis projects. 
Study Questions How 
Indoor Air Affects 
Mothers, Children 
The National Institute of Environmental 
Health Sciences has awarded the John 
B. Pierce Laboratory and the School of 
Medicine a $3.5 million grant to study 
how indoor air pollutants affect the 
respiratory health of infants and their 
mothers. 
Brian P. Leaderer, Ph.D., an associate 
fellow at the Pierce Laboratory and 
associate professor of epidemiology 
(environmental health) at Yale, directs 
the five-year study. He also heads the 
division of environmental health sciences 
of the department of epidemiology and 
public health. 
Researchers suspf'ct that children 
exposed to indoor concentrations of 
gases from such sources as tobacco 
smoke, cleaning chemicals, and 
kerosene and gas heaters have increased 
risk of acute or chronic upper and lower 
respiratory symptoms. 
The researchers plan to study POO 
infants and their mothers from the New 
Haven area in a variety of environments 
to determine whether indoor pollutants 
contribute to increased coughing, 
wheezing, runny noses or breathing 
problems. They also will test whether 
pollutants affect the mothers’ lungs. 
Co-investigators are Michael B. 
Bracken, Ph.D., professor of epidemi¬ 
ology and obstetrics and gynecology; 
William S. Beckett, M.D., a Pierce 
Laboratory associate fellow and 
associate professor of occupational 
medicine and of epidemiology 
(environmental health); Theodore R. 
Holford, Ph.D., professor of public 
health (biostatistics); and Kathleen 
Belanger, Ph.D., associate research 




A chemical formed when cocaine and 
alcohol are consumed together may 
contribute to both the euphoria, or 
“high,” and to the sometimes fatal toxic 
effects cocaine u.sers experience. 
School of Medicine researchers report. 
In a late autumn presentation at the 
annual meeting of the Society for 
Neuroscience, John D. Elsworth, Ph.D., 
research scientist in psychiatry and 
pharmacology, described chemical 
changes akin to a drug-induced 
euphoria in laboratory rats that were 
given cocaethylene, a compound 
apparently formed in people who 
consume cocaine and alcohol together. 
“Cocaethylene appears to have 
cocaine-like effects on brain chemistry,” 
reports Dr. Elsworth. The findings 
could aid researchers to develop drugs 
to help wean addicts from cocaine. 
The findings may explain why 
cocaine abu.sers say they can prolong 
their “high” by drinking alcohol, 
suggests Robert H. Roth Jr., Ph.D., 
professor of psychiatry and 
pharmacology, an author of the 
research report. Half of cocaine abusers 
are estimated to drink alcohol while 
imbibing cocaine. 
Comments co-author Peter 1. Jatlow, 
M.D., professor and chaimian of 
laboratory medicine and professor of 
psychiatry. “Some cocaine abusers have 
reported that drinking ethanol with 
cocaine lessened the dysphoria,” or 
“crash,” after a cocaine high. He is 
quick to add, however, that despite this 
salutary effect, cocaethylene also may 
contribute to sudden death and the 
cardiac problems that sometimes occur 
in cocaine abu.sers. 
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le Mitikin. M.I). 
by TrKn b'trsc.bbau, 
What's Stopped Happening to Me? by 
Dale Burg and Dr. Mary Jane Minkin, 
assistant clinical professor of obstetrics 
and gynecology, Lyle Stuart (New York) 
1990. 
NEW BOOKS 
Treatment of Retinopathy of Prematurity, 
ed. Dr. Joseph W. Eichenbaum, ’73, 
Mosby-Year Book Co. (St. Louis) 1990. 
Parent vs. Parent: How Yon and Your 
Child Can Survive the Custody Battle, 
by Dr. Stephen P. Herman, assistant 
clinical professor of psychiatry. 
Pantheon (New York) 1990. 
Your Aching Back: A Doctor's Guide 
to Relief, rev. edit., by Dr. Augustus A. 
White, ’63-’66 HS, Simon and Schuster 
Inc. (New York) 1990. 
The Triune Brain in Evolution, by 
Dr. Paul D. MacLean, '40, Plenum 
Press (New York) 1990. 
Pediatric Trauma, 2nd edit., ed. Dr. 
Robert J. Touloukian, professor of 
surgery and pediatrics, Mosby-Year 
Book Co. (St. Louis) 1990. 
A Year-Long Night: Tales of a Medical 
Internship, by Dr. Robert Klitzman, 
’85, Penguin Books (New York) 1989. 
Assisting Pediatric Practice: A Clinical 
Study, by Dr. Raymond S. Duff, ’52, 
’59 M.P.H., Health Administration 
Press (Ann Arbor) 1990. 
FACULTY NEWS 
Donald J. Cohen, M.D., the Irving B. 
Harris Professor of Child Psychiatry, 
Pediatrics and Psychology, received the 
27th Annual Strecker Award sponsored 
by the Institute of Pennsylvania 
Hospital in Philadelphia. He was 
honored for his research into the 
treatment of autism and Tourette’s 
syndrome in children. 
Evan H. Dillon, M.D., assistant 
professor of diagnostic radiology, 
presented a paper, entitled “Achilles 
Tendon Healing: MRl Evaluation,” at 
the Radiological Society of North 
America annual meeting held in 
November in Chicago. 
Alfred S. Evans, M.D., M.P.H., the 
John Rodman Paul Professor Emeritus 
of Epidemiology, was honored by the 
American Public Health Association 
with the 1990 Abraham Lilienfeld 
Award for his contributions to the 
teaching of epidemiology. 
Myron Genel, M.D., associate dean 
for government and community affairs 
and a 1957 graduate of Moravian 
College in Bethlehem, Penn., was 
honored by his alma mater with the 
1990 Comenius Alumni Award. The 
award recognizes his outstanding 
contributions to society. Dr. Genel also 
is president of the newly fomied 
Connecticut United for Research 
Excellence (CURE), a coalition of 
colleges and universities, hospitals, 
voluntary health organizations, 
professional health societies and 
industries. CURE was established to 
promote public understanding of 
biomedical research. 
Nicholas M. Greene, M.D., 
professor emeritus of anesthesiology, 
was presented the American Society of 
Anesthesiologists Distinguished 
Service Award at its annual meeting in 
October. The award is given for 
meritorious service and achievement 
during a career in anesthesiology. 
Richard H. Greenspan, M.D., 
professor of diagnostic radiology and 
associate dean for clinical affairs, was 
honored with the Gold Medal of the 
Association of University Radiologists 
Society. The article he co-authored on 
in vivo magnification angiography, 
published in Investigative Radiology in 
1967, was cited as one of the 12 best 
articles published during the journal’s 
25-year history. 
Robert ,1. Levine, M.D., professor 
of medicine, has been lecturing on 
ethical issues at several international 
conferences. Over the past months, he 
has spoken at the Menendez Pelayo 
International University in Santander, 
Spain, on ethics of research involving 
human subjects; at the Pan American 
Health Organization’s “Regional 
Consultation on AIDS, Human Rights, 
Ethics and Law,” in Santiago, Chile; at 
the Council for International 
Organizations of Medical Sciences’ 
meeting, entitled “Development of 
International Ethical Guidelines for 
Epidemiological Research and 
Practice,” held in Geneva, Switzerland. 
He also spoke on scientific integrity at 
the annual meeting of the American 
College of Neuropsychopharmacology 
in San Juan, Puerto Rico. 
James Merikangas, M.D., attending 
physician at YNHH and assistant 
clinical professor of psychiatry at the 
School of Medicine, has been named to 
the editorial board of the Annals of 
Clinical Psychiatry, where he will edit 
a special treatment section. 
Bernard S. Siegel, M.D.. assistant 
clinical professor of surgery, has been 
named honorary chaimian of the newly 
organized National Wellness Coalition. 
The coalition works with Congress and 
officials from the White House, U.S. 
Department of Health and Human 
Services and the National Institutes of 
Health to shift the focus of national 
health policy from illness to wellness. 
Juan Rosai, M.D., professor of 
pathology and director of anatomic 
pathology, presented the 1990 Arthur 
Purdy Stout Memorial Lecture in 
October at the American Society of 
Clinical Pathologists fall meeting. The 
lecture was entitled “Head, Neck and 
Mediastinal Pathology Related to 
Branchial Pouch Derivatives; A New 
Histogenetic and Pathogenetic 
Proposal.” 
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Pathology, EPH 
Chairmen Named 
In an appointment that culminated a 
national search, Jon S. Morrow, M.D., 
F^h.D., professor of pathology, has been 
named chairman of the School of 
Medicine's department of pathology 
and chief of pathology at Yale-New 
Haven Hospital. Dr. Morrow, who 
received his M.D. degree from Yale in 
1976 and completed his internship and 
residency at YNHH, has been a faculty 
member and attending pathologist since 
1981. He succeeds Vincent T. Marchesi, 
M.D.. Ph.D., director of the Yale 
Center for Molecular Medicine. 
Dr. Morrow’s pioneering work has 
helped define the structure and function 
of the cell cytoskeleton, the microscopic 
filaments which serve as a foundation 
for the outer layer of cells of all bodily 
tissues, called epithelial cells. His studies 
have helped scientists delve into the 
molecular level to identify the origin of 
several inherited blood diseases in 
children. His recent research has focused 
on how disorders of cytoskeleton 
structure can disrupt the central nervous 
system and cause epithelial diseases, 
including certain forms of cancer. 
EJeyond these basic science 
endeavors. Dr. Morrow headed the team 
that designed and installed the 
pathology department’s computerized 
patient information system. This system 
has become a national model used by a 
number of institutions. 
Medical school Dean Leon E. 
Rosenberg noted Dr. Morrow’s 
"significant contributions" to the 
School of Metlicine and added, “In his 
new position as chairman of pathology, 
he will lead this well-established 
department to even greater 
accomplishments." 
Soon after Dr. Morrow’s appoint¬ 
ment was announced. Dr. Rosenberg 
made public the reappointment of 
Burton 11. Singer, Rh.D., professor of 
public health and statistics, as chainnan 
of the medical school’s department of 
epidemiology and public health (EPH). 
Dr. Singer’s three-year term will begin 
at the completion of his initial, two-year 
term as chairman in July 1991. He will 
eontinue to serve as associate dean for 
public health. 
\s he announced Dr. Singer’s 
r. ■ ipomtment. Dean Rosenberg said: 
During the past year, under his inspired 
K ..'.t Tship, the department of epidemi¬ 
ology and public health has reorganized 
its academic program and launched 
,several new initiatives that bridge 
public health with foresty, law and 
other disciplines and that encourage 
public health, medical and nursing 
students to work together. This 
reappointment will allow Dr. Singer to 
continue enhancing Yale’s long-standing 
tradition of excellence in public 
health." 
An expert in tropical diseases. Dr. 
Singer is chaimian of a World Health 
Organization steering committee for 
social and economic research in the 
tropical disease program. 
FACULTY NEWS 
Brenda Bigland-Ritchie 
Receives Humboldt Award 
Dr. Brenda Bigland-Ritchie has received 
an international Humboldt Research 
Award for senior U.S. scholars, 
recognizing her achievements in neuro¬ 
physiology. Dr. Bigland-Ritchie is 
adjunct professor of pediatrics and 
lecturer in neurology, a fellow at the 
John B. Pierce Laboratory and a professor 
of biology at Quinnipiac College. 
The award, given since 1972 by the 
Alexander von Humboldt Eoundation, 
based in Bonn, Germany, is one of IOC) 
presented annually to foster cooperation 
between foreign and German researchers 
and their institutions. Recipients are 
invited to conduct research in the Eederal 
Republic of Germany. 
Dr. Bigland-Ritchie’s prize of 95,()()() 
Deutschemarks (approximately $62,()()()) 
will allow her to spend 12 months 
throughout the next five years with Dr. 
Albrect Struppler, director of neurology 
and clinical neurophysiology at the 
Technical University of Munich, who 
studies causes of neuromuscular diseases. 
In Munich, Dr. Bigland-Ritchie will 
employ microneurography to record 
nerve impulses during muscle 
contraction to determine how 
infonnation about changing muscle 
properties is transmitted to the brain 
during muscular fatigue. She also will 
stimulate the human brain directly with 
magnetic pulses. By combining these 
techniques, she hopes to gain new 
insights about infonnation processing 
by the brain during physical activity. 
Six Yale Researchers 
Win Wakeman Award 
For Spinal Cord Research 
Six Yale researchers were numbered 
among 17 scientists who shared the 
1990 Wakeman Award for Research in 
the Neurosciences. The 17 won the 
award, one of the highest honors in the 
neurosciences, as co-authors on a study 
on methylprednisolone, a steroid drug 
that can help people paralyzed by spinal 
cord injury recover some sensation and 
movement. 
The researchers received their award 
at a ceremony held last fall at Duke 
University in Durham, N.C. They 
include: principal investigator Michael 
B. Bracken, Ph.D., professor of 
research in epidemiology and obstetrics 
and gynecology; co-principal investigator 
William F. Collins, M.D., the Harvey 
and Kate Cushing Professor of Surgery 
(Neurosurgery), chaimian of the surgery 
department; Theodore R. Holford, Ph.D., 
professor of public health (biostatistics); 
Linda Leo-Summers, M.P.H., project 
manager in epidemiology and public 
health; Joseph M. Piepmeier, M.D., 
associate professor of surgery 
(neurosurgery); and Mary Jo Shepard, 
M.P.H., associate research scientist in 
epidemiology and public health. 
Dr. James P. Comer 
Wins McGraw Prize 
James P. Comer, M.D., M.P.H., 
associate dean for student affairs and 
the Maurice P. Falk Professor of 
Psychiatry and in the Child Study 
Center, was awarded the Harold E. 
McGraw Jr. Prize in Education, which 
carries a cash award of $25,000. Judges 
cited Dr. Comer's contributions to 
urban public education. 
Two decades ago. Dr. Comer intro¬ 
duced a method for improving urban 
public schools, an approach that 
encourages parents, teachers, admini¬ 
strators and other school employees to 
work as a team. Because of the 
approach’s success in New Haven and 
other cities, last year the Rockefeller 
Foundation of New York City 
announced a multi-million dollar 
initiative to introduce Dr. Comer’s 
method nationwide. 
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Dean Elected 
To National Post 
Dean Leon E. Rosenberg has been 
elected chair-elect of the Council of 
Deans, part of the governing structure 
of the Association of American Medical 
Colleges (AAMC). 
Dr. Rosenberg’s election came in 
October at the council’s annual 
business meeting, held as part of the 
AAMC’s 101st annual meeting in San 
Francisco. The dean, who will continue 
to serve on the AAMC executive 
council, succeeds Robert E. Tranquada, 
M.D., dean of the University of 
Southern California School of 
Medicine, who becomes Council of 
Deans chairman. 
The AAMC represents the 126 
U.S.accredited medical colleges, 16 
accredited Canadian medical schools, 
more than 400 major teaching hospitals, 
including 72 Department of Veterans 
Affairs medical centers; more than 90 
academic and professional societies, 
and the nation’s medical students. 
Leading the organization of deans 
of the nation’s medical schools. 
Dr. Rosenberg says, strengthens his 
service to Yale. “By interacting with 
the leadership of the AAMC and 
medical educators throughout the 
country, I hope to help address the 
many problems found by clinicians and 
health scientists,” the dean states. 
Dr. Jay Katz Named 
Endowed Professor 
Jay Katz, M.D., professor (adjunct) of 
psychiatry, was named the first 
Elizabeth K. Dollard Professor in Law, 
Medicine and Psychiatry by University 
President Benno C. Schmidt Jr. The 
chair was recently established by the 
Elizabeth K. Dollard Trust and honors 
the 1939 Law School graduate. 
Dr. Katz, an outspoken advocate of 
patients’ rights, was among the first 
researchers to explore the problems 
created by experiments on human 
beings and to bring about changes in 
rules and procedures to protect subjects. 
In 1984, he authored the book. The 
Silent World of Doctor and Patient, 
which documents the practice of 
physicians witholding information from 
their patients and omitting patients from 
decision-making. He also is co-author 
of The Family and the Law and 
Psychoanalysis, Psychiatry and Law. 
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A member of the Institute of 
Medicine of the National Academy of 
Sciences, Dr. Katz has been honored 
for his contributions to the fields of 
legal psychiatry and health law teaching 
by the American Psychiatric 
Association, the American College of 
Physicians, and the American Society 
of Law and Medicine. 
Michael Marsland 
Bella Z. Person, M.A.L.S., has retired 
as associate university librarian and 
director of the Harvey Cashing!John 
Hay Whitney Medical Library. She was 
a 21-year Yale library staff member. 
During the past si.x years, Ms. Berson 
led the medical library through an 
extraordinary period of development, 
culminating with a $10 million 
renovation and e.xpansion which was 
completed in June. R. Kenny Fryer, 
M.L.S.. head of Medical Library 
Reference Services, now serves as 
acting director of the medical library. 
Linda Mayes Named 
First Gesell Professor 
Yale University has named Linda C. 
Mayes, M.D., the first Arnold Gesell 
Associate Professor of Child Develop¬ 
ment at the School of Medicine. A 
medical school faculty member since 
1985, Dr. Mayes is a developmental 
pediatrician whose work is in the 
tradition of Dr. Arnold Gesell, a pioneer 
in the field of child development. 
Dr. Mayes’ work parallels that of Dr. 
Gesell in her focus on the development 
of normal infants and children. Most 
recently, she has applied various 
procedures and conceptual models that 
she has developed to study the effects 
of prenatal cocaine exposure on infants’ 
and young children’s development. 
This fall. Dr. Mayes began a five-year 
longitudinal study of children first seen 
at birth who have been exposed 
prenatally to cocaine. She and her 
colleagues are examining the effects of 
cocaine exposure on young children’s 
attention and curiosity. 
A native of Winchester, Tenn., Dr. 
Mayes received a B.A. degree in 1973 
from the University of the South and an 
M.D. degree in 1977 from Vanderbilt 
University School of Medicine. She 
completed residency training in pediatrics 
and a fellowship in neonatology at 
Vanderbilt. In 1982, she came to Yale 
as a Robert Wood Johnson General 
Academic Pediatrics Fellow. She was 
also a fellow to the National Center for 
Clinical Infant Programs from Yale. 
Among her professional honors, she 
received the Amos Christie Award in 
pediatrics from Vanderbilt University, 
a research and teaching award from the 
Ambulatory Pediatrics Association in 
1985, the advanced pediatric research 
award from the John,son & Johnson 
Foundation in 1984 and 1985, and from 
1986 to 1991 holds a William T. Grant 
Faculty Scholars Award. In 1989, 
Dr. Mayes was named the Elizabeth 
Mears and Hou.se Jameson Assistant 
Professor of Child Development at the 
Yale Child Study Center. 
Dr. Reich Receives 
Diabetes Awards 
Dr. Eva-Pia Reich, associate research 
scientist in immunobiology, has 
received the Juvenile Diabetes 
Foundation International (JDF) Career 
Development Award and the Greenwall 
Foundation Award for her research on 
insulin-dependent diabetes mellitus 
(IDDM), also called juvenile diabetes 
type 1. 
The three-year JDF award, which 
carries a $45,000 prize, will support Dr. 
Reich’s project entitled “Role of T 
Lymphocytes in the Pathognesis of 
Diabetes.” Dr. Reich’s research focuses 
on why certain white cells, T lympho¬ 
cytes, from patients with IDDM 
selectively attack and destroy insulin- 
producing beta cells of the pancreas. 
Her research, conducted in collabor¬ 
ation with Dr. Robert S. Slierwin, 
professor of medicine, uses the non- 
obese diabetic mouse model which 
spontaneously develops type I diabetes. 
Dr. Reich says the researchers isolate 
lymphocytes from pancreatic tissue 
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Seven years have passed since publica¬ 
tion of the School of Medicine Alumni 
Directory. An update of this volume 
has been a high priority for me since 
my appointment as director of alumni 
affairs. In spring of 1992, another, more 
impressive edition of the directory will 
debut. It will include more than I 1,000 
medical school, public health and 
physician associate alumni/ae, as well 
as former house staff and post-doctoral 
fellows. Also featured will be school 
codes, specialty codes and specialty 
sections to enhance the volume’s utility 
as a professional reference. 
The Bernard C. Harris Publishing 
Company. Inc. will produce our directory. 
Harris Publishing soon will begin 
compiling data gathered from you, our 
graduates, via a mailed questionnaire. 
Your cooperation in providing this 
infonnation will help us publish an 
accurate, comprehensive directory. 
Harris Publishing guarantees the 
confidentiality of this database and 
takes steps to safeguard against any 
inappropriate use of it or the directory. 
Nevertheless, if you prefer not to be 
listed, and hence, not to he contacted by 
Harris Publishing, please communicate 
with the medical school alumni office 
in writing as soon as possible at: Office 
of Alumni Affairs. Yale School of 
Medicine, .TTl Cedar St., P.O. Box 3333. 
New Haven. CT 065 l()-S(),3.3. 
We are eagerly anticipating the 
alumni office's relocation to new 
quarters in the former Lee High School 
— now known as 100 Church Street 
South — in late spring or early 
summer. •'I'his space has been designed 
for efficiency and comfort by Herbert 
S. Newman Associates of New Haven. 
We invite alumni/ae to visit us and to 
see our new office. The new facilities 
emphasize the importance of our 
relationship with you by providing an 
easily accessible and comfortable place 
for us to interact. 
.A continued concern for medical 
school students as future alumni 
occupies the attention of this office. 
Nick Spinelli has volunteered to help 
organize class secretaries and agents 
bi’lAn' they leave the medical school for 
'(.-.tgraduate training. 
V.cannot rely alone on the fine 
. ■. iiing of i.iiir superb faculty to 
- i: - I'der student loyalty to their alma 
mater. Students must know that we, the 
medical .school faculty, staff and 
alumni, care about them as individuals 
and colleagues. This more than 
anything reinforces students’ desire to 
consider themselves as part of the 
medical .school family after they graduate. 
In this spirit, the alumni office has 
agreed to student council requests for 
assistance with various projects. To 
mention a few, our office supported the 
efforts of the annual dance, 
affectionately known as the Cadaver 
Ball, held in January at the Grassy Hill 
Country Club in Orange. In February, 
the alumni office hosted a student- 
faculty tea in the Beaumont Room. We 
also helped to advertise and promote 
the second-year student show, which 
was presented in March. 
Alumni, who share an open 
invitation to such events, have 
responded, but the students welcome 
even greater participation. This 
invitation is no formality; students are 
eager to talk with the alumni about their 
own medical .school experiences, and to 
learn from their predecessors about 
their life lessons. You will be favorably 
impressed with these bright, dedicated 
young people, who surely will evoke 
memories of your own student days. 
Another chance to remini.sce and 
catch up with old friends presents itself 
at our annual Alumni Reunion 
Weekend, to be held on June 7 and 8. 
Dedication of the new Boyer Center for 
Molecular Medicine will take place on 
Thursday, June 6, so that returning 
alumni/ae may share in the festivities. 
Our related theme for the weekend: 
"Clinical Medicine in an Age of 
Molecular Medicine." 
We encourage all alumni/ae to 
attend; quinquennial reunions 
(celebrated every five-years) will be 
held for classes ending in the years “I" 
and "6.” Medical class reunion 
seminars will be followed by our 
keynote speaker, Nobel laureate George 
E. Palade, M.D., Sterling Professor 
Emeritus of Biology at Yale and dean 
of scientific affairs. University of 
California, San Diego, School of 
Medicine. He will discuss “The 
Medical School Curriculum and the 
Rapid Expansion of Biomedical 
Sciences." At surgical grand rounds on 
June 8, moderator William F. Collins 
Jr., M.D., chairman of surgery, will 
discuss recent advances in this field. 
Faculty seminars include: 1) "Recent 
Advances in Disorders of 
Pigmentation,” moderated by Jean 
Bolognia, M.D. ’80; 2) “Lyme Disease: 
State of the Art,” moderated by Daniel 
W. Rahn, M.D. ’76; 3) “The Pain 
Experience,” moderated by Luke M. 
Kitahata, M.D., Ph.D. 
Dr. Vincent T. Marchesi will 
moderate a panel discussion entitled 
“Yale Center for Molecular Medicine 
— Program for the Future.” Center 
faculty members will discuss upcoming 
molecular research programs in 
genetics, cardiobiology, neurobiology, 
and oncology and development. 
The medical reunion dialogue and 
tea/sherry will conclude the scientific 
program. Arthur Ebbert Jr., M.D., 
professor emeritus of medicine, will 
moderate a discussion between Alvan 
R. Feinstein, M.D., professor of 
medicine and epidemiology, and Joseph 
Warshaw, M.D., professor and 
chairman of pediatrics, entitled 
“Fundamental Scientific Challenges in 
Clinical Care.” We encourage you to 
attend these thought-provoking sessions. 
Finally, I would invite alumni who 
have not contributed this year to the 
School of Medicine Alumni Fund to do 
so now. The Kresge Foundation 
Challenge will provide a $1 million 
donation to help complete the Center 
for Molecular Medicine if Alumni Fund 
participation rises from last year’s 43 
percent to 55 percent in 1990-1991. 
Alumni Fund giving also must reach 
$450,000 before the fiscal year ends 
June 30. As usual, your Alumni Fund 
dollars will support medical student 
financial aid unless you stipulate 
otherwise. 
If you did not support our Alumni 
Fund last year, please help us increase 
the percentage of participation with 
your gift. If you did contribute last year, 
it is vital for you to do so again this 
year to help maintain the base of 
participation on which we are building. 
Remember, every contribution counts. 
Arthur C. Crovatto. M.D. '54 
Director of alumni aff airs 
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Highlights: Alumni Weekend 
June 6-8y 1991 
Thursday, June 6 
1:30 p.m. Boyer Center for Molecular Medicine Dedication 
“Constructing a National Agenda for Biomedical Research” 
Friday, June 7 
8:00 a.m. Registration, Sterling Hall of Medicine rotunda 
9:00 a.m. Perspectives in Molecular Medicine 
1:00 p.m. Class reunion seminars (concurrent) 
I. Class of 1941 — 50th reunion 
II. Class of 1946 — 45th reunion 
III. Class of 1951 — 40th reunion 
4:00 p.m. Special address: “The Medical School Curriculum and the Rapid 
Expansion of Biomedical Sciences,” George E. Palade, M.D., dean, 
scientific affairs. University of California, San Diego, School of Medicine 
5:00 p.m. Dean’s reception 
Saturday, June 8 
9:00 a.m. Surgical grand rounds 
9:15 a.m. Concurrent faculty seminars: dennatology, rheumatology, 
immunobiology, neuroanatomy, pharmacology, anesthesiology 
10:30 a.m. Yale School of Medicine Reunion Symposium: 
“Center for Molecular Medicine — Program for the Future” 
11:45 a.m. Annual meeting of the Association of Yale Alumni in Medicine, 
Distinguished Service Award presentation 
1:00 p.m. Sherry and buffet luncheon 
2:45 p.m. Guided tours: Yale Center for British Art, historic sections of New Haven, 
Center for Molecular Medicine 
3:15 p.m. Yale medical reunion dialogue and tea/sherry: 
“Fundamental Scientific Challenges in Clinical Care” 
Yale Medicine Spring 1991 37 
ALUMNI NEWS 
Dr. Paul D. Mad .ean,'40,senior 
research scientist at the National 
Institute of Mental Health, presented 
the John F. Fulton Lecture on "Planning 
and Remembering the Future: Frontal 
Lobe Functions and John Fulton’s 
Continuing Contribution" at the 296th 
meeting of the Beaumont Medical Club 
held in November at the medical 
school. 
Dr. Robert Schwartz, 47, 
professor of pediatrics at Brow n 
University Program in Medicine and a 
member of the division of pediatric 
endocrinology and metabolism at 
Rhode Island Hospital, was awarded 
the American Academy of Pediatrics 
1990 Nutrition Award for Research. 
The academy noted Dr. Schwartz's 
research into the metabolism of 
carbohydrates in newborns and the 
mechanisms that control blood sugar 
levels in infants of diabetic mothers. 
Dr. Robert N. Hamburger, "51. 
was named professor emeritus at the 
University of California, San Diego. 
School of Medicine, in July, after more 
than 30 years as professor and head of 
the pediatric immunology and allergy 
division. 
Dr. Robert (L Petersdorf, '52. 
president of the Association of 
.American Medical Colleges, was one of 
four of this year's recipients of the 
National Medical Association Scroll of 
Merit. The award, which recognizes 
outstanding contributions to medicine, 
w as given to Dr. Petersdorf for his 
efforts in support of minority medical 
education and the improved health 
status of minority Americans. 
Dr. Robert Zeppa, '52, was 
awarded the American College of 
Surgeons (ACS) Distinguished Service 
Award in recognition of his clinical and 
surgical research on liver and portal 
circulation diseases. The award also 
cited his dedication to the University of 
Miami School of Medicine, where Dr. 
Zeppa has been a faculty member since 
1966. Dr. Zeppa. the Lucille and Dewitt 
Daughtry Professor and chainnan of 
surLory, is a fomier chairman of the 
ACS Ciraduale Medical FTlucation 
C ommitlee and a member of the ACS 
( ommiiiee on I'rauma. 
Robert Zeppa. M.D. '52 
Dr. Harry C. Miller Jr., '54, 
professor and chairman of urology at 
the George Washington University 
Medical Center, was elected president 
of the mid-Atlantic section of the 
American Urological Association. He 
also is secretary and treasurer of the 
American Association of Clinical 
Urologists. 
Dr. Paul Calabresi, '55. professor 
and chainnan of the department of 
medicine at Brown University, was 
elected a member of the Institute of 
Medicine of the National Academy of 
Sciences. Dr. Calabresi also is 
physician-in-chief at Roger Williams 
General Hospital and director of the 
Roger Williams Center for Cancer and 
Related Diseases. 
S 
Raul Calabresi. .M.D. '55 
Dr. Joseph S. Pagano, '57, was 
elected president of the International 
Association for Research on Epstein- 
Barr Virus and Associated Diseases. 
Inc. He is the Lineberger Professor of 
Cancer Research, professor of medicine 
and microbiology and immunology, and 
director of the Lineberger Comprehensive 
Cancer Center of the University of 
North Carolina at Chapel Hill. 
Dr. Joseph D. Ferrone, '62. clinical 
professor of orthopedic surgery at Tufts 
University School of Medicine and 
senior orthopedic surgeon at Tufts-New 
England Medical Center, was appointed 
to the Dean Junior College board of 
trustees. 
Helen L. Smits. M.D. '67 
Dr. Helen L. Smits, '67. director of 
the John Dempsey Hospital at the 
University of Connecticut Health Center 
and professor of community medicine 
at the UCONN School of Medicine, was 
elected chairman of the board of 
commissioners of the Joint Commission 
on Accreditation of Health Care Organi¬ 
zations. Her one-year term began Jan. 1. 
Dr. Anthony V. Proto, '71. professor 
and chairman of radiology at the Medical 
College of Virginia. Virginia Common- 
w'ealth University in Richmond, delivered 
the annual oration in diagnostic radiology 
on chest at the 76th Scientific As.sembly 
and Annual Meeting of the Radiological 
Society of North America (RSNA). His 
lecture focused on understanding newer 
observations seen on conventional chest 
radiographs to strengthen accuracy of 
diagnoses. Dr. Proto chairs the RSNA 
.scientific exhibits committee and is an 
associate editor for Radiology. 
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Dr. Robert H. Posteraro, ’73, 
professor and chairman of radiology at 
Texas Tech School of Medicine, was 
appointed commander of the 829th 
Station Hospital U.S. Army Reserve 
Unit in Lubbock. 
Francis S. Collins, ’74 Ph.D., a 
Howard Hughes Medical Institute 
associate investigator at the University 
of Michigan Medical Center, received a 
Gairdner Foundation International 
Award for his contributions to the 
identification and analysis of the cystic 
fibrosis gene. The molecular techniques 
developed by Dr. Collins and his 
colleagues also will facilitate the study 
of other genetic diseases. 
Dr. Thomas W. Smith, ’75, 
recently gave his 75th lecture to 
residents and practicing 
ophthalmologists at the Eye and Ear 
Institute of the University of Pittsburgh. 
Dr. Smith, clinical associate professor 
of ophthalmology at the Pittsburgh 
School of Medicine, has lectured for 
more than 10 years and also is a 
member of Keystone Eye Surgeons in 
Dubois, Penn. 
Dr. Christopher PL Attinger, ’81, 
was appointed assistant professor of 
surgery, division of plastic surgery at 
Georgetown University Medical Center 
in July. He specializes in extremity 
reconstruction. 
Dr. David H.W. Wohns, ’81, 
currently in practice at Butterworth 
Hospital in Grand Rapids, Mich., was 
elected a fellow in the American 
College of Cardiology. 
Margarita Acosta, ’82 M.P.H., is 
assistant administrator at Saint Peter’s 
Hospital in Olympia, Wash. 
Marie Ciacco-Tsivitis, ’86 M.P.H., 
is the infection control coordinator at 
Memorial-Sloan Kettering Cancer 
Center in New York. 
Stacey Wills, ’90 M.P.H., of 
Washington, D.C., works at the 
Employee Benefit Research Institute, a 
private non-profit organization that 
provides research and education to 
business, government and the public. 
She concentrates on state initiatives to 
cover the uninsured and on health care 
finance policy issues. 
STUDENT NEWS 
Irene M. Hegeman, a fourth-year 
medical student, was awarded a $2,500 
Rock Sleyster Memorial Scholarship by 
the American Medical Association to 
encourage her interest in psychiatry. 
Bill Rodriguez, a second-year 
student, competed on the New York 
Ultimate team in the National Ultimate 
Erisbee Championship held in November 
in West Palm Beach, Fla. Mr. Rodriguez’s 
team is the defending U.S. national and 
world ultimate frisbee champion, having 
defeated teams from 13 other countries 
in a July tournament in Norway. 
Ultimate frisbee is akin to soccer, with 
seven-member teams competing on a 
70-by-40-yard field. Players pass the 
flying disc among themselves and score 
by whirling it into the goal, located in 
the opposing team’s end zone. 
Medical Students Offer 
Youngsters Health Talks 
Seventh-graders at Roberto Clemente 
Middle School in New Haven stared 
wide-eyed at the lung specimens 
displayed by second-year medical 
students Joe Esherick and Linda Keyes, 
who explained that smoking was 
responsible for the black spots evident 
on one lung. Meanwhile, across town at 
the Career Education Center, second- 
year students Valerie Vanhoutte, Julie 
Miner and Emily Davidson stood in front 
of a classroom of high school students 
and talked with them about AIDS. 
The students are volunteering in two 
programs sponsored by the American 
Medical Students Association (AMSA), 
based in Reston, Va. The first program. 
Adolescent Substance Abuse Prevention 
(ASAP) is one of 10 two-year pilot 
projects sponsored by AMSA. Students 
Teaching AIDS to Students (STATS), 
the second program, is part of a 
national high .school AIDS education 
program initiated in 1988. 
Approximately 35 medical students 
have joined the ASAP effort, meeting 
weekly with Clemente .seventh-graders 
during science class. The program 
includes sections on the physical 
changes brought on by drugs, alcohol 
and tobacco; ASAP also presents ways 
to resist peer pressure to try drugs. 
During the STATS program’s first 
two years, Yale students have spoken 
about AIDS to more than 2,()()() teen¬ 
agers from New Haven high schools 
and middle schools. About 60 students 
from the School of Medicine, the 
department of epidemiology and public 
health and the School of Nursing have 
volunteered. 
Minority Conference 
Targets Health Care 
Leading health professionals and 
political leaders presented their views 
on “Bridging the Gap in Health Care: 
Availability vs. Access’’ when the New 
England region of the Student National 
Medical Association (SNMA) held its 
annual conference Eeb. 15 and 16 at the 
School of Medicine. More than 70 
students from the nine medical schools 
in the region and 150 undergraduate 
premedical students attended. 
“Our program focused on problems 
encountered in health care for minorities, 
and we explored ways to increase 
awareness of and access to health care,” 
reports Ellis L. Webster, a fourth-year 
medical student who chairs the SNMA’s 
Yale chapter, founded in the early 1970s. 
On Saturday, the 16th, the School of 
Medicine and the Yale chapter of the 
SNMA hosted the annual recruitment 
day conference for undergraduate 
minority students interested in 
attending the School of Medicine. Dr. 
Woodrow A. Myers Jr., New York 
City’s health commissioner, gave the 
keynote address, highlighting disease 
trends in the ’90s and outlining the 
concerted effort needed to control these 
problems. Other speakers included New 
Haven Mayor John C. Daniels; Cornell 
Scott, M.P.H. ’68, executive director of 
the Hill Health Center; and Marie 
Spizey, chief of the Connecticut Bureau 
of Community Health. 
Based in Washington, D.C., the 
Student National Medical Association 
is the nation’s oldest and largest 
organization for black. Latino and 
native American medical students. 
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Agnes V. Bartlett 
Agnes V. Bartlett, M.D., died Aug. 7 at 
Hanover Terrace Healthcare in Vermont. 
She was 79. 
A native of Kyoto, Japan. Dr. Bartlett 
graduated from Mount Holyoke 
College and in 1938 from Yale School 
of .Medicine. Following residency 
training in obstetrics and general 
practice, she served as a medical officer 
in relocation centers in .Arizona and 
California during World War 11. 
After the war. she moved to 
Thetford Hill. Maine, and began a 
general practice with Dr. William 
Putnam. She later undertook specialty 
training in Hanover and was in private 
practice in Springfield, Vt., and 
Concord, N.H. From 1964 until her 
retirement in 1976, Dr. Bartlett 
practiced at the Veterans .Administration 
Hospital in White River Junction. 
She was a director of the FJrookhaven 
Home for Boys in Chelsea and a 
volunteer parole officer. 
Memorial contributions may be 
made to the Norwich Public Library , 
Norwich. VT {)5{).35. 
Daniel S. Egbert 
Daniel S. Egbert. M.D., died April 28 
at his home in Fort Dodge. Iowa. He 
w as 84. 
.A native of Nebraska, Dr. Egbert 
graduated from the University of 
Nebraska .Medical School in 1931 and 
interned at San Diego General Hospital. 
He served on the house staff from 1932 
to 193-3 in pathology at Yale and later 
set up practice in Atlanta. From 1940 
through 1945, Dr. Egbert served as a 
medical officer in the U.S. Army and as 
a commanding officer of a portable 
surgical hospital unit in the Chica Bumia- 
India area. In. 1945. he established a 
practice in Fort Dodge, where he stayed 
until his retirement in 1983. 
Dr. Egbert was a charter member of 
the .American Society of General 
Practitioners, a charter diplomate of the 
American Board of Family Practice, 
and served a term as president of the 
Webster County Medical Society. 
He leaves his wife, Helen; a daughter. 
Nancy; two sons. James and Thomas; 
and si.x grandchildren. 
Memorials may be made to the Dr. 
Daniel S. ligbert Memorial Cancer 
Library established at Trinity Regional 
Hospital, fhe library serves families 
and friends of cancer patients. 
OBITUARIES 
Charles T. Elynn Jr. 
Charles T. Flynn Jr., M.D., died Sept. 11 
in Fairview General Hospital. Cleveland. 
He was 72. 
Dr. Flynn was fonner chaimian of 
the medical board and chief of staff at 
Meriden-Wallingford Hospital in 
Connecticut. He also was an orthopedic 
surgeon in Meriden for 33 years. He 
retired in 1984 but remained as director 
of the hospital. 
A native of Connecticut. Dr. Flynn 
was a graduate of Providence College 
and a 1943 graduate of Yale School of 
Medicine. During World War 11. he 
served in Europe as a major in the 
Army Medical Corps. 
He leaves his w ife. Martha; two 
sons. Stephen and Thomas; seven 
daughters, Barbara. Debora, Ann. Joan. 
Donna. Martha and Christine; and eight 
grandchildren. 
Erancis J. Kenney 
Erancis J. Kenney. M.D., died Aug. 13 
in Cincinnati, at the age of 62. 
A Connecticut native. Dr. Kenney 
was a 1951 graduate of Harvard 
University and a 1955 graduate of Yale 
School of Medicine. He trained in 
general and thoracic surgery at Harvard 
and the University of Michigan and was 
a diplomate of the American Board of 
Surgery and the American Board of 
Thoracic Surgery . Eollow ing a career in 
clinical practice. Dr. Kenney worked in 
the pharmaceutical industry until his 
retirement in 1989. 
He leaves his w ife, Jane; two 
daughters. Jane and Elizabeth; and two 
.sons, Francis Jr. and Edward. 
Donations may be made in Dr. 
Kenney's name to the Harvey 
Cushing/John Hay Whitney Medical 
Idbrary, P.O. Box 3333. New Haven. 
CT 065 10. or to the Choir Eund at Old 
St. Mary's Church. Over-the-Rhine, 
123 E. 13th St., Cincinnati. OH 45210. 
Laura Kuckes 
Laura Kuckes, M.D., died Aug. 5 in a 
boating accident in Admiralty Bay, 
Alaska. She was 29. 
A native of New Jersey. Dr. Kuckes 
was a 1982 graduate of Cornell 
University and a 1988 graduate of Yale 
School of Medicine. She spent one year 
before entering Yale working in 
Washington, D.C., for the Union of 
Concerned Scientists. Dr. Kuckes 
interned at the Mary Imogene Bassett 
Hospital in Cooperstown, N.Y.. and 
later practiced for the North Slope 
Borough in Barrow. Alaska. Under a 
grant from the Yale International 
Student Fellowship Program, Dr. 
Kuckes studied blood-brain barriers 
using electron microscopy at the 
Institute of Cell Biology in Romania. 
At Yale. Dr. Kuckes extended her 
schooling one year to pursue her thesis 
work and to become associated with the 
play writing program at the Yale School 
of Drama. There she co-authored two 
plays and wrote a musical, which were 
produced at the Yale Cabaret. She also 
received the medical school's 
Marguerite Rush Lemer Creative 
Writing Prize. 
Dr. Kuckes organized the medical 
school lecture series on nuclear war and 
was a delegate to the International 
Physicians for the Prevention of 
Nuclear War congresses for three years, 
during which she produced a multi- 
media show entitled “Snap-shots with 
the Red Army." 
Dr. Robert H. Gifford, associate 
dean for education and student affairs, 
who spoke at her memorial service, 
said, “During her years as a medical 
student, Laura hoped to combine her 
dramatic writing skills with her medical 
thesis work. . . She realized the close 
relationships that could be forged 
between medicine and psychiatry 
through playwriting, and became 
acutely aw are of how much art and 
medicine infomi each other. Laura had 
a natural ability to transfer enthusiasm 
to those around her. . . She lived with a 
zest and passion that captured our 
hearts and has left us full of fire and 
excitement for adventure and full of 
hope for a better world." 
Dr. Kuckes leaves her parents. 
.Arthur and Haralyn Kuckes; a sister. 
Niki; and a brother, Dylan. 
Memorial contributions in Dr. 
Kuckes' name may be made to 
Physicians for Social Responsibility, 
lOOO 16th St., NW. Suite 810. 
Washington. D.C. 2(X)36. 
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Bernard F. Mann Jr. 
Bernard F. Mann Jr., M.D., died Nov. 4 
in Fairplay, Colo. He was 76. 
A native of Maine, Dr. Mann 
graduated from Bates College in 1936 
and from Boston University School of 
Medicine in 1940. He served in the 
U.S. Navy for six years in the Pacific 
on the destroyer U.S.S. Case and at 
naval stations in Williamsburg, Va., 
and Bremerton, Wash. 
Dr. Mann was a Fulbright Professor 
of Pathology in the Medical School of 
the University of the Philippines in 
Manila. He served as assistant clinical 
professor of pathology at Yale School 
of Medicine from 1904 through 1971 
and also was associate pathologist at 
the Hospital of St. Raphael in New 
Haven. Following work in surgical 
pathology and cytopathology at the 
New England Deaconess Hospital, 
Boston, and teaching at Harvard 
University Medical School, Dr. Mann 
spent five years as chief of pathology 
services for the Arabian American Oil 
Co. in Dhahran, Saudi Arabia. 
He leaves his wife, Martha; two 
daughters, Nancy and Constance; and 
one son, Donald. 
Contributions may be sent to the 
Camden Area Y.M.C.A., Camden, ME 
04843. 
James W. Reed 
James W. Reed, M.D., died July 10 at 
the Franklin Memorial Hospital in 
Farmington, Maine. He was 85. 
A native of Maine, Dr. Reed 
graduated from the University of Maine 
and received an M.D. degree from Yale 
in 1931. He interned at New Haven 
Hospital and served residencies at the 
Boston Dispensary and the Franklin 
County Memorial Hospital. 
In 1934, he established a radiology 
practice in Farmington and later 
affiliated with Rumford Community 
Hospital. From 1942 to 1945, he served 
as a radiologist for the Maine General 
67th Hospital Unit in England. 
Dr. Reed coached the Farmington 
State Teachers College track and cross¬ 
country teams and the junior boys ski 
team of Farmington Ski Club for 
several years. He also served on the 
Farmington school board and the board 
of the Girl Scout Camp Kirkwold. 
He leaves his wife; a daughter, 
Carol; a son, James; and two grand¬ 
children. Memorial gifts may be made 
to the Franklin Memorial Hospital, 1 
Hospital Drive, Farmington, ME 04938. 
Knute Berger 
Knute Berger, M.D., died Dec. 24 at 
age 75. 
A Seattle native. Dr. Berger 
received a B.S. degree in chemistry 
from the University of Washington in 
1937 and an M.D. degree from Yale 
in 1941. 
Dr. Berger began his career as a 
surgeon but later chose to meld his 
passion for art with his devotion for 
medicine. For many years he worked 
as a medical illustrator, photographer, 
sculptor and exhibit designer. He also 
developed teaching models for use in 
medical school classes. Dr. Berger 
was the creator of the syndicated 
cartoon series, “Mr. Quiddity,” for the 
New York and Illinois state medical 
associations and was co-author of the 
children’s book, A Visit to the Doctor. 
He was a captain in the U.S. Army 
Air Force during World War 11, later 
working at Virginia Mason Hospital 
and at hospitals in South Carolina and 
Peru. He served as medical director at 
John Slade Ely Center for Health 
Education Research in New Haven. 
In 1961, he joined the research 
team of Dr. Lester Sauvage at the 
Hope Heart Institute at Providence 
Medical Center in Seattle, where he 
served for more than 20 years as head 
research pathologist. He is credited 
“Blue Embassy " ho.x art by Knute 
Berger. M.D. '41. 
for such advances as improved blood¬ 
vessel grafts and attachment 
mechanisms for artificial heart valves. 
He retired in 1982 and, with his 
wife, Margaret Haseltine Berger, 
formed Island Cupboard, a company 
that marketed gift cards featuring his 
photography and Mrs. Berger’s 
poetry. 
He is survived by his wife, two 
daughters, Barbara and Kari; a son, 
Knute; and two grandchildren. 
Paul H. Lavietes 
Paul H. Lavietes, M.D., died Dec. 27 in 
his home in New Haven. He was 83. 
Dr. Lavietes, a native of New 
Haven, received his bachelor’s and 
medical degrees from Yale in 1927 and 
1930. He completed his internship at 
Sinai Hospital, Baltimore, and his 
residency at New Haven Hospital. He 
also was a Saxe research fellow in 
metabolism at Yale from 1932 to 1933. 
Dr. Lavietes served as a captain in 
the U.S. Army at the Center for 
Tropical Disease, Treatment and 
Research in Swannanoa, N.C., for three 
years. From 1933 through 1981, he was 
an attending physician at Yale-New 
Haven Hospital. Beginning his career at 
the School of Medicine in 1933 as an 
instructor. Dr. Lavietes became an 
assistant professor, clinical assistant 
professor and later clinical associate 
professor until 1984. He also served as 
a clinical associate professor of public 
health from 1968 through 1981. 
Dr. Lavietes was in private practice 
of internal medicine in New Haven for 
25 years until he became the founding 
medical director of the Community 
Health Care Plan in 1971, a position he 
held until his retirement in 1981. 
He was a consulting physician at 
Fairfield Hills Hospital, the Veterans 
Administration Medical Center in West 
Haven, Meriden-Wallingford Hospital 
and Laurel Heights Hospital. 
Dr. Lavietes was a member of the 
Society for Clinical Investigation and a 
founding editor of the Medical Letter of 
Drugs and Therapeutics: he served on 
the publication’s advisory board from 
1959 through 1964. He also was a 
board member of Gaylord Hospital in 
Wallingford and on the medical advisory 
committee of the Jewish Home for the 
Aged from 1968 through 1986. 
He leaves his wife, Ruth Sweedler 
Lavietes; a son, Marc; a daughter, 
Sylvia; and three grandchildren. 
Memorial contributions may be 
made to the Jewish Home for the Aged, 
169 Davenport Ave., New Haven; or 
the Yale School of Medicine, Develop¬ 
ment Office, P.O. Box 3333, New 
Haven, CT 06519. 
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OBITUARIES 
Conrad Lam, M.D. '32 
Conrad Lam 
Conrad Lam. M.D., died May 14 in 
F'arniington Hills, Mich. He was K4. 
A native of Michigan, Dr. Lam was 
a 1927 graduate of Hardin-Simmons 
University, Te.xas, a 1932 graduate of 
>'ale School of Medicine and a 1938 
graduate of the University of Michigan, 
w here he received an M.S. degree in 
surgery. 
Dr. Lam served as a thoracic and 
cardiac surgeon for 30 years at the 
Henry F-'ord FFospital until his retire¬ 
ment in 1983. In 1930. in collaboration 
with Dr. FF.FF. Aram, F4r. Lam conducted 
one of the first heart-valve transplant 
surgeries. In 1936, he performed 
.Michigan's first open-heart operation 
using total heart-lung bypass. He also 
developed methods to close holes in the 
heart and to stop the heart during 
intracardiac operations. In 1980, he was 
recognized by Shiley Laboratories as 
one of the "'F'en F^ioneers of Cardiac 
Surgery." 
In 1987, Dr. F,am received a 
Distinguished Service Award from 
Yale School of Medicine. He also was 
honored by Hardin-Simmons LJniversity 
with the Keeter Alumni Award, the 
L'niversity's most prestigious alumni 
award; a Distinguished Alumnus 
■Avsard and with an honorary doctorate, 
file Henry l ord Hospital has 
I'stablishetl a cardiac and thoracic 
ur-ers lecture series in his honor. 
4.’ 
Author of more than 200 journal 
articles and co-author of a hiatus hernia 
textbools. Dr. Lam was a member of the 
American Association for Thoracic 
Surgery, the American Surgical 
Association and the Central Surgical 
Association. 
He is survived by his wife, Marian; 
two daughters, Marjorie and Janet; two 
sons, Richard and Douglas; and nine 
grandchildren. 
Contributions may be made to the 
Cowboy Band Foundation at Hardin- 
Simmons University in Abilene, TX 
79604, or to the Franlslin Community 
Church, 32473 Normanndy, Franklin, 
Ml 48023. 
Grill work, historical library promenade, 
Harvey Cushinf’Uohn Hay Whitney 
Medical Lihrarv. 
Walter L. Kulp 
Walter L. Kulp, Ph.D., died July 18 in 
Storrs, Conn. He was 99. 
Dr. Kulp retired as chairman of the 
bacteriology department at the 
University of Connecticut in 1933. He 
also served as director of the Windham 
Hospital Laboratory, and before his 
appointment at UConn, taught at Yale 
School of Medicine. 
A Pennsylvania native. Dr. Kulp was 
a 1911 graduate of Allegheny College 
and a 1923 Ph.D. graduate of Yale 
University. 
He leaves his wife, Lula Casler 
Kulp; a daughter, Carol Beagley; three 
grandchildren and five great¬ 
grandchildren. 
IN MEMORIAM 
Crutcher McClure '21 HS 
Ben Klotz 
April 25, 1990 
'26 M.D. 
Amy H. Hunter-Wilson 
.Inly 7, 1990 
'30 M.D. 
Henry Brill 
.Inne 17, 1990 
'32 M.D. 
Conrad R. Lam 
May 14, 1990 
'32 M.D. 
Lester Q. Stewart 
March 10, 1990 
'33 M.D. 
W. Howard Horner 
September 9,1990 
'33 M.D. 




March 28, 1990 
'36 M.D. 
Agnes V. Bartlett 
August 7,1990 
'38 M.D. 
Dorothea H. Scoville '38 M.P.H. 
Nathaniel Kenigsberg 
November 22, 1989 
'39 M.D. 
John F. Marchand '40 M.D. 
Frederick A. Waldron 
August 17,1990 
'41 M.D. 
David G. Decker 
July 17,1990 
'42 M.D. 
C. Thomas Flynn Jr. 
September 20, 1990 
'43 M.D. 
Rex P. Dannebaum 
February 21,1990 
'49 M.D. 
Guy W. Steuart 
June 20,1990 
'33 M.P.H 
John B. Fine '36 M.D. 
Lawrence J. Biris '79 M.D., 
'80 M.P.H. 
Gary F. Velat 
August 1, 1990 
'80 M.P.H. 
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DEVELOPMENT REPORT 
Gift of Noted Aiumnus 
To Name Yale’s CMM 
University President Benno C. Schmidt 
Jr. has announced the largest individual 
gift ever received by the School of 
Medicine. A $10 million contribution 
from Dr. and Mrs. Herbert W. Boyer of 
Mill Valley, Calif., will provide 
construction funding for the Center for 
Molecular Medicine (CMM). The 
center, which will be dedicated on June 
6, will bear the Boyer family name. 
President Schmidt said, “The 
Boyers' generous gift for the center is 
especially meaningful because this 
marvelous new research facility is built 
around an educational core; medical 
students, post-doctoral fellows, graduate 
students, and medical residents will 
benefit from its teaching programs. It is 
fitting that the Boyer name will always 
be associated with this building, for it 
will inspire young people to strive for 
scientific excellence and for innovation 
and discoveries that can benefit 
mankind.” 
From 1963 to 1966, Dr. Boyer 
undertook a post-doctoral fellowship in 
the laboratory of Edward A. Adelberg, 
Ph.D., professor of genetics, today, a 
deputy provost of the University. Dr. 
Boyer then joined the faculty of the 
University of California, San Francisco, 
where he is currently professor of 
biochemistry. A native of Derry, 
Pennsylvania, and a graduate of Saint 
Vincent’s College and the University of 
Pittsburgh, Dr. Boyer ushered in a new 
era of genetic science when he and Dr. 
Stanley Cohen of Stanford University 
invented the first recombinant DNA 
technology. 
After being awarded the National 
Medal of Technology in 1989, Dr. Boyer 
was invited to the White House in 
November 1990 to receive the National 
Medal of Science, thus making him one 
of only three persons to receive both of 
the nation’s highest research awards. 
As co-founder of Genentech, Inc., in 
1976, Dr. Boyer helped launch the 
biotechnology industry. In less than !5 
years, Genentech has grown into a 
company with annual revenues of more 
than $400 million from the development 
of such bioengineered pharmaceuticals 
as Protorpin, a human growth hormone, 
and Activase, an anticoagulant for the 
treatment of heart attack. 
Over the years, the Boyers have 
remained active in Yale affairs; their 
son, Ethan, graduated from Yale College 
in 1990. Dr. Boyer serves as chaimian 
of the Dean’s Council of the School of 
Medicine. The council, a volunteer 
group comprising leaders from business, 
science, medicine and private organiza¬ 
tions interested in the field of medical 
science, advises Dean Leon E. 
Rosenberg on matters related to the 
school’s planning and development. In 
commenting on this gift. Dean 
Rosenberg said, “Erom the earliest days 
of my deanship. Dr. Boyer has been a 
source of wise counsel and 
encouragement. I rejoice in this gift 
from two splendid friends of Yale.” 
Kresge Foundation 
Challenge Update 
The School of Medicine moved a 
major step closer to earning the Kresge 
Eoundation’s $1 million challenge grant 
when Dr. and Mrs. Herbert W. Boyer 
announced their magnificent gift (see 
accompanying article). Dr. and Mrs. 
Boyer’s gift enabled the school to 
double the amount required by the first 
of the challenge’s three terms: to raise 
$5 million toward the construction of 
the Center for Molecular Medicine. 
School of Medicine Alumni Eund totals 
also show impressive progress on the 
second and third terms of the challenge, 
which include; 
• raising $450,0(X) in current-use support; 
• reaching 55 percent participation. 
These terms must be met before June 
30, the end of the fiscal year. Because 
55 percent participation requires more 
alumni to support the school than in any 
other year, the development office and 
Kresge Challenge Chairman John B. 
(Jack) Ogilvie, ’34 M.D., have 
organized a series of phonathons in 
which alumni and students have 
contacted as many alumni as possible. 
Alumni who wish to contribute 
specifically to support the Center for 
Molecular Medicine can join other 
major donors by making a gift to name 
one of the center’s rooms. In addition, 
those who contribute $5,000 or more to 
the alumni fund before June 30 will be 
included on the dedication plaque 
which will be prominently displayed in 
the center. If you are interested in 
naming a room in the CMM, please 
contact Jay Angeletti, Office of 
Development, Yale School of 
Medicine, P.O. Box 3333, New Haven, 
CT 06510-8055, (203) 785-5576. 
Alumna Bequest Benefits 
CMM and Public Health 
Amy Hunter-Wilson, ’30 M.D., ’34 
Dr.P.H., has made a major bequest to 
support the School of Medicine’s 
Center for Molecular Medicine and the 
Department of epidemiology and public 
health. Dr. Hunter-Wikson, who made 
two significant gifts during the last two 
years of her life to establish endowed 
scholarships in medicine and public 
health, died July 7, 1990. 
Dr. Hunter-Wilson, known profes¬ 
sionally as Dr. Hunter, was bom in 
1898 in New York City. A 1921 
graduate of Vassar College, she earned 
a master’s degree in nutrition from 
Cornell University. Dr. Hunter then 
came to New Haven where she earned 
her two Yale degrees. Later, she served 
her residency at the Children’s 
Community Center in New Haven and 
was clinical instructor in pediatrics at 
the School of Medicine. In 1935 she 
became the director of the Bureau of 
Maternal and Child Health within the 
state of Wisconsin Board of Health. She 
.served in that position with great 
distinction until she retired in 1961. 
In recognition of Dr. Hunter-Wilson’s 
bequest, the school will name for her 
one of the Center for Molecular 
Medicine’s state-of-the-art laboratories, 
and will establish an endowed research 
fund for young faculty in the 
department of epidemiology and public 
health. Dr. Hunter-Wilson’s husband, 
Mr. Erederick Wilson, now age 103, is 
the retired forestry division chief of the 
state of Wisconsin agency that was 
known during his tenure as the 
Conservation Commission. In addition 
to her husband. Dr. Hunter-Wilson is 
survived by a niece and two nephews. 
Yale Medicine Spring 1991 43 
CONTINUING MEDICAL 
EDUCATION AT YALE 
Friday 
June 7, 1991 
Yale Alumni in Ophthalmology 
Director: Robert L. Lesser. M.D. 
(A) 
Friclay-Sunday 
August 16-18, 1991 
Thrombosis, Thromboembolism and Thrombolysis 
Director: Michael D. Ezekowitz, M.D.. Ph.D. 
Will provide the practicing clinician basic knowledge on the pathogenesis and treatment 




Sept. 26-28, 1991 
Methods and Application in Molecular Medicine (C) 
Director: Stephen Reeders. M.D. 
Will acquaint fellows and physician-researchers in internal medicine specialities with 
new techniques in molecular biology, molecular genetics and cell biology. 
Friday-Saturday 
Sept. 27-28, 1991 
Visiting Lecture Series in Clinical Ophthalmology 
Director: David E. Silverstone. M.D. 
Speaker: Melvin Riihin. M.D. 
Will focus on the update of ophthalmic optics. 
(D) 
Friday-Saturday Neurobiology of Affective Disorders (E) 
Oct. 25-26, 1991 Director: Geori>e K. Aghajanian. M.D. 
Thursday 3rd Annual Cardiology Update (F) 
Oct. 31, 1991 Director: Lawrence S. Cohen. M.D. 
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Y3 iLE Medicine 
Alumni Bulletin of the School of Medicine Summer 1991 
NOW being admitted to 
the high calling of the 
physician, I solemnly 
pledge to consecrate my 
life to the care of the sick, the 
promotion of health, and the 
service of humanity... 
Commencement 1991 
AIDS Research at Yale: 
Shifting into High Gear 
Yale Medicine 
Alumni Bulletin of the School of Medicine Summer 1991; Volume 25, Number 3 
Climbing the Himalayas: A Call to High Adventure 
In an article relating how a passion for mountaineering became his 
avocation, Richard Wohns, M.D. ’77, gives his answer to the call of 
the wild — medical research at 21,500 feet. 
^ The Physician as Citizen 
Delivering the medical school commencement address, James R Comer, 
M.D., exhorts the Class of 1991 to help build a brighter future for 
America through all her children. 
African-American Students: YSM’s Unfolding Legacy 
Graduating physician Daryl Daniels reveals the fascinating — 
though not unbroken — 137-year history of African-American medical 
students at Yale. 
AIDS Research at Yale: Shifting into High Gear 
As the diagnosis of America’s first AIDS patients marks its 
10th anniversary, the medical school has set its sights on 
becoming a leader in this area of basic and clinical research. 
20 1991 Lerner Award 
In a series of three poems, Christopher Fey, ’93 Med., displays 
why the 1991 Marguerite Rush Lerner Award was not the first 
of his many honors for poetry writing. 
23 Gallery 34 Scope 41 New Books 
24 Student Research Day 35 Faculty News 42 Student News 
28 Residency Placements 39 Alumni Report 43 Development Report 
30 Commencement 40 Alumni News 44 Obituaries 
On the cover: School of Medicine Chaplain Alan C. Mennann, M.D.. composed a physician's oath for graduating medical students. 
eond)ining elements of the Hippocratic Oath with selections of contemporary oaths used hy other leading medical schools. 
I'or the complete text, turn to page 33. 
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Office of Public Information. 3-‘'0 Congress Ave.. P.O. Box 333.3. New Haven, 
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LETTERS TO THE EDITOR 
Lesbian/Gay Network 
To the editor: 
I am writing on behalf of the Lambda 
Health Alliance, a new group for les¬ 
bian, gay or bisexual health profession¬ 
als at Yale, in our attempt to form an 
alumni network. 
In its first semester, the group has 
had much success and support, having 
held numerous meetings, a rap session 
and a potluck. We are looking forward 
to many more activities in the coming 
semesters, such as a dance, film screen¬ 
ings and sensitivity-raising seminars. 
Graduates interested in our alumni/ae 
network should write: 
Lambda Health Alliance 
Yale School of Medicine 
c/o 1 101 Sterling Hall of Medicine 
P.O. Box 3333 
New Haven, CT 06510-8012. 
Kyle Herhokl. '94 Med. 
Living Wills 
To the editor: 
As a Yale College graduate (’42) and 
attorney with 35 years of practice, I 
would like to comment on the Spring 
1991 interview with Angela R. Holder, 
L.L.M., entitled “Are Living Wills Nec¬ 
essary?” 
In the Cruzan case, the U.S. Supreme 
Court held that the Constitution did not 
prevent Missouri from requiring clear 
and convincing evidence of the 
comatose patient’s wishes concerning 
the withdrawal of life-sustaining treat¬ 
ment. In other words, it is up to the state 
involved to set the standards. When the 
case was returned to the Missouri court, 
further evidence, though not written 
documentation, was produced; the state 
withdrew its case, and Nancy Cruzan 
was allowed to die, although she never 
had a living will. 
In Hawaii, where 1 live, the 1991 
state legislature passed a hill to expand 
the present Hawaii living will statute to 
provide that a living will could become 
effective when a person was in a persis¬ 
tent vegetative state, even though death 
was not likely to happen in a short time. 
The bill also provides that artificial 
feeding and hydration may be with¬ 
drawn like other medical practices. 
This bill is important because it 
specifically protects the doctors and 
health care facilities who follow the 
desires of the the patient as expres.sed in 
the living will from suits by members of 
the family and from criminal prosecu¬ 
tion. The Hawaii statute, however, does 
not provide for a durable power of attor¬ 
ney being given to a family member or 
other person to decide on medical care 
when a patient is incompetent. This ren¬ 
ders the naming of such in a living will 
or other document probably a good idea, 
but of dubious legal effectiveness. 
It is not clear under such a statute 
that a doctor or care facility would be 
protected Just because the person named 
in a durable power of attorney by the 
patient approved what the doctor or care 
facility did. Hopefully, the statute can be 
further amended, but until then, it would 
appear advisable to make a living will 
that will stand on its own as the expres¬ 
sion of the desires of the maker. 
What I have said applies primarily to 
Hawaii, but the principles may be appli¬ 
cable to other Jurisdictions. 
{Mr.) Page M. Anderson 
Honolulu 
Ms. Holder’s reply: 
I believe Mr. Anderson overreacts in his 
concern about the threat of a malprac¬ 
tice claim from which physicians need 
protection. There has never been a mal¬ 
practice case in the United States 
involving a "Do Not Resuscitate” order, 
disconnection of a respirator or ending 
artificial feeding, as long as the patient’s 
wishes were known or the family made 
the decision. If the family agrees, there 
is no one else with legal standing to sue. 
(On the other hand, there have been at 
least two successful suits against physi¬ 
cians who refu.sed to disconnect respira¬ 
tors.) In 1983, the California Court of 
Appeals dismissed the only criminal 
case ever brought against physicians for 
withdrawal of life support, holding that 
these decisions cannot be the basis of 
prosecution. 
Angela R. Holder, LL.M. 
Most Famous Alumnus? 
To the editor: 
If someone were to ask who is the best- 
known recipient of a Yale medical 
degree, the answer might come as a sur¬ 
prise when I mention the name of 
Alfred Carlton Gilbert. ’09. 
Although A.C. Gilbert never prac¬ 
ticed medicine, some of his accomplish¬ 
ments include winning an Olympic 
medal, holding more than 150 U.S. 
patents and, of course, inventing and 
then manufacturing more than 150 mil¬ 
lion Erector sets, which must make his 
name a household word to almost every 
American male over age 40. 
I wonder if Yale Medicine readers 
might be interested in an article on this 
remarkable 1909 graduate. 
William McKean 
North Haven, Conn. 
Pvditor’s reply: 
Thanks for this fascinating lead. Our 
editors will seriously consider develop¬ 
ing such an article. 
Corrections 
Two captions require correction in the 
FallAVinter 1990 edition of Yale 
Medicine. On page 31, Deputy Dean 
Robert M. Donaldson’s first name was 
listed incorrectly. On page 37, renova¬ 
tion of the Morse Periodical Room at 
the Harvey Cushing/John Hay Whitney 
Medical Library was made possible by a 
$1 million gift by Mrs. Belle Morse in 
memory of her husband, Carl A. Morse, 
a 1925 Sheffield Scientific School grad¬ 
uate, and their son, Stephen 1. Morse, 
’51 M.D.,Ph.D. 
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CLIMBING THE HIMALAYAS: 
A CALL TO HIGH ADVENTURE 
Ph<»lo>iraphs cuurlcsy of Richard Wohns. M.l). 
Himalayan majesty: Mount Everest and its sihs, Niiptse and Lhotse. 
by Richard Wohns. M.D. ’77 
My eight trips over the past 17 years to various regions in the 
highest nioLiiitains of the world have transformed the 
Himalayas from a distant, unfathomable, even mystical realm 
into a place of comfortable familiarity. "Going high" has 
become my passionate escape into the beauty, challenge and 
secrets of another world. 
My mountaineering career began as a hiker and scrambler 
while ill Harvard College, then quickly progressed to an inter¬ 
est in peaks that were higher than Vermont's White Mountains. 
In 197.7, Mt. Kilimanjaro in Africa introduced me to the world 
of thin, cold air. Himalayan odysseys began while I was at 
Yale .School of Medicine. 
In 1974, 1 was fortunate to receive a Wilbur Downs fellow¬ 
ship to travel and study retinoblastomas in Sri Lanka, formerly 
known as C'eylon. This eye tumor, relatively rare in the West¬ 
ern world, occurs more commonly in the Sinhale.se and Tamils 
ol that now troubled land. I feel lucky to have lived in Sri 
Ri( hard Wohns. M.l).. is a nenrosnryeon in private practice in 
iciioma. Wash. 
Lanka at a time when civil war did not preclude outsiders from 
experiencing this wonderful country and its people. 
Prior to my return to Yale from Sri Lanka, I traveled 
through Kashmir. My visit to the Vale of Kashmir involved a 
mountaineering excursion to the Gangabal Glacier, which pro¬ 
vided an exciting combination of glacier and rock climbing, 
plus superb high-altitude lake trout fishing. 
While on Kilimanjaro and on the Gangabal Glacier, I suf¬ 
fered severe headaches, insomnia, Cheyne-Stokes "tidal” res¬ 
pirations and nausea. It wasn't until 1 returned to Yale that I 
learned 1 had experienced symptoms of acute mountain sick¬ 
ness (AMS). AMS. along with high-altitude physiology in 
general, became pet subjects of mine, and have since devel¬ 
oped into serious field research interests. Initially, I was simply 
interested in how to continue high-altitude sojourns without 
suffering AMS symptoms. Then, as my professional interests 
became focu.sed on neurosurgery, a natural inclination to study 
high-altitude cerebral pathophysiology evolved. 
At the School of Medicine. 1 was able to complement my 
medical education with my interest in travel and mountaineer¬ 
ing by arranging accredited clerkships abroad. Travel time 
opened up thanks to credit Yale granted me for the courses in 
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neurophysiology and biochemistry I had taken at Harvard 
Medical School during my undergraduate days. 
I would have finished medical school in three years were it 
not for my Yale advisor, Etsuro Motoyama, M.D., an associate 
professor of anesthesiology, who dissuaded me from this “fast 
track.” I am forever indebted to him for this sage advice. Dr. 
Motoyama, today, the vice chair of anesthesiology at the Uni¬ 
versity of Pittsburgh medical school, not only guided me intel¬ 
lectually and professionally but also shared a keen interest in 
the mountains. 
We found common ground in other areas, as well, including 
opera, flying, Japanese culture and cuisine, and skiing. Dr. 
Motoyama introduced me to Marie Lauritano, the woman I 
married, and is the godfather of Nicolai, my third child. 
The story of my medical school climbing experiences con¬ 
cludes with a 1975 trip back to Kashmir, where I worked as a 
medical student clerk in the outpatient clinic and emergency 
room at University Hospital in Srinagar. This location allowed 
me further access to the Kashmiri Himalayas. This second 
Himalayan encounter continued into the Khumbu, or Everest, 
region of Nepal, where I completed the classic trek to Ever¬ 
est’s base camp and Kala Patar, an 18,400-foot “hill” with 
spectacular views of several 8,000-meter peaks, including 
Everest, Lhotse and Nuptse. 
Life After Yale 
While in the Khumbu region, I had met a British physician 
who worked at the High-Altitude Trekkers’ Aid Clinic in 
Pheriche, on the route to Everest. He offered me the opportu¬ 
nity to work at the clinic following medical school graduation 
in 1977, thus initiating my plans to return to Nepal. In antici¬ 
pation of this trip, my remaining days in medical school 
included a self-directed training program for maximum high- 
altitude performance. 
This exercise regimen proved to be as demanding as were 
clerkships and thesis research. Warm weather workouts 
involved 100-plus miles of jogging per week, bicycle com¬ 
mutes between the Mt. Carmel section of Hamden and New 
Haven, plus weekend rides of 30 to 50 miles. Wintertime 
brought cross-country skiing in Sleeping Giant State Park and 
in various locations in Vermont. New Haven's East Rock Park 
was my favorite place for jogging up hills. Tennis continued as 
my social sport; I fondly remember my matches at the Yale 
indoor courts with classmate Doug White. 
Medical school and the exercise program allowed little time 
to climb, except for several weekend trips to Mt. Washington 
and Cannon Mountain. At the recommendation of Dr. 
Motoyama, however, I did make time for a five-day ice and 
snow climbing seminar on Mt. Rainier in Washington state. 
This course took place at Camp Muir (10,000 feet) and 
included a summit climb. In addition to ice and snow climb¬ 
ing, we practiced crevasse rescue, rope travel and technique, 
and belaying. In the evening, the camp fire brought out “war 
stories” shared between students and our instructor, the famous 
mountaineer Lou Whittaker. 
The leader of my rope team on our summit climb was 
Gombu, the Nepalese Sherpa who had accompanied Lou’s 
brother, Jim Whittaker, during the first American ascent of Mt. 
Everest in 1963. Gombu humbled us all by climbing the last 
200 meters up Mt. Rainier backwards while smoking a 
cigarette! 
Before starting my internship and neurosurgery residency at 
the University of Washington, I returned to Nepal. I was 
clearly at my peak physically. I also thought this trip might 
mark the end of my ability to maintain adequate fitness and 
have the opportunity to travel to the Himalayas, given the gru¬ 
eling nature of a neurosurgery residency. 
I arranged to meet Dr. Motoyama in Nepal, as he and sev¬ 
eral fellow mountaineers were climbing up the Arun and 
Barun Valleys to several high passes east of Everest at the 
same time that I was planning to climb Island Peak — my first 
20,000-foot summit. Our routes were very clo.se to each other. 
On arrival in the Everest area, I hired several Sherpas and 
proceeded to acclimatize myself by trekking up Gokyo Peak 
(18,500 feet), then across a pass back to the Khumbu Valley, 
then up the Imja Valley to Island Peak and the Amphu Lapsa 
Pass. There the rendezvous with the Motoyama party was to 
occur. Only, I was given a message on a match book cover 
while in the Khumbu Valley that their party encountered 
severe weather and treacherous climbing conditions. One of 
their porters had died of a head injury. 
Our meeting location was changed to Dingboche in the 
Imja Valley, from which Dr. Motoyama and I trekked up 
toward Island Peak. He had met representatives from Moun¬ 
tain Travel, Inc., in Katmandu, who had been looking for a 
doctor to accompany the first commercial group permitted by 
the Nepali government to circumnavigate the Annapurna 
Range, over the Thorong La Pass (18,400 feet). Dr. Motoyama 
could not join this group but suggested that I go with them 
instead. As a “rugged individualist,” I was prejudiced against 
commercial trekking or climbing groups; but luckily, I recog¬ 
nized this opportunity as an offer I couldn’t refuse. 
The “Around Annapurna” trip has since become a classic 
Himalayan voyage, world-renowned for its awesome exposure 
to a wide variety of Nepali and Tibetan people, villages and 
fabulous peaks, including the 8,000-meter summits of Dhauli- 
giri, Annapurna and Manaslu, and regions of subtropical, 
desert, alpine and glacial character. 
Dr. Richard Wohns at the Baltoro Glacier in Pakistan. 
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After leaving Dr. Motoyama in the Inija Valley, I proceeded 
to climb Island Peak, return to Katmandu, then travel to 
Pokhara for a few days of bird watching at Fishtail Lodge, 
again with Dr. Motoyama. The Mountain Travel Around 
Annapurna group convened thereafter, and we departed for our 
trip together. 
At the Thorong La Pass, I made a first ascent of the south 
summit of Thorongtse (21,500 feet) with two of our Sherpas. 
The Mountain Travel group consisted of the president and vice 
presitlent of the company, plus a number of fascinating indi¬ 
viduals from the LInited States and England. 1 ran daily clinics 
for the group members, Sherpas and porters, and also treated 
the local people, since there were no medical facilities or pro¬ 
fessionals in the vicinity. 
1 do not encourage medical treatment of indigenous people 
by doctors on expeditions or trekking groups, because care can 
only be offered in a cursory way. However, in this circum¬ 
stance I considered it to be appropriate and worthwhile. We 
were, es.sentially, the first Westerners seen by most of the pop¬ 
ulace, and it was very difficult to withhold simple health care 
and provisions. 
Physician Ascending 
Toward the middle of my internship, the vice president of 
Mountain Travel, Dick McGowan, called and invited me to be 
the doctor for an expedition to Pakistan that he and his wife 
were to lead during the summer of 1978. This involved an 
extremely rigorous approach up the Baltoro Glacier to K2, the 
second-highest mountain in the world. 
Considered by many to be the most spectacular mountains 
in the world, the western-most portion of the Himalayas, the 
Karakorum, proved to be the fabled "kingdom of the mountain 
gods." From the confluence of the Baltoro Glacier with the 
Godwen-Austin Glacier at Concordia (15.100 feet), we viewed 
the Karakorum giants of K2, Broad Peak, Gasherbrum, 
■Masherbrum and Chogolisa. 
An emergency appendectomy at 10,000 feet. 
We climbed up to 21,000 feet on K2. following the route 
that Chris Bonington's British expedition had Just abandoned 
due to an avalanche that killed noted climber Nick Estcoun. 
We also visited the grave of Art Gilkey of Charlie Houston's 
historic 1952 American K2 expedition and communed with 
one of the world’s greatest climbers. Reinhold Messner, and 
Japan's mountain hero, Babaguchi. 
Dr. Ensno Motoyama (left) meets up with Dr. Wolms in Nepal’s 
Imja Valley in 1977. 
Baltistan and the Karakorum were exceedingly remote, 
which signalled to me the need to be medically self-sufficient. 
Recalling the jocular motto developed at Yale among my circle 
of friends: "Always be prepared for everything," I had packed 
my medical kit with sterilely packaged surgical instruments for 
performing burr holes, abdominal procedures, and for treating 
lacerations and orthopedic injuries. To these I had added a 
multiplicity of medications, intravenous fluids, oxygen and 
anesthesia equipment. Such planning proved crucial; on this 
expedition, we experienced numerous medical emergencies, 
including a porter with a ruptured appendix and peritonitis. 
I perfomied an appendectomy on him alongside the Braldu 
River, which flows down from the Baltoro Glacier. After we 
ran out of antibiotics and fluids, we were fortunately aided by 
Bonington's doctor, who gave us his surplus supplies and 
radioed for a helicopter. 
Prior to the helicopter evacuation (our “Medivac" arrived a 
week later) the several doctors with Jim Whittaker's American 
K2 expedition “made rounds” during the postoperative period 
and provided extra help. The porter, Mohammad Ali, met me 
in Scardu after our expedition returned from K2. I brought him 
a hearty curry lunch, since he had lost a lot of weight! 
Back at Elashman's Hotel in Rawalpindi, Pakistan, 1 men¬ 
tioned to our liaison officer. Capt. Zafar. that 1 was a friend and 
Harvard classmate of Bena/ir "Pinkie" Bhutto, the daughter of 
the imprisoned Pakistani President Zulfikar Ali Bhutto. Asking 
the hotel desk clerk about Pinkie's whereabouts, we found that 
she was under house arrest in our hotel. 
I spent the next afternoon with Pinkie reminiscing about 
Harvard, cautiously discussing Pakistani politics, and then 
with true mortal fear, talking about her father's impending exe¬ 
cution. Under the circumstances, I never would have imagined 
that Pinkie herself would become Pakistan’s president one day. 
During our tete-a-tete, we were surrounded by her personal 
guards, but also by several Pakistani Army detention officers. I 
was surprised to find that our expedition's liaison officer, a 
captain in the Army, was very pro-Bhutto. 
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Everest: The Ultimate Challenge 
The following years revolved around marriage, children and 
my neurosurgery residency, until 1981, when an invitation 
arrived to join a Mt. Everest expedition in the spring of 1984. 
The team desired a climbing physician who could also direct a 
high-altitude research program. I had written several papers on 
mountain medicine and related subjects and had become active 
in the field of high-altitude physiology, and had further contin¬ 
ued climbing locally in the Cascades of Washington state. 
Thus, I leapt at the chance of Joining this expedition. 
Our group, composed of climbers from the northwestern 
United States, had been given permission to climb the north¬ 
east buttress and northeast ridge of Mt. Everest. The approach 
required travel through China and Tibet, then up the classic 
1920s British route to the summit. 
This was the route where the famous British climbers, 
George Mallory and Andrew Irvine, disappeared just beneath 
the summit. Mallory left for posterity his famous answer to the 
question: Why climb Everest? “Because it’s there.” He took to 
his death the secret of whether he and Irvine ever reached the 
summit. 
Our expedition’s research would focus on the role of cere¬ 
bral dysfunction in AMS, high-altitude cerebral edema, high- 
altitude pulmonary edema and retinal hemorrhages. There had 
never been an expedition whose research was neurologically 
oriented; thus, we pioneered the use of cortical evoked poten¬ 
tials at extreme high altitude and demonstrated a correlation 
between symptoms of AMS and increased latency of visual 
evoked potentials. 
We also carried out a double-blind, randomized, controlled 
study on the drug Dilantin and its potential prophylactic effect 
against AMS. Other research protocols involved the use of 
ambulatory EEGs, pulmonary impedance plethysmography, 
and retinal photography. Better treatment and prevention of 
AMS and high-altitude edema resulted from our studies. 
Our research was funded by grants from the U.S. Army and 
the Dreyfus Foundation, plus private contributions and 
involved a sophisticated base camp research station at 18,000 
feet. We used a Weatherport tent to shield our computers and 
other sensitive bioelectric equipment against the harsh envi¬ 
ronment of Everest’s north side, where winds often exceeded 
60 miles per hour and temperatures plummeted well below 
0 degrees Fahrenheit. A Kohler gas generator provided power. 
The research tent doubled as a clinic and mini-hospital, where 
I treated our climbers with AMS symptoms and several British 
Everest North Face Expedition members injured in an 
avalanche. 
After completing the base camp research protocols, we 
moved our research equipment to 21,500 feet in a tent under 
the North Col, which is a saddle on the northeast ridge. Here, 
we became the first to monitor climbers’ evoked potentials 
before and after extreme high-altitude exposure. It also was in 
this tent that another world’s record of sorts was set — the 
highest altitude hemorrhoidectomy ever recorded — by an 
ophthalmologist, no less, on the podiatrist in our expedition! 
Our group did very well on Everest but missed reaching the 
summit by 800 feet due to porter problems. We had carefully 
planned our load to include enough food, tents, climbing sup¬ 
plies and oxygen for several summit approaches; but when the 
high-altitude porters quit unexpectedly, only two of our climbers 
were within reach of the summit. The climbers were without a 
tent and didn’t have enough food and oxygen for a bivouac on 
the descent. Lacking such support, they wisely elected not to 
take the exceedingly high risks in trying to become the first 
Americans to summit Everest from the north side. 
1 expended so much time and energy in preparing and exe¬ 
cuting the expedition, and in the subsequent data analysis, sci¬ 
entific paper writing and slide presentations, that I actually lost 
interest in climbing for several years. 1 continued to hike and 
ski extensively in the Cascades with family and friends, but 1 
“retired” from high altitude until Dr. Motoyama and I traveled 
to Nepal again in 1989. 
At this time, we accomplished the crossing of a high-alti- 
tude pass in a remote area of Nepal near the Tibetan border. 
The Ganja-La Pass connects the upper Langtang Valley with 
the Helambu Valley and provided a first-class adventure for us. 
Over the years, I have become an avid mountaineering book 
collector and especially enjoy the classic Himalayan expedi¬ 
tion books. A collection of maps of the Himalayas and south- 
central Asia also complements my library. My avocation of 
mountain medicine has been formalized, as I am now vice 
president of the International Society of Mountain Medicine. 
The society was founded several years ago in Switzerland to 
promote scientific research related to high-altitude physiology 
and mountain rescue. For 1992, I have organized a high-alti¬ 
tude neuroscience research expedition. Once again, I plan to 
travel far and high. YM 
Dr. Wohns and colleagues profiled against Everest's legendary 
North Face. 
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THE PHYSICIAN AS CITIZEN 
hy James F. Comer. M l)., M.P.H. 
Editor's note: Dr. Comer delivered the commencement address 
to the Class of 199! on May 27. lie dedicated his remarks to 
the memory of Peter A.T. Crannnm. M.D.. associate professor 
of obstetrics and yynecoloyy. for his “combined commitments 
to professional excellence. social justice and citizenship." 
I'd like to take just a few minutes to talk about an aspect of the 
life of a physician that is given too little attention, that is. the 
physician as citizen. 
There is every reason to believe that you will become fine 
physicians. You have had the best medical education available 
in the world. And while medicine is changing, it still is and 
always will be one of the most honored professions in the 
world. It will bring you great personal satisfaction, and at the 
same time enable you to serve an appreciative patient popula¬ 
tion and public. 
It has a kind of inherent excitement that will command your 
interest and time. Thus, there is a tendency among physicians 
to feel. “My citizenship responsibilities are met through my 
dedication to my profession." But while important, our profes¬ 
sional contribution is not enough, particularly at this point in 
our history. 
We live in a remarkable time, in a remarkable country...one 
of the most successful and best countries in the world. But we 
are in trouble — economic, educational, social, even spiritual 
trouble. And whether you attend your .^O-year class reunion in 
an America that is vibrant and successful, or not. depends a 
great deal on whether you and other leaders of today and 
tomorrow adequately address citizenship tasks beyond your 
profession. But how can I suggest that we are in trouble after 
two of the most exciting and promising years of the 2()th cen¬ 
tury — perhaps any century — a period when totalitarian gov¬ 
ernments fell and much of the world called for democracy. 
And the democracy everyone wants has survived in large part 
because America had the courage and the strength to destroy 
Nazism two generations ago; and had the generosity to rebuild 
the economies of its former enemies; and several months ago 
hail the courage to crush the forces of a cruel dictator. Also, 
America hail the know-how that launched the scientific and 
technological age which created the affluence that most of us 
enjoy, and which undermined the claims of Communism. 
But we ignored, or didn't understand, the implications of 
the post-World War II science- and technology-based economy 
we pul in place. Before the I95()s. heads of households didn't 
need an education to hold living wage jobs and meet their 
adult responsibilities — to support themselves and their fami¬ 
lies. rear their children, and serve as responsible citizens. As 
late as 1930, only 20 percent of all Americans over 23 years of 
age had linished high school. But we will need a 90 percent 
high school graduation rale by the year 2000. And almost one- 
Dr. James P. Comer, the Maurice Palk Pnfessor in the Child 
Study Center and in Psychiatry, is associate dean for student 
affairs at the School of Medicine. 
third ot all new jobs created between now and the year 2000 
will require a college degree. Fewer than 10 percent of the 
nation's existing Jobs are open to low- or unskilled laborers. 
A Turning Point 
To develop people so that they can acquire the high level of 
education needed today, a society must invest in its people — 
must promote high-level family functioning, adequate health 
care and good education. Most of the industrialized countries 
of the world — especially Germany and Japan, those nations 
we put back on their feet after World War 11 — invested in 
their people. 
America, by contrast, while helping others, permitted large 
numbers of her own families to be closed out of the economic 
mainstream, to experience debilitating poverty and stress. And 
now, too many of those families are unable to give their chil¬ 
dren the kind of preschool experience that would enable them 
to succeed in school. As school dropouts and underachievers, 
they are much more likely to participate in the underground 
economy of drugs and crime and to strain the nation's social 
service systems. Their reactive behavior lowers the quality of 
life of every one of us. 
Of particular significance to medicine, poor women are 
more likely than other women to deliver low birth-weight 
babies, to be exposed to AIDS, and to experience prenatal drug 
exposure that impairs fetal development and precipitates mis¬ 
carriage and premature birth. Poor children under six are more 
likely than other children to have growth retardation and 
anemia, lead poisoning and accidental injury — with all the 
attendant social and financial costs. 
At this moment, 30 percent of all poor children under age 6 
have no health insurance what.soever, even though many of 
their parents work every day — the working poor. And though 
blacks. Latinos and native Americans have been disproportion¬ 
ately affected because of their more traumatic social histories, 
42 percent of the five million poor children under 6 are white. 
Neither have children of the aftluent escaped the effects of 
our inattention to the support of family functioning and devel¬ 
opment. Suicide, violence and vandalism, alcohol and other 
substance abuse problems are significant among our most 
affluent young people. The National Governors Association 
and the White House have proposed a .set of national goals for 
the year 2()()(). One is to have our students rank first in mathe¬ 
matics and science. But in the most recent international assess¬ 
ment of 13-year-olds across 12 nations. American students 
ranked last in mathematics and ninth in science. The average 
Japanese student scored higher than the top 3 percent of Amer¬ 
ican students in college preparatory mathematics. 
Without a healthy, better educated work force, we will not 
be able to compete economically with Germany, Japan, 
Sweden and the like. And, in turn, we will not be able to afford 
even our present level of health and education .services. We 
will be on a downhill course as a nation. 
While we need a better educated worker, nearly one-third of 
the work force in the year 2000 will be made up of minority 
group young people, disproportionately poor and underserved 
by our present educational system. Some of the people who 
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look at demographics and note the high percentage of minori¬ 
ties feel that the nation does not have the talent needed to 
remain competitive. In fact, a New York Times op-ed page arti¬ 
cle — couched in the argument of reducing the deficit — sug¬ 
gested that we must import our future work force. Not only is 
that immoral and unfair to the nations that have invested in the 
education of their people, it is unfair to the American children 
and families in which this nation has not invested. Such a 
policy would make all of our current social problems much 
worse. More importantly, the argument is simply wrong. Of 
course we have the talent. 
A Personal History 
To make my point. I’d like to tell you the story of a poor, 
African-American lady named Maggie. Maggie was born in 
1904 to a poor but caring, responsible sharecropper in rural 
Mississippi. But he was killed by lightning when she was 6 
years of age. And because there were no support systems, a 
cruel stepfather came into the lives of his widow and five chil¬ 
dren. The stepfather was abusive in every way and would not 
allow the children to go to school. As a barefoot girl working 
in the cotton field, it occurred to Maggie that the way to a 
better life was through education. And at 16 years of age, she 
ran away to try to get an education. 
She was unable to do so. When she was forced to give up 
her dream, she declared that if she ever had children, she 
would make certain that all of them got an education. And then 
she very, very, very carefully set out to find a husband. Her 
husband, Hugh, from rural Alabama had a sixth-grade educa¬ 
tion. Maggie worked as a domestic and Hugh worked as a steel 
mill laborer. And when Hugh died early. Maggie carried on. 
Eventually, the five children of Maggie and Hugh obtained a 
combined total of 13 college degrees. 
Hugh was my father, and Maggie is my mother...Tm 
delighted to tell you that two weeks ago she received an hon¬ 
orary doctorate degree from Wheelock College. Our family 
story, and that of many others, is the source of my conviction 
that our nation has the talent needed to survive and thrive in 
the 21st century. But we must clearly do some things differ¬ 
ently. For, while my family was succeeding in the high socio¬ 
economic, predominantly white school we attended, the three 
black youngsters I went off to elementary school with all went 
on a downhill course. One died early of alcoholism, one spent 
a good part of his life in jail, and the other has been in and out 
of mental institutions all of his life. And most of their children 
and grandchildren have not succeeded. Yet, my three friends 
were as bright as anybody in my family and anybody in our 
school. No nation can sustain this kind of loss of potentially 
productive people on an ongoing basis and expect to thrive. 
The difference between my friends and our family was that 
our parents had the ability to give us the kinds of experiences 
at home that allowed us to succeed in school, and my mother 
had the kind of skill that made it possible for her to interact 
with school people in a way that encouraged them to be sup¬ 
portive of our ambitions. 
Many people will say, “That’s the problem. There are too 
few Hugh and Maggie Comers among the poor families in 
America today.’’ Not true. 
Because I was so greatly concerned about the fact that my 
friends were on a downhill course at the time I finished medi¬ 
cal school, I decided to try to understand what the behavior 
was all about. And after voluntary work in poor communities, I 
decided to pursue a career in psychiatry, child psychiatry, and 
preventive psychiatry in schools rather than follow my initial 
plan to become a general practitioner in my hometown. 
Harry Bishop 
Dr. James P. Comer 
Dr. James P. Comer — 
Dedicated to the Children 
Dr. James P. Comer, the Maurice Falk Professor in the Child 
Study Center and Psychiatry and associate dean for student 
affairs, has developed techniques for making schools in urban 
communities work better for at-risk children. A member of the 
Yale faculty since 1964, Dr. Comer is well-known for his work 
in school improvement, some of which was pioneered in New 
Haven schools. 
The pathfinding work of this Yale child psychiatrist stresses 
the importance of a child’s psychological preparation for 
school and emphasizes the collaboration of school staff and 
parents in the child’s academic and social development. More 
than 150 schools use Dr. Comer’s methods, and through major 
support from the Rockefeller Foundation, his approach is 
being introduced to even more at-risk students nationwide. 
A native of East Chicago, Indiana, Dr. Comer holds an A.B. 
degree from Indiana University, an M.D. degree from Howard 
University College of Medicine, and an M.P.H. degree from 
the University of Michigan School of Public Health. 
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With the insight from my personal experience and my train¬ 
ing as a psychiatrist, we eventually developed a program in 
two inner-city schools of New Haven that brought student 
achievement from 32nd and 33rd out of 33 schools in 1969, to 
tie for third- and fourth-highest levels of achievement among 
the 26 remaining schools in the city in 1984; from the worst 
attendance record to first and second in attendance five of the 
previous six years; from the worst behavior to good citizen¬ 
ship; from school staff that burned out quickly to highly suc¬ 
cessful professionals; from single-parent welfare recipients, 
angry and alienated from the school and society, to energized, 
excited parents, some of whom went back to college and 
became professional people themselves; still others took 
employment they previously believed they could not manage. 
The approach we developed is now being used in more than 
150 schools across the country. 
Our work and that of others shows that our nation has the 
talent. Last year, the National Commission on Children 
appointed by the F^resident and the Congress and headed by 
Sen. John Rockefeller visited one of our schools. They were 
delighted by the success and the excitement they found among 
the parents, students and staff. But they were disturbed by the 
stories of drug use and abuse and related violence that the 9- 
and lO-year-old children they talked with experienced on a 
daily basis. They were rightfully concerned that many ofthe.se 
parents and children who care and want to succeed are trapped 
by conditions that may well prevent them from ever contribut¬ 
ing their talents to the gov)d of American society. They asked, 
"How can we make it possible for all of our children to con¬ 
tribute their talents to the well-being of society rather than end 
up on the social problem side of the ledger, undemiining our 
nation's future?" That question brings me back to the issue of 
the physician as citizen. 
The danger to American democracy today is not as apparent 
as swastikas and stomping boots, or bombed-out cities — 
though some sections of our cities look as if they have been 
devastated by war. Thus, there is no sense of urgency. Nor is 
there any foreign savior for America. You and me. and the rest 
of our most thoughtful, best educated and most responsible cit- 
1991 Brings Dr. Comer 
14 Honorary Degrees 
'fhis year, 14 colleges and universities will have recog¬ 
nized the distinguished career of Dr. James R Comer by 
presenting him honorary degrees. These institutions 
include; Indiana University, Bloomington, D.Sc.; Indi¬ 
ana University, Gary, D.Sc.; Wabash College, Craw- 
fordsville, Ind., D.Sc.; Wheelock College, Boston, 
Ed.D.; University of Connecticut, Storrs, LL.D.; State 
University of New York at Buffalo, L.H.D.; New School 
for Social Research, New York City, I..H.D.; Rhode 
Island College, Providence, D.Ped.; Amherst College, 
j Amherst. Mass., D.Sc.; John Jay College of Criminal 
Justice. New York City, L.H.D.; Wesleyan University, 
Midtiletown, Conn., L.H.D.; Princeton University, 
Princeton. N.J., D.H.; Northwestern University. 
F-ivanston, 111., D.Sc.; and Worcester Polytechnic Fnsti- 
uitc, Worcester, Mass., D.Sc. 
izens are America's saviors. We must call the attention of the 
nation to our country’s needs and to the urgency with which 
they must be met. 
Wherever you go from this day forward, you will be among 
the best educated, most respected leaders in the community. 
Your authority, attitudes, and opinions as physicians will intJu- 
ence public policies and practices beyond your area of exper¬ 
tise. In fact, people listened to my school improvement ideas, 
in part, because I am a physician. That gives us a great oppor¬ 
tunity and an even greater responsibility — again, in our pro¬ 
fessional areas, but also as citizens. 
But to be helpful, we must be open and informed and not 
burdened by the stereotypes, myths and rationalizations that 
have contributed to our problems. And as individual physi¬ 
cians, we have the power to treat all our patients with the kind 
of respect that simultaneously enhances their self-esteem and 
positively influences their health and citizenship behavior. (For 
those of us who have been more fortunate, it is sometimes dif¬ 
ficult to understand how some of our behaviors — disrespect, 
disdain and abuse—add to the burden of the poor.) As a pro¬ 
fessional group, your generation will have an opportunity to 
create a health system that is fair to physicians and patients 
alike; to all patients, affluent and poor alike. And 1 don’t for 
one moment hold physicians largely responsible for the 
inequities in our pre.sent system. But we can help correct them. 
As powerful and leading citizens we must, through the 
democratic process, make it possible for all of our young 
people to live in families which will give them the start that 
will enable them to obtain the education needed to participate 
in the mainstream of society — as successful workers, family 
members, child-rearers and citizens. We must contribute some 
of our time and resources to programs that will prevent serious 
social problems. 
Altruistic, maybe, but hardly. The families and children we 
enable to function well will not over-tax our own pocketbooks, 
or our education, health and social service systems. They will 
produce the goods and services that will eliminate our deficit 
and enable us to compete with Germany, Japan and Sweden in 
such a way that the America of 2021, your 30th-anniversary 
year, will be aftJuent. vibrant and strong — still the most pow- 
ertul force for democracy and fair play in the world. 
Let me close with an apocryphal story F appropriated from a 
graduation speaker I heard recently; Several teen-agers wished 
to belittle an elderly Greek philo.sopher. One youngster held a 
bird behind his back in his fist, and asked, "Old man. is the 
bird dead or alive?" If he had said that the bird was alive, the 
youth would have crushed it to death. If he had said “dead,"’ he 
would have opened his hand and allowed the bird to fly away. 
The philosopher, wise in the ways of mischievous youths, 
pau.sed thoughtfully, and then said, "My .sons, the decision 
about the life or death of that bird is in your hands." 
To the Class of 1991, 1 say to you. the future of medicine, 
the future of America, and the future of democracy is in your 
hands and in the hands of young men and women like your¬ 
selves across the country. If you carry out your professional 
and citizenship responsibilities with the dedication and talent 
you have demonstrated to date, America will survive and 
thrive in the 2Lst century. Your 3()th-class reunion will not 
only be in a vibrant and strong America, but a better America 
than we have today. 
I wish you — and all assembled with you — much success 
in medicine, in your personal lives and as citizens. 1 am 
pleased to have shared this important day with you. YM 
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AFRICAN-AMERICAN STUDENTS 
YSM’S UNFOLDING LEGACY 
by Daryl Daniels, M.D. ’91 
As I walked down the aisle to receive my Yale medical 
diploma on May 27, I became the 183rd African-American to 
do so. I was among 12 black Americans to graduate with an 
M.D. degree from the Yale School of Medicine this year, con¬ 
tinuing a long and fascinating history of African-American 
presence at YSM. It is important to view that pre,sence in con¬ 
text of the times. 
Chartered by the Connecticut Assembly in 1810, the Medi¬ 
cal Institution at Yale College awarded the M.D. degree to 
Courtlandt Van Rensselaer Creed in 1857, eight years before 
the end of the Civil War. On that occasion. Dr. Creed became 
the first African-American to earn a degree from the institu¬ 
tion, and Yale became one of the the first medical schools in 
the United States to admit, educate and award a degree to 
people of his race. 
The Town 
Circumstances surrounding Dr. Creed’s admission to Yale 
reveal an important period of transition in demography and race 
relations in New Haven. Though a small city by today’s stan¬ 
dards, with just over 20,000 people. New Haven had a decid¬ 
edly urban character. A strong manufacturing base, mostly car¬ 
riage and firearms factories, was supported by the city’s 
emergence as a regional transportation center, offering both a 
major harbor and strategic railroad access to New England. 
In spite of its industrial character. New Haven’s social 
structure remained essentially as it had been in the colonial 
era. Society and the city government were dominated by a few 
aristocratic families with close ties to the local clergy, espe¬ 
cially those associated with Center Church on the Green. 
Below these families on the social pyramid was a growing 
middle class, mostly artisans and skilled workers, followed by 
a base of unskilled manual laborers. 
African-Americans in New Haven, freed by the provisions 
of the state’s Gradual Emancipation Act of 1784, were num¬ 
bered about 1,000, and were the least privileged citizens. 
While not utterly deprived of their civil rights, they were set 
apart from the rest of society in undesirable parts of the city 
where land was too poor for farming. 
Most lived in “New Libera,” a run-down area on lower 
Chapel Street between the old waterfront and factories; some 
in the area surrounding Congress and Washington streets, 
known then and now as the Hill; others lived on “Negro Lane” 
which was that part of State Street east of the original nine 
squares. Later, quite a few settled in “Poverty Square,” the area 
around lower Dixwell Avenue. Living in substandard housing 
and working at the most menial of jobs for which they 
received the poorest wages, almost half the black population 
was employed as servants; the remainder took whatever jobs 
they could find. A few were highly skilled and worked as arti¬ 
sans in shoemaking, woodworking and other trades. Some 
worked aboard ocean vessels. Service jobs, such as barber or 
Gregory R. Huth 
Dr. Daryl Daniels 
Daryl Danielsy M.D. ’91: 
Making History by Pursuing It 
As a second-year student in 1989, Daryl Daniels began 
his M.D. thesis research into the story of African-Ameri¬ 
can medical students at Yale. Among his important dis¬ 
coveries, he traced the history of black Yale medical stu¬ 
dents back to 1854; a 1970s medical school brochure 
had mistakenly stated that YSM’s first African-Ameri¬ 
can student graduated in the Class of 1949. Dr. Daniels 
was one of five fourth-year students to give oral presen¬ 
tations at Student Research Day, held in May. Curtis L. 
Patton, Ph.D., professor of epidemiology (microbiol¬ 
ogy), served as his advisor. 
Dr. Daniels has begun a general surgery residency at 
the University of New Mexico School of Medicine. 
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waiter, were the most desirable and held by members of the 
"best” African-American families. 
Documents show that African-Americans in New Haven 
were unwilling to play the role of bystander watching a city 
prosper and move ahead. They made stunning efforts to 
improve their lot early in the last century. They organized 
political, benevolent and religious societies. 
The first clerk of a group organized in 1824 as the African 
Ecclesiastical Society was Prince Duplex, a well known 
African-American and Revolutionary War veteran. With the 
help of Simeon Jocelyn, a member of Center Church on the 
Creen. a run-down building on Temple Street between Crown 
and George Streets was purchased. On Aug. 2.‘S, 1829, the 
group was recognized by the Western Association of New 
Haven County and became the Temple Street Congregational 
Church, renamed after its move the Dixwell Avenue Congre¬ 
gational Church, the first African-American Church of this 
denomination in the country. 
With the church as their base, they opened a small day 
school, the first school in the city for African-American chil¬ 
dren. Vashti Elizabeth Duplex, Prince Duplex’s daughter, was 
the teacher, the first black school teacher in New Haven. 
Although plans for a black college were .squelched by a hostile 
press, cooperation, mutual and white support brought gains in 
education and employment. A small and significant African- 
American middle class had begun. 
An Historic Turning Point 
In the summer of 1839. a series of events would begin to 
unfold with profound ramifications for New Haven and the 
nation. The stage was set as the Aniisttul, a Spanish schooner, 
was captured in Tong Island Sound. It had sailed from West 
Africa for Cuba with a shipload of 54 Africans to be sold as 
slaves. Led by a man who came to be known as Joseph 
C’inque. the kidnaped Africans, members of the Mende tribe, 
seized control of the ship and instructed the crew to return 
them to Africa, fhe crew resisted by taking a zig-zag course, 
steering the ship towards Africa by day and pointing it back to 
America at night under overcast skies. The Amistad was inter¬ 
cepted off Montauk by the United States Navy and towed to 
New London. The captives were transported to New Haven to 
await prosecution on charges of piracy. 
At first, the fate of the.se Africans seemed hopeless, espe¬ 
cially since they spoke no European language. But Josiah 
Willard Gibbs, an intrepid abolitionist professor at Yale, 
located a Mende interpreter on the docks of New York. When 
details came to light of how the defendants were kidnaped, a 
great outpouring of public support followed. The Amistad case 
became a cause celehre for the abolitionist movement. Thanks 
in part to the efforts of the people of New Haven, the captives 
were eventually freed and returned home by a U.S. Supreme 
('(Hirt decision. 
In addition to rekindling the national abolitionist move¬ 
ment. the Amistad affair generated public sympathy for 
African-Americans in New Haven. Indeed, in this supportive 
atmosiihere, a fledgling well-to-do class developed among 
New Haven blacks, d'hey bought property, saved money, pro- 
vitied lor their poor and their young. Linder the leadership of 
fheodore Dwight Woolsey, an abolitionist and proponent of 
African-American education, who in 1846 was chosen ninth 
president of Yale, the College became a hotbed of anti-slavery 
sentiment. >'ale, then the largest college in the nation, was the 
school ol choice for many northern and southern students. 
I he Meilical Institution appears to have been caught up in 
the abolitionist fervor. In 1849. it awarded an honorary M.D. 
degree to Dr. Ezekiel Skinner of Ashford, Conn., for his work 
in Liberia, a new American colony in Africa for emancipated 
slaves. This abolitionist sentiment, coupled with the news that 
black students were being accepted at other medical schools in 
the Northeast, may have provided the impetus at Yale to admit 
its first African-American. 
An Ideal Candidate 
Courtlandt Van Rensselaer Creed was the son of John William 
Creed, a middle-class African-American who worked as a 
waiter and steward at Yale College and a caterer in business 
for himself. Dr. Creed’s mother was Vashti Elizabeth Duplex, 
the first black teacher in New Haven and a member of a highly 
successful family. They named their son for Courtlandt Van 
Rensselaer, B.A. 1820, a Presbyterian minister who was dedi¬ 
cated to helping African-Americans. There are reasons to 
believe that Van Rensselaer befriended and perhaps tutored 
Creed when he was at Yale. 
Young Courtlandt Creed, a lifelong New Haven resident, 
was qualified to attend Yale in accordance with state law. He 
prepared at the Lancasterian School, located at Orange and 
Wall streets, the precursor to Hillhouse High School. More¬ 
over, his family could afford the tuition and had connections at 
Yale and in the community. Courtlandt’s namesake was a 
friend and classmate of President Woolsey and Dr. Charles 
Hooker, dean of the Medical Institution. They had a close rela¬ 
tionship with the Rev. Leonard Bacon. This politically power¬ 
ful rector of New Haven’s Center Church was a Yale Corpora¬ 
tion member who along with Woolsey was a founder of the 
New Haven African Improvement Society. 
In 1854, Courtlandt Creed entered the Yale Medical Institu¬ 
tion. Unlike at Harvard, where three African-American stu¬ 
dents were forced to leave four years earlier as a result of 
protests from white students, there is no record of any such 
negative responses to his attendance. Why this contrasting 
reception? Perhaps Yale had the advantage of having a rela¬ 
tively small medical .school of about 30 local young men, 
while the medical .school at Harvard was perhaps twice as 
large and attracted students from North and South. 
As was practice at the time, Courtlandt Creed entered the 
Medical Institution out of secondary school and spent three 
years earning his degree. His M.D. thesis, entitled “On 
Blood,” was a study on the chemistry and physiology of blood 
in health and disease. His oral examinations took place in Jan¬ 
uary 1857 before repre.sentatives of the Connecticut Medical 
Society, the faculty of the Medical Institution and President 
Woolsey. On Thursday evening, Jan. 16, 1857. Courtlandt van 
Rensselaer Creed and 10 other members of his class received 
the M.D. degree in the college chapel. 
Triumph and Tragedy_ 
After graduation. Dr. Creed opened an office in his father’s 
house on Chapel Street, and soon developed a large and pros¬ 
perous practice. Neither professional success, nor happy mar¬ 
riage, nor births of four sons would portend the difficult years 
ahead for the family. 
On April 12. 1861, Confederate troops fired on Fort Sumter. 
At the outbreak of the Civil War, Dr. Creed wrote to the gover¬ 
nor of Connecticut asking for a commission to serve as a sur¬ 
geon in the state militia but was refused becau.se of his race. 
As the war dragged on, however, it became clear that African- 
Americans would be needed for the Union cause. In the fall of 
1863, the governor issued a call to amis to Connecticut’s 
African-American men. Dr. Creed wrote the governor again, 
this time to thank him. declaring, "On every side we behold 
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(Connecticut’s] colored sons rallying to the sound of ‘Liberty 
and Union.’” 
Dr. Creed enlisted on Jan. 29, 1864, and was appointed 
acting surgeon of the 30th Connecticut Volunteers, a company 
of African-Americans. They trained at Grapevine Point in the 
Fair Haven section of New Haven during the winter and spring 
of 1864. On June 4th of that year the Army deployed the vol¬ 
unteers to Cold Spring, Va., where they joined other compa¬ 
nies to form the 31st U.S. Colored Infantry. 
Dr. Creed did not remain with the 31st. Toward the end of 
hostilities, he was detached to the Army’s Department of the 
East. Before he was mustered out on Nov. 7, 1865, Dr. Creed 
also may have served with the 13th Connecticut Volunteers 
and the 55th Massachusetts Colored Infantry. 
During the war, the fortunes of the Creed family had begun 
to deteriorate. After Dr. Creed’s father died, the family began 
to deplete the resources of his estate; they auctioned off what 
remained of the family’s property to pay debts following his 
mother’s death in 1879. Dr. Creed eventually returned to live 
in New Haven and practice medicine but never attracted the 
number of patients he had before the war. Poverty and illness 
dogged him during the last decade of his life. He died on Aug. 
8, 1900, of Bright’s disease, a spectrum of kidney and heart 
ailments, at the age of 65, and was buried in the family plot in 
Grove Street Cemetery in New Haven. 
Sixteen years after Dr. Creed graduated, Bayard Thomas 
Smith and George Robertson Henderson transferred to Yale 
from the Medical Department of Lincoln University in Penn¬ 
sylvania, the nation’s first historically black college. Lincoln’s 
Medical Department, founded in 1869, was poorly funded and 
closed after four years. It did not graduate any students; those 
George Henry Jackson, M.D. 1892, documented the therapeu¬ 
tic value of moderate wine intake in his 1928 hook. 
who did complete their studies did so at other schools. 
Although there were less expensive and less rigorous medical 
schools. Smith and Henderson entered Yale in 1874. 
Their decision may have been indirectly influenced by Dr. 
Creed. Dr. Elmore C. Hine, M.D. 1861, a white physician and 
the dean of Lincoln University’s Medical Department, studied 
medicine at Yale when Dr. Creed was practicing in New 
Haven. Although no record of direct communication between 
Dr. Hine and Charles Lindsley, then dean of medicine at Yale 
was found, it is a reasonable speculation that their relationship 
helped the two students from Lincoln transfer to Yale. Dr. 
Smith completed his studies in one year, graduating in 1875. 
He returned to his home state of Delaware to practice. Dr. 
Henderson graduated in the spring of 1876 and began a prac¬ 
tice in New York City; he moved to Brooklyn in 1888 where 
he died of an accidental morphine overdose at the age of 45. 
A Period of Leadership 
The year 1888 opened a remarkable period for what had 
become the Yale Medical School. During the 15 years that fol¬ 
lowed, Yale would graduate eight African-Americans, with at 
least one present in the school during this entire period. While 
perhaps not impressive by today’s expectations, their pre.sence 
represented a strong commitment to African-American educa¬ 
tion at a time when only a few of the white northern medical 
schools admitted blacks, making Yale a leader in African- 
American medical education. 
The first black physician to graduate during this period was 
Dr. Henry Eloyd Gamble, born in slavery in North Carolina, 
Jan. 16, 1862. He took his education very seriously and even 
employed a tutor to ensure the quality of his early learning. 
Working as a steward, he managed to save enough money by 
age 20 to begin studies at Lincoln University, graduating with 
honors in 1888. He entered Yale Medical School that fall and 
worked long hours at night as a janitor and waiter. My com¬ 
mencement marks the centennial year of Dr. Gamble’s gradua¬ 
tion with honors. 
Dr. Gamble moved to Charleston, W. Va., where he became 
widely known for his skills as a surgeon. His publications 
include papers on thoracic aneurysm and caesarean .section. 
His contributions to medicine, medical education and civic 
organizations were many and significant. He organized the 
West Virginia State Medical Association and in 1912 was 
elected president of the National Medical Association (NMA). 
He died in September 1932. 
The year after Dr. Gamble graduated. Dr. George Henry 
Jackson received his M.D. degree from Yale. His remarkable 
life would seem to justify the praise of his contemporary, the 
Rev. A.C. Powell, who described him as an “all-round genius.” 
Born in 1863, in Natick, Mass., he spent his early life working 
as a Erench interpreter and as a manager in a shoe factory. 
Erom there he went to Madison Seminary, now Colgate Uni¬ 
versity, graduating in 1887. He earned the Bachelor of Divin¬ 
ity degree in 1889 and an M.D. degree in 1892 from Yale. He 
also earned an M.A. degree from Shaw University in Raleigh, 
N.C. He was ordained and became the pastor of Immanuel 
Baptist Church in New Haven. 
Dr. Jackson traveled to the Congo Eree State as a medical 
missionary, returning to New Haven in 1897. Two years later 
he headed overseas again, this time to France as the United 
States Consul to Cognac and La Rochelle. While in France, Dr. 
Jackson started a successful import-export business. In 1928 
he published The Medicinal Value of French Brandy. He 
retired in 1935 and died eight years later from a stroke, in Los 
Angeles. Continued on page 13 
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Altlioui’li this photograph has been handed down without documentation, the two African-Americans in the hack row meet the descrip¬ 
tion of Arthur Leslie Howard and William Fletcher Penn of the Class of 1897. The year 1895 painted on the soles of the shoes of stu¬ 
dents in the front row implies that this may have been an early portrait of the class. 
1888-1903:15 Years of Leadership 
In African-American Medical Education 
At the turn of the 2()th century. Yale Medical School took a 
leading role in educating African-American physicians. Num¬ 
bered among them were: 
Isaac Napoleon Porter. '93. A native of Summit Bridge. 
Del.. Dr. Porter remained in New Haven after graduation. 
From a house on Dixwell Avenue, he started a practice which 
soon grew into one of the largest in the city. He served on the 
New' Haven Board of Aldermen, the Chamber of Commerce, 
the Historical Society, the Connecticut Medical Society and 
the American Medical Association. 
Arthur Leslie Howard and William Fletcher Penn, '97. Dr. 
Howard was the son of a wealthy New York merchant and a 
favorite of his classmates. After graduation, he went to Eng¬ 
land where he died of an unknown illness at the age of 28. Dr. 
F’enn. who claimed to be a descendent of William Penn, the 
founder of Pennsylvania, had a long and distinguished career 
m surgery. He practiced originally in Atlanta, but in 1926 
moved to Tuskeegee. Ala., where he gained wide regard as the 
chief of surgery at the Tuskeegee Veterans Administration 
Hospital. 
Charles William Snyder and William Houston Wright. '()(). 
Dr. Snyder, of Hartford, came to Yale from Fisk University, 
where he had earned a B.A. degree in 1896. After medical 
school, he practiced in New Albany, Ind., and Louisville, Ky., 
where he was active in the National Association for the 
Advancement of Colored People. Dr. Snyder’s classmate. Dr. 
Wright, attended high school in Bridgeport, Conn. No record 
of his undergraduate education was found. He interned at 
Freedman's Hospital in Washington, D.C., one of only three 
programs in the country open at that time to African-Ameri¬ 
cans. Dr. Wright practiced in the Baltimore area. In 1908 he 
was elected president of the National Medical Association. He 
also served as president of: the Maryland Medical. Dental and 
Pharmaceutical Association; the Board of the Maryland 
School for Girls; the local and national YMCA; and the local 
and national Urban League. An avid sports fan. he became 
chief umpire for the National Tennis Association. 
Cleveland Ferris, '03. The last African-American to gradu¬ 
ate from Yale during this period. Dr. Ferris was born Dec. 27. 
1877. in Philadelphia. He attended Peekskill Military 
Academy in New York and before entering the Yale Medical 
School in 1899, he attended Phillips Andover Academy. After 
Yale, Dr. Ferris went to Lincoln Hospital in New York City 
where he practiced urology. He was admitted to the American 
Medical Association and was elected a fellow of the New York 
Academy of Medicine. He died suddenly of blood poisoning in 
1913, at the beginning of his career. 
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Cleveland Ferris, M.D. '03, graduated from what had then 
become the Yale University School of Medicine; it would be 
41 years before the next African-American would receive a 
degree from the school. There are several reasons for this 
hiatus. The decades following the end of Reconstruction gave 
rise to nationwide racial intolerance, as marked by the virtual 
abandonment of African-Americans by the Republican Party 
and the legalization of segregation in the South. What is more, 
rapid industrialization opened the doors of the country to 
unprecedented numbers of Roman Catholic and Jewish immi¬ 
grants from Europe. As much as America would benefit from 
their labors, many in the United States would have preferred 
that the “wretched refuse” never left their teeming shores. 
The Ku Klux Klan resurfaced in 1915 to reaffirm the supe¬ 
riority of white Protestants. By 1924, New Haven, once a 
hotbed of abolitionism, claimed Connecticut’s largest Klavern 
with some 2,000 members. This wave of intolerance had a dra¬ 
matic effect on Yale as well as on its host city. The College 
made a deliberate and concerted effort to limit the number of 
matriculants of certain ethnic and religious groups in the 
1920s, a trend evident in many of the northeastern universities. 
In 1920, the dean of Brown University submitted the topic 
“The Limitation of Jews and Negroes” for discussion at a 
meeting of deans of New England colleges. 
In New Haven, the School of Medicine followed the lead of 
Yale College. By 1935, the medical school’s official admission 
policy stated, “the number of women is restricted...as are some 
racial groups including Europeans, South Americans, Hebrews 
and Orientals.” Perhaps the most blatant example of docu¬ 
mented racial discrimination at Yale during this time period 
occurred in 1941, when School of Nursing Dean Effie J. 
Taylor denied a student entry becau.se of her race. 
In the ensuing controversy, it was revealed that the medical 
and nursing schools had adopted an “unwritten policy” of 
racial exclusion. The purported basis for this policy was the 
fear that white patients at New Haven Hospital would find 
black students unacceptable on the wards. When details of the 
unwritten policy became public, Yale President Charles Sey¬ 
mour had it stopped. African-Americans were admitted once 
again. Backlash from white patients never materialized. Yale, 
it would seem, had been frightened by a ghost. 
Yale Returns to its Ideals 
Immediately after the “unwritten policy” was discontinued, 
Beatrix Anne McCleary, M.D. ’48, was admitted, becoming 
the first African-American woman to graduate from the School 
of Medicine. 
Today, Dr. McCleary G. Hamburg practices pediatrics in 
New York City. After Dr. McCleary, a black student was 
admitted to the medical school every two or three years. This 
trend continued until the civil rights movement rocked the 
country in the mid-196()s and demands to increa.se minority 
enrollment grew. 
Much of the support for increased minority admissions 
came from the school’s African-American faculty; Drs. James 
P. Comer and Augustus White, for instance, joined the admis¬ 
sions committee. During this activist time, Courtland Wilson, a 
re.searcher in the physics department, picketed in one-man 
demonstrations to demand increased minority admissions. He 
later became a lecturer in public health and coordinator of the 
medical school’s Committee for the Recruitment of American 
Black and Spanish-speaking Students. The School of Medicine 
admitted nine African-Americans in the fall of 1969, the 
largest number up to that time. Since then, about 10 black stu¬ 
dents have enrolled in each class. 
Nearly two decades later, the medical school took its next 
steps toward advancing the cause of minority student enroll¬ 
ment and faculty recruitment. On Sept. 8, 1988, in a convoca¬ 
tion speech to Yale’s incoming graduate and professional stu¬ 
dents, Dean Leon E. Rosenberg exhorted the University to 
renew its dedication to minority medical education and 
advancement. (See “America’s Disadvantaged Minorities: Re¬ 
kindling The Torch,” Yale Medicine, FallAVinter 1988-1989. | 
At the School of Medicine, the dean acted according to his 
own call. Beginning in January 1989, Martin Luther King Day 
celebrations have included a .school-wide forum to explore 
minority social and health-care issues. The Office for Minority 
Affairs was established that same year with the appointment of 
Ms. Maxine Whitehead as its first director. In recent years, the 
number of African-American students entering the school has 
increa.sed. For example, the Class of 1993 includes 12 African- 
Americans, the Class of 1992, 13. As the School of Medicine 
looks forward to graduating its 2()()th African-American physi¬ 
cian, it is appropriate to reflect not only upon its historical role 
in the education of black physicians, but its commitment to the 
future as well. Yale can be an important beacon for the nation; 
in the words of Dean Rosenberg, “to rekindle the torch.” YM 
Courtesy Kdmund .S. C’relin, M.I)., .Sc.l). 
t 
Beatrix McCleary Hamburg, M.D. '48, shown here in a first- 
year portrait, was the first A frican-American to he admitted to 
the medical school in 40 years and the first black woman ever 
to graduate from the School of Medicine. 
Editor’s note: Special thanks to Curtis L. Patton, Ph.D., 
professor of epidemiology (microbiology), for reviewing and 
helping edit this article. 
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AIDS RESEARCH AT YALE: 
SHIFTING INTO HIGH GEAR 
hy Diane E. Loupe 
Eight-year-old "Bobby," dressed in Army fatigues, shoots at 
imaginary enemies with his fingers as he frenetically spins 
around in a swivel chair in a Yale Physicians Building waiting 
room. The irony of such child's play is not lost on Bobby’s 
pediatricians; they suspect that his hyperactivity is due to his 
AIDS, which has begun to erode Bobby's memory and may be 
giving him delusions. 
I'he devastation this disease has wreaked on Bobby's 
family is no delusion, however. AIDS has killed his mother, 
two brothers, stepfather and uncle. His father, recently relea.sed 
from prison, contracted the virus through intravenous drug use 
and then transmitted it sexually to his mother. In a grim family 
legacy, she passed the virus on to Bobby and two other sons at 
their birth, and through sex to Bobby’s stepfather. 
Although chronic pneumonia has left the child with cardiac 
and respiratory problems, his grandmother, with whom he now 
lives, will not allow an oxygen tank into her apartment. 
Already, bullets have chipped the brick exterior of her build¬ 
ing; she fears that a stray shot might smash through a window, 
strike the tank and trigger an explosion. 
To help them cope. Bobby and his grandmother have found 
an ally in Warren Andiman, M.D.. associate professor of pedi¬ 
atrics. epidemiology and laboratory medicine. He and his col¬ 
leagues in the Pediatric AIDS Program have treated Bobby 
since I MS.'S, two years before the pediatric AIDS clinic opened, 
freatment extends beyond Bobby's physical needs; the boy's 
spirits have been bouyed by program staffers who have 
arranged such outings as picnics, parties, trips to amusement 
parks and summer camp. 
As medical director of the AIDS Program at Yale, Dr. Andi¬ 
man oversees the clinical care of about 220 children born to 
women infected with the human immunodeficiency virus 
(HIV), the agent that causes AIDS. This number includes 6,^ or 
more infected children. The adult clinic cares for approxi¬ 
mately 7.S() people infected by HIV. 
Bobby's case illustrates the social problems that lend a 
sense of urgency to the work of up to 7S researchers and clini¬ 
cians at Yale University and the School of Medicine who are 
trying to understand and defuse the AIDS virus. Approxi¬ 
mately Sb.4 million in federal and private grants and contracts 
support the medical school's studies, which include examining 
the natural history and pathogenesis of infection in women and 
children, developing and testing anti-retroviral pharmaceuti¬ 
cals, clinical investigations into new treatments, and studying 
chemictil and cellular interactions of HIV. Other Yale physi¬ 
cians and scholars are focusing on ethical and social issues. 
When .AID.S first appeared in the early 'SOs, no one in the 
metlical establishment including the School of Metlicine — 
I nunc E !oilin’ is stajj w riter at the incilical sehool's office of 
piihlii infonnation. 
had foreseen the appearance of such a destructive virus. With 
mass immunization bringing the decline of polio, smallpox 
and measles, it seemed as if the age of infectious diseases had 
ended. That assumption proved tragically wrong. 
As AIDS emerged as the next great epidemic, the medical 
.school rued the day in the I96()s when it had phased out its 
department of microbiology. Moreover, there was little coordi¬ 
nation among those Yale scientists who were doing AIDS 
research. 
Under the leadership of Dean Leon E. Rosenberg, M.D., the 
School of Medicine is embarking on a course to strengthen its 
AIDS re.search and clinical programs. Among tho.se steps are: 
• coordinating research efforts through a University-wide 
consortium of faculty studying medical, psychological, 
social and economic aspects of the disease; 
• recruiting a major AIDS researcher, Gerald H. Friedland, 
M.D.. to lead this consortium. [See “Pioneer AIDS 
Re.searcher Comes to the University,’’ page 17.| 
• moving AIDS care into expanded facilities in the Nathan 
Smith Clinic and increasing the number of clinicians 
treating AIDS patients; 
• establishing a section of microbiology; 
• opening a virology laboratory at the Laboratory of Epi¬ 
demiology and Public Health (LEPH) to serve as a core 
facility providing state-of-the-art biological containment. 
Comments Acting Dean Robert M. Donaldson, M.D.. “1 
think that there will be more interdisciplinary research to 
advance knowledge about AIDS and a greater awareness in the 
University community about the challenge of AIDS. Both of 
those should combine to facilitate new advances for people 
with AIDS." 
Quiet Crusaders 
From its advent, AIDS riveted Dr. Andiman's attention 
because it seemed to comprise an “encyclopedia of infectious 
diseases." Patients were getting illnes.ses he had never seen 
before, such as Pneumocystis carinii pneumonia (PCP), and 
Kaposi's sarcoma, a sometimes aggressive skin tumor. Other 
opportunistic pathogens — cytomegalovirus (CMV), a herpes 
virus; Toxoplasma gondii protozoa; and the Candida fungus — 
ravaged people with HIV-weakened immune systems. 
As he worked with AIDS patients and their families. Dr. 
Andiman discovered that he had to consider their social diffi¬ 
culties Just as .seriously as their medical problems. 
"All of society's ills — poverty, discrimination, drug abuse 
— are rellected in this disease," he asserts. "It seemed like an 
extraordinary opportunity to really think about the social, 
political and ethical aspects of medicine." 
B. Joyce Simpson, R.N., a research nurse and coordinator 
of the pediatric AIDS program, notes that discrimination 
against people with AIDS .so frightens parents that they often 
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will not let infected children know that they, the children, 
harbor HIV. To protect the secret, some parents avoid taking 
their children to AIDS clinics for care and counseling; others 
decline home visits from nurses in fear of attracting the atten¬ 
tion of neighbors. 
Brian W. Forsyth, M.D., assistant clinical professor of pedi¬ 
atrics, affirms; “The stigma exists and exists dramatically. 
Mothers tell us stories of people crossing the street saying, 
'Don’t go near them, they’ve got AIDS.’ ” 
To help families cope with such problems. Dr. Forsyth and 
colleagues have started the Comprehensive Support Program 
for HIV-Infected Children. In the program, family support 
workers offer mothers or other caregivers of HIV-infected chil¬ 
dren such services as delivering diapers or food, arranging a 
ride to the clinic, or providing emotional support. Dr. Forsyth 
serves as its medical director. 
The program’s social services director, Steven F. Nagler, 
M.S.W., points out that providing social support to the family 
of an HIV-infected child can save money by reducing unneces¬ 
sary hospitalizations. Citing a 1988 study published by Dr. 
Forsyth and colleague Kathy Kemper, M.D., Mr. Nagler notes 
that more than 30 percent of the days HIV-infected children 
spent in Yale-New Haven Hospital during 1987 were due to 
such non-medical problems as not having a responsible adult 
available to care for the children upon discharge. 
Prenatal Challenges 
Such research into social support complements basic and clini¬ 
cal studies being undertaken by medical school scientists. 
Some pediatric AIDS researchers, for instance, are trying to 
determine how and when mothers transmit the virus to their 
babies during pregnancy or childbirth. 
Although all babies born to HIV-infected mothers carry 
antibodies to the virus, most lose the antibodies within six to 
15 months after birth and never develop the disease. Dr. Andi- 
man, Ms. Simpson and colleagues found that only about 25 
percent of HIV-infected women giving birth at Yale-New 
Haven Hospital transmit the virus to their children. Studies 
elsewhere show rates of 15 to 40 percent. 
Why some babies get the disease and others do not presents 
one of the most perplexing questions facing pediatric AIDS 
researchers. In the course of caring for approximately 200 
HIV-infected pregnant women since 1984, Richard Viscarello, 
M.D., assistant professor of obstetrics and gynecology, and 
Nancy DeGennaro, R.N., M.RH. ’91, have studied 12 pairs of 
twins born to infected mothers. They found three babies who 
were infected when their twins were not. 
Most infected babies acquire the virus before or during 
birth. Dr. Viscarello says, but researchers are not sure how 
often the virus is transmitted via two major routes, across the 
placenta or through contact with secretions during birth. Physi¬ 
cians advise HIV-infected women not to breast feed, to elimi¬ 
nate this occasional route of infection. 
To try to identify HIV-infected children early in life — 
before birth if possible — Drs. Viscarello, Andiman and 
George Miller, the John F. Enders Professor of Pediatric Infec¬ 
tious Disease, are perfecting several screening tests. 
Dr. Viscarello notes that if physicians could determine ear¬ 
lier which babies will become sick, it might be possible to start 
preventive treatments, such as prophylactic antibiotics or 
antiviral drugs, sooner. Developing an accurate prenatal test of 
fetal infection would also be helpful. He adds, “Women who 
knew their babies would become infected could make 
informed decisions about terminating their pregnancies.” 
Dr. Andiman’s group has determined that when a baby’s 
Some Facts Regarding AIDS 
• An estimated 1.5 million of the world’s people have 
had AIDS; half of them have died. 
• As of May I, the U.S. Centers for Disease Control 
(CDC) listed 174,893 Americans who have had 
AIDS; 110,530 have died. 
• The World Health Organization estimates that by the 
year 2000, 40 million people will be HIV-infected, 
including more than a million U.S. residents. 
• In fiscal year 1991, the U.S. government will spend 
$1,152 billion on AIDS research and treatment. 
• Connecticut health officials estimate that 1 in 200 
residents is infected with HIV, roughly the same as 
the national rate. 
• As in other states, Connecticut’s AIDS cases are con¬ 
centrated in urban areas. New Haven has an esti¬ 
mated 2,800 residents infected with HIV and one of 
the nation’s highest cumulative incidences of children 
with AIDS. 
Ph()((»graphs by .lames H. Anders<m 
Dr. Warren Andiman and Joyce Simpson put one of their young 
patients at ease. 
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blood contains high levels of antibodies that prevent cells from 
fusing, the infant is likely to develop a more benign fomi of 
the disease, one associated with longer life. The researchers 
attribute this to the fact that white blood cells infected with the 
AIDS virus tend to spread infection by fusing with uninfected 
cells. If scientists could develop a vaccine to elicit a similar 
antibody response, it might inhibit the spread of the virus. 
In another study of 31 women. Dr. Viscarello's group found 
that HIV-infected women whose blood carried antigen from the 
HIV core protein p24, became progressively sicker after deliv¬ 
ery or abortion, while women who lacked the antigen remained 
clinically stable. In another study, they found that infection 
appeared more often in babies born to antigen-positive women 
than in babies born to HIV-infected women without this anti¬ 
gen. Testing for the presence of the protein might warn physi¬ 
cians that an HIV-infected woman is at risk and should be 
observed closely, or that a newborn is more likely to develop 
AIDS, he suggests. 'Hie researchers also have discovered that 
Dr. Rii hard Msc arello counsels a pregnant patient. 
irregular PAP smears in seropositive women progress much 
faster to invasive cervical cancer than in uninfected women. 
Such differences in disease progression are one reason 
women, including pregnant women, should be included in 
more clinical trials of AIDS medications, argues medical ethi- 
cist Robert .1. l.evine, M.D., professor of medicine and chair¬ 
man of the medical school's human investigation committee. 
“C'linical trials should include populations which are often 
excluded, such as women who could become pregnant, intra¬ 
venous drug users, prisoners, racial and ethnic minorities, and 
patients taking other AIDS medications and with other ill¬ 
nesses," he says. 
Dr. l.evine has co-authored national guidelines urging 
researchers to involve persons with AIDS and other commu¬ 
nity members in the tiesign of tests of new AIDS treatments. 
16 
The guidelines were adopted in the fall of 1990 by a group of 
prominent AIDS re.searchers, patients and community activists 
meeting in New York. 
Dr. Levine has also worked on developing national and 
international policy governing the use of human subjects in 
AIDS research. He directs the World Health Organization’s 
project for developing guidelines for testing of HIV drugs and 
vaccines. Among other groups. Dr. Levine advises the Council 
for International Organizations of Medical Sciences, the Pan 
American Health Organization and the AIDS Program Advi¬ 
sory Committee of the U.S. Department of Health and Human 
Services. 
Drugs Plus Sex: A Dangerous Combination 
Although homosexual men still make up the largest category of 
U.S. AIDS sufferers, increased infection among heterosexual 
drug abusers is amplifying sexual infection of women, the 
fastest growing population of AIDS patients, and through child¬ 
birth, their children. 
This paradigm tends 
to concentrate the 
spread of the disease 
in poor urban areas. 
[See “Public Policy 
in the Age of AIDS," 
Y,.\le Medicine, Fall- 
Winter 1990-1991.] 
The fact that three 
of every 10 AIDS 
patients in New 
Haven are women — 
triple the national 
rate — reflects the 
spread of AIDS 
among drug abusers. 
Nearly all of these 
women either have 
used intravenous 
drugs or had sexual 
intercourse with an 
IV-drug abuser, 
observes Dr. Vis- 
carello, who also 
runs a program to 
treat substance-abus¬ 
ing pregnant women. 
In a study. Dr. 
Viscarello's group 
has treated 32 preg¬ 
nant women with 
zidovudine, or AZT, the first federally approved AIDS medi¬ 
cation. AZT slows HIV's progression by interfering with 
reverse transcriptase, an enzyme crucial to the virus’ reproduc¬ 
tive process. [See “Making Viral Replication Crystal Clear," 
page 18.1 Dr. Viscarello's preliminary evidence suggests that 
the drug usually does not adversely affect the fetus and may 
improve maternal health. 
To treat both male and female HIV-infected substance 
abusers. Thomas R. Kosten. M.D., associate professor of psy¬ 
chiatry, and Marc Rosen. M.D., instructor in psychiatry, are 
directing several studies of drugs to improve mental function, 
riiey have conducted a small study evaluating peptide T, an 
analog of a key neurotransmitter, in IV-drug users with AIDS. 
The compound, by binding to the same site in brain cells 
attacked by HIV, appears to relieve the dementia that can 
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afflict AIDS patients. Dr. Kosten is also testing Ritalin, a cen¬ 
tral nervous system stimulant that has shown promise in 
improving mental functioning in HIV-infected patients. 
In pursuing the source of cognitive problems, Scott W. 
Woods, M.D., associate professor of psychiatry and diagnostic 
radiology, and Chris van Dyck, M.D., postdoctoral fellow, 
have used SPECT — single photon emission computerized 
tomography — to detect increased blood flow in the brains of 
infected individuals, a possible signal of neurological prob¬ 
lems. Dr. Kosten believes SPECT offers a valuable tool in 
monitoring patients for early signs of mental dysfunction. 
The Quest for New Treatments _ 
While many physicians use AZT to slow the progression of 
HIV, the drug harbors .serious problems. Among these are bone 
marrow suppression and the tendency of patients to develop a 
tolerance to the drug. Yale researchers are among the many 
clinicians, pharmacologists and virologists trying to create, test 
and evaluate treatments to improve on or supplement AZT. 
One such promising experimental drug is didehydro- 
deoxythymidine, or d4T. William H. Prusofl', Ph.D., professor of 
pharmacology, and Tai-shun Lin, Ph.D., senior research scientist 
in the department of pharmacology, have discovered that d4T, 
like AZT, blocks reverse transcriptase and effectively suppresses 
some symptoms associated with HIV infection. Moreover, slight 
chemical differences between the two drugs may mean that d4T 
will fight the virus even after a patient has developed AZT toler¬ 
ance. Keith A. Joiner, M.D., professor of medicine and chief of 
the infectious diseases section, and Dr. Eriedland are directing a 
clinical study of d4T, in collaboration with Helen Brett-Smith, 
M.D., AIDS fellow; Yung-chi Cheng, Ph.D., the Henry Bronson 
Professor of Pharmacology, who is affiliated with the Yale Com¬ 
prehensive Cancer Center; and John W. Mellors, M.D., associate 
re.search scientist in medicine. 
AIDS patients at Yale-New Haven Hospital are also receiv¬ 
ing dideoxyinosine, ddl, another promising nucleoside analog. 
Frank J. Bia, M.D., associate professor of medicine in the 
infectious diseases section, and Thomas F. Patterson, M.D., 
assistant professor of medicine, have been co-directing the 
Yale .segment of a 12-center study comparing ddl with AZT in 
AIDS patients who are not responding well to AZT. 
In still other drug research. Dr. Patterson is conducting a 
clinical study of a new way to administer the antifungal drug 
amphotericin B to patients with cryptococcal meningitis, an 
opportunistic infection. The compound is packaged in lipo¬ 
somes, lipid vessicles that deliver the drug with less toxicity. 
An unwelcome side effect of such analogs as dideoxycyti- 
dine (ddC) and d4T, and to a lesser extent ddl, is peripheral 
neuropathy, or numbness and nerve inflammation in the legs or 
arms. When these symptoms first appeared in AIDS patients 
taking ddC, Samuel Broder, M.D., director of the National 
Cancer Institute, turned to his colleague. Dr. Cheng, at Yale. 
Becau.se of the way neurological symptoms first appeared. 
Dr. Cheng suspected that the drugs were acting on target 
organs to selectively inhibit the synthesis of DNA of mito¬ 
chondria, small bodies in the cytoplasm which produce the 
cell’s energy. 
Dr. Cheng and colleagues have developed a compound 
closely related to ddC which they call S-ddC, for thia-dideoxy- 
cytidine. In cell cultures, the drug seems to inhibit HIV repli¬ 
cation but not mitochondrial DNA synthesis. Phamiaceutical 
companies are now undertaking animal studies on this agent. 
Other anti-HIV compounds in Dr. Cheng’s lab are likely to 
come from an unorthodox source: traditional Chinese herbal 
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Dr. Gerald Friedland 
Pioneer AIDS Researcher 
Comes to the University 
Gerald H. Friedland, M.D., professor of medicine, who will 
facilitate Yale’s AIDS research and clinical programs Univer¬ 
sity-wide and at Yale-New Haven Hospital, is a national expert 
on HIV transmission modes. Working in New York at the 
Montefiore AIDS Center, which he co-directed. Dr. Friedland 
was the first to document that the virus is not spread by casual 
contact. 
In 1982, Dr. Friedland and colleagues also were among the 
first to alert the public that AIDS could be transmitted hetero- 
sexually and from mother to child. Later, they described the 
importance of intravenous drug use in fueling the epidemic. 
Dr. Friedland studies the complex interactions among 
behavior, gender, socioeconomic status, race and HIV infec¬ 
tion. He has developed Montefiore’s model multi-disciplinary 
AIDS program, involving physicians, nurses, social workers, 
drug counselors, nutritionists, mental health workers, clergy 
and others. 
A Brooklyn native. Dr. Friedland earned an A.B. degree 
from Columbia College in 1959 and an M.D. degree from the 
New York University School of Medicine in 1964. He was 
professor of medicine, and epidemiology and social medicine 
at the Albert Einstein College of Medicine. 
Comments Dr. Friedland, “My vision for Yale and New 
Haven is to provide superior, comprehensive clinical care for 
individuals with HIV infection and their families, to establish 
programs to train physicians, nurses and other health care 
workers in caring for HIV-infected patients, and to develop 
large scale epidemiologic studies, and clinical trials of experi¬ 
mental therapies.” 
Yale Medicine Summer 1991 17 
Making Viral Replication Crystal Clear 
Basic research into cell function may lead Yale researchers to 
new or improved drugs that will thwart HIV by exploiting the 
peculiar way it reproduces. Nonnally, a cell’s DNA produces a 
negative copy of itself called RNA, a nucleic acid which 
directs the manufacture of vital proteins. But HIV, a retrovirus, 
uses the enzyme reverse transcriptase to transfer genetic infor¬ 
mation from RNA into DNA. 
Since retroviruses have reverse transcriptase but human 
cells do not, researchers in the department of molecular bio¬ 
physics and biochemistry (MB&B) are trying to learn about 
the enzyme's structure to help develop anti-retroviral chemi¬ 
cals. The Yale scientists are studying reverse transcriptase and 
the chemical structure and function of other HIV proteins 
under a 5-year, $4.6 million National Institutes of Health grant 
with support from the Howard Hughes Medical Institute 
(HHMl). One of the program’s early successes has been the 
growth of crystals of reverse transcriptase suitable for x-ray 
crystallography. Using this technique, Thomas A. Steitz, 
Ph.D., professor of MB&B and an HHMI investigator, will be 
able to determine the enzyme’s molecular structure by study¬ 
ing the patterns of x-rays scattered by the crystal. 
“Nobody’s been able to get suitable crystals to solve the 
structure until now,’’ explains Dr. Steitz. 
If successful. Dr. Steitz and his collaborators will be the 
first to determine a structure for reverse transcriptase, informa¬ 
tion that will help develop medications to block reverse tran¬ 
scriptase, thus halting HIV with minimal side effects. 
His collaboration with Donald M. Crothers, Ph.D., the 
Alfred E. Kemp Professor of Chemistry, has uncovered infor¬ 
mation about how a fragment of the HIV protein, called trans¬ 
activator protein, or tat, may trigger viral replication. William 
C. Summers, M.D., Ph.D., professor of therapeutic radiology, 
human genetics and MB&B and in the Cancer Center, made a 
clone that mass produces reverse transcriptase in bacterial cell 
cultures. 
The coordinator of MB&B’s NIH grant, Donald M. Engel- 
man, Ph.D., professor and chairman of the department of 
MB&B and professor of biology, is collaborating with Frederic 
M. Richards, Ph.D., the Sterling Professor of 
MB&B, to study how the lipid membrane 
enveloping HIV fuses with white blood cell mem¬ 
branes. This fusion allows the virus to inject 
genetic particles into the cell and spread infec¬ 
tion. 
The culprit. Dr. Engelman thinks, is glycopro¬ 
tein 41, which is found in the membrane envelop¬ 
ing the virus. Dr. Engelman and his group are 
working to develop a way to screen drugs that 
would block the aggregation of gp41, thereby 
preventing HIV’s spread. 
Outside of the MB&B projects, medical school 
researchers are seeking information about HIV 
genetics. For instance, I. George Miller, M.D., the 
John F. Enders Professor of Pediatric Diseases, 
has spliced genetic segments of two HIV strains, 
one that seems to reproduce rapidly and one that 
does not. Dr. Miller hopes the resulting recombi¬ 
nant virus will help him locate the HIV gene that 
controls rapid replication. 
In another project. Dr. Miller, who also has 
appointments in epidemiology, MB&B and in the 
Cancer Center, is working with John K. Rose, 
Ph.D., professor of pathology and cell biology. 
Dr. Rose’s laboratory has developed an intracellu¬ 
lar trap for a critical HIV surface protein. HIV 
normally binds to the CD4 molecule found on the 
surfaces of white blood cells called T cells. Dr. 
Rose and Linda Buonocore, P.A., associate in 
research pathology, have genetically crafted a T 
cell that also contains a mutated CD4 molecule 
retained inside the cell. In theory, this CD4 will 
prevent production of infectious AIDS virus in 
the.se cells by trapping the critical surface protein 
of the virus inside the cell. 
All these scientists are contributing to a deeper 
understanding of basic virology, not just HIV, 
observes Dr. Engelman. “We’ll undoubtedly learn 
something about the basic structures of viral 
enzymes,” he comments. Adds Dr. Steitz, “We’re 
putting a lot of effort into reverse transcriptase, 
however, because of its importance in HIV.” 
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remedies. After screening more than 150 such remedies for 
antiviral and anti-cancer properties. Dr. Cheng and colleagues 
identified about two dozen plants which seem to block reverse 
transcriptase. Now they are trying to identify the active sub¬ 
stances in three herbs with apparent anti-HIV potential. 
In yet another project. Dr. Cheng is collaborating with Dr. 
Mellors to learn how HIV strains become resistant to antiviral 
compounds. Dr. Mellors conducts his research at the Depart¬ 
ment of Veterans Affairs Medical Center in West Haven. 
A colleague of Dr. Mellors' at the West Haven VA, Marie 
L. Landry, M.D., associate professor of laboratory medicine 
and medicine, directs the Virology Reference Laboratory, 
which includes a retrovirus diagnostic section directed by 
Brigitte R Griffith, Ph.D., associate professor of laboratory 
medicine. The section serves the VA system nationwide as a 
resource for testing for the antibody, antigen and infectious 
virus in clinical specimens. The laboratory of Drs. Landry and 
Griffith was the second in the U.S. to recover HIV-2 from a 
patient’s blood sample. Dr. Griffith and her colleagues also 
actively develop new improved tests for the laboratory diagno¬ 
sis of retroviruses. 
Also at the VA, G.D. “Edith” Hsiung, Ph.D., professor 
emeritus of laboratory medicine and a research career scientist. 
draws upon her experience developing accurate, rapid diagnos¬ 
tic techniques to evaluate compounds against HIV and 
cytomegalovirus (CMV) infections. She uses an electron 
microscope to identify new antiviral drugs that can interact at 
the cellular level to prevent AIDS virus from entering and 
infecting healthy cells. She afso uses guinea pigs to evaluate 
new drugs for the treatment of CMV infections in humans. 
Another opportunistic infection under scrutiny on the 
School of Medicine campus is PCP, Pneumocystis carinii 
pneumonia. Martine Y.K. Armstrong, M.D., a research scien¬ 
tist in epidemiology, says the organism responsible for PCP is 
difficult to study because it grows poorly outside the body. Its 
sticky properties also make the organism difficult to purify in 
any quantity. She and her colleagues are working to develop a 
short-term culture system that will facilitate the search for 
better PCP medications. 
These varied research projects will be enhanced by Univer¬ 
sity-wide efforts to coordinate work in AIDS. Says Dr. Fried- 
land. "The broad and deep expertise at Yale in the social .sci¬ 
ences as well as the biologic sciences offers a special 
opportunity to study the epidemic in all its varied manifesta¬ 
tions. We are still at the beginning of the HIV epidemic; its full 
force has yet to be felt. It’s imperative to make this a central 
focus of scholarly work.” YM 
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Dr. Yung-chi “Tommy” Cheng is investigating potential anti-HIV agents among traditional Chinese herbal medicines. 
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1991 LERNER AWARD 
The Depression Man 
1931 
I knew a Depression man who could 
dream flavor into his soup, through iron cauldrons; 
You have seen him in the newsreel breadlines: 
his dreams, his dreams of cigarettes and dimes 
He walked the mudfield, flowering velvet 
roses from useless rosehips 
And there was a tune whistled on his lips to which 
marigolds would boing from the tired earth 
When hunger rang in him, his spirits jangled too: 
a scrap filled him like a loaf of bread 
Or if it rained and he stood there a wilting rabbit 
then a sunbeam would seem to gild his head 
He stubs a toe and wincing 
pirouettes in exquisite pain 
holding it, or if it rained. 
He had a luxury of thoughts, he hummed, 
a rhapsody in dustbowl 
He relished watery coffee and stews 
He sang with bright the blues 
and yellows 
Hey brother hey remember his 
sinewy Rockwell frame and trousers aluff 
in the field, the sour circus 
on a field of smiling mud when he 
vacuumed sunlight into a tin cup 
Tell the lost coins that call for him 
he cannot wait, 
1 cannot forget the Depression man 
in the thirties with the hate, the hate 
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Christopher Fey 
Christopher Fey, ’93 — 
Medical Student as Poet 
Christopher Fey began writing poems in high school in Suf- 
fern, N.Y., and in his junior and senior years won his school’s 
poetry prize. Majoring in English at Amherst College, he 
attended the Breadloaf and Wesleyan writers conferences and 
won the Rolfe Humphries poetry prize at graduation. He is 
attracted to several fields of medicine, particularly cardiology. 
With an interest in medical ethics, Mr. Fey is considering the 
pursuit of a law degree in addition to his training in medicine. 
Editor’s note: The 1991 Marguerite Rush Lerner Prize for 
creative writing hy a medical student was shared by 1993 
classmates Christopher Fey and Lisa./. Nelson. Because of the 
outstanding quality of their entries, a selection of each submis¬ 
sion will be featured in Yale Medicine, with Ms. Nelson’s 
work appearing in the FalllWinter 1991-1992 issue. 
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To a Dying Man, Once Like a Tree 
Merely a bed holds him now, spoiled rind of a giant; 
Once my Goliath, a spectre masquerades in human flesh. 
“Many things charade as truth,” he would say. 
And so had taught suspicion: this a superficial 
Film, that a crude veneer. 
Those are pages turning before his sunken eyes; 
The pastel plates of a children's book, 
A giant man stitched to the ground; 
A Victorian house near a giant triple-tree. 
Then grasses ameliorate with their softness the 
Scene and what is said; 
Thickets knit to restrict what once were paths. 
Trellises curl with thorns. 
Paint falls away from the wood in peels. 
Those are pages turning before his eyes — or only 
Truth shrouded in hope — truth colored with my desire. 
See what has descended — indestructible quiet; 
A quilt of breezeless solitude. 
The tree lush and heady has now folded. 
Its iron limbs have soaked, cracked. 
Fallen from the famous triple-trunk: 
One sister bows, one is broken, one stands, still. 
Wanting only collapse. 
“You should not want melancholy here,” we say. 
For the trickle of the stream is now swollen. 
Its brown banks are soft as cake — 
Perhaps some light glazes the wet trunk. 
You should not ask for melancholy here, as if 
A river would form as if 
A new tree were promised rise. 
As if one could want anything of a new tree. 
— Christopher Fey. Med. '93 
YM 
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GALLERY 
Plague scene from Johannes de Ketham’s Fasciculus medicinae 
Yale Medical Historical Library 
In the 14th century the bubonic plague, also known as the 
Black Death, destroyed from a quarter to a half of Europe’s 
population. Plague epidemics continued to devastate 
Europe into the 17th century. 
This woodcut, which appeared in Ketham’s Fasciculus 
medicinae, shows a physician attending to a plague victim 
whose opulent surroundings reveal his prosperity. The 
doctor holds a vinegar-soaked sponge or pomander to his 
nose to ward off infection while taking the pulse of the 
moribund patient. According to Robert S. Gottfried in The 
Black Death (1983), plague specialists were either incom¬ 
petent or unestablished doctors who nonetheless earned a 
respectable income because of the danger of their practice. 
Fasciculus medicinae. first published in 1491 in Venice, 
was one of the earliest printed medical books and is consid¬ 
ered to be the first showing anatomical illustration. The 
above illustration did not appear until a 1493 edition. The 
book contains several full- and partial-page woodcuts, which 
are lavishly hand-colored in the copy in the Yale collection. 
The artist is unidentified, although attributions have been 
made to Venetian painters Gentile Bellini (c. 1429-1307) and 
Andrea Mantegna (1431-1306), based on the characteristic 
style of the illustration. 
.fanice Braun, Historical Library 
Harvey Cushing!John Hay Whitney Medical Library 
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STUDENT RESEARCH DAY 
Photographs by Harry Bishop 
Bernice Kafni (Hover explains to Dr. John M. Leventlial her findings o)i the relationship between previous benign biopsies and snb- 
seipient malignant melanoma. 
Opening Remarks 
I'he health of student research at this medical school is excel¬ 
lent. The best evidence for this is the 52 scientific posters you 
have just been viewing at the Fifth Annual Student Research 
Day. 1 applaud the scientific output and the student-faculty col¬ 
laboration that they vividly display. 
Another measure of the health of student research is the 
growth in the number of students receiving competitive fund¬ 
ing tor their research. At the time of our first poster .session 
five years ago, 92 students received stipends totalling 
SIS4.0()(). I'his year, IXK students received competitive fund¬ 
ing totalling .S471,()(K). This entire increase has resulted from 
external grants, from agencies and gifts from donors. 
We now have named research fellowships in honor of FTlith 
llsiung. James Hirsch, Vernon Lippard, Richard llirschfield, 
Idta Chidsey and Richard Gershon. 4'he Student Research Pro¬ 
gram has received external grant support from the American 
Ill-art .Association. National and Connecticut affiliates; the 
t onnecticut Cancer Society, four grants from the National 
Institutes ol Health, as v\eil as the Howard Hughes Medical 
Institute and the Juvenile Diabetes [foundation. 
1 want to acknowledge the valuable help of our thesis com¬ 
mittee. In addition to serving as the prize committee, these 
individuals have been of major assistance to our office in rais¬ 
ing the external grants to support student re.search. 
Finally. I want to recognize the excellent art work done by 
biomedical communications, particularly by Linda Seigneur 
and Gail Beamon. Dean Gifford and Betsy Winters continue to 
give considerable effort and support to the program. Our spe¬ 
cial thanks today goes to Nancy Dometios. who. for the fifth 
year, has organized this day and run our office. Every grant, 
student application, poster, even every paycheck generates vol¬ 
umes of paper, phone calls and work, and Nancy handles it all. 
1 would also like to welcome Dr. Lee Farr and Mrs. Farr, the 
sponsors of the lectureship, who are with us from California. 
John N. Forrest Jr.. M.D. 
Professor of medicine 
Director, office of student research 
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Abstracts 
Immunology of Human Peripheral Nerve 
and the Response to Nerve Transection 
in a C3H/HeJ Mouse Model 
hy James Edward Stanislaw 
Advisor: Thomas Trumhle, M.D., associate professor 
Chief, hand surgery service, department of orthopaedics 
University of Washington. Seattle 
Research in limb reconstruction using peripheral nerve tissue 
has been hampered by tissue rejection. Animal models of 
peripheral nerve transplantation have exhibited significant 
rejection reactions leading to poor outcomes. The reactions 
have occurred despite cross-matching the nerves for MHC 
(major histocompatibility complex) Class I antigens. Other 
research has shown MHC II antigens to be instrumental in 
graft rejection, perhaps more important than the role of MHC 
Class I antigens. Despite claims that MHC Class II antigens 
are not present in peripheral nerve, this study attempted to 
define the immunology of peripheral nerves with respect to the 
presence of MHC II antigens. The presence of such antigens 
could add to the explanation of nerve graft rejection. 
The specific aims of this study are: 1) search for MHC class 
II antigens on peripheral nerve; 2) determine what cell type 
expresses the antigen if present; and 3) using a mouse model, 
investigate changes in the antigen concentration after trauma. 
In order to provide more information on the immunology of 
peripheral nerves, 35 specimens (26 from seven cadavers and 
nine from surgical biopsies) were analyzed for the presence of 
MHC Class II antigens using monoclonal antibodies raised 
against HLA-DR, HLA-DP, and HLA-DQ (human leukocyte 
antigen is the human synonym for MHC) and an avidin-biotin 
enzyme complex with chromogen. MHC II antigens were 
noted in all human nerve specimens and the percentage area 
under light microscopy of positive staining by computer ana¬ 
lyzed immunohistochemistry were significantly higher (3.82 
percent +!- 1.01 percent) than negative controls (0.05 percent 
+j- 0.02 percent) (p=0.01). 
S-100 double staining techniques as well as electron micro¬ 
scopic tissue fixation were used to identify cell types. 
A C3H/HeJ mouse model was used to evaluate the effect of 
nerve transection (trauma) on the presence of MHC II anti¬ 
gens. Monoclonal anti-IA antibody was used in the same 
method of light microscopic, computer analyzed immunohisto¬ 
chemistry as performed in the human study. Fifteen to 21 days 
after transection of the sciatic nerve in 10 mice, there was a 
statistically significant increase (p=0.05) in the presence of 
MHC Class II antigens in the distal portion of the nerve (4.49 
percent +!- 0.78 percent) versus samples from eleven mice 
that had exposure of the nerve without transection (1.44 per¬ 
cent +!- 0.21 percent) or in nerves from 17 mice that had no 
surgery (1.02 percent -I-/-0.21 percent) in that limb. 
Clinical relevance: The presence of MHC Class II antigens 
could require more complex cross-matching for tissue trans¬ 
plantation. Nerve grafts which have undergone Wallerian 
degeneration may actually be more prone to rejection than 
other peripheral nerve tissue transplants, depending upon the 
length of time of degeneration. 
Paid Isenharger displays his hypermedia computer program, 
designed to provide interactive instruction in cardiac magnetic 
resonance imaging. 
The Image of the Woman Physician 
in 10 Victorian American Novels 
hy Sonya S. Erickson 
Advisor: John Harley Warner, Ph.D. 
Associate professor of the history of medicine 
Between 1871 and 1886, in the midst of sweeping changes in 
the status and representation of women, at least 10 novels fea¬ 
turing female physicians and medical students were published 
in America. Their authors were generally well-known to Victo¬ 
rian American readers and included Mark Twain, Henry 
James, Louisa May Alcott, and Harriet Beecher Stowe. 
Despite the differences among both their creators and their sto¬ 
ries, these heroines had a great deal in common. In general, 
they were constructed as “American” figures, meaning they 
were young, single, attractive, white, middle- to upper-middle 
class, and blessed with a long-standing New England pedigree. 
Veritable pictures of health, they followed the dictates of the 
contemporary dress-refomiers and moved freely throughout 
their surroundings. 
Their respective career paths were similarly uniform, begin¬ 
ning with their mutual childhood interest in the art and science 
of healing. Having received their formal medical training in 
American and European universities, the heroines proved 
capable of carrying out a variety of tasks, including ligating 
arteries, compounding remedies, and easing a patient’s final 
days. 
The medical heroines’ unconventionality, however, had its 
limits. While fully aware of the women’s rights movement and 
grateful for its achievements, for example, they maintained a 
respectable distance from the organization. Though society in 
general was depicted as unsupportive of their plans, the char¬ 
acters who knew them best approved of their professional 
goals wholeheartedly, a sign that readers and critics should 
applaud the heroines’ actions as well. 
Available reviews and letters indicated that many contem¬ 
poraries did so, often arguing that the heroines were “real” in 
the process. The representation of and response to the woman 
doctor in Victorian American fiction raise questions about the 
impact her monolithic image had on contemporary society. As 
the numbers of women doctors, both real and imaginary, 
increase again, such questions remain relevant today. 
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David J. Eisenman answers Dr. Joseph W’ar- 
shaw's question about his research into 
chronic hypoxia in developing rats. 
Steroid Hormonal Effects on 
Choleeystokinin Binding in the Central Nervous System; 
P(»tential Role in the Control of Appetite 
h\ Jeanne B. .Acknian 
.Advisors: Neil J. .MacLusky. Ph.D. 
Professor of obstetrics and gynecology 
Toronto (ieneral Hospital 
Frederick Naftolin. M.D. 
Professor and chairman of obstetrics and gynecology 
Among cholecystokinin's (CCK's) multiplicity of physiologi¬ 
cal roles is its role as an appetite suppressant. The purpose of 
this study was to detemiine the effects of two hinds of steroid 
hormones known to intluence feeding behavior and body 
weight, namely estrogens and glucocorticoids, or "stress hor¬ 
mones." on CCK receptor levels. Particular attention was 
gi\en to their effect in the ventromedial nucleus of the 
hypothalamus (VMN). a neural center of feeding and repro¬ 
ductive behavior. 
Experiment 1(a) was perfomied to detemiine if the sex dif¬ 
ference in rat feeding behavior is borne out in a differential 
response of CCK binding to estrogen treatment in males and 
females. Male and female rats were gonadectomized and 
adrenalectomized (.ADX) and. after 7 to 10 days of rest, were 
implanted subcutaneously v\ith Silastic capsules containing 
either cholesterol vehicle or 10 percent estradiol. The animals 
were weighed pre-and post-treatment and sacrificed after three 
days of treatment. Specific binding of 1125-1] CCK-8S was 
determined in this experiment and in the ones that follow after 
in vitro incubation of frozen brain sections, autoradiography, 
and quantitation of the images with computer-assisted densito¬ 
metry. F2xperiment 1(a) revealed a sex difference in CCK find¬ 
ing in response to estrogen treatment — w hile estrogen caused 
dow n-regulation of CCK receptors in females (p=0.()()()l), it 
had no effect on CCK binding in males. The regional speci- 
licity ol this effect in females (VMN and cingulate cortex) was 
suggested by this experiment and confimied in a subsequent 
study. The suggestion of higher overall levels of CCK binding 
in the female cingulate cortex and VMN when compared with 
males was also confimied in this subsequent study. The fact 
that onl\ males showed a decrease in body weight gain on 
estrogen therap) that approached statistical significance 
(p=().()7) can be explained bs the typical 4 to 6 week post-cas- 
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tration hyperphagia that exists only in females. Both males and 
females have been shown repeatedly to lose weight on estro¬ 
gen therapy (when unopposed by progesterone). 
Experiment 1(b) was performed to detemiine if the effect of 
estrogen on CCK binding is exerted locally in the VMN or 
more proximally in the neural chain. Eemale rats were ovariec- 
tomized. given at least 8 days of rest, and then bilaterally 
implanted by stereotactic means with 23-gauge steel guide 
tubes over the VMN. Three days after intracranial surgery, the 
hormonal/cholesterol treatments were begun via 30-gauge 
internal cannulae. The animals served as their own controls, 
receiving 1.0 percent estradiol (diluted with cholesterol) on 
one side and cholesterol vehicle on the other side. After three 
days of treatment, the animals were sacrificed. Cannula place¬ 
ment was histologically verified. No effect of local estrogen 
treatment on CCK binding was noted (no difference between 
left and right VMN CCK densities was observed). Hence, the 
effect of estrogen on CCK binding in the VMN appears to be 
indirect. 
Experiment 2 was perfomied to detemiine if dexametha- 
sone. an essentially pure glucocorticoid, also affects CCK 
receptors levels. Male rats were partitioned into three groups: 
the experimental group was ADX and treated with daily morn¬ 
ing subcutaneous dexamethasone (DEX) injections at a 
"stress" dose=200 ug/kg body weight in a vehicle (10 percent 
ethanol, 10 percent propylene glycol, 80 percent nomial 
saline); one of the control groups was .ADX and injected with 
vehicle only; and the other control group (SHAM) was ether¬ 
ized but not .ADX and injected with vehicle only. Each group 
was caged separately and all animals were weighed pre- and 
post-treatment. .After three days of treatment, the animals were 
sacrificed. .All DEX-treated animals showed decreased CCK 
binding (p=0.01) and decreased body weight (p=0.001) when 
compared with the control groups. 
In summary, the above results suggest a sexually dimorphic 
distribution of CCK receptors in rat brain and a role for estro¬ 
gens and glucocorticoids in modulating these receptors. Sev¬ 
eral proposals are made w ithin this medical doctorate thesis: 1) 
estrogen is proposed as a feedback signal of body adiposity to 
the VMN; 2) CCK is proposed as the neural ami of both estro¬ 
gens and glucocorticoids in the CNS; and 3) CCK is proposed 
as an instrumental neuropeptide at the interface between stress, 
feeding and reproductive behavior. 
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African-Americans at the Yale University 
School of Medicine: 1810 to 1960 
by Daryl K. Daniels 
Advisor: Curtis Patton, Ph D. 
Professor of epidemiology (microbiology) 
African-Americans have had a long and interesting history at 
the Yale School of Medicine. Through extensive researching 
of primary and secondary sources, this history is documented 
for the first time. The first African-American known to have 
graduated from the School was Dr. Courtlandt Van Rensselaer 
Creed. Because of strong abolitionist sentiment at Yale and in 
New Haven during the 1850s and his family’s prominence in 
New Haven, Dr. Creed was able to matriculate at the School of 
Medicine in 1854. He graduated in 1857 and practiced in New 
Haven. He also served as a surgeon in the Civil War. 
Two more African-Americans graduated from the Yale 
School of Medicine in 1875 and 1876. These students. Dr. 
Bayard T. Smith and Dr. George R. Henderson, transferred to 
Yale from Lincoln University. 
In 1888 the School of Medicine became a leader in African- 
American medical education, graduating eight African-Ameri¬ 
cans in 12 years. Many of these people made significant con¬ 
tributions to medicine and their community. This lead was lost 
when a rise in intolerance caused Yale’s schools of medicine 
and nursing to adopt an “unwritten policy” of racial exclusion. 
The policy was disclosed in 1941 when an African-American 
applicant applying to the School of Nursing was turned away 
due to her race. In the controversy that followed, the policy 
was rescinded and African-Americans were again allowed to 
attend the medical and nursing schools. In 1948 Dr. Beatrix A. 
McCleary became the first African-American woman to grad¬ 
uate from the School of Medicine. African-Americans contin¬ 
ued to graduate from the school at a rate of approximately one 
every other year until 1960. 
By using this history as a guide, it is thought that the Yale 
School of Medicine can better recognize the contributions made 
by its African-American students and take steps to regain its 
leadership role in African-American medical education. 
Transcriptional Regulation of 
Apolipoprotein Gene Expression 
by Agiisti'n Melidn 
Advisor: Andrew Stewart, M.D. 
Associate professor of medicine (endrocrinology) 
Apolipoproteins are the polypeptide subcomponents of the 
lipoprotein lipid transport system. They play a vital role in the 
transport, delivery and metabolism of cholesterol and triglyc¬ 
erides. Variations in lipoprotein levels correlate with risks for 
arteriosclerosis and heart disease. Variations in individual 
apolipoproteins also are as.sociated with various disease states. 
In an effort to understand the mechanisms controlling 
apolipoprotein synthesis at the level of gene expression, we 
examined the 5’ regulatory regions of these important hepati- 
cally expressed genes. We identified a similar cisacting 
sequence element (C3P element) in the proximal promoters of 
the apo cm, apo B, apo AI and apo CII genes. In each case 
this element maintains a highly conserved sequence, activates 
transcription in hepatic cells and hinds a common protein, AF- 
I. We demonstrate that the C3P element activates transcription 
in hepatic specific gene expression and suggests a method by 
which the production of functionally related proteins might be 
regulated. 
Back row (from left): .James Stanisiaw, Sonya Erickson, Augustin Melidn, .Jeanne Ackman and Daryl Daniels. 
Front row: Drs. Robert Gifford, Sidney Altman, Leon Rosenberg and John Forrest. Dr. Altman, the Sterling Pro¬ 
fessor of Biology and a 1990 Nobel laureate, delivered this year’s Lee Farr Lecture. 
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RESIDENCY PLACEMENTS 1991 
CALIFORNIA 
Children’s Hospital, Oakland 
Stacy BeWer. pediatrics 
Children's Hospital of San Francisco 
Ole AAssar, medicine 
Janies Hicks, medicine 
Community Hospital, Santa Rosa 
Colleen Foy, famiiy practice 
Kaiser Permanente Medical Center, Oakland 
Narisse Kendrick (Daye), medicine 
Naval Hospital, San Diego 
Symphorosa Williams, medicine 
Christopher Steevens, transitionai 
University of California, Los Angeles 
Daniel Geschwind, medicine, neuroiogy 
Edward McNellis, ophthaimoiogy 
University of California, San Diego Medical Center 
David Bernard, anesthesioiogy 
Elizabeth Bower, anesthesioiogy 
Scott Edwards, obstetrics and gynecoiogy 
University of California, San Francisco 
Ole AAssar, diagnostic radioiogy 
Jorge Arroyo, ophthaimoiogy 
Michael Capozza, anesthesioiogy 
David Chiu, medicine, neuroiogy 
Steven Finkbeiner, medicine, neuroiogy 
Ethan Halm, internai medicine 
Marc Seltzer, nroiogy 
Margaret Toth, internai medicine 
University of Southern California, Los Angeles 
Philip Chen, ophthaimoiogy 
Paul Isenbarger, diagnostic radioiogy 
Quoc Nguyen, otoiaryngoiogy 
Veterans Administration Medical Center, Martinez 
Bernice Glover, internai medicine 
COLORADO 
University of Colorado School of Medicine, Denver 
Ngozi Okezie, psycinatry 
CONNECTICUT 
Danhury Hospital 
David Bernard, medicine 
(ireenwich Hospital 
Jeanne Ackman, medicine 
Michael Borodkin, medicine 
Hospital of St. Raphael, New Haven 
fdizabeth Bower, medicine 
Norwalk Hospital 
Christopher Hobbie, diagnostic radioiogy 
St. Mary’s Hospital, Waterbury 
James Hartleroad, generai surgery 
Alex Ortiz, primary carelinternai medicine 
St. \ incent’s Medical Center, Bridgeport 
Edward McNellis, transitionai 
Yale-New Haven Hospital 
William Andrews, internai medicine 
Ercem Atillasoy, medicine 
Mark Barad, medicine 
Peter Bernstein, obstetrics and gynecoiogy 
Mark Bianchi, surgery, otoiaryngoiogy 
Donna Brezinski-Caliguri, pediatrics 
Gaetane Francis, obstetrics and gynecoiogy 
David Frankfurter, obstetrics and gynecoiogy 
Gwendolyn Grant, internai medicine 
Lawrence Hirsch, medicine 
Michael Leehy, medicine!primary 
Ellen Markstein, medicine 
Marc Siherherg, pathoiogy 
Robert Spillane, medicine 
Naomi Taylor, pediatrics 
Marco Verga, diagnostic radioiogy 
DISTRICT OF COLUMBIA 
Children’s National Medical Center 
Gonzalo Paz-Soldan, pediatrics 
George Washington University Hospital 
Lauren Rodgers, obstetrics and gynecoiogy 
Walter Reed Army Medical Center 
Betty Kim. generai surgery 
FLORIDA 
.lackson Memorial Medical Center, Miami 
Pablo Quintela, internai medicine 
GEORGIA 
Emory University, Atlanta 
Cargill Alleyne. neurosurgery 
IOWA 
University of Iowa Hospital, Iowa City 
Ellis Webster, surgery, otoiaryngoiogy 
MASSACHUSETTS 
Baystate Medical, Boston 
E. Vivek David, medicine 
Beth Israel Hospital, Boston 
Jean Fraser, pathoiogy 
Paula Watnick, internai medicine 
Mindy Wiser, obstetrics and gynecoiogy 
Boston City Hospital, Boston 
Douglas Fleming, internai medicine 
Andrea Polesky, internai medicine 
Brigham and Women’s Hospital, Boston 
E. Vivek David, diagnostic radioiogy 
Karen Hsieh, obstetrics and gytiecoiogy 
Charles Lu, internai medicine 
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Agustin Melian, internal medicine 
Brenda Sirovich, internal medicine 
Children’s Hospital, Boston 
Bruce Horwitz, pediatrics 
Massachusetts Eye and Ear Hospital, Boston 
Young Kwon, ophthalmology 
Massachusetts General Hospital, Boston 
Jeanne Ackman, diagnostic radiology 
Robert Spillane, diagnostic radiology 
McLean Hospital, Belmont 
Marc Agronin, psychiatiy 
Mount Auburn Hospital, Cambridge 
Jorge Arroyo, medicine 
Young Kwon, medicine 
Gina Solomon, medicine 
University Hospital, Boston 
Jeffrey Schechner, medicine 
MARYLAND 
Francis Scott Key Medical Center, Baltimore 
Margaret Stevens, medicine 
MICHIGAN 
University of Michigan Hospitals, Ann Arbor 
Stephen Bell, orthopedic surgery 
Funda Meric, general surgery 
MINNESOTA 
University of Minnesota Hospital and Clinics, Minneapolis 
James Levine, internal medicine 
Mayo Graduate School of Medicine, Rochester 
Monica McDonald, general surgery 
MISSOURI 
Barnes Hospital, St. Louis 
Sarah Davidson, internal medicine 
Larry Horesh, general surgery 
Richard Ihnat, internal medicine 
Robert Orlowski, internal medicine 
St. Louis Children’s Hospital, St. Louis 
Denise Ihnat, pediatrics 
St. Louis University School School of Medicine, St. Louis 
Jeffrey Carter, general surgery 
NEW HAMPSHIRE 
Dartmouth-Hitchcock Medical Center 
Grant Shumaker, surgery, neurosurgery 
NEW MEXICO 
University of New Mexico School of Medicine, 
Albuquerque 
Daryl Daniels, general surgery 
NEW YORK 
Columbia-Presbyterian Medical Center, New York 
Lawrence Hirsch, neurology 
Montefiore Medical Center, Bronx 
N. Ruth Harris, obstetrics and gynecology 
Mount Sinai Hospital, New York 
Michael Borodkin, ophthalmology 
Leacroft Green, surgery, otolaryngology 
Presbyterian Hospital, New York 
Melanie Moses, medicine 
St. Luke’s-Roosevelt Hospital Center, New York 
Dale Johnson, surgery 
St. Vincent’s Hospital, New York 
Philip Chen, transitioned 
Strong Memorial Hospital, Rochester 
Irene Hegeman, medicine, neurology 
Eric Richard, interned medicine 
The New York Hospital, New York 
Sonya Erickson, obstetrics and gynecology 
Winthrop-University Hospital, Mineola 
Marco Verga, medicine 
OHIO 
University Hospitals of Cleveland 
Steven Care, orthopedic surgery 
Roger Duncan, anesthesiology 
James Stanislaw, orthopedic surgery 
OREGON 
Emanuel Hospital and Health Center, Portland 
Paul Isenbarger, transitional 
PENNSYLVANIA 
Hospital of the University of Pennsylvania, Philadelphia 
Kenneth Laughinghouse, internal medicine 
Eleanor Poliak, pathology 
Michael Romanelli, internal medicine 
Steven Ugent, medicine 
TEXAS 
Wilford Hall U.S.A.F. Medical Center, San Antonio 
Jonathan Cha'i, pediatrics 
WASHINGTON 
University of Washington Affiliated Hospitals, Seattle 
K. Eric De Jonge, medicine/primary 
Richard Ingber, internal medicine 
Mark Price, general surgery 
Ellen Rosenthal, internal medicine 
CANADA 
McGill Hospital, Montreal 
Alain-Marc Werner, orthopedic surgery 
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COMMENCEMENT 1991 
W illiam H. Stew art, Ph D., as.sociate professor of 
siirt’ery (yross anatomy), was presented the Charles 
U. Bohnf 'alk Prize for e.xeellenee in teaehing the 
hasie seienees. Sinee J9<S5. he has direeted the 
anatomy course for first-year students. 
In accepting the Bohmfalk Prize for excellence in 
teaching in the clinical sciences, Richard S.K. 
Young, M.D., M.P.H., associate professor of 
pediatrics and neurology, recalled his own Yale 
medical school days w hen Dr. James P. Comer 
brought his children to child development lectures. 
Dr. Young has continued this tradition by inviting 
his own soft, John. JO. to class. 
In a lighter moment, {from left) Dean Rosenberg 
and faculty members Angela Holder and Drs. Robert 
Gifford and Alvati Feinstein serenade the graduating 
class. {To the tune of “Let It Be." with apologies to 
John Lennon.) 
Chorus: 
So we say, now’s the day 
To slate oiir hopes that all goes well. 
And give you our best wishes 
Hail farewell, Yale farewell. 
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M.P.H. graduates Richard MarottoU, 
Dympha McGiiinness Egglin, 
Jane Miisen and Teryl Hundley 
joyfully enter into a new phase 
of their professional lives. 
Pamela Carter, M.P.H., 
proudly stands ne.xt to 
the sign of her alma mater. 
{From left) Jennifer Sancho, M.D., 
receives congratulations from a friend 
as Helen Roberts, M.D., and Mitchell Pepper, 
two fellow M.P.H. graduates, look on. 
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Epidemiology and Public Health (EPH) 
commencement speaker. Iris R. Shannon, 
Ph.D., R.N., a former president of the 
American Public Health Association, 
speaks on community and public health 
nursing at ceremonies held outside the 
EPH laboratory. 
Graduating medical students 
Donna Brezinski-Caligiiri (left) 
and Elizabeth Bower recite the new 
Yale Physician’s Oath, composed by 
Chaplain Alan Mermann 
(see facing page). 
Betty 5.Vy, Kim was among the medical school 
graduates who received active duty commissions 
in the medical corps during ceremonies following 
commencement. Col. Norman Ream of Washington, 
D.C., (left) and Ms. Kim's father, Yoon Mo Kim, of 
River Edge, N..f., congratulate her on becoming a cap¬ 
tain in the U.S. Army. She is serving a five-year 
surgical residency at Walter Reed Army Medical 
Center in Washington. D.C. 
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A YALE PHYSICIAN’S OATH 
Now being admitted to the high calling of the physician, / solemnly 
pledge to consecrate my life to the care of the sick, the promotion of 
health and the service of humanity. 
I will practice medicine with conscience and in truth. The health 
and dignity of my patients will he my first concern. I will hold in 
confidence all that my patients relate to me. I will not permit 
considerations of race, religion, nationality, or social standing to 
influence my duty to care for those in need of my service. 
I will respect the moral right of patients to participate fully in the 
medical decisions that affect them. I will assist my patients to make 
choices that coincide with their own values and beliefs. 
I will try to increase my competence constantly and respect those 
who teach and those who broaden our knowledge by research. / will 
try to prevent, as well as cure, disease. 
When / am qualified to instruct, / will impart my knowledge gladly, 
holding my students and colleagues in affectionate though 
evaluative esteem. 
In the spirit of those who have inspired and taught me, I will seek 
constantly to grow in knowledge, understanding, and skill and will 
work with my colleagues to promote all that is worthy in the ancient 
and honorable profession of medicine. 1 will maintain the honor and 
the noble traditions of the medical profession. My behavior will be 
honorable and thoughtful and reflect justice toward all. 
If I fulfill this Oath and do not violate it, may it be granted to me to 
enjoy life and the practice of the Art. This pledge I make freely and 
upon my honor. May my faith strengthen my resolve. 
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SCOPE 
Cushing/Whitney Library 
Microfilms Fulton Diaries 
Dr. John F. Fiilton, Rhodes scholar, 
scientist, biographer, historian — and 
Yale professor of physiology at the age 
of .^0 — was a co-founder of the Yale 
Medical Library in 1939. 
Now the Cushing/Whitney Medical 
Library has microfilmed the 46 volumes 
of Dr. Fulton’s diaries through support 
from the National IJbrary of Medicine's 
National [^re.servation Program for 
Biomedical laterature. Beginning in 
1920 and ending with his death in I960, 
the diaries are available to researchers 
worldwide, reports Janice E. Braun, 
assistant medical historical librarian, 
who supervised the project. 
Dr. Fulton’s diaries reveal a keen 
intellect and a variety of interests, and 
his observations about .scholars have 
made the diaries a treasure for 
biographers. Dr. Fulton, a neurophysiol¬ 
ogist, was a respected scientific author 
and prolific medical historian, writing 
more than .600 books and articles. He 
joined Drs. Harvey Cushing and Arnold 
Klebs to pool their personal collections 
of medical books and found the Yale 
Medical Library, renamed for Drs. 
Harvey Cushing and John Hay Whitney 
following a major expansion in 1990. 
Yale Journal Publishes 
Cancer Symposia Papers 
This autumn, the Yale Journal of 
Biology and Medicine will publish for 
the third time the proceedings of the 
Id la Cirasso Memorial Conference on 
gynecological cancer. Advanced 
planning and cooperation between jour¬ 
nal staff and conference organizers 
allows those attending the meeting to 
have the text of papers in hand as they 
are presented. I’he journal invites other 
groups who are idanning symposia to 
avail themselves of this service; 
ad- anced notice of at least a year is 
required. 
I his year the journal will again 
publish abstracts of M.D. theses submit- 
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ted by graduating Yale medical students. 
These abstracts offer a picture of the 
wide scope of research undertaken by 
the students. Akso, since the journal is 
indexed by all major reference bodies, 
the thesis titles will be available to 
scholars internationally through such 
services as Index Medicus and Medlars. 
A special issue of the journal in late 
1991 will be dedicated to the late Arthur 
J. Viseltear, Ph.D., associate professor 
of the history of medicine, in 
recognition of his many years of 
devoted membership on the editorial 
board. This issue will feature articles 
reflecting Dr. Viseltear’s deep concern 
with studies in the history of medicine, 
his contributions to medical school life, 
and his dedication to promoting equal 
access to medical care for all 
Americans. 
Y.A.G. Program 
Marks 26 Years 
Twenty-six years ago, most Connecticut 
patients with a complicated ulcer had to 
travel to Boston or New York for 
treatment. Today, these patients have 
up-to-date treatment available in many 
locations throughout their home state, 
thanks to the Yale-Affiliated 
Gastroenterology Program (YAGP), 
which marked its 26th anniversary this 
spring. The program was the forerunner 
of many subsequent affiliations between 
Yale and Connecticut hospitals. 
In 1964, Howard M. Spiro, M.D., 
then chief of the gastroenterology unit at 
the School of Medicine and Yale-New 
Haven Hospital, entered into an 
agreement with Dr. Vincent A. DeLuca 
Jr., chief of medicine at Griffin Hospital 
in Derby. They established an 
experimental residency program in 
gastroenterology. 
d’heir agreement involved a tradeoff 
that benefitted both the residents and the 
Griffin physicians: As the residents 
trained under the community 
gastroenterologists, the specialists kept 
up with the state of the art through their 
contact with the residents. The 
arrangement blossomed into a formal 
jirogram in 1968 umler a U.S. Public 
Health Service grant. 
Today, in addition to Yale-New 
Haven and Griffin, affiliated hospitals 
include the Hospital of St. Raphael in 
New Haven, plus Norwalk, Bridgeport, 
St. Vincent’s and Waterbury hospitals, 
and the Department of Veterans Affairs 
Medical Center in West Haven. 
Dr. Robert M. Donaldson Jr., deputy 
dean of the School of Medicine, says 
one of his "great joys” is interacting 
with the affiliated hospitals, attending 
hospital symposia and training YAGP 
residents. Dr. James L. Boyer, director 
of the digestive disease section and pro¬ 
fessor of medicine at Yale, adds he still 
“learns something every time I go out to 
consult at participating hospitals.” 
Comments Edwin Cadman, chairman 
of Yale’s department of internal 
medicine. "YAGP has had an influence 
on other programs around the country. 
Its goal is to provide training for its 
fellows in broader depth and give 
experience that the fellows couldn’t 
have gotten at a solely university- 
affiliated program.” 
Yale/VA PET Center 
Opens in West Haven 
Connecticut’s first positron emission 
tomography (PET) center and cyclotron 
made its debut in June at the 
Department of Veterans Affairs Medical 
Center in West Haven. The Yale Univer¬ 
sity/Veterans Affairs Positron Emission 
Tomography Center offers the most 
advanced technology in providing infor¬ 
mation about disease processes. 
Director of the center is Robert 
Soufer. M.D., associate professor of 
diagnostic radiology and medicine, who 
initiated and developed the $6 million 
project over the past five years. As Dr. 
Soufer explains. “PET offers physicians 
a highly accurate, non-invasive tool for 
studying metabolism and blood flow in 
the heart, brain and other soft tissue.” 
PET distinguishes itself from other 
diagnostic imaging systems by 
pre.senting metabolic data. Such data 
make possible the diagnosis of various 
cardiac, neurologic, psychiatric and 
oncologic di.seases with unprecedented 
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subtlety and precision. 
The PET scanner, a large, donut¬ 
shaped instrument, gleans its data from 
the decay of positron-emitting isotopes. 
An on-site cyclotron prepares isotopes 
with extremely short half-lives — rang¬ 
ing from a few minutes to 
approximately two hours. PET 
technicians use the isotopes to label sub¬ 
stances such as glucose or water, which 
the body metabolizes. 
A solution containing the labeled 
substances is injected into the patient’s 
bloodstream. A computer then translates 
the resulting signals into images that 
offer data about the metabolic processes 
taking place within the targeted organ. 
FACULTY NEWS 
Michele Barry, M.D., associate profes¬ 
sor of medicine, and Frank J. Bia, 
M.D., M.P.H., associate professor of 
medicine and laboratory medicine, have 
been appointed by the United States 
Pharmacopeial (USP) Convention, Inc., 
to a new advisory panel of experts in 
parasitic diseases. During its 1990-1995 
term, the panel will help detemiine the 
content of the USP data base and advise 
about clinical aspects of its work in the 
area of drug standards and infomiation. 
Paul G. Barash, M.D., professor and 
chairman of anesthesiology, was named 
to the Yale-New Haven Hospital hoard 
of trustees. 
William F. Collins .In, M.D., 
chaimian of the department of surgery, 
has been awarded the American Associ¬ 
ation of Neurological Surgeons’ 
Cushing Medal. He was presented the 
medal at the association’s annual 
meeting in April in New Orleans. Dr. 
Collins, the Harvey and Kate Cushing 
Professor of Surgery, is past chaimian of 
the American Board of Neurological 
Surgery, past president of the Society of 
Neurological Surgeons and of the 
Neurosurgical Society of America. 
James P. Comer, M.D., M.P.H., the 
Maurice Falk Professor in the Child 
Study Center and Psychiatry, was 
honored by the Community Children 
and Family Services for his efforts on 
behalf of children and families in educa¬ 
tion. The “Comer Process,” which has 
been implemented in more than 100 
schools throughout the country, 
emphasizes parental involvement and 
promotes social skills. 
Dr. Robert Soufer, associate professor of 
diagnostic radiology and medicine, is 
director of the new YalelVA PET Center. 
Charles B. Cuono, M.D., Ph.D., 
professor of surgery and director of the 
Yale Burn Center and Skin Bank, began 
a two-year temi as president of the 
American Association of Tissue Banks 
(AATB) Board of Governors on May 1, 
1991. The AATB inspects and accredits 
tissue banking facilities. 
Peter J. Hotez, M.D., Ph.D., instruc¬ 
tor of pediatrics and epidemiology and 
public health, was named a Charles E. 
Culpepper Foundation Scholar in Medi¬ 
cal Science for 1991. Dr. Hotez will 
receive $100,000 annually for three 
years to fund his research into the 
molecular basis and prevention of hook- 
womt disease in children. 
Stanley W. Jackson, M.D., 
professor of psychiatry and history of 
medicine, will assume the editorship of 
the Journal of the History of Medicine 
and Allied Sciences as it returns to Yale 
after 18 years. 
Theodore Lidz, M.D., Sterling 
Professor Emeritus of Psychiatry, has 
been elected to serve a one-year tenn as 
president of the American College of 
Psychoanalysts. The honorary society is 
composed of 250 members and fellows 
in North America. 
Paul McCarthy, M.D., professor 
and section chief of pediatrics, has been 
honored with the 1991 George 
Armstrong Award of the Ambulatory 
Pediatric Association (APA), of which 
he is past president. The award, named 
for the 18th-century Englishman consid¬ 
ered to he the father of modern 
pediatrics, honors Dr. McCarthy’s 
outstanding research, teaching and work 
to improve health-care services to 
underserved populations. Dr. McCarthy 
delivered the Armstrong lecture at the 
APA’s annual meeting in New Orleans. 
Marcia Mclnerney, Ph.D., postdoc¬ 
toral fellow in immunobiology, has been 
awarded a postdoctoral fellowship for 
1991 -1992 by the Juvenile Diabetes 
Foundation International. The $28,()()() 
award will support Dr. Mclnerney’s 
research, which identifies immune cells 
(T cells) in non-obese mice. The cells 
may play a role in suppressing the 
development of diabetes. 
James G. McNamara, M.D., 
assistant professor of pediatrics, will 
conduct research on HIV infection of 
fetal T cells through a $78,000 grant 
from the Pediatric AIDS Foundation. 
Dr. McNamara seeks to learn whether 
the virus’ ability to infect fetal cells dif¬ 
fers from the way it infects adult cells. 
Ethan R. Nadel, Ph.D., director of 
the John B. Pierce Laboratory and 
professor of epidemiology and cellular 
and molecular physiology, delivered the 
26th annual Harry G. Armstrong 
Lecture at the Aerospace Medical Asso 
ciation’s annual meeting in May in 
Cincinnati. Dr. Nadel spoke on “The 
Physiological Challenges of Human- 
Powered Flight,” based on research he 
conducted in association with Project 
Daedalus, which resulted in the longest 
human-powered flight in history. 
William H, Prusoff, Ph.D., 
professor emeritus and senior research 
scientist of phamiacology, delivered the 
Paul Neumann Association for 
Scientific Re,search’s annual Paul 
Ehrlich Lecture in July at the 27th Inter¬ 
national Meeting of Medicinal 
Chemistry in Caen, France. 
Judith S. Rodin, Ph.D., chaimian 
and the Philip R. Allen Professor of 
Psychology, has been appointed dean of 
the Graduate School of Arts and 
Sciences effective July I, making her 
the first woman in the LIniversity’s 
history to serve at this post. During her 
five-year tenn. Dr. Rodin will oversee 
academic policies involving more than 
3.000 graduate students and faculty 
members. 
Gordon M. Shepherd, M.D., 
D.Phil., professor of neuroscience, has 
been appointed deputy provost for the 
biological sciences effective July 1, and 
will assume the duties in November 
after a scheduled leave of absence. 
Albert J. Solnit, M.D., Sterling Pro¬ 
fessor Emeritus of Pediatrics and 
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Psychiatry, has been named commis¬ 
sioner of the Department of Mental 
Health by Gov. Lowell P. Weicker. With 
this appointment. Dr. Solnit hopes to 
find a way to improve the quality and 
distribution of state .services. 
.lohn T. Stitt, Ph.D., associate 
professor of epidemiology and cellular 
and molecular physiology and a fellow 
at the John B. Pierce Laboratory, has 
been awarded a $868,()()() grant by the 
National Institutes of Health. The grant 
enables Dr. Stitt to continue his re.search 
on the mechanisms by which normal 
body temperature is altered when the 
body is invaded by infectious agents. 
Peter K. Stys, M.D., associate 
research scientist in neurology, has been 
awarded the American Neurological 
As.sociation's Presidential Award and the 
Canadian Medical Research Council’s 
Centennial Fellowship. Both awards rec¬ 
ognize his research on the effects of lack 
of oxygen on nerve fibers in the central 
nervous system and the mechanism by 
which calcium, normally a vital ingredi¬ 
ent for cell life, .sometimes floods the 
cells, damaging or killing them. This 
research has implications for the treat¬ 
ment of stroke and spinal cord injuries. 
.Samuel (). Thier, M.D., president of 
the Institute of Medicine of the National 
Academy of Sciences and a member of 
the Dean's Council at the School of 
.Medicine, has been named president of 
Brandeis University in Waltham, Mass. 
From 1975 through 1985, Dr. Thier 
served as professor and chairman of 
medicine at Yale. 
Stephen (L Waxman, M.D., f^h.D., 
professor and chairman of neurology at 
the School of Medicine and chief of 
neurology at Yale-New Haven Hospital, 
has been appointed to a three-year term 
on the Institute of Medicine’s Board on 
Biobehavioral Sciences and Mental Dis¬ 
orders. The 12-member board identifies 
key issues in the fiekls of mental and 
atkiictive disorders and the 
biobehavioral sciences; develops 
concepts for activities in these areas that 
might be appropriate for the Institute of 
Medicine, and responds to requests for 
studies and advice from Congress and 
federal agencies. Dr. Waxman also 
presented the first Vivian L. .Smith 
Lecture at Baylor College of Medicine 
in Houston. 'Hie lecture, entitled "The 
Neurobiological Basis ol Restorative 
Neurology of Multiple Sclerosis.” began 
a series to honor the late founder of the 
Vivian 1,. Smith I'oundation for 
Restorative Neurology at Baylor. 
.John H. Warner, Ph.D., associate 
professor of the history of medicine, 
received the American Association for 
the History of Medicine’s 1991 William 
H. Welch Medal for his book entitled 
The Therapeutic Perspective: Medical 
Practice, Knowledge, and Professional 
Identity in America, 1820-1S85. The 
annual award is given to the author of “a 
book of outstanding scholarly merit in 
the field of medical history.” Published 
in 1986, the book examines medical 
activity to evaluate shifts in patient care. 
While underscoring regional variations, 
it also provides a nationwide view of 
American medical history. 
FACULTY NEWS 
Harry Bishop 
Linda M. Bartoshnk, Ph D. 
Faculty Honored 
At Commencement 
During the graduation ceremony at the 
School of Medicine, several awards 
were presented, including the Charles 
W. Bohmfalk Prize for excellence in 
teaching. William B. Stewart, Ph.D., 
associate professor of surgery (gross 
anatomy), received the prize in the basic 
sciences, while Richard S.K. Young, 
M.D., M.P.H., was awarded the prize in 
the clinical sciences. Each physician 
receives a $5,()()() award. 
Department chairmen, directors of 
medical studies and medical students 
nominate outstanding teachers in each 
category, and a committee of students 
and faculty selects recipients. The 
annual awards, funded by the Bohmfalk 
Family Charitable Trust, reflect a 
renewed emphasis on teaching at the 
School of Medicine. 
Since 1985, Dr. Stewart has served as 
director of the anatomy course for first- 
year students. Of Dr. Stewart, students 
and colleagues comment: “He truly sets 
the tone of the 'Yale System’....He has 
an excellent sense of students’ wants, 
needs and anxieties about anatomy and 
medical school in general....A 
wonderful teacher, very caring and 
enthusiastic.” 
In 1965, Dr. Stewart received a B.S. 
degree from the University of Illinois 
and a Ph.D. from Emory University. He 
started a post-doctoral fellowship in 
physiology at Yale in 1976. Dr. Stewart 
joined the medical faculty in 1982 and 
has centered his research on the sense of 
smell. 
Dr. Young, who joined the medical 
faculty in 1986, researches the effect of 
oxygen deprivation on the brain as it 
develops. In 1973, he received 
combined M.D., M.P.H. degrees from 
Yale, after earning a B.A. degree in 
biology from Stanford University. 
Of Dr. Young, students and 
colleagues state: “He single-handedly 
revitalized the pediatric component of 
the Introduction to Clinical Medicine 
course....He is equally adept at the 
bedside as in the classroom and has 
given an abundance of time to the teach¬ 
ing mission....Dr. Young is a gifted and 
effective teacher.” 
Other medical school awards and 
recipients include: 
Erancis Gilman Blake Award 
(posthumously) to Peter A.T. Grannum, 
M.B.B.S., associate professor of obstet¬ 
rics and gynecology. Established in 
1952 by Nil Sigma Nu, the award 
honors a medical faculty member whom 
the senior class designates as the most 
outstanding teacher of the medical 
sciences. 
Betsy Winters House Staff Award to 
Yvonne Gollin, M.D., resident in obstet¬ 
rics and gynecology. The award is 
presented annually to a Yale-New 
Haven Medical Center house staff 
member whom the senior class believes 
has made the most significant 
contribution toward the medical 
students’ education. 
Leah Lowenstein Award to Linda M. 
Bartoshnk, Ph.D., professor of surgery 
(otolaryngology), of epidemiology and 
of psychology. The Office for Women in 
Medicine pre.sents the award to a full¬ 
time faculty member who.se work repre¬ 
sents the highest degree of excellence in 
non-sexist education. 
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Neuroscientists Earn 
Javits Research Awards 
Two Yale University School of 
Medicine researchers have been named 
recipients of this year’s Senator Jacob 
Javits Neuroscience Awards given by 
the National Institute of Neurological 
Disorders and Stroke (NINDS). 
Pasko Rakic, M.D., Sc.D., the Dorys 
McConnell Duberg Professor of Neuro¬ 
science and professor and chairman of 
neurobiology, received a $3.5 million 
award; the award to Leonard K. 
Kaczmarek, Ph.D., professor of pharma¬ 
cology and physiology and chairman of 
the department of pharmacology, 
totalled $2.1 million. This is the second 
Javits Award presented to Dr. Rakic, 
who was among the first neuro.scientists 
to receive one in 1984, when the 
program was launched. 
NINDS established the awards, 
which support scientists for seven years, 
to honor the late U.S. Sen. Javits of 
New York. 
Dr. Rakic, a native of Yugoslavia, 
joined the Yale faculty in 1977. He is a 
member of the National Academy of 
Sciences, the Yugoslavian Academy of 
Arts and Science, and the Serbian 
Academy of Arts and Sciences. 
Since the early 1970s, Dr. Rakic has 
studied the basic events of how neurons 
originate, move and converge to form a 
“wiring diagram” in the mammalian 
central nervous system. His work 
attempts to unravel the individual cellu¬ 
lar interactions that lead to the 
development of the primate brain. 
“Understanding the molecular and 
cellular mechanisms of brain 
development is widely regarded as one 
of the central issues in neurobiology, 
and the field of brain development is 
one of the most exciting and robust 
areas of neuroscience,” says Dr. Rakic. 
Dr. Kaczmarek, a native of the 
United Kingdom, joined the Yale 
faculty in 1981. He has co-authored the 
books Neiiwmodulation and The 
Neuron. His previous honors include the 
Klingenstein Award in Neuroscience. 
Dr. Kaczmarek studies how electrical 
and secretory properties of neurons con¬ 
trol prolonged changes in such animal 
behaviors as reproduction, eating and 
sleeping. He and his colleagues work 
with the nerve cells of a slug-like 
mollusk, Aplysia, also called a sea hare. 
Scientists can work easily with the mol- 
lusk’s large nerve cells. By studying 
electrical changes in nerve cells, they 
hope to understand how they translate 
into behavior changes in animals. 
Dr. Kaczmarek has isolated neurons 
which, when fired, stimulate the mollusk 
to initiate a number of reproductive 
behaviors. He is working to understand 
how biochemical changes affect the 
electrical properties of these cells. 
“Our ultimate goal is to understand 
how neurons control long-lasting 
changes in an animal’s behavior,” says 
Dr. Kaczmarek. 
Other Yale researchers who hold 
Javits awards include William S. 
Agnew, Ph.D., associate professor of 
cellular and molecular physiology; 
William W. Douglas, M.D., M.B.Ch.B., 
professor of pharmacology; Dorothy W. 
Gallager, Ph.D., associate professor of 
psychiatry and neuroanatomy; Carole 
M. Choate LaMotte, Ph.D., professor 
(adjunct) of research in surgery 
(neurosurgery) and anesthesiology; 
Robert H. LaMotte, Ph.D., associate 
profes.sor of anesthesiology and 
neuroanatomy; and J. Murdoch Ritchie, 
Ph.D., D.Sc., the Eugene Higgins 
Professor of Pharmacology. 
FACULTY NEWS 
Dr. Siegel Awarded 
Kidney Research Grant 
Dr. Noiman J. Siegel, professor of pedi¬ 
atrics and medicine and director of the 
pediatric nephrology section at the 
School of Medicine, was named an 
Extramural Grant Program recipient by 
the Baxter Healthcare Corporation. The 
award will further his research on the 
treatment of acute renal failure with thy¬ 
roxin. a hormone produced in the 
thyroid gland. Dr. Siegel’s studies 
concentrate on kidney failures due to 
such impairments as blood flow 
obstruction or toxic substances in the 
urinary tract. 
Dr. Siegel joined the Yale medical 
faculty in 1972 as assistant professor of 
pediatrics and director of the pediatric 
nephrology section. He is chairman of 
the National Kidney Eoundation 
Council on Pediatric Nephrology and 
Urology and a member of the 
foundation’s scientific advisory 
committee. He also is a member of the 
medical advisory committee for the 
Connecticut Kidney Foundation. 
Dr. Siegel was one of 11 recipients of 
the Baxter grants which total $500,000. 
Dean Rosenberg 
Takes Sabbatical 
In May, Dean Leon E. Rosenberg 
announced that he would begin a six- 
month sabbatical leave on July 1. He 
stated; “After seven years in this job, I 
believe it is both prudent and necessary 
for me to have this time for reflection, 
writing, planning and ‘doing’ science. I 
fully expect that such a respite will 
allow me to take up the deanship again 
with renewed vigor and clear vision. 
“I take this leave with a sense of ease 
knowing that our stellar deputy dean. 
Bob Donaldson, will ably serve as 
interim dean and that you will give him 
the kind of loyal and dedicated support 
you have always afforded me.” 
Melville Corporation 
Supports Comer Program 
The Melville Corporation has joined 
with the Rockefeller Foundation in 
funding a project which will replicate 
Dr. James P. Comer’s model school 
development program in a number of 
inner-city school systems across the 
country. 
A specialty retail company based in 
Rye, N.Y., the Melville Corporation has 
made an initial gift of $250,000 with the 
expectation of providing continued sup¬ 
port over four years to improve urban 
schools by applying Dr. Comer’s 
concepts. 
Dr. Comer, the Maurice Falk 
Professor in the Child Study Center and 
Psychiatry at the School of Medicine, 
has developed educational reforms 
which address the difficulties of educat¬ 
ing low-income and minority children 
living in cities. Developed in 
collaboration with the New Haven 
public school system, the Comer model 
is being used by 165 schools in 15 
districts throughout 12 states and 
Washington, D.C. 
The program focuses on a child’s 
preparation for school and the 
collaboration between school staff and 
parents in the academic and social 
development of children. 
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FACULTY NEWS 
Dr. Howard Pearson and friend. 
Yale Pediatrician 
To Lead Academy 
Howard A. Pearson, M.D., professor of 
pediatrics, has been named vice 
president-elect of the American 
Academy of Pediatrics (AAP), a 
national organization dedicated to 
promote the physical, mental and social 
health of children, adolescents and 
young adults. 
Dr. Pearson, who also serves as 
medical/executive director of Paul 
Newman’s Hole-in-the Wall Gang 
Camp for children with cancer and 
blood diseases, will take office as the 
academy’s national vice president in 
October. He will serve a one-year term 
as AAP president, beginning in 1992. 
With 41.()()() members in the United 
States, Canada and Latin America, the 
academy is dedicated to advocacy for 
children, research, public and profes¬ 
sional education, and serving as a voice 
for pediatricians. 
In I96S. Dr. Pearson came to New 
I laven as professor and head of 
pediatric hcmatology/oncology at the 
School of Medicine. Between 1974 and 
19X7, he chaired the department of pedi¬ 
atrics and organized a continuing educa¬ 
tion course for practicing pediatricians, 
now in its IXth year. He continues to 
care for children w ith blood diseases. 
More than 20 years ago. Dr. Pearson 
initiated the first comprehensive pro¬ 
gram for diagnosing sickle cell anemia 
in newborns, which became a model for 
the neonatal blood screening programs 
mandated in more than 30 states and in 
other countries throughout the world. 
The National Heart, Lung and Blood 
Institute used it as the basis for the new¬ 
born component of the National Coop¬ 
erative Study of Sickle Cell Diseases. 
An AAP member since 1966. Dr. 
Pearson wrote a nutrition committee 
statement on iron, and its 
recommendations led to the eradication 
of severe iron deficiency in this country. 
Three Faculty Receive 
Endowed Professorships 
President Benno C. Schmidt Jr. 
announced the appointment of three 
School of Medicine faculty members to 
endowed professorships. Carolyn W. 
Slayman, Ph.D., has been named the 
Sterling Professor of Genetics; Alvan R. 
Feinstein, M.D.. the Sterling Professor 
of Medicine; and Burton H. Singer, 
Ph.D., the Ira V. Hiscock Professor of 
Epidemiology and Public Health. 
Dr. Slayman became the first woman 
to assume a medical department chair at 
Yale when she was appointed chair of 
the human genetics department in 1984. 
The department she leads plays an 
active role in the emerging field of gene 
therapy and in efforts to map and 
sequence the human genome. During 
her career, she has centered her research 
on the proteins that transport nutrients 
across cell membranes, and the genes 
that code for those proteins. 
Born in Portland, Maine, Dr. 
Slayman graduated from Swarthmore 
College in 1958 with highest honors in 
biology and chemistry. She received her 
Ph.D. degree in biochemical genetics 
from Rockefeller Llniversity in 1963. 
and spent the following year as a 
National Science Foundation (NSF) 
post-doctoral fellow at Cambridge 
University. She joined the Yale faculty 
in 1967 as an assistant professor of 
microbiology and physiology. In 1972, 
she was promoted to professor. 
Among her numerous professional 
activities. Dr. Slayman serves on the 
National Advisory General Medical Sci¬ 
ences Council at the National Institutes 
of Health. She also is a member of the 
board of trustees of Bowdoin College in 
Brunswick, Maine, and of Hopkins 
School in New Haven. 
Dr. Feinstein, a Yale medical faculty 
member and an attending physician at 
Yale-New Haven Hospital since 1962, 
also is director of the clinical epidemiol¬ 
ogy unit and of the Robert Wood 
Johnson Clinical Scholars Program. 
Since its onset at Yale in 1975, the Clin¬ 
ical Scholars Program has provided a 
fellowship for training post-graduate 
physicians working in clinical 
epidemiology, health care delivery or 
health policy. 
Dr. Feinstein, a Philadelphia native 
who received B.S., M.S. and M.D. 
degrees from the University of Chicago 
in 1947, 1948 and 1952, conducted 
research on rheumatic fever at 
Rockefeller Institute and Irvington 
House. He has developed clinical 
research techniques that have improved 
methods for the prognosis and treatment 
of cancer. For example, he pioneered 
methods to quantify such phenomena as 
pain, distress and disability. Dr. 
Feinstein advocates that clinical 
epidemiology and clinimetrics be devel¬ 
oped as additional humanistic “basic 
sciences” for clinical practice. 
Dr. Singer, associate dean as well as 
chaimian at EPH, is one of the nation’s 
outstanding biostatisticians. During 
much of his career, he has studied the 
dynamics of infection in tropical 
diseases, beginning with his work on 
malaria in Nigeria. At present, he is 
working on the social and economic 
impact of malaria and other tropical dis¬ 
eases as they relate to high-technology 
drug development and vector control 
methods in developing countries. 
As chaimian of a World Health Orga¬ 
nization steering committee for social 
and economic research in the tropical 
disease program. Dr. Singer has been 
involved in the international debate con¬ 
cerning the extent that high-technology 
drugs and vector control methods 
interrupt disease and improve the health 
of people in developing countries. 
Before Joining the Yale faculty in 
1985, Dr. Singer had chaired for two 
years Columbia University’s department 
of statistics. His career also includes 18 
years of teaching and research at 
Columbia and 12 years as an adjunct 
professor at Rockefeller University. 
A native of Chicago, Dr. Singer 
received B.S. and M.S. degrees from 
Case Institute of Technology in 1959 
and 1961. In 1967, he received a Ph.D. 
degree in statistics from Stanford 
Lhiiversity. 
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ALUMNI REPORT 
Many alumni returning for their annual 
reunion weekend shared in the 
dedication of the new Boyer Center for 
Molecular Medicine on June 6 and 7. 
Symposia were presented before and 
after the dedication of this fine addition 
to the medical school campus. 
Discussants from the academic, govern¬ 
mental and business communities 
presented their views on “Constructing a 
National Agenda for Biomedical 
Research” before a reception and tour of 
the center on June 6. “Perspectives in 
Molecular Medicine” commemorated 
the four programs in the center: molecu¬ 
lar genetics, molecular and developmen¬ 
tal neurology, molecular oncology and 
development, and molecular 
cardiobiology. 
Following registration on June 7, 
class reunion seminars met. The Class 
of 1941 (50th reunion) heard Willys M. 
Monroe, M.D., discuss “The U.S. Public 
Health Service: A Virginia Tradition;” 
Martin E. Gordon, M.D. ’46, who was 
local 45th-reunion chaimian, organized 
an outstanding program entitled “From 
Then to Now — Panoramic Views of 
Medicine: 45 Years of Personal 
Observation.” Ten members of the class 
read 10-minute papers about topics in 
their specialty. Thomas Kugelman, 
M.D. ’60, greeted attendees and Dean 
Rosenberg welcomed the alumni. Nobel 
laureate George E. Palade, M.D., 
Sterling Professor Emeritus of Biology 
at Yale and dean of scientific affairs at 
the University of California, San Diego, 
School of Medicine, discussed the 
“Medical School Curriculum and the 
Rapid Expansion of Biomedical 
Sciences.” A reception followed at 
Harkness auditorium. Returning alumni 
then joined class members at dinners, 
parties and picnics. 
At surgical grand rounds on June 8, 
moderator William F. Collins Jr., M.D., 
chairman of surgery, discussed recent 
advances in this field. Concurrent 
faculty seminars included: “Recent 
Advances in Disorders of Pigmentation” 
by Jean Bolognia, M.D. ’80, and 
“Genetic Control of Pigmentation” by 
Ruth Halaban, Ph.D.; “Lyme Disease: 
State of the Art,” moderated by Daniel 
Rahn, M.D. ’76; “The Pain 
Experience,” moderated by Luke M. 
Kitahata, M.D., Ph.D. 
Dr. Vincent T. Marchesi moderated a 
panel discussion entitled “Yale Center 
for Molecular Medicine — Program for 
the Future.” Center faculty members 
discussed upcoming molecular research 
programs and their clinical application. 
The medical reunion dialogue and 
tea/sherry concluded the scientific 
program. Arthur Ebbert Jr., M.D., 
professor emeritus of medicine, 
moderated a provocative discussion 
between Alvan R. Feinstein, M.D., 
professor of medicine and 
epidemiology, and Joseph Warshaw, 
M.D., professor and chairman of 
pediatrics, entitled “Fundamental Scien¬ 
tific Challenges in Clinical Care.” 
Lively audience participation ensued. 
Friendships were renewed, 
reminiscences exchanged, family Joys 
and sorrows were shared. Alumni had 
matured but remain young at heart. Indi¬ 
vidual classes convened picnics and din¬ 
ners arranged by New Haven-area class¬ 
mates. The golden anniversary of the 
graduation of the Class of 1941 was cel¬ 
ebrated at a dinner at the Colony Inn 
hosted by the Friends of the 50th for 
class members and spouses. Dr. 
Gioacchino Parrella presented a paper 
entitled “The Way We Were — 50 Years 
Later” to rekindle memories of their 
four years at Yale. Each returning 
member of the class spoke briefly. The 
Class of 1986 returned for their first 
five-year reunion and were introduced 
by Dr. John Wysolmerski, dinner chair. 
Two members of the Class of 1931 and 
two from the Class of 1936 were 
introduced. 
Dean Leon E. Rosenberg presented a 
stimulating State of the School Address 
at annual meeting of the Association of 
Yale Alumni in Medicine (AYAM) at 
Harkness auditorium on June 8. The 
dean cited Dr. Kugelman for 
outstanding service at the completion of 
his term as president of AYAM. Muriel 
Wolf will serve as president for a two- 
year term. Marie-Louise T. Johnson, 
M.D. ’56, will serve as vice president, 
and Gilbert Hogan, M.D. ’57, as 
secretary. Elected to the executive com¬ 
mittee to replace members who have 
completed their term are Erederic K. 
Cantor, M.D. ’62; R. Leonard Kemler, 
M.D. ’43; Michael H. Owens, M.D. ’78; 
and Barbara Ross, M.D. ’81. Nicholas 
M. Passarelli, M.D. ’59, has agreed to 
serve a second term. 
Elected as representatives to the AYA 
are W. Scott Peterson, M.D. ’71, and 
Benjamin E. Lyons, M.D. ’38. Andrew 
S. Wong, M.D. ’51, will fill the 
unexpired term of Marie-Louise 
Johnson. 
We thank Thomas Kugelman for an 
outstanding term in office. 
Congratulations are also extended to 
those members of the executive 
committee and representatives to the 
AYAM whose terms have expired. 
A Distinguished Alumni Award was 
awarded to Lowell I. Goodman, M.D. 
’51, for his accomplishments as 
chairman of the Yale School of 
Medicine Alumni Eund. Samuel 
Kushlan, M.D. ’35, a previous recipient, 
presented Dr. Goodman with a Yale 
chair after appropriate remarks. 
Maxwell Bogin, M.D. ’26, received a 
special citation commemorating 65 
years in the practice of pediatrics and 
long tenure as class agent for the Class 
of 1926. Nicholas P.R. Spinelli, M.D. 
’44, presented Dr. Bogin with a framed 
certificate. 
There will be .ample opportunity in 
the coming year for AYAM members to 
participate in student activities. Each 
year there is an annual dance in Decem¬ 
ber or January. The association sponsors 
a student-faculty tea, and we assist with 
the second-year show. Alumni are 
welcome to all of these activities. 
Schedules will be available. 
Alumni/student interaction was 
further enhanced by participation in the 
Kresge Challenge phonathons. Thirty- 
two students and 22 alumni were joined 
by Dean Rosenberg at the alumni fund 
office on March 19, 20, and 26, 27. The 
$33,000 collected will be used by the 
alumni fund for financial aid and for 
unrestricted use by the dean. 
Arthur Crovatto, M.D. '54 
Director of alumni affairs 
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Dr. Hoyt C. Taylor, ’40-’43 HS, 
worked part-time for 10 years in the 
Lawnwood Regional Hospital 
emergency room after retiring to Florida 
in 19k). He continues 40 hours of medi¬ 
cal education to retain his medical 
license. 
Dr. John H. Grossman II, ’41 -’45 
HS. has retired from the private practice 
of gynecology and conducts a weekly 
one-hour radio talk show in Ansonia, 
Conn. 
Julian Frieden, M D. '48 
Dr. Julian Frieden, ’48, chief of car¬ 
diology at New Rochelle Hospital Med¬ 
ical Center, was honored in May by the 
hospital for his more than 35 years of 
contributions. Dr. Frieden initiated 
several new programs at the medical 
center, including a progressive care unit 
and a cardiac telemetry unit. He also is 
an attending physician and 
electrocardiographer at Montefiore 
Medical Center in New York City and a 
clinical profes.sor of medicine at the 
Albert Einstein College of Medicine. 
Dr. T. Timothy Crocker, ’48-’50 
HS, clinical professor of internal 
medicine (occupational and 
environmental) at the University of Cal¬ 
ifornia. San Francisco, was professor of 
internal medicine (infectious diseases) 
and cancer research at the University of 
California. San Francisco from 1950 
through 1971. From 1971 through 1990, 
he served as professor and founding 
chair for the department of community 
and environmental medicine at the Uni¬ 
versity of California, Irvine. 
ALUMNI NEWS 
Dr. Paul Calahresi, ’55, professor 
and chairman of the Brown University 
department of medicine, was appointed 
chairman of the National Cancer 
Advisory Board by President Bush. His 
five-year term began in January 1991. 
The 18-member board reviews grant 
applications of $50,000 or more made to 
the National Cancer Institute. 
Dr. Joseph P. Wierzbinski, ’58. and 
Susan S. Addiss, ’69 M.P.H., have been 
appointed by Connecticut Gov. Lowell 
P. Weicker to served in state health 
service positions. Dr. Wierzbinski has 
been named state surgeon general, an 
appointment which makes him a 
member of the governor’s military staff. 
Ms. Addiss now serves as commissioner 
for the Department of Health Services 
after nine years as chief of the 
department’s bureau of health planning 
and resource allocation. 
Dr. Jack N. Blechner, ’57, professor 
and head of the department of obstetrics 
and gynecology at the University of 
Connecticut Health Center, has been 
named president of the Obstetrical Soci¬ 
ety of Boston. Dr. Blechner also is asso¬ 
ciate dean for clinical affairs at the 
health center's School of Medicine. 
Jack D. Barchas, ’60. of Westwood. 
Calif., serves as associate dean for 
neuroscience at University of 
California. 
Dr. Robert L. Johnson, ’60-’64 HS, 
is clinical professor of otolaryngology at 
the University of California. San 
Francisco, and is chief and director of 
residency training in otolarygnology at 
Children’s Hospital in San Francisco. 
Dr. John T. Harrington, ’62, gover¬ 
nor for the Massachusetts chapter of the 
American College of Physicians, 
received an honorary fellowship in May 
from the Royal College of Physicians of 
Ireland for his work in renal physiology, 
nephrology and as editor of Nephrology 
Forum in the journal. Kidney 
International. 
Dr. Stephen C. Joseph, ’63, has 
been appointed dean of the school of 
public health and professor of public 
health and pediatrics, at the University 
of Minnesota. 
Dr. Donald (i. Skinner, ’64, 
professor and chairman of urology at the 
University of Southern California 
School of Medicine, has been named the 
Stephen C. Joseph. M.D. '63, M.P.H. 
1991 Barringer Medal recipient. The bi¬ 
annual award given for achievement in 
cancer research was presented to Dr. 
Skinner at the American Association of 
Genitourinary Surgeons’ annual 
meeting held in April in Naples, Fla. 
Dr. David S. Fedson, ’65. professor 
of internal medicine and head of the 
division of general medicine at the Uni¬ 
versity of Virginia School of Medicine, 
was appointed to a four-year term on the 
National Vaccine Advisory Committee, 
beginning in July. He also has served on 
the U.S. Public Health Service 
Immunization Practices Advisory Com¬ 
mittee, and chaired the American 
College of Physicians’ Task Force on 
Adult Immunization. 
Dr. Charles R. Rosenfeld, ’66 HS, 
has been on the faculty at the University 
of Texas Southwestern Medical School 
at Dallas since 1973 and is director of 
the division of neonatal-perinatal 
medicine, and professor pediatrics and 
obstetrics and gynecology. He currently 
is on an administrative leave, working 
in the physiology department on 
vascular smooth muscle alterations in 
pregnancy. 
Dr. Peter N. Herbert, ’67. has been 
appointed chairman of medicine for at 
the Hospital of St. Raphael in New 
Haven. 
Dr. Donald R. Coustan, ’68, has 
been appointed obstetrician and 
gynecologist-in-chief at Women & 
Infants Hospital of Rhode Island and 
chairman of the department of obstetrics 
and gynecology at Brown University. In 
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Donald R. Coustan, M.D. '68 
1982, Dr. Coustan joined the hospital 
staff to establish and direct the division 
of maternal/fetal medicine and later 
became director of obstetrics and 
associate chief of obstetrics and 
gynecology. He was appointed full 
professor in 1986. 
Dr. Anthony V. Proto, ’71, Joined 
the staff of the Medical College of 
Virginia, Virginia Commonwealth 
University, in 1984, as professor and 
director of pulmonary radiology. He 
served as chainnan of the division of 
diagnostic radiology for three years, and 
as interim chairman of the department 
of radiology from July 1989 through 
October 1990. Dr. Proto has been a con¬ 
sultant for the National Institutes of 
Health since 1986 and also has served 
as national civilian consultant in 
diagnostic radiology to the Surgeon 
General, U.S. Air Force, since 1980. He 
was recently honored by the Annual 
Oration of the Radiological Society of 
North America. 
Dr. Paul Vignola, ’71, ’71-’74 HS. 
has been appointed director of the 
cardiac catheterization laboratory at 
Mount Sinai Medical Center in Miami 
Beach. 
Dr. Raymond L. Sphar, ’72 M.P.H.. 
has been appointed director of medical 
research service for the Department of 
Veterans Affairs in Washington, D.C. 
He retired from the U.S. Navy, where he 
headed several research units and served 
as medical research advisor in the 
Office of the Secretary of Defense. 
ALUMNI NEWS 
Dr. Warren R. Palterson, ’72-’74 
HS, of Nashville, Tenn., completed a 
plastic surgery residency in 1986 and 
became board certified in 1990. 
Dr. .John H. (Jrossman III, ’72-’75 
HS, is professor of obstetrics, 
gynecology and microbiology and also 
director of the division of maternal-fetal 
medicine at George Washington Univer¬ 
sity medical school in Washington, D.C. 
Dr. David A. Adler, ’73, is chief of 
adult psychiatry at the New England 
Medical Center Hospitals and professor 
of psychiatry at Tufts University School 
of Medicine. 
Dr. Mary .Jane Minkin, ’75, was 
honored by the New Haven Rape Crisis 
Services of the YV/CA with its first 
annual Arnold Markle Award for her aid 
to rape survivors. The award, named for 
the late state attorney in honor of his 
advocacy of sexual assault victims’ 
rights, was presented to Dr. Minkin at a 
ceremony in January at the New Haven 
District Courthouse. 
Michael H. Owens. M.D. '78 
.serves the Los Angeles area. Before his 
appointment. Dr. Owens served as exec¬ 
utive vice president and chief health 
officer for the Watts Health Foundation, 
Inc. and United Health Plan, where he 
was responsible for the organization’s 
health delivery systems. 
Dr. Wayne E. Julian, ’81 HS, 
foreign service medical officer for the 
United States Department of State, has 
been assigned as regional psychiatrist 
for South America, and will be posted at 
the U.S. embassy in Santiago, Chile. 
Dr. David S. Weiss, ’81, was 
inducted as a fellow of the American 
Academy of Orthopaedic Surgeons 
during the academy’s 58th annual meet¬ 
ing in March in Anaheim, Calif. 
Dr. Aswine K. Bal, ’86 M.P.H., 
completed a residency in pediatrics at 
Beth Israel Medical Center in New 
Jersey and is a fellow in pediatric infec¬ 
tious diseases at Yale-New Haven 
Hospital. 
Michael Huncharek, ’86 M.P.H., 
graduated from Boston University 
School of Medicine and has accepted a 
resident position in radiation oncology 
at Massachusetts General Hospital. 
I.orraine M. Almo, ’90 M.P.H., is 
employed at Indian Health Service 
Community Health Nursing in Fort 
Defiance, Ariz. 
Stacey Wills, ’90 M.P.H., is a 
re.searcher at the Employee Benefit 
Research Institute in Washington, D.C., 
where she examines health care cost 
issues, particularly insurance, and 
publishes reports on current policy 
agendas in Congress, state governments 
and private businesses. 
Christina Wypijewski, ’90 M.P.H., 
works on prevention policies and 
programs for the federal Office of 
Disease Prevention and Health 
Promotion, Department of Health and 
Human Services. 
NEW BOOKS 
Dr. Michael H. Owens, ’78. was 
appointed medical director for CIGNA 
Private Practice Plan, CIGNA 
Healthplans of California. Dr. Owen’s 
responsibilities include physician 
relations, utilization management and 
quality assurance of the 12,()()0-member 
health care delivery system, which 
Child and Adolescent P.sychiatr\: 
A Comprehensive Te.xthook, Dr. Melvin 
Lewis, profes.sor of pediatrics and 
psychiatry. Williams & Wilkins 
(Baltimore) 1991. 
The Trehlinka Virus. Dr. Robert B. 
Litman, ’72 HS, The Ivy League Press, 
Inc. (New York) 1990. 
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STUDENT NEWS 
Gregor> R. Huth 
John B. Houston and Jonathan E. 
Sears, third-year students, were selected 
to participate in the Juvenile Diabetes 
Foundation's lOth annual Medical 
Student Workshop. The workshop, enti¬ 
tled "Introduction for Potential 
Investigators," was held in April in 
Bellevue, Wash., and introduced 
students from 65 universities in the 
United States and Canada to progress 
made in the treatment of diabetes 
complications, islet transplantation, dia¬ 
betic nephropathy, and insulin treat¬ 
ment. Mr. Houston also was selected by 
the Howard Hughes Medical Institute to 
participate in the Cloister Program, a 
National Institutes of Health Research 
Scholars program which allows him to 
perform research in an NIH laboratory 
of his choice for one year. 
Dr. Steven Herber, who is 
completing his first year of plastic 
surgery residency at Yale, has been 
selected as a 1991 recipient of the 
American Medical Association (AMA) 
Burroughs Wellcome leadership award 
based on a commitment of community 
service and interest in organized 
medicine. He has a keen interest in 
international medical service and 
accompanied Dr. Gary Price to 
Guatemala, where they performed 
reconstructive operations for congenital 
and acquired deformities. Dr. Herber 
will be attending this year's national 
AMA House of Delegates meetings as a 
representative of the Connecticut 
Medical Society. 
DIVERTICULUM 
Divcri 'u iiluni: 799/'.v nu’dical student 
literary magazine was edited hy first- 
year student James Aim. 
Joanna B. Rosen and William F. King Jr. 
Second-year Students 
Win Elm-Ivy Awards 
William F. King Jr. and Joanna B. 
Rosen, two second-year medical 
students, received Elm-Ivy Awards for 
community service. They and 10 other 
recipients were feted at the annual Elm- 
Ivy Awards luncheon held at University 
Commons on May 24. Each spring, the 
city of New Haven and Yale honor indi¬ 
viduals from the University and the 
local community who make an extra¬ 
ordinary contribution to New Haven. 
Mr. King and Ms. Rosen organized 
the Adolescent Substance Abuse 
Prevention (ASAP) Program, in which 
35 Yale medical students educate 
seventh-grade children from the 
Roberto Clemente Middle School in 
New Haven about the hazards of drugs, 
alcohol and tobacco. Their program is 
one of 10 two-year ASAP pilot projects 
nationally, sponsored by the American 
Medical Student Association. 
Eor their efforts through ASAP, Mr. 
King and Ms. Rosen were selected by 
their classmates to receive the 1991 
CIBA-GEIGY Award for outstanding 
community service. 
Miles Scholar Award 
Recipient Selected 
Shalina Mahajan, a graduate student in 
human genetics, is the third annual 
recipient of the Miles Scholar Award 
established by Miles Inc., a health care 
company headquartered in Elkhart, Ind. 
Two years ago. Miles Inc. created the 
award at Yale to encourage graduate 
study in the biomedical sciences by stu¬ 
dents with high potential to achieve 
research excellence. 
Ms. Mahajan conducts research on 
oogenesis, the formation and 
development of mature eggs, called 
oocytes, in the fruit lly. She studies the 
transport of nutrients and molecules 
between cells to learn how cells 
communicate with each other during 
development. Molecular disruptions in 
this process may result in abnomial egg 
production. “This research is a genetic 
approach to understanding the 
molecular basis of intercellular transport 
by studying specific mutations or 
disruptions," states Ms. Mahajan. who 
in 1989 received an A.B. degree in biol¬ 
ogy from Smith College. 
The Miles Scholar Award provides 
tuition, supplies and other costs, plus a 
two-year stipend. Candidates were 
selected from second-year Ph.D. and 
M.D., Ph.D. students in Yale's biomedi¬ 
cal .sciences program and its biology 
department. 
42 Yale Medicine Summer 1991 
DEVELOPMENT REPORT 
Parkinson Foundation 
Issues $500,000 Grant 
The National Parkinson Foundation 
(NPF) has awarded the School of 
Medicine a $500,000 grant to establish a 
basic scientific and clinical research 
program to advance knowledge about 
and treatments for this neurological dis¬ 
ease. NPF, based in Miami, cited Yale’s 
interdisciplinary approach, which com¬ 
bines basic research with clinical care. 
The NPF program will enable the 
school to expand its comprehensive 
research activities, especially into the 
function of the neurotransmitter 
dopamine. For 20 years, Yale has been a 
leader in dopamine research. Dopamine, 
a chemical messenger, provides the 
communication link between the 
neurons which degenerate in 
Parkinson’s disease and the cells in the 
brain which are involved in movement. 
Comments Dean Leon E. Rosenberg, 
“Through NPF’s generosity, our depart¬ 
ment of psychiatry, which conducts 
extensive neuroscientific research, and 
our department of neurology, which 
treats patients with Parkinson’s disease, 
will expand their programs.” 
The National Parkinson Foundation 
Research Program at Yale University, 
administered by the department of 
psychiatry, will be headed by Dr. Ariel 
Y. Deutch, assistant professor of psychi¬ 
atry. Dr. Deutch is also the chairman of 
the scientific advisory board of the 
National Parkinson Foundation. 
This basic research program will be 
complemented by the National 
Parkinson Foundation Clinical and 
Therapeutic Service Programs at Yale 
University, directed by Dr. Kenneth 
Marek, assistant professor of neurology. 
Under his leadership, the department 
will expand state-of-the-art diagnosis 
and treatment for patients with 
Parkinson’s disease; physicians and sci¬ 
entists will advance research by 
conducting clinical studies of new and 
promising strategies. 
Herman Family Gift 
To Benefit EPH 
Samuel S. Flerman, ’48 M.P.H., ’50 
Ph.D., and his wife, Liselotte, have 
donated a remainder interest in their res¬ 
idence to the department of 
epidemiology and public health (EPH). 
The funds from the sale of their home 
will be used to support the work and 
research of EPH faculty. 
Born in Boston, Mass., Dr. Herman 
attended Harvard College, where he 
received his A.B. degree. He then came 
to study at Yale’s department of public 
health, where he earned M.P.H. and 
Ph.D. degrees. After graduating. Dr. 
Herman joined the National Institutes of 
Health (NIH) in Bethesda, Md., where 
he established research training and fel¬ 
lowship programs for the Eye Institute 
and the Environmental Health Sciences 
Institute. He also served as the deputy 
director for extramural affairs at the 
National Cancer Institute. 
Dr. Herman left the NIH to join 
Temple University in Philadelphia, as 
associate vice president for research and 
graduate studies at the Health Sciences 
Center, as well as associate dean for 
research and graduate studies at Temple 
Medical School. During that time, he 
directed of a Congressionally mandated 
study conducted by the National 
Research Council for the National 
Academy of Sciences to determine 
national needs for biomedical and 
behavioral research personnel. 
Since his retirement from Temple, 
Dr. Herman has established a consulting 
practice for education and research 
organizations. His company specializes 
in Washington representation for these 
institutions and in biomedical research 
administration. In this capacity, he 
serves as a consultant to the Lucille B. 
Markey Charitable Trust. 
Dr. Herman has been an active 
volunteer on behalf of EPH and the 
School of Medicine, serving on several 
boards and as class agent. Donald S. Hetzel, M.D., vice president of Becton Dickinson and Company, speaks at a 
reception where he presented a check for $150,000 to the department of laboratory 
medicine to help support its Molecular Diagnostics Development Laboratory. 
Department chairman Peter /. Jatlow, M.D., said the gift will allow basic and clinical 
scientists to intensify their efforts to clinically apply advances in molecular 
biotechnology. 
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Joseph Axelrod 
Joseph Axelrod, died March 31 
in an auto accident near Guaymas, 
Sonora, Mexico. He was 74. 
Before his retirement, he directed the 
Yale University Health Plan and had 
been executive director of the Michael 
Reese Health Plan in Chicago. 
A native of New Haven, Mr. Axelrod 
was a 1938 graduate of the University 
of North Carolina and in 1951 received 
a M.P.H. degree from Yale. 
He leaves his wife. Patricia; two 
daughters, Carol and Janet; three grand¬ 
sons; four stepchildren; and five step- 
grandchildren. 
Contributions may be made to the 
Scholarship Committee of Alamos, c/o 
Elizabeth Nuzum, Calle Comeccio 2, 
Alamos, Sonora, Mexico 85760. 
Walter E. Barney 
Walter E. Barney. M.D., a retired 
general practitioner and 
anesthesiologist, died Eeb. 18 at 
Willows of Woodbridge Nursing Home 
in Connecticut. He was 85. 
Ur. Barney formerly was chief of 
staff at Milford Hospital before he 
retired in 1981 after 50 years in practice. 
He was a 1931 graduate of the 
Catholic University of America and a 
1935 graduate of Yale School of 
Medicine. During World War II. Dr. 
Barney was a major in the Army. 
He is survived by his wife, Mary; a 
son, John; and two grandsons. 
Contributions may be made to the 
Milford Hospital Memorial Eund, 2047 
Bridgeport Ave., Milford. CT. 
David H. Clement 
David 11. Clement. M.D., died March I 
in Yale-New Haven Hospital at the age 
of 81. 
Dr. Clement began his pediatric prac¬ 
tice in New Haven in 1946. when he 
also became a clinical professor of pedi¬ 
atrics at the School of Medicine. At 
Yale-New Haven Hospital, he .served as 
director of the pediatric hematology lab¬ 
oratory and was associate chief of 
pediatrics. 
I le attained the rank of major during 
World War II and later served in 
military hospital centers in Naples and 
Vittel. Italy. He also helped establish a 
research ward for the U.S.A. Typhus 
Commission in the Dachau 
concentration camp, I'or which he was 
OBITUARIES 
awarded the Commission Medal. 
A native of Buffalo, N.Y., Dr. 
Clement graduated from Yale College in 
1931 and received an M.D. degree in 
1935 from Harvard Medical School. Eor 
20 years he was official examiner for 
the American Board of Pediatrics. He 
leaves his wife, Constance; and a 
daughter, Constance. Contributions may 
be made to the Yale-New Haven Hospi¬ 
tal Office of Development. P.O. Box 
1849, New Haven, CT 06509. 
Wilbur G. Downs 
Wilbur G. Downs. M.D., clinical profes¬ 
sor of epidemiology. died Feb. 17 in his 
Branford home. He was 77. 
Dr. Downs, former director of the 
Yale Arbovirus Research Unit, founded 
the Trinidad Regional Virus Laboratory, 
now the Caribbean Epidemiology 
Centre, in Port-of-Spain, in 1952. He 
.served as chief of preventive medicine 
for the Island Command in Okinawa 
during World War II, for which he 
received the Bronze Star. After the war, 
he directed a malaria control program in 
Mexico for the Rockefeller Foundation; 
in 1963, he negotiated to move the foun¬ 
dation’s virus laboratory to Yale, where 
it became the Arbovirus Research Unit. 
He remained as its associate director. 
A New Jersey native. Dr. Downs 
graduated from Cornell University and 
its medical school in 1935 and 1938, 
respectively. In 1941, he received a 
master's of public health degree from 
Johns Hopkins School of Public Health 
and Hygiene. 
Dr. Downs was a member and 
chairman of many public and private 
organization advisory committees, 
including those of the World Health 
Organization, the United States Public 
Health Service and the National 
Academy of Sciences. 
He leaves his wife, Dorothy; two 
sons, W. Montague and Thomas; four 
daughters, Helen Haller, Anne Carroll, 
Isabel, and Nancy Eeedy; and 15 grand¬ 
children. 
Contributions may be made to the 
Downs Student International Travel Fel¬ 
lowship, c/o Elizabeth Young. Yale 
Arbovirus Research Unit, P.O. Box 
3333, New Haven. CT 06510. 
Peter A.T. Grannum 
Peter A.T. Grannum, M.D., associate 
professor of obstetrics and gynecology, 
died Jan. 21 at the Yale Health Service. 
He was 42. 
Dr. Grannum. a native of Barbados, 
was a graduate of the University of West 
Indies Medical School and had been 
director of medical studies for the 
department of obstetrics and 
gynecology at Yale since 1979. He was 
a two-time recipient of the medical 
school's Francis Gilman Blake Award 
for outstanding teaching. He akso was an 
attending physician at Yale-New Haven 
Hospital and a fellow of the American 
College of Obstetrics and Gynecology. 
He is survived by his parents. Contri¬ 
butions may be sent to the Peter 
Grannum M.D. Fund. Department of 
Obstetrics and Gynecology, Yale 
University School of Medicine, P.O. 
Box 3333, New Haven, CT 06510. 
Leona Baumgartner 
Langmuir 
Leona Baumgartner Langmuir. M.D., 
New York City's commissioner of 
health from 1954 to 1962, died Jan. 15 
in Chilmark, Mass, at the age of 88. 
Dr. Baumgartner joined the 
Department of Health in 1937 and after 
her appointment as first female commis¬ 
sioner, she was appointed assistant 
administrator of the Agency for Interna¬ 
tional Development. One of her last 
achievements as health commissioner 
was to win a political battle to fluoridate 
the city's water supply. In 1962, 
President John F. Kennedy appointed 
her to head the Office of Technical 
Cooperation and Research at the United 
States Agency for International 
Development, where she established a 
research advisory council to improve 
standards in grants for health and 
welfare programs worldwide. In 1966, 
she was named visiting professor of 
.social medicine at Harvard Medical 
School, a post she held until her 
retirement in 1972. 
A native of Chicago, Dr. 
Baumgartner received bachelor's and 
master's degrees from the University of 
Kansas and was a Rockefeller Research 
Fellow at the Kaiser Wilhelm Institute 
in Munich before winning a Sterling 
Fellowship to study at Yale, where she 
earned Ph.D. and M.D. degrees. Dr. 
Baumgartner has been honored with 14 
honorary degrees and numerous awards, 
among them the Sedgwick Medal and 
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Lasker Award of the American Public 
Health Association, of which she was a 
past president, and the Public Welfare 
Award of the National Academy of 
Sciences. She was an active member of 
several professional societies, including 
the Institute of Medicine and the Ameri¬ 
can Academy of Arts and Sciences. 
She leaves her husband. Dr. Alexander 
Langmuir, and six stepchildren. 
Memorial contributions may be sent to 
the Leona Baumgartner Student Loan 
Fund, Yale University School of 
Medicine, New Haven, CT 06510. 
Jacob Mellion 
Jacob Mellion, M.D., died Feb. 23 at the 
age of 93. 
Dr. Mellion served as the New 
Britain school system’s health director 
from 1927 until he retired in 1962. He 
continued as the high school’s team 
physician for 12 years after his 
retirement. A native of New Haven, 
Dr. Mellion was a 1923 graduate of Yale 
School of Medicine and a veteran of 
World Wars I and II, serving in North 
Africa and Italy. 
He is survived by his wife, Ethel; a 
daughter, Patricia Allen; and a 
grandson. 
Memorial donations may be made to 
Hadassah, c/o Mrs. Selma Zager, 231 
Lowery Place, Newington, CT 06111. 
Brigitte A. Prusoff 
Brigitte A. Prusoff, Ph.D., died April 4 
at Yale-New Haven Hospital at the age 
of 64. 
A native of Berlin, Germany, Dr. 
Prusoff had been a member of the Yale 
faculty since 1961 and was a founder of 
Yale’s Depression Research Unit. She 
was a research scientist in the genetic 
epidemiology research unit in the 
department of psychiatry. 
Dr. Prusoff received a master’s 
degree in biometry from the department 
of epidemiology and public health at 
Yale in 1967 and a doctoral degree in 
epidemiology in 1978. Dr. Prusoff was 
the recipient of the American 
Psychiatric Association’s Foundation 
Fund Prize and the Anna Monika Foun¬ 
dation Prize. She was an editorial 
consultant for several psychiatric 
publications as well as a member of 
numerous professional organizations. 
She leaves her husband. Dr. Wiliam 
H. Prusoff; a son, Alvin; a daughter, 
Laura; and three grandchildren. 
OBITUARIES 
Henry K. Silver 
Henry K. Silver, M.D., a pediatrician 
who developed pioneering programs in 
the 1960s, died Jan. 13 at LIniversity 
Hospital in Denver. He was 72. 
Dr. Silver joined the faculty at the 
University of Colorado School of 
Medicine in 1957 after teaching at the 
University of California Medical School 
and Yale School of Medicine. 
He was a 1942 graduate of the 
University of California at Berkeley 
Medical School. In 1964 he developed 
the first national program for nurse- 
practitioners and also instituted a 
program at the University of Colorado 
to train students as physicians’ 
assistants specializing in pediatrics. 
Since 1978 he served as associate dean 
of admissions at the University of 
Colorado Medical School. 
In 1985, he conducted a study of 
abuse of medical students by faculty 
members and supervisors and in 1990, 
co-authored a study revealing that 80 
percent of the students in one medical 
school reported some form of verbal, 
physical or sexual abuse. 
He is survived by his wife, Harriet; 
and a son, Andrew. 
Hoyt C. Taylor 
Hoyt C. Taylor, M.D., died Jan. 4 at 
Martin Memorial Hospital in Palm City, 
Fla. He was 79. 
Dr. Taylor, a Connecticut native, was 
a graduate of Norwich Academy and 
received his bachelor’s and master’s 
degrees from Wesleyan University. In 
1938, he received an M.D. degree from 
Cornell Medical School and served for 
two years on the house staff at the New 
York Lying-in Hospital. He transferred 
to New Haven Hospital where he served 
a residency and was an instructor in 
obstetrics and gynecology at Yale. 
During World War 11, Dr. Taylor 
served with the advanced amphibious 
units in England, and upon his return 
was appointed head of the department of 
gynecology at Chelsea Naval Hospital, 
Mass. He later opened his own practice 
in Meriden, Conn., which he retained 
for 25 years and was chief of ob/gyn at 
Meriden-Wallingford Hospital for 15 
years. He was a founding fellow of the 
American College of Obstetrics and 
Gynecology and American College of 
Surgeons and a member of the 
Connecticut Medical Society, the Amer¬ 
ican Medical Association and the 
Marting County Medical Society. 
He is survived by his wife, Dorothy; 
three daughters, Deborah Gaffney, 
Jacqueline Vineis and Patricia 
Linthicum; two stepsons; four 
stepdaughters; and 21 grandchildren. 
David Weinman H 
David Weinman 11, M.D., died Feb. 2 at 
his home in California at age 82. 
A native of New Mexico, Dr. 
Weinman received a B.A. degree from 
Columbia College in 1929 and an M.D. 
degree from the University of Paris in 
1935. 
Dr. Weinman, professor emeritus of 
epidemiology at the School of 
Medicine, held positions at Harvard 
University Schools of Medicine and 
Public Health, Columbia College of 
Physicians and Surgeons, and the 
University of California, San Francisco, 
Medical Center. He was a consultant to 
the American Medical Association 
council on drugs and a member of the 
World Health Organization Expert Panel 
on Parasitic Diseases. 
Warren H. Weiswasser 
Warren H. Weiswasser, M.D., M.P.H., 
died in his home in Orange, Conn, on 
Eeb. 18, at age 46. 
Dr. Weiswasser had been a 
pediatrician associated with the 
Community Health Care Plan Inc. in 
New Haven since 1977. He also served 
several positions with the Quality 
Assurance Network Committee, includ¬ 
ing medical director and chaimian. 
A native of Detroit, Dr. Weiswasser 
graduated from Monteith College and 
the University of Michigan Medical 
School. He received a master’s of public 
health degree from the University of 
Washington. 
Dr. Weiswasser held a clinical 
faculty appointment at the School of 
Medicine and was a member of the 
Mayor’s Task Eorce on AIDS in New 
Haven. 
He is survived by his wife, Janet; two 
sons, Charles and Michael; and a daugh¬ 
ter, Julie. 
Contributions may be made to the 
Child Development Unit, Yale Child 
Study Center, P.O. Box 3333, New 
Haven, CT 06510. 
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IN MEMORIAM 
William Cohen '23 M.D. Edward W. Holland '32 M.D. Frank J. Kenney Jr. '55 M.D. 
December 3, 1990 July 5,1990 August 13,1991 
Jacob Mellion '23 M.D. Raymond E. Miller '33 M.D. Charline S. Buck '55 M.P.H. 
February 23, 1991 December 25,1990 December 5,1990 
John J. Batchelor '24 M.D. John J. Wolfe '33 M.D. James F Schwartz '56 HS 
.lanuary 8, 1991 April 21,1990 October 1990 
Wilfred S. Clark '25 HS William R. Sweetman '34 M.D. Robert T. Miller '58 HS 
September 18, 1989 December 3,1990 June 3,1990 
Dorence S. Cowles '25 M.D. Edward F. Falsey '35 M.D. Edward H. Futterman '59 HS 
December 13, 1990 November 3,1990 March 23,1991 
Ernesto Icaza '27 M.D. Frederick A. Post 
April 1990 
'36 M.D. Edward A. Janasz '61 M.P.H. 
Sander E. Lachman '27 HS Gary Van Galder '63 M.D. 
November 2, 1988 Carl J. Tracey 
August 7,1989 
'36 ex med January 31,1990 
George C. Wilson '28 M.D. Leland S. Berger '64 M.D. 
December 28, 1990 Byron C. Smith 
December 5,1990 
'38 HS May 4,1990 
John W. Cass Jr. '29 M.D. David R. Stewart '65 HS 
May 10, 1990 Howard B. Rindge 
December 12,1990 
'39 ex med October 1986 
Lydia G. Dawes '29 M.D. Edward 1. Sweet '69 HS 
December 4, 1990 Knute E. Berger 
December 24, 1990 
'41 M.D. December 21,1988 
Paul H. Lavietes 
December 27, 1990 
'30 M.D. 
William I. Lourie Jr. '41 M.P.H. 
Michael L. Stratton '72 HS 
September 19, 1990 
Peter A. Grannum '76 HS 
Helen R. Gilmore '31 M.D. 
Samuel W. Budd Jr. '42 M.D. 
January 21,1991 
James W. Reed '31 M.D. 
January 21, 1991 
Warren H. Weiswasser 'll HS 
,luly 10, 1990 
Wilson E. Hughes '42 M.D. 
February 18,1991 
Winfield L. Butsch '32 HS 
June 2,1990 
Samarjit Ghuman '84 HS 
October 24, 1989 August 1989 
Charles W. Lloyd '45 HS 
George H. Burke '50 HS 
June 1,1990 
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79 YEARS OF SERVICE 
(j.D. Edit!} Hsuing. Fli.D., professor enter it us of laboratory medicine, shares a 
Student Research Day program with second-year student Eileen Deignan. In 1990. 
Ms. Deignan received the first research fellowship named in honor of Dr. Hsuing. 
a db-year faculty member. 
ERH registrar Vera Wardlaw checks the commencement schedule with Eric U. 
Mood. M.F.II.. who has been a lecturer in environmental health for 43 years. 
4S Yale; Medicine Summer 1991 
CONTINUING MEDICAL 
EDUCATION AT YALE 
Friday The Children’s Hospital at Yale-New Haven Hospital Annoiinees (A) 
Sept. 13, 1991 the First Annual Conference on Congenital Heart Disease 
Director: Michael Dewai'. M l). 
Friday-Satlirday Visiting Lecture Series in Clinical Ophthalmology (B) 
Sept. 27-28, 1991 Director: David E. Silverstoiie, M.D. 
Speaker: Melvin Rtihi)i, M.D. 
Will focus on the update of ophthalmic optics. 
Friday-Saturday Neurobiology of Affective Disorders (C) 
Oct. 25-26, 1991 Director: George K. Aghajanian. M.D. 
Primary focus will be upon underlying brain mechanisms and the mechanism(s) of action 
of antidepressant and antimanic drugs. 
Thursday Third Annual Cardiology Update (D) 
Oct. 30, 1991 Director: Lawrence S. Cohen. M.D. 
Thursday-Friday Cell Biology and Membrane Transport Process (E) 
Dec. 5-6, 1991 Director: Michael .1. Caphin. M.D.. Ph.D. 
CIRCLE THE APPROPRIATE LETTER(S) ON THE ATTACHED POSTCARD TO OBTAIN MORE INEORMATION ON 
CONEERENCES DISCUSSED IN THIS ISSUE. PLEASE BE SURE TO INCLUDE YOUR NAME AND ADDRESS. 
Yale Medicine 
350 Congress Avenue, 3-D 
P.O. Box 3333 
New Haven, CT 06510-8011 
Address Change Requested 
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Farewell to Yale 
Editor’s note: As of August 31, Leon E. 
Rosenberg, M.D., resigned as medical 
school dean to begin his new post as 
president of the Bristol-Myers Squibb 
Pharmaceutical Research Institute. The 
following letter, dated Aug. 28, was dis¬ 
tributed to the medical school commu¬ 
nity. For further news about Dr. Rosen¬ 
berg’s departure, turn to Faculty News, 
page 32. 
To members of the Yale School of 
Medicine community: 
As I prepare to depart after 26 years as a 
member of the Yale faculty, the leave 
taking is even more difficult than I 
anticipated. The unexpected offer from 
Bristol-Myers Squibb has left little time 
to prepare emotionally, or even to say 
goodbye to the many people at Yale 
who have made these years so reward¬ 
ing and enjoyable. I will miss the many 
talented and dedicated people of this 
school — faculty, students, staff, alum¬ 
ni, friends — who create a richly woven 
tapestry of competence, humane ideals, 
and personal warmth. 
During the past seven years as your 
dean I have been deeply moved by the 
spirit of community demonstrated by so 
many people. It has enabled us together 
to build on Yale’s tradition of excellence 
in medicine and to enlist new friends 
and partners to move this great institu¬ 
tion forward. I am proud of our accom¬ 
plishments. There have been new build¬ 
ings and programs, of course; even 
more gratifying is the knowledge that 
we have added strong new leaders in the 
departments and offices, recruited 
superb scientists, teachers, and clini¬ 
cians, and voiced loudly our support for 
such values as fairness, decency, toler¬ 
ance, integrity, and excellence. 
What first attracted me to the world 
of science was the limitless challenge 
that lies before us. My next assignment 
will be a fresh approach to that chal¬ 
lenge. As president of the Bristol-Myers 
Squibb Pharmaceutical Research Insti¬ 
tute, I will continue to pursue three 
career-long themes: developing young 
scientists; using medical science to 
improve human health; and building a 
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strong, cohesive research organization. 
Further, I hope to take part in creating 
new avenues of cooperation among 
industry, government and universities. 
Our nation’s strength in biomedical 
research is the envy of the world. We 
must utilize our resources yet more effi¬ 
ciently to improve health and to reduce 
suffering. 
The decision to leave Yale is the 
most difficult decision of my profes¬ 
sional life. My years as a faculty 
member, department chair, and dean 
have taught me over and over again 
what a great center of teaching, discov¬ 
ering, and serving Yale is. This decision 
turns a major page in my life’s book and 
those of my family. It will also mean 
changes and challenges for those I leave 
behind at Yale. Bob Donaldson, the 
associate deans, the department chairs, 
and administrative directors will need 
your cooperation more than ever before. 
You can depend on Benno Schmidt to 
lead an exemplary search for my succes¬ 
sor. He has always been a great advo¬ 
cate of the School of Medicine and he 
understands well the importance of this 
moment in the School’s evolution. 
Although Diane, Alexa, and I will be 
moving to Princeton on September 1, 
we will keep our home in Guilford. That 
will enable us to maintain close ties to 
our many friends here. Please know that 
we are grateful for the many kindnesses 
you have shown us. Most of all, I thank 
you for your part in making Yale the 
special place it continues to be. 
Leon E. Rosenberg, M.D. 
Corrections 
In the Summer 1991 YALE medicine, on 
page 2, an editing error mistakenly 
named the White Mountains for the 
Green Mountains of Vermont. Also, the 
caption on page 4 misspelled the first 
name of Etsuro Motoyama, M.D.; our 
apologies. Harry Bishop should have 
been credited for photographs appearing 
on pages 14, 15, 16 and 18. Finally, in 
Alumni News on page 41, Dr. Michael 
H. Owens, M.D. ’78 is medical director 
for CIGNA Private Practice Plan, 
CIGNA Healthplans of California, a 
120,000-member health care delivery 
system serving the Los Angeles area. 
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An EPH Issue 
A. C. Gilbert (left) in medical school: fascinated by how things work. 
To the editor: 
I am a 1951 graduate of the Department 
of Public Health as it was known when I 
attended. All these years I have received 
and read Yale Medicine and enjoyed it. 
The FallAVinter 1990-1991 issue 
provokes this note. At no time in the 
past, at least to my recollection, was so 
much space devoted to our School of 
Epidemiology and Public Health. I am 
greatly pleased and so wished to 
express. 
Many thanks. 
Leonard F. Menczer, D.D.S., M.P.H. '51 
Hartford. Conn. 
AIDS Statistics 
To the editor: 
On page 15 of the Summer 1991 Yale 
Medicine “AIDS Research at Yale: 
Shifting into High Gear”), the table 
mentions “one in 200 Connecticut resi¬ 
dents is infected with HIV, roughly the 
same as the national rate.” And then 
above, “the [Centers for Disease Con¬ 
trol] listed 174,843 Americans who 
have had AIDS...” 
Now, 174,893 times 200 equals 
approximately 35 million — not 250 
million Americans. How come? Can it 
be that the natural incidence of AIDS is 
closer to one in 2,000? 
Francis Coughlin, M.D. '52 
New Canaan. Conn. 
Editor’s reply: Your calculation is in¬ 
valid because it mistakenly equates the 
HIV infection rate with the incidence of 
full-blown AIDS. The CDC statistic pro¬ 
vided in the article listed the number of 
reported cases of symptomatic AIDS in 
the United States: the one-in-2()() figure 
for Connecticut, quoted from the state 
Department of Health's “AIDS in Con¬ 
necticut Annual Surveillance Report,” 
estimates the number of people who 
have been infected with HIV. With a 
latency period of up to seven years or 
longer, not every person who tests posi¬ 
tive for HIV antibodies e.xhibits symp¬ 
toms of AIDS. 
As for national HIV infection statis¬ 
tics. the National HIV and AIDS Infor¬ 
mation Service of the American Social 
Health Association estimates that 
roughly one million Americans are HIV¬ 
positive. Given a population of 250 mil¬ 
lion. that would put the estimated inci¬ 
dence of HIV infection at one in 250. 
Alumnus A.C. Gilbert 
Recalled at Exhibit 
On Sept. 22, the Eli Whitney Museum 
in Hamden, Conn., opened a nine- 
month exhibition, “A.C. Gilbert and the 
Tools of Learning.” The museum, 
located on the site of Eli Whitney’s gun 
factory, is celebrating the legacy of 
Alfred Carlton Gilbert, M.D. ’09, with a 
display of Erector sets. American Elyer 
trains, chemistry sets, magic kits and 
other Gilbert inventions, which were 
manufactured in New Haven. 
Bom in Salem, Ore., in 1884, A.C. 
Gilbert excelled in many fields. As a 
Yale undergraduate, he was an accom¬ 
plished athlete, establishing records in 
wrestling and gymnastics. In the pole 
vault, he replaced the traditional hickory 
pole with spineless bamboo and won an 
Olympic gold medal. 
No less skilled at sleight-of-hand, 
Gilbert paid for his university education 
by putting on magic shows. In his last 
year at Yale, he received as much as 
$100 per performance, a considerable 
sum for the time. A few months before 
he graduated with his medical degree, 
he and a fellow magician formed the 
Mysto Manufacturing Company to pro¬ 
duce and distribute magic sets. Their 
modest enterprise presaged far greater 
things to come. 
When A.C. Gilbert earned his degree 
from the School of Medicine, he 
intended to start a career as a physical 
education instructor. Soon after gradua¬ 
tion, though, he succumbed to the lure 
of invention — especially toys — a pas¬ 
sion that dominated the rest of his life. 
By age 77, when he died, he held more 
than 150 patents. 
In 1916, the inventor parted ways 
with his partner and the company 
became his namesake. By the mid- 
1940s, the A.C. Gilbert Company could 
boast that it was the world’s largest toy 
manufacturer. At its peak, the company 
employed 2,500 at its site in the Eair 
Haven section of New Haven. 
Dr. Gilbert’s most successful and 
best known creation was the Erector 
Set, comprising miniature steel girders 
that children used to fashion buildings, 
airplanes, automobiles and other struc¬ 
tures. This toy may have been the most 
popular in history; at the company’s 
50th-anniversary celebration, employ¬ 
ees presented its founder with a gold- 
plated Erector Set representing the 10- 
millionth unit sold. 
A turning point came when the first 
“television generation” failed to display 
the affinity for A.C. Gilbert toys that 
their parents and grandparents had. The 
company’s sales declined throughout 
the 1950s. When the great inventor died 
in 1961, his company passed away with 
him. 
For millions of adults in their middle 
years and older, however, the name A.C. 
Gilbert still conjures up the nostalgic 
sound of a toy train whistle and the 
image of an Erector Set town diffused in 
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WHY YOU ARE HERE 
hy Robert M. Donaldson Jr., M.D. 
What a wonderful day this is for the School of Medicine. What 
could be more exciting for Dean Gifford and his student affairs 
office, or more rewarding for the admissions committee, than 
to see all in one room this group of such marvelous individuals 
whom they have worked so long and so hard to identify and 
recruit to Yale. 
Let me tell you something about yourselves — and I’m 
most grateful to Lynne Wootton, director of admissions, for 
compiling this information. You number 59 men, 41 women. 
Your diversity is remarkable. There are among you 11 African- 
Americans, one native American, four Americans of Hispanic 
origin and 25 Asian-Americans. Your origins are truly interna¬ 
tional, with families coming from countries on every inhabited 
continent of this planet. 
Nine of you have already received advanced degrees — in 
disciplines as different as public health, engineering and 
music. Forty-five of you seriously pursued other endeavors 
before entering medical school. You have worked as engineers, 
photographers, bartenders, computer programmers, emergency 
medical technicians, writers, instructors, security officers, edi¬ 
tors, truck drivers, lifeguards, cashiers, secretaries, sales repre¬ 
sentatives, word processors and phlebotomists. Among you are 
a management consultant, a financial analyst, a genetic coun¬ 
selor, an architect and a dockmaster. 
You have worked in all sorts of settings, from radio stations 
to children’s theaters, even a planetarium. One of you ran his 
own landscaping business for a decade. Another worked as a 
health planner and community development specialist for the 
Muscoge Creek Indian Nation. You have volunteered not only 
in hospital emergency rooms, but in shelters for battered 
women, soup kitchens, suicide prevention centers. Headstart 
programs, and many other programs and facilities for the dis¬ 
advantaged and underserved. You have helped the homeless, 
the handicapped and patients with AIDS. You possess a wealth 
of musical talent and have played in orchestras and chamber 
groups, and one of you formed a band which had three world 
tours and two albums. 
You have received numerous prizes and honors. One of you 
was recently elected to serve on the board of trustees of your 
undergraduate college. You have conducted independent stud¬ 
ies in the finest laboratories and research institutes in this 
country. You have investigated and published on everything 
from French history, to astronomy, to medical ethics. 
You must be very proud of all you’ve accomplished and, 
yes, we really are lucky to have you here. What all of us 
should do right now is simply celebrate. But this is also the 
real world, a place of hard facts, and before we celebrate, we 
must get oriented. 
I realize how stressful orientations can be. As you confront 
stark realities that never before entered your mind, I suspect 
that by now some of you may be asking yourselves, “Is this 
This article is based on an address delivered on Aug. 29 hy 
Acting Dean Robert M. Donaldson Jr. to the incoming School 
of Medicine Class of 1995. 
where I really want to be? Why am I here at the Yale School of 
Medicine?” 
Let me presume to tell you why. First and foremost, you are 
here because this school acknowledges your maturity. This 
means that the responsibility for your education belongs to you 
and to you alone. Ever since first grade, you have lived with an 
educational paradigm in which you were provided with a 
defined body of information and then graded on your capacity 
to comprehend, retain and regurgitate that information. That 
educational paradigm no longer applies. 
In the first place, the biomedical sciences embrace a rapidly 
changing database far beyond what even extraordinary talents 
such as yours can assimilate in four short years. Moreover, 
medicine is far too important a discipline to be learned merely 
for the sake of grades, no matter how valid the grading system 
may be. No, you are here to learn for yourselves, for your 
future and for your patients. 
At the Yale School of Medicine you will not spend four 
years filling your brains with as many facts as possible. 
Instead, you will begin a lifetime of study. You will learn how 
to learn, how to find the information you need, how to judge 
the quality of data and how to interpret them and, most impor¬ 
tant, how to challenge the many so-called “facts” you will con¬ 
front. 
This leads me to a second reason why you are here: for the 
excitement of generating new information, coming closer to 
the truth and not just passively accepting what we tell you. 
Most of you will gain this experience from a required doctoral 
thesis completed during four years of medical school. Judging 
from previous classes, I would guess that about 20 of you will 
become excited enough to spend a fifth year on a major project 
and that 11 of you will be so committed to academic careers 
that you will invest the several years needed for the combined 
M.D., Ph.D. degree. 
Third, you are here because your marvelous backgrounds 
and experiences will enrich each other and enrich this place. 
You will work together in small groups, learning not only from 
a large and talented faculty, but also from each other. There are 
in fact among you several talented experienced teachers who 
have been teaching in elementary schools, secondary schools, 
colleges, and even in the School of Public Health at Yale. 
Undoubtedly, the best way to truly master a subject is to teach 
it, and you will all be teaching each other in a variety of set¬ 
tings from the seminar room to the clinic to the bedside. 
What I have been talking about is the Yale System of medi¬ 
cal education, which has been with us for more than half a cen¬ 
tury. Our colleagues at Harvard have recently unveiled what 
they proudly call “the new pathway;” we are equally proud of 
our old pathway. Although long with us, the Yale System is 
unquestionably alive and well. 
You should understand one hazard of the Yale System, 
however. Learning how to learn for a lifetime, learning at your 
own pace, and being responsible for your own education does 
not add up to a journey through some sort of educational lotus 
land. You will, in fact, work very hard to meet very difficult 
educational challenges. 
After all, the fourth reason you are here is because this 
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Robert M. Donaldson Jr. 
Appointed YSM Acting Dean 
The trustees of the Yale Corporation have approved the 
appointment of Robert M. Donaldson Jr., M.D., as acting dean 
of the School of Medicine. Dr. Donaldson, the David Paige 
Smith Professor of Medicine, succeeds Leon E. Rosenberg, 
M.D., who resigned, effective Sept. 1, to assume the presi¬ 
dency of Bristol-Myers Squibb Pharmaceutical Research 
Institute, based in Princeton, N.J. 
Yale President Benno C. Schmidt Jr., who heads the faculty 
search committee to find Dr. Rosenberg’s successor, com¬ 
mented; “1 am very pleased that Dr. Donaldson will ably lead 
our medical school as we conduct our search for a new dean. 
The 16-member search committee which I chair is hard at 
work on its task, and we hope to appoint a new dean by next 
July. Yale is fortunate to have an experienced and distin¬ 
guished physician, scientist and administrator in Bob Donald¬ 
son to carry forward the medical school’s tradition of excel¬ 
lence during this year.” 
A gastroenterologist. Dr. Donaldson has served as the med¬ 
ical school’s deputy dean since 1987 and on the Yale faculty 
since 1973. During his career, he has been chief of the medi¬ 
cal service at the Department of Veterans Affairs Medical 
Center in West Haven and vice chairman and acting chairman 
of internal medicine. 
Dr. Donaldson has conducted research on the role of cer¬ 
tain bacteria in digestion and in diseases that cause the mal¬ 
absorption of nutrients. He holds a special interest in the 
basic mechanisms in the absorption of vitamin B12. The 
acting dean’s clinical studies relate to peptic ulcer disease, 
chronic liver disease and the ways physicians use diagnostic 
technology. His research is cited in more than 100 publica¬ 
tions. 
From 1967 to 1972, Dr. Donaldson chaired the advisory 
committee for National Institutes of Health (NIH) training 
programs in gastroenterology and nutrition. There he devel¬ 
oped the concept of 
a clinical investiga¬ 
tor (young scien¬ 
tist) award that the 
NIH would spon¬ 
sor. For his out¬ 
standing contribu¬ 
tions to the field of 
gastroenterology. 
Dr. Donaldson was 
awarded the 
Friedenwald Medal 
by the American 
Gastroenterologi¬ 
cal Association. 
Active in scien¬ 
tific publishing. Dr. 
Donaldson edits the 
journal Current 
Opinion in Gas¬ 
troenterology and 
serves on the edito¬ 
rial board of the 
New England Jour¬ 
nal of Medicine. He 
also edited the jour¬ 
nal from 1970 to 1977. 
A past president of the American Gastroenterological 
Association, Dr. Donaldson was elected to the American Soci¬ 
ety for Clinical Investigation and the Association of American 
Physicians. Between 1984 and 1990, he was a member of the 
American Board of Internal Medicine and served on its exec¬ 
utive board in 1987. 
A native of Wellesley, Mass., Dr. Donaldson received a 
B.S. degree from Yale College in 1948 and an M.D. degree 
from Boston University School of Medicine in 1952. He 
received his clinical and post-doctoral training at the Montreal 
General, Boston Veterans Administration and Peter Bent 
Brigham hospitals. 
school enjoys an excellent reputation. That reputation is no 
accident. We identify and recruit students like you who have 
enomious potential for excellence, mix those students together 
with a large, first-rate faculty, add in an outstanding library, 
make available a wide array of patients, and then impose the 
highest standards of excellence on the outcome. How well you 
fulfill your astonishing potential for excellence will be a matter 
of serious concern to you and to this school. 
You cannot really learn how to evaluate data without seri¬ 
ously confronting those data. You cannot truly challenge 
knowledge without the hard work that goes into fully compre¬ 
hending what it is you wish to challenge. As is true for any 
enterprise, you will get out of your Yale medical education 
exactly what you put into it, nothing more, nothing less. 1 urge 
you to immerse yourself totally in this exciting educational 
enterprise. Those who do not run the real danger of getting lost 
in the shuffle. 
The fifth reason you are here is to bring to this place your 
diverse racial, ethnic and cultural backgrounds. They are 
essential for the kind of sensitivity and compassion needed to 
care for the poor and for members of disadvantaged minorities. 
You will have ample opportunity not only to involve yourself 
in the care of such patients, but to heighten everyone’s aware¬ 
ness of the special needs of those who are not only ill but who 
are made especially vulnerable by poverty and bigotry. 
Nothing elevates the quality of medical care more than this 
kind of awareness. Therefore, at the very beginning of your 
medical school career, you will participate actively in work¬ 
shops designed to promote awareness of. sensitivity to and 
respect for cultural differences, attitudes which are absolutely 
crucial to the credibility of this medical center as a place of 
healing. 
Finally, you are here because this school is situated in a 
community that will challenge you to grow rapidly and well, 
both personally and professionally. You will soon find your¬ 
selves confronting the serious and complex health needs of 
New Haven and, like your predecessors, you will meet those 
needs with innovative solutions. 
These, then, are the reasons you are here. You are here in 
essence to make a real difference — in yourselves, in this 
school, in this community and ultimately in the nation. These 
are also the reasons 1 am so proud to welcome you and to wish 
you well as you take advantage of the most exciting challenges 
and opportunities you’ve ever had. YM 
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PHYSICIAN-SCIENTISTS 
A VANISHING BREED 
hy Francis S. Collins, M.D., Ph.D. 
“The physician-scientist is an ‘endangered species.”' 
An article bearing this disturbing title appeared 12 years 
ago in the New England Journal of Medicine. It was written by 
Jim Wyngaarden, who subsequently became head of the 
National Institutes of Health (NIH). In the intervening years, 
matters have gotten even worse — a decreasing number of 
physicians are playing a meaningful role in basic science. 
To define my terms, I refer to a physician-scientist as some¬ 
one who runs a laboratory and who has funding from a grant¬ 
ing agency. I distinguish this activity from routine therapeutic 
trials. While acknowledging the latter as crucial, I think M.D.s 
carrying out such trials are less likely to disappear from our 
ranks; it is difficult to imagine clinical trials being conducted 
solely by Ph.D.s. The group I am concerned about are physi¬ 
cian-scientists who are involved in more basic research, and 
who are trying to balance its challenges with the roles of 
physician and teacher. 
A Matter of Style_ 
The gap is widening between research and clinical practice, as 
is the related rift between Ph.D.s and M.D.s. Although Ph.D.s 
and M.D.s have traditionally approached basic research from 
different perspectives, the alienation between the two camps 
seems to be getting worse. 
Inevitably, tensions arise from fundamental differences in 
job description. By way of illustration, consider the following 
two vignettes. They might unfold on any day at a leading med¬ 
ical center: 
John Doe, M.D., a fellow in hematology!oncology, is 
working late at night. He has just admitted a female patient 
with chronic granulocytic leukemia who has gone into blast 
crisis. She is bleeding, and has a high fever. Wasting no 
time. Dr. Doe works up the patient and searches for some 
source of the fever. When he fails to find one, he obtains the 
appropriate cultures and administers broad spectrum 
antibiotics, knowing that to wait for a precise diagnosis of 
the infectious cause is tantamount to signing this patient's 
death warrant. 
Dr. Doe explains to the patient, and later to her anxious 
family, the seriousness of the situation, the fact that even if 
the crisis passes, the chances of long survival are bleak. He 
discusses these issues at length with the family; they pour 
out their fears and their grief. 
Dr. John Doe crawls into bed about 3:00 a.m. feeling 
thoroughly drained. Though the physician may not thor¬ 
oughly realize it, however, something important has tran¬ 
spired during the time he spent with the patient and her 
family trying to sift through these new developments. I’ll 
return to this point later. 
Dr. Francis S. Collins 
Francis S. CollinSy M.D.y Ph.D.: 
Award-winning Geneticist 
Dr. Francis S. Collins played a leading role in the discov¬ 
ery of the cystic fibrosis gene, a contribution that won him 
the 1990 Paul di-Sant’Agnese Distinguished Achievement 
Award from the Cystic Fibrosis Foundation. A year later, 
his research group identified the gene for neurofibromato¬ 
sis. A professor of internal medicine and human genetics 
at the University of Michigan, he also is an investigator 
with the Howard Hughes Medical Institute. In 1974, he 
received his Ph.D. degree in physical chemistry from Yale 
and in 1977, his M.D. degree from the University of North 
Carolina. He returned to Yale for a post-doctoral fellow¬ 
ship in human genetics after completing his internship and 
residency at North Carolina Memorial Hospital. 
This article was based on an address Dr. Collins delivered to 
University of Michigan medical school graduates at the 
Honors Convocation, May 1990. 
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Now let’s turn to the second vignette: 
Little does Dr. Doe know that earlier in the day. in a 
building adjacent to his hospital. Jane Smith. Ph D., was 
hard at work in a research lab. trying to understand the 
molecular basis of chronic granulocytic leukemia. Dr. 
Smith is studying the peculiar protein which is produced in 
this disease when chromosome 9 sequences are fused to 
chromosome 22 sequences (the Philadelphia chromosome), 
and a funny hybrid protein that contains part of an onco¬ 
gene called abl gets produced. She has deduced that this 
protein works as an unrestrained tyrosine kinese. which 
means it goes around adding phosphate groups to other 
proteins. 
Dr. Doe rolls over with a sigh and enters an uneasy 
sleep. Dr. Smith returns to her apartment after having cele¬ 
brated the evening with her research team. After years of 
tedious work, she has finally identified the mechanism that 
will provide the crucial link in understanding how this 
translocation, this rearrangement of chromosomes, leads to 
malignancy. 
While it is certainly true that society was well served by 
both these professionals, I suggest that it would have benefit- 
ted even more if Drs. Doe and Smith had been the same person 
in two parts of his or her daily activity. In the first story, it may 
have been an extraordinary comfort for the family to know that 
their physician was doing research into the possible cause of 
their loved one's disease. In vignette two, I suspect that the 
insights which the Ph.D. obtained in the lab would have been 
more meaningful — and potentially more immediately trans¬ 
lated into therapeutic ideas — if she were also personally 
familiar with the ravages of the di.sease. 
M.D. Alienation 
Our widening gulf between the M.D. physician and the Ph.D. 
researcher contributes, 1 think, to the .sense that many M.D.s 
have that they don't belong in basic research. They are not 
always treated kindly by Ph.D.s, and are often looked down 
upon in the laboratory as second class. Similarly, Ph.D.s, when 
they try to understand the clinic, are often not treated kindly. 
An insightful article called “Cultures in Conflict: M.D.s and 
Ph.D.s.” appeared in the New York Times in April 1990. It was 
written by Natalie Angier, who has since won the Pulitzer 
Prize for her medical and science reporting. In the article, Ms. 
Angier contrasted a Ph.D. molecular biologist, in this case 
Richard Mulligan at M.I.T., and an M.D. pediatrician, Kenneth 
Culver, who works in gene therapy at the NIH. 
Ms. Angier writes: 
Thirty years ago the British scientist and novelist C.P. 
Snow wrote Two Cultures (about the philosophical gap 
between the humanities and the sciences). Today another 
sort of cultural rift seems to deny union or even comity, the 
gap between the doctor and the scientist. In the biomedical 
community, physicians and Ph.D.s alike are probing the 
fundamental mechanisms that underlie human disease, 
health and development. Sometimes the doctors and the sci¬ 
entists work side-by-side in a research laboratory or at 
least on the same university floor. But by training, philoso¬ 
phy. motivation and research style, doctors and scientists 
might as well be from different phyla. And they are forever 
arguing about which is the more highly evolved. 
I’hough this passage may overstate the case a bit, it does 
effectively evoke the differences in mindset that the physician 
must carry to the hospital ward versus what the scientist takes 
into the laboratory. Sometimes those mindsets can get in the 
way of those who are trying to be healers as well as basic 
researchers. 
Note that John Doe, M.D., had to make a decision about 
treating his patient with antibiotics without really knowing 
what was going on. The usual situation in clinical medicine, in 
fact, is that the information one deals with is woefully incom¬ 
plete and uncertain. It is a rare circumstance indeed where doc¬ 
tors are absolutely sure that they are doing the right thing. Suc¬ 
cessful physicians eventually learn to live with this 
uncertainty. It is the best that you can do. 
But this is very different from the approach one must take 
to carry out good science. In that setting, one must never be 
satisfied with information that is incomplete, inadequate or 
lacking. Physicians, however, can sometimes stumble when 
they try to transfer their clinical thought processes into sci¬ 
ence, as they may be inadequately critical of the data. The data 
have to be more solid. 
Another contrast that emerges from the John Doe-Jane 
Smith vignettes is the importance of defining precise causa¬ 
tion. A physician treating a patient with chronic granulocytic 
leukemia is usually not concerned with the chromosome 9 to 
chromosome 22 translocation, no matter that this is the cause 
of the disease. The physician is not concerned because thera¬ 
peutically, there is nothing he or she can do about it. 
By contrast, to a scientist, fundamental causes are what it’s 
all about. A scientist is driven by the desire to understand for 
understanding’s sake. If that eventually leads to a therapy, so 
much the better. 
The final difference between John Doe and Jane Smith pre¬ 
sents itself in their source of satisfaction, and that is to my 
mind an enormous difference. A physician, at least as I per¬ 
ceive it from my own experience, gains satisfaction primarily 
from interacting with patients. Even in situations like the one I 
described, where what is offered therapeutically is far too inad¬ 
equate for the demands of the situation, the opportunity to 
enter the lives of patient and family, to interact with them and 
comfort them, and to explain a frightening event to them, pro¬ 
vides an immediate sense of gratification. It is a real gift to be 
able to share that experience with other people. 
Compare this with the scientist’s gratification, which is the 
joy of discovery. A key attribute of this joy is that it doesn’t 
come along every day. In most laboratories like mine, about 75 
percent of the experiments are a complete disaster. If you’re 
not prepared for that, you get frustrated rather quickly. It’s the 
25 percent that partially work that keep you going. If you’re 
fortunate, perhaps 1 percent actually make some new observa¬ 
tion, and that’s what makes it all worthwhile. 
This is different from the clinic, where almost every time 
that I see patients, talk with them about their diseases, and pre¬ 
scribe some course of treatment, I feel good about it. Physi¬ 
cians who try to play both the roles of healer and basic 
researcher have to constantly change their mindset to deal with 
those differences as they don their different hats. 
Such adjustments make it difficult for an unprepared physi¬ 
cian to enter research. Even when M.D.s do commit them¬ 
selves to the dual track, the differences in approach and expec¬ 
tations can prove discouraging. Fortunately, most of these 
problems can be avoided through proper training. 
Eluding the Pitfalls_ 
The problem with preparing physicians for research is twofold. 
First, as I just mentioned, in some ways the thought processes 
6 Yale Medicine FallAVinter 1991-92 
Office of Student Research 
Nurtures Physician-scientists 
Yale School of Medicine has a long tradition of educating 
physician-scientists; its M.D. thesis requirement, involv¬ 
ing original research, is one of the few such requirements 
in the country, and dates back to 1839. To facilitate stu¬ 
dents in writing the thesis, the student research office pro¬ 
vides monetary support which comes from private dona¬ 
tions and grants as well as from school and departmental 
sources. More than 150 full-time faculty members serve as 
mentors for student research activities and provide labora¬ 
tory space and equipment. 
The school’s One-year Student Research Fellowship 
Program, which supports students as they devote an entire 
year to research, has 14 students enrolled this year. As an 
added incentive to taking a fifth year, students are not 
charged tuition for the extra year. Funding for this program 
comes from government, charitable and private sources. 
Another program that encourages students to pursue a 
career in academic medicine is the M.D.-Ph.D. program, 
directed by James D. Jamieson, M.D., Ph.D., professor 
and chairman of cell biology. Since its inception in 1969, 
enrollment has grown from 14 students to 60. 
of the healer and the scientist are different. Second, physicians 
who try to do bench research often devote insufficient time to 
their training. No M.D. would dream of going out and practic¬ 
ing medicine after two years in medical school. But many 
physicians try to do research with only one or two years of 
experience in the laboratory, and that can be very frustrating. 
The issue of adequate training brings to mind the wonderful 
experience 1 had last year in meeting Dr. James Shannon, who 
was the director of the NIFI from 1955 to 1969, during its time 
of enormous growth. Many of the things that we look to with 
pride in this country’s biomedical research stem from Dr. 
Shannon’s vision and insight. He is now 86 years old. 
As he reminisced about his time as an assistant professor on 
a medical school faculty in the 1930s, he painted a dramati¬ 
cally different picture of medicine and biomedical research 
than we know today. Upon finishing his internship and resi¬ 
dency, Dr. Shannon was offered a job in a department of physi¬ 
ology without any significant research training. In the course 
of six years, he taught himself and published 19 papers, some 
of which are classics in the study of the glomerular filtration 
rate. On 17 of those papers he was the sole author. 
You would never see that happening in today’s world of 
complicated research. Basic scientists need more people to 
help them, and the scientists themselves need a more pro¬ 
longed period of training. We make a mistake, 1 think, by 
advising students and new physicians that they can get away 
with sketchy research training and still make a success of it. 
Why does all this matter? Do we really need physician-sci¬ 
entists anyway? Here I will cite a less enlightening experience 
1 had in 1984 at the major meeting of my specialty, human 
genetics. In the president’s address to the society, he asserted 
that we ought to retire the concept of the physician-scientist. 
It’s an idea whose time had passed, he asserted, impossible to 
do well. Therefore, it was time to dig the grave and bury the 
concept forever. 
His argument was a practical one, that you just can’t do it 
all and do it well. 1 must disagree, based on the large number 
of successful examples I see around me. 
In the John Doe-Jane Smith vignettes, I have already 
alluded to my philosophy on this issue. I would argue that the 
familiarity that a physician has with the clinical arena is abso¬ 
lutely critical for advancing the course of biomedical re.search, 
and brings to every problem a perspective that a basic scientist 
just will not have. 
If you still have doubts, 1 need only cite the example of 
Brown and Goldstein, who won the Nobel prize three years 
ago for their fundamentally important work on the LDL recep¬ 
tor. Joe Goldstein came to that problem initially from a clinical 
vantage point, trying to understand a disease called familial 
hypercholesterolemia. The field of receptor-mediated endocy- 
tosis and the area of lipid metabolism have been enormously 
advanced because this physician’s training led him to consider 
a clinical problem and then to investigate it in the laboratory 
with a healer’s perspective. 
I could cite many other examples. On a much smaller scale, 
my own interest in genetic diseases like cystic fibrosis and neu¬ 
rofibromatosis was first and foremost a clinical one. I felt com¬ 
pelled to move into the laboratory to try to understand these 
puzzling diseases that so ravaged those affected. Had I not had 
the clinical training, I would have worked on something else. 
Not only does clinical training lead to a new perspective in 
pursuing a problem, but I firmly believe that such training 
leads to an acceleration in converting new observations into 
therapeutic advances, which is what biomedicine is aiming for. 
Dr. Wyngaarden summarizes this point of view cogently: 
“The physician-scientist has a very special role, both in posing 
relevant medical questions and in applying new knowledge to 
the investigation of disease and the teaching of students. These 
roles cannot be adequately filled by Ph.D. scientists, however 
seminal their contributions may be.” 
Evidence of Crisis_ 
How are we physician-scientists faring? To illustrate briefly, I 
will quote some statistics that reveal who is receiving federal 
grant funding in biomedical science. 
Financial Support for 
YSM Student Research 
Endowed Research Fellowships 
In honor of: Edith Hsiung, James Hirsch, Vernon 
Lippard, Richard Hirschfield, Etta Chidsey and Richard 
Gershon. 
Student Research Program External Support 
American Heart Association (national and Connecticut 
affiliates), Connecticut Cancer Society, National 
Institutes of Health (NIH), Howard Hughes Medical 
Institute (HHMI), Juvenile Diabetes Foundation. 
One-year Student Research Fellowship Program 
(Five-year M.D.) 
American Heart Association (national and Connecticut 
affiliates), the NIH, HHMI, HHMI Cloister Program, 
Samoff Fellowship Award, Pathology Award, private 
sources. 
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In 1970, 51 percent of the grants awarded by the NIH were 
to Ph.D.s, 37 percent to M.D.s, and 6 percent to M.D.-Ph.D.s. 
In 1987, the proportion given to M.D.s dropped to 26 percent 
while that to Ph.D.s ro.se to 66 percent. From 37 percent to 26 
percent is a substantial drop, indicative of a real decline in the 
grant funding that the NIH is awarding to physicians. 
This really reflects a decline in submitted grants; if you 
look at the success rate of M.D.s and Ph.D.s in obtaining 
grants once they submit them, it has remained about the same 
over the course of time. Physicians who choose this course are 
in general no less successful in competing with Ph.D.s. 
I should add that there is great concern about the biomedi¬ 
cal research enterprise in general and the decrease in the NIH 
budget. We are in one of those unfortunate downward oscilla¬ 
tions which trouble working scientists greatly. I can only say 
that such oscillations have occurred before, and people have 
survived them. One of the things that 1 think we must not do is 
to terrify students by making the NIH funding crisis sound 
even worse than it is. 
What must we do to remove physician-scientists from the 
endangered species list? Medical schools need to be sure that 
they provide visible role models for students to show that it is 
in fact viable to be a compassionate physician involved with 
patients and also to run an effective, productive, laboratory 
research program. 
1 am happy to report that there are in fact many such indi¬ 
viduals at the University of Michigan, where I now serve on 
the faculty. I commend Yale and other leading medical schools 
that offer a plethora of physician-scientists as role models. 
1 would encourage medical students who are interested in 
possible careers as physician-scientists to study carefully the 
careers of such people as Joe Goldstein, who made a substan¬ 
tial commitment early on to learning basic research. Look at 
someone like Stuart Orkin, an enormously productive molecu¬ 
lar biologist and hematologist at the Boston Children's Hospi¬ 
tal, from whom I have learned much. He took the time to learn 
firsthand the “ins and outs” of molecular biology. 
Secondly, I would recommend to faculty members that we 
stop complaining so much about how dreadful it is to deal with 
these responsibilities of being both physicians and researchers. 
1 suspect that probably we enjoy it in some way, or we 
wouldn't be doing it. Although the research funding situation 
may seem a hit scary at the moment, it has been scary in the 
past, and we have survived nicely. 
Sometimes we behave like hens who fret so much that they 
step on all of the eggs. We really must not do that to the next 
generation of physician-researchers. We should strive to pre¬ 
sent a more balanced view, and to remind them also of the ben¬ 
efits of this life-style, which 1 perceive as substantial. 
Thirdly, we need to advise students realistically about 
what's involved in undertaking a career of this sort. One needs 
to have some serious time protected to learn bench research up 
close and personal. You can't run a lab in the future which 
does things that you yourself are not really familiar with. 
Many M.D. researchers never had the opportunity to learn this 
lesson, and have gotten into hot water as a result. 
Various tracks allow for excellent research training of 
M.D.s. Certainly M.D.-Ph.D. programs such as those at Yale 
and Michigan are a wonderful way to approach this problem. 
To those who were not so sure at medical school application 
that they wanted to do re.search, but now are tempted, plenty of 
tracks allow protected time to do research. 
Although 1 myself have an M.D. and a Ph.D., I completed 
my Ph.D. in physical chemistry, quantum mechanics, before 
entering medical school. I haven't used that part of my training 
a lot; every bit of what I know about molecular biology I 
learned as a fellow at Yale in a three-year period after finishing 
my residency. 
As I worked with Sherman M. Weissman, M.D., that fel¬ 
lowship provided excellent clinical training in genetics, and 
very solid training in bench research. During those three 
invaluable years, I spent about 80 percent of my time in the 
laboratory. 
At the University of Michigan, I have joined with col¬ 
leagues in trying to establish a two-year residency program 
followed by a research-oriented fellowship. Such programs are 
an excellent way to avoid the problem of physician-scientists 
finding themselves old and gray by the time they complete 
their training. 
Such an approach would complement a wonderful fellow¬ 
ship program at Michigan in which we immerse new M.D.s in 
bench research. For three months, 50 to 60 hours per week, 
these young physicians learn vast amounts about protein bio¬ 
chemistry and molecular biology, carefully overseen by some 
of our best faculty members. Programs like this ought to spring 
up at leading schools of medicine nationwide. 
A Nurturing Environment 
Finally, we in academic medicine have to develop a way to 
provide better support for people who want to pursue the 
career of physician-scientist. Most physician-researchers are 
never going to enjoy the financial perks of someone in private 
practice. Indeed, if they are going to be successful, physician- 
scientists must be driven by more than dollars. Nevertheless, 
with educational costs skyrocketing, medical students who 
have accrued heavy debts must foresee a good chance of find¬ 
ing employment that will enable them to pay off their loans 
and live a reasonably comfortable life-style. 
Other support must come in providing protected time for 
physicians who wish to commit a substantial effort to research. 
In my view, a physician-researcher cannot really be successful 
without devoting 60 to 70 percent of his or her time to the lab¬ 
oratory. To do less than that is to run the risk of falling behind 
and becoming frustrated. Conversely, I do think that it is possi¬ 
ble to maintain reasonable clinical competence with 30 percent 
of your time. 
We must protect junior faculty from being swamped with 
clinical duties, or they will never have the chance to develop. 
At the University of Michigan, this has been given a high pri¬ 
ority, and the fruits can be seen in the many examples of junior 
M.D. faculty who are enormously productive in research. 
When the combination of clinical medicine and basic 
research does not work due to lack of commitment, lack of 
training, or lack of support, the result can be discouraging to 
everyone to behold. When it does work, the benefit to society 
is spectacular. There is a cost, in dollars, in time demands on 
personal life, in trying to wear both hats and sometimes feeling 
as if neither one fits very well. But surely those of us who have 
the opportunity to experience both the intensely personal chal¬ 
lenge of patient care, and the exultation of .scientific advance, 
are among the luckiest of all human beings. YM 
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TASTE AND SMELL: 
EXPLORING SISTER SENSES 
Dr. Linda Bartoshuk administers a taste test similar to the one that she gave to her mentor. Dr. Carl Pfaffmann. 
by Diane E. Loupe 
If biomedical science ever begins awarding medals for “Pro¬ 
fessional Valor in the Face of Personal Adversity,” an inaugu¬ 
ral candidate should be Carl Pfaffmann, Ph.D. 
In the spring of 1988 a bout of herpes zoster oticus — a cra¬ 
nial nerve attack triggered by the activation of a latent chicken 
pox virus — affected Dr. Pfaffmann’s hearing. Most patients 
would have accepted the bad news that the hearing loss would 
be permanent and left it at that. But not this professor emeritus 
and former vice president at Rockefeller University. He 
viewed his illness as an opportunity to learn more about the 
human senses. 
Having spent his life studying how people taste. Dr. 
Pfaffmann knew the cranial nerve regulating hearing — the 
eighth or vestibulocochlear — nestles between the seventh and 
ninth cranial nerves, which regulate taste. Although he could 
Diane E. Loupe, former staff writer at the School of Medicine 
Office of Public Information, is a free-lance writer in Atlanta. 
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still savor his favorite foods. Dr. Pfaffmann suspected that the 
virus might be subtly affecting his ability to taste. 
To test his hypothesis, he contacted a former student, Linda 
M. Bartoshuk, Ph.D., who studies taste disorders as a professor 
of surgery (otolaryngology), epidemiology and psychology at 
Yale. A few weeks later, she appeared in the kitchen of Dr. 
Pfaffmann’s 262-year-old home in Killingworth, Conn., and 
methodically unpacked her color-coded bottles of salty, sweet, 
bitter and sour solutions. Thus began a series of experiments 
which were to greatly expand our knowledge about the physi¬ 
ology of taste. 
In the first of these experiments. Dr. Bartoshuk discovered 
that the left side of her mentor’s tongue, affected by the virus, 
could taste nothing. But the right side remained perceptive. 
Subsequent tests over the next few months revealed that as 
taste returned to the left side of Dr. Pfaffmann’s tongue, per¬ 
ception waned on the right. This supported findings from 
another study Dr. Bartoshuk had done which suggested that 
taste buds on one side of the tongue normally inhibit their 
counterparts on the other side. 




















undertaken by School of Medicine scientists to understand 
how we taste and smell. Their work ranges from applied clini¬ 
cal studies, such as evaluating taste and smell perception in the 
elderly, to molecular and cellular research into how odor 
molecules are translated into brain signals. Among its many 
applications, this research is helping physicians to diagnose 
disorders of smell and taste, architects to improve indoor air 
quality, and safety officials to develop more effective odorant 
systems to signal the danger of a gas leak. 
Tasting Life’s Banquet_ 
The relationship between taste and smell is no recent revela¬ 
tion. For centuries, the best cooks have known that a food’s 
aroma enhances its flavor. Only recently, however, have scien¬ 
tists discovered how much more subtle our sense of smell is 
than our ability to taste. 
Our taste buds, tiny, onion-shaped structures embedded in 
the tongue, can perceive but four flavors: sweet, salty, sour or 
bitter. Were it not for our sense of smell, all taste would be lim¬ 
ited to relatively unsophisticated combinations of these four 
sensations. We owe more subtle taste perception to our olfac¬ 
tory .sense, which allows us to smell thousands of aromas, 
from roast beef to red wine. 
Dr. Bartoshuk’s experiments with her mentor have revealed 
a key interaction between taste and yet another sense, touch. 
As she painted flavored solutions across Dr. Pfaffmann’s 
tongue, he perceived taste even on the dysfunctional side — as 
long as the painting began on the good side of his tongue. This 
revealed the important tie between touch and taste. 
Explains Dr. Bartoshuk, “The brain doesn’t care where taste 
is coming from. It doesn’t register location in taste. All it cares 
about is quality and intensity. So you perceive taste to come 
from the area that’s touched. When you chew your food, your 
whole mouth is filled with this touch sensation.” 
That's why a person tastes food across the tongue, although 
“taste receptors are located very preci.sely in an oval around 
the edge of your tongue and a little bit in the middle,” Dr. 
Bartoshuk says. “There are almost no taste receptors in the 
center of the tongue, and there aren’t any in other areas of the 
mouth. But you don't have any subjective awareness of this.” 
I’hat’s because of the tactile effect. 
Dr. Bartoshuk thinks that temporary, partial taste loss, such 
as Dr. Pfaffmann's, may be relatively common. Because of the 
tactile effect, however, most people never notice the deficit. 
Other experimental subjects have helped Dr. Bartoshuk 
learn more about another taste disorder: dysgeusia, a chronic 
unpleasant taste in the mouth. Such di.sorders can have a rela¬ 
tively simple cause, such as a medication, or a more serious 
and complex origin, such as a brain tumor which affects the 
nerves of taste sensation. 
One of Dr. Bartoshuk’s subjects was a woman who was left 
with a chronic salty taste in her mouth after surgeons removed 
infected bone from near her ear and severed the seventh cranial 
nerve. In an attempt to relieve the dysgeusia. Dr. Bartoshuk 
anesthetized the wotnan's tongue by deadening the ninth cranial 
nerve, the other nerve that transmits taste signals to the brain. 
'I'o Dr. Bartoshuk’s surprise, the treatment had a paradoxical 
effect — the phantom taste doubled. This led her to hypothe¬ 
size that the ninth cranial nerve inhibits the seventh cranial 
nerve, where the salty taste originated. She is now conducting 
experiments to confirm this finding. 
Complicating research into taste disorders is the fact that 
even normal taste sensations can differ widely. “The taste 
world you live in is not the same as the person who sits next to 
you,” Dr. Bartoshuk explaitis. Another aspect of her re.search 
explores genetic taste differences. 
An important tool in these studies is a drug called propy- 
thiouracil, or PROP, which is used to treat hyperthyroidism. 
One in four people is incapable of tasting PROP. To others the 
drug tastes bitter. Researchers think the trait is genetic, inher¬ 
ited recessively. 
PROP tasters perceive saccharine both as sweeter and more 
bitter than do non-tasters. Moreover, graduate student Tracy 
Karrer, who works with Dr. Bartoshuk, has discovered that 
tasters are more sensitive to capsaicin, the chemical that puts 
the zing in chili peppers and cayenne. 
Other researchers have shown that non-PROP-tasters have 
fewer taste buds. Since pain fibers wrap around each taste bud, 
individuals with more taste buds may have more nerve fibers 
that can perceive capsaicin’s bum. Dr. Bartoshuk also is work¬ 
ing with Robert H. LaMotte, Ph.D., professor of anesthesiology 
and neurobiology, in trying to discover why the irritant capsaicin 
paradoxically relieves chronic mouth pain in some adults. 
A Subtle Interaction_ 
Many taste and smell studies are undertaken at the John B. 
Pierce Laboratory, which is affiliated with Yale and dedicated 
to sensory, physiological and environmental research. One 
Pierce researcher, Joseph C. Stevens, Ph.D., a senior research 
scientist and lecturer in psychology at Yale, is looking at taste 
and smell losses in older people. 
In one test. Dr. Stevens and his colleagues prepared two 
batches of carrot soup, one spiced with marjoram the other 
without. A person “tastes” marjoram as the spice’s aroma 
floats up through the back of the nose. While most young adult 
volunteers, aged 20 to 32, were able to identify the spiced 
soup, most subjects aged 35 to 55 could not. This middle-aged 
group, in turn, performed better than subjects aged 66 to 89. 
Such studies suggest that the sense of smell declines gradu¬ 
ally throughout adulthood. In similar tests using salted tomato 
soup. Dr. Stevens detected a parallel decline in the sense of 
taste with age. He notes the potential danger of people at risk 
for high blood pressure needing to add more salt than younger 
people in order to achieve the desired effect. 
Dr. Stevens points out that a declining sense of smell has 
ramifications that go beyond the enjoyment of one’s food. 
“Smell is a warning sense as well as a pleasure sense,” he 
notes. Older people are disproportionately represented among 
fire victims, perhaps because they are not as good at detecting 
smoke or natural gas odorants. 
Dr. Stevens and William S. Cain, Ph.D., professor of epi- 
Dr. Joseph C. Stevens displays a bottle he uses for tests of the 
sense of smell. 
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Dr. Lawrence E. Marks adjusts some equipment that he uses 
for auditory experiments. 
demiology (environmental health) and psychology, collaborate 
to test the ability of people to detect odorants, such as ethyl 
mercaptan, which are added to scent naturally odorless 
propane (LP) gas. Forty-five percent of subjects over age 60 
were unable to detect this skunky smelling chemical at levels 
that met minimum federal safety standards. Ten percent of sub¬ 
jects under age 40 were not able to smell the chemical at this 
concentration, either. 
In ongoing studies, the PierceA'ale researchers are testing 
the ability of volunteers of various ages to detect different mix¬ 
tures and concentrations of gas odorants. Their results will 
prove useful to gas companies in improving the mixture of 
scents they use to warn against gas leaks. 
Old age and illness are not the only antagonists to our abil¬ 
ity to taste and smell. Every year many people lose their sense 
of smell to accidents, especially head injuries. 
Dr. Stevens remarks: “If you hit your head on a dashboard 
or fall off the back of a truck, you’re very likely to shear the 
olfactory nerve fibers,” which thread through small perfora¬ 
tions of bone in the skull. 
Such injuries can cause anosmia, a complete lack of smell, 
or hyposmia, diminished olfaction. In either case, the sense of 
smell returns in about 20 percent of cases, although recovery 
can take years. Dr. Cain estimates that 1 percent of the popula¬ 
tion will experience some prolonged loss of smell during their 
lives. Besides head trauma, smell losses can be caused by 
exposure to corrosive chemicals, chronic sinus infections, 
nasal polyps and upper respiratory infections. 
The problem is common enough for Dr. Cain to develop 
clinical tests to measure possible loss of smell. Reliability is 
critical; in the case of an accident, test results may be used as 
evidence in lawsuits alleging negligence. How is it possible to 
determine if someone is faking a loss of olfaction? Dr. Cain 
meets this challenge in some ingenious ways. 
In one of his tests, he asks subjects to taste a variety of 
sugar solutions, some of which are enhanced with tasteless. 
aromatic fruit oils. Although presented as a taste test, the task 
also measures olfaction; people with normal smell think the 
fruit-scented samples taste stronger. This helps identify people 
who exaggerate their loss of smell. 
Says Dr. Cain; “It’s a very powerful illusion. When I taste 
that solution with the tutti-frutti odor, it seems like I have more 
flavor in my mouth, even though I know the ingredients.” 
Dr. Cain also is helping to develop a test of the ability to smell. 
Here researchers attach electrodes to a person’s scalp to mea¬ 
sure electrical changes that may occur as the subject sniffs dif¬ 
ferent odors. 
Dr. Cain’s interest in indoor air quality also has produced 
some novel approaches. Surprisingly, for tests to determine 
whether an airborne substance is an irritant, he recruits people 
with no sense of smell. Anosmic subjects prove ideal; not dis¬ 
tracted by bad odors, their noses do retain what is called the 
common chemical sense. Controlled by the fifth cranial nerve, 
this sense perceives such sensations as stinging, irritation, 
freshness, prickling, piquancy, burning and tingling 
These anosmic volunteers help Dr. Cain determine the pun¬ 
gency of certain chemicals as part of his research into “sick 
building syndrome.” Buildings can make their occupants ill 
when new carpets, furnishings, paint, office machines or other 
items introduce noxious fumes into the environment faster 
than the circulating air can flush them out. Research by Dr. 
Cain and Yale colleagues have helped improve engineering 
standards for air circulation to help avoid this problem. 
A Molecular Common Denominator 
Sensory perception is a psychological as well as a visceral 
experience, explains Lawrence E. Marks, Ph.D., professor of 
epidemiology (environmental health) and psychology. Dr. 
Marks, a Pierce laboratory fellow, submits “certain principles 
and processes are common to many different sensory systems, 
despite fundamental differences among them.” 
To illustrate his point. Dr. Marks poses the question: Which 
is brighter, a cough or a sneeze? Though this may sound like a 
conundrum, developmental studies he has conducted indicate 
that most people, no matter what their age, will choose the 
sneeze. Cross-cultural studies by other researchers confirm this. 
Why? Dr. Marks thinks the nervous system may respond 
similarly to the frequency of waves whether those waves be 
perceived as sound or light. In other words, the brain draws 
parallels between high-pitched sounds and bright colors, each 
comprised of high-frequency waves, and between low-pitched 
sounds and darker colors, with their lower frequencies. 
“Maybe the nervous system uses the frequency of neural 
impulses to some extent to encode both pitch and loudness, 
although in slightly different ways,” suggests Dr. Marks. 
Such considerations come under the heading of “synaesthe- 
sia,” in which one kind of sensory stimulation evokes the sen¬ 
sation of another. Throughout history, many artists have 
reported synaesthetic experiences, observes Dr. Marks in a 
1978 book. The Unity of the Senses: Interrelations Among the 
Modalities. Nineteenth-century French poet Charles Baude¬ 
laire, in his sonnet “Correspondences,” drew analogies 
between vision, taste and smell when he wrote “There are 
odors as fresh as children’s skin/As sweet as oboes, as green as 
prairies.” 
Sir Isaac Newton proposed parallels between musical notes 
and colors, leading 18th-century Jesuit priest Louis-Bertrand 
Castel to build a “color organ.” This clavichord unfurled col¬ 
ored ribbons that corresponded to different notes; audiences 
feasted on both the music and the visual display. 
“It was all part and parcel of this notion of the unity of the 
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senses. There were similarities and analogies and relation¬ 
ships,” Dr. Marks says. 
To explore whether some associations between sound, light 
and size are innate. Dr. Marks and his colleagues tested chil¬ 
dren and young adults. They found that even young children 
perceived sunlight as louder than moonlight, a pebble as higher 
pitched than a boulder; red was higher pitched than blue but 
lower than yellow. The researchers also discovered that people 
respond more quickly and accurately to .sensory combinations 
that are synaesthetic complements, such as white and high- 
pitched, than contrasting pairs, such as black and high-pitched. 
Dr. Marks has constructed mathematical models to help 
describe these sensory connections. His models may help pre¬ 
dict conditions that would maximize performance of aircraft 
pilots, air traffic controllers and others who monitor complex 
displays of information. Similarities between tactile perception 
and hearing could enhance the development of hearing aids that 
translate sound into vibrations which deaf people can interpret. 
Olfactory Neurons: A Basic Analysis_ 
Any synaesthetic connections that the mind creates may reflect 
cellular and molecular processes involved in perception. 
Gordon M. Shepherd, M.D., D.Phil., professor of neuro¬ 
science, reports that his studies of olfaction have led him to 
think that, neurologically speaking, organisms smell, see, taste 
and hear in very similar ways. 
He explains, “Smell is a kind of odor image, an image 
evoked by the pattern of activation set up by the receptor cells 
and elaborated by the smell pathway in the brain. It functions 
like an image in a visual system.” 
When a person sniffs a gardenia, for example, a five-stage 
molecular relay race lets the brain identify the odor. As the nose 
inhales the volatile molecules that comprise the flower's fra¬ 
grance, the race begins. The second leg occurs when molecules 
dissolve in the mucus covering the cilia, tiny hair-like structures 
in the nasal cavity extending from the olfactory neuron. 
During leg three, protein molecules called receptors, which 
line the cilia, respond to the fragrance molecules in much the 
same way as a lock is opened by a particular key. The fourth 
leg of the race is run as the receptor protein activates a 
sequence of enzymes that amplify the odor signal. Finally, this 
produces a second messenger, a protein that completes the race 
by translating odor molecules into electrical impulses for 
nerves to pass along to the brain. 
Stuart Firestein, Ph.D., assistant professor of neurobiology, 
studies the tiger salamander to discover how the home stretch of 
the relay race — the .second messenger system — functions. He 
and his co-workers connect a microscopic electrode to one of 
the unusually large olfactory cells of the reptile. They then spray 
the cell with a cocktail of banana, cinnamon and nutlike odors. 
The odors trigger the opening and closing of tiny channels in the 
cell's membrane, flooding the cell with ions, atoms with a posi¬ 
tive or negative charge. Dr. Firestein measures the resulting 
electrical change, which the brain interprets as an odor. 
Drs. Firestein and Shepherd believe that humans can detect 
about 1,()()() "basic” odors, analogs to the mere handful of 
basic taste sensations. Using these basic scents as building 
blocks, the brain builds a repertoire of 10.000 or more con¬ 
glomerate odors that it can recognize. 
“There are smells that evolution could never have put into 
our noses, like new car smell,” observes Dr. Firestein. “And 
yet. we can perceive that smell as a very distinctive odor.” 
Dr. Firestein uses an alphabetical analogy to illustrate the 
theory. Conglomerate smells, he says, correspond to English 
language words, which are combinations drawn from the let¬ 
ters of the alphabet. Basic smells, by contrast, are like Chinese 
language ideograms; each symbol represents one concept. 
Molecular genetic research is also making its contribution 
to olfactory research. Earlier this year, Columbia University 
researchers greatly advanced the field by cloning and decoding 
the genetic sequence of olfactory receptor proteins. Dr. 
Shepherd thinks that the Columbia studies confirmed the pre¬ 
dictions of some scientists that olfactory receptor proteins 
belong to the largest family of genes known. 
Olfactory proteins also belong to a group of protein recep¬ 
tors that respond to different types of neurotransmitters, small 
hormone-like molecules used by nerve cells to communicate 
with each other. Such neurotransmitters as serotonin, dopamine 
and adrenaline help regulate emotional and physical states. 
In recent experiments. Dr. Eirestein bathed a salamander’s 
olfactory cells in beta-blocking drugs, thus suppressing the 
cells’ ability to perceive odors. Physicians prescribe beta- 
blockers, which block human neurotransmitters, to control 
hypertension. Dr. Firestein’s work suggests that the olfactory 
receptor may resemble these neurotransmitter receptors. 
Therefore, the salamander’s nose might be useful to scien¬ 
tists who wish to learn more about how cells translate other 
chemicals into brain signals. This represents only one of many 
potential contributions that olfactory research may offer to 
other areas of medical research. For instance, a better under¬ 
standing of cellular signalling may aid cancer researchers, who 
know that some forms of the disease are triggered by a signal 
that tells cells to replicate without restraint. 
Dr. Firestein believes that the olfactory receptor cell could 
have value as a model for other sensory phenomena, such as 
sensory adaptation. “When you walk into a room with an 
unusual or unpleasant odor, after a couple of minutes, you no 
longer sense that odor,” explains Dr. Firestein. “But if you 
walk out and come back in, you smell it again. You know that 
the odor is still there, but your perception of it has dimin¬ 
ished.” Drawing a parallel between this adaptation and the tol¬ 
erance patients can develop toward therapeutic drugs. Dr. 
Firestein suggests that experiments with olfactory cells may 
help scientists understand such tolerances and develop ways to 
limit them. 
Even the budding field of nerve regeneration could benefit 
from research into the sense of smell. Drs. Firestein and 
Shepherd are among the basic scientists who are trying to 
describe how olfactory neurons regenerate over long distances. 
Many nerves will not reconnect after they are severed, but 
olfactory neurons can regenerate and reconnect with appropri¬ 
ate receptors in the brain, so that the receptor responsible for 
smelling chocolate doesn’t reconnect with the brain receptor 
for smelling vinegar. 
Knowing how these neurons regenerate might enable 
researchers to stimulate nerve regeneration in other systems, 
perhaps helping in the far future to restore sight to the blind, 
hearing to the deaf and feeling and movement to victims of 
spinal cord injury. 
What research trends should soon command the public’s 
attention regarding the sense of smell? 
“The olfactory sense in human behavior,” replies Dr. 
Shepherd. 
For example, scientists are working on identifying the elu¬ 
sive human pheromones, chemicals similar to those that con¬ 
trol mating and social behavior in some insects and animals. 
Tomorrow, the allure promised by perfumes and colognes may 
be more than today’s Madison Avenue hyperbole. YM 
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CMHC CELEBRATES 
25 YEARS OF SERVICE 
At the celebration ofCHMCs 25 th anniversary, Abraham A. Ribicoff (left) speaks with chairman of psychiatry B. Stephen Bunney 
and William H. Sledge, head of CHMC's clinical division. 
Editor’s note: To protect confidentiality, patient names have 
been changed in this article. 
by Gitta Morris 
Twenty-five years ago, at the dedication of the Connecticut 
Mental Health Center (CMHC), Wilbur Cohen, undersecretary 
of welfare in the Johnson administration, spoke of a “new era” 
in the care of the mentally ill. On the same occasion Connecti¬ 
cut Gov. John Dempsey called the new $5 million facility a 
“good investment.” 
Both remarks have proven prophetic. First, CMHC has 
made significant contributions to an innovative era in which 
day hospitals, crisis units, specialized outpatient treatments, 
and residential and vocational services have helped humanize 
the mental health care system and make it more effective. 
Such innovations, in turn, have proven a good investment 
Gitta Morris is a free-lance writer based in Madison, Conn. 
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by opening the system to more people while helping to control 
costs. This has allowed CMHC to offer an improved quality of 
life to most of the 50,000 or more patients who have received 
treatment here since September 1966. 
The great need for CMHC’s services became apparent 
almost from the moment the center opened its doors. During 
its first two months, CMHC treated 700 patients — twice as 
many as expected. Last year, some 5,500 people, most of them 
poor and severely disturbed, found their way into the center's 
patient care programs. Many others benefit indirectly from the 
research and teaching that are integral to CMHC’s mission. 
A Lifelong Struggle_ 
Susan, a 34-year-old woman, has a history of mental illness 
that is typical of many of the center’s patients. Over the past 14 
years, she has been admitted 16 times to Connecticut Valley 
Hospital, a state mental hospital located in Middletown. Four 
times Susan has entered a private facility for treatment, and 






Diagnosed with a schizo-affective disorder, Susan has led a 
chaotic life, running away from family and from treatment, 
embroiled in legal problems, arrested for larceny and judged 
incompetent to stand trial. Ten years ago, she had a baby and 
gave the child up for adoption. 
When at the mercy of her illness, Susan can be paranoid, 
suicidal and emotionally explosive, living in the streets and 
involved in petty crime. When her illness is under control, how¬ 
ever, she is bright and does her best to live independently. She 
has a certain appeal that makes people want to befriend her. 
For the past year, stabilized by medication and with the 
assistance of her CMHC case manager, Susan has been able to 
live in an apartment that is managed by Continuum of Care, a 
nonprofit provider of housing for psychiatric patients. She is 
learning computer skills and, although she still must contend 
with occasional bouts of paranoia, Susan is faring better than 
at any time since she became ill. 
CHMC's anniversary celebration featured a reunion of present 
and past directors: (from left, back row) current director, Ezra 
E. El. Griffith, Eritz Redlich, Boris Astrachan: (from left, front 
row) Morton Reiser and Gerald Klerman. 
Susan’s progress, and that of thousands of others who have 
been helped at CMHC, might not have been possible were it 
not for an informal meeting that took place back in the 1950s 
in the office of newly elected Gov. Abraham Ribicoff There 
Fredrick C. “Fritz” Redlich, M.D., Sc.D., then chairman of the 
Yale department of psychiatry, and a group from the Connecti¬ 
cut Mental Health As.sociation frankly presented their con¬ 
cerns to the governor. “What do you plan to do about mental 
health?" they demanded. 
“I’ve only been in office for one day,” an embarrassed gov¬ 
ernor protested. Then the shrewd politician turned the tables 
on Dr. Redlich. “What does Yale plan to do about mental 
health?” he asked. 
Out of this exchange was bom a collaboration between the 
University and the State to create a mental health treatment, 
training and research institution. Its foundation was “Action 
for Mental Health.” a report produced by a nationwide coali¬ 
tion of mental health care advocates. The document proposed a 
national program against mental illness to be fostered by state- 
supported training and research centers. 
Further impetus came with the Community Mental Health 
Centers Act spearheaded by President John F. Kennedy in the 
early 196()s, which offered federal support for clinical care 
within a community context. Construction was launched with 
$4 million in state funds, $900,000 in federal money and a 
contribution of $100,000 from the University. 
By way of long-term support, the State maintains the 
CMHC building and underwrites its overhead costs. Connecti¬ 
cut also pays the salaries of most of the administration and 
support staff and of about 70 percent of the nurses, social 
workers and other direct care providers. Finally, the State pro¬ 
vides the senior administration, research staff, psychiatrists 
and some other professionals through a $7 million contract 
with Yale. 
With an annual budget of nearly $19 million and 41 inpa¬ 
tient beds (plus 13 beds in the research unit), CMHC is one of 
the largest psychiatric facilities administered by the Yale psy¬ 
chiatry department. The department also is responsible for 
Yale Psychiatric Institute and for psychiatric care at Yale-New 
Haven Hospital and at the Department of Veterans Affairs 
Medical Center in West Haven. 
Only a hint of the University-State relationship manifests 
itself as one approaches CMHC’s five-story brick structure at 
the comer of Park Street and South Frontage Road; the center’s 
brick facade is more reminiscent of a state government office 
building than of the Yale buildings on the medical campus. 
Appearances aside, extensive collaboration begins at the 
top level of administration. On the State side, the commis¬ 
sioner of the Department of Mental Health and the regional 
director of mental health play a major role in setting policy for 
clinical services. For Yale’s part, the chairman of the psychia¬ 
try department serves as the designate of the medical school 
dean to oversee teaching and research. 
Reporting to both the State and the University, CHMC 
Director Ezra E.H. Griffith, M.D., professor of psychiatry, 
coordinates the center’s three areas of activity — clinical ser¬ 
vice, research and teaching. As he explains it, “My job is to try 
and hold a sensible balance between and among these aspects 
of CMHC’s mission.” He is assisted by associate directors of 
the clinical, nursing and administration divisions. 
Meeting the Challenge_ 
Eor the past two years, the clinical division has been headed by 
William H. Sledge, M.D., associate professor of psychiatry. An 
Alabama accent has survived his 17 years in New Haven, 
dating back to his psychiatric residency at Yale. He explains 
that CMHC strives “to provide patients the flexibility to move 
easily among the center’s five clinical units and the many ser¬ 
vices they offer.” 
Those units include: 
Entry and Crisis. In nearly 2,700 face-to-face encounters 
and more than 4,000 telephone calls per year, this unit evalu¬ 
ates the nature and urgency of patient concerns and arranges 
help. This is the sole portal into treatment at CMHC. 
Mobile outreach and crisis intervention are extensions of 
this unit. In mobile outreach, CMHC clinicians go into the 
community to treat acutely disturbed, sometimes dangerous 
individuals; caregivers have even been called on to negotiate 
the release of hostages. Crisis intervention, a short-temt outpa¬ 
tient program, serves as an alternative to hospitalization for dis- 
tres.sed patients who can be helped by intemiittent treatment. 
Inpatient service. Offering the most intensive treatment for 
patients with prolonged, severe psychological disorders, this 
service is located on CMHC’s secure fourth and fifth floors. 
Patients may stay from a few days to several months. 
Acknowledges Martha Mitchell, M.S.N., associate director 
of nursing since 1982, “In this day and age, anyone admitted to 
a public sector inpatient unit is impoverished and severely dis- 
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turbed. There just aren’t that many beds anymore. People here 
are among society’s most disadvantaged.” 
In this setting, nurses play a major role in assuring that 
patients receive the support and the structure they need to 
reshape their lives to adapt successfully outside the institution. 
“There’s a sense of trying to do your damdest to get their trust, 
to be as flexible as possible, to provide the patient with some 
modicum of control,” says Ms. Mitchell. 
“It takes a lot of skill to relate to people who are as sick as 
they can be and denying it. Often their family gives up on 
them. They have no support system. You can get very attached 
to these people, and you get very in touch with how chaotic 
and how resourceless their lives are.” 
Outpatient services. This aspect of CMHC’s treatment 
program was reorganized by Dr. Sledge. In past years, patients 
were assigned to an individual therapist. If this therapist hap¬ 
pened to be a resident or other trainee, after the rotation con¬ 
cluded, the subsequent caregiver had to start the therapeutic 
relationship all over again. 
Today, each patient is cared for by a team of some 12 to 14 
professionals — psychiatrists, psychiatric social workers, 
nurses, social workers, trainees and other mental health profes¬ 
sionals. Each group is coordinated by a team leader, usually a 
social worker or nurse, who works closely with a CMHC psy¬ 
chiatrist. Though trainees rotate on and off the team, the other 
team members provide the continuity that minimizes any dis¬ 
ruption of therapy. 
CMHC offers outpatient services not only at its Park Street 
headquarters, but also at the West Haven Mental Health Clinic 
Ezra E.H. Griffith — 
Strengthening a Vital Institution 
Dr. Ezra E.H. Griffith, CMHC’s director for the past two years, 
is a brusque, outgoing man who is long on self-confidence and 
comity. His assured air may have something to do with his cos¬ 
mopolitan past. 
Bom and raised in Barbados, he came to the United States 
with his family as a teen-ager. Tme to the heritage of his 
homeland, he journeyed to France to earn his medical degree 
before coming to New York City for residency training at 
Albert Einstein University. Dr. Griffith’s research too reflects 
his international background; he has studied the therapeutic 
effects of African-American and Caribbean religious rituals 
and the cultural aspects of psychiatry. 
In 1977, Dr. Griffith came to Yale as an assistant professor 
of psychiatry and to CMHC as associate director of the inpa¬ 
tient unit. He was named the center’s acting director in 1987, 
and two years later was appointed director. 
From the start. Dr. Griffith has put a heavy emphasis on 
community relations. As soon as he became director, he relates, 
“I met with community groups and pastors, and was quite 
shocked when they said they would never come into the center. 
They saw it as a distant Ivy League, Yale institution and never 
thought of it as a resource for them and their constituencies. If a 
member of the congregation was suffering, they would not 
think to say ‘Let me call the CMHC to see if you can get help 
there.’ That bothered me seriously,” he acknowledges. 
To remedy the situation. Dr. Griffith began meeting with 
Hispanic and African-American health and social service 
providers, with pastors and city representatives. “Getting a 
sense of community,” he calls it. During these encounters he 
explained the mission and the wide range of services available 
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and the Hispanic Clinic at 1 Long Wharf Drive in New Haven. 
The latter, explains Dr. Sledge, is to provide Hispanics “a spe¬ 
cial clinic that is sensitive to them, one that is really theirs.” 
Day Hospital. Here patients spend six hours each weekday 
in therapy designed to help them cope with the practical tasks 
of life, like dressing appropriately for work, shopping for food 
and clothing, and managing a checking account. 
Patients also acquire the social skills that will ease their 
transition back into the community. Says Dr. Sledge, “The day 
hospital staff teach about normal, everyday interactions that 
most of us take for granted, like making eye contact during a 
conversation or how to ask the bus driver for change.” 
Other patients benefit from the crisis respite program in the 
homelike Brownell House. Located in a pleasant residential 
neighborhood near the day hospital, Brownell House accom¬ 
modates four patients for an average of 15 days each. Part of a 
three-year federally funded research demonstration project, the 
program is a joint venture of CMHC, the State Department of 
Mental Health and Continuum of Care, with Dr. Sledge as the 
principal investigator. 
By providing a short-term halfway house, the crisis respite 
program fills the gap between inpatient and day hospital care. 
The experimental project randomly assigns patient volunteers 
to either the inpatient hospital or the crisis respite program; 
researchers then compare for clinical effectiveness and cost 
efficiency. 
Substance Abuse Treatment (SATU). This fifth clinical 
unit serves as a national model for substance abuse treatment 
programs. Its immediate past director, Herbert D. Kleber, 
Dr. Ezra E. H. Griffith 
at the center. 
Such efforts have had a dramatic effect. When Dr. Griffith 
assumed the CMHC directorship, the center cared for 3,000 
patients. Last year, that number topped 5,500. 
Dr. Griffith sees CMHC’s faculty, staff and students as a 
wellspring of expertise that should flow generously into the 
community. Comments Dr. Griffith, “We have some powerful 
brains here that reflect on a wide range of health care issues, and 
their expertise should be made available to the community.” 
15 
CMHC Teams Row Against 
Tide of Urban Poverty 
“It’s very difficult to work in our community in the tradi¬ 
tional manner, with patients coming in here to get medica¬ 
tion and therapy once a week,” observes Kenneth S. 
Thompson, M.D., assistant professor of psychiatry. “More 
and more of our patients have a history of having had to be 
hospitalized at some point in their lives. Now they’ve been 
deinstitutionalized to the community. They need a lot of 
care, especially as conditions in the neighborhoods they 
live in have become worse and worse. Poverty there is as 
bad as ever, if not worse, and it’s accompanied now with a 
wave of drugs, violence and disease.” 
Moreover, many CMHC patients face the challenge of 
breaking an endless circle: Because they are mentally ill, 
they cannot find or hold jobs; because they do not work, 
they remain poor — often with no health insurance — and 
with nothing constructive to occupy their time. 
CMHC uses a team approach to cope with its burgeon¬ 
ing population of low-income, severely disturbed patients. 
Dr. Thompson serves as medical attending physician for 
one such team, which is responsible for some 300 outpa¬ 
tients. 
On a recent morning, the team, comprised of 12 to 14 
professionals — physicians, psychiatric social workers and 
nurses, trainees and mental health workers — discussed 
several patients. Jack, a musician, had made some of the 
most dramatic progress. 
Jack arrived at CMHC two months before, psychotic, 
depressed and obsessed with his health. Having just 
learned that he had diabetes, he was convinced that he was 
dying. 
To complicate matters, “we had a terrific time convinc¬ 
ing his family to let him go on medication” for his mental 
illness. Dr. Thompson recalls. “They were very resistant.” 
Team therapist Kate Young, a nursing student at Yale, 
worked hard and long with the patient and his family. She 
finally was able to persuade the family to allow Jack to 
enter treatment at CMHC. 
For his first few weekly medication and therapy ses¬ 
sions, Jack showed up overweight, disheveled and miser¬ 
able. Dr. Thompson is pleased to report, however, that 
after two months of treatment, “1 literally did not recognize 
him. Jack was clean, he felt better, and was taking care of 
some issues in his life. It was really a profound change.” 
Thanks to CMHC’s leading role in a statewide managed 
care system, the center can help patients like Jack from the 
greater New Haven area and throughout Connecticut. The 
system, which divides the state into 23 catchment areas, 
each coordinated by a lead agency, helps the mentally ill 
make the best use of the many services — from crisis cen¬ 
ters to soup kitchens — that are available to them. 
As lead agency in Catchment Area 7, CMHC coordi¬ 
nates mental health care in New Haven, Hamden, Wood- 
bridge and Bethany. In these towns 15 agencies provide a 
wide range of clinical .services, residential treatment, voca¬ 
tional rehabilitation and social support. CMHC also works 
with other lead agencies to help place patients who need 
inpatient care, but live in catchment areas with no such ser¬ 
vices. or with inpatient beds that arc filled. 
M.D., was named deputy director of demand reduction for the 
federal Office of Drug Control Policy. Current director 
Richard S. Schottenfeld, M.D., associate professor of psychia¬ 
try, also is a nationally known drug researcher and clinician. 
To help New Haven deal with its epidemic of substance 
abuse, SATU offers an evaluation and brief treatment unit, an 
alcohol unit and SATU outpatient services. The cocaine clinic 
is widely recognized for outpatient cocaine treatment using 
psychological interventions. In addition, SATU’s award-win¬ 
ning research component is one of two major sites for National 
Institute of Drug Abuse research in the United States. 
Where Psyche Meets Soma 
In the basic science laboratories, every effort is made to gear 
research toward possible clinical applications. Comments 
George Heninger, M.D., professor of psychiatry and director 
of CMHC’s Abraham Ribicoff Research Center, “Many of our 
scientists are undertaking basic re.search leading to clinical 
trials. We’re always thinking how we might apply our results 
to improve the treatment of our patients.” 
In addition to the work done at the Ribicoff center, 
CMHC’s strength in research comes to the fore at such pro¬ 
grams as the Center for the Studies of Prolonged Psychiatric 
Disorder and the Consultation Center. Together, these pro¬ 
grams have advanced psychiatric re.search, especially into the 
treatment of depression, schizophrenia and substance abuse. 
CMHC’s Laboratory of Molecular Psychiatry also focuses 
on these three areas. Typical is the research of Ronald S. 
Duman, Ph.D., assistant professor of psychiatry. Dr. Duman 
studies the biochemical mechanisms that underlie the thera¬ 
peutic action of antidepressant treatments. 
As one approach, his research team is “cloning nerotrans- 
mitter receptors from the locus coeruleiis, a region of the brain 
which is involved in depression,” he explains. The Laboratory 
of Molecular Psychiatry has recently isolated a cDNA clone 
for a neuropeptide Y receptor, a protein that has been impli¬ 
cated in depression. Dr. Duman says that improved medica¬ 
tions may result from a better understanding of the molecular 
mechanisms of antidepressant treatments and characterization 
of neurotransmitter receptors that play a role in depression. 
George K. Aghajanian, M.D., the Foundations Fund for 
Research in Psychiatry Professor of Psychiatry and Pharma¬ 
cology, is conducting pathfinding studies into how psychoac¬ 
tive drugs affect brain function at a single neuron level. His 
re.search, involving lone neurons from minute slices of rat 
brain, attempts to explain how neurotransmitters pass along the 
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electrical impulses that are key to brain cells communicating 
with each other. 
Dr. Aghajanian’s studies involve two elements: 
• how receptor proteins for the brain chemicals nore¬ 
pinephrine, serotonin and opioid peptides work at the 
molecular level; 
• how these receptors induce changes within brain cells 
that may be relevant for schizophrenia, depressive illness 
or drug dependence. 
Dr. Heninger’s studies at the Clinical Neuroscience 
Research Unit have been based in part on Dr. Aghajanian’s 
findings. Armed with data about the role that serotonin plays 
in depression. Dr. Heninger and colleagues have been able to 
develop treatments that regulate this brain chemical to relieve 
depressive illness. He works closely with Lawrence H. Price, 
M.D., associate professor of psychiatry, and with assistant pro¬ 
fessors Wayne E. Goodman, M.D., and Christopher J. 
McDougle, M.D. 
Like Dr. Aghajanian, CMHC scientist Michael Davis, 
Ph.D., professor of psychiatry and psychology, studies the 
brains of laboratory rats. Dr. Davis’ research is helping to iden¬ 
tify the basis of panic attacks and other anxiety disorders. He is 
discovering how the neural systems involved in learning and 
memory are affected by fear conditioning. 
His studies of the startle reflex — which causes mammals 
to Jump when surprised — are revealing the pathways between 
the amygdala, the brain’s fear center, and the brain centers that 
control breathing and heart rate. Such reactions as rapid 
breathing or increased heartbeat, useful to defend against phys¬ 
ical danger, are maladaptive when evoked by everyday stress. 
Learning more about the neural pathways involved in the 
“fight or flight’’ reaction could lead to improved drug or other 
treatments for anxiety or panic disorders. 
Many CMHC patients find their psychological problems 
exacerbated by addiction to illegal drugs. Trying to improve 
drug treatments through basic research is Eric J. Nestler, M.D., 
Ph.D., the Elizabeth Mears and House Jameson Associate Pro¬ 
fessor of Psychiatry and Pharmacology. His research has 
revealed some of the biochemical mechanisms by which 
cocaine and opiates produce addiction in laboratory animals. 
Dr. Nestler notes that on an acute level, “these addictive 
drugs exert very different effects and react with different pro¬ 
tein receptors.” Still, the various drugs have a similar func¬ 
tional effect — addiction. 
This chronic effect may be traced to similar protein changes 
in the brain’s me.solimbic dopamine system, which many sci¬ 
entists believe plays a key role in addictive behavior. This is 
the area of the brain on which Dr. Nestler’s research team is 
focusing, with the aid of a strain of rats that is more vulnerable 
to drug addiction. 
Dr. Nestler’s research may soon offer a direct benefit for 
CMHC patients. Along with CMHC researcher Thomas R. 
Kosten, M.D., associate professor of psychiatry, he has applied 
to the University’s Human Investigations Committee to initiate 
a clinical trial for a drug that may help reduce addicts’ craving 
for cocaine. 
Along with encouraging basic research that will result in 
better treatments for CMHC’s patients, center director Dr. 
Griffith works to insure that the teaching program serves the 
needs of both patients and students. Last year, 83 professional 
students were trained at the center, most of whom were psychi¬ 
atric residents, and predoctoral or postdoctoral fellows in psy¬ 
chology. Other trainees include social work interns, nursing 
students and chaplaincy interns. 
Dr. Griffith points out that as CMHC moves steadily toward 
treating seriously ill patients with chronic disorders, the center 
offers students a unique educational challenge. “How many 
places can you go,” he asks, “where you can learn how to 
develop a treatment program for someone who doesn’t have a 
place to live and no support services?” 
As CMHC moves beyond its silver anniversary, the mount¬ 
ing pressures of society — especially on those who are poor 
and disenfranchised — will make this already difficult charge 
all the more daunting. YM 
In a relaxing moment of conversation before dinner, a day-hospital patient is flanked by 
associate director Edna Akiin, C.I.S.W., (left) and director Jeanne Steiner, D O. 
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BRIDGING THE GAP: 
PATHOLOGY AT YALE 
Assistant professor of pathology Brain West. M.D., (right) examines slides from an ischemic colon. With him are YNHH resident 
Marc L. Silverherg, M.D. '91, (left) and Joe Esherick, a third-year medical student. 
hy John Dinolfo 
Early afternoon on a typical weekday: In his office on the 
second floor of Yale-New Haven Hospital's Memorial Unit, 
Stuart Elynn. M.D., associate professor of pathology, receives 
a phone call from the operating room. A surgeon has just 
removed a worrisome growth from the right breast of a 46- 
year-old woman. Eine needle aspiration of the mass, done the 
previous week, had revealed atypical cells, raising the specter 
of breast cancer and necessitating today's biopsy. 
By phone, the surgeon advises the pathologist that he has 
discovered no evidence of a well-defined mass. Dr. Flynn 
quickly assesses the possibilities: Either the lesion is benign or 
a diffuse infiltrating neoplasm, a cancer that does not produce 
a tumor but insidiously penetrates normal tissue. 
In the OR, the biopsy, roughly the circumference of a silver 
dollar, is packed in ice and rushed to a tissue processing lab in 
the pathology department, where Dr. Flynn carefully examines 
the sample for gross evidence of cancer, notably, discol¬ 
orations or hard irregular areas. Finding none, he dissects the 
lesion and discovers a 2 centimeter cyst—the site that had been 
previously aspirated. 
He slices two small segments of tissue and quickly passes 
them to a lab technician who immerses the samples in liquid 
nitrogen. The frozen tissue section is deftly sliced again, by 
machine, into sections thinner than a snowflake, then mounted 
on slides. 
Soon after, the surgeon arrives from the OR. He and Dr. 
Flynn examine the slides under a micro.scope. “It's benign,” 
Dr. Flynn says with a sigh of relief. 
Though happy with the result—and the expected impact the 
good news will have on the patient—Dr. Flynn has little time 
to savor the satisfaction of the moment. He returns to his 
office, where other patients’ slides await inspection. 
This recent case illustrates how Yale's practicing patholo¬ 
gists help establish a diagnosis, thus playing a key role in 
John Dinolfo is a free-lance writer based in Eairfield, Conn. 






patient care. These pathologists evaluate an average of five 
breast biopsies each weekday. Elapsed time for such a frozen 
tissue section assessment, from initial contact in the OR to the 
clinical decision, is usually about 10 minutes. Fortunately, 
most breast biopies done at Yale-New Haven are benign. Dr. 
Flynn explains. When a biopsy does prove malignant, the sur¬ 
gical pathologist employs a battery of histopathologic and 
molecular tests to try to determine cancer severity and spread. 
Such tests, usually done within a week of the biopsy, typically 
offer vital insights into the patient’s prognosis and likely 
course of therapy. 
Often unknown to the patient, the pathologist plays a key, 
behind-the-scenes role as a member of the clinical team. “The 
pathology report is often the most important single piece of 
information in the patient’s chart,” explains Jon S. Morrow, 
Ph.D.’76, M.D.’76, chairman and chief of pathology since 
September 1990. “There’s often very little way to tell until that 
tissue is removed whether it is benign or malignant. That deci¬ 
sion rests on the shoulders of the pathologist.” 
In addition to assessing breast biopsies, Yale pathologists 
routinely help to diagnose other potentially malignant condi¬ 
tions. For example, sometimes a cancerous lesion cannot be 
distinguished from simple inflammation by gross examination, 
or a tumor margin needs clarification so that a surgeon can tell 
if all diseased tissue has been removed. In such cases, the 
pathologist establishes the diagnosis in the laboratory—often 
before the conclusion of surgery. 
Indeed, on a typical work day, pathologists and their staff 
analyze 20 to 50 frozen tissue specimens. “The rate of error for 
frozen sections approaches zero,” Dr. Morrow points out. If 
doubt persists as to whether a lesion is malignant, the patholo¬ 
gist errs on the conservative side, deferring diagnosis until 
more information is available. 
Although vitally important, frozen tissue sections are just a 
small part of the pathology story. This year alone, Yale pathol¬ 
ogists will evaluate up to 35,000 scrapings, biopsy samples, 
fluids or cytologic specimens. Most tissues are sent by col¬ 
leagues at Yale-New Haven Hospital and the Department of 
Veterans Affairs Medical Center in West Haven, although 
every year physicians from as far away as Brazil and Japan 
turn to Yale pathologists for help in assessing difficult cases. 
Autopsies also play a vital part in the work of Yale patholo¬ 
gists, providing a powerful tool for quality assurance and con¬ 
tinuing medical education. Up to 30 percent of autopsies 
reveal information that would have altered clinical care, had 
the information been known prior to death. 
In combining varied clinical duties with research and teach¬ 
ing, Dr. Morrow says that each of his department’s faculty 
members is faced with “a job with enormous responsibilities.” 
Providing a Keystone 
In one sense, every physician is a pathologist; pathology’s 
Latin roots translate as “the study of disease.” More than most 
biomedical disciplines, however, pathology serves as a nexus 
between basic research and clinical medicine. “The real chal¬ 
lenge is to form a bridge so that new developments in the labo¬ 
ratory are quickly applied to clinical studies and vice versa,” 
explains Dr. Morrow. He himself is an expert on the cell’s cor¬ 
tical cytoskeleton—the protein infrastructure that supports the 
cell membrane. 
Roughly half of the department’s 20 full-time faculty mem¬ 
bers conduct research into cell growth and differentiation 
while the other half are engaged in clinical studies designed to 
improve patient care. Many faculty members undertake both. 
Among those engaged in both basic and applied research 
High-technology Tools 
Aid Today^s Pathologist 
Among the sophisticated technologies used by School of 
Medicine pathologists are: 
• electron, flourescent and confocal laser microscopy; 
• advanced cell-biological and biochemical techniques, 
including electrophoresis, high- pressure liquid 
chromatography, and in-vitro cell culture; 
• molecular genetic and recombinant DNA techniques, in¬ 
cluding DNA cloning and sequencing. Northern and 
Southern blotting, ILFLP mapping, and in-situ hybridiza¬ 
tion; 
• specialized monoclonal and polyclonal antibodies and 
protein markers; 
• the preparation of recombinant proteins in bacteria; 
• retroviral mediated gene transfer; 
• computer-assisted image analysis; 
• flow cytometry, the laser-induced flourescent analysis 
of cell cycles. 
Stephen L. Warren, M.D., assistant professor of pathology, 
loads a gel of cells cultured with the c-src oncogene. 
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are Vincent T. Marchesi, M.D.’63, Ph.D., the Anthony N. 
Brady Professor of Pathology, Cell Biology and Biology, and 
Sally Marchesi, M.D., professor of laboratory medicine and 
pathology. In collaboration with Dr. Morrow, this husband and 
wife team have identified cellular and genetic mechanisms in 
the cortical cytoskeleton that appear to cause hemolytic ane¬ 
mias—hereditary diseases in which red blood cells break 
down. This research stems from Dr. Vincent Marchesi’s pio¬ 
neering work at the National Institutes of Health in 1968, 
where as a Public Health Service medical officer he discovered 
spectrin—the main protein comprising the red blood cell 
cytoskeleton. 
Dr. Vincent Marchesi, director of the new Boyer Center for 
Molecular Medicine (BCMM), points out that sophisticated 
molecular tools now allow scientists to study normal and 
abnormal molecules in a cell at the same time—a dramatic 
advance since the late 196()s. “It's like having a window 
instead of trying to look through a brick wall,” he observes. 
Dramatic views from the window of molecular research 
have dramatically changed the way inherited anemias are diag¬ 
nosed. Today, Dr. Morrow explains, it’s not enough simply to 
detect red blood cell shape abnormalities under a light micro¬ 
scope: “Increasingly, you want to know what the molecular 
defect is, where the mutation is and in which protein.” 
Yale clinicians have found that genetic mutations affecting 
spectrin production in the cytoskeleton appear to account for 
two hemolytic anemia.s—hereditary elliptocytosis and heredi¬ 
tary spherocytosis. Awareness of such genetic factors has led 
to improved screening for hemolytic anemias, explains Dr. 
Sally Marchesi. Because of Yale’s expertise in this field, pedia¬ 
tricians from around the nation send blood samples of anemic 
patients for evaluation of difficult cases. 
“If we determine that it is a cytoskeletal defect, it’s quite 
Yale Pathologists Pursue 
Wide Range of Research 
Major research areas within the pathology department 
include: 
• molecular oncology involving breast, skin, ovarian and 
gastrointestinal cancers; 
• the molecular basis of oncogene action; 
• control of viral replication and infection (AIDS); 
• the molecular basis of neuronal changes in several 
diseases involving the brain, such as stroke, AIDS, and 
Alzheimer’s disease; 
• transplant rejection in heart, liver and kidney and the 
immunology of the vascular system; 
• cell-cycle control and mitotic structure; 
• cardiovascular pathology; 
• nonnal and abnormal endothelial and epithelial cell 
growth and differentiation; 
• gastrointestinal and immunological disorders in 
neonatal, pediatric or geriatric patients. 
• cellular and molecular basis of ischemic and 
anoxic injury. 
Drs. Sally and Vincent Marchesi. 
clear that splenectomy will improve the patient’s hematologic 
status,” Dr. Sally Marchesi says. That alone may normalize a 
patient’s blood counts. 
On another front. Professor of Pathology and Biology 
Michael Kashgarian, M.D.’58, employs his expertise in the 
pathogenesis of kidney injury and disease. In collaboration 
with Dr. Morrow, he is trying to identify molecular factors in 
the renal cortical cytoskeleton that help determine kidney cell 
polarity—the directional arrangement of proteins within each 
cell. Dr. Kashgarian explains that restoring the proper polarity 
is necessary to restore kidney function after acute ischemic 
damage, in which the organ is deprived of oxygen-rich blood 
due to a heart attack, traumatic injury or other such event. 
“We’re also interested in the way that injury initiated in the 
kidney seems to progress independently after the injury has 
been removed,” Dr. Kashgarian says. “When this secondary 
injury progresses to end-stage renal disease, the patient must 
have a kidney transplant.” Dr. Kashgarian hopes that research 
into molecular mechanisms underlying progressive renal fail¬ 
ure may lead to improved therapies to arrest the disea.se. 
The PathologisTs Little Black Bag_ 
In the quest to discover the root of a disease, “any tool is fair 
game if you can bring it to bear,” says Dr. Morrow. In roughly 
95 percent of cases, evaluation of morbid anatomy or the use 
of a light microscope provide enough information to make a 
.sound therapeutic decision. Yale’s pathologists employ a wide 
range of molecular tools, from electron microscopes to flow 
cytometry — the laser-induced analysis of cell cycles — to 
confimi other, less definitive clinical findings, or to gain a 
better understanding of the underlying causes of disease. [See 
“High-technology Tools Aid Today’s Pathologist.”] 
One of the most dramatic of these tools is polymerase chain 
reaction (PCR), a simple yet powerful biochemical technology. 
PCR can replicate and harvest unlimited amounts of DNA 
from the cells of any host, whether alive or dead, even the cells 
of Egyptian mummies. Capable of duplicating DNA from even 
a single cell, PCR offers an incomparable window on the 
world of gene amplifications and rearrangements. 
To maximize the u.se of its advanced investigational tools in 
the clinical .setting and to facilitate disease-related research in 
the University and throughout Connecticut, the pathology 
department has recently consolidated many of its activities in 
the Molecular Diagnostics Laboratory (MDL). The purpose of 
this facility is two-fold: 
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1) to make sophisticated and innovative molecular analyses of 
patient tissues available on a routine basis to practicing 
pathologists and clinicians; 
2) to serve as a resource that can provide patient tissues, and 
scientific and medical expertise to University scientists who 
may be working on problems with potential medical 
applications. 
Key areas of focus in the MDL include immunologic and 
molecular markers that identify specific tumors and the identi¬ 
fication of DNA alterations in solid tissue neoplasms. MDL 
also offers an oligonucleotide synthesis facility, used by 
researchers throughout the University. 
Dr. Michael Kashgarian recently served on an NIH panel 
which determined that the small amount of mercury used in 
tooth fillings did not pose a health risk to dental patients. 
One aim of the MDL is to serve as a principal resource for 
in-state hospitals and clinics. “We anticipate that in the next 
few years, we will become a much larger reference laboratory 
for the state,” Dr. Morrow says. Currently, six faculty and staff 
scientists participate in the MDL’s work; Dr. Morrow envi¬ 
sions that 10 or more faculty members will be directly 
involved in the laboratory’s efforts in coming years. 
In research as well as in patient care, cancer remains a pri¬ 
mary focus within pathology. Cancer studies illustrate the 
increasingly interdisciplinary nature of biomedical research. 
Take, for example, the use of flow cytometry to detect 
multi-drug resistance in patients undergoing chemotherapy. Dr. 
Flynn has been using various assays to measure expression of 
a molecule called P-glycoprotein. Using flow cytometry, he 
has found that elevated P-glycoprotein levels often correlate 
directly with multi-drug resistance—a finding helpful to col¬ 
leagues in oncology and pharmacology. 
By administering various drugs to modulate the effects of 
chemotherapy on patients with elevated P-glycoprotein levels, 
Yale clinicians are attempting to re-sensitize drug-resistant 
individuals to cancer therapy. Preliminary results of clinical 
studies have been encouraging. “That keeps us going day after 
day, because it is so exciting,” Dr. Flynn says. 
Dr. Flynn is also using flow cytometry in the prognosis of 
breast cancer with no lymph node involvement. Early findings 
from flow cytometry studies suggest that breast cancer patients 
with no evidence of chromosomal abnormalities or increased 
tumor proliferation may benefit from less aggressive therapy. 
A long-term follow-up study is now underway. 
Other Yale pathologists are trying to improve the chances of 
surviving breast cancer (the national mortality rate stands at 33 
percent) by predicting early in the course of disease which 
patients will be high-risk. Physicians hope to target chemother¬ 
apy and radiation more effectively by minimizing therapy to 
low-risk patients. 
That goal may be closer thanks to recent discoveries about 
the neu (also called erhB-2) protein, which represents a large 
family of oncogene products that are growth factor receptors. 
This area of research is the purview of David Stem, Ph.D., 
assistant professor of pathology and an expert in the genetic 
and molecular mechanisms that direct tumor growth. 
Dr. Stem explains that neu proteins act as receivers at the 
cell surface that sense the presence of growth-stimulating hor¬ 
mones, or growth factors, outside the cell. The receptors then 
initiate a chain of events inside the cell that eventually results 
in cell proliferation. 
Explains Dr. Stem: “Genes encoding proteins that act along 
this signalling chain are frequently altered in cancers because 
excessive stimulation of these pathways leads to uncontrolled 
cell division, a hallmark of cancer cells.” 
Dr. Stem’s laboratory is investigating the exact means by 
which the signal is transmitted across the cell membrane by 
growth factor receptors, and the cascade of intracellular events 
that follows. “Because the basic mechanisms of cell division 
are similar in unicellular and multicellular organisms,” notes 
Dr. Stern, “we are investigating these problems in yeast, which 
are amenable to the powerful tools of genetic analysis, as well 
as in mammalian cells.” 
Potential improvements in the diagnosis of breast cancer 
stem from recent findings suggesting that in 15 to 30 percent 
of breast tumors, the neu gene is altered; in these tumors, the 
gene is present in abnormally high numbers of copies. Drs. 
Stem and Flynn are studying whether neu protein overexpres¬ 
sion—in itself, a weak prognostic indicator—may point the 
way to a more reliable marker for breast cancer. 
Toward that end, the researchers are collaborating with 
Barry M. Kacinski, M.D., Ph.D., associate professor of thera¬ 
peutic radiology, obstetrics and gynecology. This team is test¬ 
ing specimens from hundreds of patients with breast or ovarian 
cancer to determine if severity of disease is associated with 
certain key alterations in the neu protein, known as autophos¬ 
phorylation. These complex biochemical changes may offer 
valuable insights into the biology of breast cancer. 
“There’s no doubt in my mind that either receptor autophos¬ 
phorylation or phosphorylation of receptor substrates will turn 
out to be strong diagnostic markers,” says Dr. Stem. This 
prospect offers the potential clinical application of improved 
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screening and more accurate ways to determine the stage of 
breast, ovarian and other cancers. 
Crucial Animal Research_ 
Laboratory animals make a vital contribution to human health 
through Yale pathology studies. Assistant Professor G. Paolo 
Dotto, M.D., Ph.D., has bred a line of transgenic mice that 
expresses key human oncogenes. The animals allow Dr. Dotto 
to study the production of primary epithelial tumors—cancers 
that closely resemble human carcinoma of the skin and cervix. 
Why not simply use cell cultures to learn about such 
tumors? 
“It is very important to use primary cells, cells freshly pre¬ 
pared from the animal,” Dr. Dotto notes, “because if you use 
cell lines, they probably will have undergone significant 
changes already. If you don't study all the steps, you might 
miss some that have already occurred.” 
In fact. Dr. Dotto’s research shows how cell culturing and 
animal studies complement each other: “You can genetically 
manipulate the cells in culture, put them back into the animal 
and study whatever your gene is doing in that situation.” 
By identifying key genetic signals and protein transforma¬ 
tions that occur in the first few minutes of epithelial tumor 
growth in mice. Dr. Dotto hopes to learn how human onco¬ 
genes and tumor suppressor genes, acting in concert, activate 
epithelial tumors—the bulk of solid tumors seen in humans. 
His team is also studying how healthy keratinocytes, the prin¬ 
cipal cell in the epidermis, suppress the growth of primary 
tumor cells by producing a molecule called “diffusable growth 
inhibitory factor.” 
Yale scientists also hope to develop new cancer treatments 
by studying how tumors are fed by blood vessels. On the vas¬ 
cular front, Joseph Madri, M.D., Ph.D., professor of pathology 
and biology, is trying to identify key molecular signals that 
direct the early stages of blood vessel formation in tumors. He 
is focusing on the role of certain cell surface receptors—pro¬ 
teins that bind to extracellular proteins in lock-and-key fash¬ 
ion, triggering a complex series of biochemical events that 
result in angiogenesis, the formation of new blood vessels. 
By learning how to inhibit or even arrest this process in its 
very early stages. Dr. Madri hopes to reduce or eliminate the 
blood supply to tumors and thus rob them of the oxygen and 
nutrients they need to survive. 
“If one could effectively modulate angiogenesis,” he says, 
“one would have a tremendous handle on the neoplasia prob¬ 
lem, on metastasis.” 
Taking the opposite tack, some vascular researchers in the 
Madri laboratory are learning how key cell surface receptors 
act to increase blood vessel growth. Dr. Madri speculates that 
such studies may one day allow scientists to develop 
improved, long- tenn skin grafts for bedridden elderly patients 
with decubitus ulcers and trauma patients with severe burns. 
The Madri team is afso studying how the endothelial cells 
that line the coronary arteries react to damage. “If we can 
better understand the response of the vessel wall to injury, we 
can design and execute therapies that will allow for a longer 
beneficial time following injury,” Dr. Madri says. The clinical 
goal; to minimi/.e the risk for blood vessels re-closing after 
patients have undergone coronary artery bypass grafting or 
angioplasty. 
.Some of the department’s most novel research involves 
viruses. Identifying and regulating factors that control viral 
reproduction is a principal concern of John K. Rose, Ph.D., 
professor of pathology, cell biology and biology. “He’s doing 
very novel molecular manipulations in genes, very revolution¬ 
ary,” Dr. Morrow says. 
Two years ago. Dr. Rose discovered that a key step in the 
assembly of the human immunodeficiency virus (HIV) could 
be blocked by a specifically mutated CD4 receptor molecule. 
Using molecular genetic tools to alter a part of the CD4 
molecule. Dr. Rose has created a soluble form of CD4 which is 
retained in the cell and binds the HIV glycoprotein before it 
can reach the cell surface—in effect, blocking HIV prolifera¬ 
tion by blocking viral exit from the cell. 
Challenges remain, however, before this in vitro work can 
yield an effective gene therapy for AIDS. “One would have to 
deliver this molecule in some way into a patient’s T-cells, prob¬ 
ably into stem cells of the bone marrow,” Dr. Rose explains. 
Scientists at Yale and elsewhere are attempting to design a safe 
and effective delivery system for Dr. Rose’s genetically engi¬ 
neered AIDS-blocker, a task that could take years. 
A Powerful Data Base 
AIDS researchers, cancer investigators and other scientists 
benefit from Yale’s pathology computerized data base, or Co- 
Path™, which the pathology department has been assembling 
since 1983. Developed at Yale by a team headed by Dr. 
Morrow and now marketed nationally, Co-Path is one of the 
nation’s most sophisticated and comprehensive anatomic 
pathology information systems. 
By September 1991, more than 750,000 patient records had 
been programmed into the data base, representing every 
patient specimen evaluated by the Yale pathology department 
since 1915. “We never purge our data,” Dr. Morrow says with¬ 
out a hint of overstatement. 
Information compiled during the past 50 years provides an 
especially valuable basis for retrospective or prospective stud¬ 
ies in the diagnosis, staging and management of many dis¬ 
eases. The pathology information system also offers direct 
clinical benefits: Its comprehensive data, when used in con¬ 
junction with those of the Yale Tumor Registry, enable the 
physician to determine whether a patient is experiencing a pri¬ 
mary or recurring condition. 
A Teaching Mandate 
The training of current and future clinicians and medical 
scientists is one of the primary missions of the pathology 
department. Toward that end, the department provides: 
• a required course for second-year medical students, in 
which all pathology faculty members participate; 
• a graduate course in cancer biology; 
• a graduate program with the department of biology, 
leading to a Ph.D. degree in experimental pathology, and 
giving the department membership in both the medical 
and graduate schools. Plans call for interdepartmental 
collaboration to teach a Yale College course in the biology 
of disease; 
• training for 18 residents preparing for board 
certification, plus six fellows; 
• frequent consultations and conferences for physicians 
from every major specialty—offering continuing 
education for practitioners and diagnostic pathologists. 
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Interdepartmental cooperation: Scott A. Weed (left), a graduate student in cell biology, discusses a sequencing gel with pathology 
chairman John Morrow. Mr. Weed is conducting research into disease-causing DNA mutations in muscle spectrin. 
Pathology’s place between basic research and clinical care 
will again be put to good use as the department takes a leading 
role in the new Boyer Center for Molecular Medicine 
(BCMM). It is no coincidence that Dr. Vincent Marchesi, 
former chairman of pathology, was named the first director of 
the Boyer center; BCMM is dedicated to interdisciplinary 
basic research that can be applied clinically. 
Many of the Boyer center’s 25 full-time faculty members 
and other scientists will collaborate with pathology researchers 
to evaluate molecular mechanisms underlying a range of dis¬ 
eases. During clinical consultations, seminars and other 
instructional presentations both within and beyond the Univer¬ 
sity, Yale’s pathologists will discuss key research and promul¬ 
gate important findings made by Boyer center scientists. 
“Because pathology involves every other clinical activity,” 
says BCMM director Marchesi, “pathology is going to be the 
unique vehicle by which the center can extend into the clinic, 
particularly in the areas of oncology and vascular biology.” YM 
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YM INTERVIEW: 
HARRY M. ZIMMERMAN 
What was neuropathology like at Yale in the 1930s? 
In the early 1930s neuropathology was virtually nonexistent in 
this country. 1 graduated from the medical school in 1927 and 
spent the next two years with Dr. Milton C. Winternitz, dean of 
the school and chairman of pathology, as a resident and then an 
instructor in pathology. One day he said to me, “We ought to 
have a section of neuropathology.” There was no one in the 
country to learn neuropathology from. The best place was Ger¬ 
many, where they had a well-organized department in Munich 
at the Deutsche Forschungsanstalt fur Psychiatrie. The head 
of the institute was a world-famous neuropathologist, Walther 
Spielmeyer. So I wrote to Spielmeyer, he accepted me and I 
left in February of 1929. Dr. Winternitz provided me with a 
Charles Linaus Ives fellowship to make it possible for me to 
travel. 
What was it like to study in Munich? 
I found in Spielmeyer's laboratory a large number of foreign 
students like me, who were learning neuropathology with the 
intent of taking the knowledge hack to their countries. That is 
where I met Ko Hirasawa of Japan. Fie became dean of the 
medical school of Kyoto University and a few years later 
became president of Kyoto University. Many of the fellows 
whom I trained were recommended originally to me for train¬ 
ing by Dr. Hirasawa. Altogether, I have trained 88 Japanese 
men, most of whom are professors or associate professors in 
Japan. At my 9()th birthday, 77 of them signed their business 
cards and presented them to me in a plaque. I came back from 
Spielmeyer's laboratory to New Haven and began organizing 
the section, along with my other duties in general pathology. 
One day, Winternitz said to me, “You're making slow 
progress. Would Spielmeyer be willing to come here and help 
you get the laboratory organized? Write him, tell him we will 
give him an honorarium of $10,000 if he will come to New 
Haven and work with you a few months.” So I wrote to Dr. 
Spielmeyer, who had never been to America before, and he 
accepted the offer. 
What were some of your first studies in the new section? 
During the Great Depression in the 1930s, it occurred to me 
that this epidemic, this crisis in funds and jobs, led to alot of 
starvation and produced alot of neurological disorders like 
beriberi and pellagra and should be studied experimentally. 
I studied the brains of dogs with beriberi produced by a 
deficiency of vitamin B1 and compared them to the human 
cases that we were getting because people were dying with 
these diseases all through the United States, especially in New 
Haven. There was a city dump where starving people would 
rummage through and eat the scraps. Eventually they deve- 
I'his interview was conducted hy Rosalind D'Eugenio, media 
specialist at the YSM Office of Public Information. 
Dr. Harry M. Zimmerman. 
Harry M. Zimmerman, M.D. ’27 
Right Man at the Right Place 
Harry M. Zimmerman, M.D. '27, is the dean of American neu¬ 
ropathology. Bom in 1901 in Lithuania, he graduated from 
Yale College in 1924 and the School of Medicine in 1927. 
Serving first as a resident and then an instructor in pathology 
under Dr. Milton C. Winternitz, Dr. Zimmerman studied nearly 
two years in Munich, Germany, to learn the emerging specialty 
of neuropathology. Upon his return to Yale in 1930, he estab¬ 
lished the first full-time neuropathology section in the country. 
During World War II, he served in the Pacific as a Comman¬ 
der in the medical corps in a research unit established by Vice 
Admiral Ross T. Mclntire, Surgeon General of the United 
States Navy. There he became an expert in Japanese encephali¬ 
tis and helped develop the first vaccine against the disease. 
After the war. Dr. Zimmerman was a founder of Albert Ein¬ 
stein Medical College in New York City, and established its 
neuropathology department. In the process of founding the 
school, he became a close friend of its famous namesake and 
was chosen by Dr. Einstein to perform the autopsy on his brain 
when the great physicist died in 1955. 
Eor decades neuropathology fellows and residents from 
around the world have come to New York City to study with 
Dr. Zimmerman. Eor his role in teaching many of the leading 
neurologists and neurosurgeons of Japan, in 1973 he was 
awarded the Order of the Sacred Treasure, that country's high¬ 
est civilian honor. And in 1981, Dr. Zimmemian became the 
first neuropathologist to receive the Gold Headed Cane Award 
from the American Association of Pathologists. 
Today, Dr. Zimmerman is an emeritus professor and consul¬ 
tant in the department of pathology at Albert Einstein Medical 
College/Montefiore Medical Center. 
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oped either beriberi or pellagra or both. We discovered that if 
you injected these dogs with a dose of vitamin A, kerotin or 
thiamine, it resulted in a response within 24 hours, so that a 
paralyzed animal was able to walk again even if their lesions 
were not completely healed. These experiments helped support 
the therapeutic practice of thiamine injections in human 
beriberi. When affluent times developed in '35, ’40, these dis¬ 
eases disappeared, nutrition was adequate. Then I began to 
work on brain tumors. A friend of mine at the Harvard Medical 
School produced a brain tumor in a mouse by injecting a 
chemical carcinogenic agent like methylcolatrete and brought 
me the slide of the brain to identify. I took over these experi¬ 
ments at Yale and wrote a series of papers which attracted 
Harvey Cushing’s attention and helped bring him to Yale. We 
had a neuropathology laboratory at New Haven better than any 
other in America at the time. I was the right man, at the right 
time, in the right place. 
Did you collaborate with Dr. Cushing when he was at Yale? 
Dr. Cushing arrived in New Haven with 2,000 brain specimens 
from all the operations he did in Boston. And with him came a 
complete transcription of all the clinical records of these 2,000 
cases. 1 looked at many of the specimens and would offer my 
views on the work. He had a system; on the anniversary of a 
brain operation that he did, either the patient would appear on 
a yearly basis or would write a letter describing his or her 
progress. Many patients appeared in New Haven. Cushing’s 
laboratory adjoined my own and if a patient came to see him 
that he thought I’d be interested in, he’d knock on the wall. 
That was a signal for me to come. 
In cases that were difficult to diagnose, the patient would be 
brought before the neurological study unit. The group met 
weekly and included representatives from neuroanatomy, neu¬ 
rophysiology and neurology, among them Harvey Cushing. 
Plans for treatment were outlined, and the student body was 
allowed to come in and listen to what these experts were talk¬ 
ing about. 
Harvey Cushing lived in a home where his backyard and 
my backyard were separated only by a fence. Periodically I’d 
get a call from him to come over and see a new rare book he 
just got. So I would hop the fence and he would unpack a book 
that now probably costs well over a million dollars. And he 
made a world-famous collection which is now at the Harvey 
Cushing/John Hay Whitney Medical Library. 
You performed Dr. Cushing’s brain autopsy, didn't you? 
Harvey Cushing told me about an illness he had in France in 
General Pershing’s army; while doing an operation, he col¬ 
lapsed and was paralyzed from the hip down. He was shipped 
back to Boston and was in bed for about four months until he 
recovered the use of his legs so that he was able to operate 
again. He always thought that he had a viral infection, a myeli¬ 
tis. Then one day, he said, “I feel numbness in my left hand. 1 
must have a lesion up on the right side of my brain. One day 
you’ll have a chance to look and see if I was right or not.” He 
asked that when he died, if I would do the autopsy. 
At his expressed wish I performed a postmortem examina¬ 
tion that revealed encephalomalaci of several gyri on the right 
side. The sudden onset of paralysis while in France was caused 
by a massive thrombus in the aorta that extended from below 
the renal arteries to the bifurcation of the iliacs. This old blood 
clot was already partly calcified. His paralysis wasn’t due to a 
viral infection after all. 
While we're on the subject of autopsies, your most famous was 
of Albert Einstein. How did you get to know him and how were 
you selected to perform the autopsy of his brain? 
I was asked in 1950 by the president of Yeshiva University 
to help build a medical school. 1 told him I wouldn’t help with 
a parochial school; 1 had enough of restrictions in the admis¬ 
sions of women, blacks and Jews, but he said they didn’t want 
a restricted school either. Then I asked if we had to call it 
Yeshiva University School of Medicine. And they said not if I 
didn’t want to. So 1 said okay, 1 will help you build a medical 
school. 
After 1 had raised $2.5 million, 1 thought we had enough 
money to start building the school. Now, what to call it? One 
of my advisors suggested calling it the Albert Einstein College 
of Medicine. 1 didn’t know Einstein, but I had a good friend in 
New York, Dr. Gustave Bucky, who did and got him to arrange 
a meeting for me. 
That was in January of 1953, on a blustery cold day. As we 
drove up to Einstein’s house, this man with disheveled gray 
hair came out, no necktie, with a gray woolen sweater, with a 
hole in one elbow, and no socks. He never wore stockings 
except on formal occasions. 
He greeted us and ushered us into the house. We talked a 
little while and pretty soon he said to me, “Dr. Bucky tells me 
you want to ask me something. What is it?” So I told him 1 was 
raising money to build a nonsectarian medical school. He liked 
the idea because he had suffered prejudice as a Jew in Ger¬ 
many and had to go to Switzerland when the Germans 
wouldn’t give him an appointment to the university. “In what 
way can I help?” he asked. I told him by letting us use his 
name. 
He was truly a modest man. He said, “Dr. Zimmerman, how 
would it look to the public to know that a non-M.D. is being 
given the name of a medical school?” So I said, “If you don’t 
let us use your name, then we’ll have to call it the Joseph 
Goldberger Medical School.” He said, “Who is Joseph Gold- 
berger?” I said, “If I call this the Albert Einstein College of 
Medicine, who would call me and say, ‘Who is Albert Ein¬ 
stein?”’ A twinkle in his eye arose and he turned to Dr. Bucky, 
and said, “Over the telephone you told me Dr. Zimmerman 
was an M.D. He sounds like a lawyer to me.” Then he gave us 
the use of his name for the school and we became very good 
friends. 
How were you selected to autopsy his brain? 
He asked me to. I agreed to do the autopsy and also to the con¬ 
dition that I didn’t write a paper on my findings. After he died 
and the brain was brought to me here at Montefiore, a reporter 
from the New York Times came and offered me $5,000 for a 
photo of a genius cell from Einstein’s brain. I told him I 
couldn’t do it. So he then offered me $10,000. I told him I 
couldn’t give him a photo of a genius cell because there was 
no such thing. I could have given him a photograph of Ein¬ 
stein’s brain, that’s not a genius cell. It’s not the way cells 
look. They don’t look any different from anyone else’s. It’s 
what they do that makes the difference. He was a genius 
because his cells were able to do things that neither you nor I 
can do. I got many letters from children saying they heard I 
examined Einstein’s brain and wanted to know what 1 found. 
So finally, the editor of the Book of Knowledge, a reference 
book they publish for children, wrote me and said would you 
write just a page explaining Einstein’s brain and other brains 
and so forth? So 1 got pemiission from the executor of the Ein¬ 
stein estate and did write a small article. 
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A 1973 photograph of Dr. Zimmerman and his wife. Miriam, at a reception in Japan after he received the Order of the Sacred 
Treasure, which is visible on his suit coat. 
E.xplain a little of the work you did in the North Pacific Islands 
on encephalitis and amyotrophic lateral sclerosis (ALS). 
In 1943, I was asked by the Navy and by the commanding offi¬ 
cer of Naval Medical Research to help set up a research unit in 
the Far Pacific. All kinds of rumors had arisen as to what tropi¬ 
cal diseases our soldiers would encounter. There was no record 
of what diseases were common, and many were neurological 
diseases. 
Tom Rivers, the chairman of that Naval Medical Research 
Unit, brought me to the Mariana Islands, where we conducted 
experimental work with cows, monkeys, dogs, sheep and 
chickens. We would stop at various islands and the peasants 
would meet the ships and we frequently gave them a couple of 
chickens. We'd go back a year or two later and found that they 
had built chicken coops and it changed their whole economy. 
You were promoted to commander cptickly. How did that come 
about'!’ 
After our re.search was well on its way, Tom developed a 
bleeding ulcer and had to go back to the states. He recom¬ 
mended me to the Bureau of Personnel in Washington to suc¬ 
ceed him as the Commanding Officer of our unit, but Dr. 
Richard ,Shope. of Princeton, was longer in the service than 1 
and had a higher rank. He would be the natural choice to suc¬ 
ceed Tom, but the bureau in Washington solved the problem by 
my early promotion to Commander. 
How did you come to investigate Japanese encephalitis? 
I went to Okinawa to establish a laboratory' on the beach of 
Bruckner Bay, and the Army sent in Albert Sabin, professor of 
virology at New York University, who joined my unit. The 
Army sent him in because an epidemic of Japanese encephali¬ 
tis was ravaging the island, and like polio, it involved mostly 
children. But our troops were going to land on Naha, the 
southern capital of Okinawa, and they were going to march up 
and clean out the Japanese that occupied Okinawa to the north 
end, which was several hundred miles distant. And the Army 
people got worried that some of our soldiers may come down 
with Japanese encephalitis. 
You and Dr. Sabin developed a vaccine didn't you? 
Yes. I was doing autopsies on children who had died from 
Japanese encephalitis, and 1 gave Sabin a fresh piece of brain 
from one such child. He injected the specimen into several 
hundred white Swiss mice and made a crude vaccine. He inoc¬ 
ulated 200.000 American soldiers who were going to go 
through the island. And not one developed Japanese encephali¬ 
tis. At that time, nobody really knew the pathology, so I wrote 
a paper on it during the w ar and it was published. 
What other diseases did you work with during the war? 
While 1 was on Guam I saw patients in the native hospital in 
Agana. The Japanese occupied the island and they only had 
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polished rice to live on, which does away with all the thiamine 
and all the vitamin A. So the natives who were eating only pol¬ 
ished rice came down with beriberi, which I was able to diag¬ 
nose and treat quickly. I also noticed some of the patients had a 
fatal paralytic disease like Lou Gehrig had, namely, amy¬ 
otrophic lateral sclerosis. The incidence seemed unusually 
high for the total population, so I confirmed the disease at 
autopsy and sent a report to Washington, alerting them. But the 
report was stamped “secret” and was not disclosed until after 
the war. 
In 1973, you received the Order of the Sacred Treasure by the 
Japanese emperor, the highest civilian award bestowed in 
Japan. How were you selected? 
Most of the Japanese who learn neuropathology learn it from 
me in America; some of the most influential neurologists and 
neurosurgeons in Japan are former students of mine. So the 
Japanese government, through the emperor’s office in Tokyo, 
invited me to receive the Order of the Sacred Treasure. 
My wife and I went to Japan, and at Hunata airport the 
stewardess opened the door and a band burst into the “Star 
Spangled Banner.” There was a whole committee to greet me 
and two small children brought my wife and me flowers. At 
the ceremony the commissioner of education made a speech 
and said, “You are hereby given the Order of the Sacred Trea¬ 
sure, second-class.” My wife jokingly asked the secretary who 
gets the first-class. He answered, “Only the emperor. General 
MacArthur got the Order of the Sacred Treasure, fourth-class. 
The Japanese hold teachers in higher esteem than generals or 
almost anybody else.” 
How has neuropathology changed during your career? 
There are fewer and fewer clinicians like neurologists and neu¬ 
rosurgeons and psychiatrists doing neuropathology. It has 
become technically so complicated with the advent of electron 
microscopy especially, that if you don’t devote your whole 
time to neuropathology, you don’t make any progress. Clini¬ 
cians have given up the study and especially the teaching and 
the experimental work in neuropathology. Neuropathology 
also has become a well-recognized specialty like pediatrics 
and surgery and medicine. Emphasis has shifted from descrip¬ 
tive morphology to considerations of etiology and pathogene¬ 
sis of diseases of the nervous system. 
What developments have most advanced the field of 
neuropathology ? 
Neurovirology has helped greatly in advancing neuropathol¬ 
ogy, especially in making it possible to work experimentally in 
areas of etiology. This is also true of electron microscopy, an 
instrument first employed by metallurgists and in recent years 
adapted to biology. Molecular biology is another field that has 
had a mutually beneficial impact on neuropathology. 
What do you think currently is the most exciting work taking 
place in neuropathology? 
This is probably in the field of Alzheimer’s disease, where the 
work of Dr. Robert Terry, whom I trained for six years and 
who is now professor of neuropathology at the University of 
California in San Diego, is outstanding. He has trained most of 
the researchers in degenerative diseases. His most recent 
research has led him to believe that amyloid has nothing to do 
with Alzheimer’s. 
A second field of great import is the Parkinson-Dementia- 
ALS complex that has been advanced by Dr. Asao Hirano, 
who has been at Montefiore for the past 36 years. And Dr. 
Elias Manuelidies at Yale was able to transmit the human 
Creutzfeldt-Jakob disease to guinea pigs, hamsters and mice. 
These are just a few examples of some very important 
advances. 
What do you feel is your greatest professional contribution? 
My training of all these people. I’ve got 39 professors in 
America I’ve trained, not only Japanese. The only Western 
country where 1 haven’t got a man trained in neuropathology is 
in England. In the 2nd World War, much of science in Ger¬ 
many was destroyed, so young Germans came here to learn 
neuropathology from me and to take it back to Germany. 
That’s the way I paid Spielmeyer back, you see. 
What other countries have your fellows come from? 
The three leading professors in neuropathology in France were 
trained here by me. An ambassador from Japan wrote me a 
long letter of thanks on behalf of the French government for 
training their neuropathologists. Some years ago, I was asked 
to chair an international meeting in Budapest. I was having 
lunch with Dr. Briole and my wife when a young man walked 
up to me and said, “Dr. Zimmerman, I want to introduce 
myself. I’m your grandson.” My wife looked at me in shock. 
Then the young man realized that he had to explain himself. 
He said, “You trained Dr. Hassoun and Dr. Hassoun trained 
me, so I’m your neuropathological grandson!” 
Three people in Israel were trained here by me. One of 
them was even the dean of the medical school in Tel Aviv. I 
trained two Greek neuropathologists, one Turkish neuropathol¬ 
ogist and several from South America, but not as many as from 
Japan. I now have seven fellows in training for whom the 
Japanese government supplies funds. 
With all the technological advances made in the field, are you 
still comfortable in neuropathology? 
To be frank with you, I haven’t got time to think of anything 
else. In addition to the seven fellows from Japan, I presently 
have several from this country. I haven’t got the opportunity to 
change my mind because I’m constantly doing more. And I get 
consultations from different doctors, neurosurgeons, different 
patients in different parts of the country, who send me in their 
histories and slides to make the diagnosis. Even if I wanted to 
get out of neuropathology, the demand on my service is such 
that I couldn’t entirely get out. Unless I told people 1 am no 
longer willing to help. 
What direction do you think neuropathology is taking, and 
what would you like to see happen in the field? 
I think the concentration will be in basic chemistry, virology to 
study the mechanism of brain function and nerve cell function. 
Obviously the functions are different from the glia, which is 
the supporting structure in the brain. We know practically 
nothing of what the glial cells really do. And certainly, we 
don’t know what brain ganglion cells do; and that requires 
ultra-microscopic chemistry, structures that deal not with 
structures that you can see with a naked eye, even with the 
electron microscope. It deals with subatomic structures. And 
that’s the function, molecular structure and function, that I 
think is the future of neuroscience in general and neuropathol¬ 
ogy as part of neuroscience. YM 
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GALLERY 
Portrait of Milton C. Winternitz and the Yale Pathology Department 
1926, photographer unknown 
In this portrait taken at the peak of the Roaring ’20s, Milton 
C. Winternitz, M.D., is pictured front and center. In 1926, 
he was serving his ninth year as chairman of the pathology 
department and his sixth year as medical school dean. 
Bom in Baltimore in 1885, Dr. Winternitz worked his 
way through college and medical school at Johns Hopkins 
selling penny insurance. Upon graduating with his M.D. 
degree in 1907, he continued his studies with Dr. William 
Henry Welch, a Yale College and Columbia medical school 
graduate who began the first modern pathology department 
at Johns Hopkins. Dr. Winternitz came to Yale in 1917 to 
establish the second such department. 
Under his leadership as dean. Sterling Hall of Medicine 
and Lauder Hall were built. He established the Institute of 
Human Relations to encourage interdisciplinary coopera¬ 
tion within medicine and with the social sciences, an idea 
that proved decades ahead of its time. He initiated the Yale 
System of medical education emphasizing independent 
study, and in 1923, at his behest, the University founded the 
Yale School of Nursing. 
Among his many accomplishments in biomedical 
research, in 1933, he initiated a study group on the biology 
of cancer that laid the groundwork for many subsequent 
discoveries in the field. In the 1940s, he collaborated with 
Dr. Max Taffel and others at Yale to isolate elements in 
nitrogen mustard gas that were used as the first cancer 
chemotherapy. 
Dr. Winternitz completed his deanship in 1935 and 
retired as pathology chair in 1950. He died in 1959 having 
left an indelible legacy for his department, the School of 
Medicine and Yale University. YM 
Gregory R. Huth, M.P.H. 
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SCOPE 
Dr. Lorraine V. Klerman 
Klerman Documents 
Poverty’s Effects 
On Poor Children 
A report authored by Lorraine V. 
Klerman, Dr.P.H., professor of public 
health, has documented the adverse 
influence of poverty on the nation’s 5 
million poor young children. “Alive 
and Well?; A Research and Policy 
Review of Health Programs for Poor 
Young Children” was released by 
Columbia University’s National Center 
for Children in Poverty. The review 
described the many ways that poverty 
can be hazardous to children’s health. 
According to the report, poor 
children are more likely than other chil¬ 
dren: 
• to be bom too early or too small; 
• to die in the first year of life; 
• to experience acute illness, injury 
or lead poisoning; 
• to experience abuse or neglect; 
• to suffer from nutrition-related 
problems and chronic illnesses 
— many of which are 
preventable. 
“The reasons for higher levels of 
health problems among poor infants 
and children are complex and difficult 
to analyze,” comments Dr. Klerman 
from her office in the Laboratory of 
Epidemiology and Public Health. “But 
they all lead to one overriding and 
disturbing indicator: that your chances 
of being healthy increase with your 
income.” 
Among the policy strategies 
suggested by the report to reverse this 
situation are to expand programs such 
as Special Supplemental Food Program 
for Women, Infants and Children 
(WIC) and Head Start, so that the 
programs could serve all the poor 
women and children who could benefit 
from them. The Klerman report also 
recommends adoption of a universal 
health care system and improved 
financing strategies that would offer 
adequate reimbursement to private 
practitioners who serve poor families. 
Scientists Find Sunlight 
Alters Cancer Gene 
By studying New England and Swedish 
patients, researchers have identified a 
gene—p53—that they say interacts with 
sunlight to lead to squamous cell car¬ 
cinoma, a common form of skin cancer. 
In normal skin cells, gene p53 limits 
cell division. However, the researchers 
report in the Nov. 15 issue of the 
Proceedings of the National Academy of 
Sciences, that the sun’s ultraviolet (UV) 
rays alter this gene. 
“Our results show for the first time 
how a common human carcinogen 
works,” says biophysicist Douglas E. 
Brash, Ph.D., assistant professor of ther¬ 
apeutic radiology and a member of the 
Yale Comprehensive Cancer Center. He 
led the eight-member, multidisciplinary 
research team from Yale, Massachusetts 
General Hospital, Dermatopathology 
Associates of New York in New 
Rochelle, and University Hospital in 
Uppsala, Sweden. 
“Sunlight is a carcinogen to which 
everyone is exposed, and is an example 
of an ’all-natural’ carcinogen,” Dr. 
Brash points out. 
Skin cancer, usually caused by 
overexposure to sunlight, is the most 
common cancer in the United States. 
According to the Centers for Disease 
Control, 632,000 new cases are reported 
each year, and 8,500 deaths annually 
result from the disease. 
Of 24 patients, 72 percent from New 
England and 46 percent from Sweden 
showed changes in the p53 gene, identi¬ 
fied by sequencing the gene’s DNA. 
The mutations did not appear to be 
inherited and did not resemble changes 
found in cancers of internal organs, such 
as colon and lung. Instead, Dr. Brash 
concludes that the mutations resembled 
those caused by ultraviolet light, a com¬ 
ponent of sunlight. 
The researchers chose p53, originally 
discovered elsewhere in 1979, as a 
candidate gene because they knew that 
the mutated p53 gene causes 
premalignant lesions in mouse skin. The 
same gene, p53, is also altered in other 
types of cancer. 
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Three-Year Grant 
Supports Tanaka Study 
As part of its Focused Giving Program, 
Johnson & Johnson has committed 
$270,000 over three years to support 
research that Kay Tanaka, M.D., profes¬ 
sor of genetics, will conduct at the Yale 
University School of Medicine. 
Dr. Tanaka will examine the molecu¬ 
lar structure of three inherited disorders 
of fatty acid metabolism. The project is 
intended to contribute to the 
development of new, accurate 
diagnostic tests and to increase 
understanding of the diseases. 
Johnson & Johnson has awarded pre¬ 
vious awards to Yale’s department of 
genetics toward the development of the 
DNA Diagnostic Laboratory and to 
Charles A. Janeway Jr., M.D., professor 
of immunobiology, biology and in the 
Cancer Center, for studying the function 
of cells in the immune system. 
29 
Lead Hazard to Bridge 
Workers Studied 
Construction workers involved with 
bridge rehabilitation in Connecticut are 
the focus of a five-year, federally 
funded study and surveillance project 
designed to limit lead exposure hazards. 
Yale researchers in the 
occupational/environniental medicine 
program are conducting the study in 
cooperation with other occupational 
medicine clinics throughout the state, 
the state departments of health and of 
transportation, several labor unions and 
the construction industry. 
CRISP, the Connecticut Road 
Industry Surveillance Project, is 
supported by $849,600 from the 
National Institute for Occupational 
Safety and Health of the Centers for 
Disease Control. 
This funding comes at an auspicious 
time, notes Kathleen F. Maurer, M.D., 
M.P.H., a postdoctoral associate in 
occupational medicine, because the 
Connecticut Department of 
Transportation is midway through a 10- 
year, $7.5 billion bridge rehabilitation 
program involving 3,700 bridges, more 
than 2.000 of which still are coated with 
lead-based paint. 
Dr. Maurer directs the project under 
its principal investigator. Dr. Mark R. 
Cullen, director of the occupational/ 
environmental medicine program and an 
associate professor of medicine and epi¬ 
demiology at Yale. 
Dr. Maurer explains, “The project 
will establish a state-wide medical eval¬ 
uation system to identify and treat work¬ 
ers with lead toxicity from bridge 
repair." She and her colleagues, 
including industrial hygienist Irene 
Smith of Groton, will “propose remedial 
action for health and safety hazards 
found at bridge sites, and also establish 
a computer infonnation system to docu¬ 
ment occupational disease among 
construction workers." 
Concern over lead poisoning in 
bridge w(vrkers was heightened in the 
fall of 1989 when the occupational 
health center at Lawrence and Memorial 
Hospitals in New London, Conn., which 
is affiliated with Yale, identified eight 
construction workers from a single com¬ 
pany who tested positive for lead 
toxicity. Subsequently, the Lawrence 
and Memorial occupational health care 
professionals discovered workers from 
other companies who had high lead 
levels. 
For bridge workers, lead exposure 
generally comes when layers of old 
lead-based paint are sandblasted off 
steel bridges, and the workers inhale or 
ingest lead dust particles. 




The Yale Corporation has approved 
changes in the names of the department 
of human genetics and the section of 
neuroanatomy recommended by the 
School of Medicine's Board of 
Permanent Officers. 
To reflect more accurately its current 
breadth, the department of human 
genetics, chaired by Carolyn W. 
Slayman. Ph.D., becomes the 
department of genetics. The department 
encompasses basic research, teaching, 
diagnostic laboratories, patient care and 
clinical research in all aspects of 
genetics. 
The section of neuroanatomy, headed 
by Pasko Rakic, M.D., Sc.D., the Dorys 
McConnell Duherg Professor of Neuro¬ 
science, becomes the section of neurobi¬ 
ology, which has this broader field as its 
research and educational mission. 
The name change also benefits 
faculty with joint appointments in such 
areas as anesthesiology, neurosurgery, 
ophthalmology, otolaryngology and 
psychiatry. In addition, the change will 
facilitate research funding and 
recruitment of faculty and students. 
Yale Study Disputes 
Alcoholism Gene 
A gene that has been claimed to cause 
t alcoholism may not be related to the 
'7 disorder according to a team of Yale 
I researchers. Dr. Joel Gelemter, assistant 
■o professor of psychiatry at Yale and chief 
of the laboratory of psychiatric genetics 
at the Department of Veterans Affairs 
Medical Center in West Haven, has 
shown no association between the D2 
dopamine receptor gene (DRD2) and 
alcoholism. 
The gene in question, is really a 
marker and because the original study 
indicated that alcoholics have an 
increased incidence of the marker, 
scientists felt a link between the actual 
gene, which codes for a chemical called 
dopamine, and alcoholism was likely. 
At issue is whether the presence of a 
genetic marker known as “A1 allele” on 
that gene predisposes a person to 
alcoholism or other behavioral 
disorders. 
A new study has been unable to 
repeat results indicating a genetic 
association with alcoholism. “We were 
not able to replicate the results pre¬ 
viously reported,” states Dr. Gelemter. 
His data does not support an associa¬ 
tion between a marker for the gene 
DRD2 (the dopamine D2 receptor gene) 
and alcoholism. 
The authors studied 44 unrelated 
white subjects diagnosed as alcoholic 
and a random sample of 68 white 
subjects. They compared the frequency 
with which A1 or A2 appeared at DRD2 
in the alcoholics and the controls. 
The Yale/VA team of researchers 
lead by Dr. Gelemter include: Stephanie 
S. O’Malley, Ph.D., associate professor 
of psychiatry and director of Alcohol 
and Drug Treatment Unit at the 
Connecticut Mental Health Center in 
New Haven; Neil J. Risch, Ph.D., 
associate professor of public health and 
genetics; John H. Krystal, M.D., 
assistant professor of psychiatry and 
chief of neuropsychiatric studies unite at 
the VA; Kathleen R. Merikangas, Ph.D., 
associate professor of psychiatry and 
epidemiology; Kenneth L. Kidd, M.D., 
professor of genetics, psychiatry and 
biology; Henry R. Kranzler, assistant 
professor of psychiatry and director of 
the division of addictive disorders at the 
University of Connecticut. 
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Program Opened 
For Autistic Adults 
Christopher J. McDougle, M.D., 
assistant professor of psychiatry, and the 
Yale Child Study Center have started 
the Yale Adult Pervasive 
Developmental Disorders Program, one 
of the first programs dedicated solely to 
studying and treating adults with autism 
and related disorders. 
The Yale Child Study Center has an 
internationally known program to study 
and treat autistic children, which 
includes studies of autistic adults. In its 
30-year history, the center has studied 
the neurobiology of autism and autistic 
adults. 
Advising the adult program are Child 
Study Center Director Donald J. Cohen, 
M.D., the Irving B. Harris Professor of 
Child Psychiatry, and Fred R. Volkmar, 
M.D., the Harris Associate Professor of 
Child Psychiatry in the Child Study 
Center. Drs. Cohen and Volkmar are 
professor and associate professor, 
respectively, of pediatrics, psychiatry 
and psychology. 
Dr. Cohen comments: “The 
knowledge about adults with autism that 
will be gained from the work of Dr. 
McDougle will shed important light on 
underlying processes and better ways of 
caring for autistic individuals as whole 
people.” 
To date, most autism research has 
focused on children. Approximately 1 in 
2,000 people suffer from autism. Dr. 
McDougle estimates. But as autistics 
grow into adults, their symptoms often 
change, leading to misdiagnosis, he 
says. Also, most governmental funding 
for education and other services for 
autistic people runs out when they turn 
21. 
Extending previous work with 
autistic individuals pioneered by the 
Child Study Center, Yale's new program 
began last fall to study and treat adults 
between the ages of 18 and 70. 
Participants attend twice monthly 
outings designed to enhance social 
skills. A group of 25 autistic adults, all 
from the New England area, participates 
in such activities as bowling and 
shopping. The program has begun a 
support group in which parents, friends, 
professionals and others meet monthly 
to discuss results of ongoing research 
and new ideas. 
In the research program, Yale faculty 
members are studying the biochemistry 
of autism, especially the relationship 
between autism and serotonin, a potent 
chemical in the brain that transmits 
nerve impukses between cells. Serotonin 
is thought to be involved in controlling 
mood and social behavior. Child Study 
Center researchers first noted a link 




Dr. Donald J. Cohen 
Child Study Center Aids 
Police in New Program 
Leaders of the New Haven Department 
of Police Services and the Yale Child 
Study Center have announced an 
innovative, cooperative venture to 
reduce the impact of violence on the 
lives of the children of New Haven. 
During the past several months, 
faculty members of the Child Study 
Center and New Haven Police officers 
have collaborated to develop: 
• a graduate-level course on child 
development for all police 
recruits; 
• a system for officers in the field to 
receive consultation about, and 
referrals for, clinical interventions 
for at-risk youth; 
• a fellowship for selected police 
officers to learn about available 
mental health services for 
children. 
The program is funded by a $50,000 
Rockefeller Foundation grant and 
$50,000 in private donations and is part 
of a broader effort by the University, 
New Haven Police, and the New Haven 
public school system to coordinate their 
response to the emotional needs of chil¬ 
dren exposed to violence. 
The program developed out of the 
Police Department’s community 
policing program and the Child Study 
Center’s Forum on Education and 
Society, created this year in response to 
concerns about children’s fears 
emerging from the Persian Gulf War. 
“However,” points out Dr. Donald J. 
Cohen, director of the Child Study 
Center, “we soon realized that the most 
immediate sources of trauma for inner 
city children occurred much closer to 
home, in the violence they experience in 
their daily lives.” 
New Haven Police Chief Nicholas 
Pastore observes, “The worst victims of 
violence are children. They are sub¬ 
jected to violence directly and trauma¬ 
tized by their exposure to the violence 
they must witness in their daily lives. 
Children, especially poor children in our 
society, have the fewest resources avail¬ 
able to protect themselves,” he adds. 
Robert Venturi To Design 
Clinical Science Building 
Robert Venturi, winner of the 1991 
Pritzker Prize — one of the most presti¬ 
gious awards in architecture — has been 
commissioned to design the School of 
Medicine’s Laboratory for Clinical 
Science. The five-story structure will 
offer the latest technology to physician- 
scientists and other basic researchers 
from a variety of disciplines as they 
conduct studies to advance clinical care. 
Mr. Venturi is principal architect in 
charge of design at Venturi, Scott 
Brown and Associates, Inc. (VSBA), 
based in Philadelphia. VSBA has 
garnered 80 major design awards since 
it was founded in 1966. 
VSBA’s projects include two 
research laboratories at Princeton 
University and science buildings at the 
University of Pennsylvania, Dartmouth 
College and the University of California 
at Los Angeles. VSBA will collaborate 
with Payette Associates of Boston, a 
specialist in designing laboratory 
modules inside research buildings. 
In announcing the selection, Yale 
President Benno C. Schmidt Jr. said, “I 
am tremendously pleased that Robert 
Venturi will undertake a major commis¬ 
sion at Yale at the medical school, 
where the University in recent years has 
enjoyed such important and interesting 
architectural contributions.” 
The location of the Laboratory for 
Clinical Science has yet to be 
determined. 
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Dr. Lawrence S. Cohen 
Lawrence S. Cohen Named 
YSM Acting Deputy Dean 
Lawrence S. Cohen, M.D., a world- 
renowned cardiologist, research scien¬ 
tist and educator, has been named acting 
deputy dean of the medical school. Dr. 
Cohen, the Ebenezer K. Hunt Professor 
of Medicine and an attending physician 
at Yale-New Haven Hospital, has been a 
Yale faculty member for 21 years. He 
was named to his endowed professor¬ 
ship in 1981. 
Dr. Cohen is past president of the 
Connecticut Affiliate of the American 
Heart Association (AHA) and has been 
active nationally with the AHA's 
Council on Clinical Cardiology and the 
.Scientific Sessions Committee. Dr. 
Cohen's early research focused on 
cardiac catheterization. In the mid- 
196()s, at the National Heart Institute, he 
was one of the first investigators to 
perform x-rays of the heart's arteries. 
Subsequently, he developed a major 
interest in coronary artery disease. 
For the past eight years. Dr. Cohen 
has been a principal investigator at Yale 
in the area of thrombolytic, or blood- 
clot dissolving, therapy to treat patients 
with a kind of heart attack called acute 
myocardial infarction (MI). He also 
directs Yale's TIMI clinic program, part 
of a multicenter study on different 
aspects of the most appropriate 
treatment of Ml patients using 
thrombolytic therapy. 
A native of New York, N.Y., Dr. 
C’ohen received an A.B. degree in I9.‘i4 
from 1 larvard College and an M.D. 
degree in 19S8 from New York 
fi'niversity. He completed his internship 
and residency training at YNHH. He 
served as associate professor of 
medicine and chief of clinical 
cardiology at the University of Texas 
(Southwestern) Medical School in 
Dallas between 1968 and 1970, after 




Dr. Leon E. Rosenberg 
Leon Rosenberg Resigns 
To Accept Corporate Post 
Leon E. Rosenberg, M.D., has resigned 
as medical school dean to become presi¬ 
dent of Bristol-Myers Squibb 
Pharmaceutical Research Institute. Dr. 
Rosenberg, who had served as medical 
school dean since July 1984, began his 
new post on Sept 1. 
Yale President Benno C. Schmidt Jr. 
named fomier Deputy Dean Robert M. 
Donaldson Jr., M.D., a gastroenterolo¬ 
gist, as acting dean. Dr. Lawrence S. 
Cohen, a cardiologist who is the 
Ebenezer K. Hunt Professor of Medi¬ 
cine, is serving as acting deputy dean. 
President Schmidt will chair the search 
committee for Dean Rosenberg's 
successor. 
Dr. Rosenberg commented. 
“Throughout my career at Yale, I have 
endeavored to educate young scientists 
and to employ scientific methods to 
understand disease mechanisms and help 
patients with inherited disorders. I am 
excited about the opportunity to join a 
leading health care company whose mis¬ 
sion, similarly, is to use science to 
improve human health. I will be fortu¬ 
nate beyond measure if my years at Bris¬ 
tol-Myers Squibb turn out to be as fulfill¬ 
ing and meaningful as my years at Yale.” 
An internationally known research 
geneticist, teacher and clinician. Dr. 
Rosenberg began his 26-year career at 
Yale in 1965 as an assistant professor of 
medicine, and in 1972 was appointed 
professor and the first chairman of a 
new department of human genetics. In 
1980, he was named C.N.H. Long 
Professor of Genetics. 
During his deanship. Dr. Rosenberg 
advanced the school’s missions in teach¬ 
ing, research and patient care. He 
provided leadership for the school’s 
capital campaign that raised $155 
million to increase endowment, help 
meet research and program needs, and 
provide new and renovated facilities. 
Several major construction projects 
were completed, including the Boyer 
Center for Molecular Medicine, the Yale 
Psychiatric Institute, the Yale 
Physicians Building, expansion and ren¬ 
ovation of the Harvey Cushing/John 
Hay Whitney Medical Library, 
renovation of the Boardman Building 
for the Yale Eye Center, and 
construction of the Magnetic Resonance 
Center, the latter a joint project with 
Yale-New Haven Hospital. 
An academic plan to chart the 
school’s strategic course in the 1990s 
was completed, and a department of 
orthopaedics and rehabilitation, a 
section of immunobiology and a center 
for medical infonnatics were 
established. An Office for Minority 
Affairs was also set up. 
Said Mr. Schmidt, “Lee Rosenberg is 
an extraordinary man who has made 
extraordinary contributions to Yale Uni¬ 
versity and its School of Medicine. His 
vision, drive and inexhaustible energy 
have contributed to a remarkable dean- 
ship. His years as dean have seen not 
only significant growth in virtually 
every critical field of medical education 
at Yale, but also a great invigoration of 
the school, its facilities and its program. 
We will miss him, and we wish him 
well.” 
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Benno Schmidt Names YSM Dean Search Panel 
Sixteen members of the Yale faculty serve on the committee to search for a new 
dean for the School of Medicine. Yale President Benno C. Schmidt Jr., chairs 
the committee. Carolyn W. Slayman, Ph.D., Sterling Professor of Genetics and 
chair, department of genetics, serves as vice-chair. 
Other members include; 
Thomas N. Byrne, M.D., associate clinical professor of neurology: 
Edwin C. Cadman, M.D., Ensign Professor of Medicine and in the Cancer 
Center, and chair of the department of internal medicine: 
Donald J. Cohen, M.D., director of the Child Study Center, Irving B. Harris 
Professor of Child Psychiatiy, and professor of pediatrics, psychiatry, and 
psychology: 
Lawrence S. Cohen, Ph.D., acting deputy dean of the School of Medicine and 
Ehenezer K. Hunt Professor of Medicine, ex officio: 
Gerhard H. Giebisch, M.D., Sterling Professor of Cellular and Molecular Phys¬ 
iology: Dr. Barbara Kinder, professor of surgery and in the Cancer Center, 
and chief of surgery at the Department of Veterans Affairs Medical Center: 
Forrester A. Lee, M.D., assistant professor of medicine: 
Vincent T. Marchesi, M.D., Ph.D., director of the Boyer Center for Molecular 
Medicine and Anthony N. Brady Professor of Pathology, Cell Biology, and 
Biology. 
Judith Rodin, Ph.D., dean of the Graduate School of Arts and Sciences, profes¬ 
sor of medicine and psychiatry, and chairman of the Mac Arthur Eoundation 
Center for Studies of Health and Behavior Psychology: 
Frank T. Ruddle, Ph.D., Sterling Professor of Biology and Genetics and chair¬ 
man of the biology department: 
Alan C. Sartorelli, M.D., Alfred Gilman Professor of Pharmacology and direc¬ 
tor of the Comprehensive Cancer Center: 
Clarence T. Sasaki, M.D., Charles W. Ohse Professor of Surgery and in the 
Cancer Center: 
Burton H. Singer, Ph.D., associate dean for public health, Ira V. Hiscock Pro¬ 
fessor and chairman of the department of epidemiology and public health, 
and professor of economics and statistics: 
Joan A. Steitz, Ph.D., professor of molecular biophysics and biochemistry: 
Joseph B. Warshaw, M.D., professor and chairman, department of pediatrics. 
James D. Jamieson 
Appointed M.D., Ph.D. 
Program Director 
James D. Jamieson, M.D., Ph.D., 
professor and chairman of the 
department of cell biology, has been 
appointed director of the School of 
Medicine M.D., Ph.D. program. 
The program enrolls a limited 
number of qualified students who 
complete the first four terms of the med¬ 
ical school curriculum, then a doctoral 
thesis and clinical clerkships in the 
department in which the Ph.D. degree is 
sought. Students pursue a course of 
study which ultimately leads to joint 
M.D., Ph.D. degrees in any of the 
relevant graduate programs of the 
University. 
The M.D., Ph.D. program, which 
began in 1968 and graduated its first 
students in 1973, currently enrolls 61 
students, 13 percent of students at the 
medical school. 
Dr. Donald M. Engelman 
Donald Engelman 
Named Acting Dean 
Of Undergraduates 
Donald M. Engelman, Ph.D., professor 
and chairman of molecular biophysics 
and biochemistry (MB&B), has been 
named acting dean of Yale College by 
Yale President Benno C. Schmidt Jr. 
beginning July 1 while Dean Donald 
Kagan is on a year-long leave from the 
University. The Yale Corporation 
confirmed the appointment at its 
November meeting. 
Dean Kagan, a historian of ancient 
Greece, will spend the year at the 
Institute for Advanced Study in the 
Behavioral Sciences at Stanford Univer¬ 
sity, where he will work on a long- 
planned book about the origins of war. 
Dean of the University’s 5,100 
undergraduates since July 1989, Profes¬ 
sor Kagan plans to return to Yale July 1, 
1993, to resume his post as the 
College’s chief academ.ic and 
administrative officer. 
In announcing the selection. 
President Schmidt stated: “1 am very 
pleased Don Engelman has agreed to 
accept the important responsibilities of 
the acting dean of Yale College. He is 
an outstanding scientist. He is a proven 
administrator. He has a broad 
understanding of the values of liberal 
education. He is devoted to students and 
has been deeply in the academic and 
social life of Yale College.” 
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Faculty 
News 
Dr. Paul G. Barash 
Paul Barash Named 
Associate Dean 
For Clinical Affairs 
Paul G. Barash. M.D.. chairman and 
chief of the department of 
anesthesiology at the medical school 
and YNHH, has been named associate 
dean for clinical affairs. In his new posi¬ 
tion. Dr. Barash will administer the 
comprehensive, specialty outpatient 
care that Yale faculty physicians provide 
through the Faculty Practice Plan. 
Dr. Barash's appointment, effective 
July 1. is concurrent with his 
departmental chair. He succeeds 
Richard H. Greenspan. M.D.. professor 
of radiology, who will return to 
teaching, research and patient care. 
In announcing the appointment, 
former medical school Dean Leon E. 
Rosenberg stated: “Paul Barash has 
demonstrated his leadership, scholarship 
and organizational skills at the School 
ol Medicine and Yale-New Haven 
Hospital. His diverse experience will 
enhance the administration of the 
school's clinical programs. We can be 
assured of a smooth transition from 
Dick Greenspan's five years of able ser¬ 
vice to Paul Barash's new and exciting 
vision for clinical service at Yale." 
Dr. Barash came to Yale as an 
assistant professor of anesthesiology in 
1973. and a decade later was named 
chairman and chief of the department of 
anesthesiology. He also serves on the 
YNHH board of trustees, and between 
1974 and 1982 directed the surgical 
intensive care unit. 
His research has centered on patients 
with cardiovascular disease who 
undergo surgery, the use of new drugs in 
aesthesiology, children's responses to 
anesthesia during surgery, and the phar¬ 
macology of cocaine. Twelve years ago. 
Dr. Barash and colleagues introduced 
echocardiography to the operating 
room. This technique uses ultrasound to 
monitor the heart during surgery. 
Dr. Barash has served as president of 
the Connecticut State Society of 
Anesthesiologists and president of the 
Society of Cardiovascular Anesthesiolo¬ 
gists. A fellow of the American College 
of Anesthesiology, he also serves as a 
senior examiner of the American Board 
of Anesthesiology, which certifies anes¬ 
thesiologists. 
Dr. Barash is senior editor of the 
textbook Clinical Anesthesia and serves 
on the editorial boards of the Journal of 
Clinical Monitoring and the Journal of 
Clinical Anesthesia. 
A Brooklyn, N.Y., native. Dr. Barash 
received a B.A. degree from the City 
College of New York in 1963 and an 
M.D. degree from the University of 
Kentucky College of Medicine in 1967. 
He completed his internship at Kings 
County, N.Y., Medical Center and 
residency training at Yale-New Haven 
Hospital, where he was chief resident. 
Genetics Sponsors 
Visiting Professor 
As part of a National Science 
Foundation initiative to encourage the 
participation of women in U.S. science 
and engineering research, Terry Ashley, 
Ph.D., an adjunct research associate 
professor at the University of 
Tennessee-Knoxville, is spending two 
years in Yale's genetics department. Her 
research will attempt to transfer 
techniques for mitotic labeling of DNA 
sequences for light and electron 
microscopy to both meiotic 
chromosomes and nuclei. 
Ms. Ashley also will develop and 
coordinate a .series of guest lectures by 
women in genetics, a series jointly 
spon.sored by the department of genetics 
and the office for women in medicine. 
Ralph Horwitz Named 
To Hines Professorship 
Ralph Horwitz, M.D., has been named 
the Harold H. Hines Jr. Professor of 
Internal Medicine and of Epidemiology 
and Public Health. A leading scholar in 
the field of clinical epidemiology. Dr. 
Horwitz came to the University in 1978 
as an assistant professor of medicine 
and co-director of the Robert Wood 
Johnson Clinical Scholars Program at 
the School of Medicine. In 1982, he was 
named associate professor and chief of 
the section of general internal medicine 
and in 1983, associate professor of 
epidemiology. 
Dr. Horwitz has made major 
contributions toward improving the 
quality of basic data used in clinical 
research, including the development of 
rigorous methodologic standards for 
observational case-control studies and 
the development of new methods to 
improve research on the efficacy of 
therapeutic agents. His methods have 
been used in studies on the cause-and- 
effect relationships of estrogen and 
endometrial cancer, tampons and toxic 
shock, and anticoagulants and 
myocardial infarction. 
Dr. Horwitz earned his B.A. degree 
from Albright College in 1969 and his 
M.D. degree from the Pennsylvania 
State University College of Medicine in 
1973. He served his internship at the 
Royal Victoria Hospital of McGill 
University in Montreal and was a fellow 
of the Robert Wood Johnson Clinical 
Scholars Program at Yale from 1975 to 
1977. He was a senior assistant resident 
at Massachusetts General Hospital from 
1977 to 1978. 
A fellow of the American College of 
Physicians and the American College of 
Epidemiology, Dr. Horwitz has won 
several awards for his work, including 
the C.V. Mosby Award for General Aca¬ 
demic Excellence from the 
Pennsylvania State University College 
of Medicine (1973) and the Henry J. 
Kaiser Family Foundation Faculty 
Scholar Award (1981-1986). In addition 
to his teaching, research and administra¬ 
tive work, he also serves as a reviewer 
for numerous medical journals, 
including the American Journal of 
Epidemiology, the American Journal of 
Medicine and the Journal of the 
American Medical Association. 
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28 Faculty Members Appointed, Promoted 
The Office of the Dean at the School of Medicine has announced the following 
appointments or promotions to senior ranks, effective July 1. In recognizing fac¬ 
ulty members’ excellence in teaching, research and patient care, these faculty 
become members of the Board of Permanent Officers (BPO), the school’s 
governing board which is responsible for major academic decisions. 
Five faculty members were appointed to senior ranks with tenure. They 
include: Peter Cresswell, Ph.D., professor of immimohiology; Gerald H. 
Friedland, M.D., professor of medicine: Jordan S. Pober, M.D., professor of 
pathology: Reinhard Jahn, Ph.D., associate professor of pharmacology: and 
Joseph Santos-Sacchi, Ph.D., associate professor of surgery (otolaryngology). 
Eighteen faculty members in various departments were promoted to 
professor, the highest academic rank. They are: William Agnew, Ph.D., cellular 
and molecular physiology: Margaret J. Bia, M.D., medicine: Michael B. 
Bracken, Ph.D., epidemiology: Toni Claudio, Ph.D., cellular and molecular 
physiology: Gary S. Kopf, M.D., surgery (cardiothoracic): Jeffery Koscis, 
Ph.D., neurology: Carole C. LaMotte, Ph.D., surgery (neurosurgery) and 
anesthesiology: Robert LaMotte, Ph.D., anesthesiology and neurohiology: 
Brian Leaderer, Ph.D., epidemiology (environmental health): Robert M. Liskay, 
Ph.D., therapeutic radiology: Joseph Madri, yi.D., pathology: Ira Mellman, 
Ph.D., cell biology: Manohar M. Panjabi, Ph.D., orthopaedics and 
rehabilitation: Richard R. Pelker, M.D, orthopaedics and rehabilitation: 
Richard E. Peschel, M.D., therapeutic radiology: Gary Rudnick, Ph.D., 
pharmacology: Sally E. Shaywitz, M.D., pediatrics and in the Child Study 
Center: and Frederick J. Sigworth, Ph.D., cellular and molecular physiology. 
Five faculty members were promoted to associate professor with tenure, 
including J.G. Collins, Ph.D., anesthesiology: Daniel C. DiMaio, M.D., Ph.D., 
genetics: Susan Hockfield, Ph.D., neurobiology: Richard J. Robbins, M.D., 
medicine: and William B. Stewart, Ph.D., surgeiy (anatomy). 
These faculty members may hold joint appointments with one or more of the 
following institutions affiliated with the medical school: Yale-New Haven 
Hospital, the Department of Veterans Affairs Medical Center in West Haven and 
the John B. Pierce Laboratory. 
Eleanor R. Adair, Ph.D., senior 
research scientist and lecturer in 
psychology and a fellow at the John B. 
Pierce Laboratory, has been honored by 
the Institute of Electrical and 
Electronics Engineers with the United 
States Activities Board Award for her 
paper entitled “Currents of Death Recti¬ 
fied.’’ The award recognized 
outstanding journalistic or other efforts 
that contribute to the enhancement and 
expansion of public understanding of 
the engineering profession. 
Edward A. Adelberg, Ph.D., professor 
emeritus of genetics, was honored with 
a symposium, “Bacterial Genetics: Past, 
Present, Euture,’’ by the department of 
human genetics in May. 
Erank J. Bia, M.D., associate professor 
of medicine and laboratory medicine, 
was selected by the W.K. Kellogg Foun¬ 
dation for its National Fellowship 
Program. The program, established in 
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1980, increases individuals’ skills in 
areas outside their chosen disciplines to 
more effectively handle society’s 
problems. 
Edwin C. Cadman, M.D., Ensign 
Professor of Medicine and chairman of 
the department of internal medicine, has 
been appointed to the new Scientific 
Advisory Board of Argus 
Pharmaceuticals, Inc. The board 
consists of seven leading international 
experts in the fields of immunology, 
oncology, infectious disease and 
biochemistry. 
Patricia Goldman-Rakic, Ph.D., 
professor of neuroscience, has been 
awarded the $50,000 Lieber Prize by the 
National Alliance for Research on 
Schizophrenia and Depression. Dr. 
Goldman-Rakic is the fifth recipient of 
the award, which recognizes 




Gabor B. Huszar, M.D., research 
scientist in obstetrics and gynecology 
and pediatrics, is a member of the 
Reproductive Biology Study Section, 
Division of Research Grants at the 
National Institutes of Health for a term 
of three years. Study sections review 
grant applications submitted to the NIH, 
make recommendations to the appropri¬ 
ate NIH national advisory council or 
board and survey the status of research 
in their fields of science. 
Michael Kashgarian, M.D., professor 
of pathology and biology, is a member 
of a National Institute of Health 
committee which was formed to 
examine evidence of risks or side effect 
from silver amalgam, a material used 
for dental fillings. They found that mer¬ 
cury used in the fillings had no harmful 
side effects. 
Lorraine V. Klerman, Dr.P.H., 
professor of public health, has been 
selected to receive a CAHS Human Ser¬ 
vices Award by the Connecticut Associ¬ 
ation for Human Services. The award, 
which was presented in November, 
recognizes the outstanding efforts to 
improve the delivery of human services 
to the people of Connecticut. 
Irvin M. Modlin, M.D., professor of 
surgery, has received an honorary 
degree of Doctor of Medicine from the 
Goteborgs University in Sweden. 
David E. Musto, professor in the Child 
Study Center, psychiatry and the history 
of medicine, has been selected to partic¬ 
ipate in two symposia on substance 
abuse problems and prevention 
measures. The symposia, entitled “Hard 
Drugs, Hard Choices in Connecticut,’’ 
were broadcast on Connecticut Public 
Television in September. 
Pilar N. Ossorio, Ph.D., a postdoctoral 
associate in the division of infectious 
disease, was selected by the American 
Association for the Advancement of 
Science to participate in a workshop of 
intensive study on the values and ethical 
issues associated with science and tech¬ 
nology. The workshop, held July 28 to 
Aug. 3, explored various minority 
perspectives on science and technology, 
how they compare to prevailing 
Continued on page 36 
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perspectives, and the different influence 
that these perspectives can have on 
scholarship, individual practices, and 
policy decisions. 
Scott A. Rollins, Ph.D. a postdoctoral 
fellow in the section of immunobiology, 
has been awarded a 1991 Jane Coffin 
Childs Fellowship. The $73,500 award 
will support his research on the role of 
the human anti-inflammatory protein 
CD59, which protects transplanted 
tissue and organs from rejection. 
Frank H. Ruddle, Ph.D., chairperson 
and the Sterling Professor of Biology 
and Genetics, has been appointed chair¬ 
person of the Genome Study Section, 
Division of Research Grants by the 
National Institutes of Health. 
Kevin A. Sevarino, M.D., Ph.D., assis¬ 
tant professor of psychiatry, was named 
one this year's Pfizer Scholars and Post¬ 
doctoral Fellows. Ten physician- 
scientists were honored with awards by 
Pfizer to pursue clinical or basic 
biomedical research at U.S. medical 
.schools. Dr. Sevarino conducts research 
on human psychiatric di.sorders and 
focuses on the regulation of known and 
unknown cellular signal transduction 
proteins by cocaine. 
Albert ,1. Solnit, M.D., Sterling Profes¬ 
sor Emeritus of Pediatrics and 
Psychiatry, was presented the American 
Academy of Child and Adolescent 
Psychiatry's Simon Wile Award, 
recognizing his outstanding leadership 
and continuous contributions to child 
psychiatry. Dr. Solnit is the state of 
Connecticut's Commissioner of Health. 
,Iody L. Sindelar, Ph.D., associate 
professor of public health and of the 
Institution for Social and Policy Studies, 
has been selected by the New York State 
Public Health Department to serve on 
the independent board (the panel of 
health economics) to establish hospital 
rates and trend factors in the state of 
New' York. 
Stephen (J. Waxman, M.D., Ph.D., 
professor and chaimian of neurology 
and professor of pharmacology, was 
presented the 1991 Distinguished Alum¬ 
nus Award by the Albert Einstein 
College of Medicine of Yeshiva Univer¬ 
sity in June. 
Alumni 
News 
Joseph A. Zaccagnino 
Joseph Zaccagnino 
Named President, CEO 
Of Yale-New Haven 
In a joint session on Sept. 16, the boards 
of trustees of Yale- New Haven Hospital 
and its parent corporation, Yale-New 
Haven Health Services, Inc. appointed 
Joseph A. Zaccagnino, M.P.H. '70, as 
president and chief executive officer of 
both of YNHH and its parent 
corporation. 
Mr. Zaccagnino, who has served as 
the hospital's executive vice president 
and chief operating officer since 1978, 
assumed the position of president and 
CEO on Oct. 1, succeeding C. Thomas 
Smith, who left to become president of 
Voluntary Hospitals of America in 
Irving, Texas. 
As executive vice president, Mr. 
Zaccagnino has been involved in the 
recruitment and development of the 
senior management team and chiefs of 
clinical services. He has guided the hos¬ 
pital's strategic and business planning 
and has been involved in restructuring 
many hospital services. 
Under his direction, effective man¬ 
agement systems and financial controls 
have resulted in significant improve¬ 
ments in YNHH’s financial position and 
in upgrading the hospital’s credit rating. 
Dr. David M. Raskind, '24, has 
retired from orthopedics and consults 
for the Hospital for Joint Diseases in 
New York City. In September, he com¬ 
peted in the age 85 to 90 tennis tourna¬ 
ment at Longwood Cricket Club as the 
oldest competitor in the U.S.A. 
Dr. Allan J. Ryan, ’43-'45 HS, was 
elected co-president of the International 
Association for Dance Medicine and 
Science, for whom he prepared and pre¬ 
sented the first annual meeting in 
Baltimore in June. 
Dr. Morris A. Wessel, '43, and Uni¬ 
versity Secretary Sheila A. Wellington, 
M.P.H.’ , were honored for their 
commitment to people with disabilities 
by Marrakech Inc., at its annual 
founders’ dinner in May. 
Dr. Charles A. Hall, ’44, was 
honored with a symposium by the 
Department of Veterans Affairs and 
Albany Medical College for his signifi¬ 
cant contributions to medical education, 
writing chapters for books and mono¬ 
graphs and as a review editor for many 
scientific journals. 
Dr. Richard C. Thompson, ’44 HS, 
inventor of the Thompson Retractor in 
1960, has retired for anesthesiology and 
resides in San Mateo, Calif. 
Dr. Martin E. Gordon, ’46, clinical 
professor of medicine and consulting 
gastroenterologist at Yale-New Haven 
Hospital and the Hospital of St. 
Raphael, was awarded the 1991 Ameri¬ 
can College of Physicians’ Laureate 
Award. This award honors senior physi¬ 
cians who are masters or fellows of the 
college who have demonstrated a com¬ 
mitment to excellence in medical care. 
Dr. Francis R. Coughlin, ’52, 
received a J.D. degree in 1988 and seeks 
to change a federally mandated, state 
implemented, administrative law system 
for medical malpractice. 
Dr. William O. Minturn, ’52, retired 
after 30 years of general thoracic and 
vascular surgery in Sun City, Ariz. He 
was one of the area’s “pioneers,” 
opening a medical clinic in 1965. Dr. 
Minturn was the area’s first thoracic and 
vascular surgeon and the first to perfomi 
vascular grafts in heart surgery. 
Dr. Robert (J. Petersdorf, ’52, pres¬ 
ident of the Association of American 
Medical Colleges, received an honorary 
D.Sc. degree from Georgetown Univer¬ 
sity School of Medicine in May. A 
36 Yale Medicine FallAVinter 1991-92 
member of Georgetown University 
Medical Center’s clinical faculty, he 
participates in more than 40 profes¬ 
sional organizations and has authored 
more than 400 publications. 
Dr. Alan H. Covey, ’54, has a 
cardiology practice in New York with 
his son. Dr. Alexander G. Covey. 
Dr. Eiji Yanagisawa, ’56-’59 HS, 
clinical professor of otolaryngology, has 
been named president-elect of the New 
England Otolaryngological Society 
and vice president of the American 
Broncho-Esophagological Association. 
Thomas P. Weil, M.P.H. ’58, Ph.D., 
has been honored by the University of 
Missouri-Columbia with the creation of 
the Thomas P. Weil Distinguished Pro¬ 
fessorship in Health Services Manage¬ 
ment. The professorship will honor Dr. 
Weil for his contribution as an educator, 
consultant and statesman in the field of 
health services organization and 
management. 
Dr. Thomas Lau, ’60, is a pathology 
consultant for seven north central 
Florida medical laboratories, teaches at 
art and natural history museums and is 
president of the Yale Club of 
Gainesville. 
Dr. Melvin Dollinger, ’60 serves 
with Cancer Care Associates in 
Torrance, Calif., and as a clinical pro¬ 
fessor of medicine at the University of 
Southern California School of 
Medicine. 
Dr. John K. Pearce, ’61, directs The 
Family Center of Somerville, Mass., 
and co-edited Ethnicity and Family 
Therapy and Family Therapy: Combin¬ 
ing Psychodynamic and Family Systems 
Approaches. 
Dr. David H. Groth, ’62, ’62-’64 
HS, has retired after 24 years from the 
U.S. Public Health Service at the 
National Institute for Occupational 
Safety and Health and has started as 
pathology consultant in occupational 
and environmental health. 
Dr. John T. Harrington, ’62, chief 
of medicine at Newton- Wellesley 
Hospital and professor of medicine at 
Tufts University School of Medicine, 
was inducted into the Royal College of 
Physicians of Ireland as an honorary 
fellow at a Dublin ceremony. He was 
cited for his excellence in patient care, 
medical education, clinical research in 
nephrology, basic research in acid-base 
physiology and medical editing. 
Alumni 
News 
Dr. Glenn L. Kelly, ’ 62, associate 
clinical professor of surgery at the 
University of Colorado School of 
Medicine, has a private vascular surgery 
practice in Englewood, Colo. He also 
invented the Kelly-Wick graft tunneling 
device and is president of the Rocky 
Mountain Vascular Surgery Society. 
Dr. Gary L. Tischler, ’62-’65 HS, 
has been appointed profes.sor and execu¬ 
tive chairman of the department of 
psychiatry and biobehavioral sciences 
and director of the Neuropsychiatric 
Institute at the University of California, 
Los Angeles School of Medicine. 
Rosemary A. Stevens, ’63 M.P.H., 
Ph.D., was appointed dean and Thomas 
S. Gates Professor at the University of 
Pennsylvania School of Arts and 
Sciences in September. 
Dr. David S. Fedson, ’65, professor 
of medicine at the University of Virginia 
Medical Center Primary Care Center, is 
a member of the National Vaccine Advi¬ 
sory Committee, created by the U.S. 
Public Health Service to coordinate gov¬ 
ernment and non- government activity in 
vaccine research, production and use. 
Dr. Meivyn S. Korobkin, ’67, from 
Ann Arbor, Mich., was named a fellow 
of the American College of Radiology 
at its annual meeting in September. 
Dr. Marc E. Lippman, ’68, profes¬ 
sor of medicine and pharmacology at 
Georgetown University School of Medi¬ 
cine in Washington, D.C., and director 
of Georgetown’s Vincent T. Lombardi 
Cancer Center, has been selected by the 
Endocrine Society as its 1991 Edwin B. 
Astwood lecturer for his outstanding 
basic and clinical contributions to the 
understanding and treatment of breast 
cancer. His lecture was entitled “Growth 
Factor Control of Normal and Malig¬ 
nant Mammary Cell Growth.” 
Kenneth W. Price, M.P.H. ’68, has 
been named director of radiation safety 
at the University of Connecticut Health 
Center. Since 1974, he has served as 
deputy director of radiation safety at 
Yale and since 1975, as a lecturer in 
radiological health. He will remain a 
lecturer in environmental health at the 
School of Medicine. 
Dr. Lionel M. Nelson, ’69, was 
elected to the board of trustees of Health 
Dimensions, Inc. and continues to prac¬ 
tice otolaryngology in San Jose, teach at 
Stanford University and serve as an 
Army reservist, leading medical teams 
into the Pacific and Asia. 
Dr. Anthony V. Proto, ’71, became 
chairman of the department of radiology 
at the Medical College of Virginia, 
Virginia Commonwealth University in 
November 1990. 
Dr. Paul A. Vignola, ’71, ’71-’74 
HS, directs the cardiac catheterization 
laboratory at Mount Sinai Medical 
Center in Miami, Fla. 
Dr. Jesse B. Jupiter, ’73, was 
appointed associate professor of ortho¬ 
paedic surgery at Harvard Medical 
School and remains an associate ortho¬ 
paedic surgeon at Massachusetts 
General Hospital. 
Dr. Donald L. Kent, ’72, ’73-’76 
HS, has been elected vice president of 
the Long Island Society of Otolaryngol¬ 
ogy - Head and Neck Surgery for 1991- 
1992. 
Arthur L. Lanckton, ’74 M.P.H., of 
Sarasota, Fla., has served dual careers 
over the past 50 years as an inter¬ 
national business executive and as a 
professor, administrator and board 
member in higher education at four col¬ 
leges and universities. 
Dr. Mary Lake Polan, ’75, co-chair- 
ed the 10-member NIH Task Force for 
Research on Women’s Health at a public 
hearing in June. Testimony focused on 
the leading causes of death among 
women, including heart disease, breast 
cancer and AIDS, and on conditions that 
disproportionately affect women, such 
as osteoporosis, autoimmune disea.ses, 
urologic disorders and sexually trans¬ 
mitted diseases. 
Lawrence M. Wexler, ’76 M.P.H., 
has been promoted to director of 
research for the department of ortho¬ 
paedic surgery, and associate professor 
of community and preventive medicine 
at New York Medical College in 
Valhalla, N.Y. 
Dr. Harvey J. Berger, ’77, president 
of Centocor, a biotechnology company, 
spoke at a workshop in Palo Alto, Calif., 
sponsored by the National Institutes of 
Health to obtain a consensus on policies 
to guide the exchange of research data 
among scholars. 
Robert W. Buckingham, ’78 
Dr.P.H., has been named dean of the 
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College of Health and Human Perform¬ 
ance at Mankato State University, 
Minnesota State University System. In 
his new position, he will be responsible 
for academic departments, as well as 
athletics for men and women. 
Dr. Michael K. Lindsay, '79, 
assistant professor in the department of 
obstetrics and gynecology and a mem¬ 
ber of the division of maternal-fetal 
medicine at Emory University Medical 
School of Atlanta, received an M.P.H. 
degree from Emory University School 
of Public Health this year. 
Dr. Susan C. Schachner, '81, is an 
associate attending physician in the 
department of medicine at the Long 
Island Jewish Medical Center Affili¬ 
ation at Queens Hospital Center. 
Dr. Robert W. Plant, ’82-’86 HS, 
serves as director for the Anxiety and 
Depression Program and the Psychiatric 
Partial Hospital Program at Sterling 
Institute for Neuropsychiatry and 
Behavioral Medicine in Stamford. 
Conn. In April, Dr. Plant spoke at the 
conference on Hospice Care and the 
Chemically Dependent AIDS Patient 
and Eamily in Norwalk, Conn. 
Dr. .lefTrey Satinover, '82-’86 HS, is 
as co-founder and executive director of 
Sterling Institute, medical director of 
the Temenos Institute in Westport, 
Conn., and president of the C.G. Jung 
Foundation of New York. He was a key¬ 
note speaker at the conference on Hos¬ 
pice Care and the Chemically 
Dependent AIDS Patient and Family. 
Dr. Robert A. Aronowitz, ’85, has 
been named a recipient of the Charles E. 
Culpepper Foundation Scholarships in 
Medical Humanities for 1991. This 
$.7(),()()() award will fund his research at 
the University of Medicine and 
Dentistry of New Jersey/Robert Wood 
Johnson Medical School, where he is 
assistant professor of medicine. 
Michael S. Huncharek, '86 M.P.H., 
a radiation oncologist from Boston, 
wrote a chapter entitled “Asbestos in 
Buildings and Cancer Risks: Public 
Health and Public Policy Considera¬ 
tions," which appeared in Sourcebook 
on Public Health Diseases. 
Linda V. Bergonzi, ’90 M.P.H., 
teaches health communications courses 
at the department of epidemiology and 
public health at Yale and works on 
health documentaries with lecturer 
Alberta Jacoby. She also has her own 
video company, "Bella Productions.” 
.78 
New Books 
Coping with Grief, by Robert W. 
Buckingham, '78 Dr. Ph.H., and Sandra 
K. Huggard. Rosen Publishing (New 
York)1991. 
Everyone’s Guide to Cancer Therapy, 
by Dr. Malin Dollinger, ’60. Andrews & 
McMeel (Kansas City, Mo.) 1991. 
Exiles Erom Eden: Psychotherapy Erom 
an Evolutionary Perspective, by 
Kalman Glantz, Ph.D., and edited by Dr. 
John K. Pearce, ’61. W.W. Norton & 
Co., Inc. (New York) 1989. 
Eamily Therapy: Combining 
Psychodynamic and Eamily Systems 
Approaches (Japanese edition), by Dr. 
Student 
News 
Kaveh Khoshnood, a graduate student 
in the department of epidemiology and 
public health, is a member of AIDS- 
Busters, a program in which volunteers 
John K. Pearce, ’61, and Leonard J. 
Friedman. W.W. Norton & Co., Inc. 
(New York) 1991. 
Integrating Pharmacotherapy and 
Psychotherapy, edited by Dr. Bernard 
D. Beitman, '68, and Dr. Gerald L. 
Klerman. American Psychiatric Press, 
Inc. (Wa.shington, D.C.) 1991. 
The Profit Motive and Patient Care: The 
Changing Accountability of Doctors 
and Hospitals, by Bradford H. Gray, ’73 
Ph.D. Harvard University Press 
(Cambridge, Mass.) 1991. 
Treating Personality Disorders, New 
Directions in Mental Health Series No. 
47. by Dr. David A. Adler, ’73. Jossey- 
Bass (San Francisco, Calif.) 1990. 
What’s New in Medicine, Dr. Ludmil A. 
Chotknowski, ’42. FACP Health Press 
(Santa Fe.N.M.) 1990 
distribute bleach packets, condoms and 
infonnation pamphlets about AIDS test¬ 
ing and drug treatment in parts of New 
Haven with high concentrations of intra¬ 
venous drug users. 
Carolyn G. Shapiro, a Ph.D. 
candidate in the history of medicine, has 
been awarded one of nine 1991 Albert J. 
Beveridge grants for research in the his¬ 
tory of the western hemisphere. 
At the annual Wilber Downs Eellowship poster presentations held in late October, 
second-year student Christopher Gilligan talks with first-year students Dan Stolar 
and Marjorie Rosenthal about his research into Chagas disease in Zimbabwe. Nine¬ 
teen Downs fellows presented posters about their overseas e.xperiences. 
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ALUMNI REPORT 
Plans for the 1992 annual spring reunion 
on June 5 and 6 are almost complete. 
All alumni are invited to attend, 
especially the quinquinnial (fifth-year) 
reunion classes, those ending with num¬ 
bers two or seven. This year the Class of 
1942 will be honored at the Friends of 
the 50th festivities. We look forward to 
a record attendance. 
We encourage each reunion class to 
consider a presentation, featuring class 
members who offer short papers about 
their specialities, research or about 
professional issues. Connie Tolliver, 
assistant to the director, is available to 
advise reunion classes about these 
programs. Connie and our 
administrative assistant, Patty DiNatale, 
also will help the local class chair to 
make reunion arrangements — lodging, 
class dinner and activities, meeting 
facilities and so forth. Please do not hes¬ 
itate to contact us. (Our telephone 
number and new address are listed at the 
end of this article.) 
Congratulations to our alumni for 
exceeding the conditions of the Kresge 
Challenge. Contributions by 56 percent 
of alumni to the fund exceeded last 
year’s rate of 43 percent. This 13 
percent increase allowed us to exceed 
the 55 percent alumni participation 
required by the challenge. 
Helping greatly in meeting the 
challenge were the efforts of Leonard 
Kemler, M.D., outgoing chairman of the 
alumni fund. Also contributing 
significantly to our success were Dean 
Leon E. Rosenberg, alumni and students 
who joined a series of phonathons. Your 
alumni affairs director and John Foster, 
M.D., the new fund chairman, 
encourage you all to maintain this 
record of generous giving. It represents 
a vote of confidence in and expression 
of loyalty to the school and all it 
represents. 
If you have not received your 
questionnaire from the Harris 
Publishing Company for the medical 
school alumni directory, please contact 
the alumni affairs office immediately so 
that we can have one mailed to you. It is 
imperative that you complete and return 
the form as soon as possible. An 
accurate directory depends on the 
promptness of your response. 
The form has been simplified so that 
only corrections of information need to 
be recorded. If your biography is 
unchanged, you need only return the 
form. Note again that Harris Publishing 
guarantees the confidentially of the data 
base and takes steps to safeguard against 
inappropriate use of it or the directory. 
We are eagerly waiting for the 
completed directory which is scheduled 
for release in the spring of 1992. 
This call for cooperation emphasizes 
the fact that the office of alumni affairs 
functions effectively only when alumni 
are actively involved with their alma 
mater and alumni association. Such 
involvement allows us to thank our 
school for what it has given us in 
training and education. 
Opportunities to serve include the 
various boards and committees that are 
open to our alumni. For example, John 
Foster is actively seeking volunteers to 
serve on the alumni fund board. The 
executive committee of the Association 
of Yale Alumni in Medicine too seeks a 
working, representative board. In 
addition, class agents and secretaries 
play a crucial role in maintaining class 
identity and in helping to organize 
reunions. 
Nicholas Spinelli, M.D., helps medi¬ 
cal students establish a class identity by 
encouraging them to form into effective 
class groups that will continue to 
function after graduation. This process 
is aided by alumni attendance at student 
affairs, both academic and social, which 
is welcomed by the students. We 
enhance the sense of family within the 
association by paying early attention to 
students and continuing our interest 
after their graduation. The alumni office 
can provide you with the dates of 
student events that alumni can attend 
and benefit from. Call us for details. 
Turning to news about our school. 
Dr. Rosenberg has resigned after a 
distinguished and outstanding tenure as 
professor and dean to become president 
of research at Bristol-Myers Squibb. He 
leaves an improved physical plant with 
many new buildings, a distinguished, 
caring faculty and an institutional 
concern for societal needs and the 
humane practice of medicine. His 
legacy will be the foundation for an ever 
stronger and more influential institution. 
Dr. Robert Donaldson has been 
named acting dean. He has been 
intimately involved in planning the 
medical school’s growth and 
development, and is superbly prepared 
to lead YSM as a search committee 
headed by Yale President Benno C. 
Schmidt Jr. looks for a new dean. Dr. 
Lawrence S. Cohen, the Ebenezer K. 
Hunt Professor of Medicine, has been 
appointed acting deputy dean. 
Finally, the alumni office has 
relocated to new quarters at 100 Church 
St. South, the former Lee High School. 
Except that we are now further removed 
from the rotunda, we are pleased with 
our ample, newly renovated space and 
its modem decor. 
Our new mailing address is 
Yale University School of Medicine 
Office of Alumni Affairs 
P.O. Box 7613 
New Haven, CT 06519-7613 
This is also the mailing address for 
the Association of Yale Alumni in 
Medicine. Our telephone number 
remains (203) 785-4674. 
Arthur Crovatto, M.D. '54 
Director of alumni affair 
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Memorials 
Deceased medical alumni and 
friends may be memorialized by a 
gift at any time to the Medical 
School Alumni Fund endowment in 
the name and class of the person so 
honored. The next-of-kin of a de¬ 
ceased medical alumnus/a is advised 
about this In Memoriam Program by 
a mailing from New Haven some 
weeks after the School of Medicine 
receives notification of the death. 
The letter of information includes a 
copy of the Testament of Remem¬ 
brance in which the names of all per¬ 
sons so memorialized are listed in 
the medical section by class, thus 
establishing a lasting memorial. Do¬ 
nors receive a personally penned 
note of appreciation from the In 
Memoriam program director. Your 
inquiries and interest are welcome. 
Deceased alumni and friends so 
honored in 1990-1991 were: 
George Frederick Converse 1887 
Jacques D. Soifer ’24 
Paul H. Lavietes '30 
Raymond Miller ’33 
Walter E. Barney ’35 
W. Howard Homer ’35 
Nathan Kenigsberg ’39 
Arthur Tucker ’39 
Knute Berger ’41 
David G. Decker ’42 
Wilson E. Hughes ’42 
Joseph P. Kriss ’43 
Erederick Waldron ’43 
Charles S. Judd, Jr. ’46 
Lawrence P. Shea ’47 
Haavik Arne ’56 
John B. Pine ’56 
John Gallagher ’58 
Leland S. Berger ’64 
Morris Shultz (friend) 
Richard G.Jordan 
Dircctiir Emeritus 
In Memoriam Program 
Lester W. Burket 
Lester W. Burket, M.D., former dean of 
the University of Pennsylvania School 
of Dental Medicine, died June 29. He 
was 84. 
A Bozeman, Mont., native. Dr. 
Burket earned his A.B. and dental 
degrees from the University of Pennsyl¬ 
vania and in 1932 became a Rockefeller 
fellow at Yale School of Medicine, 
where he received his M.D. degree in 
1936. 
He was an instructor in dental pathol¬ 
ogy at Yale for one year and later taught 
at the University of Pennsylvania 
School of Dental Medicine from 1937 
through 1977. He served as dean of the 
school from 1951 through 1972. 
Dr. Burket was named a Sterling 
fellow in pathology at Yale University 
and in 1950 received an honorary 
degree from the University of Antioquia 
in Medelin, Colombia. He also was 
named an honorary professor at the 
National University in Bogota. 
In 1948, he was decorated by Queen 
Wilhemena of the Netherlands for his 
assistance to Dutch dentists after World 
War 11. He was a consultant to the 
Army, Navy, Veterans Administration 
and the U.S. Public Health Service. He 
also represented the United States in 
dentistry at the World Health 
Organization. 
Dr. Burket served as president of the 
American Association of Dental 
Schools and chairman of the Council on 
Dental Education and authored the text¬ 
book Oral Medicine. He was a recipient 
of the Pons Medal from the Connecticut 
State Dental Society and the Pauchard 
Award from the Pauchard Academy. 
He is survived by his wife, Grace. 
Willard A. Krehl 
Willard A. Krehl, M.D., died May 11 at 
his home in Sun City West, Ariz. He 
was 77. 
Dr. Krehl received an A.B. degree 
from Cornell College in Iowa, M.S. and 
Ph.D. degrees in biochemistry from the 
University of Wisconsin, Madison, and 
a M.D. degree from Yale School of 
Medicine in 1957. 
A native of Illinois, Dr. Krehl was a 
fellow in biochemistry at the University 
of Wisconsin and a fellow in nutrition 
at Yale. 
Throughout his academic career, he 
served as associate professor of 
nutrition and biochemistry at Yale; 
director of clinical laboratories at 
Milwaukee County General Hospital; 
professor of internal medicine and 
director of the clinical research center at 
the University of Iowa College of Medi¬ 
cine, University Hospitals; and profes¬ 
sor in and chairman of the department 
of community health and preventive 
medicine at Jefferson Medical School in 
Philadelphia. 
Dr. Krehl also held positions as vice 
president of development at Lenz Indus¬ 
trial Testing Laboratory in Kentucky 
and as medical director for the Pederal 
Reserve Bank in Philadelphia. 
He was a member of the American 
Medical Association and of the 
Philadelphia College of Physicians. 
Contributions may be made to the 
College of Physicians Library of 
Philadelphia, 19 S. 22nd St., 
Philadelphia, PA 19103. 
Obituaries 
Neville Kirsch 
Neville Kirsch, M.D., died July 18 at 
Yale-New Haven Hospital. He was 79. 
Dr. Kirsch graduated from Ohio State 
University and Long Island College of 
Medicine. He served his internship at 
Grace New Haven Hospital from 1940 
through 1942. 
Dr. Kirsch retired from his private 
dermatology practice in West Hartford 
in 1984 after 37 years. He also was a 
clinical professor of dermatology at 
Yale and a consultant for the Commu¬ 
nity Health Care Plan in New Haven. 
He was a past president of the New 
England Demiatology Society and the 
dermatology section of the Connecticut 
State Medical Society. 
Contributions may be made to Yale 
University School of Medicine, Depart¬ 
ment of Demiatology, PO. Box 3333, 
New Haven, CT 06510. 
40 Yale Medicine FallAVinter 1991-92 
Harvey L. Young 
Harvey L. Young, M.D., died May 
25 at age 66. 
A Washington native. Dr. Young 
served with the Navy during World War 
II and graduated from Washington State 
University in 1948 and from Yale 
School of Medicine in 1952. He in¬ 
terned at Deaconess Hospital and had a 
private practice as a family physician in 
Spokane Valley from 1953 through 
1969. 
Dr. Young was a founding member 
and first chief of staff of the Valley Hos¬ 
pital and Medical Center. He also was 
president of the Deaconess staff and a 
clinical instructor at the University of 
Washington’s Spokane Family Practice 
Unit. In 1977, he was appointed medical 
director of the Medical Service Corp. of 
Eastern Washington and served as vice 
president of the Washington State Medi- 
Obituaries 
Harrison F. Wood 
Harrison F. Wood, M.D., died July 26 at 
the Hebrew Home and Hospital in West 
Hartford, Conn. He was 73. 
A native of Chicago, Dr. Wood 
served seven years during the 1950s as 
an associate at the Rockefeller Institute 
for Medical Research in New York 
where he studied strep infections. 
Concurrently, he was medical director 
of Irvington House, a research and treat¬ 
ment center in New York for children 
with rheumatic diseases. There he 
participated in a study that found that 
continuous doses of antibiotics could 
ward off strep infections and thus 
prevent rheumatic fever. 
Dr. Wood joined the Yale faculty in 
the 1970s. He taught immunology for 
eight years and served on the staff of the 
Veterans Administration Hospital in 
West Haven. 
Dr. Wood received undergraduate 
and medical degrees from New York 
University and served an internship at 
Bellevue Hospital. 
He leaves his wife, Nina, and two 
sons, Stephen and Matthew. 
cal Association and as a member of the 
Spokane County Medical Society’s 
executive committee and board of 
trustees. In 1978, he was named Doctor- 
Citizen of the Year by the Spokane 
County Medical Society. 
Dr. Young was named to the 
Washington State Nursing Home 
Administrators Board and the State 
Nursing Home Advisory Council as 
the State Medical Association’s repre¬ 
sentative. He was director of medical 
services and vice president of the Madi¬ 
son Convalescent Centers Inc. and 
director of Spokane Visiting Nurses. 
He leaves his wife, Hilda; a daughter, 
Robin; two sons, Stephen and Roger; 
and two grandchildren. 
Memorials may be sent to Yale Uni¬ 
versity School of Medicine, c/o Alumni 
Fund, P.O. Box 1890, New Haven, CT 
06508. 
Charles L. Wood 
Charles L. Wood, M.D., pediatrician 
and educator, died July 20 in Delray 
Beach, Fla. 
A native of New York City, Dr. 
Wood graduated from New York 
University and in 1930 from Yale 
School of Medicine. After serving an 
internship and as an instructor in 
pediatrics at New Haven Hospital, and 
as a resident at Babies Hospital, 
Columbia Presbyterian Medical Center 
in New York, Dr. Wood opened a 
private practice in Manhattan. 
In 1962, Dr. Wood joined the staff of 
the University of Pittsburgh and served 
as chairman of the department of pediat¬ 
rics at the Children’s Hospital where he 
was recognized with several teaching 
awards. He served as an associate 
clinical professor of pediatrics and an 
attending physician at Babies Hospital 
for more than 25 years. In 1989 he was 
the first recipient of the Babies Hospital 
Distinguished Alumni Service Award. 
Dr. Wood was a lieutenant colonel in 
the Air Force During World War II. 
Dr. Wood is survived his wife, Doris; 
a son, Charles Jr.; and four grand¬ 
children. Contributions may be sent to 
the Charles L. Wood J.D. Pediatric 
Scholarship Fund, School of Medicine, 
University of Pittsburgh, Pittsburgh, PA 
15261. 
In Memoriam 
Israel E. Blodinger 
January 24, 1991 
’22, ’25 M.D. 
Leonard Greenburg ’23 Ph.D., ’23 
March 13, 1991 PHSP, ’30 M.D. 
Davis H. Pardoll 
April 8, 1991 
’25 MED 
Dominic J. DeU’aguilla ’31 HS 
March 1989 
Leonard F. Ciner 
February 23, 1991 
’32 M.D. 
Edgar W. Warren 
July 21, 1991 
’32, ’36 M.D. 
John H. Lawrence 
July 7, 1991 
’34 HS 
H. Stuart Irons 
February 3, 1991 
’36, ’40 M.D. 
Ewilym A. Edwards 
January 15,1989 
’39 HS 
Jarrett H. Folley 
August 11, 1991 
’41 HS 
Phillip H. Gates 
May 31, 1991 
’41 HS 
Sydney E. Sinclair 
May 17, 1991 
’41 HS 
Robert J. Schaffer 
February 24, 1991 
’43 HS 
Hoyt C. Taylor 
January 4, 1991 
’43 HS 
Charles A. Hall 
July 27, 1991 
’44 M.D. 
Henry G. Brickman 
June 5,1991 
’50 M.P.H. 
George A. Cohn 
June 11,1991 
’51 HS 
Orman H. Glazier 
April 7, 1991 
’51 M.P.H. 
Harvey L. Young 
June, 1991 
’52 M.D. 
Harold R. Bemshock 
Aprils, 1991 
’53 M.P.H. 
Daniel R. Rectanus 
September 21, 1989 
’55 HS 
F. Brantley Scott, Jr. 
July 27, 1991 
’55 M.D. 
Richard D. Gerlack 
June 27, 1991 
’58 HS 
Embree H. Blackard, Jr. ’59 HS 
January 3, 1991 
Carmine W. Terraciano ’59 HS 
January 18,1991 
Norman J. Lewiston 
August 6, 1991 
’59 HS 
Brigitte Prusoff ’67 M.P.H., 
April 4, 1991 ’78 Ph.D. 
Jeffrey M. Nakamura 
January 3, 1991 
’76 HS 
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DEVELOPMENT REPORT 
R. Leonard Kemler, M.D.'43, (center) is honored for his five years of outstanding ser¬ 
vice as chairman of the School of Medicine Alumni Fund. Presenting his award is 
Acting Dean Robert M. Donaldson Jr.. M.D., (left) and the new YSM alumni fund 
chairman. John W. Foster Jr.. M.D.'Vl. 
Alumni Fund Success 
Meets Kresge Challenge 
On June 7, University President 
Benno C. Schmidt Jr. named the Center 
tor Molecular Medicine for Dr. and Mrs. 
Herbert Boyer in recognition of their 
$10 million gift in support of the 
facility's construction. He also 
expressed his great appreciation for Dr. 
and Mrs. Boyer's role in satisfying the 
first term of The Kresge Foundation 
Challenge — to raise the remaining $5 
million needed to complete the 
building's construction. 
With the challenge's first term 
satisfied, success then depended on 
alumni support to satisfy the two 
remaining terms: 
• to raise $450,000 in alumni fund 
support for current operations 
• to reach 55 percent in alumni fund 
participation. 
Under the direction of The Kresge 
Foundation Challenge Chairman John 
B. Ogilvie, '3 IS, '34 Med., and alumni 
fund Chairman Leonard Kemler '39S. 
'43 Med., School of Medicine 
volunteers put in motion an 
unprecedented alumni fund effort to 
secure the Kresge Foundation's $1 
million challenge grant. The alumni 
fund board, class agents, and alumni and 
student phonathon volunteers provided 
additional leadership. 
By June 30, the close of the alumni 
fund year, alumni had soared past both 
of the challenge's remaining terms. 
Alumni fund giving for current 
operations totalled $541,427 — a 28 
percent increase over the 1989-1990 
total. Alumni also exceeded the most 
formidable term of the challenge, to 
reach 55 percent participation in the 
1990-1991 alumni fund. A total of 2,041 
alumni, or 56 percent, did support the 
fund, and in so doing secured the $1 
million challenge grant. 
Highlights of the alumni effort to 
meet the challenge include the 
generosity of Sanfurd Bluestein, '46, 
who in honor of his 45th reunion offered 
to match all increa.sed and new gifts up 
to a maximum of $45,000. Class agent 
letters and a four-night spring 
phonathon helped earn all of Dr. 
Bluestein's matching gift well before 
the fiscal year's end on June 30. During 
the phonathon, 30 callers spoke with 
more than 1,000 alumni; 323 alumni 
pledged nearly $33,000. 
In recognition of Chairman John B. 
Ogilvie's gift in support of the Boyer 
Center's construction, and of his leader¬ 
ship throughout The Kresge Foundation 
Challenge, a dining room was named 
for him at the center. Finally, as the 
class which achieved the highest 
percentage of participation among the 
10 youngest graduating classes, the 
Class of 1982 won the Kresge Cup, with 
38 percent participation. 
1989-1991 Alumni Fund Final Figures 
(living for Current Use 
1989-1990 The Kresge Foundation 
Challenge Goal 
1990-1991 
$421,822 $450,000 $541,427 
Participation 
1989-1990 The Kresge Foundation 
Challenge Goal 
1990-1991 
45 percent 55 percent 56 percent 
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Aniyans Donate Estate 
To School of Medicine 
Announcing the largest gift in the 
history of the School of Medicine, 
University President Benno C. Schmidt 
Jr. said that John Anlyan, M.D.’45, a 
prominent California surgeon, and his 
wife Betty Jane will donate their entire 
estate to Yale — a gift valued at $25 
million. Dr. Anlyan, also a member of 
the Yale College Class of 1942, and 
Mrs. Anlyan have named the University 
as sole beneficiary of their joint estate. 
Most of the funds will be applied to 
the School of Medicine — the exact 
designations of the gift to be determined 
by the president. School of Medicine 
dean, and members of the Yale Corpora¬ 
tion at the time the funds are received. 
Some $2 million will endow a profes¬ 
sorship in the humanities, which is Mrs. 
Anlyan’s area of academic interest. 
Mr. Schmidt announced the gift at an 
October 3 dinner in New Haven given 
by the Yale School of Medicine Dean’s 
Council in Dr. and Mrs. Anlyan’s honor. 
As Mr. Schmidt awarded Dr. Anlyan 
a special Yale presidential medal, he 
said: “Dr. and Mrs. Anlyan’s gift is an 
act of splendid generosity and vision. 
By providing unrestricted general 
support for the medical school, this gift 
will greatly benefit future generations. 
The humanities endowment symbolizes 
and strengthens the close ties between 
the University and the medical school 
generally. Everyone at Yale owes Dr. 
and Mrs. Anlyan a great debt of 
gratitude.” 
Said Dr. Anlyan: “This is a thank- 
you gesture for making my life possible. 
My wife and I feel that Yale has done 
very well for us. I came here on a wing 
and a prayer on August 29,1939, just 
days before Hitler marched into Poland, 
and I could not have made it without 
Yale’s help. 
“We feel that all alumni should 
voluntarily give as much as they can to 
Yale,” continued Dr. Anlyan. “The best 
thing we can do for the youth of the next 
generation is to educate them.” 
Dr. Anlyan was bom and raised in 
Alexandria, Egypt, where he attended 
Victoria College (an elementary- 
through-high school level institution), 
and was admitted to Yale College in 
1939. He completed his undergraduate 
work in three years to begin his pursuit 
of a medical degree. He finished both 
courses of study in just six years. 
Reflecting on his medical school 
education. Dr. Anlyan commended the 
Yale System: “Medical school was a 
pleasant surprise because of the opening 
remarks of Dean Milton Wintemitz to 
our class of fewer than 60 students. He 
said that we were old enough to monitor 
ourselves. We were not required to 
attend classes and we would be treated 
as adults who wanted to learn.” 
After a surgical residency at the Uni¬ 
versity of Chicago and at Ohio State — 
his wife’s alma mater and where he 
received his master’s degree in surgery 
— Dr. Anlyan returned to Yale, serving 
as instructor in surgery from 1949 to 
1951. He then spent three years as a 
Damon Runyon Fellow at Memorial- 
Sloan Kettering Institute in New York 
City, after which he moved to San Fran¬ 
cisco and established a practice in can¬ 
cer surgery. Dr. Anlyan’s two brothers, 
William G. Anlyan, M.D. ’49, and Fred¬ 
erick, both attended Yale as well. 
The Aniyans have consistently 
supported the School of Medicine and 
the Yale Alumni Fund over the years, 
and have contributed generously to the 
Campaign for Yale and Berkeley 
College. In 1986, the Aniyans donated 
$1 million to the School of Medicine for 
renovation of laboratories in molecular 
neurobiology. That contribution has 
helped further Yale scientists’ research 
on the structure and function of the 
brain at the molecular level. 
In expressing his appreciation to the 
Aniyans, Acting Dean Robert M. 
Donaldson said: “We are immensely 
proud that the largest gift to Yale 
University since 1967 has been made by 
a Yale School of Medicine alumnus and 
his wife.” 
D'- J,'hn A. Anlyan (left) and his wife, Betty Jane, with Benno C. Schmidt Jr. 
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REUNION REPORTS 
Nicholas D'Esopo, M.D.’21. and Yolande Lyon, M.P.H.’52 
1926 
65th-year reunion 
h\ Dr. Ma.xw ell Bogin 
And now the 65th reunion is history. 
Attendance was double that of the 60th 
reunion. Present were Dr. Elizabeth R. 
Harrison and myself, the class agent. 
Dean Rosenberg’s address was very 
infonnative and inspiring. He touched 
on many subjects, including the new 
construction of the past few years. 
My personal observations, while 
traversing areas that I had trodden 
before, gave the illusion that the same 
steps were a bit steeper and the same 
distances a bit longer. But there are 
always the memories. 
1931 
60th-year reunion 
hy Dr. A.J. Schechter 
.Abraham J. Schechter and James A. 
Springham attended their 60th reunion, 
a grand event for both. 
Abe has been retired since 1979 
when he left New York with his wife, 
Vivian, for the more equitable climate 
of Los Angeles. Their son, Robert, and 
his wife, Amy, Yale School of Medicine 
graduates of 1974, are responsible for 
three grandchildren, while daughter 
Minda (Stanford Law 1975) 
contributed a pair of twins. All are in 
Los Angeles, which makes this a happy 
retirement for Abe and Vivian. 
Jim is active in the practice of 
psychiatry in Evanston, 111. He has spent 
many years in India and China, combin¬ 
ing medical and surgical care with 
Christian missionary work, aided by his 
now deceased wife, a graduate of Yale 
School of Nursing. Jim has seven 
children who live in various parts of the 
United States. He has his usual vigor, 
enthusiasm and good health. 
1936 
55th-year reunion 
hy Dr. Nicholas D' Esopo 
The 55th-year reunion of the Class of 
1936 w as attended by Dr. Nicholas 
D’Esopo and his wife. Rose, and by Dr. 
Stephen Nagyfy and his wife, Ava. Dr. 
D’Esopo received communications with 
three other classmates who were unable 
to attend. 
The two classmates and their wives 
enjoyed the reunion weekend 
immensely. Especially outstanding was 
the molecular medicine symposium 
moderated by Dr. Vincent Marchesi. 
The review of Lyme disease was also 
exciting, and the Eriends of the 5()th 
dinner on Saturday night was also much 
enjoyed. Noteworthy was the large 
number of returnees for their 5()th-year 
reunion, among them a remarkable 
number of pediatricians. The occasion 
has motivated us to attend our 6()th-year 
reunion in 1996! 
1941 
50th-year reunion 
hy Dr. Rohert W. Ollayos 
One word describes the 5()th reunion 
activities of 1941 YSM: great. 
Seventeen members, 13 accompanied 
by spouses, attended; Areson, Bell, 
Carey, Diefendorf, Duncan, Fenton, 
(jrilbert, (ilike, Lasell, Lih, Monroe, 
Neighbor, O'Connell, Parrella, 
Pecora and Walton. To attest that the 
names of romance still burn brightly, 
Willys Monroe provided a special extra 
with the introduction of his recent bride, 
the former Dr. Louise Robertson. 
The consensus was that the group 
overall looked fit. Evidence of the 
encroachments of increasing age was 
small; a few showed of what is usually 
described as a “more mature figure.” 
Eortunately, all seemed nimble of wit, 
most have traded stethoscope for 
rocking chair. Exceptions included Pete 
Duncan, Sid Lasell, Ed O’Connell and 
Ed Rogers, who still maintain at least 
part-time medical functions. 
Those attending the dedication of the 
Boyer Center for Molecular Medicine 
on Thursday were impressed by the 
magnificence of the facilities, and 
enjoyed the sociability of the hospitality 
hour which followed. On Friday, at the 
class reunion seminar, Willys Monroe 
presented his paper, “The U.S. Public 
Health Service: A Virginia Tradition.” 
He represented our class very well, and 
his paper received much commendation. 
For Friday evening Charlie Cheney 
arranged a special class dinner at The 
Graduate Club. Unfortunately, because 
of illness, Charlie was unable to attend 
this and other events of the reunion. 
Jack Parrella served ably as master of 
ceremonies. Following dinner, all class 
members took turns offering a variety of 
personal reminiscences and 
commentaries. These provided a lot of 
fun and climaxed a happy day. Jack Par- 


















Mis. Esther Diefendoif and Herbert W. Diefendorf, M.D.’41 
rella had prepared a brochure containing 
a series of observations, reflections and 
reminiscences of the past 50 years. For 
those unable to attend, a copy will be 
provided through the office of alumni 
affairs. 
The celebration ended with the 
“Friends of the 50th” dinner, at which 
’41M was honored. Attendance was so 
large that the event had to be held at the 
Colony Inn. This great dinner concluded 
with appropriate and interesting 
comments from representatives of YSM 
and the office of alumni affairs. 
My special thanks to Charles 
Cheney, Willys Monroe and Jack 
Parrella for their help in facilitating our 
class reunion activities, and for 
providing me a news-line, and to those 
classmates unable to attend who 
provided letters of information in 
response to my inquiries. These letters 
will form the basis of a more detailed 
newsletter which hopefully will reach 
every member of the class. 
1946 
46th-year reunion 
by Dr. Martin E. Gordon 
An enthusiastic Class of ’46 returned to 
New Haven in large numbers, and the 
many activities of their 45th-year 
reunion earned their meritorious 
support. After the dedication of the new 
Boyer Center for Molecular Medicine, 
an impressive scientific program 
followed, replete with Nobel laureates. 
The class met on the steps of 333 Cedar 
St. for still another classic Hall of Fame 
photomural, oblivious to the passage of 
time and the sepia tone. They were then 
led to the historical library for a 
nostalgic reexamination of the plates of 
Vesalius and other awesome treasures of 
their Yale experience, including Harvey 
Cushing’s memorabilia, rekindling 
images of student days. 
The class then presented a seminar, 
“From Then to Now — Panoramic 
Views of Medicine: Personal 
Observations,” that proved to be a 
remarkable survey of the progress in 
medicine, influencing the career 
developments of 10 class 
representatives of various specialties. 
These included Margaret J. Albrink’s 
“Triple Threats of Diet, Diabetes and 
Obesity on Coronary Artery Disease” 
(lipid research), Franklin C. Behrle’s 
“How Small is Too Small” (neonatal 
progress), Sanfurd G. Bluestein’s 
“Radiology Alters the Scene” (clinical 
radiology’s growth), Vincent Congo’s 
“By the Way Doc” (sexual dysfunction), 
Joe D. Morris’ “Cardiac Restoration: A 
Half-century of Miracles” (originating 
the initial ICU and extracorporeal pump 
units). An additional presentation 
included: Julian A. Sachs’ “From Gen¬ 
eral Practice to Emergency Medicine — 
A Specialist in Spite of Myself’ (the 
growth of hospital trauma and 
emergency rooms), Donald P. Shedd’s 
“Restoration of Voices Lost—Tea with 
the Duchess” (advances in head and 
neck surgery), Robert R. Wagner’s 
“Infectious Diseases Then, Molecular 
Biology Now” (the growth and research 
aspects of virology), William J. 
Wedemeyer’s “The Road to 
Automation” (technological changes in 
pathology and laboratory medicine). 
Aaron T. Beck, the “Father of 
Cognitive Therapy,” gave insights into 
his pioneering work on depression and 
suicide. 
Vincent Pepe’s assessment of a prac¬ 
titioner’s role in obstetrics and gynecol¬ 
ogy and other equally cogent comments 
from all attending members of the class 
were followed by the summation by 
Martin E. Gordon, seminar organizer 
and chairman, who had presented “The 
Evolution of On-Sight Viewing and 
Doing—Trends from the Magenkrazer 
to 3-D Imaging” (gastroenterology/ 
endoscopy and travel medicine). 
Class members and companions 
were then shuttled for dinner 
overlooking Long Island Sound, 
followed by a Long Wharf Theatre’s 
production of “Picnic.” A specially 
arranged backstage tour and 
personalized discussions with the cast 
completed the memorable evening. 
On June 8, the morning scientific 
programs and the traditional lavish Yale 
luncheon were followed by an afternoon 
of warm comraderie, group psychother¬ 
apeutic discussions and informal 
lakeside relaxation at the Gordons’ 
home. The evening’s traditional dinner 
at Mory’s conveyed the most intimate 
and hilarious aspects of the class’ versa¬ 
tility. Letters and comments from 
classmates unable to attend were shared. 
The impressive accomplishments and 
stellar achievements of the children of 
the class were further evident when the 
biographic summaries were exchanged. 
Memories of the deceased class 
members were evoked, in reaffirmation 
of the close amalgamation of this YSM 
Class of 1946. Toasts to the past and 
hopes for at least matching attendance at 




by Dr. John L. Sullivan 
What a happy weekend. The weather 
was perfect. Our medical school reunion 
program concentrating on molecular 
medicine was outstanding! 
The old medical school atmosphere 
was even better. We rubbed shoulders 
with the medical students out on the 
Harkness dormitory courtyard. 
Frank and Dolly Allen, Tom and 
Barbara Amatruda, Paul and Polly 
Bruch, Sid and Ina Furst, Lowell and 
lone Goodman, John and Betty Lou 
Haxo, Carrold and Luanna Iverson, 
Jocelyn Malkin, Wally and Pat 
Morgan, Jim and Jan Riley, Bob and 
Claudia Small, John and Mary 
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Sullivan, and Andy and Irene Wong 
were there. The old boys looked great 
and the girls were lovely. 
The lighter side of the program 
started at Mory's on Friday evening. We 
were on the upper floor for cocktails 
and dinner. It was the old days all over 
again, casual and spontaneous. 
Everyone had a chance to take the floor 
and reminisce or bring us up to date on 
classmates not present. The wine 
flowed, the food was great — it got 
better and better as the night went on. 
Saturday was notable for two events 
dear to the heart of Class of ’51. At the 
annual business meeting, our own 
Lowell Goodman received the AYAM 
Distinguished Service Award. Did you 
know he was the bantam weight boxing 
champion of Yale in his undergraduate 
days? 1 didn’t. His acceptance speech 
was a highlight of the program. 
In the afternoon we went to the dedi¬ 
cation of the Tom Forbes study in the 
historical library. He was a sincere 
friend and mentor of the Class of '51. 
We expressed our feeling on Dr. Forbes 
to Mrs. Forbes. She remembered our 
class and sent her love. 
Next came the highlight of the week¬ 
end, cocktails at Sid and Ina Furst’s in 
Woodmont. Their beach-front home is 
so pleasant it’s better described by the 
feeling it gives you. We were out on 
their lawn with a spectacular view of 
Long Island Sound. We were part of a 
beautiful, peaceful scene. Nobody 
wanted to leave for Scribner’s 
restaurant! 
But we were glad we did — one of 
Connecticut’s best shore restaurants. We 
were in the right place. Goodie, our 
music minister, brought his tapes of the 
’40s and ’50s. Nostalgia, nostalgia! 
Back to Sid and Ina’s for after-dinner 
drinks on the lawn. I suggested skinny- 
dipping, but there were no takers. Forty 
years will do it to you. 
That was it. Let’s all make the 45th. 
1956 
35tb-year reunion 
by Dr. John H. Gardner 
The weekend of June 7 and 8, was the 
35th-year reunion of the Yale School of 
Medicine Class of 1956. Five of us, 
mostly with wives, arrived in New 
Haven early enough to attend a cocktail 
buffet at my mother’s apartment on 
Thursday. On Friday, many of us 
attended lectures on various subjects 
(the Lyme disease discussion was excel¬ 
lent), including the ubiquitous 
discussion of molecular biology. 
Friday night was one of the high 
points of the reunion and probably the 
best attended event. Poor Helen and 
Steve Downing appeared to have set a 
dangerous precedent by agreeing to 
offer Friday night dinners at reunions; 
we all assembled at their hospitable 
house in Guilford for an appropriately 
bibulous evening with catered dinner. It 
was a wonderful occasion upon which 
to renew acquaintances, and we are very 
grateful to our hosts for the thought and 
effort that they put into the occasion. 
Saturday was more formal, not only 
in terms of the medical school presenta¬ 
tions but our class dinner, which we had 
at Amarante’s Restaurant on the 
“eastern shore” of New Haven harbor. 
It was here that the class picture was 
taken, unfortunately, without those who 
came only for the Friday dinner. 
Overall, those depicted do not look too 
different from times before. There have 
been some changes in hair and some 
changes in weight, but overall, we seem 
fairly hearty. 
Don Nalebuff still looks vertically 
somnolent, quite as in the last picture I 
took of him. Although many of us form 
a hard core of reunion attenders, there 
were some exceptions, and it was partic¬ 
ularly pleasant to see Charlie Zigun 
again. I hope that all of us, plus some of 
those who do not come so often, can 
attend the 40th reunion. This was a 
great occasion to get together with very 
remarkable people. 
Twenty-one of us returned to New 
Haven for part or all of the reunion pro¬ 
gram. This is 30 percent of our class, 
which isn’t bad, but we hope for even 
more at the next reunion. Those who 
attended were the following: Al Apfel, 
Leo Boyajian, John Carroll, Joe 
Cerny, Jim Collias, Don Dalessio, 
Steven Downing, Mitch Edson, John 
Gardner, Bob Hill, Bill Hindle, Chuck 
Hopper, Marie-Louise Johnson, Pres 
Manning, Dwight Miller, Norman 
Moon, Don Nalebuff, Fred North, Bill 
O’Brien, David Page and Charlie 
Zigun. Most of the above came with a 
spouse, and so we had a fairly sizable as 
well as very enjoyable gathering. 
1961 
30th-year reunion 
by Dr L.T. Chiaramonte 
The 30th-year reunion was quieter and 
more personal than the 25th. My wife, 
Ann, and I enjoyed ourselves by 
catching up with what has been going 
on with our classmates. Sally and 
Vincent Marchesi hosted a cocktail 
party Friday evening at their waterfront 
home in Guilford. I, for one, was 
impressed with the two of their five 
children I happened to meet. Vincent, 
who is in charge of developing Yale’s 
new Boyer Center for Molecular 
Medicine, moderated a seminar on 
Saturday morning. He also graciously 
gave us a private tour. 
Saturday evening dinner with John 
Fenn and David Brooks at our table 
was stimulating. Imagine talking to the 
chief of staff at Yale-New Haven Hospi¬ 
tal and a psychiatrist at the same time. 
The quiet recollections of George Lodi, 
Continued on page 48 
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Mr.s. Helen l-orbes and Muriel Wolf, M.D.' 59. converse at the dedication of the 
Thomas R. TOrbes Study at the medical historical library. 
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DISTINGUISHED SERVICE AWARDS 
Dr. MaxH’ell Bogin with (from left) daughter Debbie Cohen, 
his wife, Edith Bogin, and daughter Abby Kenigsburg. 
Maxwell Bogin, M.D. 
Class of 1926 
On the 65th anniversary of his graduation, teacher of clinical 
pediatrics to generations of students, beloved and conscien¬ 
tious physician to thousands of children, your loyal service to 
Yale University School of Medicine as class agent and liaison 
has been exemplary. As a faithful alumnus and son of Yale, we 
salute you. 
The Kresge Foundation Challenge 
Chairman John B. Ogilvie,’34 M.D., was 
cited for his leadership in helping to 
secure the $1 million grant. 
Dr. towel L Goodman (left) with Samuel D. Kushlan, M.D. '35. 
Lowell I. Goodman, M.D. 
Class of 1951 
Starting as a farm boy from Indiana, a fifth generation 
Hoosier, your destiny took you to Yale College, Yale School of 
Medicine, and to a research career in psychiatiy. 
Your loyalty and love for our School of Medicine forged a 
lasting connection to alumni affairs. You assumed an effective 
leadership role in the exceptional Class of 1951. 
Since 1975, you served as class agent for your class in its 
alumni fund activities. Your efforts were so innovative and 
fruitful that within five years you were selected to be the 
national chairman of the Yale University School of Medicine 
Alumni Fund. You brought the same creativity and energy to 
this function, personalizing the relationship of the fund and its 
agents with your personality and good humor. 
You met the record challenge of your predecessor in this job 
by doubling his achievement. 
It is not for your material accomplishments, but rather the 
love for your school and the service to it that you are honored 
today. 
As a distinguished physician, father of a physician, husband 
of an educator, and loyal alumnus we salute you. 
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Roy Ronke and Bob Briggs never fail 
to impress me as well as their faithful 
attendance at every reunion. Roy, in his 
understated way. told of being one of 
the first combat medical officers in Viet¬ 
nam. This impressed me, as one who 
spent his service time as a weekend 
warrior with the National Guard. 
As for me, a few pounds heavier and 
several hairs grayer, I have made the 
mistake of editing a text on food allergy. 
1 have my hands full supervising a new 
practice dedicated exclusively to people 
who perceive they are allergic to foods 
and food additives, in addition to my 
“normar’ activities. If you missed the 
fun in '91, come alive for reunion 35. 
1966 
25th-year reunion 
hy Dr. Arne Yoiingherg 
The Class of 1966 25th-year reunion can 
be judged a great success. On a 
beautiful Friday evening on the shores 
of Long Island Sound we had 
champagne and a sumptuous spread of 
hors d'oeuvres at Clarence and 
Carolyn Sasaki’s beautiful home in 
Stony Creek. Special surprise guests 
were Ed and Joy Crelin. Later on, some 
of us en joyed pizza, beer and laughs at 
Sally’s in Wooster Square. Saturday 
brought more beautiful weather, 
meetings, tours of the campus, and then 
a class dinner at the New Haven Lawn 
Club. The highlight of the evening had 
each classmate give a short biography of 
his/her years since medical school, and 
the response was a mixture of 
admiration, pride and plenty of good 
laughs. The passing of Bill Yeagley and 
Bruce .lackson was sadly noted, and 
news of classmates who couldn't attend 
was shared by friends. After some talk 
about future get togethers, we parted 
with some wistful goodbyes. 
A list of all those attending the week¬ 
end festivities includes: John and Lee 
Baxter (endocrinology), Robert and 
Patricia Bazemore (medicine and 
psychiatry), Frank and Kathy Bell 
(ophthalmology), Phil and Arlene 
Bernstein (orthopedics), F.ugene and 
Hollis (/assidy (pathology), Donald 
and Phyllis Cohen (psychiatry). Bob 
and Betsy Dragon (general surgery), 
.\nthony and Olive P'appiano 
(pathology), Peter and Christine 
(libbons (radiology), Stanley and 
Nancy (ireenspan (psychiatry), Mac 
and Helle (JrifTiss (infectious disea.se). 
Stuart and Barbara Hauser 
(psychiatry), Richard Howard 
(surgery), Gordon and Barbara Kelly 
(ophthalmology), Stuart and Sheila 
Kotler (radiology), Sidney and Lynn 
Lipton Levitsky (pediatric 
endocrinology), Henry and Nancy 
Mann (psychiatry), Caroline McCagg 
(rehabilitation medicine). Bob 
McRoberts (orthopedics), John and 
Marian Mateyka Melish (medicine 
and pediatric infectious disease), Tony 
Robbins and Phyllis Freeman (public 
health), James and Victoria Sansing 
(dermatology), Clarence and Carolyn 
Sasaki (otolaryngology), Joel and Cyn¬ 
thia Singer (plastic surgery), Larry and 
Susan Toder (orthopedics), and Arne 
and Patti Youngberg (radiology). 
Special thanks to Donald Cohen and 
Clarence Sasaki for putting the 
weekend together. For those who 
couldn’t attend, please send me a short 
biography so we can put together a class 
newsletter. 
The most ironic part of the weekend 
was that while we were partying, Stu 
Kotler’s daughter, Yale Med. '93, was 
studying for second-year boards....And 
the beat goes on! 
1971 
20th-year reunion 
hy Dr. Barry B. Perlman 
“How time flies.” This phrase expresses 
the feeling of the 26 or so members of 
the Class of '71 who gathered for the 
20th-reunion. The class dinner again 
was held at the beautiful shoreside home 
of John (now professor of neurology at 
Yale) and Ellen Ebersole. Space limita¬ 
tions permit only brief mention of class 
members but, unfortunately, not of their 
family members who attended and 
contributed to the pleasure of the day. 
Those living either in the New Haven 
area or nearby Connecticut included 
pediatricians Tom Etkin, Dave Rinzier, 
Semeon Tsalbins and Lenny Eisenfeld, 
whose specialty is neonatology. Al 
Weihl is the director of education in the 
emergency department at Yale. Richard 
Kaufman practices internal medicine in 
nearby Branford. Barbara Kinder, who 
was instrumental in making reunion 
arrangements, is now the director of 
surgery at the Department of Veterans 
Affairs Medical Center in West Haven. 
John Foster practices radiology nearby. 
Several psychiatrists attended. Mike 
Piercey, the medical director of Four 
Winds Hospital in Katonah, N.Y., and 
Dave Lippman, who lives in Great Bar¬ 
rington, Mass., were the parents with 
the youngest children, while Barry 
Rand, who practices in Brooklyn, was 
the most recently married. Frank 
Miller, at Cornell, and Jon Stewart, at 
Columbia, are both involved in 
academic research. Barry Perlman is 
director at St. Joseph’s Medical Center 
in Yonkers, N.Y Peggy Finston, living 
in Prescott, Ariz., just returned to 
practice; she authored Parenting Plus: 
Raising Kids with Special Health Needs, 
and is at work on a novel. 
Among those travelling long 
distances to attend were: Paul Vignola, 
who directs the cardiac catherization lab 
at Mt. Sinai Hospital in Miami, Fla., and 
Bob Vranian, who practices cardiology 
in Virginia. Doug Schmidt and Mike 
Gallant are both plastic surgeons work¬ 
ing in Denver, Colo., and St. Petersburg, 
Fla., respectively. Bruce Block, 
unfortunately without Marian, came 
from Pittsburgh, where he runs a family 
practice center for a residency program. 
Coming from the Midwest were Jerry 
Woodhead, an academic pediatrician in 
Iowa City, and Jared Gardiner, a 
radiologist in Wichita, Kan. Allan 
Graham cares for “New York City drug 
addicts in peaceful Vermont.” Richard 
Moggio is a cardiac surgeon at New 
York Medical College in Valhalla, N.Y. 
Judith Bader practices radiation oncol¬ 
ogy in Maryland after many years at the 
National Cancer Institute. It was nice to 
have her return to her first reunion, and 
we hope others will follow suite for the 
25th in 1996. 
1976 
15th-year reunion 
hy Dr. Alfredo L. Axtmayer 
Greetings from Wallingford, Conn! It’s 
hard to believe that 15 years have come 
and gone. 1 am pleased to say that the 
reunion was attended by 15 of us. It’s 
also hard to believe that those of you 
who live nearby, i.e. New York and the 
Boston area, could not drag your bodies 
back to New Haven at this juncture. 1 
am pleased to report that all of those 
who did attend look well and are doing 
great.... 
Peter Swanson continues in family 
practice in Shelton, Conn., and has been 
at that for 12 years. Charlie Swenson 
looked great, perhaps a little less hair on 
top, but the beard is still going strong. 
He lives in White Plains, N.Y, and com¬ 
mutes between there and New York 
City, running a Cornell-affiliated 
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treatment program for suicidal people. 
He keeps thinking of family practice. 
Rich Kayne made it late to the 
reunion dinner but continues to practice 
endocrinology in the MeridenAValling- 
ford/Cheshire area. He and I work 
together at the newly named Veterans 
Memorial Medical Center in Meriden. 
His children are 12, 9 and 7. Maria is 
still busy with her import/export 
business. 
Florence (Comite) Cabin and her 
husband, Henry, were also present at our 
dinner. He is an honorary class member 
from the Class of ’75. Florence is back 
at Yale in reproductive endocrinology. 
Their children are Jonathan, age 12, and 
Mikey, 7 years-old. They look like they 
keep a very busy schedule. 
Dan Rahn, who has been back on 
the faculty at Yale University School of 
Medicine since 1988 directing a clinical 
program in Lyme disease, is making the 
big move from the New Haven/Guilford 
area to a new position as vice chairman 
of the department of medicine in 
Augusta, Ga. It will be a big move for 
Dan, Lana, Jaron, age 9, Rebecca, age 
6, and Zachary, age 4. We wish them 
well! 
Cindy Mann looks great, continues 
to practice pediatrics in New Haven at 
Connecticut Health Care Plan. Ken 
Dobuler also is in New Haven, 
practicing pulmonary medicine in a 
group with 29 other M.D.s. Vinny 
DiCola also continues in New Haven in 
cardiology in a group with six others. 
He has a son age 4 and a daughter age 3. 
Bill Levy and Doug Mann came 
from the Philadelphia area. Bill is a little 
league coach who moonlights as a cardi¬ 
ologist, and Doug practices ear, nose 
and throat surgery in Media, Penn. He 
has three children and his wife, Jane, is 
an ophthalmologist. He gets the award 
for the most physically unchanged 
appearance since graduation. 
Rich Pelker is professor of 
orthopaedics at Yale but aspires to be a 
full-time sailor and beach bum. Norm 
Kohn came all the way from Chicago 
just for reunion dinner. He still lives 
near the University of Chicago and 
practices psychiatry there. 
The prize for the longest trip for our 
reunion goes to Randy Hawkins and 
his wife. Penny, who came all the way 
from San Diego. He is a neurologist 
with a big group downtown and loves 
California (as expected). He has 
extended an invitation for anyone going 
to San Diego to look him up while they 
are there. I am sorry to report his hair is 
shorter and he is playing golf! 
I continue to do general orthopedics 
in Wallingford and am too busy to make 
it down to New Haven except every five 
years for reunions! 
Best wishes to one and all. Let’s 




by Dr. Barbara Ross 
The lOth-year reunion dinner for the 
Yale School of Medicine Class of 1981, 
held at the Chart House on June 8 was a 
big success, with 21 people attending. 
Scott Hundahl made the longest trip, 
from Honolulu, where he is a surgical 
oncologist and his wife, Leilani, is an 
internist. East Coast oncologists 
included David Lebwohl (medical 
oncology), here with his wife, Sally, an 
archivist, and Yvedt Matory (surgical 
oncology fellow), with husband Randy, 
a law professor at Harvard. Both David 
and Yvedt are at Memorial-Sloan 
Kettering, along with Ines Carrasquillo 
and Richard Rodman. 
The three rheumatologists at reunion 
were Dean Noritake, Stewart 
Greisman and Barbara Roach. Dean 
and Lynn came all the way from 
Pasadena and have two children, Daren 
and Alison. Stewart shares a practice in 
Manhattan with his wife, Lisa Babitz 
(geriatrics), and they have two 
daughters, Laura and Jill. Barb 
practices in New Haven, and she and 
husband Rick have two energetic 
toddlers, Matthew and Emily. 
Not surprisingly, the New York area 
was very well represented. David Weiss 
is an orthopedist in Manhattan — his 
specialty is dance medicine, .so he is at 
the ballet several times a week. Dovelet 
Shashou is a pediatric ophthalmologist 
in New Jersey. Her husband. Jon, is a 
radiologist at Einstein and they have a 
2-year-old son. Donald Moore 
practices family and emergency 
medicine in Brooklyn; he and wife 
Christine have one daughter. Robert 
Kenet is an instructor in cardiology at 
Cornell, and is president of Vanguard 
Imaging. His interests include digital 
imaging in cardiology and dermatology 
as well as the harpsichord. Jane Asch 
has a private psychiatry practice in New 
York City, and she is in psychoanalytic 
training at Columbia. Also representing 
psychiatry is Marty Teicher, who is at 
Harvard and divides his time between 
research, clinical work, his two children 
and speaking to the press about Prozac. 
It was wonderful to see so many 
classmates come back to New Haven for 
reunion, and we are looking forward to 
our 15th in 1996! 
1986 
5th-year reunion 
Attendees: Catherine Ann Arnold, 
Cristina Brunet, Amanda Dill, Daniel 
Fierer, Cynthia Hall, Roberto Lewis- 
Fernandez, Steven Waisbren and 
John Wysolmerski. 
Donald Moore. M.D.'Sl, and his wife, Christine Moore. 
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1990-1991 ALUMNI FUND REPORT 
From the YSM 
Alumni Fund Chairman 
The alumni of the Yale University 
School of Medicine have much of which 
to be proud. We have been blessed by 
being educated in what is recognized as 
one of the five best medical schools in 
this country. Our faculty is known 
throughout the world for its research 
activities, teaching abilities, and for its 
unwavering commitment to student edu¬ 
cation. The Yale System allows for 
personal growth as well as intellectual 
scientific achievement. It is no wonder, 
therefore, that our alumni remain 
steadfast and loyal in their support of 
our school. At no time was this more 
evident than in the 1990-1991 campaign 
of the School of Medicine Alumni 
Fund. All previous records were broken. 
Faced with a $ I million dollar challenge 
from the Kresge Foundation, and a 
S4(),()()0 challenge from Dr. Sanfurd 
Bluestein, you met them both with 
resounding success. 
In the 1990-1991 campaign, we 
raised $69.‘S,839.37, breaking all 
previous records for annual giving. 
Equally as important, however, was that 
our level of participating reached 56 
percent. We share first place with the 
Law School for the highest percentage 
of participation among the graduate and 
professional schools at Yale. 
There are many people to thank for 
this noteworthy achievement. The 
professional staff, under the guidance of 
alumni fund Director Monica Robinson, 
were diligent in their pursuit of our 
goals. Class agents responded to calls 
for action promptly and with 
enthusiasm. 
Most of all, thanks must be given to 
you, our alumni for answering the call 
of our school so willingly and 
generously. The board of the School of 
Medicine Alumni Fund tips its 
collective hat to all of you. 
My term as chairman of the School 
of Medicine Alumni Fund has come to a 
close. Personal thanks go to Monica 
Robinson and her staff, members of the 
alumni fund board, and to all of the 
class agents. You have made my job 
easy by doing all the work, and interest- 
Dr. R. Leonard Kemler 
ing by being such stimulating people. It 
has been a wonderful experience. 
Best wishes go to my successor. Dr. 
John Foster. May you enjoy the work as 
much as I have, and may you break all 
the recently established records. 
R. Leonard Kemler, M.D. '43 
Chairman 
Dean’s Message 
No task plea.ses me more as acting 
dean than to thank the Yale medical and 
EPH alumni for generously contributing 
their time, energy and talent to help pro¬ 
vide for the continuing needs of their 
school. I truly appreciate your loyalty 
and commitment to the well-being of 
the Yale School of Medicine and its 
Department of Epidemiology and Public 
Health. 
Medical alumni's total gift of 
$695,830 to the School of Medicine 
Alumni Eund, with 56 percent participa¬ 
tion, not only set new records for total 
giving and percent participation, but 
exceeded the requirements of the 
Kresge Eoundation Challenge, thus 
earning a $1 million donation to the new 
Boyer Center for Molecular Medicine. 
Special thanks go to R. Leonard 
Kemler, M.D., the outgoing chairman of 
the School of Medicine Alumni Fund, 
and John Ogilvie, M.D., who 
coordinated the program for meeting the 
Kresge Challenge. The class agents’ 
work also was crucial to this success. 
The highlight of the EPH Alumni Fund 
was the extremely generous gift of 
$300,000 over three years by Samuel S. 
Herman, M.P.H., Ph.D., and his wife, 
Liselotte. I hope that our alumni 
continue to vigorously respond to their 
school’s needs. 
Because of the ongoing 
accumulation of debt that medical and 
EPH students accrue when acquiring 
their education (medical student debt at 
graduation averages more than $49,000, 
while EPH students’ tops $31,000), Yale 
will continue to designate your financial 
contributions to student aid. Our 
students greatly appreciate your 
support; helping them meet their 
financial needs allows the School of 
Medicine to attract the outstanding 
talent which we traditionally expect at 
Yale University. 
As we implement the newly adopted 
academic plan, we intend to integrate 
curriculum revisions that will enable us 
to attain the plan’s goals within the 
parameters of the Yale System. The 
expansion of the school’s physical plant, 
as well as construction of the Children’s 
Hospital at Yale-New Haven, also are 
essential elements in helping us meet 
the goals of our academic plan. 
Your generous contributions not only 
represent important investments in the 
academic plan, but they also support the 
future clinicians, basic scientists and 
public health specialists who are needed 
to address the pressing medical and 
public health challenges that we will 
continue to face as we enter the 21st 
century. 
Robert M. Donaldson Jr. 
Acting Dean 
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Medical School Alumni Fund Class Participation 
1989-1990 1990-1991 
CLASS AGENT TOTAL % PART TOTAL % PART. 
1922 and prior $2,011 100 2,370 100 
1923 William Cohen 686 100 1,.546 100 
1924 David Raskind 11,334 100 12,214 100 
1925 Alice Whittier 5,473 50 611 75 
1926 Maxwell Bogin 1,720 60 841 75 
1927 Harry Zimmerman 1,136 63 1,710 83 
1928 3,580 60 2,191 100 
1929 Paul McAlenney 1,376 67 1,553 89 
1930 147,690 71 70,425 67 
1931 Michael D’Amico 3,426 91 3,256 KX) 
1932 2,339 50 2,514 85 
1933 Franklin Foote 2,103 69 2,303 113 
1934 John Ogilvie 4,652 75 7,028 100 
1935 James Haralambie 6,780 52 6,975 100 
1936 3,991 34 4,361 61 
1937 Wilbur Johnston 2,289 64 2,040 83 
1938 Nelson Ordway 1,346 72 1,488 92 
1939 Rebecca Solomon 4.131 69 3,869 90 
1940 James Ferguson 16.441 65 12,070 95 
1941 Charles Cheney 4,593 76 9,776 90 
1942 Walter Burdette 3,600 64 5,369 85 
1943A Dorothea Peck 6,743 74 29,174 100 
1943B Brownlee Brinkley 5.930 7.092 93 
12,673 64 36,266 97 
1944 Nicholas Spinelli 10,131 65 10,297 100 
1945 Richard Breck 10,573 67 5,806 94 
1946 Thomas Whelan 8,800 70 55,973 79 
1947A George Barnes 6,834 78 5,191 93 
1947B W. Roy Breg 2.653 64 2.444 93 
9,487 71 7,635 93 
1948 Anne Godley 7,675 56 8,644 82 
1949 Daniel Elliot 3,930 60 3.864 84 
1950 74,952 71 8,886 79 
1951 Lowell Goodman 10,581 59 15,324 69 
1952 4,275 42 5,634 60 
1953 Vincent Gott 8,710 55 8,737 72 
1954 John Rose 6,034 60 /,435 79 
1955 Robert Kramer 6,932 58 6,085 68 
1956A John Gardner 4,862 47 10,262 75 
1956B Donald Dalessio 3.235 53 6.855 74 
8,097 50 17,117 75 
1957A Harry Briggs 3,575 57 7,275 73 
1957B Howard Minners 4.575 64 5.485 
8,150 61 12,760 70 
1958A Andrew McGowan 9,702 53 9,746 65 
1958B Paul Rudnick 4.820 52 4.955 66 
14,522 53 14,701 66 
1959A Asa Barnes 7,222 61 8,859 83 
1959B Muriel Wolf 4.474 57 5.051 70 
11,696 59 13,910 77 
1960A Eugene Gaenslen 5,333 57 .3,171 59 
1960B Thomas Kugelman 6.500 57 5.375 63 
11,833 57 8,546 61 
1961A Robert S. Briggs 3,305 51 4,650 60 
1961B Warren Widmann 4.610 57 9.425 77 
7,915 54 14,075 67 
1962A A.R. Pschirrer 4,090 60 3,101 66 
1962B Frederic Cantor 3.051 39 3.826 50 
7,141 50 6,927 58 
1963 Craig Llewellyn 6,984 32 8,722 50 
1964A William J. Houghton 2,185 41 3,885 48 
1964B Robert Lyons 10.650 68 10.750 79 
12,835 55 14,635 64 
1965 David Hill 13,299 50 14,243 53 
1966A Mary Alice Houghton 2,975 57 3,150 59 
1966B Gary Townsend 3.400 52 3.495 55 
6,375 55 6,645 57 
1967A James Dowaliby 3,428 54 3,572 63 
1967B Anthony Lovell 5.715 74 6.390 71 
9,143 64 9,962 67 
1968A Frank Lucente 9,053 45 16,353 58 
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1968B Donald Lyman 4.830 58 6.188 
13,883 52 22,541 
1969 Adrian Schnall 7,602 52 11,307 
1970 James Missett 5,823 46 5,403 
197IA John Cieply 3,468 43 5,944 
197IB Barbara Kinder 5.725 44 10.450 
9.193 44 16,394 
1972 Harry Malech 9,835 47 10,386 
I973A Lee Goldman 1,766 48 1,-599 
1973B John McQuade 2,015 39 2,831 
1973C Jerrold Rosenbaum 1.691 43 2.029 
5.472 43 6,459 
1974A Amy Schechter 1,755 49 1,745 
1974B Robert Schechter 3.800 37 3.040 
5,555 43 4,785 
1975 A 1,570 31 1,631 
1975B Mary Jane Minkin 1.179 20 1.559 
2,749 26 3,190 
I976A William Levy 3,(X)0 35 4,570 
1976B Glenn Gorlitsky 1.260 36 2.725 
4,260 36 7,295 
1977 A 2,420 24 5,910 
I977B Ronald Vender 2.527 47 1.570 
4.947 36 7,480 
1978A Duke Cameron 1,770 22 3,070 
I978B Seth Powsner 325 27 350 
1978C Thomas Smith 115 25 200 
2.210 25 3,620 
1979A Jeffrey Kaine 685 34 1,770 
1979B Cynthia Sherman 1.900 24 3.160 
2.585 29 4,930 
1980A Eduardo Alfonso 2,375 35 1.855 
1980B Stevem Rosenfeld 1.056 27 1,357 
3,431 31 3.212 
1981 Anthony Urbano 1.645 20 3,703 
1982A Muriel Cyrus 650 12 948 
1982B Jed Gorlin 300 35 385 
I982C S. Wolf-Rosenblum 470 38 970 
1,420 28 2,303 
1983A Michael Tom 276 9 971 
I983B David Schwartz 330 30 585 
606 20 1,556 
1984A Hinggr Hsu 485 26 620 
1984B Jay Kostman 500 19 750 
985 23 1,370 
1985 A Greg Sachs 695 26 807 
I985B Fred Santoro 190 23 700 
885 25 1,507 
I986A Eric Bernstein 230 16 958 
1986B Clinton Lindo 95 11 125 
I986C Eric Suan 35 7 700 
360 12 1,783 
1987A Barry Weinstock 261 20 745 
1987B Subba Gollamudi 50 17 123 
1987C Mindy Schuster 100 14 360 
1987D Mark Widmann 725 
411 17 1.953 
1988A Michael Mockovak 57 19 237 
1988B Susan Valley 145 17 168 
1988C Hedi Zaghi 20 8 215 
222 15 620 
1989A Stephen Bharucha no 13 250 
1989B Lewis Lipsey 245 24 175 
1989C Melissa Myers 50 11 76 
1989D Roger Widmann 35 13 205 
440 15 706 
1990A Chander Sarny 160 
1990B Daniel Stryer 75 
I990C Jonathan Foster 88 
1990D Roberto Soto 5 
I990E Thomas Christopher 150 
1990F Tracy Nelson 
I'AiilG Ercem Atillasoy 30 
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CONTRIBUTORS 1991-1992 
The names and data included on the following pages were provided hy the 
Yale School of Medicine Alumni Fund and reflect contributions made 









Charles R. Mitchell* 
1908 
Michael A. Parlato* 
1912 
Walter Clark Tilden* 
1913 









Chester E. Hurwitz* 
Helen R Langner 
1923 
William Cohen* 
Julius Anthony Olean* 
Hyman W. Weinstein* 
1924 
Donato Anthony D'Esopo* 
David M. Raskind 
Myron A. Sallick* 
Jacques Diamond Soifer* 
1925 
Waldo F. Desmond* 
William E. Hall 
Samuel Reback 
Eli Hyman Rubin* 
Alice A. S. Whittier 
Howard Asa Wood* 
1926 
Stanton T. Allison* 
Maxwell Bogin 
William H. Hahn* 
Joseph L. Hetzel* 
Morris Hinenburg 
Joseph T. Matteis 
1927 
Wallace Robert Bostwick* 
Henry Irwin Fineberg* 
John Martin Freiheit* 




William C. Meredith 
Alfred F. Seibert 
Theodore H. Sills 
M. Dawson Tyson 
Harry M. Zimmerman 
1928 
Max Alpert* 
Sheldon A. Jacobson 
Edward P J Kearney 
Ralph E. Knutti 
R. Harold Lockhart 
Edward W. Ludwig* 
Nathan E. Ross 
Robert 1. Rubinstein* 
John M. Russell* 
Alvin A. Schaye* 
George C. Wilson* 
1929 
James Rae Ameill Jr.* 
John M. Bailey* 
John W. Cass Jr.* 
Frank H. D'Andrea 
Robert A. Frisch 
Olive Gates 
George S. Goldman 
Alexander O. Haff* 
John A. Hangen 
Tony Liebman Rakieten* 
William Frederick Roth 
Jr.* 




Julius G. Weiner* 
Mabel Wilson 
1930 
Daniel N. Beers* 
Frederick Fitzherbert 
Boyce 
Charles A. Breck* 
Lewis Dickar* 
Vincent A. Doroszka* 
Knox H. Finley 
J. Roswell Gallagher 
Leonard Greenburg* 
Amy H. Hunter Wilson* 
Paul Harold Lavietes* 
Moses D. Lischner* 
James Merriman Lynch* 
John W. Maroney 
Paul Watson* 
Charles L. Wood 
1931 
Henry H. Briggs Jr. 
Benjamin Castleman* 
Michael D'Amico 
Paul A. Harper 
Morris Heller* 
Thomas C. Jaleski 
Rhoda M. Mickey 
Nelson Newmark 
Abraham J. Schechter 
James A. Stringham 
Max Taffel 
1932 
Louis K. Alpert 
Reginald V. Berry 
Frank Carroll 
Clement C. Clarke 
Hester B. Curtis 
Joseph P. Donnelly 
Lee E. Farr 
Thomas E. Farthing* 
Lewis F. Foster 
Elizabeth M. Ramsey 
Benjamin N. Tager 
Myron E. Wegman 
Roland T. Wehger* 
1933 
Myron J. Adams* 
Fred W. Buse 
Warren P. Cordes 
Franklin M. Foote 
Jack Greenberg 
Daniel Foster Harvey* 
George K. Hirst 
Robert Watkinson 
Huntington Jr.* 
John G. Martin 
Raymond Everett Miller* 
Ashley Pond III* 
Paul L. Saffo 
Edwin B. Seelye* 
Sidney Stringer* 




Francis P. Guida* 
Derick Algernon January* 
Knowles B. Lawrence 
Herbert C. Miller 
Edward Thomas 
O’Donnell* 
John B. Ogilvie 
Lucien M. Pascucci 
Harry Sherman 
Wedgwood P. Webber 
William R. Willard 
George Zalkan* 
1935 
Walter E. Barney* 
George A. Carden Jr. 
Edgar S. Childs 
Edward F. Falsey* 
H. Hoffman Groskloss 
James Quintin Haralambie 
W. Howard Homer* 
Mildred Hartshorn January 
Samuel D. Kushlan 
Donald P. Morris* 
Norman E. Peatfield 
John D. Preece 
Norman P. Rindge 
Milton Rose* 
Clark P. Searle 
Walter A.L. Thompson 
1936 
Lester W. Burket 
Albert W. Diddle 
Margaret C. L. Gildea 
George A. Hahn* 
Louise G. Hutchins 
Philip M. LeCompte 
Donald F. Marshall 
Stephen F. Nagyfy 
Frederick A. Post* 
Hugh Allan Smith 
Margaret Sommers 
Morris Tager 
Rafael Amllaga Torrens 
1937 
Edmund R. Blower 
William G. Cooper Jr. 
D. Crosby Greene 
Wilbur D. Johnston 
Alfred E. King 
Dunham Kirkham 
Julia Mehlman 
James P. Morrill 
T. Dennie Pratt 
Alan A. Rozen 
Morgan Sargent 
Albert D. Spicer 
John M. Thomas 
Jean Wells 
Lorande M. Woodruff 
1938 
Roy N. Barnett 
Henry L. Carideo 
S. Charles Kasdon 
Benjamin E. Lyons 
John J. McGillicuddy 
Nelson K. Ordway 
Charles J. Petrillo 
Edward W. Pinkham Jr. 
James Radcliffe Jr. 
George E. Roberge 
Theodore W. Steege 
Lester J. Wallntan 
1939 
Stephen W. Collins Jr.* 
Harold H. Coppersmith 
Norman L. Cressy 
William H. Druckemiller 
Robert Goodfellow Ernst* 
John P. Ferguson Jr. 
Joseph B. Forman 
S. Jerome Greenfield 
Nathaniel Kenigsberg* 
Margaret A. Lennox 
Ward J. McFarland* 
James Peter Murphy 
Russell Nahigian* 
SCHOOL OF MEDICINE 
ALUMNI EUND BOARD 
Daniel L. Arons, M.D. '67 
Sharon L. Bonney, M.D. '76 
M. Felix Freshwater, M.D. '72 
Harry C. Briggs. M.D. '57 
James M. Dowaliby, M.D. '67 
Alex R. Gaudio, M.D. '63 
Herbert S. Hurwitz, M.D. '54 
Sidney S. Lee, M.D. '50 
Benjamin E. Lyons, M.D. '38 
Andrew J. McGowan Jr., M.D. '58 
John B. Ogilvie, M.D. '34 
Helen L. Smits, M.D. '67 
Ronald J. Vender, M.D. '77 
Marcia J. Wade, M.D. '78 
OFFICERS 1991-1992 
John W. Foster, M.D. '71 
Chairman 
J. Roswell Gallagher, M.D. '30 
Bequest and endowment co-chairman 
Samuel D. Kushlan, M.D. '35 
Bequest and endowment co-chairman 
Former house staff chairman 
EPH Alumni Fund 
Stephen Skorcz, M.RH. '70 
Chairman 
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Douglas S. Riggs 
Roger N, Ryley 
Ernest L. Sarason 
Bradford Simmons 
Rebecca Z. Solomon 
John D. Tobin 
Arthur S. Tucker* 
Darrell G. Voorhees 
Douglass W. Walker 
John H. Wentworth 
Malvin F. White 
1940 
Theodore E. Allen 
Joseph V. Baldwin 
Ronald S. Beckett 
Jack S. Blaisdell 
Philip S. Brezina 
David Crocker* 
Wynant Dean 
Richard E. Dormont 
James F. Ferguson Jr. 
Eugene J. Fitzpatrick Jr. 
Henry D. Humphrey 
H. Stuart Irons* 
Donald G. Johnson 
Ira D. LeFevre Jr. 
John D. MacAllister 
Paul D. MacLean 
Edward Martin 
K. Alvin A Merendino 
Maurice Ross* 
Lee S. Sannella 
W. Norman Sears* 
Joseph E. Sokai* 
J. Champneys Taylor 
Patricia E. Wanning 
Helen H. Woods 
1941 
Robert H. Alway 
Robert H. Areson 
W. Randal Bell 
Knute E. Berger* 
William A. Carey 
Joseph P. Carson Jr. 
Charles B. Cheney 
Herbert W. Diefendorf 
Robert F. Dine* 
Peter A. Duncan 
Lloyd D. Flint 
John Franklin 
Robert L. Gilbert 
Frederick P. Glike 
Thomas S. Harvey 
William Edmund Kenney 
William Lee 
Bjorn Lih 
John R. McDermott* 
Willys M. Monroe 
Malcolm C. Murfitt 
Jean E. Neighbor 
Edward B. O'Connell 
Robert W. Ollayos 
Gioacchino S. Parrella 
David V. Pecora 
Edwin D. Rogers 
Leslie Simmonds 
1942 
William E. Bloomer 
James M. Bunce 
Walter J. Burdette 
Robert E. Carroll 
Donald S. Childs Jr. 
Ludmil A. Chotkowski 
Vincent J. Collins 
Eugene M. de Hostos 




Allan V.N. Goodyer* 
William Harrison Jr. 
Wilson E. Hughes* 
Leo Kellerman 
John R. Lincoln 
Patrick S. Mullins* 
Dean Nichols* 
Samuel Ritvo 
Lois Knight Rogers 
Richmond W. Smith Jr. 
Carter Stilson 
Edgar B. Taft 
Maurice Tulin 
Francis P. Vose* 
Anhur A. Ward Jr. 
Irving Norman Wolfson 
Med. memorial 1942 
Classmates* 
1943A 
Ralph D. Alley 
Anonymous 
John R. Brobeck 
Edward S. Brown 
Lycurgus M. Davey 
Donal L. Dunphy 
R. M. Fasanella 
Gerard Fountain 
Edward Douglas Homing* 
Stuart L. Joslin 
R. Leonard Kemler 




J. Philip Loge 
Henry E. Markley 
Walter J.J. Nero 
Dorothea R. Peck 
Edward F. Rabe 
Earl J. Rhoades 
Henry A. Riedel 
Bernard R. Rowen 
Marcus E. Sanford 
Robert A. Sears* 
Edward Hersey Soule 
Hilliard Spitz 
Nicholas M. Stahl 
Sophie Trent Stevens 
Oliver G. Stonington 
Robert G. Turner 
Frederick A. Waldron* 
John J. Weber 
Morris A. Wessel 
Robert H. Wyatt 
1943B 
Richard N. Abbott 
John R. Almklov 
David G. Borden 
James L. Bradley* 
Robert F. Bradley 
S. Brownlee Brinkley 
Henry B. Bruyn Jr. 
Thomas L. Bucky 
Jane B. Cadbury 
Philip B. Chase 
Hunter H. Comly 
Norman 1. Condit 
Thomas D. Cook 
Ronald W. Cooke 
Joseph I. Epstein 
Robert H. Fumian 
Victor C. Hackney 
Fred M. Haddad 
Frank R. Hurlbutt Jr. 
Henry H. Jones 
Joseph F. Kell 
Sawyer E. Medbury 
Hoyt B. Miles Jr. 
Benjamin R. Robinson Jr. 
Donald W. Seldin 
Francis A. Spellman* 
W. Keasley Welch 
1944 
Carl E. Andrews 
Joseph Ciola* 
Edward J. Conway 
Robert E. Cooke 
John C. Coolidge 
George B. Corcoran Jr. 
Frank W. Countryman 
Lawrence S. Crispell 
Charles H. Crothers 
Lawrence G. Crowley 
John H. Doherty 
Robert W. Frelick 
Carol Goldenthal 
Charles A. Hall 
Howard B. Hamilton 
Robert 1. Hinkley 
W. Raymond James 
Ward S. Jenkins 
Edith M. Jurka 
Harvey W. Kausel 
Jerome J. Kaye 
John Weaver King 
Frederick F. Krauskopf 
Ronald E. Losee 
Ellen P. MacKenzie 
Elias J. Marsh 
Katharine Hawley Martin 
Joseph Massaro 
A. Reese Matteson 
Paul E. Molumphy* 
Russell R. Monroe 
Lawrence K. Pickett 
Laurence G. Roth 
Haynes W. Sheppard 
Sarah P. Sherwood 
Eugene Smith 
Nicholas PR. Spinelli 
Mrs. Gertrude Spinelli* 
Priscilla Dienes Taft 
Anthony Varjabedian 
Calvin Watts Woodruff* 
Reuben Zucker* 
1945 
George Howard Allison 
Albert S. Atwood 
Frederic M. Blodgett 
Richard W. Breck 
Louise H. Burr 
Alice Shepard Cary 
Sanford F. Cockerell 
Jay B. Cohn 
Richard R. Dyer 
Robert S. Easton 
Sidney S. Feuerstein 
Alice Dershimer Friedman 
James D. Gardam 
Philip S. Good 
Herbert S. Hamed Jr. 
Isao Hirata Jr. 
Paul W. Hoffert 
O. Roger Hollan 
John R. Howick 
Hans R. Huessy 
Leland W. Jones 
John A. Knapp 
William E. Laupus 
Mark McD Lindsey 
James R. Mason 
Charles E. McLean 
George W. Naumburg Jr. 
Fitzhugh C. Pannill 
Richard M. Peters 
Elliot R. Reiner 
Charles E. Sherwood 
Joseph R. Stanton 
Kenneth C. Steele 
1946 
Margaret J. Albrink 
William G. Bantleld Jr. 
Franklin C. Behrle 
Sanfurd G. Bluestein 
Linus W. Cave 
Thomas J. Coleman 
James F. Cooney* 
Thomas A. Doe 
Edward F. Edinger 
Gregory E. Flynn 
Martin E. Gordon 
Charles Sheldon Judd Jr.* 
Benjamin F. Kitchen Jr. 
James A. Kleeman 
Vincent J. Longo 
Richard Hess Mann* 
Thomas J. Mathieu 
Hugh J. McLane 
Joe D. Morris 
John H. Morton 
Thomas J. Murphy 
John F. Neville Jr. 
Laura W. Neville 
Harry Dickson Patton 
Vincent Pepe 
Francis G. Reilly* 
David H. Riege 
Phillips E. Roth 
Julian A. Sachs 
Donald P. Shedd 
Richard G. Sisson 
R. Bruce Thayer 
Robert R. Wagner 
William P. Walsh 
William J. Wedemeyer Jr. 
Thomas J. Whelan Jr. 
Hugh R. Williams* 
1947 
George R. Barnes Jr. 
Albert W. Bostrom Jr. 
John E. Bowers 
W. Roy Breg Jr. 
Richard G. Britton* 
David L. Brook 
Rocco A. Calandruccio 
John L. Cannon 
M. Richard Carlin 
John C. Carpenter 
Arthur Harry Chapman 
Robert A. Chase 
Amoz I. Chemoff 
William F. Collins Jr. 
Bradford S. Colwell 
Robert P. Darrow 
Jean H. Dougherty 
Owen W. Doyle 
Franklin Harold Epstein 
Edward Foord* 
Richard K. Friedlander 
Frank L. Golbranson 
Frank H. Horton 
Robert J. Kerin 
Don F. Kimmerling 
Anton N. Lethin Jr. 
Richard P. Levy 
Brock Lynch 
Victor A. Machcinski 
William K. McClelland 
Robert F. Newton 
Myron K. Nobil 
Lawrence C. Perry* 
Philip H. Philbin 
Olive E. Pitkin 
Irving Rudman 
Lawrence P. Shea* 
Alvin Somberg 
Igor Tamm 
William F. Thompson 
Patricia B. Tudbury 
Ellis J. Van Slyck 
M. Henry Williams Jr. 
1948 
Russell J. Barmett* 
George F. Batten 
Edith M. Beck 
Jonathan S. Bishop 
Allyn G. Bridge 
Arthur L. Coleman Jr. 
Ruth E. Cortell 
Richard H. Cote 
G. Robert Downie 
Victor A. Drill* 
Elizabeth Euller Eisner 
Albert A. Fisk 
Boy Frame* 
Emil Frei III 
Julian Frieden 
Anne Godley 
Paul S. Goldstein 
Allan Green* 
B. Herold Griffith 
Sylvia Preston Griffiths 
Richard M. Hannah 
Halsted R. Holman 
Paul B. Koehler 
Robert E. Lempke 
John P. Morris 
John B. Morrison 
David E. Morton 
James W. Needham 
George P. Rostel 
Lewis P. Rowland 
Benjamin F. Rush Jr. 
Gabriel A. Saviano* 
Jerome H. Shapiro 
Jessie Parkinson Spear 
Paul Talalay 
Wallace W. Turner 
Paul Woodbury Weld 
1949 
William G. Aniyan 
Alfred E. Bacon Jr. 
William D. Bevis 
Jonathan S. Bishop 
Mary Pucci Couchman 
Phillip G. Couchman 
N. Joel Ehrenkranz 
Daniel W. Elliott 
Gunnar O. Eng 
Albert A. Fisk 
Eleanora C. Gordon 
Frederic W. Gray 
Jackson Harris 
Frederick R. Hine 
Benjamin A. Johnson 
Orval 1. McKay 
Orlando J. Miller 
Timothy F. Nolan Jr. 
Julian 1. Pichel 
Charles L. Rennell Jr. 
Murray Z. Rosenberg 
Daniel Rudman 
Carl M. Russell 
William H. Sewell 
Martha Vaughan 
Vernon T. Watley 
Mary-Agnes P. Wine 
1950 
Russell N. Anderson 
Lyal D. Asay 
Sylvia L. Axelrod 
Malcolm A. Bagshaw 
John E. Borowy 
William H. Bucher 
Class Of 1950* 
Alvin Davis 
Claude W. Delia 
Marie C. Duncan 
Kent Ellis 
Thomas J. Ferraro Jr. 
Daniel Fine 
Lawrence R. Freedman 
David A. Frucht 
Carl A. Gagliardi 
Archie James Golden* 
Melvin H. Kaplan 
Lucian S. Lapinski 
Sidney S. Lee 
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Pictured at the June 6 dedication of the Boyer Center for Molecular Medicine, are (from left) Benno C. 
Schmidt Jr., Herbert W. Boyer, Ph.D., his wife, Marigrace, their son, Ethan, and Dean Leon E. 
Rosenberg. This photograph and others in this section, taken at The Boyer Center dedication scientific 
symposium, celebrate YSM alumni’s generosity in meeting the $1 million Kresge Eoundation Challenge. 
(See the Development Report, page 42.) 
Janus C. Lindner 
Margaret S. Lyman 
Harold March 
Harry L. McClelland 
Marina P, Meyers* 
John H. Meyers 
Orlando J. Miller 
Charles A. Nugent Jr. 
Robert Edward Quinn* 
Robert T. Sceery 
Cynia B. Shimm 
Jane B. Shumway 
Martin E. Smith* 
John S. Strauss 
Myra D. Tyler 
Erederick Edward Vultee* 
1951 
Karel Bedrich Absolon 
W. Robert Adams 
Thomas T. Amatruda Jr, 
Stanley D. Ardell 
John W. Berg 
Eleanor Clay Bigley 
John J. Egan 
Eerdinand H. Flick 
Sidney S. Furst 
Joseph M. Garland 
Lowell I, Goodman 
John T. Groel 
Robert N. Hamburger 
John V. Haxo 
Carrold K. Iverson 
William Kiekhofer 
Robert D. King 
Jocelyn S. Malkin 
Francis L. Merritt 
Paul D. Millikin 
Walter S. Morgan 
Albert R. Mowlem 
Richard S. Munford 
Ismail Nik Nevin 
Gerard B. Odell 
Alfred Owre Jr. 
Jose Felix Patino 
Arthur A. Pava 
Majic S. Potsaid 
Robert G. Small 
William F. Stephenson 
Harold M. Sterling 
Bradley R. Straatsma 
John L. Sullivan 
William A. Taylor* 
Andrew S. Wong 
1952 
John W. Arnold 
Maurice L. Bogdonoff 
Siegried A. Centerwall 
Willard R. Centerwall 
Frank R. Coughlin Jr. 
Barbara B. Coughlin 
Richard N. deNiord Jr. 
John P. Filley 
Richard D. Floyd 
Robert P. Gerety 
Thomas S. Kelly 
James Kent Luce 
N. Karle Mottet 
Robert L. Nolan 
Sidney Nathan Paly 
Robert G. Petersdorf 
Leon A. Phillips 
John Macklin Roberts 
Leonard Rush 
Mary Wheatland Schley 
Donald H. Schultz 
Robert B. Schultz 
John H. Wagner Jr. 
Doris L. Wethers 
John L. Wolff 
Harvey L. Young* 
Robert Zeppa 
1953 
Seth F. Abramson 
Jonathan Barry* 
Claude Bloch 
Harold D. Bomstein Jr. 
William R. Chaffee 
Allen Chetrick 
Rex B. Conn 
Louis R M Del Guercio 
John Leo Doppman 
James P. Dunn 
Donnell Dencil Etzwiler 
Vincent Lynn Gott 
Robert Emanuel Hamlisch 
A. Daniel Hauser 
George L. Hoffmann 
David Purdy Holman 
Peter Biggs Hukill 
Alvin Joseph Keroack 
Robert Francis Kiley Jr. 
Richard Robert Knowles 
III 
Frederick Martin Lane 
Hildegard Mueller Leslie 
John Dutch Lord 
Robert N. Melnick 
Harvey Martin Peck 
Warwick Potter Jr. 
Paul G. Quie 
Jose Ramirez-Rivera 
Irwin K. Rosenberg 
Barbara F Rosenberg 
Virginia C. Saft 
William Lindsay Shepard 
Richard Andrew Sinnott Jr. 
Ora K. Smith 
John Frazier Snyder III 
Lynn Cortland Stoker 
William Junior Vandervort 
William A. Whalen Jr. 
William August Wilson 
James Frederic Young 
1954 
Frank P. Berg 
George W. Bostwick 
Richard J, Bouchard 
George N. Bowers Jr. 
Ralph K. Campbell 
John R. Cole 
William D. Cone 
Arthur C. Crovatto 
Donald D. Davis 
Walter J. Freeman 
Orlando F. Gabriele 
John A. Gariepy 
Edward J. Gerety 
Samuel T.J. Giammona 
Frank L. Gruskay 
Nicholas A. Halasz 
Katherine H. Halloran 
Robert P. Hatch 
Walker R. Heap Jr. 
Eva H. Henriksen 
Samuel J, Hunter 
Herbert S. Hurwitz 
Robert F. Hustead 
Robert J. T. Joy 
Donald S. Komfeld 
Lowell A. Kristensen 
Richard Lamb 
Harry C. Miller Jr. 
Paul N. Neufeld 
James J. Nora 
Lowell E. Olson 
William J. Paule 
Anthony V, Piccirillo 
Richard D. Pullen 
Jacques M. Quen 
John Keith Rose 
Elihu M. Schimmel 
Leonard M. Silverman 
Robert L. Stein 
Martin B. Vita 
John W. Vosskuhler 
1955 
John C. Bailar III 
George E. Becker 
E. Edward Bittar 
Jerome Bobruff 
Joseph 1. Boylan Jr. 
Irwin M. Braverman 
Edward Noel Brennan 
Padraic Bums 
Leo R. Cardillo 
Nicholas A. Coassin 
Edward D. Coppola* 
Milton Com 
Pasquale James Costa 
Robert G. Crounse 
John G. Daley 
Fred Wendell Doyle 
Leroy Engel 
F. Robert Fekety Jr. 
Edwin G. Fernand 
Mahlon V.R. Freeman 
James Conway Garlington 
Barbara W. Gibson 
Paul Gonick 
Ion Grosser 
John H. Hodge 
D. Franklin Johnson Jr. 
Harry O. Kendall 
David R. Kessler 
Robert A, Kramer 
Edward A. Kmll 
William E. Lattanzi 
James Lum 
Alexander Maitland III 
Joseph S. McGuire Jr, 
Robert C. Nodine 
James P. Nolan Jr. 
Sherwin B. Nuland 
Edward J. Ottenheimer Jr. 
John C. Pace Jr. 
Robert H. Peters Jr. 
Gregory Peterson Jr. 
Robert A. Reich 
Paul J. Robinson 
F Brantley Scott Jr. 
Clement B. Sledge 
Phillip W. Smith 
Alan A. Stone 
Myron P. Walzak Jr. 
1956 
Alan E. Apfel 
Suzanne S. Becker 
Alvin D. Benjamin 
Peter Bios Jr. 
Levon Z. Boyajian 
Thomas M. Brown 
Rosalie A. Bums 
John F Carroll 
Joseph C. Cemy 
Edwin L. Child 
James C. Collias 
Donald J. Dalessio 
Chandler Dawson 
S. Evans Downing 
Mitchell Edson 
Gilbert M. Eisner 
Thomas F. Ferris 
John B. Fine* 
John H. Gardner III 
Sumner Gochberg 
Val Shea Greenfield 
Alan R. Gurwitt 
Ame G. Haavik* 
Armen Charles Haig 
John Herd Hart 
Robert L. Hill 
William H. Hindle 
Marie-Louise T. Johnson 
George T. Kammerer 
Jerome O. Klein 
William V. Lewit 
Leo Lutwak 
Preston C. Manning 


















Dwight F. Miller 
Elmer T. Mitchell Jr. 
Norman F. Moon 
Donald J. Nalebuff 
William M. Narva. MC 
A. Frederick North Jr. 
William M. O’Brien 
David A. Page 
James Richard Patrick 
George W. Paulson 
Stewart E. Pursel 
Roben J. Rice 
Robert Lee Scheig 
Edward C. Senay 
Benjamin A. Shaver Jr. 
Donald William Sherrick 
Daniel R. Silbert 
TJieodore K.L. Tseu 
1957 
Donald Agostinelli 
Joseph S. Amenta 
Jane Barbara Battaglia 
F. Calvin Bigler 
Jack Norman Blechner 
Richard 1. Breuer 
Harry C. Briggs 
Carl A. Brinkman 
John P. Carey 
Albert K. Chun-Hoon 
Louis Z. Cooper 
Harold Dick Cross 
Thomas H. Danaher 
James R. Dorr 
Salvatore Falbo 
Harold J. Fallon Jr. 
Robert E. Fishbein 
Ronald H. Fishbein 
James R. Fitzgerald 
Anthony L. Fons 111 
Elizabeth H. Forsyth 
Edward O. Fox 
Gary A. Fry 
Robert H. Glass 
Anne H. Good 
Jack Peter Green 
Gilbert F. Hogan 
Warren R. Johnson 
Richard Lee Kahler 
Stanley E. Kilty 
William L. Kissick 
Willard A. Krehl 
Jack Levin 
Edgar H. Levin 
Bennett F. Markel 
Mark D. Marshall 
Howard A. Minners 
Robert K. Modlin 
Hugh Lamson Moffet 
George Albert Nelson Jr. 
Herbert A. Newman 
Thomas Francis O'Brien Jr. 
Jo.seph S. Pagano 
Clittord B. Reitler 
Arnold Schoolman 
Stanley Simbonis 
Kenneth A. Simon 
Gilbert B. Solitare 
Donald C. Stahl 
William J. Waskowitz 
Herbert Winston 
1958 
George K. Aghajanian 
Don P. Amren 
Joseph E. Angelo 
John P. Amoi 
(lerard N. Burrow' 
Benjamin Bursten 
John A. Carlston 
John A. Creatura 
Robert J. Donohue Jr. 
Lawrence Dubin 
Donald A. Duncan 
Joel C. Eberlin 
Philip R. Fazzone 
Michael E. Fishman 
Raymond A. Gaito 
John Currier Gallagher* 
Marcia Kraft Goin 
William M. Gould 
James Greenwald 
Charles A. Hall Jr. 
Michael Kashgarian 
Haskins K. Kashima 
Jay Ward Kislak 
Theodore W. Lieberman 
Myron Lotz 
Thomas J. Mauro Jr. 
Michael J. McCabe 
Leo T. McCallum 
Andrew Joseph McGowan 
Jr. 
Albert Muggia 
Robert S. Neuwirth 
David W. O'Keeffe 
Carol F. Phillips 
David M. Pugh 
William B. Radcliffe 
Paul A. Rudnick 
Bruce H. Sklarew 
Richard E. Sledden 
Edward Lloyd Socolow 
Ray mond W. Turner 
Margaret Smith Wenzel 
Joseph P. Wierzbinski III 
John Patrick Wood 
Pauline B. Wood 
1959 
Scott Ingram Allen 
Carol J. Amick 
Robert M. Amick 
Asa Barnes Jr. 
Francis A. Beer 
Jack F. Bowers 
Med. Class Of 1959 
Edwin M. Clayton 
Sidney M. Cohen 
Martin Colodzin 
Lyall S. Crary Jr. 
Ronald C. De Conti 
William L. Donegan 
Gerald Fenichel 
Robert L. Fisher 
Paul Jay Friedman 
Robert J. Gonyea 
Gerald B. Gordon 
David Gowing 
W. Keith Hadley 
James H. Halsey Jr. 
H. Rodney Hartmann 
William H. Heydom 
C. Richard Hinckley 
Leonard Inker 
William J.A. Jablonski 
John J. Jasaitis 
Edvardas Kaminskas 
Herbert J. Kaufmann 
Kristaps J. Keggi 
David W. Kingsbury 
Myron S.S. Lee 
Kathryn Huxtable Lewis 
Raymond Mark 
John C. Marsh 
Brian J. McGrath 
Peter M. Molloy 
N. Ronald Morris 
James A. O'Neill Jr. 
Robert H. Ostberg 
Nicholas M. Passarelli 
Charles A. Phillips 
James D. Prokop 
James R. Ralph 
David Pardee Reed 
Joseph D. Saccio 
Constantine J. Sakles 
Marc D. Schwartz 
Richard M. Senfield 
Owen .A. Shteir 
David B. Skinner 
Sanford P. Solomon 
James J. Stagnone 
Lisa A. Steiner 
John S. Strauss 
Lois W. Tice* 
Leo H. Von Euler 
Munel D. Wolf 
1960 
Alan W. Ames 
Jack D. Barchas 
Stuart P. Bowne 
Donald P. Buebendorf 
Thomas E. Carson 
Stanley M. K. Chung 
Gerald N. Cimmino 
Francis D. Cogliano 
Louis A. D'Avanzo 
Malin Dollinger 
David Paul Dunn* 
March Enders 
Warren H. Fisher 
Paul Jay Friedman 
Eugene C. Gaenslen Jr. 
James 1. Gilman 
Maxwell E. Gottesman 
Sylvia D. Grant 
Roland H. Ingram Jr. 
Daniel M. Jones 
William S. Kaden 
Eric P. Kindwall 
Susan T. Kleeman 
Thomas P. Kugelman 
Edward R. Lang 
Thomas Lau 
Thomas L. Lincoln 
Donald L. Miller 
Richard G. Morrill 
Fred Palace 
Jerrold M. Post 
Martin L. Reite 
Charles H. Robinson Jr. 
Albert Matthew Ross 
Daniel J. Rubin 
John J. Schrogie 
Ross L. Snyder Jr. 
Fred Stargardter 
Constantine M. Voyagis 
Roben C. Wallach 
May Yung-Fun Woo Wang 
Ronald A. Yankee 
1961 
Kenneth A. Arndt 
Earl L. Baker 
Frank H. Baker 
Albert A. Bechtoldt Jr. 
Robert S. Briggs 
Paul David Deiter 
Ronald A. Dierwechter 
Jon Dudley Dorman 
T. Wayne Downey 
Christopher Francis 
Durham 
John E. Fenn 
Charles F. Gibbs 
James M. Giffin 
Edward C. Gilbert 
David D. Griffith 
J. Dale Howe 
Louis D. Hunt 
Richard L. Keefe 
Thomas Kirsch 
Robert Isaac Levy 
George M. Lordi 
Hugh James Lurie 
Sally Lockwood Marches! 
Vincent T. Marches! 
David B. Matloff 
Joseph W. McDaniel 
Anoush Miridjanian 
Richard Allen Moore 
Norman 1. Moss 
Roland D. Paegle 
John Curtis Parker 
John Pearce Jr. 
Elaine Pitt 
Bruce C. Robinson 
William M. Rogoway 
Roy E. Ronke Jr. 
Shaun J. Ruddy 
Thomas H. Sakoda 
Stanley G. Schade 
Robert R. Springer 
John J. St. Andre 
Robert N. Taub 
Hugh C. T'hompson III 
Eranklin H. Top Jr. 
David E. Weaver 
John V. Weil 
Warren D. Widmann 
John R. Woodward 
1962 
Jon M. Aase 
Michael H. Alderman 
Charles B. Anderson 
Frederic P. Anderson 
Dean E. Burget Jr. 
Fredric K. Cantor 
Thomas Newell Chase 
Oliver Townsend Dann 
Arnold Joel Eisenfeld 
1. Bruce Elfenbein 
John W. Foreman 
Leroy A. Forstrom 
Stephen John Fricker 
Anthony V. Furano 
John N. German 
John A. Godley 
David H. Groth 
Roderick C. Haff 
John H. Hageman 
John T. Harrington 
Patricia C. Hassakis 
Gary Jacobson 
Walter Watson Kamey 
Glenn L. Kelly 
David E. Knoop 
Bernard Kosto 
Allan L. Mattem 
Stanley E. Matyszewski 
David J. McConnell 
William G. Meffert 
William A. Miller 
Malcolm S. Mitchell 
David D. Nicholas 
A. Richard Pschirrer 
Joseph Ross 
James A E Spencer 
Nancy Ann Staley 
Larry Lee Stewart 
Seth Thaler 
Sherwood Waldron Jr. 
William Farnsworth Weber 
1963 
Barbara Rosenthal Almond 
Richard J. Almond 
Miguel R. Alonso 
V. Richard Back 
Charles W. Carl Jr. 
Theodore J. Chu 
Andrew Edin 
B. Allen Flaxman 
David H. Fram 
William T. Friedewald 
David H. Fulmer 
Alexander R. Gaudio 
Lee D. Goldberg 
Peter B. Gregory 
Benjamin Keith Harris 
Brian C. Judd 
Constantine D. Kyropoulos 
William B. Lehmann 
Peter B. Livingston* 
Craig H. Llewellyn 
Edward G. Lund Jr. 
Herbert Meltzer 
Robert E. Mueller 
Sheldon R. Pirmell 
Jay M. Pomerantz 
Gene R. Profant 
Lee Bland Talner 
Richard M. Thompson 
Thomas W. Tillack 
Peter V. Tishler 
Lawrence Tremonti 
Peter G. Weiner 
James G. Wepsic 
Jerome Allen Winer 
Alfred J. Wise 
1964 
William A. Alonso 
Berton W. Ashman 
Leland S. Berger* 
Robert M. Briggs 
Thomas A. Cardella 
Joseph E J Curi 
Mary V. Digangi 
Alfonso Esguerra 
Anthony Eerrante 
Norman C. Post 
Peter A. Gross 
John F.B. Haney 
Christopher W. Hauge 
Richard Hockman 
Lawrence Horwitz 
William J. Houghton 
William E. Knight 
Lewis Landsberg 
Richard V. Lee 
Thomas L. Lentz 
James S. Levine 
Paul R. Lightfoot Jr. 
Richard Murray Linburg 
Robert W. Lyons 
Andrew E. MacMahon 
William E. Matchett 
Robert L. Mitchell 
James J. Murphy 
William B. Pratt 
Jack S. Rice Jr. 
Stanley J. Rosenberg 
Jonathan J. Russ 
Saul M. Schanberg 
Norman Scher 
Robert L. Shelton 
Diane Shrier 
Donald G. Skinner 
A. Thomas Snoke 
Lyall C. Stilp II 
Sigrid L. Tishler 





Susan A. Aoki 
Thomas T. Aoki 
John H.M. Austin 
Victor J. Burner 
Thomas B. Caldwell III 
David G. Campbell 
Robert M. Cohn 
Michael J. Cummings 
Phyllis Hurwitz Duvdevani 
Carl Ellenberger Jr. 
David S. Fedson 
Robert 1. Finkel 
Michael P. Flynn 
Christopher C. Gates 
Frank J. Grady 
Robert Andre Gryboski 
James K. Gude 
Reid R. Heffner Jr. 
David A. Hill 
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Carl E. Hunt 
Virginia Burnham Johnson 
Ronald J. Karpick 
Mohandas M. Kini 
Sandra Chook Levine 
Mark W. Lischner 
Philip D. Manfredi 
Michael B. Mayor 
Walter W. Noll 
A. Lawrence Ossias 
Robert L. Pickens 
Alan N. Rachleff 
William A. Renert 
Gene A. Robinson 
George B. Rowland 
John F. Schilke 
John H. Seashore 
Margretta Ann Reed 
Seashore 
David P. Simmons 
Robert T. Solis 
Alan William Stone 
1966 
Patricia Bazemore 
Robert P. Bazemore 
Philip Bernstein 
James Edward Brown 
Eugene Patrick Cassidy 
Thobum Aaron Dadisman 
Jr. 
Joseph A. Donadio 
Robert E. Dragon 
Robert N. Frank 
Peter D. Gibbons 
Jeffrey B. Gluckman 
Stanley I. Greenspan 
J. McLeod Griffiss 
Robert A. Gunn 
Henry G. Hanley 
Stuart T. Hauser 
Jay G. Hayden 
Mary Alice Houghton 
Richard J. Howard 
Gordon R. Kelly 
Stuart M. Kotler 
Wilbur L. Kukes 
David C. Law 
Caroline O. McCagg 
Robert L. McRoberts 
David B. Melchinger 
John Stephens Melish 
John J. Mooney 
Eli H. Newberger 
Edward J. O’Keefe 
Neil J. Peterson 
William D. Peterson 
James D. Slavin Jr. 
Lawrence J. Toder 
Gary L. Townsend 
Jon S. Wayland 
Joan T. Wayland 
Arne S. Youngberg 
1967 
Daniel L. Arons 
Arthur L. Beaudet 
Richard S. Bockman 
Daniel J. Booser 
Gary C. Burget 
William T. Cave Jr. 
Kenneth F. Crumley 
Cynthia Rapp Curry 
Marian C. Davidson 
James J. Dineen 
James M. Dowaliby II 
John A. Drews 
Peter R. Egbert 
Dennis Grant Egnatz 
Herbert W. Felsenfeld 
Richard J. Hart Jr. 
Richard L. Heppner 
Peter N. Herbert 
George P. Herr 
David L. Ingram 
Mary Jurbala 
Melvyn Korobkin 
Anthony P. Lovell 
Stephen W. Miller 
Joseph L. Morris 
Jennifer Robinson Niebyl 
John O. Pastore 
William E. Perkins 
Daniel F. Phillips 
Brian F. Rigney 
Jonathan L. Saveli 
Alfred Q. Scheuer 
Stephen C. Schimpff 
Sidney C. Smith Jr. 
Helen L. Smits 
Lewis S. Solomon 
Robert S. Steinberg 
Richard B. Swett 
M. David Tilson III 
Karen H. Toker 
Robert A. Vogel 
Robert A. Vollero 
Joseph F. Walter 
Martin Wand 
Robert J. Winer 
Robert S. K. Young 
Peter M. Zeman 
1968 
Julius H. Anderson 
Philip L. Barry 
Daniel I. Becker 
Bernard D. Beitman 
Stuart J. Brill* 
Donald R. Coustan 
Rutledge W. Currie 
Robert G. Dillard 
Edward M. Druy 
Barbara Mayer Egbert 
Alan G. Finesilver 
Richard A. Getnick 
Mark Gilbert Grand 
Leonard Grauer 
Ralph S. Greco 
Kevin N. Hennessey 
John R. Hill II 
Harry S. Holcomb III 
Peter JokI 
William F. Keane 
Jeffrey S. Lee 
Marc E. Lippman 
Peter A. Livingston 
Frank E. Lucente 
Donald O. Lyman 
Stephen I. Marglin 
Rodrigo Martinez 
John Allen McCutchan 
Maria S. McCutchan 
David P. Millett 
Richard P. Mills 
Richard M. Morehead Jr. 
John A. Ogden 
James W. Ogilvie 
Margot Onek 
Henry F. Panek 
Jackson B.E. Pickett III 
Charles T. Post Jr. 
Ralph Jerome Rauch 
Joseph L. Renda 
Gordon H. Sasaki 
Jacob J. Schlesinger 
Bruce Stuart Schoenberg* 
Frederick C. Sherman 
Elizabeth M. Short 
Howard W. Siegel 
Gerald L. Springer 
Lee H. Strohl 
Edmund C. Tortolani Jr. 
James L. Weiss 
Per Henrik Wickstrom 
Creed W. Wood 
1969 
Charles S. Angell 
David G. Ansel 
David W. Barry 
Robert E. Belliveau 
David A. Berkowitz 
Donald H. Buchholz 
Bruce W. Burleigh 
N. Roger Cooke 
Leo M. Cooney Jr. 
Richard J. Daly 
Michael W. Dennis 
Charles A. Dinarello 
Douglass T. Domoto 
Ralph J. Falkenstein 
Gary S. Famham 
Lesley Forman Fishelman 
Steven A. Frankel 
William H. Frazier 
Royal J. Gay 
David A. Geer 
Sander G. Genser 
Robert O. Gordon 
Steven M. Herzberg 
John Frederick Hiatt 
Larry C. Horowitz 
Thomas C. Howard 
Lee M. Jampol 
Joel Mark Kaufman 
Lynn G. Lagerquist Jr. 
Michael R. Liebowitz 
Elliot M. Livstone 
Robert L. Marier 
Arnold F. Mazur 
Ellen B. Milstone 
Thomas F. Minehan 
Bruce K. Nagle 
Lionel M. Nelson 
Nancy Olmsted 
Timothy A. Pedley 
Deborah A. Putnam 
N. Burgess Record Jr. 
Joseph D. Robinson 
Joseph M. Rochford 
Dennis J. Rudzinski 
Lutz H. Schlicke 
Adrian M. Schnall 
David J. Schulak 
Gerald J. Smallberg 
David L. Upton 
Robert J. Walat 
1970 
Elissa B. Arons 
Gregory W. Bartha 
John W. Blanton Jr. 
Richard A. Charlat 
Henry Chessin 
Michael J. Chusid 
C. Norman Coleman 
James E. De Lano Jr. 
Daniel Frizell Dedrick 
Margaret W. DeLano 
W. Montague Downs 
Jonathan Ecker 
Robert Alan Epstein 
Bruce A. Fabric 
Steven L. Fish 
Robert D. Gilbert 
Thomas H. Gouge 
Paul C. Hessler 
Jay H. Hoofnagle 
Jonathan D. Katz 
Kenneth A. Khoury 
Ely A. Kirschner 
Thomas L. Lewis 
Anne W. Lucky 
Jay W. Marks 
William K. Mueller 
James J. O’Donnell 
Lynn Whisnant Reiser 
Bruce A. Reitz 
Robert M. Rosa 
Dennis E. Shield 
Stuart S. Short 
Richard A. St. Onge 
Robert S. Stem 
Ray W. Tripp 111 
C. Bruce Wenger 
Daniel Wuensch 
Marc O. Yoshizumi 
1971 
Judith L. Bader 
Laurie J. Bleicher 
Bruce Block 
Marian H. Block 
Willard Cates Jr. 
John L. Cieply 
Frederick L. Cohn 
Edward C. Cottle 
Robert B. Diasio 
John S. Ebersole 
Leonard I. Eisenfeld 
Thomas Etkin 
Daniel E. Feldman 
Harvey Fembach 
Fred Finkelman 
Peggy A. Finston 
John W. Foster Jr. 
Michael C. Gallant 
Jared J. Gardner 
Richard Gloor 
Allan W. Graham 
Jerold Alan Haber 
William W. Hay Jr. 
N. Timothy Jette 
Geoffrey P. Kane 
Richard E. Kaufman 
Robert M. Kessler 
Barbara K. Kinder 
Michael E. Klein 
William L. Krinsky 
Gary M. Lande 
David H. Lippman 
Sten B. Lofgren 
Sherry W H Loo 
Wallace J. Matthews Jr. 
Patrick T. Minihan 
Steven H. Moffic 
Richard Albert Moggio 
Martin Pans 
Robert Park 
John A. Patti 
Barry Bruce Perlman 
Stuart B. Phillips 
Michael C. Piercey 
Anthony V. Proto 
Irving G. Raphael 
Douglas R. Schmidt 
James P. Southwick 
Charles J. Sutherland 
Daniel R. Synkowski 
Richard D. Travers 
Semeon G. Tsalbins 
Yvonne E. Vaucher 
Paul A. Vignola 
Robert B. Vranian 
Ray C. Walker 
Albert Carl Weihl 
Jerold C. Woodhead 
Bums Woodward 
Daniel G. Wright 
1972 
Robert D. Arbeit 
Michael A. Catalano 
Michael L. Chamey 
Alan J. Clark 
Leonard H. Cohen 
Philip L. Cohen 
Gloria Cummings* 




















Alumni 3,735 1,630 44 $ 607,960 3,735 1,630 44 $ 607,960 
Former House Staff 2,112 221 10 28,932 2,093 207 10 71,366 
Parents/ Friends 432 69 16 7,946 432 39 9 10,761 
Interest/Miscellaneous — — — 11,337 — — — 13,285 
TOTAL 6,279 1,920 31 $ 656,175 6,182 2,287 37 $695,839 
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William H. Druckemiller 
Jr. 
William F. Duke 
M. Felix Freshwater 
Robert B. Geehr 
Robert D. Glassman 
Robert F. Goodman 
Andrew H. Greenhill 
Bruce B. Haak 
Andrew E. Hoover 
Thomas L. Horn 
Vernon H. Humbert Jr. 
Fred Hyde 
Richard J. Inwood 
Anthony H. Jackson 
Jesse B. Jupiter 
Frank M. Kahr 
David L. Kneapler 
Paul A. Lucky 
Harry L. Malech 
Jeffrey S. Menkes 
Jerome H. Meyer 
David B. Moyer Jr. 
John P. O'Grady 
Marc B. Osias 
Peter J. Panzarino Jr. 
John N. Posch 
Louis Reik Jr. 
William L. Risser 
Richard S. Robbins 
David H. Romond 
Philip M. Rothfeld 
Carl D. Sorgen 
Frederick D. Stockwell 
Gary .M. Strauss 
Lawrence P. Temkin 
Philip J. Weyman 
Brooke M. Wolf 
John D. Wright Jr. 
Michael W. Yogman 
Steven M. Zeldis 
1973 
David A. Adler 
David Nelson Bailey 
Mary Ann Brunstetter- 
Shafer 
James N. Campbell 
Marvin M. Chassin 
George B. Colson 
Joseph M. Connors 
David L. Coulter 
Carolyn G. Dedrick 
Christopher M. Doran 
Jane H. Ferguson 
Richard J. Fingeroth 
Robert A. Florin 
Lee Goldman 
Frederick M. Henretig 
Howard S. Honig 
Andrew G. Kadar 
Michael S. Kramer 
Lynne M. Liptay 
George Lister Jr. 
Douglas E. Mattox 
John F. McQuade, III 
Jerry Nagler 
John Frederick Neil* 
Claes M. Nilsson 
David E. Peach 
David Pickar 
Robert Joseph Polackwich* 
Charles F. Reynolds III 
James S. Robertson 
Thomas J. Romano 
Harry S. Rornanow itz 
Jerrold F. Rosenbaum 
John P. Sherck 
Joseph F. Simeonc 
Robert A. Sirota 
John R. Stratton 
Charles F Stroebel 
James F. Sullivan 
Robert J. Ursano 
Christine A. Walsh 
Richard S.K. Young 
1974 
Stephen B. Arnold 
Irving M. Asher 
Leonard 1. Banco 
Douglas A. Berv 
Neil Blumberg 
Ronald C. Brown 
Peter J. Buchin 
Bert D. Collier Jr. 
Paul David 
Roger H. Emerson Jr. 
Gerald O. Franklin 
Allan B. Friedland 
Michael A. Gerber 
Ary Louis Goldberger 
David Grant 
Robert F. Hempton 
Robert C. Jimerson 
Marie T. Kelly 
Robert M. Kolodner 
Saul Lande 
Olusegun O. Lawoyin 
Edward L. Marut 
James R. McMonagle 
Daniel A. Moros 
Ronald D. Neumann 
Jerome B. Orlin 
Richard C. Pasternak 
Andrew L. Ries 
David Z. Ritvo 
Daniel 1. Rosenthal 
Amy S. Schechter 
Robert J. Schechter 
Frederick S. Shessel 
Alan B. Silken 
James A. Strom 
George H. Talbot 
Carol C. Teitz 
Edward M. Wolin 
1975 
Donald S. Bairn 
Robert M. Bell 
Ralph E. Binder 
Sharon L. Bonney 
William S. Bush 
Rodney J. Butch 
Brendan Clifford 
Stanley W. Gale 
Lana L. Holstein 
Carol L. Kandall 
Kevin Kane 
Bernhard H. Lisker* 
Richard J. Loewenstein 
Yvonne E. Lomax Burnett 
David A. London 
Mary Jane Minkin 
Robert G. Nankin 
Andrew B. Newman 
Edwin G. Olson 
George J. Pardos 
Mary Lake Polan 
Stirling M. Puck 
Vivian Reznik 
Philip J. Rich 
Salvatore V. Romano Jr. 
Fred P. Rosenfelt 
Steven A. Schwartz 
Barbara J. Stoll 
David J. Taylor 
Richard L. Wagner 
Mark F. Wheeler 
David W. Wiltse 
Douglas R. Zusman 
1976 
Sarah S. Auchincloss 
Alfredo L. Axtmayer 
John C. Bartlett 
William G. Bithoney 
Peter B. Bitterman 
Alan B. Bloch Peter M. Ting Sharon R. Weinstein 
Helen Y.Y. Chang John C. Wiles John E. Whitcomb 
Pauline Y. Chao Jerome B. Zeldis J. Douglas White 
Richard S. Childs Jr. 
Ellen C. Cooper 
Carol M. Ziminski Daniel Wohlgelemter 
Vincent C. Dicola 1977 1978 
Kenneth J. Dobuler Michael G. Adelberg Thomas T. Amatruda 
Gary S. Dorfman Phyllis August Michael J. Anderson 
Thaddeus P. Dryja Jr. John J. Boronow Patricia Bell 
John A. Elefteriades Barbara Jeanne Brin Joann N. Bodurtha 
Leonard Firestone Stuart Brian Dubin Booker T. Bush Jr. 
Dennis M. Fisher Marybeth Ezaki Duke E. Cameron 
Ira H. Gewolb Anne H. Flitcraft Paul M. Copeland 
Rose Hannah Goldman James A. Fox James N. Dreyfus 
Glenn A. Gorlitsky Julia B. Frank Emily A. Fine 
Joel Kabak Barbara K. Gehrett Maija G. Freimanis 
Richard D. Kayne Steven R. Hahn Arthur M. Gershkoff 
Norman V. Kohn Robert W. Hand George M. Golenwsky 
Richard E. Kremer Bruce L. Innis Linda J. Hall 
William J. Lederer Howard K. Koh Jerald D. Hansing 
William K. Levy David J. Kreis Jr.* Jeffrey Neal Hausfeld 
Sidney Mandelbaum Margaret S. McKenna Alexandra N. Helper 
Cynthia F. Mann Robert J. Mitchell Anne A. Knowlton 
Douglas G. Mann Alan S. Penziner Cynthia S. Kretschmar 
Jon S. Morrow Richard E. Peschel Kendrick E. Lee 
Richard L. Neubauer Theodore M. Pitts Gertrude Wilkins 
O’dell M. Owens Jordan S. Pober. PhD Manchester 
Daniel W. Rahn Leonard A. Rappaport Sanford D. Markowitz 
Paul R. Ramirez Rachel Z. Ritvo Jose Luis Martinez 
Mark C. Ruchman Steven J. Scheinman Robert K. McLellan 
Susan H.K. Ryu Susan Bromberg Schneider Michael J. Mitchell 
Lawrence E. Samelson Ricky M. Schneider Yvette L. Piovanetti 
Richard S. Schottenfeld Simeon A, Schwartz Barbara H. Pober 
John T. Sladky Kenneth M. Stallings Seth M. Powsner 
Charles R. Swenson Ronald J. Vender Jeffrey David Roth 
Jacob E. Tauber Steven L. Warsof Sally Rudicel 
Roy P. Vagelos, M.D.. chairman and CEO of Merck and Co., Inc. 
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Neal D. Ryan 
Donald C. Simonson 
Timothy J. Swartz 
Rebecca A. Taub 
Caroline R. Taylor 
Marcia J. Wade 
John D. Wagner 




Guthrie S. Birkhead III 
David A. Brenner 
J. Kenneth Burkus 
Roy D. Carlson 
Paul E. Collier 
Isabel Cunningham 
Jeffrey Neil Dombusch 
Norman L. Elliott 
John A. Fox 
Joel I. Franck 
John Jay Gargus, Ph.D. 
Phillip M. Gendelman 
David E. Golan 
Bruce Halperin 
Edward C. Halperin 
Marc Hellerstein 
Jonathan H. Holt 
Arthur C. Johnson III 
Jeffrey L. Kaine 
Leslie Jay Katz 
Helen H. Kay 
Jonathan Kolitz 
Wing-Yin Leong 
Michael K. Lindsay 
Shirley McCarthy 
Timothy W. McKeithan 
David E. Ness 
Barbara Ann Peters 
Jean Rosenthal 
Lynn K. Rudich 
Gary L. Schaer 
Cynthia Anne Sherman 
Jill A. Silverman 
Gary Vitale 
John T. Woo 
Jeffrey Work 
1980 
David E. Adelberg 
Eduardo Alfonso 
Seth Leo Alper 
Frederick R. Aronson 
Alan B. Astrow 
David Allen August 
Jay M. Baraban 
Mark S. Bernhardt 
Patricia Church Brown 
Daryl F. Browne 
Michael W. Champeau 
Michael M. Chang 
Thomas F. Deering 
Barbara G. Fallon 
Todd J. Garvin 
Marc F. Glickstein 
David Jay Goldberg 
Gary I. Greenwald 
Maria White Greenwald 
Jonathan L. Jacobs 
Barry M. Kacinski 
Theodore W. Marcy 
Mary Polly McKinstry 
Eric J. Nestler 
Mark J. Ratain 
Neal L. Rosen* 
Steven I. Rosenfeld 
Alan E. Schlesinger 
Gerri A. Schulman 
John A. Selling 
Jeffrey N. Siegel 
Hille! D. Skoff 
Kim R. Swartz 
Phillip I. Tarr 
Howard W. Telson 
Walter H. Williams 
Mary Hill Wise 
Lawrence H. Young 
Raphael Zahler 
1981 
Adaora A. Adimora 
Lisa E. Babitz 
Alicia Barela 
Sherri L. Brown 
Stephen Wilson Burgos 
Patricia A. Burke 
Chee C. Chow 
Christine M. Duranceau, 
Ph.D. 
Paula M. Fracasso 
Ramona Q. Fung 
Robert L. Galli 
Laurie J. Gordon 
Stewart G. Greisman 
Neil D. Gross 
Jeffrey A. Gruskay 
Stephen R. Harrison 
Scott A. Hundahl 
Donald Ingber, Ph.D. 
Thomas Kievan 
Brian K. Kobtlka 
Elliot Each 
Aiziz Laurent 
David E. Lebwohl 
Bernard Lewin 
Barton N. Milestone 
Robert M. Milstein 
Richard L. Mogeiman 
David A. Paly 
Robert B. Portney 
Susan Burdette Radoux 
Barbara A. Roach 
Dovelet Shashou 
Martin H. Teicher 
Anthony M. Urbano 
Alan B. Wagshal 
John C. Wong 
Frank E. Yeomans Jr. 
1982 
Sylvia R. Beck 
Cathleen R. Belden 
Paula K. Braverman 
Thomas J. Brennan 
David Goldstein 
Jed B. Gorlin 
Jessica Herzstein 
Kenneth M. Huttner 
Henry Jampel 
Laurie B. Komreich Katz 
Michael E. Katz 
Patricia Kellner 
Kathleen Anne Nolan 
Joyce A. O’Shaughnessy 
Christopher N. Otis 
Robert Pierattini 
Carrie A. Redlich 
Steven D. Resnick 
Robert J. Rizzo 
Christopher W. Roberts 
Paula C. Schlesinger 
Cary S. Sennett 
William M. Sikov 
Yuen Tat So 
Don L. Stromquist 
Paul E. Sylvan 
Lynn T. Tanoue 
Patrick Toth 
Albert L. Ungricht 
David A. White 
Stephanie Wolf-Rosenblum 
Sandra L. Wolin 
Jon P. Younger 
1983 
John Taylor Adams* 
Robert E. Bookstein 
Michael Brines 
Elena Citkowitz 
Nancy Kraemer Crocker 
Nancy Czarkowski 
Anil Mohan DeSilva 
James S. Grober 
Tammy C. Harris 
William Kadish 
Robert M. Kotloff 
Ana Maria Lamas 
David Lindgren 
Laurie Margolies 
Edouard R. Martin 
Miguel A, Martinez 
David P. Norton 
Dan A. Oren 
Victor M. Perez 
Augusta S. Roth 
Moshe Rubin 
Daniel Paul Sabbeth 
Daniel M. Sosin 
Philip M. Spiro 
Kenichi Takeshita 
Barbara E. Tardiff 
Abby S. Van Voorhees 
Pamela Leslie Zeitlin 
1984 
Martha Ray Arden 
Robert W. Arnold 
John F. Babich 
Leonard Bell 
Jessica Berman 
Barbara Ann Coda 
Leon Eisikowitz 
David J. Fillmore 
David A. Frank 
Robert John Havlik 
Sabra Lynn Jones 
Emilio J. Juncosa 
Jeffrey N. Katz 
Michel Kliot 
Daniel M. Kolansky 
Jay R. Kostman 
John H. Krystal 
John Gerhart Lane 
James G. Linakis 
Dominic D. Pennachio 
Jill S. Ratain 
Ronnie G. Rosenberg 
Paul B. Rothman 
Joshua D. Schor 
David A. Shrier 
Michael Simons 
Paul M. Snyder 
Mark Stein 
Susan P. Tredwell 
1985 
Jaime I. Arroyo 
Barry D. Bergquist 
Jane E. Carter 
Calixto E. Dimas 
Guy Fried 
William D. Gaillard 
Richard Bruce Garber 
Samuel D. Goos 
Marie Hobart 
Stuart Neal Isaacs 
Susan Korrick 
Shirley J. Lee 
Ted W. Love 
Jeffrey A. Lowell 
Anthony Marks 
John Jerome Merendino 
Robert D. Needlman 
Thomas Newton 
Leslye C. Pennypacker 
Anne Regenstein 
Ellen C. Rieur 
Maria Suzette Rivera-Mac- 
Murray 
Greg A. Sachs 
Fred Santoro 
Gary L. Shapira 
Timothy Alan Shapiro 




Catharine Ann Arnold 
David Atkins 
W. Lee Bailey 
Eric F. Bernstein 
Cristina M. Brunet 
Suzanne D. Conzen 
Ian A. Cook 
John A. Detre 
Amanda B. Dill 
Gerard M. Doherty 




Jeremy L. Holtzman 
Jay D. Kranzler 
Roberto Lewis-Femandez 
Julia Whiteside Michel 
Matthew R. Moore 
Steven Waisbren 




David M. Fujii 
John Michael Gaziano 
Laurence Adam 
Greenbaum 
Marian Lee Greenburg 
Glenn A. Healey 
Hugh C. Hemmings Jr. 
Peter T. Ho 
Amy Caroline Justice 
Rebecca E. Kadish 
John F. Keaney Jr. 
Joseph Thomas King Jr. 
Christopher King 
Susan Deborah Kruger 
Elliott Levy 
John Harlan Meyer 
Nancy D. Olson 
Patricia M. Powell 
Lauri R. Robertson 
Seth A. Rosenthal 
Patrick A. Ruwe 
Mindy G. Schuster 
Michael H. Solon 
Lynn Street 
Richard P. Tierney 
Robert C. Urban Jr. 
Pradeep Kumar Varma 
Leslie Vogel 
David H. Weingold 
Barry Weinstock 
Mark D. Widmann 
1987 Classmates* 
1988 
Kenneth A. Andreoni 
Joi Barrett 
Susan J. Baserga 
John Pieter Belzer 
K. Lisa Cairns 
Kathleen Camey-Godley 
David P. Cheimow 
Robert W. Dorns Jr. 
Joshua E. Freedman 
Dean Kedes 
Lisa Conrad Larkin 
Frederick Long 
Michael E. Mahig 
Lance Arlen Markbreiter 
Peter Alexander Merkel 
Theodore Miclau 
Michael Emeric Mockovak 
Jacqueline G. Pachon 
Donna Richman 
Michael A. Rothschild 
Mitchell J. Sklar 
Walter Michael Stadler 
Philip Adam Stull 




Maura Jo Brennan 
Don H. Chin 
David M. Cromwell 
William S. Curtis 
Alexandra Flather-Morgan 
James M. Ford 
Susan Garetz 
Anita Goodrich 
Adam L. Greene 
Joni H. Hansson 
Kraig E. Humbaugh 
Howard Kesselman 
Lawrence R. Kleinberg 
Zachary Klett 
Gregory M. Koshkarian 
Marc Levesque 
Robert L. Levin 
Lewis Lipsey 
H. Michael Morris 
Lisa Ragen 
Viviann Mattson Rubin 
Virginia Jordan Sink 
Stephen M. Smith 
David M. Stier 
Andrew Thomas Walker 
Dora-Linda Wang 
John Thomas Whalen 
Roger F. Widmann 
Darryl S. Wong 
1990 
Susan G. Anderson 
Nancy R. Angoff 
Ercem S. Atillasoy 
Thomas J. Christopher 
Mark A. Dettelbach 
Ronald Ennis 
Jonathan Todd Foster 
Douglas Marc Freedman 
Joanna Mara Girard 
Alan Sander Hilibrand 
Betty Shin Wun Kim 
Kathleen Alexia Kline 
Toshiko F. Magnus 
Ira Meisels 
Erika H. Newton 
Jack Parent 
Jane E. Rasmussen 
Chander N. Sarny 
Susie K. Sharpe 
Neil A. Solomon 






Phillip R. Aaron 
William R. Adams 
N. Erick Albert 
John L. Albrigo 
Arthur Ames 
William F. Arndt 
John P. Amot 
John M. Aversa 
Adel H. Ayoub 
Arnold M. Baskin 
Richard Bass 
Carl Bennett Bean 
Gerald A. Belkin 
Norberto A. Belleza 
Gregory Kent Bergey 
Ralph Daniel Bien 
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Richard A. Blasband 
Gary Bloomgarden 
Malcolm B. Bowers Jr. 
Christine Brahney 
Ronald W. Braun 
David Braun 
John K. Burkus 
Dennis J. Card 
Claudia TTiomas Cany 
Richard S. Casden 
J. Richard Casuccio 
Whei C. Chang 
Richard Allen Chase 
Rys/.ard Chetkowski 
Chang Song Choi 
Michael Chun 
Ian M. Cohen 
Bunon H. Cohen 
David L. Copen 
Leandro Cordero 
Susan Covey 
Sidney L. Cramer 
Roben E. Crootof 
Michael Martin Deren 
Alexander Deutsch 
Philip Sheridan Dickey 
Daniel M. Divack 
Donald S. Dock 
June F. Donnelly 
John 1. Dortman 
William R. Drucker 
Paul Duray 
Stephen A. Edelstein 
David E. Eibling 
■Malcolm Mitchell Ellison 
Walter Ettinger 
Robert A. Feldman 
Jeffrey C. Femyhough 
Louis B. Fiemian 
Richard Webster Finner 
Stephen V. Flagg 
Morris A. Flaum 
Bruce T. Fletcher 
John V. Forrest 
Julia B. Frank 
Daniel J. Friedenson 
Josephine Fuhrmann 
Norman H. Gahm 
Phillip H. Gates* 
David M. Gershenson 
V. Philip Glassman 
Barry Goldberg 
Neal Benjamin Goldberg 
Joel S. Golden 
John W. Goldkrand 
Isaac Goodrich 
Richard Reed Gramse 
Willard F. Greenwald 
Mary Gregg 
Gordon W. Grundy 
Jo.seph Guaraldo 
Kenneth Gwirt/ 
Hedda Ann Litowitz 
llaning 
Ray V. Haning Jr. 
Richard B. Harvey 
Mary .M. Hennan 
Karen Hermansen 
Philip D. Herrick 
Douglas P. Hobson 
Robert J. Holmes 
Gregory L. Holmes 
David Smith Hubbell 
Eric A. Hyson 
Robert M. Johnston 
Clifford Joseph 
Juliana Haeng-Cha Kang 
Neil B. Kappelman 
Jill P. Karpel 
Falward Kent 
Stephen King 
Samuel ('. Klagshrun 
Arthur H. Knowlton 
Alexander Sandor Koleszar 
W) 
Thomas J. Koontz 
Boonsri Kosarussavadi 
Eugene Kuchner 
Joel C. Labow 
Sheri J. Lagin 
Pritchard T.C. Lam 
Emmanuel Landau 
Robert Jan Lerer 
Vincent Leung 
Douglas M. Levin 
Arthur L. Levy 
John D. Lewis 
Luke K. Licalzi 
Deborah Lightner 





Richard J. Maunder 
Robert McDonnell 




John H. Monroe 
Yasmeen A. Moody 
Patrick E. Moriarty 
Sheila M. Moriber Katz 
Lewis B. Morrow 
John Moses 
Hirotsugu Munechika 
Seymour Cy Nash 
Ethel H. O'Brien 
Edgardo Ortiz 
Robert L. Paltzik 
George W. Paschal Ill 
Lawrence Pass 
Samuel J. Potolicchio Jr. 
Edward W. Powers 
Geoffrey R. Priest 
Robert Princenthal 
Shubhinder Puri 
Edward L. Racek 
Donald C. Rankin 
Gilbert A. Ratcliff 
Ranjit Rath 
Robert R. Rickert 
James A. Robb 
Jeffrey P. Robbins 
Robert L. Rowley 
James R. Sabetta 
Julia Sabetta 
Michael Saruk 




Ronnie G. Schlesinger 
Jonathan Schreiber 
Doug Schulman 
James Thomas Sehn 
Howard Senter 
Edwin C. Severinghaus 
Thomas E. Shaffer 
Daniel W. Shapiro 
David H. Shapiro 
Irving Sherman 
Gary R. Siegel 
Joel Silidker 
Frederic N. Silverman 
Earl J. Simburg 
Daniel Simon 
Ethan A H Sims 
Thomas J. Spackman 
Stephanie S. Spangler 
Richard I. Staiman 
Phillip Stark 
John G. Steciw 
Sturla Stefans.son 
Judit Stenn 
Elsa L. Stone 
Barry S. Strauch 
Fred Leslie Strieker 
Nobel laureate George E. Palade, M.D., Sterling Professor Emeritus of Cell 
Biology and dean of scientific affairs, the University of California San Diego 
School of Medicine. 
Herbert Tabor Hans Graichen 
Imad F. Tabry Dr. Earl Hellerstein 
James P. Taitsman Frederick W. Heilman 
Marc J. Taylor Mrs. Gloria F. Holmes 
Lee Lawrence Thibodeau Guenther August Kaiser 
Troy L. Thompson II Chang-Wuk Kang 
Carol Touloukian Jacob Byung Kim 
James S. Touloukian Andrew S. Kim 
Kenneth Towbin Kenneth P. Kinney 
L. Newton Turk III Leighmin James Lu 
Daniel W. VanHeeckeren Mrs. Virginia G. Mannick 
Romulo L. Villar Mr. Shizuo Matsui 
Robert S. Waldman Mr. and Mrs. Victor M. 
Gary R. Wanerka Newman 
Thomas A. Warthin Mr. and Mrs. Louis Parent 
Lionelle Wells D. Helaine Patterson 
Herbert Allan Wenner Dr. and Mrs. Levi V. Perry 
George Wharton Henri Peyre* 
Benjamin B. Whitcomb Ann D'Esopo Phillips 
Princess Williams Mr. Leonard Portney 
Robert J. Williamson R. Donald Reich 
Philip Witorsch Harold and Frances 
Eiji 'Yanagisawa Sampson 
Robert C. Young Henry S. Sanematsu 
Marvin Paul Zimmerman Mrs. Duangduen Schulick 
Kenneth Alan Stein 
FORMER HOUSE David Donaldson Strachan 
OEEICERS Prof, and Mr. Lubert Stryer 
Richard Walter Mrs. Leo Teitz 
Zimmerman Thomas M. Tierney 
Mark Tyma 
PARENTS AND Jack Weingold 
FRIENDS James Wells 
Yvonne and Badri Aghassi 
Mrs. Bieggi 
Bryan Birch 
Harriet Farnsworth Brown 
Lloyd and Margo Zbar 
Mr. and Mrs. Abe Cazen 
Mr. Howard Chin 
Willibald H. Conzen 
Mrs. Judy Coppola 
Carolina Anca De Hostos 
Anthony Delica 
Mr. Arthur E. Dolnansky 
Mr. and Mrs. Kenneth T. 
Doran 
Mrs. Vincent A. Doroszka 
Dorothy Marie Ference 
Philip Arthur Fey 
Mr. Max Finkelman 
William J. German* 
Gideon Goldstein 
* Deceased 




Myron A. Sallick '24* 
Berthold M. Comeau ’28* 
Nathan E. Ross ’28 
J. Roswell Gallagher ’30 
Amy H. Hunter Wilson 
’30* 
Robert R. Wagner ’46 
Myra D. Tyler ’50 
SPONSOR 
Myron A. Sallick ’24* 
Leonard Greenburg ’30* 
John B. Ogilvie ’34 
H. Stuart Irons ’40* 
David V. Pecora ’41 
Anonymous ’43 March 
Sanfurd G. Bluestein ’46 
Lowell 1. Goodman ’51 
Warren D. Widmann ’61 
Mohandas M. Kini ’65 
Stuart J, Brill ’68* 
M. Felix Freshwater ’72 
Michael G. Adelberg 'll 
FORMER HOUSE 
OFFICERS 
Richard Allen Chase 
PATRON 
Donald P. Morris ’35* 
Theodore E. Allen ’40 
Robert H. Furman ’43 
December 
Martin E. Gordon ’46 
Thomas T. Amatruda, Jr. 
’51 
Harold D. Bomstein Jr. ’53 
William H. Hindle ’56 
Edward O. Fox ’57 
John A. Carlston ’58 
Philip R. Fazzone ’58 
A. Thomas Snoke ’64 
Leonard Grauer ’68 
James W. Ogilvie ’68 
FORMER HOUSE 
OFFICERS 
Ronald W. Braun 






William Cohen ’23* 
Nathan E. Ross ’28 
Henry H. Briggs Jr. ’31 
Nelson Newmark ’31 
Harry Sherman ’34 
Margaret C. L. Gildea ’36 
Alfred E. King ’37 
Willys M. Monroe ’41 
William Fleeson ’42 
William Harrison Jr. ’42 
Ralph D. Alley ’43 March 
Lawrence G. Crowley ’44 
Frederick F. Krauskopf ’44 
A. Reese Matteson ’44 
Nicholas PR. Spinelli ’44 
Jay B. Cohn ’45 
Franklin C. Behrle ’46 
Thomas J. Coleman ’46 
Owen W. Doyle ’47 
Allyn G. Bridge ’48 
Anne Godley ’48 
Paul B. Koehler ’48 
Jerome H. Shapiro ’48 
Claude W. Delia ’50 
Kent Ellis ’50 
Harry L. McClelland ’50 
Gerard B. Odell ’51 
Arthur A. Pava ’51 
Mary Wheatland Schley 
’52 
Ora K. Smith ’53 
Arthur C. Crovatto ’54 
James J. Nora ’54 
John F. Carroll ’56 
Mitchell Edson ’56 
Marie-Louise T. Johnson 
’56 
Preston C. Manning ’56 
F. Calvin Bigler ’57 
William L. Kissick ’57 
Donald C. Stahl ’57 
Gerard N. Burrow ’58 
Robert J. Donohue Jr. ’58 
Paul A. Rudnick ’58 
Raymond W. Turner ’58 
Carol J. Amick ’59 
Robert M. Amick ’59 
Kiistaps J. Keggi ’59 
Leo H. Von Euler ’59 
John J. Schrogie ’60 
Constantine M. Voyagis 
’60 
John E. Fenn ’61 
Anoush Miridjanian ’61 
Seth Thaler ’62 
Alexander R. Gaudio ’63 
Robert E. Mueller ’63 
Peter G. Weiner ’63 
Alfonso Esguerra ’64 
Peter A. Gross ’64 
Richard Murray Linburg 
’64 
Robert W. Lyons ’64 
Robert L. Mitchell ’64 
Donald G. Skinner ’64 
Michael J. Cummings ’65 
Philip D. Manfredi ’65 
Jay G. Hayden ’66 
Gary L. Townsend ’66 
Kenneth F. Crumley ’67 
M. David Tilson, III ’67 
Joseph F. Walter ’67 
Ralph J. Falkenstein ’69 
David A. Geer ’69 
Joseph M. Rochford ’69 
Dennis J. Rudzinski ’69 
Laurie J. Bleicher ’71 
John W. Foster Jr. ’71 
Michael C. Gallant ’71 
Barbara K. Kinder ’71 
Richard Albert Moggio ’71 
Lynne M. Liptay ’73 
Jacob E. Tauber’76 
Marcia J. Wade ’78 
Michael K. Lindsay ’79 
Scott A. Hundahl '81 
FORMER HOUSE 
OFFICERS 
Samuel C. Klagsbrun 
PARENTS AND 
FRIENDS 
Mrs. Vincent A. Doroszka 
Frederick W. Heilman 
Jacob Byung Kim 
ASSOCIATE 
Michael A. Parlato ’08* 
Walter Clark Tilden ’12* 
Julius Anthony Olean ’23* 
David M. Raskind ’24 
Maxwell Bogin ’26 
John Martin Freiheit ’27* 
Ernesto Icaza ’27* 
Ralph E. Knutti ’28 
Knox H. Finley ’30 
J. Roswell Gallagher ’30 
Lee E. Farr ’32 
Myron E. Wegman ’32 
Jack Greenberg ’33 
Edgar S. Childs ’35 
Samuel D. Kushlan ’35 
Norman E. Peatfield ’35 
Philip M. LeCompte ’36 
Frederick A. Post ’36* 
Rafael Arrillaga Torrens 
’36 
Stephen W. Collins Jr. ’39* 
William H. Druckemiller 
’39 
John P. Ferguson Jr. ’39 
Richard E. Dormont ’40 
Patricia E. Wanning ’40 
Peter A. Duncan ’41 
Robert W. Ollayos ’41 
Hendrik DeKruif ’42 
R. Leonard Kemler ’43 
March 
Jonathan Trumbull Lanman 
’43 March* 
Hunter H. Comly ’43 
December 
Henry H. Jones ’43 
December 
Hoyt B. Miles Jr. ’43 
December 
Carol Goldenthal ’44 
Elias J. Marsh ’44 
Benjamin F. Kitchen Jr. ’46 
Joe D. Morris ’46 
Vincent Pepe ’46 
William J. Wedemeyer Jr. 
’46 
George R. Barnes Jr. ’47 
David L. Brook ’47 
William F. Collins Jr. ’47 
Robert J. Kerin ’47 
Igor Tamm ’47 
Edith M. Beck ’48 
G. Robert Downie ’48 
N. Joel Ehrenkranz ’49 
Malcolm A. Bagshaw ’50 
Sidney S. Lee ’50 
Margaret S. Lyman ’50 
John L. Sullivan ’51 
Sidney Nathan Paly ’52 
Robert G. Petersdorf ’52 
John Macklin Roberts ’52 
Robert Zeppa ’52 
Seth F. Abramson ’53 
Richard Andrew Sinnott Jr. 
’53 
James Frederic Young ’53 
Lowell E. Olson ’54 
Leonard M. Silverman ’54 
Leroy Engel ’55 
James Lum ’55 
Rosalie A. Bums ’56 
James C. Collias ’56 
Sumner Gochberg ’56 
William V. Lewit ’56 
William M. Narva, MC ’56 
George W. Paulson ’56 
Stewart E. Pursel ’56 
Theodore K.L. Tseu ’56 
Donald Agostinelli ’57 
Albert K. Chun-Hoon ’57 
Robert K. Modlin ’57 
Clifford B. ReitJer ’57 
John Currier Gallagher 
’58* 
William M. Gould ’58 
Paul Jay Friedman ’59 
Herbert J. Kaufmann ’59 
James A. O’Neill Jr. ’59 
James R. Ralph ’59 
David B. Skinner ’59 
Paul Jay Friedman ’60 
Eugene C. Gaenslen Jr. ’60 
Thomas P. Kugelman ’60 
Albert A. Bechtoldt Jr. ’61 
Ronald A. Dierwechter ’61 
Jon Dudley Dorman ’61 
Thomas H. Sakoda ’61 
Nancy Ann Staley ’62 
Peter B. Gregory ’63 
Edward G. Lund Jr. ’63 
Lawrence Tremonti ’63 
Stephen Waltman ’64 
Michael P. Flynn ’65 
David A. Hill ’65 
Robert L. Pickens ’65 
Robert T. Solis ’65 
Wilbur L. Kukes ’66 
David B. Melchinger ’66 
John A. Drews ’67 
Helen L. Smits ’67 
Rutledge W. Currie ’68 
Ralph S. Greco ’68 
Kevin N. Hennessey ’68 
Jeffrey S. Lee ’68 
Margot Onek ’68 
Charles T. Post Jr. ’68 
Frederick C. Shemtan ’68 
Per Henrik Wickstrom ’68 
Leo M. Cooney Jr. ’69 
Larry C. Horowitz ’69 
Adrian M. Schnall ’69 
Robert M. Rosa ’70 
Bruce Block ’71 
Frederick L. Cohn ’71 
Daniel E. Feldman ’71 
Sten B. Lofgren ’71 
Patrick T. Minihan ’71 
Martin Paris ’71 
Robert Park ’71 
John A. Patti ’71 
Michael C. Piercey ’71 
Charles J. Sutherland ’71 
Albert Carl Weihl ’71 
William H. Druckemiller 
Jr. ’72 
Jerome H. Meyer ’72 
John F. McQuade. Ill ’73 
Saul Lande ’74 
Olusegun O. Lawoyin ’74 
Edward L. Marut ’74 
Douglas R. Zusman ’75 
Gary S. Dorfman ’76 
John A. Elefteriades ’76 
Leonard Firestone ’76 
O’dell M. Owens ’76 
Gary Vitale ’79 
David Atkins ’86 
Amanda B. Dill ’86 
Michael H. Solon ’87 
FORMER HOUSE 
OFFICERS 
John L. Albrigo 
John M. Aversa 
Christine Brahney 
John V. Forrest 
John P. McGovern 
Robert L. Rowley* 
Daniel Simon 
Carol Touloukian 




Andrew S. Kim 
R. Donald Reich 
Prof, and Mr. Lubert Stryer 
MEMBER 
Charles R. Mitchell ’06* 
Alice A. S. Whittier ’25 
Tony Liebman Rakieten 
‘29+ 
Robert Tennant ’29 
Frederick Fitzherbert 
Boyce ’30 
Michael D’Amico ’31 
Paul A. Harper ’31 
Thomas C. Jaleski ’31 
Joseph P. Donnelly ’32 
Elizabeth M. Ramsey ’32 
John G. Martin ’33 
Ashley Pond, 111 ’33* 
Sidney Stringer ’33* 
James Quintin Haralambie 
’35 
Stephen F. Nagyfy ’36 
Hugh Allan Smith ’36 
Margaret Sommers ’36 
Alan A. Rozen ’37 
Benjamin E. Lyons ’38 
John J. McGillicuddy ’38 
Edward W. Pinkham Jr., 
Ret ’38 
Rebecca Z. Solomon ’39 
Malvin F, White ’39 
Henry D. Humphrey ’40 
Edward Martin ’40 
Robert H. Areson ’41 
Knute E. Berger ’41* 
Herbert W. Diefendorf 41 
Robert L. Gilbert ’41 
Robert E. Carroll '42 
Leo Kellerman ’42 
Dean Nichols ’42* 
Lois Knight Rogers ’42 
Maurice Tulin ’42 
Irving Norman Wolfson 
’42 
Lycurgus M. Davey ’43 
March 
J. Philip Loge ’43 March 
Edward F. Rabe ’43 March 
Henry A. Riedel ’43 March 
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Edward Hersey Soule ’43 
March 
John J. Weber '43 March 
Norman I. Condit ’43 
December 
Victor C. Hackney ’43 
December 
Sawyer E. Medbury ’43 
December 
W. Keasley Welch ’43 
December 
Edward J. Conway ’44 
John C. Coolidge ’44 
Robert W. Frelick ’44 
Charles A. Hall ’44 
W. Raymond James ’44 
Edith M. Jurka ’44 
Jerome J. Kaye ’44 
Laurence G. Roth ’44 
George Howard Allison 
’45 
Albert S. Atwood ’45 
Alice Shepard Cary ’45 
Richard R. Dyer ’45 
Robert S. Easton ’45 
Alice Dershimer Friedman 
’45 
James D. Gardam ’45 
O. Roger Hollan ’45 
George W. Naumburg Jr. 
’45 
Richard M. Peters ’45 
Gregory E. Flynn ’46 
Charles Sheldon Judd Jr. 
’46* 
Robert R. Wagner ’46 
William P. Walsh ’46 
W. Roy Breg Jr. ’47 
John L. Cannon ’47 
Robert A. Chase ’47 
Franklin Harold Epstein 
’47 
Richard K. Friedlander ’47 
Brock Lynch ’47 
William K. McClelland ’47 
Myron K. Nobil ’47 
Olive E. Pitkin ’47 
Jonathan S. Bishop ’48 
Ruth E. Cortell ’48 
Richard H. Cote ’48 
Elizabeth Fuller Eisner ’48 
James W. Needham ’48 
George P. Rostel ’48 
Benjamin F. Rush Jr. ’48 
Paul Talalay ’48 
William G. Anlyan ’49 
Jonathan S. Bishop ’49 
Eleanora C. Gordon ’49 
Jackson Harris ’49 
Benjamin A. Johnson ’49 
Timothy F. Nolan Jr. ’49 
Julian I. Pichel ’49 
Charles L. Rennell Jr. ’49 
Carl M. Russell ’49 
Martha Vaughan ’49 
John E. Borowy ’50 
Alvin Davis ’50 
Lucian S. Lapinski '50 
Janus C. Lindner’50 
Harold March ’50 
Jane B. Shumway ’50 
John S. Strauss ’50 
Stanley D. Ardell ’51 
Eleanor Clay Bigley ’51 
John J. Egan ’51 
Sidney S. Furst ’51 
Joseph M. Garland ’51 
John T. Groel ’51 
Carrold K. Iverson ’51 
Robert D. King ’51 
Jocelyn S. Malkin ’51 
Paul D. Millikin ’51 
Albert R. Mowlem ’51 
Richard S. Munford ’51 
Majic S. Potsaid ’51 
Andrew S. Wong ’51 
Thomas S. Kelly ’52 
Leon A. Phillips '52 
John H. Wagner Jr. ’52 
Doris L, Wethers ’52 
John L. Wolff ’52 
William R. Chaffee ’53 
Rex B. Conn ’53 
John Leo Doppman ’53 
A. Daniel Hauser ’53 
Peter Biggs Hukill ’53 
Richard Robert Knowles 
III ’53 
Paul G. Quie ’53 
Jose Ramirez-Rivera ’53 
Irwin K. Rosenberg ’53 
Barbara F. Rosenberg ’53 
William A. Whalen Jr. ’53 
Richard J. Bouchard ’54 
Herbert S. Hurwitz ’54 
Robert J. T. Joy ’54 
Paul N. Neufeld ’54 
Anthony V. Piccirillo ’54 
Richard D. Pullen ’54 
John Keith Rose ’54 
Robert L. Stein ’54 
John W. Vosskuhler '54 
Padraic Bums ’55 
Edward D. Coppola ’55* 
Milton Com ’55 
David R. Kessler ’55 
Robert A. Kramer ’55 
John C. Pace Jr. ’55 
Robert H. Peters Jr. ’55 
Phillip W. Smith ’55 
Peter Bios Jr. ’56 
Levon Z. Boyajian ’56 
Thomas M. Brown ’56 
Joseph C. Cemy ’56 
Donald J. Dalessio ’56 
Thomas F. Ferris ’56 
John H. Gardner, III ’56 
Val Shea Greenfield ’56 
John Herd Hart ’56 
George T. Kammerer ’56 
Jerome O. Klein ’56 
Donald J. Nalebuff ’56 
Robert Lee Scheig ’56 
John P. Carey ’57 
James R. Dorr ’57 
Anthony L. Fons III ’57 
Anne H. Good ’57 
Richard Lee Kahler ’57 
Jack Levin ’57 
George K. Aghajanian ’58 
Joseph E. Angelo ’58 
Lawrence Dubin ’58 
James Greenwald ’58 
Michael Kashgarian ’58 
Jay Ward Kislak ’58 
Thomas J. Mauro Jr. ’58 
William B. Radcliffe ’58 
Edward Lloyd Socolow ’58 
Joseph P. Wierzbinski III 
’58 
Asa Barnes Jr. ’59 
Francis A. Beer ’59 
Sidney M. Cohen ’59 
Robert L. Fisher ’59 
Robert J. Gonyea ’59 
H. Rodney Hartmann ’59 
William H. Heydom ’59 
C. Richard Hinckley ’59 
Leonard Inker ’59 
John J. Jasaitis ’59 
Myron S.S. Lee ’59 
James D. Prokop ’59 
Sanford P. Solomon ’59 
Lisa A. Steiner ’59 
Muriel D. Wolf ’59 
Stuart P. Bowne ’60 
Roland H. Ingram Jr. ’60 
Daniel M. Jones ’60 
Edward R. Lang ’60 
Donald L. Miller ’60 
Jerrold M. Post ’60 
Daniel J. Rubin ’60 
Fred Stargardter ’60 
May Yung-Fun Woo Wang 
’60 
Ronald A. Yankee ’60 
Earl L. Baker ’61 
Robert S. Briggs ’61 
Edward C. Gilbert ’61 
Richard L. Keefe ’61 
Robert Isaac Levy ’61 
George M. Lordi ’61 
John Curtis Parker ’61 
Elaine Pitt ’61 
Shaun J. Ruddy ’61 
Stanley G. Schade ’61 
Hugh C. TTiompson, Ill "61 
John V. Weil ’61 
Charles B. Anderson ’62 
Fredric K. Cantor ’62 
Thomas Newell Chase ’62 
Oliver Townsend Dann ’62 
I. Bruce Elfenbein ’62 
Anthony V. Furano ’62 
John N. German ’62 
David H. Groth ’62 
David E. Knoop ’62 
Allan L. Mattem ’62 
Stanley E. Matyszewski 
’62 
William A. Miller ’62 
Larry Lee Stewart ’62 
Miguel R. Alonso ’63 
Charles W. Carl Jr. ’63 
Andrew Edin ’63 
B. Allen Flaxman ’63 
Benjamin Keith Harris ’63 
William B. Lehmann '63 
Peter B. Livingston ’63* 
Lee Bland Talner ’63 
Peter V. Tishler ’63 
William A. Alonso ’64 
Berton W. Ashman '64 
Thomas A. Cardella ’64 
Anthony Ferrante '64 
Christopher W. Hauge ’64 
William J. Houghton ’64 
Lewis Landsberg ’64 
James S. Levine ’64 
William F. Matchett ’64 
William B. Pratt ’64 
Stanley J. Rosenberg ’64 
Robert L. Shelton ’64 
Sigrid L. Tishler ’64 
Oscar Wand ’64 
Thomas B. Caldwell, III 
’65 
Robert M. Cohn ’65 
Phyllis Hurwitz Duvdevani 
’65 
Carl Ellenberger Jr. ’65 
Robert I. Finkel ’65 
James K. Gude ’65 
Carl E. Hunt ’65 
Virginia Burnham Johnson 
’65 
Ronald J. Karpick ’65 
Sandra Chook Levine ’65 
Mark W. Lischner ’65 
A. Lawrence Ossias ’65 
Gene A. Robinson ’65 
John H. Seashore ’65 
Margretta Ann Reed 
Seashore ’65 
Robert N. Frank ’66 
J. McLeod Griffiss ’66 
Stuart T. Hauser ’66 
Caroline O. McCagg ’66 
John J. Mooney ’66 
Daniel L. Arons ’67 
Herbert W. Felsenfeld ’67 
Richard J. Hart Jr. ’67 
Peter N. Herbert ’67 
Anthony P. Lovell ’67 
Joseph L. Morris ’67 
John O. Pastore ’67 
Jonathan L. Saveli ’67 
Alfred Q. Scheuer ’67 
Sidney C. Smith Jr. ’67 
Robert S. Steinberg ’67 
Richard B. Swett ’67 
Robert A. Vogel '67 
Martin Wand ’67 
Robert J. Winer ’67 
Daniel I. Becker ’68 
Alan G. Finesilver ’68 
Richard A. Getnick ’68 
William F. Keane '68 
Peter A. Livingston ’68 
John A. Ogden ’68 
Gordon H. Sasaki ’68 
Lee H. Strohl ’68 
David G. Ansel ’69 
Bruce W. Burleigh ’69 
Richard J. Daly ’69 
Michael W. Dennis ’69 
Lesley Forman Fishelman 
’69 
Royal J. Gay ’69 
Sander G. Genser ’69 
Thomas C. Howard ’69 
Nancy Olmsted ’69 
Timothy A. Pedley ’69 
Joseph D. Robinson ’69 
Lutz H. Schlicke ’69 
Gerald J. Smallberg ’69 
Gregory W. Bartha ’70 
James E. De Lano Jr. ’70 
Jonathan Ecker ’70 
Thomas H. Gouge ’70 
Jay H. Hoofnagle ’70 
Ely A. Kirschner ’70 
Jay W. Marks ’70 
Bruce A. Reitz ’70 
Richard A. St. Onge ’70 
C. Bruce Wenger '70 
Marc O. Yoshizumi ’70 
Judith L. Bader ’71 
Marian H. Block ’71 
Edward C. Cottle ’71 
Richard E. Kaufman ’71 
Wallace J. Matthews Jr. '71 
Stuart B. Phillips ’71 
Irving G. Raphael ’71 
Douglas R. Schmidt ’71 
Richard D. Travers ’71 
Semeon G. Tsalbins ’71 
Yvonne E. Vaucher’71 
Paul A. Vignola ’71 
Robert B. Vranian '71 
Jerold C. Woodhead '71 
Bruce B. Haak '72 
Thomas L. Horn '12 
Vernon H. Humbert Jr. ’72 
Fred Hyde ’72 
Jesse B. Jupiter ’72 
David L. Kneapler ’72 
Richard S. Robbins ’72 
David Nelson Bailey ’73 
David L. Coulter "73 
Richard J. Fingeroth ’73 
Andrew G. Kadar ’73 
David Pickar ’73 
James S. Robertson ’73 
Harry S. Romanowitz ’73 
Joseph F. Simeone ’73 
Charles F. Stroebel ’73 
Irving M. Asher '74 
Amy S. Schechter ’74 
Robert J. Schechter ’74 
Carol C. Teitz ’74 
Edward M. Wolin ’74 
Sharon L. Bonney ’75 
William S. Bush ’75 
Rodney J. Butch ’75 
Mary Jane Minkin ’75 
Alfredo L. Axtmayer ’76 
John C. Bartlett ’76 
Pauline Y. Chao ’76 
Vincent C. Dicola ’76 
Glenn A. Gorlitsky ’76 
Norman V. Kohn ’76 
William K. Levy ’76 
Sidney Mandelbaum ’76 
Mark C. Ruchman '76 
Susan H.K. Ryu ’76 
Ronald J. Vender 'll 
Duke E. Cameron ’78 
Cynthia S. Kretschmar ’78 
Isabel Cunningham ’79 
Phillip M. Gendelman ’79 
David E. Ness ’79 
Barbara Ann Peters ’79 
Cynthia Anne Shennan ’79 
David E. Adelberg ’80 
Michael W. Champeau ’80 
Todd J. Garvin ’80 
Hillel D. Skoff ’80 
Ramona Q. Fung ’81 
Thomas Kievan ’81 
Martin H. Teicher ’81 
John C. Wong ’81 
Cathleen R. Belden ’82 
Thomas J. Brennan ’82 
Don L. Stromquist ’82 
Michael Brines ’83 
Ellen C. Rieur '85 
FORMER HOUSE 
OEFICERS 
Adel H. Ayoub 
Norberto A. Belleza 
Dennis J. Card 
Whei C. Chang 
Michael Chun 
Stephen A. Edelstein 
Richard Webster Finner 
John W. Goldkrand 
Isaac Goodrich 
Karen Hermansen 
Robert J. Holmes 





Robert R. Rickert 
James R. Sabetta 
Daniel W. Shapiro 
Ethan A H Sims 
Barry S. Strauch 
James P. Taitsman 
PARENTS AND 
FRIENDS 
Willibald H. Conzen 
Chang-Wuk Kang 
Leighmin James Lu 
Henry S. Sanematsu 
* Deceased 
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Alice S. Baldwin 
1930 
Ruth E. Grout 
1933 
Miriam M. Campbell 
Eunice Nickerson Tyler 
1934 
Amy 11. Hunter Wilson* 
Iwao M. Moriyama 
1935 




William R. Willard 
1938 
Willard H. Boynton 
Richard K C Lee 
1939 
Carl I. Cohen 
1941 
Roslyn L. MacNish 




Henry F. Canby 
Leonard Parente 
Charles D. Spangler 
1943 
Richard F. Clapp 
Eric W. Mood 
Miriam 11. Rohde 
1943 
Muriel Bliss Wilbur* 
1944 
Massimo Calabresi* 
Jean F. Heston 
Jane Y. Parker 
1945 
Roslyn R. Bill'ord 
Naomi Barer Golden 
Joe Bales Graber 
Lois M. Jund 
Ha/el M. Whitesel 
1946 
Dorothy B. Hamilton 
1947 
Sidney S. Chipman 
Edna Miller Finberg 
Anne 11. Pulton 
Lillian L. Konick 
From the EPH Alumni Fund Chairman 
I am pleased to acknowledge a $30(),()00 
donation (over three years) to the department of 
epidemiology and public health (EPH) from 
Samuel S. Herman, M.P.H. ’48, Ph.D. '50 and 
his wife, Liselotte. 
Born in Boston, Mass., Dr. Herman attended 
Harvard College, where he received his A.B. 
degree. He then came to study at Yale’s 
department of public health, where he earned 
M.P.H. and Ph.D. degrees. After graduating. Dr. 
Herman joined the National Institutes of Health 
in Bethesda, where he established research 
training and fellowship programs for the Eye 
Institute and the Environmental Health Sciences 
Institute. He also served as the deputy director 
for extramural affairs at the National Cancer 
Institute. 
Dr. Herman left the NIH to join Temple Uni¬ 
versity in Philadelphia as associate vice 
president for research and graduate studies at 
the health sciences center, as well as associate 
dean for research and graduate studies at 
Temple Medical School. During that time, he 
directed a congressionally mandated study con- 
Stephen Skorcz 
ducted by the National Research Council for the 
National Academy of Sciences to determine 
national needs for biomedical and behavioral 
research personnel. 
Since his retirement from Temple, Dr. 
Herman has established a consulting practice 
for education and research organizations. His 
company specializes in Washington, D.C., 
representation for these institutions and in 
biomedical research administration. In this 
capacity, he serves as a consultant to the Lucille 
B. Markey Charitable Trust. 
The funds from a remainder interest in their 
home will support EPH faculty research. 
Besides thanking Sam Herman, I thank those 
classes that passed the $ 1,000 per class goal. 
This helped us reach 97 percent of our goal for 
$140,247 from 654 donors. 
Thanks to all of you. 
Stephen Skorcz, M.P.H. ’70 
Chairman 
Class Agent(s) Amount 
1948 Samuel S. Herman $100,575 
1959 Dorothy M. Wilson 2.200 
1969 Robert L. Young 2.097 
1971 John Bihldorff 1.719 
1976 Elaine P. Anderson 1.685 
1967 James M. Malloy 1.650 
1975 Linda K. Broker 1.568 
1970 Susan W. Balter 1,350 
1980 Christina P. Quinn 1,320 
1978 Ann T. Freedman 1.145 
1952 Yolande F. Lyon 1,100 
1973 Gary Dean Sax 1.085 
1986 Indu B. Ahluwalia 
Aric T. Wilt 1,085 
1977 Dorothy A. Rice 1,050 
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Raymond W. Leonard 
Cecil G. Sheps 
Oscar Sussman, D.V.M. 
1948 
John B. Dibeler 
Mary L. Ellis 
Joseph Hanford Gerber 
Samuel S. Herman. Ph.D. 
Dorothy S, Hoffmeyer 
Richard E. Johnson 
Beatrice H. Kaasch 
Dorothea S. LaBelle 
Hiram Sibley 
1949 
Edgar L. Geibel 
Eleanor R Kostant 
Hilda H. Kroeger 
Christine R. Owre 
William B. Parsons 
Elizabeth D. Robinton 
Matilda Rudnick 
1950 
Dorothy Reese Bloomfdd 
Henry G. Brickman* 
Ida M. Bucher 
Helen P. Cleary 
Austin J. Evans 
Jerome M. Glassman 
Dorothy R. Granoff 
Martha P. Jayne 
Frances K. Reynolds 
Elizabeth M. Scully 
Nathan M. Simon 
1951 
Clarissa E. Boyd 
Norton G. Chaucer 
Joanne E. Finley 
Homer P. Hopkins Jr., 
Ph.D. 
Robert L. Johnson 
Leonard F. Menczer 
Jessie Parkinson Spear 
James M A Weiss 
Walter Wenkert 
John J. Zugich 
1952 
Cahit H. Corbacioglu 
Howard Dunphy 
Mary O. Gabrielson 
Joanna Adele Henry 
Malcolm C. Hope 
Charles Holway Lawrance 
Sidney S. Lee 
Helen Kardys Loria 
Yolande F. Lyon 
Hannah Eileen MacHenry 
Jeanne Ellen Paty 




Laurence K. Rainsford 
Milton H. Sisselman 
Constance B. Thomas 
1954 
Ruth M. Taber 
1955 
Amy L. Cawley 
Evelyn S. Farnsworth 
Morris London 
Mary Me C. Mogan 
Frances R. Ogasawara 
Gerald Rosenblatt 
Daniel E. Ross 
1956 
David D. Boyd 
Marvin H. Burton 
Kathleen H. Howe 
John E. Ives 
Paul I. Kaufman 
John F. Mullett 
Julia R. Nole 




William A, Clermont 
Edward R. DeLouise 
Gaston Jules Deslouches 
Sheldon Selig King 
Edna May Klutas 
Shirley T. Steidel 
Paul W. Stemlof 





Helen H. Davenport 
Normand E. Girard 
Patricia P. Grimaila 
E. Field Horine Jr. 
Edward H. Noroian 
Mary K. Spiker 
1959 
William L. Kissick 
Marvin A. Lavenhar. Ph.D. 
Lee J. Podolin 
John S. Pullman 
Ellwyn D. Spiker 
Mattie Lee D. Wade 
1960 
Bruce A. Barron 
Gyla E. Brooks 
Kathryn L. D’Amico 
Wouter Ekker 
Maxine Geeslin 
Rose A. lannotta 
Katharine Anna Keppel 
John J. Kwasnowski 
R. John C Pearson 
Hannah Clark Russell 
Else Niebuhr Schulze 
1961 
Gordon R. Beem 
Martin Donabedian 
Helen M. O’Connell 
Margaret P. Parker 
Angela M. Russo 
William R. Slivka 
1962 
Thomas A. Biumenthal 
Thomas R. Mayhugh 
1963 
Raul R. Cuadrado 
David Dolins 
C. DuVe Florey 
Edward M. Kenney 
Jean M. Maynard 
Samuel B. Webb Jr. 
1964 
Katherine Maria Detre 
Neal L. Maslan 
Estelle Siker 
Monroe W. Spero 
Claudewell Sidney Thomas 
1965 
Robert M. Edwards 
Edgar W. Francisco III 
James F. Jekel 
Michael E. Kove 
Peter J. Levin 
Charlotte Miller 
Francia M. Pagano 
Elliot A. Segal 
Viola J. Spinelli 
David S. Weiner 
1966 
Allen Cohen 
Anne B. Collart 
Richard H. Ferraro 
1967 
Carlos E. Alvarez Herrera 
Caroline Fong-Cheng 
Ann Gomez 
Joel Kavet, Sc.D. 
Patricia D. Mail 
Charles J. Petrillo Jr.. 
Dr. PH. 
Nancy Ruth Phillips, Ph.D. 
Brigitte Prusoff* 
Bruce J. Steinhardt 
Beth M. Whelan 
Irma Willner. R.N. 
Robert L. Woodward 
Peter T. Wotton 
1968 
Richard W. Ashton 
Sonia M. Colon 
Joseph L. Dorsey 
Elizabeth Schwartz Elliot 
Robert R. Everett 
Carl R. Fischer 
Francis J. Greaney 
William D. Harkins 
Susan F. Klein 
R. Elizabeth Leif 
Margaret J. Lindsay 
Jean C. MacCorison 
Richard L. Petrelli 
Arnold R. Saslow 
Sheila W. Wellington 
1969 
Susan S. Addiss 
Janet A. Albrecht 
Victor Crown 
James M. Dawson Jr. 
Beryl 1. Ford 
Sharon A. Garcia 
Catherine E. Hanley 
Gerald R. Harpel 
Sylvia N. Holtzberg 
Charles C. Jeffrey 
Samuel P. Korper 
Marva Serotkin 
Wanda Vierthaler 
Carolyn K. Wells 
Chester W. Zamoch Jr. 
1970 
Susan W. Balter 
Katherine Benesch 
Michael B. Bracken. Ph.D. 
Hamilton B. Brown Jr. 
Walter M. Gawlak 
Robert S. Gureasko 
Shirley O. Labrum 
Scott W. Lite 
C. P. Noel McCarthy 
Andrea W. Nevins 
Anthony M. Orlando 
Peter Orris 
William L. Pedersen 
Nancy Norton Reitz 
Charlotte F. Schwartz 
1971 
J. David Amundson 
John Bihldorff 
Evelyn J. Bromet 
William F. Carey Jr. 
Willard Cates Jr. 
Katrina H. Clark 
Dale A. Culp 
John A. Daeley 
Harvey Fembach 
Anne-Marie A. Foltz 
Dennis R. Hamilton 
Sara P. Hartman 
Mohamed Ismail Johnson 
William P. Koughan 
Mark J. Magenheim. 
M.P.H. 
Joan L. Martinez 
Eugene S. Mayer 
Nancy P. Mogielnicki 
William C. Okulicz 
Wan Hin Ooi 
David A. Osgood 
Carol L. Paul 
Marcia Russell. Ph.D. 
Jane Silver 
Walter O. Spitzer 
Robert E. Steele 
Barbara R. Stoloff 
Judith Whitcomb 
1972 
David P. Barone 
Frances L. Bushnell 
Catherine A. Connolly 
Daphne deJ. Gemmill 
Susanne Harris 
Dorothy N. Lewis 
Sergio Ruschel 
Jo Ann K. Silverstein 
Laurence A. Tanner 
Frederick A. Vago 
Joyce R. Waksman 
1973 
Emily M. Barclay 
Eva Danielsson Cohen 
Ellen B. Doft 
1973 
Jerone A. Gamble 
Marilyn S. Halper 
Dennis P. May 
George A. Million 
Marjorie E. Nelson 
Gary Dean Sax 
Janet B. Schoenberg 
Alice S. Stark 
Thomas J. Stranova 
Irene Trowell-Harris 
Bonnie C. Yankaskas. 
Ph.D. 
Carl J. Zack 
1974 
Thomas A. Benoit 
Ian B. Berger 
Carl A. Cappello 
Beth G. Crocker 
J. Breckenridge Eagle 
Elizabeth M. Helming 
Roberta Lawrence 
Heather Maycock Ogilvy 
Nils R. Richardson 
Abigail L. Smith 
Myma M. Weissman, 
Ph.D. 
Bienvenido G. Yangco 
1975 
Edith N. Baum 
Ralph E. Binder 
Linda K. Broker 
Ann C. Cunningham 
Linda K. Demlo 
Jack A. Eiferman 
Joyce H. Glazer 
Gerard R. Goulet 
William J. Grego Jr. 
Donna Brown Grossman 
Anne H, Hall 
Barbara R. Unterman Jones 
Philip D. Kennedy 
Amy P. Kentera 
Kathy S. Keuning 
James E. Knoben 
Marion Lee 
Stuart L. Lefkowich 
Hillary Demby Malafronte 
Laurence F. McMahon Jr. 
Lois S. Michaels 
Edward J. O’Neill 
Mary W. Palshaw 
Dale P. Sandler, Ph.D. 
Edward V. Sargent 
Audrey Weiner Solomon 
Raymond Chiu-Ping Tang 
Franziska U. Ulrich 
1976 
Elaine P. Anderson 
William F. Appicelli 
Rochelle Arcus-Ting 
Cheryl F. Austein 
Joanna M, Erikson 
Paul H. Etkind 
Robert H. Frazier 
Wendy Com Friedman 
Annette B. Garofalo 
Karen A. Gordon 
Robert T. Kauer, Ph.D. 
Cleve Lee Killingsworth 
Robert A. Knauf 
Eric Malz 
Robert C. Marquardt 
Gino A. Nalli 
James B. Rokos 
Robert Risdon Schwarz 
Mary Jo Shepard 
Gladys A. Williams 
Thomas S. Wingardner Jr. 
1977 
Richard B. Burford Jr. 
Patrick F. Carone 
Steven R. Cohen 
Bruce D. Cummings 
Annette T. Eichenbaum 
Gerard J. Foley 
Henry C. Gift 
Travis K. Hedrick, Ph.D. 
Rhona Kantor Kershnar 
Teri J. Klein 
Thorsten Kruse 
Ronald F. LaPensee 
Wendy K. Lefkowich 
Polly W. Marvin 
Harris Pastides 
Linda Mendelsohn Pottem 
Dorothy A. Rice 
Abby Rothschild 
Carroll Schilling 
Young S. Shin 
Gail M. Sullivan 
Virginia R. Towle 
1978 
Vijaya V. Bapat 
Kathleen M. Berman 
Alan B. Bloch 
Robert W. Buckingham 
Ann T. Freedman 
Janice F. Gold 
Cynthia R. Gross 
David W. Houck 
Jean Crum Jones 
Margaret Long Karis 
Rosalyn I. Liss 
H. James Myers 
Marguerite Nelligan 
Patricia Lynn Noeker 
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Peter F. O'Connor 
David W. Osborne 
Ellen J. Reitler 
Ellen D. Rothberg 
Irene Schapiro 
Karen C. Schneider 
Robert E. Schwartz 
Alan J. Siniscalchi 
Lucy Ellen Weiger 
1979 
Bruce S. Anderson 
Virginia P. Bainbridge 
Gertrud S. Berkowitz 
Mananne Berwick 
Mania P. Borgstrom 
Christopher M. Cannon 
James F. Consedine II 
Susan De Renzo 
Elizabeth Feuer 
Lynn Fielden-Smith 
Judith B. Gancher 
Debra Haffner 
Karen G. Hellenbrand 
Joseph D. Henn-DeMayo 
Lucinda H. Hogarty 
Geoffrey P. Kane 
Loren R. Kantor 
Phillip S. Katz. Ph.D. 
Karen Kmetzo 
Paul Anthony Kowalski 
Benjamin Krevsky 
Renee S. Leary 
Mary Elisabeth Lorenzi 
Osvaldo Marrero 
Patricia J. Moore-Pastides 
Dolores Peneet 
Marcia C. Richardson 
Lisa Klar Rosenfeld 
George B. Rowland 
William E. Schweizer 
Ralph Tartaglione Jr. 
Elizabeth Tedder 
Mary Jane A. Teta 




Phillip R. Aaron 
Gary J. Aboff 
Frederick R. Aronson 
Diane Denis Aye 
Curtis S. Breslin 
Antoinette M. Brooke 
Richtud L. Buck 
Gary L. Busack 
Martha G. Dale 
Alfred E. Fasulo Jr. 
Barbara H. Granger 
Ellen B. Greif 
Irwin J. Halperin 
Samuel S. Hamilton 
Virginia S. Humphrey 
Helen E. Kelly 
Yee-Lean Lee 
Robert V. Levine 
LeRoy F. Ludwig 
Kristina Obom Maldarelli 
James S. Marks 
Steven Morrow 
Jane Ungate O'Connor 
Ann L. Prestipino 
Nancy Maguire Rhodes 
Jeri Ann Rose 
Norman M. Schlossberger 
Lydia A. Selling 
Marsha L. Silverman 
Benita J. Sticca-O'Colmain 
R. Blake Whitaker Jr. 
Philip A. Witman 
Mane L. Zanotti 
1981 
Christopher J. Bevan 
Harold J. Burdo Jr. 
Carlos Ceballos 
Patricia J. Checko 
Rollin C. Chew 
Angelo J. Devita 
Alfred P. Dufour 
Peggy A. Gallup 
Judy E. Garber 
Marie F. Gavula 
Joan Urquhart Goodman 
Diane E. Goren 
Gerlinde B. Kehlenbach 
Cindy F. Kleinian 
TTiomas J. Krause 
Katherine M. McCormack 
Blackford Middleton, M.D. 
Marlee D. Mooney 
Mary' E. Papke 
Ellen Gallagher Parsons 
Barbara Gaugler 
Pennebaker 
Elizabeth N. Shapiro 
Susan M. Stoecker 
Karin Swanson 
Keith D. Tait 
Kathleen R. Yager 
1982 
Margarita Acosta 
Jamie L. Amaral 
Martha Livingston Bruce 
Francis L. Crowley 
Doris Gordon 
Denise Heinemann 
Susan Eberle Levy 
Linda F. McCaig 
William F. McKeon 
David L. Mork 
Susan G. Rice 
Sally R. Rinaldi 
Lisa E. Stone 
Carol L. Vander Wal 
Michele T. Visconti 
Sandra Michaelson Warren 
Maud Helen White 
Alvin C. White 
Amy B. Wilson 
Jill Okrent Zaheer 
1983 
Barbara W. Abraham 
Dean S. Archibald, M.D. 
Mark L. Dembert 
Lorraine DeNicola 
Eileen McDonald Egan 
Susan Earis 
James N. Gaito 
Ellen M. Ginzier, M.D. 
Daniel A. Graybill 
Wendy L. McGill 
Cynthia M. Meyer 
Scott K. Mock 
Shinsuke Morio 
Judith F. Nelson 
Suzanne Nutt 
Jeannee Parker-Martin 
Barbra G. Rabson 
Keith A. Radcliffe 
Nano G. Rush 
Lynn Marie Saphire 
Paul M. Schur 
Elizabeth C.H. Stevenson 
Patricia C. Weber 
Vicki L. Wilson 
Nancy K. Wright 
1984 
Laura D. Gibowski 
Alexandra H. Giraud 
Carolyn H. Grantham- 
Millman 
Kim S. Griswold 
Penny H. Hausser 
Marcia Lipkind Hirsch 
Sarah M. Horwitz 
Gregory R. Huth 
Mehrdad Jalali 
Georgia Jennings 
Jean G. Larson 
Andrea C. McCrensky- 
Kremer 
Grael M. O'Brien, Ph.D 
Mitchell A. Portnoy 
Jessica L. Richer 
Julie A. Russem 
Gerald L. Springer 
Marie Ann Tobin 
1985 
Rene S. Cabral 
Katherine Santella 
Fitzpatrick 
Shirley J. Lee 
P. Douglas McConatha 
Mara Natkins 
Donna ITierese Perla 
Adrian J. Pinsince 
James V. Soscia 
Priscilla A. West 
Terry Martin Zingman 
1986 
Clare F. Averbach 
Andrea Lee Boissevain 
Lewis P. Bower Jr. 
Louise M. Brenner 
Marijane L. Carey 
Katherine H. Ciacco 
Reid M. Davis 
Joe Tom Easley 
Susan Anne Egerter 
Nancy E. Eithian 
Stephen B. Gruber 
Michael S. Huncharek 
Roxanne Kapikian 
Wendy Lee 
Amy June Lippmann 
David C. Lowy 
Adrienne Marks 
Monica Ann O'Neill 
Philip O. Renzullo 
Denise Amy Riedel 
Eric Triffin 
Virginia M. Westra 
Katherine Burdick Wilson 
Lynn D. Wilson 
Aric T. Wilt 
1987 
Hilda C. Chaski 
Margaret D. Corbae 
Deirdre A. Darsh 
Nicolas N. Doan Van 
Meg B. Domino 
Robin N. Eastman 
Jolie H. Eries 
Bridgid M. Garrison 
Carol Guardiano 
Charlotte Hitchcock 
Sara A. Holdcroft 
Timothy A. Jacobs 
Kastytis V. Kaleda 
Michael T. Koff Jr. 
Catherine A. Leda 
Mary Ann Lillie 
Peter James Malloy 
Barbara J. Moggio 
Maureen Brady Moran 
Joseph J. Napolitano 
Judith Ann Natale Sabino 
Pamela Fitzgerald 
Pomputius 
Anita A. Roth 
Michael J. Testa 
Joel A. Wasserman 
Elizabeth A. White 
1988 
Barbara Ellen Andrews 
Robert Joseph Anthony 
Ellen Elizateth Banach 
Elaine P. Berger 
Giselle Charlotte Bleecker 
Lydia Jeanne Landis 
Mark William Legnini 
Paul Alan Lindia 
Saifuddin Taiyeb Mama 
Carrie A. Redlich 
Lawrence Vincent Silvia 
Bnan A. Triplett 
Darlene Uten Zimmermann 
1989 
Judy Gardner Audette 
John K. Cantelmo 
Daniella Duke 
Michael Joseph Gillespie 
Eddie Sim Go 
Elizabeth Harrison Hadley 
Wen Hsiao 
Marcella Perez Jones 
Clifton Ping L,ee 
Angela A. Mattie 
Joanne Susan Mosca 
Deena Beth Myers 
Elizabeth Ann Platz 
Robert P. Sbriglio 
Nipon Sermpanich 
Joy Misako St. Germain 




Sylvia Elaine Bailey 
Linda V. Bergonzi 
Nicholas A. Daniels 
Amy Margaret Davis 
Cheryl Lynn Eattibene 
Mark Steven Lachs 
Lucie Langeler-Wilkins 
Janet McCann 
Angela B. Miller 
Jennifer Jennings Miller 
Karyn J. Nair 
Charles W. Tomatore 
Julie Ann Utroska 
FACULTY 
U. Robert Merikangas 


















BUTORS RATION TOTAL 
EPll Alumni 2,267 597 26 $135,523 2,353 654 28 $140,248 
Interest Miscellaneous ~ — — 869 — — — 940 
TOIAL 2,267 597 26 $136,392 2,353 654 28 $141,188 
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EPH Alumni Fund Class Participation 
1989-1990 1990-1991 
CLASS AGENT TOTAL % PART. TOTAL % PART. 
1941 and prior Eric Mood $ 2,499 62 2,330 62 
1942 Eric Mood 525 80 750 60 
1943 Eric Mood 301 18 176 30 
1944 Eric Mood 226 33 180 3 
1945 Stephen Skorcz 125 33 160 42 
1946 Stephen Skorcz 75 29 25 14 
1947 Stephen Skorcz 145 30 325 37 
1948 Samuel Herman 100,885 56 100,575 56 
1949 Edgar Geibel 480 35 450 35 
1950 Eric Mood 590 43 750 52 
1951 Robert Johnson 590 40 595 42 
1952 Yolande Lyon 445 33 1,100 44 
1953 Milton Sisselman 185 25 195 26 
1954 Eric Mood 45 14 25 7 
1955 Frances Ogasawara 370 47 340 50 
1956 David Boyd 520 42 390 42 
1957 Edward DeLouise 520 45 570 50 
1958 Philip Hallen 350 22 620 33 
1959 Dorothy Wilson 1,250 22 2,200 22 
1960 Gyla Brooks 350 39 625 48 
1961 Joseph Prekup 425 41 210 5 
1962 Thomas Mayhugh 250 20 
1963 David Dolins 650 30 49 32 
1964 Estelle Siker 760 36 625 23 
1965 725 41 675 34 
1966 Allen Cohen 135 23 160 12 
1967 James Malloy 1,680 38 1,650 34 
1968 Francis Greaney 1,185 36 960 36 
1969 Robert Young 1,340 33 2,097 38 
1970 Susan Balter 1,235 32 1.350 31 
1971 John Bihidorff 1,540 44 1,719 52 
1972 Dorothy Lewis 395 21 525 26 
1973 Gary Sax 1,330 30 1,085 27 
1974A Thomas Benoit 350 30 390 23 
1974B 275 20 450 26 
625 25 840 25 
1975 Linda Broker 1,178 27 1.568 35 
1976 Elaine Anderson 1,670 30 1,685 31 
1977 Dorothy Rice 740 24 1,050 25 
1978 Ann Freedman 1,210 24 1,145 26 
1979A Catherine Norton 1,010 34 670 34 
1979B Ralph Tartaglione 560 36 875 43 
1,570 35 1,545 39 
1980 Christina Quinn 820 22 1,320 32 
1981A Angelo DeVita 485 21 565 25 
1981B Barbara Pennebaker 255 33 350 43 
740 27 915 34 
1982A Constance Garowey 265 12 255 12 
1982B Jean Milton 470 26 560 35 
735 19 815 24 
1983A Jeffrey Hughes 475 22 315 17 
1983B Marybeth McNemey 245 20 570 43 
720 21 885 30 
1984A Anthony Alberg 235 18 405 22 
1984B Leslie Balch 205 12 330 16 
440 18 735 19 
1985A Joan Cleary 205 13 40 4 
1985B Katherine Fitzpatrick 305 21 233 21 
510 17 273 13 
1986A Indu Ahluwalia 625 25 655 24 
1986B Aric Wilt 510 24 430 28 
1,135 25 1,085 26 
1987A Hilda Chaski 458 15 740 29 
1987B Elizabeth Wennar 300 8 225 10 
758 12 965 20 
1988 Joseph Della Puca 425 15 370 14 
1989 Joy St. Germain 370 16 455 18 
1990 Jennifer Miller 415 12 





At of his last functions as president and CEO of Yale- New 
Haven Hospital, C. Thomas Smith (left) attended the June 6 
dedication of the Boyer Center for Molecular Medicine. 
With him are center Director Vincent T. Marchesi and Mr. 
Smith's successor. Joseph A. Zaccagnino. 
Hundreds of friends and colleagues attended a Nov. 16 
reception honoring former Dean Leon E. Rosenberg. He is 
pictured with (from left) Drs. Robert M. Donaldson Jr. and 
Donald J. Cohen and Dr. Rosenberg's wife. Diane. 
At the fall meeting of the Association of 
Yale Alumni in Medicine, Thomas P. 
Kugelman, M.D.’bO, passed the 
president's gavel to Muriel Wolf, M.D.'59. 
68 Yale Medicine Fall/Winter 1991-92 
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May 27, 1992 
Imniunocytochemistry & Cryosections: A Practical Course (A) 
Direclor: Paul Webster, Ph.D. 
For academic, governmental and industrial researchers involved in biological and medical 
research who want to familiarize themselves with all aspects of the ultrastructnral 
immnnolocalization of antigens and gain practical experience of cryosectioning. 
Bone Up On Osteoporosis (B) 
Director: Karl lusogna, M.D. 
A state of the art approach to diagnosis and management of osteoporosis. 
Advances in Transfusion Medicine and linmunoheniatology (C) 
Director: Edward Snyder, M.D. 
Fourth Annual Yale-Flarvard Symposium on advances in transfusion medicine 
and immunohematology. 
Visiting Lecture Series in Clinical Ophthalmology (D) 
Director: David Silverstone, M.D. 
Guest Speaker: George Spaeth, M.D. 
Glaucoma management in the 1990s. 
Visiting Lecture Series in Clinical Ophthalmology (Fj 
Director: David Silverstone, M.D. 
Guest Speaker: James Gills, M.D. 
Cataract and lOL surgery update. 
Fifth Annual Rheumatology Symposium - Lyme Disease (F) 
Director: Robert Schoen, M.D. 
Will provide a focused update on all aspects of Lyme disease. 
CIRCLE THE APPROPRIATE LETTER(S) ON THE ATTACHED POSTCARD TO OBTAIN MORE INFORMATION ON 
CONFERENCES DISCUSSED IN THIS ISSUE. PLEASE BE SURE TO INCLUDE YOUR NAME AND ADDRESS. 
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International Health: 
A Sleeping Giant Rouses 
A Tribute to Wilbur G. Downs 
Yale Medicine 
Alumni Bulletin of the School of Medicine Spring 1992; Volume 26, Number 2 
President’s Message 
As political changes across the globe continue at an astonishing 
pace. University President Benno C. Schmidt Jr. outlines Yale's 
commitment to leadership as a world university. 
The Gift of Sight: India’s Cataract Camps 
Medical alumni Mohandas M. Kini and Alexander R. Gaudio relate 
their experiences as surgeons in one of India's cataract camps, part of 
a system that saves the sight of thousands of people every year. 
7 International Health: A Sleeping Giant Rouses 
As Yale University unites its efforts in international health, eco¬ 
nomic development and the ecology, the School of Medicine builds 
on more than a century of experience abroad. 
A Renaissance Man in the Developing World 
Dr. Herbert S. Sacks. ’52-'55 HS, recalls his relationship with the 
late Wilbur G. Downs, and how this citizen of the world laid the 
groundw'ork for an international health program at Yale. 
East Meets West: The Yale-China Bond 
Sherwin B. Nuland. '55 M.D., a medical advisor to the Yale-China 
Association, reflects on the challenges of helping this Asian nation meet 
its goal of an advanced approach to medicine. 
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PRESIDENT’S MESSAGE 
Henry Luce III and Benno C. Schmidt Jr. discuss the site of Henry R. Luce Hall, which will house the Yale University Center 
for International and Area Studies. The Henry Luce Foundation Inc. donated $10 million to the project, to he completed in 1994. 
hy Betino C. Schnudt Jr. 
The world continues to change, and those changes pose special 
challenges and unprecedented opportunities for American edu¬ 
cational institutions, particularly those—like Yale—which are 
“world universities.” Our institutions of higher education face 
special challenges because they stand at the leading edge of 
America’s international competitiveness and as a prime example 
of the benefits of freedom and institutional pluralism. If America 
is to maintain its global leadership role into the 2l.st century, the 
continued excellence and vibrancy of American universities will 
be an important reason why. 
But our universities have a far more important role to play 
internationally than simply keeping America competitive. Yale, 
together with a relatively small number of true "world universi¬ 
ties.” will help forge both the intellectual alliances and the 
strategies that will guide leaders in every country and region. 
These “world universities” will be characterized by five 
features. First, they will stand out for their ability to attract the 
most distinguished students and scholars from all over the world 
to their undergraduate and postgradtiate programs and profes¬ 
sional schools. Second, they will demonstrate special ability to 
send their faculty and students to study, teach and pursue re¬ 
search throughout the world and particularly to assist in the 
intellectual reconstruction of universities, governments and the 
private sector in developing and newly democratized countries. 
Third, they will treat international studies as a distinct disci¬ 
pline that cuts across traditional academic and professional 
fields. They will therefore approach international studies from 
an interdisciplinary perspective, which will encourage not only 
the comparative study of the languages, arts, culture, history, and 
contemporary circumstances of all major regions of the world but 
also of such distinctively global fields as international health care 
delivery, international human rights, international political 
economy, international law and the biosphere. 
Fourth, the world universities will place high priority on 
maintaining libraries, art collections, natural history and anthro¬ 
pological collections, and other materials significant to all major 
regions and international subjects. 
Fifth and finally, the world universities will be distinguished 
by their close and extensive personal and institutional links with 
students, faculty, alumni, and administrators from the world's 
other leading universities and research entities, as well as govern¬ 
ments, foundations, corporations, and intergovernmental orga¬ 
nizations. 
Yale is committed to playing a special role in forging and 
maintaining such international educational and intellectual net¬ 
works and is well-positioned tocontinue playing an essential role 
in helping to shape responses to the problems and possibilities of 
the emerging world order. 













Dr. Martin Gordon 
reacts to a question 
posed to a student 





poster session, held 
in November 1991 in 




l o the editor: 
I understand that the Spring 1992 edition 
of Y \i 1-. MedicinI: will feature interna¬ 
tional health. No discussion ofthis topic as 
it relates to the medical school would be 
complete without a tribute to Wilbur C. 
Downs. M.D.. founder of the overseas 
travel fellowship program that bears his 
name. 
Will Dow ns' commanding presence w as 
immediately felt by all. not by an over¬ 
bearing nature, but by his carefully chosen 
statements that flowed freely of wisdom 
based on experience. His adroit responses 
to problems posed by both students, fac¬ 
ulty and friends were measuretl. impres¬ 
sively profound anil invariably convinc¬ 
ing. This characteristic was conveyed by 
his totally frank, perceptixe observations, 
'fhose w ho were fortunate enough to know 
this giant came to realize that nothing 
escaped his keen scientific grasp, surpris¬ 
ingly. in spite of the lifetime narcolepsy 
that never handicapped his intuitive prob- 
inu. 
He became a fascinated student and 
then masterofcoLintless creatures and sub¬ 
jects of nature. The world of Downs 
stretched from the sea to the skies while he 
snatched a flying arthropod, an as yet un¬ 
classified species, soon to be meticulously 
labelled, magnified and categorized. A 
feisty fish was patiently awaited and suc¬ 
cessfully hooked by a lure of secret con¬ 
coction, itself springing from a little-known 
bird, feathers extracted and hung in the 
basement for years, waiting its turn for the 
endowed opportunity. This too was of his 
disposition, the constant defense of deli¬ 
cate ecosystems' balance, expressed by 
bringing sense to the nonsense of seem¬ 
ingly glorious solutions to water supplies, 
the diverting of rivers, and glib changes by 
the "experts," soon to affect the health and 
way of life of these hungry, native people. 
The feeling of being fortunate to be part 
of this master's class was shared by stu¬ 
dents as well as colleagues, imbibing the 
many personal events of a lifetime of ad¬ 
venturous science, a man of extensive re¬ 
flection on the universal status, warmly 
discussing a better path to problem-solv¬ 
ing. His passion for "learning by doing" 
became exemplified by developing the 
international travel fellowships, which of¬ 
fer the opportunity to study in a scientific 
endeavor abroad. This fellowship was 
named for him because of the profound 
respect for his vigorous planning and in¬ 
tuitive sensing where the prepared mind 
w ill solve worthy problems. The synthesis 
of the best in a kind, consummate scientist 
and insightful individual seems to be the 
persona of Will Dow ns. Chaucer's obser¬ 
vation best expressed this: 
"He taughte and first he folwed it 
himselve..." 
Martin E. Gordon. M.D. '46 
New Haven 
Editor's note: Dr. Gordon, clinical pro¬ 
fessor of medicine, a long-tinw supporter 
of international health at the Yale Univer- 
sitv School of Medicine, serves on the 
niedical school's committee on interna¬ 
tional health. Eor further coverage of 
\\ ilhiir Downs, see ". \ Renais.sance Man 
in the Developing World" by Herbert 
Sacks. M.D.. on page 16. 
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Dr. Green during a recent trip to Munyara, Tanzania 
Emeritus in Name Only 
To the editor: 
Readers of Yale Medicine might be 
interested in learning that one of the 
medical schooFsfaculty, though emeri¬ 
tus. keeps himself professionally busy 
in other ways. Most recently, for ex¬ 
ample, I completed a one-month stint 
of teaching in Lusaka at the University 
of Zambia Medical School where I am 
Professor of Anaesthetics. The 1400- 
bed University Teaching Hospital is 
one of two locations at which I have 
established Overseas Teaching Pro¬ 
grams sponsored by the American So¬ 
ciety of Anesthesiologists. The other is 
at the non-sectarian Kilimanjaro Chris¬ 
tian Medical Center in Moshi, Tanza¬ 
nia. The programs at both sites are 
based on volunteer physician teachers 
recruited from the United States and 
Canada to teach, one at a time, in these 
two pre-existing, structured teaching 
programs for 12 months a year for four 
years at Lusaka and for three years at 
Moshi. Working in, with and for these 
two programs involves a great deal of 
time in East Africa and an equally great 
deal of time recruiting back in the States. 
The ultimate goal is to improve the 
quality and quantity of medical care in 
an area where anesthesia personnel are 
so scarce that only 15 to 20 percent of 
the amount of surgery that should be 
done can be done. 
Nicholas M. Greene. M.D. 
New Haven 
A Daughter’s Tribute 
To the editor: 
1 write in response to the notes on the 5()th- 
year reunion in Yale Medicine (FallAVin- 
ter 1991-1992). 1 am David Pecora's 
daughter, and I’d like to point out that my 
dad still works "full time." We are grate¬ 
ful for his good health, which has enabled 
him to purse his passion for practicing 
medicine. Up until October when he 
turned 75. he was taking calls, working on 
a trauma team, putting in long hours every 
day, seven days a week. Now he only 
takes surgical emergency calls. 
My only regret is that our "system” 
does not recognize and allow individuals 
like my dad, who are gifted, competent, 
and devoted physicians to continue to 
practice as long as they can. More and 
more, recently, he has been under pres¬ 
sure to retire. The impetus for this has not 
been a concern for him or his patients, but 
rather an effort to lessen the competition 
he represents to his younger colleagues, 
who often are not so well trained and 
experienced. 
Although I cannot speak for my dad, I 
can say that it is my impression that one 
of the reasons medicine is not the re¬ 
spected profession it once was, is that too 
many of its younger members no longer 
share the value of dedication to the ser¬ 
vice of their fellow human beings that the 
older members took for granted. Medi¬ 
cine today has become a business. As I 
watch my dad's career drawing to a close, 
I share his sense of loss, because I think 
we as a society will never know the likes 
of him and his generation of doctor. I 
attribute this sad situation, in large part to 
a lack of willingness of this profession to 
hold its own members accountable when 
they are unethical or greedy. 
1 also want to register my frustration 
with the waste that occurs when our soci¬ 
ety does not allow all of its citizens to be 
productive. My father is a world-class 
expert on the treatment and cure of tuber¬ 
culosis. In addition, transtracheal aspira¬ 
tion was developed by him (New E)i- 
gland Journal of Medicine. 1985, Vol. 
71, page 285). At $35 per procedure, 
transtracheal aspiration is less expensive, 
more accurate, and safer than the much 
more commonly prescribed 
bronchoscopy that costs thousands of 
dollars per procedure, does not always 
produce a sterile culture, and is poten¬ 
tially dangerous to patients. Yet. on both 
counts we ignore the timeliness of our 
heritage. 
The world is facing a rise in the inci¬ 
dence of tuberculosis, and everyone is 
concerned about lowering the costs of 
health care. Instead of looking at what we 
already have, we are going to ransom the 
next generation's well-being in order to 
reinvent what the last generation already 
discovered. 
Ann Pecora Diamond 
New Haven 
Corrections 
In the FallAVinter 1991-1992 edition of 
Yale Medicine, in the caption on page 
18, the first name of Brian West, assis¬ 
tant professor of pathology, was mis¬ 
spelled. as was the first name of Jon 
Morrow, professor and chairman of pa¬ 
thology, on page 23. To correct an error 
on page 44, Nicholas D'Esopo is M.D. 
Class of 1936. Our apologies. 
Y,\le Medicine welcomes letters from its 
readers. Letters will he published at the 
discretion of the editors and may he ed¬ 
ited for length, style and content. 





















THE GIFT OF SIGHT: 
INDIA’S CATARACT CAMPS 
Siir<^ei>ns opcrale in </ convcrtcil c la.ssrooiii in Main^alore. India. 
Hiimi 
h\ Mohandas M. Kuu. M.D.. Fh.D. '65 
and Alexander R. Gandio, M.D. '65 
World Health Organi/ation (WHO) data from 19S7 estimate 
that worldwide. 3.^1 million people are blind, of which 6.S per¬ 
cent live in Asia and 20 percent in Africa. That number is 
rajiidly increasing with the population explosion in developing 
nations. By far. the leading cause of blindness is cataracts, 
affecting an estimated 20 million people, most living in rural 
areas of rieveloping countries. 
As to cataract treatment, health professionals bear both 
good new's and bad news, d’he good news is that, unlike some of 
the other causes of blindness, cataracts can be surgically treated. 
■Such operatir)ns. with or without intra-ocular lens (lOL) im- 
plantation. have proven a safe and effective method r)f restoring 
\ision in those patients who can be accessed. In the United 
.States, w ith 100.000 ophthalmologists per person, approximately 
I million cataract operations, most involving lOLs, are per- 
formetl yearly at a cost of .S3 to 4 billion. 
The bail news reflects the status of health care in the world 
at large. Namely, in ileveloiiing nations such as those of Asia 
and sub-Saharan Africa, where the per capita annual health 
expenditure is only a few dollars, high-technology, high-cost 
cataract surgery is out of the question. The problem of limited 
funds is. compounded by a lack of supplies and a minuscule 
ophthalmologist-to-patient ratio. 
d'his makes it imperative that programs intended to assist 
developing lands be designed with such limitations in mind. 
Effective approaches provide for a high volume of cataract 
operations in a short period of time and at a price that the 
national health care system, private and governmental, can 
sustain. During each of the past several years one of us (MMK), 
has volunteered in one such successful system—the cataract 
camps of India. In 1987, both of us participated in a camp in 
Mangalore, organized by Professor C.R. Kamath, M.D.. chair¬ 
man of the ophthalmology department at Mangalore's medical 
school. For both of us. the experience was emotionally and 
spiritually exhilarating 
The conceiit of "ambulatory" cataract surgery that is the 
current norm in the U..S. has been long prevalent in cataract 
camps in India, dictated by financial exigencies. W'ith limited 
resources, a population of 8.30 million and a ratio of one oph¬ 
thalmologist for every million people, this subcontinent relies 
heavily on community involvement in its campaign against 
cataract-related blindness. Local Indian Rotary Clubs and Li¬ 
ons Clubs and a large cadre of community health workers 
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contribute magnanimously of their time and effort to the camps 
which offer, at least to some, the hope of sight. 
One can liken a cataract camp to a wheel, the ancient 
symbol of India which is featured prominently on its national 
flag. Each camp serves as a wheel's hub. connected to several 
mobile clinics, which are the spokes. These clinics screen 
patients and channel candidates for cataract surgery to “the 
center,” in our case the city of Mangalore on the beautiful 
Malabar coast facing the Arabian Sea. 
The Malabar coast has been a thriving trading area for 
2,000 years, with Arab ships, called dhows, plying the Indian 
Ocean to carry on the spice trade with the Middle East and 
Europe. Vasco Da Gama, the Portuguese explorer, discovered 
the sea route to India five centuries ago and founded the first 
Portuguese colony on the western coast of India. Jesuit mis¬ 
sionaries soon came and established a successful system of 
education. The Portuguese influence is still evident in the 
region, as is the influence of Jesuit schools. 
Vegetation here is lush and verdant, a result of the mon¬ 
soons which bring close to 100 inches of rainfall per year. 
Agriculture and related industries, the mainstays of the economy, 
provide a greater level of prosperity than is seen in many other 
parts of India. In fact, Mangalore is known as the cashew nut 
capital of the world. 
In keeping with this city’s relative "prosperity," a well- 
established medical school offers postgraduate residency pro¬ 
grams in all major fields, including ophthalmology. We came 
to the cataract camp in response to an invitation by Dr. Kamath. 
He and his colleagues apply themselves indefatigably to the 
planning and successful operation of camps throughout the 
area. Their enthusiasm and hospitality made our experience all 
the more memorable. 
Mangalore's approach for the past 17 years has been to 
send teams of ophthalmologists and technicians to surrounding 
villages to examine patients for eye pathology, especially cata¬ 
racts. The team's impending arrival is well-publicized; every¬ 
one with ocular or visual problems is encouraged to attend the 
local clinic. Careful scheduling makes it easy for people to 
attend; clinics are offered twice a year, at times chosen not to 
conlJict with the planting or harvesting seasons. 
Since India has a well-established optical industry, inex¬ 
pensive spectacles are available to patients who need only 
corrective lenses. Eor cataract patients, those who are judged 
healthy enough are scheduled for surgery in the camp. Patients 
with a history of hypertension, diabetes, anemia or other signifi¬ 
cant problems are operated on in the hospital proper. 
Camps are under the medical supervision of a faculty mem¬ 
ber from each of the departments of cardiology and anesthesiol¬ 
ogy. A cataract camp operations manual sets strict guidelines 
that emphasize service and high quality. In Mangalore, the 
cataract camp is scheduled during school vacation, so that 
schools can be temporarily converted into operating theaters 
and hospital rooms. Some children returning from break sit 
down to desks that were used as an operating table only a few 
days before. 
Converting a school into an ambulatory surgical unit is a 
fascinating process that testifies to Indian ingenuity. After 
appropriate decontamination procedures, the main classroom 
serves as the operating room, and satellite classrooms provide 
each convenient patient "bedrooms," each accommodating ap¬ 
proximately 10 patients and 10 relatives, dheir shared bed 
consists of a blanket on the floor, d’he operating room has four 
to six operating tables, so that several ophthalmologists can 
simultaneously perform surgery. 
A typical morning of surgery includes approximately l.'^O 
operations, mostly for cataracts, but also for dacryocystitis, 
pterygia, glaucoma and trachoma. Patients are prepared in an 
anteroom with dilating drops, lid and retrobulbar anesthetic 
blocks, and a subconjunctival prophylactic antibiotic injection 
to supplement antibiotic drops administered several times the 
day before surgery. 
Front left, Drs. Gaiidio, Kamath and Kitn. 
Drs. Gaiidio and Kini: 
Partners in Humanitarian Service 
Alexander R. Gaudio, M.D. '63. and Mohandas M. Kini. 
M.D. '65. have collaborated on various academic and 
clinical projects since 1959. when they were research 
fellows in pharmacology at Yale. They were co-residents 
in ophthalmology at the Massachusetts Eye and Ear Infir¬ 
mary in Boston, and subsequently did fellowships in reti¬ 
nal diseases and surgery. Today, Dr. Gaudio practices in 
Hartford, Dr. Kini in Boston. At the Mangalore School of 
Medicine in 1987, the authors served as volunteer eye 
surgeons for the cataract camp and taught postgraduate 
students and practicing ophthalmologists. As part of their 
volunteer work. Drs. Gaudio and Kini garnered easily 
transportable supplies, such as fine sutures, instruments 
and ophthalmic medicines. Reports Dr. Kini. "Numerous 
U.S. companies have been extremely generous in the 
donation of supplies, in particular Alcon Labs of Fort 
Worth. Texas, and Johnson & Johnson of Princeton, N.J. 
In addition, our own hospital, the Massachusetts Eye and 
Ear Infirmary, has been an extraordinarily generous source 
of valuable supplies over the past 15 years." 
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Operations consist of an intracapsiilar cataract extraction 
(ICCE) performed with the aid of magnifying loupes; illumina¬ 
tion is provided by a single bulb suspended from the ceiling. 
Prohibitive cost precludes intraocular lens implantation and the 
microscopic surgery taken for granted in the United States. 
Paramedical personnel assist in patient traffic, handling 
supplies and equipment, and recoridng the operation. Rotary 
Club and Lions Club volunteers serve as medical aides, bring¬ 
ing patients to and from the operating table. These local civic 
groups also help patients with transportation, board and lodging 
for their stay at the camp. 
Patients are admitted on a Saturday, have their surgery 
performed on Sunday, and are discharged by the following 
weekend. As is the usual custom in developing nations, close 
relatives often room with patients during their hospital stay, 
providing emotional support and custodial care. At each cata¬ 
ract camp, approximately 150 patients receive free surgical and 
post-operative care. 
Daily post-operative checkups are done for five to seven 
days, followed after one month by checks in the rural villages, 
where spectacles are irrovided through the generosity of local 
opticians. Complication rates have been acceptably low. As 
most of these surgical patients are blind from “white’' mature 
cataracts, they are grateful for the restoration of vision and 
happily tolerate the aphakic spectacle correction with their 
attendant magnification and distortion problems—found un¬ 
bearable by most patients in the U.S. 
While the "hub-and-spoke” system has been effective in 
channelling patients to the eye camps, much work remains; 
though the field clinic and cataract camp attract more than 
2.000 patients per session, less than 25 percent of those in the 
area needing cataract operations receive them. Moreover, the 
modern era of cataract surgery in the villages surrounding 
Mangalore awaits the availability of low-cost lOL’s and cheaper 
portable microscopes. For now. the overriding hope of Dr. 
Kamath and his colleagues, which we share, is the attainment of 
a “cataract-free" zone in Mangalore and its environs. 
What makes this hope seem achievable is the extreme cost- 
effectiveness of the cataract camp system. The total cost per 
patient, including surgical and post-operative care, amounts to 
less than $20 (U.S.). less than 1 percent of the cost in the United 
States. The.se expenses are covered by financial support from 
local and outside philanthropic agencies. 
Non-governmental organizations (NGOs) such as Sight 
Savers (U.K.) and Operation Eye Sight Universal (Canada) 
have been extremely important supporters of our cataract camp. 
Other NGOs that are active in blindness prevention programs 
both in India and throughout the world are Helen Keller Inter¬ 
national and the International Eye Foundation (U.S.A.). Fore¬ 
sight (Australia). Chiistoffel BUudenmission (Germany), and 
Organization pour la prevention de la cecite (France). 
To the credit of U.S. ophthalmologists and ophthalmolo¬ 
gists in advanced nations, many are volunteering their services 
in developing nations at their own expense. The American 
Academy of Ophthalmology, under the able guidance of Presi¬ 
dent George E. Garcia. M.D.. and Executive Secretary Bruce 
Spivey. M.D.. have started a section on international ophthal¬ 
mology. emphasizing the commitment of organized American 
ophthalmology to problems in developing nations. 
Does this burgeoning international awareness and the suc¬ 
cess of India's cataract camps offer a realistic hope of eliminat¬ 
ing preventable blindness altogether? In countries such as 
China and India, which have a reasonable number of skilled 
personnel, the answer is yes. 
In sub-Saharan Africa, however, where the health care 
challenges can best be described as staggering, prospects are 
not as bright. In sub-Saharan Africa, despite an annual inci¬ 
dence of 5()0.()()0 newly blind people, only 5().()00 cataract 
operations are performed each year, leaving an estimated “cata¬ 
ract backlog” of 3 million. Whereas the challenge in China and 
India is how to distribute manpower, in sub-Saharan Africa the 
crisis is the lack of manpower. What is more, the rapid spread 
of HIV infection, along with ocular complications of AIDS, 
introduces a menacing new factor in providing ophthalmic care 
in these nations. 
To end on a hopeful note, perhaps part of the worldwide 
peace dividend promised by the end of the Cold War will be 
directed toward improving health care in the developing world. 
In the meantime, developing countries will continue to rely on 
the critical contribution of skilled Western volunteers. There 
is much to recommend the volunteer experience. Our feelings 
upon seeing the quiet, tearful smile that comes to a patient's 
face when the eye patch w'as removed for a post-operative 
check were a mixture of exhilaration, our ow n tearfulness and 
gratitude to God. The “goose bumps” still appear when we 
think about it. YM 
Geographic Location 
Can Contribute to Blindness 
In contrast to the United States, where cataracts, glau¬ 
coma. diabetic retinopathy and age-related maculopathy 
are chiefly responsible for legal blindness, in the develop¬ 
ing world, the major causes of blindness are cataracts and 
ocular diseases peculiar to geography. These diseases 
include; onchocerciasis (river blindness), trachoma and 
xerophthalmia, with the latter two conditions attributable 
to poor hygiene and poverty. Onchocerciasis, which oc¬ 
curs mostly in West Africa and in small pockets of Cen¬ 
tral and .South America, is treated by oral ivermectin. 
Vector control is achieved by spraying the breeding sites 
of the Simulium black fly with larvicide. Along with 
treating trachoma wdth tetracycline ointment, commu¬ 
nity-based health education programs emphasize simple 
hygiene to prevent intrafamily transmission. 
Xerophthalmia and keratomalacia are caused by vitamin 
A deficiency, a major cause of measles-associated blind¬ 
ness of Africa, t reatment consists of oral vitamin A 
capsules, 2()(),()()() ILL for two consecutive days, along 
w'ith maintenance supplements. Recent studies have also 
shown that vitamin A supplements increase childhood 
sLiiA'ival significantly. 
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INTERNATIONAL HEALTH: 
A SLEEPING GIANT ROUSES 
Robert Liu. M.P.H. '92. a 1991 Downs Iiitenuitional Travel Fellow, assists a couuuiuiity health worker in Patau. Nepal. 
by Gregouy R. Huth, M.P.H. '84 
Outside, the plate glass windows of the University Art Gallery 
lecture hall impassively defied the cold October rain. Inside, 
wami and dry. sevei'al score graduates who had returned for the 
Association of Yale Alumni's 39th Assembly listened in rapt 
attention as Gaddis Smith. Ph.D.. led a faculty panel discussing 
Yale's future as an international university. 
As Dr. Smith, director of Yale's Center for International and 
Area Studies, invited questions from the audience, a venerable, 
tweed-jacketed alumnus rose and asked whether Yale could be 
considered an international university even today. 
'if you're asking if we should be." said Dr. Smith, "my reply 
is a definite yes. If you're asking ’are we.' the answer is a 
qualified yes." 
Gregory R. Huth is publications editor at the Yale University 
School of Medicine Office of Public Infonuatiou. 
Although his response rings true for the Yale School of 
Medicine (YSM) as well, growing efforts at the school promise 
to help launch the University into international leadership. 
Ever since 1834. when medical missionary Peter Parker 
graduated with his M.D. and M.Div. degrees and trekked to 
Canton to establish the first Western hospital in China [see 
"Gallery." page 27]. generations of YSM faculty and graduates 
have produced leaders in international health. Some of these 
efforts have been the result of University-affiliated programs, 
such as the Yale-China Association's founding of Chang-Sha 
Hospital in 19Us by Yale College alumnus Edward Hume. M.D.. 
and Fu-Chen Yen. M.D. '04. 
Historically, other Yale contributions in international health 
have resulted from federal government initiatives, such as YSM's 
involvement with the Atomic Bomb Casualty Commission, which 
began ongoing epidemiological studies in Japan at the end of 
World War II. Individual efforts too have played a role. For 
example, since his retirement in 1989. Nicholas M. Greene. 
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M.D.. professor emeritus of anesthesiology, has been making 
regular trips to East Africa to train physicians in his specialty. 
This academic year should prove a hallmark, however, for 
the international efforts of Yale and its medical school as they 
cr)ordinate their hurgettning—though heretofore disparate—edu¬ 
cational anri research resources in this field. 
On the education front. 1991-1992 is witnessing the third 
side of what Gaddis .Smith calls, the "Yale Triangle" falling into 
place. Sides one and two. he e.xplains. were created in 1990 with 
two joint graduate degree progratiis. The first was in epidetiiiol- 
ogy and public health (EPH) and international relations; the 
second, internatiotial relations anil forestry/environmental stud¬ 
ies. This academic year should complete the triangle with ex¬ 
pected faculty apprmal of a joint program in forestry/environ¬ 
mental studies and EPH. Thus, the Lhiiversity will have laid the 
groundwork for interdisci|ilinary cooperation in the areas of 
health, econotnic development and the ecology. 
Building on this foundation, the international relations cen¬ 
ter. forestry/environmental studies and EPH have received fund¬ 
ing from Yale's new Bass Center for Biospheric Studies to fomi 
a Center for Human Ecology. Environmental Change and Infec¬ 
tious Diseases. This cooperative venture will focus on Brazil, 
especially the destruction of its rain forest. 
Refen ing to the three crucial, related areas of development, 
ecology and human health. Dr. Smith observes. "Through 40 
years of the Cold War. policy makers were so obsessed with the 
military balance that they ignored other aspects of the interna¬ 
tional political equation. Erom now on. universities have to train 
people w ho know what the real problems are." 
Erom all indications. Yale and its School of Medicine are 
rapidly mew ing to assume their share of that responsibility. 
I he Big Picture 
In recent years. YS.M's strength in international health has been 
growing in all three aspects of its mission: research, education 
and patient care. Research has been particularly strong, with 
much of It undertaken at the EPH Laboratory (LEPH). 
Department Chairman Burton H. Singer. Ph.D.. the Ira 
Vaughan Hiscock Professor of Public Health and Statistics, has 
brought to bear his own extensive research experience abroad— 
particularly in South America—as he shapes and expands the 
department's international role. As chair of the Steering Com¬ 
mittee on Social and Economic Research for the World Health 
Organi/ation (WHO) Tropical Disease Research Program. Dr. 
Singer advocates an interdisciplinary approach. He has led EPH 
111 developing joint degree programs and in forming Yale's new 
Center for Human Ecology. Environmental Change and Infec¬ 
tious Diseases. 
Dr. Singer sa\s. "Countries can still do well economically 
without destroying the ecology." He adds that it's acadetnia's 
job "to de\ clop a rigorous scientific basis for land-use and health 
policies in iiartnership with developing countries." 
Dr. Singer is continuing a three decade-old tradition of 
leadership in international health at EPH which began in 1964. 
when Wilbur Downs. M.D.. and his research team movetl to the 
department Irom the Rockefeller Eoundation. fhey came to 
found the ^’ale .\rbo\irus Research Unit (\'.‘\Rl ). The 
Rockeleller Eoundation, along with the National Institutes of 
Curtis Patton. Ph.D. 
Health and other donors, funded construction of the nine-story 
EPH Laboratory, which included space for YARLf Eor years, 
the Rockefeller Foundation also contributed program funds to 
YARU. which serves as the World Health Organization (WHO) 
Reference Centre for Arboviruses. 
Directed since 1971 by Robert E. Shope. M.D.. professor of 
epidemiology. YARU comprises 10 faculty members and other 
researchers who study diseases such as leishmaniasis, dengue 
and encephalitis, which are transmitted by biting insects and 
ticks. Such diseases affect millions of people and their domestic 
animals throughout the world. 
Scientists from many countries come to study at "I'ARU. 
furthering their graduate and post-graduate education. Cur¬ 
rent students come from lands as diverse as Egypt and Australia. 
Japan and Peru. Thailatid and Brazil. Much of the basic research 
the scientists learn to perform relates to the inteiplay of ecology, 
economic development and human health. 
Take, for instance, the groundbreaking work of Rebeca 
Rico-Hesse. Ph.D.. assistant professor of epidemiology. In De¬ 
cember 1990. a colleague from Venezuela pre.sented her with a 
\ irus that neither had encountered before. Dr. Rico-Hesse and 
other '^'ARL> researchers confirmed that the virus had never been 
reported in humans. 
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Lowell Levin. Etl.D. 
Scientists determined that the infectious agent was an 
arenavirus, and named it Giianarito, after the town near which it 
was discovered. The disease the virus caused was named Ven¬ 
ezuelan hemorrhagic fever, because it is related to Argentine and 
Bolivian hemorrhagic fevers. 
How does the appearance of Guanarito virus in hu¬ 
mans relate to the ecology? Dr. Rico-Hesse notes that 
the disease has arisen in “an area where settlers have been 
clearing the rain forest for the sake of raising corn and other cash 
crops.” 
Dr. Rico-Hesse’s studies have led her to conclude that clear¬ 
ing the forest displaced hoards of rats, which moved into the 
human dwellings that were built on the new cane plantations. 
Rats cany the virus and shed it in their urine. Sometimes the 
rodents come in contact with food stored on open bins; simply 
sweeping a floor tainted by dried rat urine can aerosolize the 
virus and expose humans to it. 
Dr. Rico-Hesse and her YARD colleagues have recently 
received grants from the National Institutes of Health and the Pan 
American Health Organization to identify the species of rodent 
that carries the Guanai ito virus. The scientists want to detennine 
ways to control the rats or at least to limit human contact with 
them. 
Another YARD researcher. Robert B. Tesh. M.D., professor 
of epidemiology, explains how cutting down the rain forest in 
tropical areas of South Amei ica has brought about malaria epi¬ 
demics. "Anopheles dorlinpi. the species of mosquito that carries 
Lalciparnin malaria, requires open pools of water in which to 
breed. Clearing the rain forest and its dense canopy increases the 
luimber of unshaded pocds. This offers new breeding areas for 
the insects," says Dr. Tesh. even as the number of non-immune 
human targets in the area increases dramatically with new settle¬ 
ments. 
For years. Dr. Tesh has been conducting reseairh on another 
tiny insect that wreaks major havoc in tropical and subtropical 
areas—the sand fly. Sand flies spread viral diseases, such as 
sand fly fever and parasitic diseases, such as leishmaniasis. The 
latter disease appears in several forms. In cutaneous and muco¬ 
cutaneous leishmaniasis, the di.sease can cause severely disfigur¬ 
ing lesions on the nose, mouth and in other mucous membranes. 
Visceral fonns can cause severe anemia and other symptoms 
which can be fatal. 
Dr. TeslTs research into sand fly-borne diseases has taken 
him to Venezuela. Brazil, other nations in South America and the 
Middle East. A leishmaniasis sttidy that he has undertaken in 
Colombia since 1984 has revealed a new organism, Leishniunia 
colonihiensis, which causes a kind of cutaneous leishmaniasis in 
northern South America. His current work also is focused on 
how to control the sand fly vector. 
A Neglected Branch of Medicine 
As a carrier of parasitic as well as viral diseases, sand flies also 
command the attention of a second major YSM basic research 
group, the MacArthur Center for Molecular Parasitology, di¬ 
rected by Frank F. Richards. M.D., professor of medicine. Pail 
of the depailment of internal medicine, the center includes 44 
faculty and other researchers who have appointments in various 
departments, ranging from medicine to EPH, chemistry, pediat¬ 
rics, and molecular biophysics and biochemistry. 
Dr. Richards explains that the center's name comes from the 
John T. and Catherine D. MacAilhur Foundation, which pro¬ 
vided start-up funds eight years ago. While the foundation offers 
continuing financial support under a 10-year agreement, today, 
major funding comes from the National Institutes of Health, for 
which the center serves as one of two Tropical Disease Research 
Units in the United States. The MacArthur Center is one of the 
largest of a woi ldwide consortium of 10 research centers on the 
biology of parasitic di.seases. 
Dr. Richards observes that while most tropical diseases 
occur in less-developed countries, most medical research is con¬ 
ducted on the diseases of the First World. Dr. Richards sees 
hope, however, in research centers such as the MacArthur. which 
are applying new techniques to solve biological mysteries at the 
cellular and molecular levels. 
Having thrown down the high-technology gauntlet, center 
scientists must employ every bit of their knowledge and insight 
to overcome the subtleties of parasitic organisms. Among their 
most challenging foes are trypanosomes, which are cariied by the 
tsetse (which means "fly” in Swahili). These microorganisms, 
which cause sleeping sickness in man and widespread disease in 
cattle and other animals, have adapted against host immune 
responses in an insidious way. 
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Molecular Parasitology Searches 
For ‘'Silver Bullet'' in RNA Evolution 
Researchers applying molecular technology to study such 
single-celled parasites as Leishmania and tr\ panosomes 
have produced dramatic results which give scientists hope 
for discovering new. safer methods of treating parasitic 
diseases. A key discovery has been the wa}’ host organisms 
have evolved in their use of RNA for protein manufacture, 
as opposed to parasites, which are lesser evolved. 
Explains Dr. Frank F. Richards, director of the 
■MacArthur Center for Molecular Parasitology. "Organisms 
that live inside larger organisms are often spared the evolu¬ 
tionary pressures to which most living things are exposed. 
There is no drought, cold or excess heat inside the body. 
Parasites have, as a consequence, sometimes held onto 
ancient biological mechanisms since they have not felt the 
competition to replace them by newer, more efficient mecha¬ 
nisms." 
These archaic mechanisms may offer scientists the 
".Achilles heel" they look for that would allow medications 
to destroy the invading organisms without harming their 
hosts. By way of illustration, in the cells of parasites and 
higher species alike, the formation of proteins—a critical 
process on which all life is based—takes place in three 
stages: 
1) First. DNA is transcribed, or copied, into RNA. 
2) Next, certain amino acids move along the RNA 
strand, creating messenger RNA (mRNA). In a 
process called splicing, the amino acids create an 
information template, selecting and assembling the 
genes that the cell will need to make the needed 
protein. 
.M Finally, the mRNA template produces the coding 
information that allows the cell's ribosomes, en¬ 
zymes and other "biosynthetic machinery" to manu¬ 
facture the required protein. 
Dr. Richards explains that trypanosomes assemble mes¬ 
senger RNA in a different way. using cell machinery that is 
not present in the host. Some of these organisms make 
mRNA by stitching together more than one piece ot RNA. a 
process called trans-splicing; others employ "RNA edit¬ 
ing." using one piece of RNA to transmit more than one 
message. 
"'rhese differences can be exploited." Dr. Richards 
says, "by using drugs which affect the parasite cell mecha¬ 
nism. but lea\e the host unharmed." 
Both biologists and disease experts, including some at 
Yale. ha\'c joined in the pursuit of such a therapeutic "silver 
bullet." Dr. Riehards hopes that "it w ill not be long before 
the results begin to improve health in the developing coun¬ 
tries of the world. " 
The immune systems of mammals are able to kill off almost 
all—perhaps more than 99 percent—of the invading typanosomes 
by making antibodies to the glycoproteins that serve as an over¬ 
coat to each microorganism. UnfoUunately for the host animal, 
the remaining I percent of trypanosomes sure ive by shedding 
their protective coating, revealing a new. slightly altered protein 
overcoat. The antibodies custom-made to the old overcoat can¬ 
not attack the new one. and while the immune system busies 
itself manufacturing new antibodies that can destroy the new 
coat, a window of opponunity opens, providing time for the 
microorganisms to reproduce. 
However, when the immune system finally does produce a 
set ot antibodies to destroy microt)rganisms with the new over¬ 
coat. 1 percent of this generation of typanosomes survives, and 
the destructive cycle continues. Typanosomes can produce up to 
1.000 generations of progeny with altered overcoats, more than 
enough to exhaust the immune system. Without medication, 
immune exhaustion leads to the death of the host animal. 
Alan C. Sartorelli. Ph.D.. director of the Yale Comprehen¬ 
sive Cancer Center, and Curtis F. Patton. M.D., professor of 
epidemiology (microbiology), are two Yale researchers who are 
leading teams to develop new drugs against trypanosomes. 
Explains Dr. Sailorelli. "Trypanosomiasis represents a seri¬ 
ous threat to the health of man and domestic animals. We have 
developed a new class of methylating agents that can cure labora¬ 
tory mice bearing African trypanosomes. The drug that we have 
selected for funher development, called TSM. is orally active, 
has a high therapeutic index and is inexpensive to produce. In 
addition, it has a unique mechanism of action causing differentia¬ 
tion of the parasite to a fomi which cannot survive in the blood¬ 
stream." 
Drs. Patton and Sartorelli hope to evaluate the 
antitrypanosomal efficacy of TS.M in African livestock 
to determine its potential in agricultural use. 
EPH's tradition of foreign sendee goes beyond basic medi¬ 
cal and epidemiological research. Since the mid-l94()s, for 
example. EPll lecturer Eric W. Mood. M.P.H. "43. has travelled 
the globe on behalf of WHO. offering his expeilise on environ¬ 
mental health projects. And since November 1989. the Yale- 
WHO Collaborating Centre for Health Promotion Policy and 
Research has been providing educational and public health con¬ 
sultations. 
Directed by Fowell S. Fevin. Ed.D., M.P.H.. professor of 
public health, this WHO centre has played a role in supporting 
the newly emerging nations of Eastern Europe. As Dr. Fevin 
explains. "WHO asked us to gather data on leading health educa¬ 
tion programs in the Ldiited States for the Czech and Slovak 
Republic. Hungary. Albania and other countries who were devel¬ 
oping new health promotion curricula for their schools." 
Dr. Fevin and centre associates contacted health educators 
throughout the L'nited States and asked them to recommend w hat 
they thought were America's best programs in the field. He then 
refined the resulting list and provided descriptive summaries to 
WIK) so that the nations requesting assistance could apply the 
information in ways that would best suit their own cultures. 
WHO also has assigned shorter-tenn projects to the centre. 
For instance, w ithin 24 hours of an urgent telephone call from the 
French Ministrv of Health, the centre was able to furnish exten¬ 
sive data about the impact of .American anti-smoking regula- 
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tions. This information helped tlie French government in their 
deliberations on anti-smoking legislation. 
Hands-on Experience 
One cannot discuss the medical school's involvement with inter¬ 
national health in any depth without returning to the legacy left 
by Wilbur Downs. In addition to his role in establishing the 
Arbovirus Research Unit—in the very construction of LEPH— 
Dr. Downs' influence continues in the International Health Stu¬ 
dent Travel Fellowship program named in his honor in I9S4. 
Dr. Downs began the Comtnittee on International Health in 
1966 with a small grant from the Rockefeller Foundation. He 
served on the committee for the rest of his life, raising funds and 
building an endowment. More than 233 medical and EPH 
students have benefited from the travel fellowships, 21 in 1991 
alone. Since the late 197()s (except for a brief sabbatical) the 
committee has been chaired by Dr. Downs' colleague, Curtis 
Student Involvement Grows 
In International Health 
Many international specialists note the similar health challenges 
facing the people of developing nations and underserved people 
in the United States—especially low-income minorities—the so- 
called Third World within our borders. This linkage also is 
rellected in the makeup of the Task Force on International Health, 
a new medical student organization at Yale. 
The task force is an outgrowth of YSM's Student National 
Medical Association (SNMA) chapter, an organization of minor¬ 
ity students. Cunently, the task force is comprised of its chair, 
Dina Strachan, an African-American; Sylvia Garcia, a Hispanic- 
American; and Rajen Naidoo, a black South African of Indian 
descent. All three second-year medical students were 1991 
Wilbur Downs fellows. 
Patton. 
As Dr. Patton explains. "Downs fellowships pay for trans¬ 
portation to and from health-related projects, most of them in 
developing countries, where students assist the permanent stalf 
and gather data for research." Room and board are usually 
arranged by a Yale or overseas sponsor, in addition to a modest 
stipend provided by the committee. 
Prospective fellows submit proposals for overseas research 
projects in late winter to the committee. The committee's 24 
faculty members evaluate the proposals and award fellowships 
oti merit, based on the amount of funds available for the year. In 
the autumn following their overseas experience, students present 
their research in poster sessions: in addition to poster displays, 
five fellows, whose research represents a cross section of studies 
undertaken din ing the year, make oral presentations. 
(ContiniieJfrom po<^e II) 
{Conrinucil on IS) 
Ms. Strachan proudly reports that during its first year, the 
task force has organized a series of four lectures which have been 
well attended by both students and faculty. Speakers have 
included experts in international health, tropical medicine and 
primary care, including H. Jack Geiger, M.D.. a professor at City 
University of New York Medical School, who is renowned for 
having set up more than 500 community-based health clinics 
worldwide. 
“Our goal for 1992 is to raise $10,000 so that two or three 
medical students from developing countries can visit the School 
of Medicine as part of a clinical exchange program," reports Ms. 
Strachan. 
In recent years, several foreign student exchanges have been 
arranged through the YSM chapter of Physicians for Social 
Responsibility. This group has sponsored such exchanges be¬ 
tween Yale and medical schools in the Czech and Slovak Repub¬ 
lic and other Eastern European lands. 
Dina Strachan. M.D. '93. ex¬ 
plains her Doxns Overseas 
Travel Fellowship research to 
Dr. Robert Shope at the 1991 
poster session in the Jane Ellen 
Hope Biiiltling. 
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Drs. Marie-Loiiise and Kenneth 
Johnson and friends in front of 
the Peace Cathedral in 
Hiroshima, Japan, following a 
memorial service they attended 
there in 1966. 
Maiie-Loiiise and Kenneth Johnson: 
30 Years in International Health 
Marie-Louise T. Johnson. M.D.Yi.'S. Ph.D.'54. vice president of 
the Association of Yale Alumni in Medicine, and her husband. 
Kenneth. M.IJ.. HS are among the YSM alumni/ae who 
have been leaders in the field of international health. 
fhey begtin their overseas activities in 1962 as associate 
professors at the School of Medicine. At that time, the husband- 
and-wifc team travelled to the Bahamas island of Eleuthera, 
where they helped to establish an ambulatory care facility. In 
196.^ they implemented a serologic suiwey of the island's 3,()()() 
inhabitants for the WHO Reference Serum Bank, then directed 
by noted Yale faculty member, the late John R. Paul. M.D. 
In 1964. the Johnsons left New Haven to become the founh 
generation of Yale faculty members to work in the department of 
medicine at the Atomic Bomb Casualty Commission (ABCC) in 
Hiroshima and Nagasaki, Japan. As ABCC chief of medicine, 
Kenneth completed several epidemiologic studies on the late 
effects of radiation in atomic bomb survivors, Marie-Louise, as 
the first dermatologist assigned to the ABCC, completed the first 
clinical study on the prevalence of skin conditions in the study 
population. 
In 1968. Kenneth, as director of epidemiologic research at 
Cornell University, worked with the Jamaica. West Indies, min¬ 
ister of health to establish a primary health care system in cetitral 
Jamaica. The program eliminated the Kwashiorkor/Marasmus 
and neonatiil tetanus which were endemic among the 17,0()() 
rural residents. 
•Marie-Louise. then director of dermatology at Belle\ ue Hos¬ 
pital in New \'ork, helpeil train Jamaica’s first group of commu¬ 
nity health aides. The Johnsons' continuing interest in interna¬ 
tional medicine has taken them as consultants to Guam, Micronesia 
and Ecuador. 
Since leaving Japan in 1967. the Johnsons have often returned 
to ABCC, now the Radiation Effects Research Eoundation. In 
1990. Marie-Louise made her 25th trip to Japan to consult on a 
repeat study of skin cancer in atomic bomb survivors. 
Today, Marie-Louise Johnson is a clinical professor at the 
School of Medicine and director of medical education at 
Benedictine Hospital in King.ston, N.Y. Kenneth is adjunct 
professor of community medicine at Mount Sinai Medical Cen¬ 
ter in New York City and senior program consultant with the 
Robert Wood Johnson Foundation in Princeton, N.J. 
Drs. .Marie-Louise and Kenneth Johnson 
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Those who delivered oral presentations at the November 
1991 poster session include: 
Heather Christian, M.D.’94, Jamaica, three months, sickle¬ 
cell anemia (thalassemia). “The aim of my study was to 
examine patients for hematological and clinical indices in 
sickle cell-beta thalas.semia syndromes," Ms. Christian re¬ 
ports. She searched for subpopulations that may represent 
different molecular bases. 
Aniiika M. Brown, M.D. '94, Zimbabwe, three months. She 
gathered infomiation about the attitudes and knowledge on 
tobacco use in preadolescent children. 
Syhia Garcia, M.D. '94, Venezuela. 10 weeks. Ms. Garcia 
collected epidemiologic data about the newly discovered strain 
of hemonhagic fever virus being studied by YARU. 
Christopher ./. Gilligan, M.D. '94, Brazil. 10 weeks. This 
second-year student studied vacuole membrane disruption in 
host cells infected with Trypanosonia caitzi, transmitted by 
“kissing bugs” which are displaced from the rain forest by 
human settlements. 
Mickey R. and Jay Riggs, both M.D. '92, Southern Africa, 10 
weeks. This husband-and-wife team conducted a field evalu¬ 
ation of water quality around Malamulo Hospital, Malawi. 
Although other 1991 Downs fellows travelled as far afield 
as New Guinea, Thailand and India, one student, George R. 
Bruno, M.D. '94, stayed virtually in Yale's own backyard. Mr. 
Bruno travelled to St. Kitts in the Virgin Islands to survey the 
incidence of filovirus infection in a colony of African green 
monkeys, which are bred there for biomedical research. 
Dr. Patton acknowledges that most Downs fellows will not 
pursue careers in international health. He reminds us, however, 
that recruiting physicians to overseas service is not the primary 
purpose of the program. 
“Downs fellows learn self-reliance, independent thinking 
and often must assume great responsibility under extremely chal¬ 
lenging conditions,” Dr. Patton says. 
Thus, the program provides a vital complement to the Yale 
System of medical education. 
A similar educational philosophy underlies the International 
Health Program (IMP) in the department of internal medicine, co¬ 
directed by Drs. Michele Barry, associate professor of medicine, 
and Frank J. Bia, associate professor of medicine (infectious 
diseases) and laboratory medicine. Over the past decade, these 
two faculty members have been e,stablishing sites throughout the 
Third World and in domestic disadvantaged communities for 
elective rotations for second- or third-year house officers. Wilbur 
Downs fellows also conduct research at these sites. 
More than 120 residents and faculty have taken part in the 
program, which offers training sites in Haiti in the West Indies; 
Tanzania and Zimbabwe in Africa; the Fiji School of Medicine in 
the South Pacific; and at Zuni and Navajo reservations in the 
southwestern United States. 
Drs. Barry and Bia echo their colleague. Dr. Patton, in 
pointing out that most residents who do an overseas rotation do 
not pursue a careei' in international health. Dr. Barry adds, 
however, “The program does r)ffer house officers some imiior- 
tant new perspectives.” 
Both doctors say that IHP house officers, like Downs fel¬ 
lows, learn: 
• Cost containment in an atmosphere of minimal resources; 
• The importance of preventive medicine; 
• Humanistic approaches to healing in lieu of high-cost, high- 
technology treatments; 
• Community-based health care; 
• Peifonning physical examinations without the aid of high- 
technology diagnostic tools. In the words of one recent IHP 
resident, “It's amazing how much you can learn about a 
patient Just using a stethoscope.” 
Continiieil on page 14 
At the 1991 Downs International Travel 
Fellowship poster session. Sylvia Garcia, 
M.D. '94, reports on her epidemiological 
research into newly discovered Venezuelan 
hemorrhagic fever. 
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Foreign Students Bring their Unique 
Perspective to Medical School, EPH 
Students from outside the United States add to the rich mosaic of 
the medical school and its department of epidemiology and 
public health. While most of the 16 foreign students at the 
medical school and 37 foreign students at EPH come from 
industrialized nations 
as diverse as Canada, 
Turkey. Korea and 
Taiwan, an increas¬ 
ing number come 
from the developing 
world, including 
China. Iran and vari¬ 
ous countries in Af¬ 
rica. 
While some for¬ 
eign Students will 
succumb to the lure 
of affluence and 
high-technology 
medicine and stay in 
the flnited States 
upon graduation, two 
students. Rajen 
Naidoo, M.D. '94. 
and his brother. Pat. i^ai'en Naidoo 
Dr.P.Il. '94. are ea¬ 
ger to return and work in their home country. They are black 
South Africans with Indian heritage and members of the recently 
legalized African National Congress (ANC); Pat serves on the 
ANC's health secretariat. 
Last year the brothers returned to South Africa after 10 years 
of exile. In summer 1991. as a Wilbur Downs fellow. Rajen 
Naidoo had a glimpse of the challenge that awaits him and his 
brothel' upon graduation. His fellowship took him near his 
hometown of Durban. At the ANC's request, he undertook an 
epidemiological evaluation of a primary care clinic in a squatter's 
community. 
"Although by and ku'ge the clinic functioned effectively.” com¬ 
ments Mr. Naidoo, "most of the problems 1 .saw couldn't te solved 
metlically." He cites, for extunple. inadequate housing lutd sanita¬ 
tion. luid a pit latrine system that polluted the water supply. 
Rajen Naidoo sees such conditions as "based in the apart¬ 
heid system." and foresees no easy or inexpensive solutions to 
relieving them even as apartheid is phased out in coming years. 
Pat Naidoo agrees: "Health care providers in South Africa 
face the initial task of overcoming the systemic inadequacies ot 
apartheid," he says. Emphasizing the need lor international 
cooperation, he adtis, "Developing a non-racial. democratic and 
equal health care system for South Africa is a challenging task 
that will require the collective experience of health care systems 
throughout the world. " 
foward that end. the brothers are working with EPH Chair¬ 
man Burton Singer to cotrrdinate a seniinar in developing poli¬ 
cies for AIDS and for health care in general for South .Al'rica. 
Continued from page 13 
Just as importantly. Dr. Bia adds. IHP rotations teach “a 
healthy respect for cultural diversity and the value systems of 
other cultures." Such awareness is key for physicians who work in 
urban, teiliary-care hospitals such as Yale-New Haven, where pa¬ 
tients come from a variety of backgrounds. That is one of the 
reasons that YNHH continues paying residents their stipends 
even while they are away on an IHP rotation. 
Drs. Bairy and Bia also have brought cross-cultural learning 
oppoilLinities home for YNHH residents by developing several 
innovative patient care programs. They include the Southeast 
Asia Refugee Clinic and the Tropical Medicine and International 
Traveller's Clinic at the Primary Care Center. 
Eurthermore. Dr. Barry received funding from the W.K. 
Kellogg Eoundation to train residents in working with the area’s 
homeless population. In this rotation, undertaken wdth the Hill 
Health Center, residents help staff a mobile van and work in area 
soup kitchens. 
As Dr. Ban'y reminds us, referring to New Haven's home¬ 
less and underserved people, "It is our moral imperative to care 
for the Third World that lives in our own backyard." 
Still other signs of life in the form of new' or planned 
programs, and even new construction, indicate that Yale's 
giant of international affairs is rousing indeed. This academic 
year. EPH plans to debut its international health track, devel¬ 
oped by a committee that Dr. Shope chairs. As he explains, 
"With this program, for the first time. M.P.H. and doctoral 
students will have a fomial cun'iculum—complete with field 
experience—to prepare them for an international career.” 
Meanwhile, at the medical school. Drs. Bia and Barry are 
hard at work raising the funds that would allow Yale to launch 
the nation's first physician certification program in tropical dis¬ 
eases and international health. This interdisciplinary program 
will be Jointly administered by the medical school. EPH and the 
Center for International and Area Studies. 
Yale University's contribution—and long-term commit¬ 
ment—to the global village will manifest itself in bricks and 
mortar as the $10-million Henry R. Luce Jr. Hall is dedicated in 
1994 as the pemianent home for the Center for International and 
Area Studies. The three-story. 30,000-square foot building, to be 
built between Hillhouse Avenue and Prospect Street, will bring 
under one roof all of the center's programs and provide space for 
expansion into the 21st century. 
What is the University's stake in the future of international 
studies? Comments President Benno C. Schmidt Jr.: 
The world continues to change, and those changes pose 
special challenges and unprecedented opportunities for 
American educational instituti^ms. particularly those—like 
Yale—which are ‘world universities....’ Yale is committed 
to jdaving a special role in forging and tnaintaining interna¬ 
tional educational and intellectual networks and is well- 
positioned to continue playing an essential role in helping to 
shape responses to the problems ami possibilities of the 
e)nerging world order." 
YM 
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1991 LERNER AWARD 
a cry for comfort 
by Lisa J. Nelson 
I am sure thal the "yiiuyua'' is nol good for one's health. Can you 
say stressful? Tension? Adventure in the most disastrous and 
diabolical sense of the word. I can’t decide which aspect of this 
transportation system from hell is the most amusing. Is it the 
unpredictable nature of the yuayiia, whereby it may arrive at any 
time within a wonderfully specific window of an hour and forty- 
five minutes followed by at least a 30-minute ride to the closest 
of sites. Or perhaps my daily 50-minute morning ride to the 
Medical Center from Isla Verde. That is. if there is no need to 
change guagiias. Out the back of one guagua and into the gaping 
mouth of another (when it arrives, if ever)... oh boy. a whopping 
two hours, same trip, ilos guaguus. And burning all the while in 
the pit of my stomach, pounding in my brain behind my eyes, is 
the knowledge that this could be a 20-minute trip in traffic at rush 
hour. But time is not my major worry. No. I could deal with a long 
trip, especially if it were at all regular. If I took the same giiagiia 
route on the return trip two days in a row. If there were such a 
thing as a "direct” or "best” route. If you could go back on any 
given voyage the same way that you came. But these are still not 
major worries. Major worries are really fears. Fear for my 
personal safety on random guagiia stops where a change may he 
necessary. Feai' that my uncertainty may show on my face 
followed by conversation with men Fd rather not talk to who 
make rude sucking noise with their tongues and their teeth that I 
hear are meant to be some .sort of vulgar kiss. Everywhere there 
is talk of attacks, assaults, whispered warnings from women 
while waiting. Open mouths that I travel alone. "jCuidado! 
Don't wear any jewelry...” and I don't. A bulky blue plastic watch 
is all. (A feeble attempt to find order or patterns in arrival times 
at the g;^t/g/w-stop.) "No gold. A woman, just last week, right 
around the corner...She was wearing a gold watch." Guagiia by 
night is to be avoided at all cost unless it is from one bright spot 
in front of the apartment building to another, like the Fine Arts 
Center, with no change of guagiia. I am almost constantly tense, 
anxious, frozen in an atypical expressionless and silent state, 
attempting to be invisible in my Anne Rice novel while keeping 
a careful eye on the surroundings and my proximity to my 
destination from a small space on the guagiia seat. The 25-cent 
recurring nightmare that does not dispel in immediate relief once 
a particular episode is over. The tension remains behind the eyes 
and within the stomach. YM 
Lisa ,/. Nidsoii with Aaron B. Lenier, M.D.. Pli.D.. 
professor emeritus and senior research scientist in 
dermatology. In 1981, Dr. Lerner established the 
creative writing award for medical students in memory 
of his late wife. Marguerite Rush Lerner. 
Lisa J. Nelson, YSM ’93: 
Muse among the Children 
During the summer of 1990, Lisa Nelson received a 
Wilbur G. Downs International Health Travel Fellow¬ 
ship to conduct research in Puerto Rico on the relation¬ 
ship between migration and psychiatric disorders in 
children. Her essay, "a cry for comfort,” illustrates the 
fears that can be evoked by being a young, single 
woman alone in foreign land. It is part of a collection of 
poetry and prose, written in Spanish and English, which 
Ms. Nelson composed in Puerto Rico. As an under¬ 
graduate at Yale College. Ms. Nelson majored in psy¬ 
chology and graduated magna cum laude with special 
distinction in her major. She has w-'orked in projects 
concerningchildren and theirmental health during both 
her undergraduate and medical studies. In May 1991, as 
an American Psychiatric Association mini-fellow, Ms. 
Nelson attended the APA annual meeting in New Or¬ 
leans. She is considering a career in child psychiatry. 
Lisa J. Nelson, a third-year medical student, shared the 1991 
Marguerite Rush Lerner Award for creative writing by a medical 
student for a collection (f poetry and prose written in Spanish and 
English. Her essay “a cry for comfort" is part of that collection. 
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A RENAISSANCE MAN 
IN THE DEVELOPING WORLD 
Really haw life yels on is a secret. You only know your memorx and it makes its own time. The real 
time leads yon alony and yon never know when it happens. The best that can he is come and gone. 
E.L. Doctorow. Welcome to Hard Times 
h\ Herbert S. Sacks, M.D., I IS '52-'55 
I'he mind ol Wilhiir George Downs (WGD), relentlessly search¬ 
ing. excited by new challenges and fresh discovery, is very 
much part of us who loved him. lived with him. worked with 
him. and learned from him. IIis professional identity as com¬ 
passionate physician-researcher was not limited to disease en¬ 
tities but had ramifications in his muted anger at political and 
socio-economic conditions which denied a person's indepen¬ 
dence and autonomy. He believed that such conditions bred 
dliteracy, poverty and disease. 
Wil was a complicated, versatile man with extraordinary 
talents, sensitivities and competencies. A brilliant scientist, 
his reputation as virologist, entomologist, malariologist. epi¬ 
demiologist. parasitologist, mammalogist and ornithologist 
brought him many rewards and outstanding professional hon¬ 
ors. He was an outdoorsman. expert competitive marksman 
with rifle and pistol, saltwater and freshwater fisherman with 
admirable trout fly tying skills. (Fora lyrical story of Wil's last 
fly-fishing expedition, see ''Fishing: .Stupendous Vulgarities. 
Delicate Subjects." by rin)mas McGuane. Esepdre. October 
1991. pp. 74-77.) 
.A superb bookbinder, he was also the consummate biblio¬ 
phile. reading in French. Spanish and Russian. WGD had an 
insatiable hunger for books scientific and for fiction with 
themes and plot locations pertinent to his own peripatetic life 
experience. And to lift his spirits and the spirits of those 
around him. he played great guitar. 
He was. most of all. a mentor for the young—available, 
patient and motivating, always communicating his passion for 
new learning. His elective courses and tutorials have inspired 
a sizable cohort of young people to pursue careers in interna¬ 
tional health and tiavpical medicine. Wil was retired at 60 in 
1972. but continued, without compensation, to teach, advise, 
atlminister projects and conduct research from his office and 
hiboratory at the Yale .Arbov irus Research Lhiit until he died 
on Fch. 17. 1991. 
I'he etiitors of ) \// Mioicist asked me to write about WiFs 
role in developing international health at Yale, emphasizing 
his .African experience. His leadership was not a spontaneous 
event liLit flovvcil from a confluence of early-life events, the 
powerful connection he had with his chemist father, his rela¬ 
tionships w ith mcilical school teachers/investigators at ('ornell 
Dr. \\ iihur Downs with a train porter in Africa in 1976. 
and accidental career-shaping events which occurred while 
liv ing overseas much of his life. 
Roots of a Legend 
Wil. the boy growing up in Saranac Lake. New >’ork. located 
snapping turtles by dangling his toes in the mud. Harrv 
Fowler, his high school friend, taught him fly-fishing and the 
mysteries of nature, lessons that would have a lifelong influ¬ 
ence. In high school. WGD was determined to become an 
entomologist. 
FAnhaps the reader may want to know Wil. the medical 
studetit at Corttell. the Rockefeller Foundation fellow, the 
Pacific Theater malarial control officer who was awarded the 
Bronze Star? How about Wil. the Rockefeller Foundation 
malarial control researcher in Mexico? Who will describe 
him in Trinidad founding the 4'rinidad Region Virus Labora¬ 
tory. isolating .Vs new viruses and training many of the impor¬ 
tant arbovirologists of that era? 
Why not explore his move to New Haven in I96.V relocat¬ 
ing the Rockefeller Foundation's Virus Laboratory to Yale? 











John Fuller's book. Fever (New York, Reader's Digest, 1974), 
depicts Wil as the team catalyst playing a crucial role with 
fellow scientists in isolating and characterizing the Lassa Fe¬ 
ver virus from Nigerian patients. The importance of the 
dynamics of Wil's family life over the years of remarkable 
scientific productivity would be an engaging saga in itself. 
My relationship with this Renaissance man began in 1965. 
As a senior psychiatric consultant to the Peace Corps since its 
inception, and then as policy advisor for the agency's North 
Africa, Near East and South Asia division. 1 was recruited by 
the Yale College five-year B.A. program to develop its selec¬ 
tion, orientation, evaluation and assessment components. Presi¬ 
dent Kingman Brewster proposed a radical idea for its time: to 
send Yale College students to contrasting cultures for a year to 
engage in a broad range of projects under the aegis of respon¬ 
sible researchers and administrators. 
The conflation of my experience brought me to medical 
school Dean Vernon Lippard to argue for an international 
health committee whose charge would be to pursue overseas 
research opportunities for medical students and to monitor 
international health projects independently contracted by medi¬ 
cal school faculty. It was an idea whose time had come; 
indeed, Wil had beaten me to it! With the support of Bob 
McCollum, then chairman of the department of epidemiology 
and public health (EPH), Wil had approached Dean Lippard 
two weeks earlier. And so a faculty committee was estab¬ 
lished, including George Silver, Albert Evans, Lowell Levin, 
Byron Waksman, Dorothy Horstmann and myself. 
The early years of the Committee on International Health 
were full of dedication and frustration as we sought funds 
under Wil’s optimistic chairmanship. The Rockefeller Eoun- 
dation came through with $5,000, and later, Wil’s private 
campaign began to generate contributions with medical school 
matching funds. He ran the committee meetings, encouraging 
debate in a climate of comity with a readiness to entertain 
ideas presented by accomplished, strong-willed proponents 
even when his philosophic reservations were substantive. 
In 1971, I was approached by a former Peace Corps admin¬ 
istrator who had become director of the West and Central 
Africa desk of the U.S. Agency for International Development 
(USAID) of the Department of State. The John E. Kennedy 
Medical Center in Monrovia, built and sponsored by USAID, 
needed a long-term training, service and research relationship 
with a respected American medical school. Dean Eritz Redlich 
declined the opportunity, concerned that students' intense anti- 
Vietnam war sentiments—combined with suspect USAID ac¬ 
tivities in Vietnam and with Latin American dictatorships— 
might disrupt the medical school's educational mission. The 
medical school had been narrowly spared in the May Day 
1970 campus turmoil following upon our incursion into Cam¬ 
bodia and Laos. 
Despite this disappointment, Wil’s encouragement sent me 
across town to attempt to weave together an international 
proposal incorporating health, law, economics and African 
studies. The provost aborted this early endeavor, citing Presi¬ 
dent Brewster’s reluctance to give his imprimatur to Yale- 
identified overseas projects. As a result, our later projects 
were not Yale-sponsored, only Yale-based: The principal 
Herbert S. Sacks, M.D.— 
International Psychiatrist 
Dr. Herbert S. Sacks, clinical professor in the Child 
Study Center and psychiatry, practices child, adolescent 
and adult psychiatry in Westport, Conn. He began his 
involvement in international health in 1961, as a senior 
consultant to the Vermont-based student-exchange pro¬ 
gram, Experiment in International Living, and to the 
Peace Corps. 
“My long consulting experience in the pediatrics out¬ 
patient department was invaluable in Africa." Dr. Sacks 
says, referring to an United States Aid to International 
Development assignment in 1974 to research the drought 
in the Sahel. Working with USAID and host govern¬ 
ment officials. Dr. Sacks sorted through the maze of 
international and non-governmental organization projects 
in his operational sector. He sub-contracted with the 
psychiatry departments of medical schools in Dakar and 
Abidjan for studies regarding forced internal migration 
due to governmental planning. He also arranged studies 
of the consequences of drought-compelled population 
movements. 
Dr. Sacks adds, “I was a member of the research 
team, deeply involved in and fascinated by the complex 
group dynamics associated with work-driven profes¬ 
sional colleagues and friends. We were given little relief 
from one another in an unforgiving culture, separated 
from family and for the most part possessing limited 
language facility. 
“As a psychiatrist designing research and recasting 
health policy, in a brief moment I could affect the lives 
of more people in desperate straits than I could in a 
therapeutic lifetime in my office." 
Dr. Sacks is a trustee of the American Psychiatric 
Association and serves on its Council for International 
Affairs. 
Dr. Herbert S. Sacks 











investigator was WGD; I was co-investigator. Nonetheless, 
overseas, we were known as the "Yale Group." 
During this era. an increasing number of medical and EPH 
students were sent abroad on summer travel fellowships. (In 
fact, more than 2.‘i() fellows have been sent 
overseas during the past 27 years.) Mentors 
with special expertise reviewed and critiqued 
student proposals. The selection process was 
refined, and a brief orientation program was 
created to address potential health and emo¬ 
tional problems. Reports and papers were sub¬ 
mitted upon the fellows' return; in the late fall, 
formal presentations and poster sessions were 
given by the fellows based upon their modest 
research in the developing world. Wil assigned 
the involved staff work to the tactful and de¬ 
voted Yale Arbovirus Research Unit adminis¬ 
trative assistant. Betty Young. 
Crisis in the Sahel 
In 1974. my USAID friend called with some 
urgency, asking that I constitute a health team 
to v isit the Sahel, the sub-Saharan nations be¬ 
sieged by the effects of the cyclical drought 
emergency. The agency sutfered from a limited 
health presence and questioned the reliability of 
massive requests from the stricken sub-Saharan 
nations for medicaments and equipment. 
Our team's charge was to provide USAID field representa¬ 
tives in Senegal. Niger. Upper Volta and USAlDAVashington 
with back-up expert assistance. We were to assess general 
health and nutrition proposals under the Sahel Recovery and 
Rehabilitation Program and to recommend what measures 
were needed to assure effective delivery of health, medical 
and nutrition services. Despite the daunting task of mastering 
the idiosyncratic health care delivery systems of each nation, 
primarily based on the French colonial model, our study com¬ 
mitted USAID to major actions. 
Wil. George Silver and 1 departed for a month's Journey to 
Senegal. Mali. Mauritania. Niger and Upper Volta with side 
trips to Abidjan and to the World Health Organization (WHO) 
in Geneva. The trip was enervating, with hours of interview¬ 
ing health workers: health-post iiifiniiiers. regional hospital 
doctors and government ministers. 
During our IS-hour days, we journeyed to nomadic 
camps. We consulted with USAID officers and dealt 
with Wllf) and the United Nations Children Fund. We 
exhumed voluminous collections of health and health- 
related data, collaborated with Institut Pasteur research¬ 
ers. reviewed the efforts of myriad European medical 
and relief organizations, and conferred with hospital of¬ 
ficials ami colleagues at the University of Dakar and 
University of Abidjan faculties of medicine. In our 
hurried c|uest for information, we drove through dust 
storms, coloring our hair and clothing carmine. Splash¬ 
ing through rivers, we worried faintly about 
schistosomiasis. 
Wil was at his physical peak, at b I. an imposing figure over 
six-feet tall, beaixlevl and handsome. His camera at the ready 
to photograph migrant birds, his specimen bottles prepared to 
collect insects for viral studies, his ever-present notebook in 
hand. Wil swept through the villages. He felt children’s 
spleens, assessed with dismay the inadequate and expired 
medicaments in deteriorated and fly-specked health posts; he 
queried infirniiers about their training and then read the entries 
in the infirniiers' registers. In his Danish schoolbag, we had 
gathered a limited supply of pharmaceuticals to repay the 
infirniiers for their exposure to our questions. 
During the long, hot drives across Senegal and Mauritania. 
Wil would frequently cycle between periods of wakefulness 
and nodding off. He told us of his long history of narcolepsy, 
a condition exacerbated by the rocking and pitching of the 
four-wheel drive vehicle. Eater I found him asleep at meet¬ 
ings. only to awaken and make the most salient comments of 
the group. 
During the hours of travel and at mealtime, we often re¬ 
called our experiences during World War II. WGD was a 
marvelous raconteur. Wil and his good friend. Dr. Richard 
Shope (father of Dr. Robert Shope, director of the Yale Arbo¬ 
virus Research Unit), conv inced the militarv to send them into 
Okinawa after the first waves of American soldiers and Ma¬ 
rines landed. Wil’s interest was to make a quick survey of the 
anopheline mosquito population. He wanted to make rough 
estimates of the combat effectiveness of Japanese troops and 
of the exposure of our own men to malaria. Dick's parallel 
task was to undertake a snail survey and gather evidence of 
infection referent to schistosomiasis. 
Landing under cover of night, they accomplished their 
work, and as light came up. they drove their jeep in the 
direction of the American bridgehead. Their mission, how¬ 
ever. would not go without incident: Kamikaze pilots looking 
for targets of opportunity strafed them as Wil's helmeted head 
bowed in sleep. This encounter only added to Wil's legend; 
His narcoleptic nap made him a heroic figure, oblivious to 
enemy fire! 
Making friends during a 1976 trip to the Sahel. 
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The intimacy of our drouglit-emergeiicy journey was repeated 
a decade later, when a series of projects was undeilaken by Yale 
teams in the West African Sahel. For several of us, these 
weeks became times of self-revelation. Early life memories 
came to light, often poignant and predictive of the adult char- 
A train station along the route to Boho-Dlionlasso. 
, ■ ' J 
i. 
WGD and I entrained at Gare Treichville. Cheniin de Fer- 
Ahidjan-Ongadongoii. with onr getting off'at BohodDioulasso 
796kni.and 18112 honrsaway. Price—$42 for compartment 
with climatise. The OCCGE, a French West and Central 
A frican epidennologic snrveillance organization, 
possessed 6,()()() documents of historic and current 
iniportance we were charged to review... 
The railroad transects the Ivory Coast from 
Abidjan's green coastland north to Bobo's Sahel. 
WGD c/uietly mused upon the ecological 
ti'ansformations in the region: heavy rai)} forest, 
the forest, the guinea savannah (baobab and 
acacia), then Sahel and desert. This ecological 
profile on a rainfall gradient would infold itself 
through the night. He was fascinated with the 
changing human disease patterns reflective of the 
rapid ecological alterations over the 796 km. 
train route. 
The train doesn't roar: it pussycats through 
the forest, gives a muted bellow as it charges into 
a short tunnel emerging into darkened Dinibroko 
Station with a neon RAN sign mounted on a 
yellow' brick wall. Three hundred people crowd 
the platform. In the throng are Ivorian women 
toting orange, pineapple and banana baskets, 
babies astraddle their backs. Chaos took on a 
y 
acters of the storytellers. Family issues, conflicts and deep 
concerns emerged, provoked by the disastrous climate of 
drought, and human and animal death. We were dejected by 
evidences of rampant parasitic and bacterial disease, by scenes 
of marasmic children clutching at emaciated mothers with no 
breast milk and by the thousands of displaced nomadic people 
without their animal Hocks but not without their Toureg dig¬ 
nity and pride. But there were moments of high spirits, as 
well; I can hear Wil leading us in wonderfully obscene World 
War II songs as we drove over pot-holed dirt roads to our next 
destination. 
A Human Touch 
Wilbur Downs had a great capacity to approach people 
Linthreateningly; his warmth and gentleness let him elicit a 
wealth of impressions and information. He duly noted the 
names, addresses and phone numbers of his acquaintances in 
his journal, which he kept from his days as a school boy. 
Often these connections became networks, invaluable in deal¬ 
ing with large questions emerging from our scientific projects. 
New alliances spared us the time and pain inherent in clearing 
scientific equipment through customs, getting liquid nitrogen 
aboard a jet, banking (hire w functionnaire to stand in line for 
you for three hours), competing in the motor pool for USAID 
vehicles for field trips, reserving space in hostelries, and ac¬ 
quiring camping equipment. Wil's spontaneity crossed social 
class, occupational and racial boundaries. 
An example springs from the pages of my journal, dated 
Nov. 4, 1976: 
semblance of order as second- and third-class carriages 
filled. From the train platform, many secured seats by 
thrusting packages, food and chickens through open windows. 
WGD comes to life, leaps off the train followed by me. "Wil. 
don't get left behind!" I shout at hi))}. He a)iimatedly speaks 
to a w'0))}an ve)jdor who sells him four stnall ora)}ges for 
eight ce)its. As the conductor urges everyo)ie O)) board, he 
is asking cjuestio)is about cerebral ))ialaria. 
As a result of our recommendations from that trip to the 
Sahel. C-1.^0 Hercules aircraft were dispatched with medica¬ 
ments, field hospitals, insecticides and fogging machines. What 
followed was a continuing, promising relationship with USAID 
which resulted in the agency supporting other institutional 
research undertakings and culminating in the Senegal River 
Pilot Health Research Program of 1976 to 1978. In the next 
six years, our group became the health sector design team of 
this massive, integrated development project in the Senegal 
River Basin. 
The project's aim was to construct two dams, one at St. 
Louis in Senegal and the other at Manantali in Mali: the 
intended outcome was a series of irrigated agricultural perim¬ 
eters growing three crops a year on both sides of the Senegal 
River. The project also was to promote livestock, improve 
farm-to-market transportation infrastructure, and increase river 
navigability to Kayes in Mali. The relocation of villages and 
the retraining of fishermen whose forebears had fished for 7()() 
years were project imperatives. Finally, establishing hydro- 
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electric power would bring with it light industry and, with 
careful controls, general improvement of the population's health 
and nutrition. 
The development project was funded by the World Bank. 
USAID, the European Economic Community, the African 
Development Bank, and the Erench and British development 
agencies. Also included were the host countries, the Saudis 
(enriched by huge oil price increases), the Germans and Cana¬ 
dian AID. As Wil prudently pointed out. each of the partici¬ 
pants had its own national self-interest to pursue, which tem¬ 
pered the declared altruistic motives in assisting this drought- 
stricken region. 
To emphasize the importance of careful health planning, 
we repoi ted: 
The proposed dam and irrigation projeets in the Senegal 
River Basin will produce niajor ecological changes in the 
affected regions of Senegal. Mali and Mauritania. Expe¬ 
rience with similar welter projects in other African coun¬ 
tries suggest that the newly created lakes and irrigation 
sYstems will cpuckly become infested with acpiatic snails, 
mosciultoes ami black flies. As these vector species be¬ 
come more abundant, the prevalence of the diseases that 
the\ transmit (schistosomiasis, malaria, onchocerciasis 
and certain arthropod-borne viral illness) will also in¬ 
crease. Unless appropriate control measures are insti¬ 
tuted. these iliseases could easily become the major health 
problems in the region, inhibiting both agricultural and 
economic development. 
Fast Yale studies in the Senegal River Basin indicate 
the following general pattern of human disease: A high 
prevalence of malaria, schistosomiasis and onchocerciasis 
in the upper valley: a somewhat lower prevalence of 
malaria and schistosomiasis and no onchocerciasis in the 
lower vallev. The proposed water development projects 
will probablx adversely affect this pattern, particularly in 
the middle and lower portions of the valley. 
Members of the Committee on International Health carry on 
the prom! trmlition of Hr. \\ ilbur (1. Downs. 
In 1981. we submitted a major $6 million, six-year proposal 
to USAID to help minimize the potential deleterious health 
effects of the massive dam project. Our plan depended on a 
huge, multinational investment wherein the United States was 
to contribute $53 million. The proposal included an American 
base in a West African university, medical school or other institu¬ 
tion with laboratory facilities and experience in public health, 
parasitology, medical entomology and virology. 
Implicit in our proposal was that Yale would be the pref¬ 
erential bidder based upon our prior achievements under Wilbur 
Downs’ leadership. Had the School of Medicine gained the 
contract, related research opportunities would have opened to 
Yale's Law School, and the departments of anthropology, 
economics and African studies. 
After a tw'o-year bureaucratic struggle within USAID, how¬ 
ever, deeply held personal and policy differences led the agency 
to decide upon only minor American participation in the 
Senegal project. The resignation of a senior USAID officer, 
the one who conceptualized this grand scheme, ended Yale's 
decade-long involvement with the agency. This story bears a 
disturbing footnote; Without the strong health component 
recommended in the Yale proposal, the dramatic increase in 
water-borne diseases and illnesses caused by arthropod vec¬ 
tors did accompany the development project, problems that 
continue today. Ten years after our prediction of a Rift Valley 
Lever epidemic, in 1987 our worst fears were realized. 
Despite this setback, Wilbur Downs continued to consult with 
international health agencies for the rest of his life. He also 
w'orked detemiinedly at Yale to build the endowment for the 
Committee on International Health, which funds the Downs 
International Travel Eellowships. Thus, he continued—and 
continues today—to enrich the lives of Yale students and 
improve the health of people in developing nations. 
Wil’s ongoing influence also is felt personally among those 
of us who knew him well. On a bookshelf in my study, I 
recently came across a half-dozen books he had given me. 
And my "WGD Correspondence" folders bear witness that 
nary a w'eek passed since 1984 when Wil didn't send me a 
letter enclosing a clipping from New Scientist. The Guardian. 
Nature or Science, or a copy of a recent letter from his daugh¬ 
ter. who cared for Rumanian orphans after Ceascesau's down¬ 
fall. And. of course, there were the thoughtful critiques of 
African political evolution w-hich would have health sequelae. 
Often we'd talk of our frustrations w ith the American bureau¬ 
cracy and the lack of political will of health professional in 
government service to foster international health progress. 
Even a year after Wil's death, my dream-life, provoked by 
this writing assignment, reconstitutes vi\id African scenes 
and fragments of WGD conversations. Such is the strength of 
character of this extraordinary man for all seasons. His legacy 
lies not in his glow ing scientific achievements alone, but even 
more in his abiding friendships, his gifted leadership in inter¬ 
national health, and his remarkable mentorship of students and 
young faculty. VM 
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EAST MEETS WEST: 
THE YALE-CHINA BOND 
Fred S. Kantor. M.D., (he Paul B. Beeson Professor of Medicine, views a tissue sample with Chinese colleagues. 
by Shenvin B. Niiland, M.D. '55, HS '55-'6J 
It is difficult to escape the conclusion that forces of consider¬ 
able magnitude will retard efforts by the People's Republic of 
China to develop a scientifically based system of health care. 
The single most important obstacle appears to be the belief 
system of a society that has no tradition of science. 
Here I must point out several implicit characteristics in any 
reasonable description of that often misunderstood concept that 
we call science. The word itself is abstract. Attempts to define 
it in any absolute sense are fraught with the threat of confusion. 
If you don't believe that, try looking up science in an un¬ 
abridged dictionary. 
Dr. Sherwin B. Nuland, associate clinical professor of surgery, 
is a member the Yale-China Association board of trustees and is 
a 24-year member aiid former president of the Beaumont Medi¬ 
cal Club. An earlier version of this article appeared in China 
Update, a publication of the Yale-Ciuna Association. 
The science that I have in mind has allowed Western 
medicine to achieve its present accomplishments. This science 
relies on the experimental method and inductive reasoning. It 
implies a certain rigor with which observations are made, veri¬ 
fied and interpreted. Such are the foundation stones upon 
which we have built the extraordinary discoveries of the last 
250 years, since the scientific method was first propounded in 
the 17th century. 
Chinese culture is imbued with the concept that sickness is 
part of an inevitable cycle of nature, against w-hich man is 
foolish to struggle. It is the old story of the fragile reed that 
survives by bending with the wind, while the great oak resists 
and falls. Traditional Chinese medicine is. in fact, the medicine 
of harmonies. The two cosmic forces of Yin and Yang form the 
material basis of all creation, and its soul as well; their interac¬ 
tion determines whether the universe is to be disordered or 
ordered, wiiether sickness or health is to be the lot of any 
individual within it. The tw'o forces generate the five elements 
of Metal. Wood. Water, Fire and Earth, of which all other 
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things, including the hiinian organs, are made. Everything is 
related to everything else, is acted upon by everything else, in 
ways that are both physical and spiritual. 
In such a system, it would be self-defeating to separate 
natural phenomena into their component elements in order to 
microinvestigate each contributing factor individually and with¬ 
out prejudgment. The Western scientist divides and then subdi- 
N'ides his studies into ever more scrutable parts, attempting to 
remoxe them from outside influences that might change the 
course of the events he is trying to observe in their pure state. 
Ilis ultimate purpose is to understand nature so that he may 
influence it wherever he can. in order to make life better. But it 
is a fundamental teaching of Chinese thought that such separa¬ 
tion is senseless, because it frustrates the very principle upon 
w hich nature must be understood, the principle that interdepen¬ 
dence. harmony and bowing to nature's inexorable will are the 
true paths to making life better. The Chinese physician has 
been taught from childhood that mankind does not influence 
nature — mankind lives w'ith nature's unremitting rhythms. 
I do not argue that the Western way is right and the 
Chinese way is wrong, simply that they are different. And so 
different are they, that a culture imbued with the spirit of one 
has difficulty, no matter the purity of its motivation, in adapting 
to the other. Even the modern education of a Western-style 
program in today's China is affected by the subtle authority of 
4.()()() years of contemplative philosophy. 
Although I had been to the People's Republic before, my 
first visit to the Hunan Medical Lhiiversity (IIMLI) took place in 
March of 19(S9. three months before the Tiananmen Square 
uprising. I had reviewed the report of the delegation of Yale 
professors who travelled to China to renew the Yale-China 
affiliation in 19S(). The report is suffused w ith their enthusiasm 
about the possibilities that lay ahead. Although it contains a 
soberly realistic evaluation of the disabilities of the Chinese 
system and of some factors that might inhibit development, the 
prospects for a successful exchange program are excellent. An 
air of optimism runs through the report like a pleasingly recur¬ 
rent theme. 
Perhaps this optimism reflects the rc/>gc/.s7 that character- 
i/ed much of American thinking about the People's Republic in 
that yeasty post-Mao period. Emergence from the stultifying 
ef fects of the Cultural Revolution seemed certain to bring about 
not only a political and economic rapprochement with the West, 
but also to foster an intellectual openness in which partnerships 
might thrive in such supposedly culture-independent areas as 
science and health care. 
Comments of delegation members convey their excitement 
about the proposed joint undertaking, an excitement which, 
seen with the benefit of hindsight, seems to arise less from real 
cwidence than it did from the hopefulness of that period. The 
generosity of spirit found in the report mirrors. 1 will guess, the 
generosity of spirit with w hich the delegation was welcomed by 
Its Chinese hosts, fhe pervading atmosphere of genuine amity 
so characteristic of relationshi|is developed with Chinese col¬ 
leagues is frequently an unacknowledged influence in decisions 
that shoukl be made on more substantive grounds. 
One ol the most realistic cautionary notes in the 1980 
report stresses ''the need to tleveloii approaches to science and 
medicine which stress the orderly collection of facts and the 
deductive reasoning process rather than relying in the intuitive 
rea.-<oning that seems to characterize much of the current [Chi¬ 
nese] medicine." The caveat provides a discriminating insight. 
The reasoning process by which a Chinese researcher or clini¬ 
cian arrives at his conclusions is often quite at variance with the 
method used by his Western colleague. This fact, well known 
to those even slightly familiar with China, is often disregarded, 
as if ancient patterns could be discarded merely by wishing 
them away. 
The way in which most inhabitants of our planet evaluate 
the evidence of our five senses is determined by a cultural bias 
so strongly ingrained that it takes a conscious re-training to 
change it. What a faculty member of a school like HMU view's 
as proof of a proposition is often independent of what his 
Western colleague would call rigorous logic. This in itself 
presents a major obstacle to the development of modern medi¬ 
cal .science in China. What is more, the all-too-frequent failure 
of Americans to acknowledge this lack of rigor only adds to the 
obstruction. 
Outside Influences 
We have failed to take other matters into account, as well. 
Among them is the Chinese emphasis on appearances, and on 
the honors that accrue to seniority. Although the 1980 report 
refers to "the pro\ ision of a period of edtication for the leaders, 
hut most importantly, the younger members of the Chinese 
medical establishment", in practice it has been the fomier. and 
rarely the latter, who have come to New' Haven. 
Policy conferences between Americans and representa¬ 
tives of the People's Republic confront a dilemma that has 
existed ever since China decided that the West has some things 
that might be of value to its national development. The di¬ 
lemma concerns not only how to adapt Western concepts to 
Chinese society, but also how traditional Chinese cultural pat¬ 
terns might benefit from improvements in modern technology, 
and actually contribute to them as well. 
In the past, two great impediments blocked the accomplish¬ 
ment of such a goal. Eirst is the understandable Chinese resis¬ 
tance to the West's historical attitude of "cultural imperialism;" 
second is its polar opposite, our own equally understandable 
reluctance to be so forthcoming with Western notions that we 
risk being accused of cultural imperialism. The mix of old and 
new apprehensions has resulted in a bit of a stand-off. in w hich 
neither side is accomplishing as much as it should. In being 
overly sensitive to each viewpoint, we may have been too 
insensitive to the job that both sides acknow ledge must be done. 
I believe in the universality of psychological responses; to 
me. cultural differences are only the outer layers of a mental 
machinery driven by the same subconscious forces in Changsha 
as in New Haven. Cultural differences. I believe, grow' out of 
choices made by societies at various periods in their history. 
They should not be allowed to obscure psychological dy namics 
that are the common heritage of all members of our species. 
This is a roundabout way of saying that I am convinced, perhaps 
simplistically. that people are the same everywhere; each of us 
responds to the same unspoken messages that underlie all ver¬ 
bal communication. On some not-quite conscious level we 
di\'ine the truth about each other. 
Y.ale Medicine Spring 1992 
During our visit to Beijing on the 1989 trip, John Bryan 
Starr, president of the Yale-China Association, and I met with 
Dr. Cao Ziyi, at that time the PRC's vice minister of public 
health. The meeting had been arranged at my request, because I 
wanted some sense of the central government's priorities in 
relation to health and medical education. Cao's office is located 
in the building in which the deposed Emperor Pu Yi lived after 
he was forced to leave the Forbidden City. It was the perfect 
setting in which to discuss transitions. 
Cao was at the door to greet us. A short, full-faced, rather 
wholesome looking man of about 45, he wore a neatly tailored 
navy-blue business suit. The first thing that struck me about 
him was the golden smoothness of his skin, a quality that made 
his face appear to beam when he smiled. I watched those smiles 
carefully throughout our hour-long discussion. Although in 
general they appeared in response to something John Starr or I 
was saying, there seemed to be a deeper source as well. I had a 
vague perception that our conversation was setting off brief 
trains of thought in his mind, and his smile was sometimes the 
result of his own inner musings. He struck me as a person who 
not only listens, but has the ability to analyze and synthesize 
what he is hearing as he is hearing it. I felt as though we were in 
the presence of a man whose power comes from an intimidating 
ability to out-think everyone around him. 
Three other officials attended the meeting: Dr. Liu Bingxun, 
director of China's department of medical education; Dr. Liu 
Yinsheng, chief of that department's division of science and 
technology exchange; and Mr. Tan Sui, deputy director of the 
national medical examination center. Joining John Starr and 
me was Mrs. Geraldine Kunstadter. who was in Beijing as a 
member of the Yale-China hoard of trustees. Geri Kunstadter, 
who has a degree in electrical engineering from M.I.T., is 
chairman of the Albert Kunstadter Family Foundation, a philan¬ 
thropic trust that has long devoted much of its advisory and 
financial resources to the assistance of developing nations. 
Our discussion with the vice minister covered a wide range 
of areas that relate to health policy and medical education. Of 
the 133 medical schools in China, 13 have been designated as 
what are called “key" schools. Five of these are in a category 
that might be called “superkey." because they are given special 
funding and other kinds of support. These selections were 
made in the I95()s and have never been changed. They include 
two institutions in Bei jing, and one each in Shanghai. Guangzhou 
and Chengdu in West China. A look at the map confimis that 
geography played a major role in the choice of schools, as did 
historical development and the quality of the institution at the 
time of selection. 
Obviously, this status of superkey was of considerable 
concern to us because it does not include HMU, which is merely 
a “key" school. As we discussed the matter, there occurred one 
of those brief bits of talk that sometimes provide clues to an 
entire philosophy. Wanting to know whether there was any 
possibility that other .schools might rise to the category of 
superkey, 1 turned to Liu Bingxun, who had not changed his 
stolid expression even once, and asked if the present designa¬ 
tions were meant to continue forever. He delivered up his reply 
with a face of stone; “Yes, it is forever," he said very firmly, 
“For now." 
Dr. Slierwiii B. Niiland 
Sherwin B, Nuland, M.D. ’55: 
Encountering China 
Dr. Sherwin B. Nuland joined the medical advisory com¬ 
mittee of the board of trustees of the Yale-China Associa¬ 
tion in 1986 and assumed the committee chair in 1988. In 
that capacity. Dr. Nuland is responsible for shaping the 
association's work in the field of medicine in China— 
work that began with the opening of Xiangya Hospital in 
Changsha in 1906. 
Under Dr. Nuland's direction, the association has 
launched two new collaborative research and training 
programs that link Yale School of Medicine faculty mem¬ 
bers with colleagues in two medical schools in China. 
The focus of the first project, based at Hunan Medical 
University in Changsha, is pediatric cardiology. The fo¬ 
cus of the second project, located at Shanghai Medical 
University, is the treatment of breast and liver cancer. 
Dr. Nuland recently took a leave of absence from his 
private surgery practice in New Haven to devote more 
time to his vocation as author and medical historian. His 
critically acclaimed first book: Doctors: The Biography 
of Medicine (Alfred A. Knopf, 1988) was a Book-of-the- 
Month Club alternate selection and has been translated 
into three languages. He is currently at work on a book 
about the physiology and history of disease and dying, to 
be published by Alfred A. Knopf. He recently has com¬ 
pleted the text for a pictorial history of military medicine. 
That small statement exemplifies what I can only think of 
as a vast undercurrent of pragmatism that runs through all 
official Chinese policy, and even through areas where there is 
less policy than Westerners believe. Behind the obdurate pos¬ 
ture that government leaders often display to public view lies 
hidden an unspoken promise to yield just a bit, should there be 
some visible advantages for China. The apparent inflexibility is 
more a bargaining position than a fixed reality. 
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We spoke of many other things—delivering health care to 
proxincial farmers (farmers make up 80 percent of China's 
population), retraining China's 7(K).00() "barefoot doctors." pro¬ 
viding specialty education for surgeons and internists, enhanc¬ 
ing the financial and social status of Chinese physicians. Of 
course, we also discussed the priority that an overpopulated 
nation's central government places on medical education and 
the health care of individual citizens. 
Cao took ad\ antage of this part of our discussion to make 
an obviously political statement: "The first problem to be 
Sur'^eons pciforni their art at I liman MeJica! University. 
solved is population control. Without it. all other reforms and 
constructions are nonsense." He believes, he told us. that if 
population control can be achieved, every other problem—the 
economy, agriculture, transportation, energy, population, edu¬ 
cation—will be easily overcome. Until then, these other areas 
must remain at a higher level of priority than the health of the 
people. 
The one couple-one child solution has been difficult for 
many American experts to accept. Not only simplistic, it also 
risks tearing at the fabric of a culture so dependent on the 
consanguineal and extended family. Although 1 was not hesi¬ 
tant to disagree with several other of Cao's view s, it would have 
been senseless to debate a principle that has become such an 
idee fi.xe of national policy. This is one area of domestic affairs 
where immoxability is as real as it appears. 
As the meeting concluded, the two Lius, both Mao-suited 
men in their mid-bOs. asked us xvhether they might meet again 
w ith the three of us that afternoon, at the Sheraton Great Wall 
Hotel at 2 p.m. that meeting xve reviexved our relationship 
with H.MC and described the new plan of affiliation. 
Liu 't’unsheng again brought up the old refrain to xvhich we 
had been exposed so many times—the x oimg are too inexperi¬ 
enced in science to make optimal use of their studies in the 
West. This time I did dig in my heels and insisted that all the 
science in the xxoiid is of no use to a visiting scholar xxho is 
handicapped by poor linglish. I had by this time concluded that 
officials xxho insist on describing their young people as scien¬ 
tifically naive are i.|uite axvare of the error of that position. What 
the> are realix insisting on is the yai inianzi. the prix ilege due 
senior people. 
We eoneluiled our meeting by discussing one of the most 
serious problems lacetl by returning Chinese medical scholars. 
the lack of institutional support required for them to use what¬ 
ever knoxvledge they have gained. Researchers come home to 
inadequate laboratories; clinicians find none of the diagnostic 
and therapeutic equipment they have become familiar with in 
the West. Based on the statements made by Vice Minister Cao, 
as xvell as xvhat the two Lius xvere now saying. I am not 
optimistic about a quick fix for this issue. 
.\ Job. Not a Profession 
After our meeting xvith the ministry officials ended that mid¬ 
afternoon. John Starr. Geri Kunstadter and I sat down in the 
hotel lounge to discuss the day's events, over coffee. Listening 
to these two articulate people, both of them so much better 
acquainted w ith China than 1. helped to crystallize some of my 
own emerging ideas. 
Perhaps the greatest clarifx ing element xxas a single remark 
of Geri's based on her experiences with medical treatment in 
China—"They don't seem to care about their patients the xvax 
American doctors do." That sentence affimrs an obsen ation so 
readily verified that it is virtually axiomatic. It cannot be ex¬ 
plained by invoking the difference in xalue our txxo cultures 
place on indixidual human lixes. And it certainly cannot be 
explained by any intrinsic character differences betxxeen Chinese 
and American doctors, because everx' piece of ex idence indicates 
that inteipersonal relationships betxx een strangers are distinguished 
by greater kindness in their countrx’ than in ours. 
The amount of caring that a healer exhibits toward the sick 
is determined by complex factors. The outcome of those factors 
is xvhat xve in America call the doctor-patient relationship, a 
bond that develops for as long as a patient considers a physician 
to be his or her doctor. In this transaction, two individuals relate 
to each other on two distinct levels of understanding. The first is 
personal, and involxes the same considerations that determine 
the tone of transactions between any txvo people who begin a 
partnership xvith certain preconceptions about each other's role. 
The second level is societal. The Western physician occu¬ 
pies an elex ated position. Call it parental, or authoritatixe or 
even magisterial. Call it anything that implies respect for those 
xx ho. by X irtue of their superior knoxvledge. society allows to 
make pronouncements and decisions about our lives. In the 
West, medicine is one of the learned professions. 
In the classical sense, a profession has a contract xvith 
society. Society prox ides it with status, privilege, good income, 
and permission to choose, train and discipline its members 
without outside interference. Of the profession of medicine, 
society asks in return only for a guaranteed constant supply of 
health care; in effect, a kind of beneficent noblesse oblige. 
Hence, doctors in the West assume a great moral responsibility 
in return for the special status granted them by society. Upon 
this basis medicine is a profession—a calling and not a craft. 
With no such special contract in communist China, medi¬ 
cine is not. in either the societal or the moral sense, a profession. 
It is simply a job. The mere fact that it requires more education 
than most other jobs does not increase its xalue. There is little 
prix ilege, and therefore little assumption by doctor or patient of 
the healer's xx illingness to accept extraordinarx obligation. 
This simple truth, once recognized, explained a great deal 
of xvhat 1 had seen in China, and xvhat had been described to me 
by colleagues xxho had visited there. Doctors in the People's 
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Republic work at vvhal is essentially a low-esteem Job. Particu¬ 
larly in present-day China, where farmers and factory workers 
are far better remunerated than healers, the inadequate financial 
rewards of physicians rellect their inadequate image in society. 
They do not produce what current Chinese society values most— 
goods and money. 
1 was not shy, either in Changsha or Beijing, about asking 
people what they earn. Having had the question put to me a few 
times on my previous visit, once by a young man who walked 
up to me on a Guangzhou street. 1 did not consider it personal or 
rude. I found out that the average physician earns less than $30 
a month; the highest paid doctor to whom 1 spoke did not earn 
$1,200 in his best year, and yet his rank and title are at a level 
that is stratospheric compared to his colleagues. 
Regardless of differences in purchasing power, such sala¬ 
ries mean that China's highest ranking physicians live in very 
small hospital-based apartments without regular hot water; they 
do not own cars; their vacations, if they can afford to go away, 
are simple and cheap; they do not have funds to visit foreign 
countries; the expense of books and Journals is beyond them; a 
translator whose English is no better than theirs earns, at a 
conservative estimate, five times their salary. 
But most countries provide doctors with better rewards 
than money alone can buy. They include recognition, esteem 
and trust, with the understanding that doctors, in the words of 
Robert Louis Stevenson, “stand above the common herd." Nei¬ 
ther I nor any American medical or diplomatic visitor to whom 
Young physicians: the future of Chinese medicine. 
1 have spoken has .seen evidence of this in China. Doctors are 
workers. The value of workers is proportional to an output that 
can be measured in units of money. For doctors, that figure is 
very low. and for this reason, medicine does not attract nearly as 
great a proportion of highly motivated, ambitious young people 
as it does here at home. 
And then, there is the other obstacle to modernizing the 
health care system—neither it nor medical research are very 
high among the central government's priorities, and they are 
not likely to rise higher during our lifetime, d’he United States' 
recognition of individual health as a basic right simply does not 
equate in China. What appears to be the same game is played 
by different rules in the two countries. 
Science Confronts Harmony 
Having come to this conclusion, what should the medical repre¬ 
sentatives of a friendly nation consider to be their role? It has 
been the received wisdom that Americans cannot set goals for 
other countries, and especially for a country with problems as 
complex and cultural characteristics as inconsonant with our 
own as are China's. And yet, our Chinese colleagues seek out 
exchanges, point with pride to those few medical advances they 
have managed to make, and in numerous other ways indicate 
that they want what we perceive them to need—a science-based 
system of medical education and health care. 
Does any kind of assistance fall outside that category of 
“cultural imperialism" against which we tell each other to be 
constantly on guard? Perhaps clues present themselves all over 
the landscape, not only from China, in its history and present 
situation, but also from the West. 
Whether foreign or native, those who wish to modernize 
China must understand and deal with the traditional belief in 
totality and harmony. But in their sensitivity to this belief, they 
cannot ignore that the People's Republic has decided to bring 
the strengths of modern science to bear on their nation's prob¬ 
lems. Although it is no longer fashionable to quote Mao Tsetung, 
he was articulating his country's fundamental approach to mod¬ 
ernization when he said, "Make the past serve the present and 
foreign things serve China." 
What has not served China, at least in the eyes of the West, 
are the ineradicable memories of the Tiananmen massacre that 
occurred a few months after our visit. The cruelties of that 
unforeseeable event and its aftermath have influenced every 
aspect of our relationship with the People's Republic. Support 
for cultural and scientific exchanges has waned, and there has 
been a marked diminution of the optimistic enthusiasm with 
which Americans approach collaborative efforts with Chinese 
colleagues. In fact, some of those colleagues have been dis¬ 
placed. Cao Ziyi, for example, was seen as too supportive of 
the students, and someone else now occupies his office. These 
are the political facts of life in present-day China. 
But the work of the Yale-China Association, though slowed 
for a time, remains unchanged. In a new mission statement 
ratified last year, the board of trustees reaffirmed its nearly 
century-old commitment to “changing lives: Chinese lives and 
American lives. Teaching and learning are the heart of this 
endeavor." In order to teach and to learn, it is necessary to make 
use of every experience we have had since Yale-China founder 
Dr. Edward Hume first set foot in China in the earlv IPOOs, and 
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especially the new insights of the years since we resumed our 
collaborative efforts in 1980. With this in mind, the medical 
program of Yale-China has been allowed a rapid evolution of 
perspective, to incorporate the requirements of a relationship 
that is not only bilateral but symmetrical and mutually benefi¬ 
cial. in a way that circumstances have not previously permitted. 
Both sides have now agreed that the focus of Yale-China's 
attention should he young medical scholars, those most likely to 
benefit by a program whose mission is to change lives. It is 
realistic to expect that, in addition to its other virtues, such a 
policy is likely to result in the forging of long-standing relation¬ 
ships between individuals w ith similar academic interests in our 
two countries. We have insisted that the Chinese participants 
demonstrate English-language ability by achieving a high grade 
on a standardized examination, so that they make the most 
effective use of their fellowship time. We have replaced our 
previous, rather general approach to the character of the visits 
back and forth. Now we offer a highl\ organized program in 
which specific departmental sections are chosen, and the mem¬ 
bers of those sections plan the objectives of their exchange. 
Hunan Medical University leaders have chosen pediatric 
cardiology as a specialty that particularly needs strengthening 
at their institution. Dr. Charles Kleinman. director of that 
section at Yale, will fashion, in meetings with his Chinese 
counterpart, a program of affiliation in which young scholars 
come to New Haven for var\ing periods of time to learn the 
methods of their specialty as they are practiced at the Yale-New 
Haven Hospital. 
Senior Chinese doctors, even those who have no familiarity 
with English, are not excluded from participation, but they will 
fulfill a supeiA isor_\ role. Visits they may make to New Haven 
w ill be relatively brief, and for the purpose of seeing to it that 
things are proceeding to their satisfaction, as well as to learn 
about American clinical and research methods. 
During the course of a visit to the Shanghai Medical Uni¬ 
versity m 1990. John Starr and I discussed with the leaders of 
their faculty a new affiliation with that "superkey” school. Eor 
reasons of both history and economics. Shanghai is more West¬ 
ernized than any other city in the Peoples' Republic, and its 
major medical school is much more advanced in scientific 
medicine than is our sister school at Changsha. A few months 
later. Ii)r. Tang Zhaoyou. the university's president, came to 
New Haven to set up groundwork for an exchange in oncology. 
Meeting w ith T.S. Ravikumar. M.D.. Yale's chief of surgi¬ 
cal oncology, and Dr. William Hait. clinical director of the Yale 
Comprehensive Cancer Center. Dr. Tang outlined the ways in 
which our tw'o schools might mutually benefit by such a pro¬ 
gram. and work together on major research projects. On return¬ 
ing from an exploratory visit to the Shanghai Medical Univer¬ 
sity last spring. Drs. Ravikumar and Hait drew up proposals for 
clinical and research affiliations in breast and liver cancer. By 
the lime this article reaches print, x isiting scholars from Shang¬ 
hai and Changsha will he planning their arrival in New Haven 
to begin work. 
PassingtheTorch 
One of the lessons of the past 150 years of Western medicine 
derives from the way in which various medically underdevel¬ 
oped countries have sent their young physicians off to study in 
leading foreign centers so that they could return home and 
develop a form of health care and research that is most suitable 
to their own culture and national characteristics. Not only 
knowledge, but ascendancy in medical leadership passed by 
this process from Erance to the German-speaking countries to 
the United States. In each case, a form of biomedical science 
developed that was indigenous to conditions and precedents in 
the home country. This is a lesson for China too. and it reflects 
the pragmatic w isdom of Mao's dictum. 
In a classic canon of traditional Chinese medicine called 
the Nei Ching. its alleged author, the mythical Yellow Emperor 
Huang Ti. conducts a dialogue with a learned physician. Chi Po. 
At the beginning of Book V. the Yellow Emperor asks Chi Po. 
"What is the way of medical treatment?" The first sentence of 
the physician's answer is a classic in itself: "The way of 
medical treatment is to be consistent." 
Perhaps those words convey part of the answer to develop¬ 
ing scientific medicine in China—an answer that must accom¬ 
modate 4.000 years of tradition, as well as the country's need 
for the most advanced form of biomedicine. This means modi¬ 
fication and compromise, and the compromises will have to be 
made not only in the rigorous applications of Western scientific 
thinking but also in the rigorous adherence to a tradition that is 
no longer consistent with China's emerging role in the society 
of nations. It is not within the pow'er of well-meaning American 
friends to design the structure of this second kind of compro¬ 
mise; by having signified their wish to modernize. Chinese 
authorities have made a commitment to go much further than 
they yet have, to make tradition bend in the interest of their 
people's well-being. 
This commitment will require a significant re-ordering of 
national priorities. A nation's productivity depends in large 
part on the health of its people. Not only that, but a government's 
investment in its individual citizens brings with it a return that is 
incalculable: the strengthened resolve and solidarity that the 
citizenry feel when their leaders demonstrate an empathetic 
understanding of basic daily life. 
And there is more. It will be necessary (and here compro¬ 
mise guarantees failure) to elevate the societal status of physi¬ 
cians. It is not merely a matter of better salaries: It is a matter of 
recognition that the nation values the health of its individual 
citizens enough to put great value also on those who provide 
their care. There must be found within the cultural framework 
of Communist society, the ground rules of the social contract 
that makes medicine a profession. 
^'oung people w ill have to be giv en reason to dedicate their 
lives to healing. In the West, that dedication has always come 
from society's recognition that medicine is not a job. but a 
calling. When more of the best youth of China feels itself called 
and privileged, it will respond to that call and that privilege with 
the same enthusiastic sense of obligation that has brought a 
century of medical progress to the United States. VM 













Portraits of Peter Parker, M.D., and a Tumor Patient; Lam-Qiia, Late-1830s 
In the mid-1800s. Chinese artist Lani-Qua painted nearly 200 
portraits of Dr. Peter Parker's tumor patients. Lam-Qua did so 
at no charge, in gratitude for the free medical services Dr. 
Parker (1834 M.D.) peiformed for the people of China. A 
graduate of the Britain Royal Academy. Lam-Qua captured the 
most intricate medical details of Dr. Parker's patients before and 
after surgery, often including delicate Cantonese landscapes as 
backgrounds. Lam-Qua created the images first as sketches on 
rice-paper and then as a .series of Western-style oil portraits. 
The portraits were used by Dr. Parker on his trips to England 
and the United States to raise funds for his missionary work. 
More than 80 of Lam-Qua’s portraits are part of a permanent 
collection in the Harvey Cushing/John Hay Whitney Medical 
Library at Yale. 
Dr. Parker, who graduated with degrees from the medical 
and divinity schools at Yale, amved in China in 1834 to estab¬ 
lish that country’s first Western hospital. With little clinical 
training. Dr. Parker founded Canton's Ophthalmic Hospital in 
1835, and within its first year treated more than 2,000 patients. 
Although many Chinese did not embrace Dr. Parker's Christian 
religious teachings, his medical “miracles” so impressed Canton 
residents that they formed the Medical Missionary Society to 
continue funding the hospital. 
Dr. Parker devoted more than 20 years introducing progres¬ 
sive medicine and surgery into the Orient. He was the first to 
train native surgeons, including artist Lam-Qua's nephew, in 
lithotomy, amputation, cataract removal and other surgical pro¬ 
cedures. Dr. Parker also introduced sulphuric ether as China’s 
first anesthetic. 
In addition to his medical duties. Dr. Parker served as secre¬ 
tary and interpreter to the Mission of the United States to 
China. For several years, he served as acting U.S. commis¬ 
sioner to China and in 1855 was named commissioner to the 
Chinese Empire. 
During the Opium War between Great Britain and China, all 
foreigners were expelled from Canton, and Dr. Parker's hospital 
was forced to close. A few years later, however, he returned to 
Canton and reopened the hospital. Dr. Parker stayed until ill 
health forced him to leave in 1857. He died in 1888 at age 83, 
after treating more than 52.000 patients in China. 
Rosalind D'Eugenio, media specialist 













American Cyanamid Co. lias av\ arded a 
five-year. $6 million grant to Yale 
University to support basic scientific 
research in the School of Medicine's 
new Boyer Center for Molecular 
.Medicine (BCMM). With the agree¬ 
ment. which represents one of Yale's 
largest corporate collaborations. 
Cyanamid and its Lederle Laboratories 
will provide basic support for the 
endothelial cell program in molecular 
cardiobiology. 
Vascular endothelium, the single 
layer of cells lining the heart, blood 
vessels and lymphatic vessels, is thought 
to play a major role in heart disease. As 
Cyanamid E.xecutive Vice President 
Frank V. AtLee explains, the grant 
"imobes Yale's scientists and Lederle's 
best research talent to produce basic 
science that may lead to novel therapies 
for the major medical threat posed by 
atherosclerotic disease." 
Comments Yale President Benno C. 
Schmidt Jr.. "Because of the contribu¬ 
tions to the biomedical sciences that the 
agreement will make possible. Yale's 
teaching and research programs will 
advance the frontiers of knowledge and 
enhance patient care. 1 am most grateful 
that our commitment to scientific 
inquiry and education in the 21st 
century has received such generous 
support." 
Lederle Laboratories is a research¬ 
intensive organization that has produced 
important therapeutic agents for heart 
disease, psychiatric illness, infection and 
cancer. In addition to ethical pharma¬ 
ceuticals. Lederle manufactures child¬ 
hood and adult vaccines. 
Vincent T. Marchesi. M.D.. Ph.D.. 
BCMM director, established the 
program in molecular cardiobiology. 
He has conducted path-breaking studies 
into the structure of membrane proteins 
in red blood cells. Dr. Marchesi 
observes that "Interest in endothelial 
cells' immune properties and inflamma¬ 
tory reactions is increasing as more 
scientists work to determine the role 
these cells play in thrombosis and 
IF//// a ,S'b million i’rcin! from American Cyanamid Co., all four programs of 
I he Boxer Ceiiler for Molecular Medicine are fully operational. 
vascular disease." 
Molecular cardiobiology. directed by 
Jordan S. Pober. M.D.. Ph.D.. is one of 
four programs in the Boyer Center 
which have been established along 
programmatic, rather than departmental 
lines to encourage interdisciplinary 
collaboration. 
Other BCMM programs include 
molecular genetics, headed by Joan A. 
Steitz. Ph.D.; molecular and develop¬ 
mental neurobiology, headed by 
Spyridon Artavanis-Tsakonas, Ph.D.; 
and molecular oncology and develop¬ 
ment. headed by Sherman M. 
Weissman. M.D. Clinically oriented 
basic researchers will play key roles in 
each program to speed the discoveries of 
basic science to the bedside. 
Study Finds Dyslexia 
Occurs in Continuum 
A School of Medicine study has 
challenged the conventional understand¬ 
ing of dyslexia. That view suggests that 
dyslexia is a specific disorder in which 
the reading abilities of affected children 
differ fundamentally from those of other 
poor readers and do not change over 
time. 
"Dyslexia is not an all or none 
phenomenon." said the study's principal 
investigator. Sally E. Shaywitz. M.D.. 
professor of pediatrics. "Dyslexia is 
much more like hypertension and occurs 
along a continuum with gradations or 
degrees." 
She reported her results in the Jan. 16 
issue of the New Engkuid Journal of 
Medici)te. Dyslexia, a specific difficulty 
in learning to read, is believed to be 
biologically based and can be experi¬ 
enced by people of average to above- 
average intelligence. 
Although estimates vary, some 
experts believe it affects as many as 12 
percent of the nation's students. In the 
stud). which currently is funded by the 
National Institute of Child Health and 
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Human Development, the researchers 
charted the reading development of 414 
randomly selected Connecticut children 
from first through sixth grade. They 
found that in any given year, as well as 
from year to year, the children's reading 
ability varied predictably, fitting a 
normal distribution curve—a distribu¬ 
tion of values that appear on a graph as a 
bell-shaped curve. 
Dr. Shaywitz said the importance of 
the finding for dyslexia is that it 
recognizes that reading ability is not 
constant over time, but rather that there 
is a predictable variability in reading 
ability in all children from year to year. 
"Current policies for the identifica¬ 
tion of dyslexic children are based on 
the belief that dyslexia is invariant over 
time, that a small group of children can 
be identified as dyslexic in the early 
school years and that this group will not 
change from year to year," said Dr. 
Shaywitz. She added that educators 
may need to idenitfy a larger number of 
children who are “at risk” for reading 
difficulties. 
Unique Art Show Comes 
To School of Medicine 
In December, more than six talented 
artists from across the nation exhibited 
their paintings and sketches in New 
Haven. Only, some of them might not 
be able to draw a straight line. 
How to account for this paradox? 
These adult artists are autistic savants. 
Their exhibit, held at the Connecticut 
Mental Health Center (CMHC), 
featured pen and ink sketches, oil 
paintings, wood carvings and bronze 
sculptures. 
Susan T. Naylor, R.N., M.S.N., 
arranged the exhibit as coordinator of 
the Adult Pervasive Developmental 
Disorders Clinic. She explains that the 
show represents the collaborative 
efforts of adult autistic in- and out¬ 
patients at the CMHC. 
"We involved the CMHC patients in 
planning and presenting this art show," 
Ms. Naylor says, "to help them normal¬ 
ize their illness and see what it means 
to be part of society." 
New Center To Research 
Infant Lung Diseases 
The National Heart, Lung and Blood 
Institute has awarded the University 
a five-year, $4.3 million grant for an 
interdisciplinary team of physicians 
and biomedical scientists to study 
neonatal lung injury and its long¬ 
term clinical consequences. 
“Through our pediatric lung 
center, we hope to generate knowl¬ 
edge that will lead to a better under¬ 
standing of the events underlying lung 
injury,” says Dr. Joseph B. Warshaw, 
program director. “This knowledge 
will be essential before prevention 
strategies can be rigorously eleveloped 
and tested.” 
Dr. Warshaw. chairman and chief 
of the department of pediatrics, notes 
that the center will involve nine or 
more faculty members in the 
departments of pediatrics, cell 
biology, epidemiology and public 
health, and pathology. 
“We plan to study both normal 
and abnormal lung development and 
to address major questions about 
Pneumococcal Vaccine 
Proves To Be Effective 
With a recently completed study, Yale 
re.searchers hope to end some of the 
controversy about the effectiveness of the 
pneumococcal vaccine that has been used 
in the United States since 1978. Eugene 
D. Shapiro, M.D., associate professor of 
pediatrics and of epidemiology, led the 
six-year Connecticut study. 
“The main purpose of this research," 
he states, “is to assess the vaccine’s 
effectiveness in a large-scale study. We 
found that the vaccine has a 61 per cent 
efficacy in patients with healthy immune 
systems. We designed this study with 
internal controls specifically to assure its 
validity." 
The study was published in the Nov. 
21 issue of the New En^laiul Journal of 
Medicine. Results from the Yale study 
infants' lungs," Dr. Warshaw 
explains. “Lung injuries are common 
complications of premature infants; 
the incidence may be as high as 25 
percent,” he notes. 
Among the fundamental ques¬ 
tions Yale physicians and scientists 
will consider; How do lungs respond 
to injury? What process repairs the 
injury? How do lungs develop and 
function in children? How do lungs 
expand and contract? What kind of 
energy is required to breathe? In 
addition, researchers will advance 
our understanding of lung illnesses 
caused by alterations in gene expres¬ 
sion. 
Others will study the regulation 
of surfactant—a wet substance the 
body produces to reduce surface 
tension—in both injured adult and 
developing lungs. If immature lungs 
of premature babies have no surfac¬ 
tant. the lungs may collapse. 
Lung injuries may occur in 
premature babies because their 
lungs, though fragile, need aggres¬ 
sive treatment, often requiring 
prolonged hospitalization. Children 
who survive lung injuries often have 
chronic infections. 
may explain some conflicting informa¬ 
tion previously reported on the efficacy 
of pneumococcal vaccine. 
The researchers, in collaboration with 
colleagues at the University of Pennsyl¬ 
vania and the National Institutes of 
Health, proved that the vaccine worked 
against infections caused by the 23 types 
of pneumococcal bacteria included in it 
and did not work against types of the 
bacteria which were not part of the 
vaccine. 
The vaccine protects against more 
than 90 percent of pneumococcal 
infections that produce serious diseases. 
Vaccination is especially recommended 
for adults with chronic renal and 
pulmonary diseases, chronic alcoholism 
and congestive heart failure. And due to 
increased risk to serious pneumococcal 
disease among the elderly. Dr. Shapiro 
recommends the vaccine be used as a 
preventative measure for them, as well. 


















Martin Luther King Jr. Day 1992 
Cornell Scott. M.P.H. '('>8, pictured here with 
Maxitic Whitehead, director ofniinority affair.s. 
moderated a .sympo.siimt entitled. "New Haven: 
,4 Community Fii’ht.s Back." which was also the 
theme of this year's Martin Luther King Jr. Day 
events. (See photo cm facing page.) 
Rita ,/. Louard. M D.. associate research 
scientist in medicine, (foreground) attends 
one of several luuchtiuie seminars. Iti this 
seminar. Mustafta Ahdul-Salaam. director 
of the New Haven Fauuly Alliance, 
discussed how his organization works to 
support and maintain the health and 
structural integrity of families. 
John Kirk, pictured here with fellow second-year student Karen Broder. presents 
Adolescent Substance Abuse Prevention program (ASAP) t-shirts to Roberto 
Clemente Middle School sttidents. Mr. Kirk and Ms. Broder co-direct a\SAP with 
Christopher Gilligan. also '9J M.D.. and were among F^ medical school and EPH 
students who were presented awards for commtmity service. 
(See "Student News." page Jb.) 
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lliis year's syniposiiini panel featured (from left): 
Edward H. Kaplan, an associate professor in the 
schools of organization and nianagcnient and 
medicine. He spoke of New Haven's snccessfid needle 
e.vchange program, which is slowing the spread of 
AIDS among IV drug ahnsers. Gerald Friedland, 
M .D., professor of medicine, disciisseil the University¬ 
wide AIDS Consortium which he heads. New Haven 
Police Chief Nicholas Pastore and Donald .1. Cohen, 
director of the Child Study Center, described a new 
initiative between the medical school and the police 
department to aid children and families who have 
suffered from violence. 
William //. Gray III, president and chief e.vecntive officer of 
the United Negro College Fund (left), receives the key to the 
city from New Haven Mayor John Dainels as Acting Dean 
Robert M. Donalds(m Jr. looks on. Mr. Gray delivered this 
year's Martin Luther King Jr. Day keynote address. 
Entertainment by the Yale University Gospel 
Choir is becoming a tradition at the School of 
Medicine's Martin Luther King Jr. Day. 




Javits Research Awards 
Two School of Medicine researchers 
have been presented Javits 
Neuroscience Investigator Awards by the 
National Institute of Neurological 
Disorders and Stroke (NINDS). 
Robert 11. LaMotte. Ph.D.. professor 
of anesthesiology and neurobiology, and 
Bruce R. Ransom. M.D.. Ph.D.. associate 
professor of neurology and of cellular 
and molecular physiology, were selected 
for the award, which recognizes out¬ 
standing contributions to neurological 
sciences. They are among 12 Javits 
award recipients at Yale. 
NINDS established the awards, which 
support scientists for seven years, to 
honor the late Li.S. Sen. Jacob Javits of 
New York. 
Dr. La.Vlotte. a native of Washington. 
D.C.. joined the Yale medical faculty in 
ld77. With the award, he will conduct 
research on the nerve function of pain 
and itch and the sensation response that 
occurs after a skin tissue injury. He also 
will continue to stud_\ the conditions 
under which changes in the spinal cord 
neuron can become prolonged and 
possibly contribute to the suffering of 
patients with chronic pain that persists 
long after a tissue injury has healed. 
Dr. Ransom, a native of Santa Fe. 
N.M.. joined the Yale medical faculty in 
ldK7 and was named director of the 
school's outpatient neurology clinic a 
year later. With the award, he will 
expand his notable work on the physiol¬ 
ogy of neuroglial cells, the non-neuronal 
cells in the brain, and their relationship 
to neurons. Dr. Ransom is focusing on 
the effects that glial cells have on ions, 
positively or negatively charges atoms 
that play a key role in intercellular 
communication. 
Marion Morra: Longtime crusader against cancer. 
NCI Award Named 
For Marion Morra 
The first annual award for 
outstanding leadership of the 
National Cancer Institute's (NCI) 
Cancer Information Service (CIS) 
was presented to Marion Morra. 
associate director of the Yale 
Comprehensive Cancer Center, by 
Marilyn Quayle. wife of Vice 
President Daniel Quayle, and Samuel 
Broder, M.D.. director of the NCI. 
who announced the award henceforth 
will be named after Ms. Morra. 
Following the presentation, the 
Marion Morra Award was also given 
to Kate Duffy, head of the CIS 
section at NCI in Bethesda, Md. The 
presentations were part of a 
ceremony marking the 15th 
anniversary of the CIS. 
The CIS. through its toll-free 
number. I-800-4-CANCER, annually 
responds to more than 500.000 
inquiries about cancer from the 
American public. It is the largest 
service of its kind in the world. 
In addition to her duties directing 
the CIS at Yale. Ms. Morra is 
responsible for the many communica¬ 
tions and outreach activities of the 
Yale Comprehensive Cancer Center. 
She also serves as a liaison to local, 
state and national organizations 
involved in cancer control and 
research. 
Ms. Morra. associate clinical 
professor at the School of Nursing, 
teaches graduate level courses in 
communications and health market¬ 
ing. She is also associate research 
scientist in the department of 
epidemiology and public health, 
where she teaches about advances in 
cancer prevention and control. 
Ms. Moira serves on several major 
committees of the NCI and the 
American Cancer Society and has 
written numerous articles, pamphlets 
and self-help booklets for cancer 
patients and their families. With her 
sister, the medical writer Eve Potts, 
she co-authored CHOICES: Realistic 
.Alternatives in Cancer Treatment 
(Avon Books, 1980; revised edition, 
1987); Understanding Yonr Immune 
Svstem (Avon Books. 1986); and 
TRIUMPH: Getting Back To Normal 
W'heti You Have Cancer (.Avon 
Books. 1990). 
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Yale Child Study Center 
Faculty Named to 
Endowed Professorships 
Two faculty members at the Child Study 
Center have been named to endowed 
professorships. Mary E. Schwab-Stone, 
M.D., assistant professor of psychiatry, 
was named the Harris Assistant 
Professor of Child Psychiatry, and 
Steven Marans, M,S,W., assistant 
clinical professor of social work, was 
appointed the Harris Assistant Professor 
of Child Psychoanalysis. 
Dr. Schwab-Stone, who Joined the 
Child Study Center in 1987, is the 
principal investigator for the Yale Child 
and Adolescent Psychiatric 
Epidemiologic Study and the Rural- 
Urban Study of Child Psychiatric 
Di.sorders. Concerned with the prob¬ 
lems of inner-city youth, she concen¬ 
trates her research on the relationship 
between a child’s .social environment 
and psychiatric conditions of childhood 
and adolescence. She also researches 
problems in linking children and 
families who need treatment with 
appropriate psychiatric services. 
Mr. Marans focirses his research on 
the role of aggression in children and on 
methods for studying observations 
derived from psychoanalytic interviews. 
He is program coordinator for the Child 
Study Center/New Haven Department of 
Police Service Project, a program that 
arranges counseling for children 
exposed to violence. This Joint venture, 
initiated last fall, includes a course on 
child development for all police recruits; 
a consultation for field officers regard¬ 
ing services for children who are victims 
or witnesses of violence; and a fellow¬ 
ship for selected police officers to learn 
about available mental health services 
for children. 
In 1986. Irving and Neison Harris, 
brothers who graduated from Yale in 
1931 and 1936 respectively, donated $5 
million to the Yale Child Study Center 
to establish these endowed fellowships. 
Rosemary H. Balsam. M.D.. 
associate clinical professor of psychiatry 
and staff psychiatrist at the Yale Health 
Plan, was appointed training and 
supervising analyst at the Western New 
England Institute for Psychoanalysis by 
the American Psychoanalytic Associa¬ 
tion in December. 
Alexander Baumgarten. M.B.B.S., 
Ph.D.. professor of laboratory medicine, 
was appointed to the U.S. Food and 
Drug Administration general and plastic 
surgery devices advisory panel. The 
panel met in February to offer advice on 
the continued use of silicone gel breast 
implants. 
.lames P. Comer. M.D., M.P.H.. the 
Maurice Falk Professor in the Child 
Study Center and Child Psychiatry, 
received a $50,600 Charles A. Dana 
Award for using psychiatry's insights 
into child development to forge a 
pioneering model of collaboration 
between parents and teachers in public 
.schools. 
Alvaii R. Feinstein, M.D., Sterling 
Professor of Medicine and Epidemiology 
and co-director of the Robeil Wood Johnson 
Clinical Scholais Program, and .Ioann G. 
Elmore, M.D., a Robert Wood Johnson 
Clinical Scholar, have been awarded a 
pi'ogram development grruit of $38,000 by 
the Ameiican Cancer Society to support 
research on the efficacy of m;immography 
for breast cancel' screening. 
(Jary E. Friedlaender. M.D., 
professor and chairman of orthopaedics 
and rehabilitation, will serve a four-year 
term on the National Advisory Board for 
Arthritis and Musculoskeletal and Skin 
Diseases for the National Institutes of 
Health. 
R. Kenny Fryer. M.L.S.. head of 
reference services in the Harvey 
Cushing/John Hay Whitney Medical 
Library, was named a distinguished 
member of the Academy of Health 
Information Professionals of the 
Medical Library Association. 
(Jerhard H. Giebisch, M.D.. 
Sterling Professor of Cellular and 
Molecular Physiology, was granted the 
degree of Docteur Honoris Causa in 
October by the University of Lausanne. 
Switzerland. Dr. Giebisch studies the 
cellular mechanism of dissolved 
substance transport to the kidney. In 
Executives from Boehriiiger-Ingelheim Pharmaceuticals. Inc. (BIPI) meet the first 
recipient of the Boehringer-lugelheim Young Investigator Awai'cl. Carl flashimoto, 
Ph.D., assistant professor of cell biology, received the award for his research into the 
development of the fruit fly embryo. He studies how the Drosophila embryo 
differentiates into front and back, a process that has molecular ec/uivalents in other 
organisms, including humans. (Front row. from left) Alan Rosenthal, M.D.. senior 
vice president scientific affairs. BIPI: Dr. Hashimoto: Acting Dean Dr. Robert M. 
Donaldson .Jr. (Back row. from left) Richard Asch. district sales manger. BIPI: Victor 
Hartmann. M.D., vice president, medical. BIPI: and Gordon Letts. Ph.D.. director of 
pharmacology. BIPI. 
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particular, he and his associates have 
investigated the mechanisms of renal 
potassium transport. Dr. Giebisch spent 
a sabbatical year in Lausanne from 1974 
to 1975. 
Charles \. (ireer. Ph.D.. associate 
professor of surgery (neurosurgery) and 
neurobiology, will serve a four-year 
term as a member of the Sensory 
Disorders and Language Study Section. 
Division of Research Grants, at the 
National Institutes of Health. 
(Jeorge R. Heninger. M.D.. profes¬ 
sor of psychiatry, summarized the latest 
knowledge about affective disorders at 
the third annual Bristol-Myers Squibb 
Symposium on Neuroscience Research 
held at Yale in October. 
Charles A. .laneway .Ir.. M.D.. 
professor of immunobiology and a 
Howard Hughes Medical Institute 
investigator, was awarded a Doctor of 
Medicine Honoris Causa degree in 
(October by the Nicholas Copernicus 
School of Medicine in Krakow. Poland, 
for his studies on the activation of T 
lymphocytes. 
Ira S. .Mellman. Ph.D.. professor of 
cell biology, will serve a four-year term 
as a member of the Cellular Biology and 
Physiology Study Section. Division of 
Research Grants, for the National 
Institutes of Health. 
Fasko Rakic. M.D.. Sc.D.. Dorys 
.McConnell Duberg Professor of 
Neuroscience and chairman of neurobi¬ 
ology. was granted the degree of Doctor 
Honoris Causa by the Albert Szent- 
Gyorgyi University in Szeged. Hungary, 
for his studies on the mechanisms of 
brain development. 
Robert E. Shope. M.D.. professor of 
epidemiology, director of medical 
studies for epidemiology and public 
health, and director of the Yale Arlx)vi- 
rus Research Unit, was named an 
hoiK)rary diplomate by the American 
College of Veterinary Microbiologists 
tor his contributions to this field. 
■loan A. Steitz. Ph.D.. professor of 
molecular biophysics and biochemistry, 
has been avs arded the Christcipher 
Columbus .Award in Biomedical 
Research b\ the National Institutes of 
Health Christopher Columbus Medical 
.Sciences Committee. 
Edward F. Zigler. Ph.D.. Sterling 
Professor of Psychology, was pre.sented 
the Loyola-Mellon Social Science 
Award in October, for his contributions 
to the scientific study of human behav¬ 
ior and the nature of social institutions. 
Howard V. Zonana, M.D., associate 
professor of psychiatry, received the 
Outstanding Service Award from the 
American Academy of Psychiatry and 
the Law (A.APL) at its national meeting 
in Orlando, Fla., in October, and was 
elected AAPL president for 1992-1993. 
Dr. Zonana also spoke at the third 
International Congress on Psychiatry 
Law and Ethics held in Jerusalem in 
November. His address was titled 
"Voluntary Psychiatric Hospitalization 




Samuel D. Kushlan, M.D.'35, was 
honored by the School of Medicine's 
di\'ision of digestive diseases w ith the 
23rd annual Kushlan Lecture, "AIDS 
and the GI Tract." delivered by Marvin 
H. Sleisenger. M.D.. professor of 
medicine at the University of California 
at San Francisco. 
Rocko M. Fasanella, M.D.'43. was 
honored by the Italian-American 
Historical Societv of Greater New 
Haven at its annual distinguished award 
dinner in December for his more than 40 
years of service to the greater New 
Haven area as an eye surgeon, educator 
and humanitarian. Dr. Fasanella was a 
founder of the Caribbean Ophthalmo- 
logical Society and is also a member of 
professional societies in the United 
States, France. Spain and Peru. 
B. HerokI (Jriftlth, M.D.'4,S. '48- 
'49 HS. has retired after 21 years as 
chief of idastic surgery at Northv\ estern 
University, but continues as a professor 
of surgery. 
Asa Barnes, M.D.'59, '63-'65 HS. 
clinical professor of pathology at the 
University of California. Irvine. College 
of Medicine, has been elected president 
of the California Blood Bank. He is also 
president of the boards of directors of 
the American Red Cross Los Angeles 
and Orange Counties Regional Blood 
Center and the greater Long Beach 
chapter of the American Red Cross. In 
the latter capacity, he traveled to 
Cambodia to coordinate medical 
assistance projects with the Cambodian 
Red Cross and other agencies. 
Alan Lieberson, M.D.'62. serves on 
the Norwalk Bioethics Committee as a 
patient advocate, and advises clients 
troubled by the health-care system. 
David M. Holden, M.D.'63. has 
been appointed to the Accreditation 
Council for Graduate Medical Education 
Residency Review Committee for 
Family Practice as a representative of 
the American Academy of Family 
Physicians. He has been professor and 
chairman of the department of family 
medicine at the State University of New 
York at Buffalo School of Medicine and 
Biomedical Sciences since 1983. 
Ian C. MacLeu)]. M.D. 
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Ian C. Mac-Lean, M.D.. '63-’65 HS, 
was installed as the 33rd president of the 
American Academy of Physical Medi¬ 
cine and Rehabilitation at its annual 
assembly held in Washington. D.C. in 
October. A member since 1967. Dr. 
MacLean served on the academy's 
board of governors since 1986. He is 
also a director of the American Board of 
Electrodiagnostic Medicine and is the 
American Medical Associations’s House 
of Delegates representative for the 
American Association of 
Electrodiagnostic Medicine. 
Diane K. Shrier, M.D.'64. has 
accepted a position as vice chair and 
director of clinical psychiatric services 
of the department of psychiatry at 
Children's National Medical Center in 
Washington. D.C. She concurrently has 
been appointed professor of psychiatry 
and pediatrics at George Washington 
University Medical School. 
Morris B. Mellion, M.D.'70. was 
elected president of the American 
Academy of Eamily Physicians, which 
represents 71,000 family physicians and 
medical students. In addition to his 
private medical practice. Dr. Mellion 
teaches at the University of Nebraska 
Medical Center and in the School of 
Health, Public Education and Recreation 
at the University of Nebraska, Omaha. 
Henry R. Black, M.D.. '71- 74 HS, 
has been named Roberts Professor and 
chainnan of the department of preven¬ 
tive medicine and professor of medicine 
at Rush Medical College in Chicago, 
effective April 30. 
Albert C. Pottash, M.D.'74, was the 
recipient of the 1991 Distinguished 
Alumnus Award from Eriends' Central 
School, Wynnewood, Penn., recognizing 
his unique contributions to medicine and 
psychiatry. He is the executive director 
of seven psychiatric hospitals located in 
New York, New Jersey and Elorida, and 
also serves as a clinical professor at 
New York University Medical School. 
Alan M. Levine, M.D.’74, ’75-’80 
HS, was promoted to professor of 
orthopedic surgery and oncology at the 
University of Maryland. 
Richard B. Biuford. '77 M.P.H 
Richard B. Burlorcl, 'll M.P.H., 
vice president for administration at 
Yale-New Haven Hospital (YNHH) 
since 1988, joined the medical school's 
Eaculty Practice Plan as executive 
director in Eebruary. Eor the past 14 
years, Mr. Burford has worked in 
hospital operations at YNHH. He is a 
past president of the Yale University 
Hospital Administration Alumni 
Association. Mr. Burford also is a 
lecturer in the department of epidemiol¬ 
ogy and public health, teaching hospital 
organization and management. 
.Jordan S. I^ober, M.D.'77. fomierly 
of Harvard University, has been named 
head of the molecular cardiobiology 
program at Yale’s Boyer Center for 
Molecular Medicine. 
Mark .J. Rataiii, M.D.'KO, director 
of clinical pharmacology and associate 
professor of medicine for the department 
of hematology/oncology at the Univer¬ 
sity of Chicago Medical Center, has 
been awarded the American Cancer 
Society’s Clinical Oncology Career 
Development Award, which provides 
financial support for three years to 
individuals who have demonstrated a 
.serious commitment to an academic 
career in clinical oncology. 
Bernard H. Selin, M.D.’8I. while 
completing his residency in emergency 
medicine in Pittsburgh, spent a month at 
the Shock- Trauma Center in Baltimore. 
1 le also traveled to Costa Rica for 
several weeks as part of an earthquake 
analysis team after a large tremor in 
April. In October, he presented a two- 
day workshop in Korea on emergency 
medical service development. 
.1. Mark Blue, M.D., '84 P.A., who 
received his M.D. degree in May 1991 
from East Carolina University in 
Greenville. N.C., has begun his resi¬ 
dency training in orthopedic surgery at 
the University of Missouri. 
W. I>ee Bailey, M.D.'86. presented 
research findings on the molecular 
mechanisms of restenosis after coronary 
artery angioplasty at the European Heail 
Congress in Amsterdam and at the 
American Heart Association meetings in 
Anaheim, Calif. He has accepted a 
position as the Interventional Cardiology 
Eel low with Dr. Geoffrey Hartzler at the 
Mid-America Heart Institute in Kansas 
City, Mo., beginning in June. 
Leslie Vogel, M.D.'87. is serving as 
an instructor in clinical psychiatry at 
Columbia College of Physicians and 
Surgeons in New York. 
.James .J. Cullen, 88 M.P.H., has 
been appointed chief executive officer 
for the Hospital of St. Raphael in New 
Haven. 
Marcia D. Morris, M.D. 89. a 
psychiatric resident at New York 
Hospital-Cornell Medical Center in 
White Plains, has been selected as one 
of the 10 American Psychiatric Asso¬ 
ciation/Burroughs Wellcome Eellows 
for a two-year term. Her husband. 
Michael Morris, M.D.'89, is a resident 
in ophthalmology at Manhattan Eye. Ear 
and Throat Hospital. 
Stacey H. Wills, M.D.. '90 M.P.H.. 
has begun a new position as a clinical 
research analyst for a consulting firm in 
Virginia, serving more than 80 pharma¬ 
ceutical companies worldwide. 






(llenn's Thoracic and Curdiovascitlar 
Surgery, fifth edition, edited h> .Arthur 
E. Baue. M.D.. with .Alexander S. Geha. 
M.D.. Graeme L. Hammond. .M.D.. 
Hillel Laks and Keith S. Naunheim. 
■Appleton and Lange (Norwalk. Conn.) 
1991. (Renamed by the editors in honor 
of senior editor of the fourth edition. 
\\ illiam W.L. Glenn. M.D.) 
. \ Fan's (iitidc to Baseball Fever; The 
(official Medical Reference, by Thomas 
Singer. '70 M.D.. and Stuart Copans. 
Elijim F^ublication (Mill Valley. Calif.) 
1991. 
Medicine: The Art of Healinii. by 
Sherwin B. Nuland. '55 M.D.. associate 
clinical professor of surgerw Macmillan 
Publishing Co. (New ATirk) 1991. 
Skeletal Traiinia by Alan M. Levine. '74 
M.D.. co-edited by Drs. Browner. 
Jupiter and Trafton. W'.B. Saunders 
(Philadelphia. Penn.) 1991. 
'/'//(' Biochemical Basis of 
.S'enropharmacoloyy- by Jack R. 
Cooper. Ph.D.. Lloyd E. Bloom. M.D.. 
and Robert H, Roth. Ph.D. Oxford 
L'niversity Press (New '^'ork. Oxford) 
1991. 
.V. 
The Liviipy Will Handbook, by Alan 
Lieberson. '62 .M.D.. J.D. Hastings 
House (New Vork) 1992. 
The New .\mericanism: How the 
Democratic Party Can Win the 
Presidency, by Steven Jonas. M.D.. '67 
M.P.H.. w ith a forw ard b>' George 
McGovern. Thomas Jefferson Press 
(New "^'ork) 1992. 
\\ hat's a \ irus Anywavi^ The Kids' 
Book .About .AIDS, by Da\ id Lassler. '82 
M.D.. and Kelly McQueen. Waterfront 
Books (Burlington. Vt.) 1990. 
Student 
News 
Marlene Coriijo. a fourth-year medical 
student, received the 1991 William and 
Charlotte Cadbury .Award from the 
National Medical Lellowships. Inc. The 
honor includes a certificate of merit and 
$2,000. 
13 YSM, EPH Students 
Earn Service Awards 
The School of Medicine presented the 
first Distinguished Community Service 
.Awards to 1.7 of its students, 
recognizing their outstanding 
community ser\ ice in the city of New 
Ha\ en. These new aw ards are to be 
given annually on Martin Luther King 
Jr. Day. This \ear's recipients are: 
Second-year medical students: 
Karen R. Broder. Christopher ,J. 
(iilligan and .lohn H. Kirk, leaders of 
the .Adolescent Substance .Abuse 
Prexention program; .Alexandra F. 
Boer. (i. Richard Bruno and Karen 
Rosewater, leaders of the Students 
Teaching .AIDS to Students program: 
Lauren L. Plawner. a trained rape- 
crisis counselor also working w ith 
\ ictims of sexual abuse and incest; Paul 
Santiago, co-president of his class, w ho 
serx es on the school's Minority .Affairs 
Committee, the Student National 
Medical .Association and w as co¬ 
coordinator of the Summer Minority 
High School Student Research program; 
\ ictoria L. Holloxvay, president of the 
Student National Medical .Association 
chapter at A'ale. xx ho also serx es on the 
Minority .Affairs Committee, xvas co¬ 
coordinator of the Summer Minority 
High School Student Research program 
and dex eloped the nexv "Cross Culture" 
program for high school students; 
Vamilee O. Berminghani and Karen 
Rosewater, xvho established and serx e 
as coordinators of a central student 
X olunteer office, lead a new student tour 
program for students at Hill Central 
Elementary School and are dex eloping a 
community group to provide serx ices to 
pregnant xxomen from the Women's 
Center at Yale-Nexv Haven Hospital and 
the Hill Health Center. 
M.D.-Ph.D. student: Suresh Karne. 
xx'ho xx'orks xvith the Hillhouse High 
School .Macy program, xvhich introduces 
students to the medical sciences. 
Second-year EPH students: Luoluo 
Hong. XX ho xvorked xvith the Nexv Hax en 
"^'WC.A. Rape Crisis Center. Rape 
Hotline; serx ed as co-facilitator for a 
support group for x ictims of incest and 
sexual assault; and is involved in .AIDS- 
related community outreach. Elizabeth 
Chiao. xx ho xx orked xvith the EPH 
Student Organization A'olunteer 
Committee and is developing a student 
tutorial program on community service. 
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HUMAN RELATIONS 
CODE OE CONDUCT 
Editor’s note: Last fall, the School of Medicine broadened its Race Relatunis Code of Conduct 
by adopting a Human Relations Code of Conduct, recommended by the Minority A ffairs Com¬ 
mittee and discussed at length by the committee, departmental chairs. Medical School Council 
and the Schoohs Board <f Permanent O fficers. We are proud to feature the complete te.xt fm 
the readers of Yale Medicine: 
Yale University School of Medicine is 
committed to the promotion of personal and 
professional development of all individuals 
in its community, and encourages dialogue 
that will foster the growth, well being and 
dignity of all its members. In pursuit of 
these goals, the school is dedicated to main¬ 
taining an environment which places the 
highest priority on collegial relationships, 
mutual respect, and sensitivity among its 
students faculty and patients. 
An educational community functions best 
when there is civility and respect for the 
dignity and worth of each individual. It must 
be ensured that our school is free from 
discrimination and acts of intolerance such 
as those based on race, gender, sexual orien¬ 
tation, religion, national origin, ancestiy, age 
or physical handicap. This commitment 
remains consonant with the obligation to 
protect open and wide-ranging public 
discourse. 
The principle of freedom of expression 
that might otheixvise protect even the most 
offensive public speech does not protect, nor 
does it even encompass, a right to threaten 
the dignity and privacy of an individual. 
Such personally directed behavior will not be 
tolerated; it is antithetical to academic values, 
debilitates its victims, compromises the 
offenders, and undennines the University's 
fundamental commitment to individual 
freedom and respect for all its members. 
Furthemiore, acts of intolerance may desti oy the 
veiy atmosphere wherein freedom of expression 
is otheiw'ise tolerated and cherished. 
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DEVELOPMENT REPORT 
Dr. and Mrs. Atkins Endow 
Paul Beeson Professorship 
Two distinguished former faculty 
members. Dr. and Mrs. Elisha Atkins, 
have funded a professorship in the 
department of internal medicine to honor 
Fkiul B. Beeson. M.D. Fred S. Kantor. 
.\I.D. "62. was named the Paul B. Beeson 
Professor of Medicine. 
Drs. Atkins and Beeson were col¬ 
leagues at Yale for nearb 10 years. In 
19.^.^. Dr. Beeson brought Dr. Atkins, a 
specialist in infectious diseases, to Yale 
from Washington University. Dr. Atkins 
earned the rank of professor in 1967. 
Mrs. Atkins was a teacher in Lee 
High School, where she taught in a 
special enrichment and remedial pro¬ 
gram. Her extensive volunteer work 
earned her the citizen's award by the 
Cornerstone Organization in 1985. 
From 1975 to 1985. upon Dr. Atkins' 
retirement. Dr. Atkins was the master of 
Saybrook College at Yale. Upon his 
retirement, the college established a 
Saybrook lectureship in their name. 
Since 1985. Dr. and Mrs. Atkins have 
de\oted their time to the Habitat Institute 
for the PaiN iix)nment in Belmont. Mass., 
a non-profit organization to promote 
environmental awareness and education 
which was founded in 1971 on the site of 
Dr. Atkins' family iKMiie. 
In 1952. Dr. Beeson became chairman 
of the department of medicine at Yale. 
He left Yale in 1965 for Oxford Univer¬ 
sity. as the Nuffield Professor of Clinical 
Medicine. In 1974. he returned tt) the 
Unitetl States and accepterl an appoint¬ 
ment as Distinguished Physician of the 
United States Veterans Administration in 
Seattle. Wash. 
Dr. Beeson is a fellow of the .Vmeri- 
can .Academy of Arts and Sciences and a 
member of the National Academy of 
Sciences. He is a master of the Ameri¬ 
can College of Physicians and received 
the .lohn Phillips Memorial .Award of 
that organization in 1976. In 1972. he 
recei\cd the Bristol .Award of the 
Infectious Diseases Society of America 
and in 197.7 the Kober Medal, the 
highest medal conferred by the Associa¬ 
tion of American Physicians. He has 
received honorar\ doctor of sciences 
degrees from Emory. McGill. Yale and 
Albany universities and in 1973 was 
made an honorary knight commander of 
the British Empire. 
He and his wife live in Redmond. 
Wash, where he continues to write and 
edit medical articles and journals that 
address a range of critical issues 
affecting the current future role of 
medicine in society. 
In commenting on the Beeson 
professorship. Acting Dean Robert M. 
Donaldson Jr. referred to both its donor 
and its namesake: "These outstanding 
physician-scholars are unassuming, 
straightforward men who maintain the 
highest standards of integrity, dignity, 
and decency. It's no wonder that both 
of them have successfully served as 
teachers and mentors for so many young 
people who themselves have become 
successful clinical investigators and 
teachers. This chair is a wonderful 
tribute to both the donor and the 
honoree." 
All iisfrolahc Jroin the Streeter Colleetion 
Dr. Spinelli Donates Estate 
To School of Medicine 
Nicholas P. R. Spinelli. '41. '45 M.D.. 
has established his second charitable 
remainder trust to benefit the Yale 
School of Medicine. Through his two 
trusts. Dr. Spinelli will receive an 
income for life and has ensured that, 
should he predecease his sister. Viola J. 
Spinelli '65 M.P.H.. she. in turn, will 
receive the income stream throughout 
her life. Afterward, the trust's assets 
will pass to Yale. 
A strong advocate of charitable trusts 
and other life-income gifts. Dr. Spinelli 
encourages other alumni to investigate 
such charitable vehicles: "These gifts 
can provide donors with important up¬ 
front tax deductions, significant income 
for life and. most importantly, enable 
alumni to leave Yale much more 
significant gifts than they can make 
during their lives." Dr. Spinelli said. 
When added to the charitable trust 
Dr. Spinelli created in 1985. this gift 
w ill establish an endowed professorship 
to be aw'arded at the discretion of the 
medical school dean. Called the 
Nicholas P. R. and Viola J. Spinelli 
Professorship, it is Dr. Spinelli's wish 
that the dean award the professorship to 
a distinguished faculty member in the 
department that most urgently needs 
such funding at the time the professor¬ 
ship becomes available. 
A charitable trust can be funded w ith 
stocks, bonds or cash. The donor then 
chooses a payout rate w hich, in conjunc¬ 
tion w ith actuarial tables, determines the 
up-front tax deduction and income 
stream the donor w ill receive. The 
income generated b>' the trust can be 
paid to one or more beneficiaries for as 
long as they live or for a specified 
period up to 20 years. 
Dr. Spinelli. a longtime supporter of 
4'ale College and the School of Medi¬ 
cine. served the medical school as 
director of alumni affairs from 1985 to 
1990. He has made many other gifts to 
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f r'' ; 
Dr. Nicholas Spinelli consults with secoiul-year medical students Emil En^^els (left) and Constantino Pena 
during a recent fundraising telethon. 
the school, including one which estab¬ 
lished an endowment in support of 
student social well-being. 
Dr. Spinelli's legacy of support far 
exceeds his charitable remainder trusts, 
his ongoing financial and volunteer 
support for the alumni fund, and even 
his support for student social well-being. 
When former patients asked Dr. Spinelli 
how they could repay him for his 
extraordinary, compassionate care, he 
often suggested that they make gifts to 
the School of Medicine: in addition to 
several other gifts, one donor, Mrs. 
Charles E. Nixdorff, astonished Dr. 
Spinelli by leaving a bequest to Yale of 
more than $500,000. 
In expressing his appreciation to Dr. 
Spinelli, Yale President Benno C. 
Schmidt Jr. said. “I remain deeply 
grateful for your outstanding personal 
and financial commitment to the mission 
of the school. Your loyal support has 
done much to nourish the school and 
University, and I thank you for your 
continuing interest and involvement." 
My Gift to Yale, Yale’s Gift to Me 
Fifty-five years ago. at age 16. I began 
an 11-year journey through my 
undergraduate, graduate, and post¬ 
graduate (medical residency) educa¬ 
tion at Yale. As a self-suppoiling 
student, the generosity and financial 
support of Yale University made this 
education possible. A lifetime later, I 
can objectively state that the quality of 
the education 1 received and observed 
was unexcelled anywhere in this 
country or the world. This is a debt 
that I can never repay materially. 
At the twilight of life. I rank 
education as among the most vital 
social values to be preserved for our 
posterity. It is one of the treasured 
gifts we can bestow upon the future 
generations of our country. In these 
sober times, extraordinary efforts and 
means must be expended to preserve 
the excellence of Yale; this means 
the support of our alumni in unprec¬ 
edented forms and dimensions. We 
all have received so much. 
It has been, in addition, my God- 
given privilege to live a lifetime just 
20 miles from New Haven. This has 
afforded me the gift of continued 
education and stimulation at our 
medical school, through the tenures of 
many deans and many University 
administrations. Throughout, the 
discipline of excellence has been a 
gift that Yale has continuously 
bestowed. It has been a privilege to 
witness excellence defined in all areas 
of Yale education and functions, be 
they music, drama, art. Renaissance 
literature: in a word, university. 
Nicholas P.R. Spinelli. M.D. ’44 
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Russell N. Anderson 
Obituaries 
\\ illtelni S. Alhriiik 
Wilhelm S. Albrink 
Wilhelm S. Albrink died July 28 at Alta 
Bates Hospital in Berkeley. Calif. He 
was 75. 
A native of Napoleon. Ohio. Dr. 
Albrink graduated from Oberlin 
College, reeeived a Ph.D. from Yale 
University in 1941 and an M.D. from 
^'ale University School of Medicine in 
1947. Following a residency in pathol¬ 
ogy at Yale-New Haven Hospital from 
1947 to 1950. he served on the faculty at 
Yale as associate professor. 
In 1961. Dr. Albrink was appointed 
professor and chairman of the depart¬ 
ment of pathology at the West Virginia 
University .Medical Center. He was 
instrumental in establishing a bioethics 
program and the History of Medicine 
Society and later served on the Institu¬ 
tional Review Board for Research on 
Human Subjects. 
He is survived by his wife. Margaret 
J. Albrink. M.D.'46. who retired as 
emeritus professor of medicine at West 
Virginia University, three sons. 
Fretlerick. John and TYter; two brothers; 
and two grandchikiren. 
Ccaitributions may be sent to the 
Wilhelm S. Albrink Lectureship in 
Bioethics. WVU School of Medicine 
De\elopment Office. 0-106 HSN. 
Moruantow II. WV 26505. 
Russell N. Anderson. M.D.. died Sept. 18 
while vacationing in the San Juan 
Islands. He was 69. 
A native of Tacoma. Wash., Dr. 
Anderson was a graduate of Willamette 
University and a 1950 graduate of Yale 
University School of Medicine. He was 
a World War II physician, and later 
practiced at Northgate Hospital in 
Seattle, where he served as chief of 
staff, a member of the board of gover¬ 
nors and president of the board of 
trustees. Fie also served on the board of 
trustees for the King County Medical 
Society. He was a diplomate of the 
American Board of Family Practice. 
In 1972, Dr. Anderson Joined the 
Joint Commission for Accreditation of 
Health Care Organizations. He was 
past-president of Seattle Preschool for 
the Blind and was avidly involved with 
environmental organizations. 
He is survived by his wife, Jo Ann; 
three daughters. Margaret, Judith and 
Elizabeth; three sons. Stephen. Carl and 
Mark; two stepchildren, Debra and 
Randall; and nine grandchildren. 
Contributions may be made to the Dr. 
Russell N. Anderson Scholarship Fund, 
c/o Liniversity Congregational Church. 
Seattle. 
Samuel Alpert 
Samuel Alpen. M.D.. died Sept. 4 at his 
home in Riverdale. N.Y. He was 84. 
Dr. Alpert specialized in endocrinol¬ 
ogy and diabetes. He served as chief of 
medicine and of the diabetes clinic at the 
Veterans Administration Outpatient 
Clinic in Manhattan. 
A fellow' of the American College of 
Physicians and a diplomate of the 
American Board of Internal Medicine. 
Dr. Alpert was a major and a flight 
surgeon in the Army Air Corps during 
World War 11. serving in North Africa 
and Italy. 
Dr. Alpert attended Yale College 
and, in 19.70. graduated from the School 
of Medicine. 
He is survived by his wife. Dorothy, 
anti a son. Robert. 
Charles 4. Hull 
Charles A. Hall 
Charles A. Hall. M.D., died at his home 
in Loudonville, N.Y., on July 27. He 
was 71. 
A native of Maine, Dr. Hall gradu¬ 
ated from the University of Maine and. 
in 1944, from Yale University School of 
Medicine. During World War II. he 
served as a troop physician on Army 
transport ships. 
For 20 years. Dr. Hall was principal 
medical investigator for the Veterans 
Affairs Medical Center in Albany and 
also was the director of the center's 
Nutrition Laboratory for Clinical 
Assessment and Research. He held 
positions as chief of hematology and 
radioisotope serv ice departments at the 
medical center and w as responsible for 
the de.scription of Transcobalamin II and 
other discoveries in enzymatic defects in 
cobalamin (vitamin B12) metabolism. 
In May, Dr. Hall was named the VA 
Medical Center's Physician of the Year. 
He was a member of the American 
Federation for Clinical Research, the 
American Institute of Nutrition, the 
Society for Experimental Biology and 
Medicine, and the International Com¬ 
mittee for Standardization in Hematol¬ 
ogy B12 Panel. 
He leaves his wife. Mary; two 
daughters. Nancy and Christine; three 
sons. Peter. Andrew and Dominic; and 
six grandchildren. 
Contributions may be sent to the 
Farano Center, 25 N. Main St.. Albany, 
NY 1220,7. 
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Robert H. Areson 
Robert H. Areson, M.D.. died Oct. 12 on 
an annual liike at Baxter State Park. Me. 
He was 75. 
A native of Montclair, N.J., Dr. 
Areson was a co-founder of the 
Montclair Medical Group, where he 
specialized in diabetes for 32 years, until 
his retirement in 1981. 
Dr. Areson was a past-president and 
chairman of the hoard of Camp Nejeda, 
a camp for diabetic children in 
Stillwater, N.J. He also was past- 
president of the New Jersey Diabetes 
Association. 
He served as corporate medical 
director for Union Camp Corp., a paper 
company in Wayne, N.J., from 1969 to 
1989. where he developed the 
company’s industrial hygiene depart¬ 
ment and. in 1975, established an 
employee alcohol and drug dependency 
rehabi I itation program. 
Dr. Areson received his B.A. degree 
in 1937 from Dartmouth College and his 
M.D. degree in 1941 from Yale. He was 
a diplomate of the American Board of 
Internal Medicine. During World War 
II, he was a lieutenant commander in the 
U.S. Navy, serving in the Aleutian 
Islands and the South Pacific. 
He also was past-president of the 
medical staff at Mountainside Hospital 
in Glen Ridge. N.J.. and of the Essex 
County Medical Society. 
He leaves his wife, Lois: three 
daughters, Nancy. Sally and Susan; 
three sons. David. Peter and Paul; and 
eight grandchildren. 
Robert M. Lowman 
Robert M. Lowman, M.D.. professor 
emeritus at the School of Medicine, died 
Dec. 4 in Yale-New Haven Hospital. He 
was 78. 
Dr. Lowman was professor of 
radiology at the School of Medicine for 
40 years before he retired in 1983. For 
10 years he directed the radiology 
department at the former Grace Hospi¬ 
tal, where he specialized in gastrointesti¬ 
nal radiology and initiated development 
of a mammography service. 
He was past-president of the New 
Haven Medical Society and the New 
England Roentgen Ray Society. A 
native of Baltimore, Dr. Lowman 
graduated from Harvard University and 
the University of Maryland Medical 
School. 
He is survived by a daughter. Gail; a 
son. George; and two grandchildren. 
Memorial contributions may be made 
to the Yale Alumni Radiology Research 
Fund, c/o Dr. Robert White. Yale 
School of Medicine, 333 Cedar St., New 
Haven, CT 06510. 
Charles L. Mache Jr. 
Charles L. Mache Jr. died Feb. 3 in 
Buffalo General Hospital at age 67. 
Dr. Mache received a B.S. degree in 
1945 from Yale College and an M.D. 
degree in 1947 from the Yale University 
School of Medicine. Dr. Mache began 
his private pediatric practice in 1953 in 
Snyder, N.Y., and also served on the 
staff at Children's Hospital. 
Dr. Mache was a member of the 
American Academy of Pediatricians, the 
American Medical Association and the 
Buffalo Pediatricians Society. 
He leaves his wife. Mary; and two 
daughters, Cynthia and Cathryn. 
Elizabeth Thomson 
Elizabeth Thomson died Dec. 29 at Yale- 
New Haven Hospital. She was 84. 
A native of Holland Patent, N.Y.. she 
was a 1931 graduate of Simmons 
College and received a master's degree 
from Mount Holyoke College. 
She was an editorial assistant for 
Mount Holyoke College and the 
National League of Nursing Education 
before joining Yale in 1945 as an 
assistant in research at the Medical 
Historical Library. Between 1951 and 
1972, she served as a research assistant 
and, later, associate in history of 
medicine. 
At the time of her death, she was 
writing a biography of Dr. John F. 
Fulton, one of the three founders of the 
medical historical library at Yale. She 
co-authored two books with Dr. Fulton: 
Beiijantin Sillinuin, I779-1S64. Fath- 
finilei' in American Science: and Harvey 
Cn.sliiny, Snryean. Antlior. Artist. 
Ms. Thomson served as editor-in- 
chief of the Journal of the History of 
Medicine and Allied Sciences. She was 
a member of the board of officers and 
trustees of the Harvey Cushing/John 
Hay Whitney Medical Library, and a 
member of the Beaumont Medical Club 
and the Nathan Smith Club at Yale. 
Memorial contributions may be made 
to the John F. Fulton Book Fund, 
Harvey Cushing/John Hay Whitney 
Medical Library, 333 Cedar St., New 
Haven, CT 06510. 
In Memoiiam 
Willis J. Snow 
September 16, 1991 
'26 M.P.H. 
Samuel Alpert 
September 4, 1991 
'30 M.D. 
Charles L. Wood 
July 20, 1991 
'30 M.D. 
Edward V. Carvey 
October 17,1991 
'35 M.D. 
Dean Lester W. Burket 
June 29, 1991 
'36 M.D. 
D. Crosby Greene'37 M.D. 
November 27, 1991 
Jean H. Nelbach 
September 2S, 1991 
'38 M.P.H. 
Robeit M. Dunlap 
October 27. 1991 
'40 M.D. 
Robert H. Areson 
October 12. 1991 
'41 M.D. 
Albert W. Bostrom Jr. 
April 19, 1991 
'47 M.D. 
Russell N. Anderson 
September IS. 1991 
'50 M.D. 
Bruce W. Jackson'66 M.D. 
June IS. 1991 
Laura Kuckes 
August 5, 1991 
'88 M.D. 
Peter A. Grannum 
January 21, 1991 
M.D. 
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ALUMNI REPORT 
Meaningful communication with 
alumni/ae is the most important function 
of the Office of Alumni Affairs. We 
design our various projects to achieve 
this goal. At times communication is 
difficult, however, because of the wide 
geographic dispersion of our classmates 
and friends. Class secretaries transfer 
available information about their peers 
but busy alumni/ae don't always inform 
their class secretaries of professional 
achievements and developments in their 
personal lives. 
The Alumni Office welcomes your 
letters. We also solicit your ideas on 
improving the school and the Associa¬ 
tion of Yale Alumni in Medicine. Are 
there programs that would make the 
association more pertinent to you? 
Inclusion of your suggestions in the 
plans for the coming year will 
strengthen our association and help us to 
represent all of you. Communication 
can avoid disappointments and misun¬ 
derstanding. 
Our office continues to offer help 
and expertise in establishing medical 
student class groups; our goal is to fonn 
the structure of a class organization that 
will be effective immediately after 
graduation. As part of this process, we 
encourage the appointment of class 
secretaries and agents before graduation. 
This process of nurturing students 
as "future alumni/ae" is aided by alumni 
attendance at students affairs, both 
academic and social, which is welcomed 
by the students and enjoyed by the 
alumni. Increasing numbers of our 
graduates are attending annual events 
such as the Cadaver Ball and the 
Second-year Show. Furthermore, the 
Medical Student Council has applied for 
and received a gift from the Yale 
Alumni Association of (jreenwich. 
Conn., to enhance the quality of student 
lil'e. The project, named "Recovery 
Room." w ill supirort the badly needed 
rchabilitalion of the basement lounge 
tirca m llarkness dormitory. 
Returning alumni/ae will share the 
oppoilLinity to reminisce and catch up 
with old friends at our annual Alumni 
Reunion Weekend held on June 5 and 6. 
All alumni/ae are encouraged to attend. 
Quinquinnial reunions (celebrated every 
five years) will be held for classes ending 
in the years "2" and "7." For a prelimi¬ 
nary schedule of events, see page 43. 
Completion of the 1992 School of 
Medicine alumni directory is expected 
in June. Questionnaires and verification 
of data by telephone are being effi¬ 
ciently completed by the Harris Publish¬ 
ing Company. Inc. We look forward to 
the directory's completion and inclusion 
in our library. The Harris Company will 
solicit your subscription after confirm¬ 
ing the questionnaire data to save you a 
second call. 
The new Office of Alumni Affairs, 
located in the former Lee High School 
(100 Church Street, South, Suite 213), is 
spacious and attractive. An area has 
been designed especially for use by our 
alumni volunteers, and plenty of free 
off-street parking is available. You are 
welcome to drop by for a visit and tour. 
Our new mailing address is Office of 
Alumni Affairs, Yale University School 
of Medicine. P.O. Box 7613. New 
Haven, CT 06519-7613. The telephone 
number is unchanged at (203) 785-4674. 
We expect to hear from you. 
Finally. 1 would encourage all who 
have not contributed to the alumni fund 
to do so. The need for student financial 
aid and for the dean’s unrestricted fund 
is real. Your response to the Kresge 
Challenge was superb; our 1992 goal is 
to maintain or exceed the participation 
rate of 56 percent and a total gift of 
$700,000. Remember, every contribu¬ 
tion counts. 
Artluir C. Crovatto. '54 M.D. 
Director of Alunuii Affairs 
Dr. Arthur Crovatto. director of alunvu affairs, and Connie Tolliver, assistant to the 
director, in their new 100 Church Street South offices. 








Highlights: Alumni Weekend 
June 5 and 6 
Friday, June 5 
8:00 a.m. Registration 
1:00 p.m. Class reunion seminars (concurrent) 
4:00 Special presentation 
“Changing the curriculum within the Yale System” 
Moderator: Robert H. Gifford, M.D. 
Associate dean, education and student affairs 
5:00 Dean’s reception 
Saturday, June 6 
8:00 a.m. Registration 
9:00 Surgical grand rounds 
Introduction: William F. Collins, M.D., chairman, department of surgery 
9:15 Faculty seminars 
I. “How We Construct a Representative First-Year Class” 
Moderator: Robert H. Gifford, M.D. 
Associate dean, education and .student affairs 
II. “The Who and the How—The Care of Your Now-Dependent Parents 
Moderators: Leo M. Cooney Jr., M.D. 
Humana Foundation Professor of Geriatric Medicine 
Ronald Miller, M.D., associate clinical professor of medicine 
III. “The Second Decade of the AIDS Epidemic” 
Moderator: Gerald H. Friedland, M.D., director, AIDS program 
Professor of medicine and of epidemiology and public health 
Elizabeth Cooney, M.D. 
Director of HIV care. West Haven Veterans A ffairs Medical Center 
10:45 Annual meeting of the Association of Yale Alumni in Medicine 
12:30 p.m. Sherry and buffet luncheon 
2:45 Guided tours: Yale Center for British Art, historic sections of New Haven 
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CONTINUING MEDICAL 
EDUCATION AT YALE 
Saturday 
May 16, 1992 
The Journey of the Contemporary American Family: (A) 
New Frontiers 
Directors: Jane Gross and Jatiet Stork 
This conference will bring together leading authorities in the areas 
of marriage, child development, parenting and family systems. 
Wednesday 
May 20, 1992 
Comprehensive Care of the Pediatric Patient: (Bi 
The Acute Abdomen 
Director: Robert J. Tonlonkian, M.D. 
Wednesday 
May 20, 1992 
Clinical Controversies in Infectious Diseases 1992 tC) 
Director: Vincott Qiiagliarello, M.D. 
This symposium commemorates the 5()th anniversary of the clinical use of 
penicillin in the United States at Yale-New Haven Hospital. 
Wednesday 
May 27, 1992 
Fifth Annual Rheumatology Symposium - Lyme Disease (P) 
Director: Robert Schoen. M.D. 
This symposium will provide a focused update on all aspects of Lyme disease. 
Friday 
June 5, 1992 
Yale Alumni/ae in Ophthalmology Symposium (E) 
Pres idem: Robert L. Lesser. M.D. 
This symposium will deal with the latest advances in excimer laser, glaucoma, 
retina and ophthalmic plastic surgery. 
Friday-Sunday 
August 21-23, 1992 
Thrombosis, Thromboembolism and Thrombolysis 
Director: Michael D. Ezekowitz, M.D.. Ph.D. 
'fhis course is designed for physicians and other health care professionals faced 
with treating patients with thromboembolic disease. 
( IRCl.l-: Till-; APUKOI’RIATH LHTTIiRlS) ON TIIH ATTACHED POSTCARD TO OBTAIN MORE INEORMATION ON 
( (;nei;ri;nci;s discussed in this isseie. peease be si re to incel'de 'i OUR name and address. 

Yale M^cine ';•• 
&xRa Box 7612 PC 
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Alumni Bulletin of the School of Medicine Summer 1992; Volume 26, Number 3 
America the Beautiful: Who are You Beautiful for? 
In his coniniencement address. Dr. Frank J. Bia asks 1992 Yale medical 
graduates to prepare themselves for the pressures of a medical system that 
often devalues the most vulnerable members of society. 
Yale Orthopaedics: Just Short of Miraculous 
Orthopaedists have harnessed the human body’s natural healing 
power to offer new hope to patients with once fatal bone di.seases. 
Discover the latest in orthopaedics and rehabilitation. 
Emerging from the Shadows 
Dr. P.H. candidate Linda Schwartz, a former Air Force nurse, 
highlights the rich history of women in the United States Armed 
Forces—much of it in medical service. 
A Partnership Renewed 
A $9()-million capital renewal project at the Veterans Affairs 
Medical Center in West Haven serves as the backdrop for 
cooperation with Yale in patient care, education and research. 
A Career in Military Medicine 
Raymond L. Sphar, M.D.. M.P.H. '72, recalls more than 30 years 
as a physician and research scientist in the Navy, a career that 
grew up with America’s nuclear fleet. 
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GERARD BURROW NAMED DEAN 
Gerard N. Burrow, M.D., previously vice chancellor lor health 
sciences and dean of the University of California, San Diego 
School of Medicine, was named dean of the Yale University 
School of Medicine, effective July I. Former Yale President 
Benno C. Schmidt Jr. made the announcement at a press confer¬ 
ence in Harkness audi- 
.I:'»■ ^ ’I' torium on April 15. 
Dr. Burrow, a 1958 
YSM graduate and a 
member of its faculty 
for 10 years, was se¬ 
lected after an interna¬ 
tional search involving 
more than 140 candi¬ 
dates. Fie succeeds Dr. 
Leon E. Rosenberg, 
who last September was 
named president of 
Bristol-Myers Squibb 
Pharmaceutical Re¬ 
search Institute, based 
in Princeton, N.J. Dr. 
Robert M. Donaldson 
Jr., now on sabbatical, 
served as acting dean. 
In announcing Dr. 
Burrow’s appointment, 
Mr. Schmidt said: "We 
are fortunate indeed that 
Gerard Burrow is re¬ 
turning to Yale to lead 
the School of Medicine 
at this important time. 
Dr. Burrow will bring 
to the deanship extraor¬ 
dinary academic and 
administrative capacity. 
He is a superb and car¬ 
ing physician who has 
carried forward impor¬ 
tant research in endo¬ 
crinology and other 
medical areas. He 
brings unparalleled ad¬ 
ministrative experience in managing the development of contem¬ 
porary medical institutions." 
Commented Dr. Burrow: "These are the best of times, and 
these are the worst of times for medicine in the United States. 
Advances in molecular and cellular biology are causing a revolu¬ 
tion in clinical medicine. At the same time, 35 million Americans 
have no health insurance. This is a historical moment for leader¬ 
ship that can come from a great university medical school. I am 
Dr. Gerard N. Barrow 
delighted to be back at Yale and look forward to working with 
the outstanding faculty and students." 
At the San Diego medical school, where Dr. Burrow has 
served as vice chancellor and dean since 1988, he guided a 
major construction program and has helped recruit an out¬ 
standing faculty. 




Dr. Burrow brings 
to Yale extensive 
experience in the 
Canadian health¬ 
care system. He 
spent I 1 years in 
Toronto, Canada. 
From 1981 to 
1987, he was phy- 
sician-in-chief at 
Toronto General 
Hospital, and the 
Sir John and Lady 
Eaton Professor 
and chairman of 
the department of 
medicine at the 
University of 
Toronto. Prior to 
that, he was direc¬ 
tor of the division 
of endocrinology 
and metabolism at 
Toronto General 
Hospital and pro¬ 
fessor of medicine 
at the University of 
Toronto. He akso 
was professor of 
obstetrics and gy¬ 
necology at the 
University of 
Toronto between 
1978 and 1987. 
Dr. Burrow, a Boston native, earned a B.A. degree in 1954 
at Brown University and completed his internship and resi¬ 
dency training at Yale-New Haven Hospital between 1958 and 
1966. He served as chief resident from 1965 to 1966. Dr. 
Burrow is a member of the Institute of Medicine of the Na¬ 
tional Academy of Sciences, Society for Clinical Investiga¬ 
tion, Association of American Physicians, and Sigma Xi. the 
national scientific honor society. 
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EDITOR’S MESSAGE 
A New Dean, a New Dawn 
It takes more to imike one soi’e today than it did to make seven of 
Greeee... Ballasar Gracian 
It is not often that I take advantage of my position as editor to write 
for 't ALi; Medicink. hut tlie appointment of a new dean deserves 
eomment. Medieine is faeing eritieal times. Health-eare delivery 
is on everyone's mind. The piiblie desires aeeess to the most 
modern of diagnosis and treatment but is also aeutely concerned 
with the quality of the care they receive. The benefits of drugs, 
prosthetic devices, diagnostic procedures and treatments must I'ar 
v)utweigh any potential risk. Indeed, our patients expect the very 
best in results and do not expect adverse effects or misadventures. 
Whereas our patients must weigh risk against benefit, employ¬ 
ers, insurers and third-party payers are more concerned with cost 
and efficiency. Health-eare costs are escalating, and business and 
industry are advocating managed health-eare systems as a form of 
medical rationing. Physicians are under constant surveillance with 
pattern-of-praetiee review and pre-admission eeilifieation. In re- 
^ponse to these eoneerns as well as the constant threat of litigation, 
they are practicing a brand id' defensive medicine which often 
over-utili/es expensive resources, and ignores the art of medicine. 
Biomedical science is also under siege. Basie scientists are no 
longer viewed as altruistic explorers of nature. The Baltimore and 
Ciallo incidents have raised questions, not only about the validity of 
new seienee. but also about the self-serving motives of scientists 
with inflated egos. The ideas and discoveries of investigators are 
no longer part of the public domain. Seienee and scientists are now 
a commercial commodity. They are the resources for venture 
capitalists. New offerings are made on Wall Street merely by 
assembling a scientific advisory board of Nobel prize winners and 
members of the National Academy. Rven the stuff we are made of. 
our genome, is being patented. 
Universities are also under scrutiny. The allocation of the 
indirect costs of sponsored research has embarrassed the previ¬ 
ously hallowed halls of ivy. New forms of resource generation are 
being sought by medical schools, ranging from expansion of clini¬ 
cal practice to patronage from the biomedical industry. These 
efforts have raiseel eoneern that the true mission of the medical 
school, education, is being subjugated to more mercenary goals. 
I bis is the unsettled, even hostile en\ ironment that w'c in medi¬ 
eine face toilay. Our traditional mission here at Yale has been to 
prepare young men and women to enter the profession of medieine 
anti to give them the knowledge anti technical skills essential to 
clinical practice, teaching anti research in biological and medical 
sciences. Our educational gtials must be modified to directly face 
the problems anti eoneerns of modern medicine in the 'dOs and in 
the century to come. The major challenge to metlieal etiueation 
now is the integration of a rapidly increasing fund of basic bio- 
■tlieal know ledge into a new pattern t)f the tlelivery of metlieal 
care. It calls for a rapid transfer of seienee and technology from 
the laboratory to the clinic. It must emphasize ambulatory care 
and preventive medicine rather than hospitalization. It must be 
productive and efficient at the same time that it is compassion¬ 
ate and earing. It must use the skilled practitioners of the 
community as well as the clinician-scientists of the academy to 
educate our students. Our institution must lead in charting new 
ways for health-eare education and delivery which embody all 
of these aspects. 
This is the challenge that our new dean faces. Gerard N. 
Burrow. M.D.. Class of 1958. is well equipped to meet it. The 
national search for a dean has succeeded in identifying an 
individual whose talents and experience are uniquely qualified 
for the task. Dr. Burrow is a product of the Yale system of 
medical education. He is both a clinician and a medical scien¬ 
tist. His career has led him through the wilds of the Canadian 
health system, and he has already tasted the rewards and ago¬ 
nies of being a dean at the University of California at San 
Diego. He combines the talents of the medical scientist, skilled 
clinician, effective educator and experienced health science 
administrator. His leadership will ensure a prominent role for 
Yale in medieine of the 21 st century. 
Welcome home. Gerry! We. the alumni of this .school, .stand 
ready to support you in every way we can. 
Miehael Kashgarian, Mdl. '5H 
Welcome Dean Burrow 
Editor’s note: The following editorial appeared in the 
April 26, 1992 edition of the New' Haven Register. It is 
reprinted with pernnssion. 
New Haven should be heartened by the words of the new 
dean of the Yale School of Medicine, Dr. Gerard N. 
Burrow. He takes over July I. At a press conference last 
week. Dr. Burrow made special mention of the city, 
saying he intends to have the medical school under his 
leadership play an important role in inner-city New 
Haven. Heaven knows New Haven, particularly its poor 
and ill, can use all the help and attention it can get. 
Infant mortality, AIDS infection, drug abuse and gun¬ 
shot wounds are just a few of the crises here that can 
challenge the Yale School of Medieine. can inspire the 
institution to look for ways it can help arrest those 
problems. A dean w ho makes it clear he’s interested in 
inner-city problems here, before he even starts the job, is 
a promising signal for New Haven. 
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LETTERS 
Sterling Associates 
To the editor: 
In the FallAVinter 1991-1992 edition of 
Yale Medicine, two alumni were omit¬ 
ted from the list of Sterling Assoeiation 
members. Sheldon A. Jacobson, M.D. 
’28, and Jacob E. Tauber, M.D. ’76, are 
both 1990-1991 Sterling Assoeiation Fel¬ 
lows. Their commitment does mean a 
great deal to the School of Medicine and 
its alumni fund, and I would like to thank 
Drs. Tauber and Jacobsen again for their 
gifts. 
Monica C. Robinson 
Director 
School of Medicine Alinnni Fund 
Future Physicians 
Still Dedicated 
To the editor: 
Ann Pecora Diamond’s letter, “A 
Daughter’s Tribute,” which appeared in 
Yale Medicine Spring 1992, was very 
touching. 1 am certain that her father is 
an extraordinary individual and has been 
a model practitioner for these past .SO 
years. Ms. Diamond’s respect for his 
work and her admiration of him is very 
heartwarming. 
However, I must take exception to 
some comments in her letter, as I think 
that they are somewhat unfair. She indi¬ 
cates . . . “that one of the reasons medi¬ 
cine is not the respected profession it 
once was, is that too many of its younger 
members no longer share the value of 
dedication to the service of their fellow 
human beings that the older members 
took for granted. Medicine today has 
become a business.” Let me respectfully 
say that I have had the privilege of teach¬ 
ing Yale medical students for the past .^2 
years. I continue to be in awe of their 
dedication, sense of earing for the poor 
and underprivileged, and high .scn.se of 
ethics and morals. Ms. Diamond’s com¬ 
ments about the younger members of the 
profession do not do justice to a large 
number of nascent doctors who repre¬ 
sent the very best of our young caregivers. 
Let me also say that I graduated from 
medical school .J4 years ago. In my 
class and in the classes of other medical 
schools of that year, there were a range 
of individuals. Some r)f them were very 
idealistic, and like her father have con¬ 
tinued to provide the best of medical 
care for all of their careers. Others were 
more interested in the monetary gains in 
medicine and looked at the profession as 
a business. Perhaps doctors of a previ¬ 
ous generation were not very different 
from current ones. 
So. I think that the issue is not .so clear 
cut as Ms. Diamond makes it to be. Again, 
I applaud her admiration for her father, but 1 
do feel she has done an injustiee to many 
wonderful young doctors. 
Lawrence S. Cohen, M.D. 
Deputy dean 
Editor’s comment: 
Yale continues to take pride in prodncing 
physicians who can combine the utmost 
skill with the special art of caring in their 
practice. The same educational philoso¬ 
phy which produced Dr. Pecora is still in 
place today. Although onr current gradu¬ 
ates enter an enviroijinent more suspi¬ 
cious, even hostile to niedicine than in 
recent memory. I ani sure that they are 
prepared to exemplify the combination of 
personal integrity ami acadennc achieve¬ 
ment essential for the idea! compassion¬ 
ate physicia)}. 
International Progress 
To the editor: 
Congratulations on the Spring 1992 edi¬ 
tion of Yale Medicine. What a splendid 
tribute to Yale’s growing tradition of 
commitment to global concerns. The 
diversity and depth of university inter¬ 
ests and talents that focus on matters 
international is a surprise, even to those 
of us involved. Sometimes being close 
to the trees. . . . 
The welding together of the Univer¬ 
sity through common concerns for our 
world’s health and welfare is Just in time 
to enter the 21 st century! 
Lowell S. Levin. Ed.D.. M.P.H. 
Professor of public health 
More Warm Memories 
Of Wilbur G. Downs 
To the editor: 
Congratulations on the Spring 1992 is¬ 
sue of Yale Medicine. It is a great issue. 
I particularly enjoyed the article about 
Wilbur G. Downs. Let me share a little 
.story about my relationship to Dr. Downs. 
During World War 11, while in the 
Army, 1 commanded the 133rd Malaria 
Control Unit. At the end of hostilities in 
Europe 1 was in Rome, Italy, where I 
was serving as the public health officer 
for the U. S. Army in Rome, controlling 
malaria in the Pontine Marshes and co¬ 
operating with the Rockefeller Lounda- 
tion on the use of DDT. 
With the war over in Europe, 1 was 
.sent to the Pacific with my unit for the 
invasion of Japan. I arrived in Okinawa, 
where my unit was assigned to work with 
Maj. Wilbur Downs, who was the 
malariologist for Okinawa. Malaria was 
not a major problem there, but Japanese 
B encephalitis was, and Wil Downs as¬ 
signed me and my unit to work on this 
problem with him. A great experience! 
Eric W. Mood. M.P.H. 
Lecturer in public health 
Corrections 
In the .Spring 1992 Yale Medicine, the 
name of Nicholas M. Greene, M.D.. was 
misspelled on page 3. On page 12. the 
medical school class year of Marie- 
Loui.se Johnson, M.D. ’56, was listed 
ineorreetly. as was the class year of Ni¬ 
cholas P.R. Spinelli, ’41, M.D. ’44. 
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AMERICA THE BEAUTIFUL, 
WHO ARE YOU BEAUTIFUL FOR? 
hy Frank J. Bia, M.I).. M.P.H. 
Dr. Donaldson, ladies and gentlemen, I'aeiilty, students, new phy- 
sieians and proud families. Weleome to this joyous eelebration of 
so many dreams fulfilled. Today that feeling is electric, and it 
charges the air around us with fresh hopes and expectations. This 
is as it should be, so I offer congratulations to all who have been 
privileged to participate in bringing these dreams to fruition. 
Ha\ ing said that 1 must ask you to reHect for a few moments 
on how immeasurably sad it would be if the visions which en¬ 
gaged your minds and spirits were not allowed to reach your 
horizons and beyond. Our species does not tlourish when its 
individual and collective dreams go wanting. Langston Hughes, 
the African-American poet, asked us this same question: 
WJnit happens to a dream deferred? 
Does it dry up 
like a raisin in the sun? 
Or Jester like a sore 
and then run? 
Does it stitik like rotten meat? 
Or crust and sugar over— 
like a syrupy sweet? 
Maybe it just sags 
like a heavy load. 
Or does it e.xplode? 
Recent events in Los Angeles, once again, have answered 
Hughes' (.|uestion and point to several converging forces which 
will, most certainly, soon touch your lives. As new physicians 
you will labor at the interface between the biomedical sciences 
and this diverse society with which you have formed a social 
contract today. In so doing you Join the fellowship of men and 
women who have aided the sick for several millennia. In that 
relationship an unspoken pledge exists, a pledge to do our best for 
those under our care, regardless of ability to compensate on the 
part of either the patient or siK'iety. Our profession has a tradition 
of doing this, even under the most adverse circumstances, be our 
patients refugees from foreign wars or from urban blight. 
Many of ycni have already contributed tr) the community. I 
have seen it-medical students teaching about AIDS to high 
school students, or introducing the biological sciences at Hillhouse 
High School under Dean Ri)bert Gifford, and a multitude of 
indi\ idual efforts to make this city a better place. 
Irank.l. Bia. M.D.. M.B.U.. associate professor of inedicine and 
lahoratorv medicine, delivered the FJ92 Vide IJniversitv School 
of .Medicine conmiencement address. 
Will you continue to care? The answer. I am afraid, could 
be “no" if you are not aware of the tide now moving against 
your very best intentions. Firstly, even your future comfort 
and status in this society can become a potent narcotic, and 
under such intluences one cannot envy your mission as it takes 
you into the next century. Secondly, for better or worse, a 
reversion to 19th-century medical economics has occurred. 
An increasing proportion of medical care is now being pro¬ 
vided by for-profit hospitals and business ventures which, 
frankly, must make their profits from illness in our society. 
How long would you expect such enterprises to remain in an 
environment serving an economically stressed inner city, or 
fragile families that are no longer “profitable" but increasingly 
in need. “But doctor," you will hear, “this market is no longer 
viable." Translation: Your patient population became an 
economic liability to the very institution or practice in which 
you work. What will you do? 
To make matters more difficult, an increasing number of 
health professionals now own parts of the,se new and useful 
entrepreneurial ventures, such as home intravenous services 
and centers for specialized care. Where do those without 
financial resources fit into such a system? You w ill become a 
part of these decisions. It begins next month when you recei\'e 
your first call from an insurance company representative who 
considers a patient admission unwarranted, or subject to se¬ 
vere restrictions. Welcome to managed care—and you are not 
necessarily considered the manager. 
The dangers of such an environment become clearer when 
the subtle shifts of our own professional mind .set. or ulterior 
milieu, are understood. The .social contract that underlies our 
respected positions in society erodes when our time and efforts 
become tied up with institutional profits. Our role in society 
has clearly been a privileged one based upon a real trust in our 
advocacy for the patient, who has primacy in all our efforts, 
regardless of economics. 
Twenty-five years ago. .Sen. Robert Kennedy spoke rather 
hopefully in the Bronx at my own college graduation. It was 
June 1967. That July, the Kerner Commission was convened 
by President Lyndon Johnson, but it concluded that we ran the 
risk of becoming two societies “one black, one white—separate 
but unequal." Senator Kennedy and Dr. Martin Luther King 
Jr. were both dead before I had e\en completed my first year 
of medical school. The '6()s were over, but I need not apolo¬ 
gize for the aspirations. Since that time our society has be¬ 
come increasingly di\ ided along those very lines which many 
then hoped to obliterate. 
Today we applaud encouraging events in the former So\ iet 
republics and South Africa, as if we are ob.ser\ ing from the 
moral high ground. In fact, our own society slips increasingly 
into apartheid itself. We are dixided into haves and have 
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nets—into alTIuent suburban and pooier urban citizens based 
upon unequal educational opportunities, and disparate techno¬ 
logical competence in a very complex and demanding world. 
What makes it so sinister is that we fracture along persistent 
racial and ethnic fault lines. 
So here you are, ready to launch your career into a tempest of 
intersecting storms. How do you maintain your empathy and 
compassion in the face of institutional demands to maximize 
your productivity and minimize that which does not generate 
profit? Incidentally, teaching, be it in grammar school or medi¬ 
cal school, often falls into that same category: No profit, no 
gain. 
Well, it has been said that your best opportunities may come 
to you disguised as unsolvable problems. What do you do in the 
meantime? You remember your original goals, and seek a 
balance. The philosopher. Hillel, asked us; 
If I am not for myself, who will he for me? 
If I am only for myself, what am I? 
If not now, when? 
What is your real social contract? In essence, to strive to 
always make a difference for the better. By contributing your 
gifts equally to all members of this society, you begin to fulfill 
that vision. Do not simply accept—or even worse—tolerate our 
ethnic, racial and cultural diversity in your professional lives. 
This society is not a melting pot, nor should it ever become one. 
It is a multicultural mosaic, with many diverse pieces, interlock¬ 
ing relationships, all in living colors, which are never static. 
Revel in it—more importantly, be a constant part of it, and teach 
your children to do the same. 
Societies must be built upon an equal access to that which is 
good—and that includes you. Remind your health-care institu¬ 
tions. group practices, and even the dreaded third-party payers, 
that you answer to yourself and to the society which gave them 
life, along with the freedom to succeed. If you do not do so, you 
run the risk of also becoming part of the problem, not part of the 
solution. If, during these expectant days between graduation 
and internship, you can neither recall what was said here, nor 
who even said it (as sometimes occurred in medical microbiol¬ 
ogy), then just hold this single thought. 
A child at what passes for an elementary school in today’s 
South Bronx was asked to write a poem to present to Jonathan 
Kozol. the author of Savage Inequalities, during his visit there. 
No longer wide-eyed and innocent, she lives a life that does not 
quite match our manufactured television sit-com images of 
reality. She is rightfully bitter and resentful about her leaking 
school roof, rotting plumbing, emphysematous heating systems, 
dangerous environment and poor health care. For they all 
punctuate the egregious process already beginning to condemn 
her to the lowest rungs on our social ladder. 
Her two-line poem is worth committing to memory for the 
rest of your professional lives. 1 offer you her poem and her 
question as my parting thought for the Class of 1992. She 
writes: 
America, the beautiful. 
Who are you beautiful for? 
The harder you try to answer that question, the better physicians 
you will become. You have my word on it, but I think she really 
has said it all. YIVl 
Dr. Frank J. Bia 
Frank J. Bia: 
Leader in International Health 
Frank J. Bia was horn in the Bronx and attended Fordham 
University, the Jesuit university in New York City. He 
received his medical degree from Cornell in 1971. and 
spent the next year in South America and at the Harvard 
School of Public Health obtaining his M.P.H. degree in 
microbiology and tropical public health. Following four 
years of medical residency at the University of Pennsyl¬ 
vania, he came to Yale as a fellow in infectious diseases in 
1976, ultimately joining the medical faculty headed by 
Dr. Samuel Thier. 
His initial laboratory investigations centered on the 
pathogenesis of viral infections. While working with Dr. 
Edith Hsiung, he isolated and characterized a new herpes¬ 
virus of animals while engaged in .studies of human cyto¬ 
megalovirus infections. His career gradually moved him 
into tropical medicine and international health, while work¬ 
ing in Haiti, China and Thailand. He is committed to 
bringing young physicians into the developing world as 
part of their clinical training, and he has a particular 
concern for the Albert Schweitzer Hospital of Haiti. 
In 1991, he was one of 45 individuals in the United 
States chosen by the W.K. Kellogg Foundation of Battle 
Creek, Mich., as Kellogg National Leadership Fellows for 
three years. These fellows are felt to have high potential 
for future leadership in their fields. He lives with his wife, 
Peggy, who is also a member of the Yale medical faculty, 
and their two young boys, Jesse and Joshua. 
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ORTHOPEDICS AT YALE: 
JUST SHORT OF MIRACULOUS 
hy John Dinolfo 
To inimduce the uninitiated to his specialty, Gary E. Friedlaender. 
M.D.. chairnian and chief of orthopaedics and rehabilitation, 
engages them in a small ritual. Turning to his desk, which is 
buried under a snowdrift of papers, he pulls out a side drawer 
and produces a framed print that depicts two gaunt, bearded 
saints named Cosmos and Damian. In the Brueghel-like paint¬ 
ing, filled with images of revival and divine light, the third- 
century physicians perform an entire leg transplant on a dying 
nobleman. 
■■'I'hey're orthopaedic surgeons,” Dr. Friedlaender suggests 
with a wry smile. "You can tell by the halos.” 
All Jesting aside, as recently as two decades ago, it would 
have taken a miracle of similar magnitude to save the leg of 14- 
year-old "Christy.” Her X-rays revealed a tumor forming at the 
distal end of the femur, the thigh bone near the knee. With a 
diagnosis of osteosarcoma—bone cancer—the best chance at 
extending the teen-ager’s life would have required amputation 
above the knee. Even with this drastic treatment, the odds that 
Christy would live to celebrate her 2()th birthday would have 
been only one in five. 
Contrast the .scenario today. Because of a range of clinical 
advances, amputation in Christy's case is unlikely. For in¬ 
stance, improvements in chemotherapy, bone banking and bone 
transplantation now provide the teen-ager with at least a 70 to 
80 percent chance to walk down the aisle at her college 
graduation—on tw'o healthy legs. 
In the orthopaedic surgical unit at Yale-New Haven Hospital 
(YNllH), Christy's surgeon replaces her distal femur with an 
allogeneic bone transplant, a frozen femur altruistically donated 
by another person at the time of death and made available 
through a national bone bank system. Although her immune 
system recognizes the dead tissue as foreign and reacts to it, 
unlike with h\ ing, solid organ transplant.s—such as the kidney, 
heart or liver—the response is not severe enough to require 
immunosuppression. 
Before Christy leaves the hospital a week later, her blood 
vessels have begun to grow into the graft and living bone cells 
are replacing those of the donated tissue, which serves as a kind 
of template. Implantation of the cadaver-derived allograft not 
only allows Christy to keep her lower leg; with rehabilitation 
o\er the next year, she will regain a remarkable range of func¬ 
tion. including up to 90 degrees of flexion of her knee. Within 
the next five years—thanks to the skeleton's natural self- 
maintenance—Christy's li\ ing bone cells will replace much of 
the (.lead tissue of the allograft. 
John Dinolfo. o frcc-loncc writer, is o frequent eontrilnitor to 
y\tt Mtotdst.. 
With such results, even saints Cosmos and Damian would 
have been pleased. For Just short of miraculous is the human 
body’s viiluosity in transforming dead, frozen bone into live, 
viable tissue. This healing ability has been a welcome discovery 
for the estimated 2.000 Americans affected annually by osteosar- 
cotna, most of whom are between ages 10 and 25. 
Many of these young people will Join thousands of other 
Americans who will receive bone transplants to repair defects 
caused by major trauma or surgery for various cancers or other 
di.seases. This year in the United States, an estimated 200.000 
bone transplants or implants of various sizes will be 
performed—more than 100 of them at YNHH. “The national 
number is expected to increase fivefold by the end of the de¬ 
cade,” notes Dr. Friedlaender. 
A former president of the American Council on Transplanta¬ 
tion. Dr. Friedlaender performs 10 to 12 large bone transplants 
each year and scores of other transplants and implants. The vast 
majority of allografts are done in young or middle-aged 
patients—those most suited to endure surgery’s rigors and many 
months of rehabilitation. The dramatic increase in bone trans¬ 
plants nationwide in the past decade has followed major ad¬ 
vances in bone banking approaches and in chemotherapy to 
prevent cancer spread or recurrence. 
“Our group at Yale has helped to pioneer the bone-banking 
methodology,” explains Dr. Friedlaender, “from the technical 
aspects of removing the bone to the ethical issues involved in 
approaching the public.” 
Bone transplants, however, represent only one aspect of the 
clinical care provided by the department. Indeed, the faculty has 
advanced several areas in musculoskeletal medicine. 
“It’s an exciting time to be in orthopaedics,” says Dr. 
Friedlaender. Medical students from around the world appear 
to agree. Each year. 400 to 500 apply for five available resi¬ 
dency positions offered by Yale-New Haven Hospital. 
Dr. Friedlaender himself came to Yale as a resident in 
orthopaedic surgery in 1971 and progressed through the ranks to 
become .section chief in 1984. When orthopaedics and rehabili¬ 
tation became a department in 1986, he was appointed chair¬ 
man. 
As a resident physician. Dr. Friedlaender received his pri¬ 
mary training in orthopaedic surgery from Wayne O. Southwick, 
M.D., professor of orthopaedics and rehabilitation, a major 
force in this field for more than 30 years and Yale .section chief 
from 1958 to 1979 and 1983 to 1984. Currently, Dr. Southwick 
is director of spine surgery at Yale-New Haven Hospital. 
Dr. Friedlaender credits his mentor with laying the ground¬ 
work for today’s department: “Dr. Southwick taught us to be 
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generalists with areas of interest." he explains. That ongoing 
tradition has allowed Yale orthopaedies and rehabilitation to 
eontribute to the astonishingly rapid developments that have 
oeeurred in the field in the past deeade—as retleeted in the 
department's eurrent elinieal and research strengths. 
Taking the Spine in for Repairs 
"()\er the years, we've been an international leader in the 
mechanics of the spine," Dr. Friedlaender notes. “We spend a 
great deal of effort learning how to hold the spine together once 
it's injured so that neurologic function will be protected or 
recover and the bone will heal and restore stability." 
In this area, as well, the influence of Dr. Southwiek comes to 
the fore. Since the late 19.S()s. he and his colleagues have 
developed a wide range of procedures and spinal fixation de- 
\iees. including screws, rods, plates and other biofixtures to 
stabilize the spine during and after reconstruction. For some 
patients, these devices eliminate the need for a body cast. 
Dr. Southwiek often collaborates with hioengineer Manohar 
Panjabi. Ph.D.. professor of orthopaedics and rehabilitation and 
director of orthopaedic biomechanics, whose innovative labora¬ 
tory tests of cadaver spines have produced a wealth of new 
inlormation about the types and amount of traumatic force the 
spine can endure. 
■'Dr. Panjabi has developed the data to understand how the 
spine is put together, what happens when it gets injured, and 
what degree of injury warrants surgical treatment," Dr. 
Friedlaender explains. These data have been used to measure 
spinal instability in patients who suffer severe vehicular acci¬ 
dents or sports injuries and in the many people who suffer from 
chronic low-back pain. 
Total joint replacement is also a major clinical focus at Yale. 
"It's now possible to reliably replace the hip joint and the knee 
joint." Dr. Friedlaender points out. “Ninety-five percent of 
these patients do well." 
Part of this remarkable success rate is due to advances in 
biomaterials—such as porous metals into which bone can grow 
and which extend the life of synthetic joints. Better techniques to 
cement metallic prostheses to bone also have advanced the field. 
In the past decade, Richard R. Pelker. M.D.. Ph.D.. a professor in 
the department and director of Yale's total joint replacement 
services, has made major contributions to the development and 
evaluation of total knee replacement systems. 
Kristaps Keggi, M.D., clinical professor of orthopaedics 
and rehabilitation, heads the joint replacement service at 
Waterbury Hospital, illustrating the department's commitment 
to statewide cooperation in patient care, education and research. 
Colleagues at Yale, Waterbury and elsewhere are trying to 
improve the success rate for joint reconstruction of the shoulder, 
elbow and wrist. 
Yale is advancing the management of other skeletal abnor¬ 
malities, as well. "We are learning how to stabilize fractures 
very rapidly and effectively, for example, complex pelvic frac¬ 
tures, to mobilize patients so they don't develop complications 
due to bed rest." Dr, Friedlaender says. Such clinical care and 
research is the purview of Michael R. Baumgaertner, M.D.. 
assistant professor of orthopaedics and rehabilitation. 
Disorders of the foot and ankle are also important to the 
department, and these responsibilities are shared by Elly 
Trepman. M.D., assistant professor of orthopaedics and reha¬ 
bilitation and chief of orthopaedics at Yale University Health 
Service, and Enzo Sella. M.D., clinical associate profes.sor of 
orthopaedics and rehabilitation. 
A Rapidly Emerging Specialty 
Sports medicine, a rising star among orthopaedics and rehabili¬ 
tation specialties, also shines brightly at the School of Medicine. 
High school and recreational athletes compri.se the largest num¬ 
ber of sports medicine patients at Yale, though a growing num¬ 
ber are professional and college athletes, including some Olym¬ 
pic hopefuls. 
Located at New Haven's Long Wharf, the Sports Medicine 
Center is a collaborative program with Yale-New Haven Hospi¬ 
tal. The center offers the full range of state of the art rehabilita- 
ti\e services, from the care of badly pulled muscles and the 
fitting of orthopaedic appliances, to advanced arthroscopic 
surgery—the most important clinical development in sports 
medieine in the past 10 years. 
"At one time we used arthroscopy just to look." explains 
Peter .1. Jokl. .M.D.. professor of orthopaedics and rehabilitation 
and president of the American Academy of Sports Medieine. 
"Now we both look and do big operations using that technique. 
We can perform arthroseopie procedures within almost any 
joint, thus dramatically reducing morbidity" as compared to 
other surtzieal methods. 
University Provides Leadership 
In National Bone Banking System 
Yale University is part of a nationwide system of bone 
banks which involves several universities and medical 
centers. Participating institutions preserve, catalog and 
store cadaver bones for grafting. This supply of donor 
bones is matched with potential recipients according to 
anatomical size and shape. 
The medical history of the donor is carefully reviewed 
tt) rule out cancer or infectious diseases, such as hepatitis, 
AID.S or venereal diseases. Unlike solid organ transplants 
or blood transfusions, however, which involve living tis¬ 
sue. matching the donor's tissue or blood type is not 
required. With a bone allograft, the skeleton uses the 
donated tissue as a template which the body breaks down 
and replaces with the patient's own cells. 
Dr. (iarv I:. Friedlaender, chairman of orthopaedics 
and rehabilitation, has been a leader in the bone banking 
system for nearly 20 years. In the early I98()s, Dr. 
I riedlaenderwas principal investigator for an NIH-funded 
multi-center study into storage methodology, logistics 
and clinical applications of massive bone grafts. 
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Dr. Gaiy Friedkiender answers residents ’ questions about a 5-year-old 
boy’s recurrent tumor revealed by a CT scan of the pro.ximal femur. 
Arthroscopic surgery at Yale is also commonly done to 
repair damage to the shoulder, elbow, hip and ankle. 
“We’re even learning to put arthroscopes into the wrists 
and small joints of the hand to correct problems,” says 
Dr. Friedlaender, referring to the innovative approaches 
being developed by Scott Wolfe, M.D., assistant profes¬ 
sor of orthopaedics and rehabilitation and director of the 
hand and upper extremity service. 
The Hip Bone’s Connected to the...[mniune System 
In an era of interdisciplinary cooperation, orthopaedists 
have discovered that their field overlaps with immunol¬ 
ogy. In recent years, for example, biomedical researchers 
have uncovered key links between bone cells and im¬ 
mune cells, which both arise from common stem cells of 
the bone marrow. “We have also learned that many of the 
signals that direct bone remodeling come from immune 
cells,” says Dr. Friedlaender. “So the immune system not 
only regulates potential bone graft rejection; it also ap¬ 
pears to maintain normal bone homeostasis.” 
Trying to throw light on these dual features of the im¬ 
mune system is Mark C. Horowitz, Ph.D., associate 
professor of orthopaedics and rehabilitation and a noted 
immunologist. Such research is crucial, he points out, 
because patients develop a detectable immune response 
to 60 to 80 percent of bone transplants, especially large 
allografts. 
Yale is a major regional site for arthroscopic repairs to 
knee ligaments. During the last two years. Dr. Jokl and 
his colleagues have even used arthroscopy to repair tears 
to the medial meniscus, the gristle-like substance at the 
end of the tibia that allows the knee and leg bone to work 
together with a minimum of friction. 
In the past, during knee surgery, menisci were usually 
removed. That practice, however, produced a high rate of 
premature arthritis. Today, as Dr. Jokl explains, “We try 
to save the meniscus. If we have to remove any of it, we 
take out as little as possible to maintain as much function 
as possible.” 
In fact, the meniscus has proved so important that 
Marc T. Galloway, M.D., assistant professor of 
orthopaedics and rehabilitation, is performing successful 
meniscal and ligament transplants in animals and in se¬ 
lected human patients. He hopes that these pioneering 
procedures will soon lead to improved surgical care of 
athletes whose damaged ligaments or tendons have been 
removed. 
Additional .staff at the Sports Medicine Center include 
John Daigneault. M.D., assistant professor of orthopaedics 
and rehabilitation, an expert in shoulder injuries. The 
center also offers the services of clinical faculty members 
J. Kevin Lynch, M.D., clinical associate professor, and 
Joseph Wu. M.D., clinical assistant professor. 
Comments Dr. Friedlaender: “The Sports Medicine Cen¬ 
ter has been a model for collaboration of full-time .staff 
and talented community-based clinicians.” Dr. Wayne Southwick explains the workings of a bone drill to Dieter 
Lindskog. a Yale undergraduate who is conducting a hip fracture study. 
























"We can demonstrate that there is a real T-cell mediated 
response directed at the graft," Dr. Horowitz states. In other 
words, T-eells direct an immune system attack on the foreign 
cells in the graft as if transplants were foreign instead of self. 
What distinguishes grafts that are rejected? In a word, 
cytokines. In cell culture e.xperiments. Dr. Horowitz and 
colleagues have found that certain cytokines, specialized pro¬ 
teins made by T-cells, aetix ate osteoblasts—bone-forming cells. 
Osteoblasts, in turn, stimulate another kind of bone cell called 
osteoclasts to begin the process of removing dead or decaying 
bone. This process, called resorption, is a key first step in the 
remodeling of normal or transplanted bone. 
Orthopaedics and Rehabilitation 
Offers a Cornucopia of Services 
Begun in 1958 as a .section in the department of surgery, 
orthopaedics and rehabilitation graduated to full depart¬ 
mental .status in 1986, in keeping with the medical school's 
.Strategic Plan to expand services in musculoskeletal medi¬ 
cine. The department currently offers expertise in eight 
clinical subspeeialties: 
• spinal disorders, Drs. Wayne Soiitinvick, Thomas 
Roishaw, Manohar Panjabi and Trey Crisco; 
• joint reconstruction, Drs. Richard Peiker, Gaiy 
Friediaender and Krislaps Keggi; 
• molecular, genetic and cellular factors related to 
bone cancer, osteoporosis, osteoarthritis and other 
disorders of the skeleton, Drs. Roiand Baron. Gary 
Friediaender, Caren Gimdherg, Mark Horowitz 
and Agnes Vigneiy: 
• sports medicine, Drs. Peter .Joki, Joim Daigneaidt, 
Marc T. Gaiioway, Kevin Lyncii and Joseph Wn: 
• disorders of childhood, including congenital and 
acquired deformities, Drs. James Marsit and 
Ihomas Reitsiiaw; 
• repair of traumatic defects and fractures. Dr. 
Miciiaei Hanmgaertner; 
• abnormalities of the hand and upper extremity. Dr. 
Scott VT. Woife: 
• foot and ankle disorders, Drs. Eiiy Trepman and 
Jjizo Seiia. 
The tieparlment includes 17 full-time faculty; 1 1 focus 
primarily on clinical research and patient care and also 
staff a surgical division at the Veterans Affairs Medical 
Center in West Haven. Six faculty members focus exclu¬ 
sively on basic science—an unusually large contingent for 
an /\merican orthopaedics department. 
"There appears to be a critical balance," Dr. Horowitz says. 
"Too much cytokine production may induce graft rejection." 
To try and prove this contention, he and his team are attempt¬ 
ing to identify what level of cytokines are made by T-cells 
during bone transplantation. Once the researchers accomplish 
this, they will use advanced biomolecular techniques to deter¬ 
mine the appropriate range of cytokine production for success¬ 
ful bone remodeling—and bone graft incorporation. 
The Molecular Mechanisms of Bone Resorption 
Roland Baron, D.D.S.. Ph.D., professor of orthopaedics and of 
cell biology and director of biological research in the depart¬ 
ment of orthopaedics and rehabilitation, has been working with 
a team of 10 investigators on elucidating the molecular mecha¬ 
nisms by which osteoclasts resorb bone. 
"The process of bone resorption is not restricted to diseases, 
such as osteoporosis, cancers or Paget’s disease," explains Dr. 
Baron, "but is a normal process involved in bone growth, bone 
repair and bone turnover, replacing 20 to 30 percent of the 
skeletal bone mass every year." Hence, resorption maintains 
both the quality and the quantity of bone. 
A key observation made by this group was published in 
1985. demonstrating that osteoclasts secrete acid in order to 
digest the matrix of bone. Following up on this observation. Dr. 
Baron's group has now demonstrated that the molecule respon¬ 
sible for this acidification is different in osteoclasts than in other 
cells, opening new avenues for specific therapeutic intervention 
in diseases where bone resorption is increased. 
Dr. Baron's research also involves the characterization of 
other ion transporting systems in osteoclasts and their regula¬ 
tion by hormones, growth factors and new ly developed drugs, in 
collaboration with industry. He hopes insights gained in this 
research will lead to highly specific treatments for diseases of 
excessive bone resorption—especially osteoporosis. More than 
15 million Americans are affected by this disea.se. most of them 
post-menopausal women. "Dr. Baron's information could be 
critical to understanding how' to improve the treatment of these 
patients." Dr. Friediaender notes. 
Agnes Vignery. D.D.S.. Ph.D., associate professor of 
orthopaedics and rehabilitation and cell biology, is discovering 
how bone cells develop and differentiate to become functional. 
Dr. Vignery and her colleagues have identified molecules that 
govern the formation of osteoclasts, and they hope to use ge¬ 
netic engineering to monitor the differentiation of these bone 
resorbing cells. By so doing, they think that it will be possible 
to control the number and activity of bone cells and therefore 
prevent bone loss. 
Recently. Dr. Vignery and colleagues have identified mol¬ 
ecules that not only inhibit bone resorption, but stimulate bone 
formation and have potent immunosuppressive effects. They 
think that these molecules may be the ideal candidates to facili¬ 
tate not only bone grafts, but organ transplants in general. They 
are now investigating the role of these molecules in animal 
models. 
In collaboration with Dr. Florence Comite, associate profes¬ 
sor of medicine. Dr. Vignery is applying her re.seareh to investi¬ 
gate the mechanism by which bone is lost in women suffering 
from endometriosis. Endometriosis is a widespread and debili- 
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lating disorder that occurs most com¬ 
monly in women who are in their 2()s 
and 3()s. Dr. Comite discovered that 
endometriosis is associated with a loss 
of bone. Drs. Vignery and Comitc hope 
to prevent the further bone loss that 
may be associated with osteoporosis in 
these young patients. 
Yet another aspect of bone resoip- 
tion is being pursued in the laboratory 
of Caren Giindberg. Ph.D., an assistant 
professor in the department. She is 
refining ways to gauge .serum levels of 
the bone protein osteocalcin, which is 
made by the osteoblasts. 
“A small amount is excreted directly 
into the blood, where it can be mea¬ 
sured directly,” Dr. Gundberg explains. 
As such, osteocalcin is an important 
marker for increased bone turnover, a 
sign that too much bone resorption is 
occiniing. i^y Peter Jokl checks 
Dr. Gundberg believes a newly avail¬ 
able blood test for osteocalcin will help primary care physicians 
to diagnose osteoporosis before debilitating fractures occur. 
The test should also help orthopaedists monitor bone response 
to drug therapy for osteoporosis, thus eliminating the need for 
biopsies. 
On the Horizon 
the progress of a patient with a broken foot. 
cedures to a large extent is directly related to how effectively we 
devise rehabilitation programs that suit the needs of patients.” 
he says, adding, "We also look forward to working with our 
strong alumni group headed by Dr. Robert N. Margoiis, clinical 
associate professor of orthopaedics and rehabilitation. These 
physicians play a key role in our educational programs.” YM 
Dr. Friedlaender’s plans for the department include recruiting 
additional faculty, especially in the areas of spine surgery, hand 
and upper extremity surgery, as well as 
physical medicine and rehabilitation. 
“Dr. Thomas Renshaw, a pediatric 
orthopaedist and formerly the director 
of orthopaedics at Newington Children’s 
Hospital, joined our faculty in July to 
help us expand our commitments to the 
pediatric population in anticipation of 
the opening of the new Children’s Hos¬ 
pital at Yale-New Haven,” he says. Dr. 
Renshaw will be working with James 
March, M.D., assistant professor of 
orthopaedics and rehabilitation. 
Dr. Friedlaender envisions a full 
range of orthopaedic pediatric .services, 
from the correction of minor gait prob¬ 
lems to the management of complex 
multisystem disorders. Such di.sorders 
require the collaboration of 
orthopaedists, pediatricians, neurolo¬ 
gists, neurosurgeons and other special¬ 
ists that only a major center such as 
Yale can offer. 
Dr. Friedlaender also foresees a 
stronger emphasis on non-surgical .ser¬ 
vices. “The success of our surgical pro- Dr. Ag)ies Vigneny in her laboratory. 
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OUR UNKNOWN VETERANS 
EMERGE FROM THE SHADOWS 
Dd Niin^. Victiuiin. March 1970: U. Gen. Lain awards a medal to a Navy nurse servini> aboard the hospital ship USS Repose. Women 
served in all branches of the Armed Forces during the Vietnam War. 
bv Linda Spoonstcr Schwartz. R.N.. M.S.N. 
No one can say if il was planned t)r a quirk of fate that the 1980 
census was the first to ask Anterican women if they had served in 
the Armed I 'orees; records on the veteran status of men have been 
kept since Revolutionary War times. To the surprise of many, 
more than 1.2 million women told the census yes, they were 
veterans. Where had these veterans been hiding? 
Despite endless references to “our fighting men” during the 
two centuries and more of U..S. military history, until Operation 
Desert .Storm, one heard little about women in uniform. Women 
are rarely ilepieted in the scores of paintings, statues and memori¬ 
als commemorating America's military. Nor are they generally 
seen in the parades and ceremonies that honor veterans. “Vet¬ 
eran" is not a word Lisually associated with women. Some say it is 
America's best kept secret that women have served in and with 
t)ur Armed b'orees since the time the nation began. 
Beyond Molly Pitcher 
In the Revolutionary War, women served as nurses, scouts, 
messengers and effective defenders of lonely, isolated settle¬ 
ments when men were away fighting. One early reconnais¬ 
sance report advised British forces that “a raid into Connecti¬ 
cut was expected to encounter only rebellions women and 
formidable hosts of boys and girls." When colonial soldiers 
caring for their wounded comrades depleted the ranks of fight¬ 
ing men, the .Second Continental Congress authorized Gen. 
George Washington to hire women to nurse the sick. 
Legend may have immortalized Molly Pitcher, heroine of 
the Battle of Monmouth (N.J.) Courthouse, who took over 
firing her husband's cannon as he lay too badly wounded to 
continue. But have you ever heard of Debra Sampson? Dis¬ 
guised as a man. her battlefield heroics earned her decorations 
for bravery at the Battle of Tarrytow n (N.Y.) 
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How about Lucy Brewer? She served three years as a Marine 
aboard the USS Constitution during the War of 1812, at the 
same time women nurses served on the warship United States 
with Commodore Stephen Decanter. 
Women, North and South, played crucial roles in the Civil 
War. Soon after the outbreak of hostilities, a physician named 
Dr. Elizabeth Blackwell organized women in towns all over the 
North to collect much needed medicines, bandages and sup¬ 
plies. These community groups formed the Women’s Central 
Relief Organization, modeled after the Sanitary Commission, 
which supported Florence Nightingale’s efforts in the Crimea. 
The first such group appeared in Bridgeport, Conn., the day 
after Fort Sumter suiTendered. 
Forbidden to engage in combat, at least 400 women dis¬ 
guised themselves as men and fought in battle anyway. Women 
also served as spies, couriers and military strategists. In a more 
traditional vein. Superintendent of Female Nurses Dorthea Dix, 
a Boston school teacher, recruited and supervised 3,200 nurses, 
several of whom served with distinction. 
Clara Barton, founder of the American Red Cross, often used 
her own supplies and food to care for Union soldiers. After the 
war. Barton was responsible for establishing the first National 
Cemetery in Arlington, Va. Barton’s contemporary, author 
Louisa May Alcott, served as a volunteer nurse in Lhiion hospi¬ 
tals, describing her work in letters that were later published as 
the book Hospital Sketches. 
During the war between the states, Mary Ann Bickerdyke 
fought so hard for the rights and comforts of the common 
soldier that she was given the name “Mother” by the men. Gen. 
William Tecumseh Sherman conceded that she outranked even 
him when it came to caring for the sick and injured. It took the 
government 80 years to recognize her devotion by commission¬ 
ing the hospital ship SS M.A. Bickerdyke. 
Soldiering wasn’t the only role denied women during the 
Civil War. Female doctors were not allowed to serve the 
military, either. Mary Walker. M.D., gave up her medical 
practice to serve with the Union Army as a nurse. Going 
beyond the call of duty, she volunteered to he a spy, was 
captured by the South and later exchanged. 
Awarded the Congressional Medal of Honor, Dr. Walker 
became the only woman ever accorded the nation’s highest 
military honor. Ironically, her medal, along with those of 
several male recipients, was withdrawn in 1917 when the 
criteria changed. A special act of Congress restored the medal 
in 1976. 
By 1898, as America fought the Spanish-AmericanWar, the 
government began recruiting women nurses to care for the 
troops. Hired only on a contractual basis, however, Washington 
did not officially recognize them as part of the military and 
hence did not provide insurance, pension or emergency assis¬ 
tance, even if a nurse was injured in the line of duty. More than 
1,500 such contract nurses served in Latin America, the Pacific 
and on the hospital ship Relief. 
Such treatment did not deter many nurses from risking their 
lives. Clara Maass, for example, assisted with research into 
yellow fever transmission, studies which paved the way to the 
development of a vaccine. In volunteering to be bitten by an 
infected mosquito, she was the last human subject to be used in 
these experiments, and the only one to die. Unlike the women 
nurses before her, she was bui'ied at government expense with 
full military honors. In 1976, the United States issued a postage 
stamp in her honor, the only stamp ever to commemorate an 
individual nurse. 
The War To End All Wars 
Women’s status in the Armed Forces made progress of a sort 
with the Army Reorganization Act of 1901, which led to the 
founding of a permanent Nurse Corps. However, the 202 
“charter members” of the corps and their sisters in the Navy 
Nurse Corps, begun in 1908, found themselves with neither 
clearly defined roles, nor rank, nor military grade. 
When the “war to end all wars” broke out in August 1914, the 
largest organized group of nurses available for duty were 8,000 
Red Cross nurses, who supplemented the mere 400 Army nurses 
and 160 Navy nurses then on duty. This first cadre of nurses 
was immediately dispatched to serve with the British Expedi¬ 
tionary Forces in Europe. 
Recruitment and training of nurses at last became a govern¬ 
ment priority when America entered the war in 1917. Annie 
Goodrich, first dean of the Yale School of Nursing, founded 
the Army School of Nursing to educate the required numbers 
of nurses. Many of these women saw duty on the front lines 
and were wounded or gassed. Some were imprisoned by the 
Germans. 
Continued on page 15 
Lai Khe, Vietnam. September 1969: Capt. Bernice Scott. Army 
Nurse Corps, aids a mediccd team treating a wounded soldier. 












l.inda Spoonster Schwartz 
Linda Spoonster Schwartz: 
A Voice for America’s Veterans 
Linda Schwartz, a Dr.P.H. candidate at the department of epide¬ 
miology and public health, is writing her doctoral dissertation 
on the physical health problems of women veterans of the 
Vietnam War. She received her diploma in nursing from St. 
Thomas Hospital School of Nursing in Akron. Ohio, is a B.A. 
graduate of the University of Maryland and received a master’s 
degree in psychiatric nursing from Yale University School of 
Nursing in 1984. 
While in the Air Force, Ms. Schwartz .served both on active 
duty and in the reserves. She earned her senior Bight nurse 
rating while on duty with the 69th and 58th Aeromedical Evacu¬ 
ation Squadron at McGuire Air Force Base, N.J.. and the 2nd 
Aeromedical Evacuation Group at Rhein Main Air Base, Ger¬ 
many. A graduate of the Air Force School of Aerospace Medi¬ 
cine. Brooks Air Force Base, Texas, Ms. Schwartz created the 
position of Senior Flight Nurse Clinical Coordinator in the 
European Command. She retired from active duty in 1986 with 
the rank of Major. Nurse Corps. 
In 1985, she was elected president of the Connecticut Nurses 
Association. During her tenure, the as.sociation founded the 
Connecticut Nurses Foundation (CNF) and secured third-party 
ri‘imbursement in the state for nurses in advanced practice. In 
1986, she became CNF president, and the following year was 
elected to the board of directors of the American Nurses Asso¬ 
ciation. 
Ms. Schwartz, an advocate on behalf of all veterans, has 
testified before both houses of Congress seven times. In 1985. 
she was appointed to the Connecticut Governor’s Advisory 
Committee on Women Veterans and in 1989 to the board of 
trustees of the state Veterans Home and Hospital. In 1989, U.S. 
Secretary of Veterans Affairs Edward J. Derwinski appointed 
her to the VA Advisory Committee of the Readjustment of 
Vietnam and Other Wars Veterans. Two years later, she was 
appointed vice chairman of the committee. 
In 1990, Ms. Schwartz was elected to the national board of 
directors of Vietnam Veterans of America, Inc. (VVA), the only 
federally chartered veterans service organization which focuses 
on the needs of the nation’s 9.2 million Vietnam era veterans. In 
1991, she was elected VVA’s regional director for the New 
England states. She was also elected president of the Vietnam 
Veterans Assistance Fund, a non-profit organization that pro¬ 
vides financial, educational and research support to improve the 
status of Vietnam veterans and their families. 
Linda Schwartz resides in Pawcatuck. Conn, with her hus¬ 
band, Stanley, a restaurateur, and her 16-year-old daughter, 
Loiraine. 
Ms. Schwartz as an Air Force nurse aboard a medical evacua¬ 
tion flight to the United States during the Vietnam War. 
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Despite plaeing their lives in such danger, the nurses, in the 
eyes of their government, were of les,ser status because unlike 
soldiers, they were not engaged in combat. Therefore, the 
government docked the pay of the nurses for the time they spent 
as prisoners of war. 
World War I also saw women outside the nursing corps 
officially in uniform for the first time. Enlisted women, 12,()()() 
Navy Yeomanettes and 305 Marine Corps Marinettes, were 
assigned mostly as clerks or drivers. Gen. John “Black Jack” 
Pershing requested telephone operators fluent in French, who 
were dubbed “Hello Girls.” While these women were autho¬ 
rized stylish uniforms and rank, no one was required to salute 
them because the Army considered them civilians. Despite the 
fact that these operators served near the front lines, they re¬ 
ceived none of the insurance or benefits accorded the soldiers 
with whom they served. 
After the close of the Great War, although women had served 
honorably in Belgium. England, Italy and Russia, their contri¬ 
butions seemed unnoticed and unrewarded. Only the Marine 
Corps extended servicemen's benefits to women. Most women, 
especially Army nurses, had difficulty proving eligibility to 
benefits and care, even when disabled in the line of duty. 
Women were not even called veterans; they were referred to as 
“ex-military members.” 
Inequities were not limited to benefits and care. The 1920 
Army Reorganization Act gave nurses “relative rank.” a kind of 
shadow recognition which meant they could wear the insignia 
but could not enjoy the privileges of that rank. They could not 
eat with the other officers, did not receive pay equal to men of 
the same rank, and could not live in the officer’s quarters. 
Such practices persisted through the early years of World War 
II. Not until 1942 would women receive pay and allowances 
commensurate with men. Unequal treatment wasn’t limited to 
privileges and pay, either; it extended to the way the Armed 
Forces treated manned women as opposed to men who were 
maiTied. It wasn’t enough for the Army to make married women 
ineligible to join its nurse corps; until World War II, maniage 
was grounds for dishonorable discharge from the Coips—a pun¬ 
ishment usually reserved for convicted criminals. 
When marriage was finally permitted, nurses were not autho¬ 
rized to be stationed with their husbands. Although marriage 
for women in the enlisted ranks was tolerated, pregnancy was 
unthinkable. For any woman, married or unmarried, pregnancy 
was also grounds for a dishonorable discharge. 
Serving in a Popular War 
With the Japanese attack on Pearl Harbor and America’s entry 
into World War II, demands for military personnel were tem¬ 
pered by the need to maintain production of war materials at 
home. To free men up for combat duty, women were put to 
work in factories and at construction sites. They were once 
again called on as the unofficial national reserve force. While 
the need was great, the Armed Forces remained reluctant to 
allow women into military service or to accord them status 
when they did serve. 
This is well illustrated by the short-lived Women’s Army 
Auxiliary Corps (WAAC). Founded in 1942, WAAC was 
authorized with the understanding that it would not be part of 
the Army “but shall be the only women’s organization autho¬ 
rized to .service the Army exclusive of the Nurse Corps.” Out¬ 
raged by this double standard, a year later, Edith Norse Rogers, 
who was serving the remainder of her deceased husband’s 
Congressional term from Massachusetts, spon.sored legislation 
to disband the auxiliary and create the Women’s Army Corps 
(WAC) as a permanent part of the regular Army. 
In a curious bureaucratic twist, however, when the auxiliary 
disbanded, 15,()()() to Ib.OOO women left the .service and did not 
join the WACs. Hence, women who served only in the auxiliary 
were not “in the military” and did not qualify for any of the 
generous veteran entitlements authorized after the war. It was 
not until 1980. long after the post-war G1 Bill had expired, that a 
special act of Congress corrected this long-standing omission. 
Reverse discrimination against men also reared its ugly head 
during and after World War II. Men in nursing were not eligible 
to serve in any nurse corps until August 1955, when they were 
finally authorized commissions in the Army Reserve. These 
men were not offered regular Armed Forces commissions until 
the Vietnam War. 
Soon after the WAC legislation, the Navy bit the bullet and 
organized the Women Accepted for Volunteer Emergency Ser¬ 
vice (WAVES) as part of the Naval Reserve. In an unprec¬ 
edented move, the Navy turned to academia for help in design¬ 
ing the training program. Mildred McAffee, then president of 
Wellesley College, was .selected the first director and given the 
highest rank permitted a woman under the law. 
Lt. Cmdr. McAffee was at firsi unwilling to use the acronym 
for the rather elongated official title of the group. But a Wash¬ 
ington newspaper headline declaring “Gobletts Come to Town” 
convinced her that calling the women WAVES was preferable. 
Sailors soon developed their own translation of the letters: 
“Women Are Very Essential Sometimes.” 
In 1942, the Coast Guard, which had taken heavy casualties 
in the South Pacific, North Atlantic and Aleutian Islands, in¬ 
ducted women as SPARs (Semper Paratns—Always Ready). 
Throughout this period and in succeeding years, the Coast Guard 
would be the leader in accepting women and offering them 
equal opportunity for advancement. 
At the other end of the spectrum during World War II were 
the 900 women of the Women’s Air Force Service Pilots 
(WASPs). Organized in 1942 at the request of Army Air Corps 
Gen. “Hap” Arnold, these women logged more than 60 million 
air miles. They served as flight instructors and ferried 12.640 
airplanes, including high-speed fighters, bombers and P-47 
“Thunderbolts.” to overseas bases. They also had the dubious 
privilege of towing targets so fighter pilots using live ammuni¬ 
tion could practice on something nun ing. 
Other than their pay, these women garnered no military 
support and had to pay for their own meals and lodgings even on 
military bases. Although their duties were directed by the 
military, the women were not even eligible for medical care or 
insurance in case of on-the-job injury. 
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Of the 38 WASPs who were killed in crashes or while towing 
targets, not one received death or burial benefits. They were 
buried with no semblance of military honors. Not even a Hag to 
drape on their coffins. Often, their female comrades would 
have to "p^iss the hat" to bury them or ship their belongings 
home. Finally, in 1977. Congress ended this shame by extend¬ 
ing veteran status to these valiant women. 
During World War II. more than 384.()()() women served in 
the military. Women were injured, wounded, imprisoned and 
killed in action at Anzio and in the South China Sea. In a 
seldom told story r)f heroism. 81 military women were interned 
for 37 months at the camps o\'SciiUo Tomas and Los Banos in the 
Philippines. They struggled with primitive conditions to care 
for the injured, sick and dying. Along with the men. they 
suffered and starved during their long imprisonment at the 
hands of the Japanese. 
A March 18. 1992. “Salute to American Women Prisoners of 
War” in Washington. D.C., included a woman who had been 
imprisoned by the Japanese when she was 10 years old. She 
recalled the nurses vividly, and said that even the terrors of 
contending with the enemy, starvation and poor conditions of 
the camps were not enough to overcome their strength and 
determination. As long as the nurses were there, the woman 
said, she had faith that everything would be all right. 
Peacetime Recognition, Peacetime Conflicts 
Such tales of heroism from World War II led President Harry S 
Truman to sign into law the Women's Armed Services Act on 
June 12. 1948. Truman's pen finally established a permanent 
place for women in the military. Despite lingering inequities 
with regard to rank and assignments, this landmark law prof¬ 
fered official recognition to the nearly two centuries of military 
service women had given the nation. For the very first time, 
women had reason to envision a military career. 
During the Korean War—or as President Truman called it, 
the "F^eacetime Coiinict”—the nation once more turned to its 
women as an untapped military reserve. With .so few women in 
the military. Secretary of Defense Gen. George Marshall formed 
the Defense Ad\isory Committee on Women in the Armed 
Forces to encourage women to join the service. Over the years 
the committee, which still meets, has evolved into a vigorous 
advocate for change and innovations for women in the military. 
Korea also saw the first combat missions for the IJedgling 
U.S. Air F'orce and its Nurse Corps and Women's Air Force 
(WAF) contingents. This was the first time Air Force flight 
nurses and a structured aeromedical evacuation system were 
used to airlift casualties from the battlefield to facilities outside 
the combat area. In a major test of the system, 3,92.3 patients 
were airlilfed in one day from Korea to hospitals in Japan. .Such 
elliciency virtually eliminated the need for hospital ships to be 
stationcrl in waters adjacent to combat areas. 
fhis system also saved countless American lives in the 
nation's next undeclared war—Vietnam—which dragged on to 
becomr the longest war in United States' history. From the Gulf 
ol lonkin in 1964 to the fall of Saigon in 197.3. more than 
263.()()() women served in the military. While neither the de¬ 
partments of defense (DOD) nor veterans affairs (VA) can 
provide reliable data on the number of women stationed in 
Vietnam, their estimates range from 7.300 to 10.000. 
In Vietnam, most of these women served as military nurses. 
Others worked as physicians or in intelligence, supply, adminis¬ 
tration. air support and additional areas. Many Americans did 
not even realize that women were stationed in Vietnam; at 
times, even the government .seemed oblivious. 
A tragic example of government insensitivity was visited 
upon the Orlowski family of Detroit. Mich, in 1967. When they 
received a telegram informing them of the death of their son in 
Vietnam, they were confused. They had no son in Vietnam. 
They did have a daughter, 1 st Lt. Hedwig Orlowski, who had in 
fact been killed in a helicopter crash. Lieutenant Orlowski and 
seven other women, all military nurses, died in Vietnam. Their 
names are engraved on the Vietnam Veterans Memorial in 
Washington, D.C. 
Vietnam redefined war. There were no front lines, no safe 
places, no rules. Even American hospitals were raided by the 
Viet Cong, who machine-gunned patients in their beds and 
threw satchel charges throughout the wards. Caring for casual¬ 
ties presented a special emotional challenge because they were 
so young, the average age of the Vietnam soldier being 19 as 
compared to the 26-year-old World War II soldier. 
Exposure to enemy fire, primitive living conditions and the 
endless streams of casualties did take an emotional toll on 
military nurses and other medical caregivers. Yet their proxim¬ 
ity to battle—sometimes in the midst of the action—allowed for 
record numbers of lives to be saved. In Vietnam, less than 2 
percent of treated casualties died of their wounds. 
Loii}^ Binli, VieDuim: Capt. Elizabeth Finn, staff' mirse, 93rd 
Evacuation Hospital, instructs a nun from a local orphanage. 
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Sadly, this remarkable accomplishment did not boost morale 
for military nurses. The unpopularity of the war, the devastat¬ 
ing nature of the injuries they treated and the empty welcome 
home left many women disheartened when they returned to 
America. My own return for a surprise visit in early May 1970 
offers a dramatic example. 
I had tlown home from Japan with a planeload of casualties 
from Vietnam so that I could attend my sister’s college gradua¬ 
tion. I arrived in northern Ohio on a beautiful spring day. My 
father greeted me at the door, expressing the shocked delight I'd 
hoped for; after all, I hadn’t seen my family in 18 months. 
When I explained why I’d come home, however, his face 
fell. There would be no graduation, he said. There had been 
trouble at my sister’s university, Kent State, the day before. 
Three students had been killed by the National Guard during 
anti-war demonstrations. The campus was closed. 
Still dressed in my uniform, I entered the kitchen where my 
sister was sitting at the kitchen table with my mother and 8- 
year-old brother. It was so wonderful to see them. But to my 
amazement, my sister abruptly stood up, slammed me against 
the wall and started screaming about the war. It wasn’t the 
homecoming I’d dreamed about. 
My sister was not part of the demonstration but had been near 
the green when the shooting started. Shooting. I knew too well 
what bullets did to human flesh. I thought about the boys I had 
come home with—missing arms and legs, missing eyes, missing 
faces. I thought about how close my sister had come to harm. I 
thought about American civilians dying at the hands of Ameri¬ 
can soldiers. And I wondered where the war really was. 
Long Binh, Vietnam, June 1967: Capt. Faye Ferrington helps a 
patient of the 93rd Evacuation Hospital feed himself 
For all its horrors, the Vietnam War furthered the cause of 
women in the military. Combined with a growing feminist 
movement, the war stimulated such changes as 1967 legislation 
lifting the ceiling on promotions for women. As a result, the 
Army saw its first woman general. In 1970, pregnant women 
were permitted to stay in the military, though, curiously, their 
condition remained a “service-connected disability” until 1975. 
During the Vietnam era. the Armed Forces disbanded the 
WAC, the WAF and—in tacit admission that women were not 
just sometimes essential—even the WAVE, and integrated their 
members into military units. When the draft ended in 1973, the 
2 percent limit on the number of women on active duty also 
came to an end. At that time, women comprised 1.6 percent of 
the military; by 1991, this increased to 11 percent of the active 
duty force and 13 percent of the reserves. 
In the late 1970s, women doctors began to serve in military 
hospitals. They were the only women to do so since Mary 
Walker became the first officially recognized woman military 
physician during the Civil War. 
The last bastion to fall came in 1980. when women were 
finally admitted to the service academies. These changes brought 
expanded roles for military women. By 1990, 100 percent of 
Coast Guard, 98 percent of Air Force. 59 percent of Navy and 
52 percent of Army positions were open to women. 
Navy and Coast Guard women who command vessels at sea 
are living proof of the progress made in these branches of the 
Armed Forces. Navy, Air Force and Army women are rated as 
test pilots and flight instructors. Some have even been assigned 
as commanders of aircraft squadrons. 
Army women participated in the invasion of Grenada and 
commanded Army companies in “Operation Just Cause” in 
Panama. Americans thought they were hearing things when 
CNN broadcast that a unit of the 988th Military Police Com¬ 
pany commanded by Capt. Linda Bray was engaged in a vigor¬ 
ous firefight with 40 members of the Panamanian Defense 
Forces. Captain Bray is thought to be the first servicewoman to 
command in combat. 
While such responsibilities reveal dramatic progress, they 
only heralded the dawn of equality. Take, for instance, the Air 
Force women who flew missions in Grenada and in the action 
against Libya. Although these women undertook the same 
missions, performed the same duties—with just as much valor 
as the men. they were not awarded the same medals because 
such decorations can only be given in combat situations. 
But they did engage in combat, you object? In a classic 
application of Catch-22, these women were denied equal recog¬ 
nition because the law states that they cannot serve in combat. 
Never mind that the heat of battle brought the hostilities to 
where the women served; because of the combat law. they could 
not receive the same medals as the men. 
In many respects, military women came into their own dur¬ 
ing the Persian Gulf War, the first large-scale military operation 
since the all-volunteer force was established. More than 33.300 
women served in key combat support positions, commanding 
battalions, manning Patriot missile placements, flying recon¬ 
naissance and tactical transport missions. Army Lt. Phoebe 
Jeter distinguished herself as the first woman to “engage the 
enemy,” by directing Patriot missile launches that destroyed 
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two Scud missiles. Several women were wounded in Operation 
Desert Storm, six were killed in action, seven others died in the 
line of duty and three were taken prisoner of war. 
Women's difficult path toward equality in the Armed Forces 
is paralleled by the struggle of women veterans. For many 
years, a bronze plaque at the entrance to the Veterans Affairs 
Central Office in W'ashington. D.C., expressed the perceived 
mission of the department. Taken from Abraham Lincoln’s 
second inaugural address, the solemn words read; “To care for 
him who shall have borne the battle.” 
If the results of the 1980 census raised many questions about 
this new found entity—women veterans—one conclusion was 
inescapable. The system was failing the million-plus women 
veterans who were not utilizing VA benefits. 
Along with the census, other dynamics were emerging to 
awaken the public and Congress to the fact that the VA should 
be providing better medical care to women veterans. Even as 
legislation was being proposed to extend benefits to the WASPs 
and WAACs of World War II. thousands of women were return¬ 
ing from Vietnam. 
.Many of this new generation of women veterans displayed 
symptoms of post-traumatic stress disorder (PTSD), yet the VA 
denied them treatment. To begin with, they were not considered 
combat veterans; a diagnosis of PT,SD was reserved for men 
w ho carried guns, not for the women who cared for them when 
they became the carnage of war. 
.Such official resistance did not sway these women from their 
conviction that Vietnam was responsible for their terrifying 
memories and readjustment problems. They were having mul¬ 
tiple miscarriages, stillborns and giving birth to children with 
cancer. They wanted answers. And they would not be ignored. 
Soon after the 1980 census. Congress finally granted veter¬ 
ans' status to the women who had .served in the Women's Army 
ALixiliary Corp (W'AAC). Ffecause the G1 Bill had expired, 
some in Congress tried to extend comparable benefits to these 
women. Although these attempts failed, the controversy only 
heightened the resolve of the Vietnam veteran women. 
One out of five women who served in Vietnam left with a 
permanent service-connected disability. Although the.se dis¬ 
abilities qualified them for care in the VA. when they sought 
sLich care, they were either turned away or received substandard 
treatment, d'he Women's Pixqect of Vietnam Veterans of 
America (VVA)—funded, ironically, by the Playboy 
Foundation -lobbied for a General Accounting Office (GAO) 
study about the matter. 
.Advling to this momentum. Lynda Van Devanter. an Army 
nurse who had served in Vietnam, published Home Before 
Morning, a book about her years of struggle to overcome her 
emotional and physical wounds of war. This book helped other 
women veterans see that they were not alone with their terrify¬ 
ing memories and illnesses. 
A 1982 GAO report. “Actions Needed to Insure that Female 
Veterans Have Equal Access to VA Benefits." noted: 
• A woeful lack of treatment facilities L)r women veter¬ 
ans; 
• Lnequal access to treatment programs and medical 
ser\ ices; 
• Insufficient provisions for privacy; 
• Incomplete physical examinations; 
• Little or no gynecological care; 
• No systematic effort to inform women about their 
entitlements. 
In 1983, the VA established an Advisory Committee on 
Women Veterans to help revise policies and adapt services to 
the growing number of women veterans. The VA also directed 
that all future research of veterans include women. Later that 
year, in a long overdue tribute, women POWs held by the 
Japanese during World War II were finally recognized at a 
Washington reception. 
Congressional hearings on women veterans held in 1983 
opened many eyes. Women veterans reported that they were 
expected to use communal showers while being treated in VA 
hospitals. Some witnesses recounted how they had been exam¬ 
ined in full view of male patients; others that they had been 
denied care altogether because of their gender. 
Rising interest in women veterans prompted the VA to com¬ 
mission a 1985 study, “The Survey of Female Veterans." which 
reported that more than half the women interviewed were un¬ 
aware of their VA benefits. The study also found that women 
veterans had twice the rate of cancers than in the general adult 
female population. Especially disturbing were the high rates of 
cervical, uterine and ovarian cancers (45 percent). Though 
initially the VA took exception to some of the.se findings, the 
department nonetheless began a vigorous campaign to acquaint 
women veterans with their benefits. 
Coincident with the belated recognition of World War II 
POWs. WASPs and WAACs came efforts to create memorials 
to servicewomen. Once again, the Vietnam servicewomen led 
the way by establishing the Vietnam Women’s Memorial Project 
in 1984. The Women in Military Service of America Founda¬ 
tion debuted in 1987 to raise funds for a memorial to honor all 
American women who had served in uniform. After making its 
way through nine years of governmental delays and red tape, the 
former memorial will break ground on Nov. 11, 1992; the latter 
is far from that point. 
Most recently, 1991 Congressional hearings on VA services 
to women veterans reported some improvements. Many wit¬ 
nesses, however, repeated complaints voiced during the 1982 
hearings. A later GAO report substantiated many of the.se 
claims. In short, the struggle continues. 
The saga of each succeeding generation of women veterans 
unfolds like a rich tapestry woven with the finest fibers of 
American traditions and values. Marvelous stories tell of cour¬ 
age in the midst of the enemy, determination in the face of 
overwhelming adversity and great devotion and caring for the 
casualties of war. The spirit and .service of these forgotten 
daughters of America have written some of the most heroic 
chapters in the history of the nation. These women have con¬ 
tributed to the time-honored tradition of sacrifice made by all 
American patriots. 
It's time that we gave them their due. 
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WEST HAVEN VA AND YSM: 
A PARTNERSHIP RENEWED 
Norman E. Browne, executive director of the Department of Veterans Affairs Medical Center. 
by Robert A. Hamilton 
Visitors to the Department of Veterans Affairs Medical Center in 
West Haven, Conn., are as likely to hear the high-pitched whine 
of a power saw as they are the beeping of a doctor's pager, as 
engineers and contractors scnrry around the grounds to complete 
a six-year, $90 million capital project. 
“Last year we had more than $22 million worth of construction 
underway at one time, the largest amount in the VA system,” 
boasts Jeremiah P. Clay, chief of building management. 
Modernizing and expanding the 39-year-old facility is adding 
to the upbeat mood at the West Haven VA, in growing recogni¬ 
tion that the medical center is again a leader in the national VA 
system. This feeling represents a dramatic turnaround. 
Only four years ago, when the West Haven VA brought in 
Norman E. Browne as its director, the institution reflected the 
distressed state of the national VA system. The physical plant, 
both inside and out, was crumbling. Only 270 of 456 acute-care 
beds were in use. The surgical residency program was in danger 
of losing its accreditation because of low workload. 
In fact, so serious was the national VA system’s health that in 
1988 Congressional hearings, Leon E. Rosenberg, M.D., then 
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YSM dean, warned that further deterioration threatened the 
VA’s affiliations with leading universities such as Yale. 
Three years after those hearings, while the national VA 
system still struggles with quality issues related to federal 
cutbacks, the West Haven medical center has blossomed. To¬ 
day, Mr. Browne notes, the average patient census is 370. with 
many units running near capacity. And in the last three years, 
the West Haven VA has seen the largest increase in workload 
of any facility in the VA system. 
What is more, the West Haven VA began several new 
national programs, and improved others already in operation. 
Pay scales for physicians, nurses and health professionals have 
been improved. As a result, the campus that overlooks New 
Haven from the west is back on the cutting edge of medical 
science. What brought about the change? 
Mr. Browne credits the School of Medicine, especially the 
leadership of former Dean Rosenberg and Acting Dean Robert 
M. Donaldson Jr., who for many years has been active at the 
West Haven VA. "Drs. Rosenberg and Donaldson breathed 
new life into the system,” Mr. Browne says. 
Robert A. Hamilton is a free-lance writer. 
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A 3()-year Partnership 
The School of Medicine's affiliation with the West Haven VA 
dates from when the latter opened its doors in 1953. This debtil 
came seven years after Gen. Omar Bradley, administrator of the 
VA system after World War 11. matched the VA's critical need 
for physicians with medical schools' needs for hospitals in 
which their students and residents could train. 
Nationally, although 103 out of the country's 126 medical 
.schools are affiliated with a VA hospital or medical center, the 
degree of cooperation varies w idely. At one e.xtreme, the affili¬ 
ation can consist of .sending a lone ophthalmology resident for a 
rotation every semester to a VA hospital 150 miles away. At 
Yale, by contrast, the affiliation is comprehensive, with the two 
institutions sharing responsibilities in patient care, education 
and research. 
In fact, all YSM clinical departments except obstetrics and 
gynecology and pediatrics have VA counterparts to which they 
are linked. With an increasingly vocal population of more than 
a million women veterans clamoring for better health care from 
the VA nationally |see “Our Unknown Veterans Emerge from 
the Shadows," page 12|, a possible program in ob/gyn is under 
discussion as well. 
Perhaps the most obvious example of the close Yale/VA 
relationship is the fact that West Haven VA staff physicians 
have Yale faculty appointments. For example, Colin E. 
Atterbury. M.D.. chief of staff at the West Haven VA. is also 
professor of medicine at Yale and associate dean for veterans 
affairs. He explains that of 300 physicians contributing to care 







/)/' Colin /-. Allcrhiirw cliicjOJ slcij'f cil ihe W est lldvcn VA. 
How much time a doctor might spend at the University 
versus the VA depends on a number of factors. “Some Yale 
faculty members spend almost all their time out here. Their 
research is centered here, they supervise patient care here," says 
Dr. Atterbury. “There are others who may only spend four or 
five hours a week” as attending physicians. 
Although many people think of the VA system simply as a 
vast patient care network, education and research also play 
important roles, says Robert H. Gifford. M.D.. associate dean 
for medical education and student affairs at Yale. For 10 years. 
Dr. Gifford has served at the West Haven VA, first as associate 
chief of staff and then as chief of medicine. He points out that 
more than half the nation’s doctors received at least some 
training in the VA system. 
“The VA nationally is an extremely important part of medi¬ 
cal education, and it’s never received the credit it should." Dr. 
Gifford says. Each year more than 3(),00() medical residents and 
22,000 students get some training in a VA facility. 
In West Haven, both Yale and the VA gain from the partner¬ 
ship. On one hand, the West Haven VA benefits from the 
services of Yale medical students and residents who bring with 
them state-of-the-art medical practice. On the other hand. Dr. 
Gifford notes, the VA offers “one of the most critical parts of 
our teaching program. The students and house staff have a great 
deal of responsibility to make decisions, under supervision. 
There's no way you can learn medicine unless you do it yourself 
with the proper guidance, and that's what you get at the VA." 
Furthermore, the physicians-in-training gain exposure to a 
different patient mix than they do at other Yale-affiliated hospi¬ 
tals. such as Yale-New Haven Hospital (YNHH). For instance, 
approximately 60 percent of West Haven VA patients have a 
chemical dependency, compared to 25 percent at YNHH. Half 
the beds at the West Haven VA serve rehabilitation patients, 
compared to one-third at Yale, and more patients at the VA have 
multiple diseases, due in part to a higher average patient age. 
Notes Dr. Donaldson. “Not only is the West Haven VA 
facility the home of some of Yale's finest physicians and clini¬ 
cal teachers, but the good will and collegiality of its veteran 
patients make it a wonderfully positive environment in which 
our students and residents can learn. By offering the best pos¬ 
sible supervision, the West Haven VA teaches how to care for 
and serve disabled people in the best possible ways." 
Finally. Yale students and residents learn the hard lessons of 
cost control on the West Haven campus. Due to federal budget 
constraints, especially during the 198()s when medical inllation 
was running at 10 percent or more a year, the VA system was 
making do with 2 percent annual increases, despite a rapidly 
growing patient load. Today, as a result, the West Haven VA, 
with 450 acute-care beds and 90 long-term care beds, has a $ 102 
million annual budget, less than some non-profit v oluntary hos¬ 
pitals in Connecticut that are half its size. 
Dr. Donaldson emphasizes that despite such constraints, the 
West Haven VA Medical Center .serves as a “model of excel¬ 
lence" in veterans' care, including service to those of modest 
means: “In an era when everyone—physicians, patients and 
healthy people alike—woiry about the frightening costs of medi- 
Continned on page 24 
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PET Offers VA, School of Medicine 
Most Advanced Imaging Technology 
Overthe entrance to the Yale University/West Haven VA Positron 
Emission Tomography (PET) Center stands the seal of the De¬ 
partment of Veterans Affairs on the left. On the right rests the 
School of Medicine's coat of arms. Of equal size, the emblems 
symbolize the partnership that has brought the latest diagnostic 
imaging technology to Connecticut. The PET center is the only 
facility of its kind between New York and Boston. 
"The PET center is going to benefit not only veterans, but all 
the people of Connecticut,” says Robert Soufer, M.D., center 
director, chief of general and cardiovascular nuclear medicine 
service at the VA and an associate professor at Yale. 
Dr. Soufer explains that while traditional imaging 
techniques—from X-ray to magnetic resonance imaging 
(MRl)—provide anatomical information, PET yields metabolic 
data. Here’s how PET works at the Yale/VA center: 
• An on-site cyclotron prepares isotopes with extremely 
short half-lives, ranging from a few minutes to approxi¬ 
mately two hours. PET technicians use the isotopes to 
label substances such a glucose or water, which the body 
metabolizes. 
As the patient lies comfortably on a table attached to the 
scanner, a solution containing the labeled substances is 
injected into the patient's bloodstream. 
• The table is passed through the opening of the donut¬ 
shaped scanner, and the PET device’s 1,320 crystals 
monitor the gamma ray signals. 
• A computer translates these signals into images that offer 
data about the metabolic processes taking place within 
the targeted organ. 
Most PET procedures last from 45 minutes to an hour; total 
radiation exposure is equivalent to approximately two X-rays. 
PET offers physicians an effective tool for early intervention 
because it can detect metabolic events that precede anatomic 
changes in many diseases, including cancer. In addition. Dr. 
Soufer notes, “PET is a tool to ensure the appropriateness of 
care. PET might not tell you a tumor is cancer. You still need a 
biopsy to do that. But it can tell you how well the patient will 
respond to an intervention.” 
PET also offers data that can avoid unnecessary surgery. Eor 
instance, a PET scan can allow a surgeon to detennine when not 
to operate on a patient’s heart, because the tissue in question is 
dead. The first papers from the PET center reporting new 
findings in myocardial metabolism were presented by Dr. Soufer 
at the International Society of Nuclear Medicine in June in Los 
Angeles. 
How did the VA and the University manage to bring such 
sophisticated technology to the New Haven area in a time of 
belt-tightening both within the national VA and at Yale? The 
two institutions pooled financial resources. The VA authorized 
a grant of almost $3 million for the center, says Dr. Soufer, the 
principal investigator for the VA grant, and Yale raised a similiar 
amount through corporate sponsors. 
Yale technical cxperti.se helped the We.st Haven VA become 
one of the first medical centers in the VA system to obtain PET 
technology. At the same time, the VA grant helped Yale obtain 
its own PET device sooner than would have been possible other¬ 
wise. because the state Commission on Hospitals and Health 
Care had not approved the technology for clinical use. 
State permission to collect from third-party payers began in 
July 1992, in part because of the many clinical applications that 
PET offers, including: 
• measuring the metabolic activity of a tumor to predict 
how quickly it might spread; 
• pinpointing tumor location for surgery; 
• measuring ammonia IJow and sugar metabolism in the 
heart to determine the extent of cardiovascular disease; 
• predicting the recovery potential of a stroke patient based 
on glucose uptake in the brain; 
• locating the foci of epilepsy in the brain as a prelude to 
surgery. 
A testament to Dr. Soufer's commitment and drive, the Yale/ 
VA PET center’s early patient statistics are impressive. During 
its first eight months, the center .served 1 15 patients. The 
facility can accommodate six patients a day. 
Dr. Robert Soufer e.xcunine.s a patient before performing a 
PET scan at the YaleA'A center. 
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PTSD Sufferers Offered Hope 
Through West Haven VA Center 
Although the Persian Gulf War ended more than a year ago, for 
"Tom," a 28-year-old veteran, the war still rages. A combat 
veteran, he guarded a compound that was attacked by Iraqi Scud 
missiles. Daily, he e.xperienced the screaming sirens which 
warned that the deadly missiles would soon follow. 
Now. when Tom is awakened at home by an ambulance 
siren, he still waits in dread of incoming missiles: Tom suffers 
from PTSD—post-traumatic stress disorder, a condition in which 
certain sounds, smells or images evoke traumatic events from 
the past. 
Tom is a patient at the Department of Veterans Affairs 
National Center for PTSD in West Haven. Several hundred 
\ eterans. from World War II to the Persian Gulf War. are served 
by the center, where treatment includes psychotherapy, group 
counseling and medication. In an effort to improve treatment of 
PTSD. the center also conducts a broad spectrum of basic and 
clinical research involving animal and human subjects in col¬ 
laboration with scientists at the medical school and its affiliated 
institutions. 
In one of those studies, scientists have discovered that trau¬ 
matic events may substantially alter the chemistry of the brain, 
sensitizing PTSD sufferers to adrenaline surges decades later. 
These surges may account for symptoms of PTSD and panic 
disorder. Pinpointing how those events change brain chemistry 
will help therapists develop drug and psychotherapeutic treat¬ 
ments for PTSD sufferers, say the Yale/VA researchers, who 
work at the Clinical Neuroscience Division of the National 
Center for PTSD. 
The West Haven PTSD center is the only center in the VA 
system devoted to studying the biology and psychopharmacol¬ 
ogy of PTSD. One such study is being conducted by Dennis S. 
Charney. M.D.. neuroscience division director and professor of 
psychiatry at Yale; Steven M. Southwick, M.D., director of 
PTSD programs at West Haven and associate professor of p.sy- 
chiatry at Yale; and John H. Krystal, M.D., chief of the center’s 
Laboratory of Clinical Psychopharmacology and assistant pro¬ 
fessor of psychiatry. This team has discovered that the drug 
yohimbine triggered panic attacks in about 50 percent of more 
than 100 PTSD patients who volunteered as subjects. 
Yohimbine blocks the action of the alpha 2 receptor, a pro¬ 
tein embedded in brain cell membranes, and which helps to 
regulate activity in the sympathetic nervous system. Yohimbine 
can boost heart rate and blood pressure and induce feelings of 
anxiety and panic. Dr. Charney says the Yale/VA research 
indicates that trauma may alter the brain chemistry in veterans 
with PTSD by sensitizing them to adreneline surges. 
In other medical school laboratories, and at Connecticut 
Mental Health Center (CMHC)—a joint program of Yale and 
the State Department of Mental Health—researchers have iden¬ 
tified a brain structure that reduces fear. In studies of mice and 
rats, scienti,sts have reduced the intensity of fear by activating 
cells in the amygdala—a part of the midbrain that regulates 
emotion and memory. 
“Clinical disorders such as obsessive compulsive disorder 
and phobias—as well as PTSD—don’t allow people to dis¬ 
criminate fearful from non-fearful situations,’’ explains Michael 
Davis, Ph.D., professor of psychiatry and psychology at Yale 
and head of the study. “This research illustrates that reduction 
or extinction of learned fear is brought about through an active 
process. We hope that our studies will lead to insights into how 
PTSD comes about and how physicians may more effectively 
treat this and other types of anxiety disorders.’’ 
Dr. Davis' research, funded by the National In,stitute of 
Neurological Communicative Disorders and Stroke, was con¬ 
ducted with colleagues William Falls, a graduate student, and 
Mindy Miserendino, a postdoctoral fellow. 
—Rosalind D'Eugenio and Diane Loupe 
Dr. Dennis Charney in an ob¬ 
servation room at the West 
Haven VA PTSD Center. 
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Addition of a new steel and glass exterior continues at Buildings I and 2. 
West Haven VA Construction 
Advances at Rapid Pace 
“The patient perception of the quality of care." In commenting 
on the West Haven VA's six-year, $90 million capital project. 
Medical Center Director Norman E. Browne coins the phrase to 
explain that a well-maintained facility is vital to patients’ sense 
of well-being. He cites studies which show that patients “judge 
medical centers based on how long they have to wait, how well 
they believe nurses have treated them, and the appearance of the 
physical plant." 
West Haven VA construction goes far beyond appearances, 
however; among the first construction efforts to get underway 
was a $7.5 million project to bring the buildings up to fire and 
safety codes, including a quick-response .sprinkler system. A 
new $1.4 million telephone system ushered the VA into the 
modern telecommunications era, doubling the old sy.stem's ca¬ 
pacity. Other projects include improved or increased clinical 
and research space, such as the new audiology and speech 
pathology unit, a new outpatient pharmacy and air conditioning 
in the virology lab. 
One of the most difficult problems posed by the aging build¬ 
ings was the brick exterior of Buildings I and 2, the .seven- and 
nine-story towers. Interior brick was mistakenly used by the 
original contractors, leaving the outer shell vulnerable to 
Connecticut’s extremes of weather. Water seeped between the 
brick and the structure underneath, and in some cases, freeze- 
and-thaw cycles caused bricks to dislodge. 
A $ 12 million project to cover the brick with a new metal and 
glass exterior is underway on Building 1, and a like amount 
soon will be spent on Building 2. Meanwhile, work is proceed¬ 
ing on: 
• renovation of the surgical intensive care unit (ICU), to 
support the VA’s open-heart surgery program; 
• renovation of the cardiac ICU; 
• a new Eastern Blind Rehabilitation Center; 
• construction of a new 10.OOO-square-foot outpatient psy¬ 
chiatry building; 
• creation of a new laboratory for cancer research. 
A $48-million clinical addition will give the West Haven VA 
its first building designed for ambulatory care—when the hospi¬ 
tal towers were built in 1953, the VA was prohibited from 
caring for veterans on an outpatient basis. Also underway are 
renovation and expansion of the operating room suite, a new 
clinical diagnostic laboratory and a canteen. 
Other projects will improve the environment by removing 
contaminated soils near fuel tanks, and by replacing an incinera¬ 
tor built more than 20 years ago. An electrical reliability project 
will upgrade the backup power supply, including in.stallation of a 
.second power line, and will bring wiring up to code. 
To minimize logistical problems, Jeremiah P. Clay, chief of 
building management, works with the clinical and research staff 
to make sure no patient unit is shut down, even for a few hours. 
“We keep the patient load up. we keep the clinical groups going, 
and cause as little disruption as possible," Mr. Clay says. 
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cal care, it is very important that oiir students and physicians-in- 
training learn all that they can about the health-care needs of the 
poor and how we can pro\ ide that care in the most cost-effective 
manner. In this complex arena, the West Haven VA Medical 
Center continues to lead the way with the strong support of the 
.School of Medicine. That support is one of Yale's best in\ est- 
ments and we should ne\ er forget that fact." 
Cutting-edge Programs 
Cooperation in biomedical research between Yale and the West 
Haven VA is assured because of the Joint appointment arrange¬ 
ment between the two institutions. .As medical school faculty 
members, the VA scientists engage in a wide range of basic and 
clinical studies. Such research helps assure that V.A 
patients benefit from the latest technology and developments in 
clinical care. 
“Research at West Haven adds an important dimension to the 
care of patients," says Fred S. Wright. M.D. Dr. Wright is 
associate chief of staff for research at the VA and professor of 
medicine and cellular and molecular physiology at Yale. He 
notes that currently 75 principal investigators are working on 
more than 300 projects at the VA. Studies range from labora¬ 
tory investigation in cell and molecular biology to trials of new 
therapeutic drugs. 
In pulmonary medicine, for example, a laboratory group is 
studying the regulation of genes that code for mediators of lung 
intlammation. Another group in this section is testing a new 
treatment for chronic bronchitis: aerosol administration of re¬ 
combinant human DNase, a product of genetic engineering. 
Nearly all of the research actixity is directed at solving 
problems related to disease and disability. Hence, a number of 
programs that directly support patient care either were started as 
research projects, or currently ha\ e an important research com¬ 
ponent. Among these are: 
• the Virology Diagnostic Laboratory, the only national 
\ irology reference laboratory in the VA system; 
• the .Mycobacteria Diagnostic Laboratory. a reference labo¬ 
ratory for tuberculosis and other mycobacterial diseases; 
• the Schizophrenia Biological Research Center, one of 
three in the VA; 
• the National Center for Post Traumatic Stress Disorder 
clinical neuroscience component; 
• the Alcohol and Substance .Abuse Center, one of two in 
the VA; 
• the West Haven V.A Comprehensive Cancer Center, re¬ 
cently funded and now being staffed; 
• the Neuropsychology Laboratory , a diagnostic facility in 
w hich electrophysiological techniques are used to locate 
regions of the brain that are causing seizures. 
So close is the relationship between Yale and V.A in neurol¬ 
ogy and neurosurgery , that the distinctions between the two 
institutions blur. Take, for instance, the Neurological Research 
Center. In a sharing agreement pioneered two decades ago. 
cix ilian epilepsy patients from Yale-New Ha\en Hospital are 
eligible for referral to the V.A. as well as VA patients from the 
West Haven campus to A'NHH. says Richard H. .Mattson. M.D. 
Dr. Mattson is a professor of neurology at '^'ale and the principal 
inxestigator on a S3.5 million, five-year National Institutes of 
Health multidepartmental grant to study epilepsy at \ ale and 
the \',A. 
He explains. ".An MRI (magnetic resonance imaging) or 
other test might be done at "^’ale. as well as placing electrodes 
before brain surgery . The resources at the V.A. on the other 
hand, allow us to provide services patients couldn't get at ^'ale. 
either because of oxeiioad or because they don't have the spe¬ 
cialized equipment such as PET (positron emission 
tomography)." an adxanced diagnostic imaging technology. 
Dr. Mattson says the epilepsy program presents the '^'ale- 
West Ha\en V.A affiliation in microcosm. On some months. 
I 'or years. Dr. Robert M. Donaldson Jr. has been a key- 
player in the Yale-West Haven V'A Medical Center rela¬ 
tionship. He emphasizes that the collaboration adds an 
important dimension to the school's community service, 
especially to low-income people. Says Dr. Donaldson: 
"Yale School of Medicine takes seriously its responsibil¬ 
ity to provide first-rate medical care for the poor. This is 
an inleyral part of our overall mission to discover and 
disseminate biomedical knowledge while establishhiit the 
hiyhesi standards of clinical excellence. Our partnership 
with the West Haven \'A Medical Center is crucial to 
meeting these responsibilities and objectives. " 
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Uuiversit}’ Secretaiy Sheila Wellington and Dr. Stephen G. Wa.xinan honor James Peters, e.xeciitive director of 
EPVA, the Eastern Paralyzed Veterans Association, for his orgainzation 's support of neurological research at Yale 
and the West Haven VA, The Paralyzed Veterans of America (PVA) also has provided major support. 
Susan S. Spencer. M.D., professor of neurology and director of 
the Yale-New Haven Hospital epilepsy unit, conducts rounds at 
the VA; John S. Ebersole, M.D., professor of neurology, is not 
only director of the VA unit but also head of the clinical neuro¬ 
physiology laboratory at Yale. Together, the two units see 
approximately 400 patients a year from across the country. 
“It’s evolved to the point where we are one big program,” Dr. 
Mattson said. “There are always logistical problems, because of 
the nuisance of being four miles apart, but we’ve been doing it 
for two decades now and the problems are not insurmountable. 
It’s a model of how two institutions can collaborate to the 
advantage of patient care and research.” 
Collaboration in research does not stop at the YaleAVest 
Haven VA partnership. A private, charitable organization sup¬ 
ports leading neurological research at the West Haven VA. In 
1988, the Paralyzed Veterans of America/Eastern Paralyzed 
Veterans of America (PVA/EPVA) Center for Neuroscience 
and Regeneration Research of Yale University opened, thanks 
to a $1.5 million PVA/EPVA grant. The center, which also 
receives ongoing funding from the veterans groups, the VA 
national research program and other sources, is directed by 
Stephen G. Waxman, M.D., Ph.D., professor and chairman of 
neurology. 
Dr. Waxman and his colleagues are advancing knowledge 
about the basic mechanisms of central nervous system develop¬ 
ment, function, injury and recovery. The center’s scientists are 
not so lost in the minutiae of research, however, that they lose 
sight of their dreams. “We’re doing basic science,” comments 
Jeffery Kocsis, Ph.D., profes.sor of neurology. “We can’t prom¬ 
ise to make wheelchair patients walk. But that exciting prospect 
is always in the back of our minds.” 
Drug Research Partnership 
The West Haven VA pioneered the concept of multi-center 
studies, now called cooperative studies. One of these early 
studies, in the 194()s, led to effective drug therapy for tuberculo¬ 
sis. The VA system, because of its network of 172 hospitals and 
its large, homogeneous patient population, is ideally suited to 
large multi-center studies. VA researchers have studied, for 
example, the efficacy of open-heart surgery over and against 
more conservative treatment in angina patients and the lowest 
effective dose of AZT in the treatment of AIDS. 
Michael D. Ezekowitz, M.D.. Ph.D., the West Haven VA’s 
chief of cardiology, is principal investigator for the cooperative 
study on the efficacy of low-dose warfarin in preventing strokes 
in patients with atrial fibrilliation (AF). The study’s prelimi¬ 
nary results were made available when President Bush experi¬ 
enced an episode of AF in the spring of 1991. Dr. Ezekowitz is 
professor of medicine at Yale. 
West Haven VA researchers are also conducting studies into 
clozapine, an anti-psychotic drug for schizophrenics. Dennis S. 
Charney, M.D., chief of the psychiatry service at the West 
Haven VA, and Robert A. Rosenheck, M.D., deputy chief, are 
the principal investigators for a $5.2 million VA study to deter¬ 
mine the full therapeutic efficacy of the drug. Dr. Charney is 
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professor of psychiatry at Yale; Dr. Rosenheek, clinical profes¬ 
sor of psychiatry. 
.More than 600 participants in the study will be given either 
clo/,apine or haloperidol. a standard anti-psychotic treatment. 
This double-blind study will last 3-1/2 years, compared to six or 
eight weeks for previous studies. Of the estimated 20.000 
patients in the VA system who could possibly benefit from 
clo/.apine. less than 100 receive the medication, principally 
because of its high cost—$4,000 per patient per year. 
For the same reason, up to 500.000 patients in the United 
•States could be helped by clozapine, but only 13.000 receive it. 
fhe study is expected to guide policy about who should receive 
the drug. Other laboratory research at the West Haven VA is 
seeking new drugs that will have the beneficial effects of 
clozapine without potential side effects, which include 
agranulocytosis, a lowering of the w hite blood cell count. 
FA'cn as the School of Medicine and the West Haven VA 
strengthen their bonds, the relationship continues to evohe. 
One of the greatest changes the VA must face nationally during 
the next 20 years will be caring for an aging patient population 
in the face of continuing federal budget cuts. Despite the lower 
per patient cost vis a vis the private hospital system, the national 
V/\'s current annual biulget stands at $14 billion. 
Of the 27 million veterans eligible for treatment now. about 
one-c|uarter of them—^^just under 7 million—are 65 or older. 
Although the number of eligible veterans is expected to decline 
tu- 17 million by 2002. the population 65 or older w ill increase to 
more than X million. I'his demographic shift will tend to pull 
the VA system away from high-technology interventions and 
towards primary care. 
Meanwhile, the national VA's “Mission Commission” has 
recommended a two-thirds reduction in the number of acute- 
care beds, and only a one-third increase in the number of long¬ 
term beds, over the next two decades. 
"It’s clear that we can’t count on any additional money in the 
system.” Dr. Atterbury says. “There is going to be an increasing 
emphasis on long-term care, ambulatory care, primary care.” 
Dr. Atterbury notes that this direction contrasts with Yale’s 
increasing emphasis on high-technology medicine, and adds 
that programs like the PET Center “will learn to live side by 
side” with increasing primary care programs. “There’s not 
going to be room for too many more high-technology programs, 
unless we can prove they’re both medically effective, and cost- 
effective.” 
Acknowledging the need to control expenses. Robert Soufer. 
M.D.. associate professor of diagnostic radiology and of medi¬ 
cine at Yale, and chief of general and cardiovascular nuclear 
medicine at the West Haven VA. emphasizes PET’s cost effec¬ 
tiveness. He points out. for instance, that PET can save money 
by reducing unnecessary surgery. 
“A physician can be more certain with regard to the appropri¬ 
ateness of coronary artery bypass surgery w ith metabolic PET 
imaging,” Dr. Soufer says. In other words, because PET 
provides data about myocardiac metabolic activity, when com¬ 
pared to traditional clinical anatomic imaging such as X-rays 
and MRI. a PET scan can help physicians avoid operating when 
heart tissue is dead. 
Despite the laudable goal of efficiency, streamlining opera¬ 
tions can only go so far before the quality of care begins to 
suffer, warns YSM alumnus Robert G. Petersdorf. M.D. ’52. 
president of the Association of American Medical Colleges. In 
testimony this spring before the Congressional Subcommittee 
on Human Resources and Intergovernmental Relations, he 
painted a grim picture of the effect that proposed cuts will have 
on the VA system and on medical education nationwide. 
“Indi\ iduals across the country express grave concern that 
inadequate resources are a noticeable threat to VA medical 
centers,” Dr. Petersdorf said. “This could result in the VA 
becoming a less suitable environment for medical education and 
training. 
“1 understand that education and training are primarily medi¬ 
cal school matters, but our joint concern is quality.” Dr. 
Petersdorf continued. “Foremost among our concerns is the 
recurring shortfall in Veterans Health Administration appro¬ 
priations, which each year Congress has been cailed upon to 
correct. The funding shortfalls have a direct impact on patient 
care. If I had to identify the greatest menace to delivering 
quality health care in the VA, it would surely be lack of fiscal 
resources.” 
Dr. Donaldson concurs: “The West Haven VA Medical Cen¬ 
ter clearly exemplifies the need for this nation to face up to its 
responsibilities with respect to the Department of Veterans 
Affairs and its health-care system. Yale’s partnership with the 
West Haven VA Medical Center is crucial to the School of 
Medicine’s commitment to excellence.” 
YiM 
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REFLECTIONS ON A CAREER 
IN MILITARY MEDICINE 
by Raymond L. Spluir, M.D., M.P.H. '72 
The first U.S. Navy ship in which I went to sea was a small 
destroyer equipped for radar patrol duty in the North Atlantic. 
Fortunately for its crew, on this occasion the ship headed south¬ 
ward from Newport, R.I., its homeport, for the Caribbean and 
spring exercises. The ship’s captain, a salty guy from New 
Bedford. Mass., took it as his task to indoctrinate this fresh doctor 
into Navy customs. 
“The Navy isn't a job, it’s a way of life," he said, words which 
he would often repeat. His statement proved cogent for the 
ensuing 28 years of my naval career. 
My service began in 1956. during my first year at Jefferson 
Medical College, during the Korean conflict. Not wanting to 
have my medical studies interrupted, I joined the Navy’s reserve 
program for medical students. It offered summer clerkships in 
research and clinical medicine and a chance for me to wear the 
uniform of naval officer. My reserve status even permitted me an 
experience I shall always treasure—a ride in a blimp out of 
Lakehurst, N.J., shortly before the Navy pha.sed out lighter-than- 
air craft. 
By then I was in a civilian internship, at a time when the 
Nautilus and other nuclear-powered vessels had captured the 
public’s imagination. My own interest soared as I read of the 
Navy’s daring journeys beneath the polar icecap. Nuclear power 
was a revolutionary advance for submarines. The earlier "boats” 
had changed little in decades. They had limited submergence 
capability using electrical propulsion from batteries, and diesel 
engines on the surface. 
Nuclear fission, the source of energy in a nuclear ship, sup¬ 
plies heat to generators which provide propulsive and electrical 
power. Other devices produce oxygen, purify the ship’s air and 
convert seawater to fresh water, making the ship a true submers¬ 
ible. Going to sea in this craft worthy of Jules Verne .seemed to 
me the ultimate in adventure. Since these vessels all carried 
medical officers, the Navy was exerting a powerful pull on me. I 
signed on. 
Preparing for Life under the Sea 
At the time, a fully qualified submarine medical officer received 
instruction in three areas: diving medicine; submarine medicine—a 
subspecialty of occupational medicine that focuses on habitabil¬ 
ity of the submarine environment—and nuclear power. Training 
took nearly a year and was divided among the Deep Sea Diving 
School, Washington, D.C., Submarine School. Groton, Conn., 
and for those who survived an interview with Adm. Hyman 
Rickover, father of the nuclear navy, one of the land-based nuclear 
prototypes. 
Dr. Raymond L. Sphar 
Raymond L. Sphar: 
Three Decades of Military Service 
Raymond L. Sphar. a native of Charleroi, Pa., and a 
graduate of Westminster College, received an M.D. de¬ 
gree from Jefferson Medical College in 1961 and an 
M.P.H. degree from Yale in 1972. He served as medical 
officer on two nuclear submarines, commanded two 
Navy research facilities, and held a variety of staff as¬ 
signments in Washington, D.C., including duty in the 
Navy Surgeon General’s office as director, undersea and 
radiation medicine, and director, research and develop¬ 
ment. He also served as military assistant to the Secre¬ 
tary of Defense for medical and life sciences research. 
Dr. Sphar’s military decorations include the Navy 
Legion of Merit and the Department of Defense Supe¬ 
rior Service medal. He retired from the Navy in 1990 
and was appointed director. Medical Research Service, 
in the Department of Veterans Affairs in 1991. He 
resides in Washington, D.C. 
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Training at the diving school was physically demanding, 
particularly for medical personnel who were not built like the 
typical Navy diver, who often resembles Mr. Universe. My 
class of 40 .M.D.s began each day with calisthenics and then 
pursued a series of familiarization dives using various diving 
equipment ranging from SCUBA (self-contained underwater 
breathing apparatus), which was fun. to the helium/oxygen 
hard-hat diving suit, which was torture. Outfitted in the latter, 
with its copper helmet, lead weight belt and enormous boots. I 
gained a profound appreciation for those who had to work with 
such an encumbering suit. 
.My class next faced the challenge of submarine training at 
Croton. Conn., a naval base shrouded with mystique, its subma¬ 
rines dark and sleek, sliding silently down the Thames River 
and out to sea. Nuclear power made these vessels all the more 
intriguing. 
After weeks of lectures on submarine systems and opera¬ 
tions. my class finally boarded a submarine, a World War II 
diesel boat used exclusixely for training. Surrounded by in¬ 
structors. each of us got a chance to try our skill at sea, diving 
and surfacing until we could accomplish this with some compe¬ 
tence; in an emergency, the entire crew needed to know how to 
surface the boat. 
Lectures on atmosphere control, personnel selection, emer¬ 
gencies at sea, radiation protection and toxicology comprised 
the medical part of the course. An cxscape training exercise 
foll(.)wed at the lOO-foot tank of watei'. although we made our 
"escapes” from the .SO-foot level; our instructors knew well the 
danger of air embolism that stalks anyone who is not able to 
continuously exhale all the way to the surface. No one had to 
iid'orm us that this training, while helpful to a submarine crew in 
shallow water. v\as moot in deep-depth operations. 
Upon graduating from the submarine course, many of us 
received orders to report directly to operational nuclear subma¬ 
rines. Nine of us proceeded to nuclear power training, some¬ 
what envious of those who were now going to sea. 
Before any t)f us could commence, however, we had to 
endure yet one more trial: an interview with Admiral Rickover 
himself. .Stories about these legendary exchanges, well-re¬ 
counted in books about Rickover and the nuclear navy, are often 
bizarre but probably not apocryphal. 
.My interv iew took place in a purposely remote section of the 
old "Main Navy” buildings on Constitution Avenue in Wash¬ 
ington. I).C. ,Mter a pre-brief by a staff officer on "dos and 
ilon'ts”—do sit down, don't speak until he speaks to you—I was 
ushered into a small, spartan r)ffice, sat down and saw for the 
first lime the famous man. about 6.S. slender and wiry, with 
close-cropped w hite hair and a prominent nose. He was scowl¬ 
ing. and I immediately doubted that I would be able to utter a 
single intelligent answer to his questions. 
'file only unifying thread to the admiral's line of bru.sque 
questioning seems to be the monumental stress that it placed on 
the person inlerx iewed—who was often seated in a chair with 
two shortened legs. This w'as a favorite way of interviewing 
miiishipmen. Perhaps because the admiral dirin't deem it neces¬ 
sary to dexote a lot of lime to grilling medical officers, my 
intcrx ii-xx xx a^ intense but mercifully brief. 1 even got to sit in a 
> hair XX ith good leg’s. I lax ing thus passed muster. I could finally 
!v-gin nui'k’ar |ioxxer training. 
Keeping Armageddon on a Leash 
West Milton. N.Y.: Of all the unexpected places for naval 
nuclear power training, our group traveled to Ballston Spa. N.Y. 
a sleepy, land-locked village upstate, near Saratoga Springs where 
for security reasons, the Navy operates several full-scale, opera¬ 
tional nuclear submarine power plants. Wandering the innards of 
this enormously complex assemblage of technology was both 
riveting and daunting. Not only did we have to learn how it 
worked—we had to qualify as power plant operators! 
Admiral Rickover's staff, who directed the training, left no 
room for foolishness. Worldly activity such as television was 
firmly di.scouraged. Keeping up with the course material pre¬ 
cluded recreation anyway—there was hardly time for meals—and 
I kept reminding myself what a unique opportunity I enjoyed. 
Despite the challenging workload, we all managed to survive 
the stress and finished the course. Having earned the white belt 
of the qualified plant operator, my eight classmates and I were 
more eager than ever for assignment to a "nuke boat." Sea duty 
remained a distant dream, however; nuclear-trained physicians 
were .scarce, so the Navy assigned the members of my class to 
ships that were still being built as Admiral Rickover wanted 
"nuke docs” on the ships in construction and shakedown. 
I received orders to an attack submarine in construction at 
New York Shipbuilding Co. in Camden, N.J. It would be the 
second of three that the yard would build. My ship was chris¬ 
tened the Haclclo after a World War II boat whose namesake, 
following Navy custom, was a fish, the variety of which I had 
not heard before or since. 
Although it could not offer the adventure of the sea. the 
shipyard did provide much opportunity for on-the-job learning 
in occupational medicine. This vast industrial complex posed 
all the hazards attendant with heavy industry; for the only lime 
in my naval career. 1 wore a hardhat and safety shoes. 
My assignment—to establish the ship's medical department, 
to keep the crew healthy, and to monitor the crew's radiation 
exposure once the nuclear reactor came on-line—was all quite 
manageable, though the focus on perfection and timeliness could 
prove stressful. Admiral Rickover was in constant touch with 
the ship’s prospective commanding officer, Cmdr. Jack Wil¬ 
liams. demanding attention to the tiniest detail of ship construc¬ 
tion. Although this dogged pursuit of excellence seemed te¬ 
dious, the time would come when we would learn firsthand just 
how crucial the details are to a vessel capable of deep dives. 
This lesson came soon after Haddo lumbered into Delaxx are 
Bay and then the Atlantic to make its maiden voyage. Admiral 
Rickover, as was his custom, conducted the sea trials person¬ 
ally. W'e knew' that Rickover expected a few amenities in his 
stateroom—a fresh set of khakis, lemon hard-candy, white grapes 
and a copy of the New York Times. Being just the right size. I 
provided the khaki uniform, which was returned to me after we 
sLirx ived the admiral's trial by water. 
.Sea trials proved downright scary, with Admiral Rickover 
repeatedly giving orders for fast dives to considerable depths. 
As the admiral barked out his orders in a Bat, rasping monotone 
all eyes in the control room were fixed on the depth gauges. 
Dix ing a new submarine with an inexperienced crew is risky 
despite safety tests done before the trials, and as we approached 
the ship's alloxvable lest depth at a steep angle. I stood riveted in 
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place, the occasional creaking of the hull reminding me of the 
sinking of the Thresher, a submarine of the same class, just 18 
months earlier off the coast of Cape Cod. If the Hciddo had even 
a minor flaw in hull construction, neither ship nor crew would 
have survived. 
Although such maneuvers were far from popular with crews 
and even with some of the top Navy brass, over the years the 
admiral stared fate in the eye with fast dives of each nuclear 
submarine he tested. Each time, fate blinked; thanks to superb 
design and construction, he never lost a submarine in sea trials. 
The practice of fast diving, however, did contribute to the 
admiral's forced retirement in 1982, four years before he died. 
Soon after Hciddo was commissioned in December 1964, I 
received orders to report for duty with the Thomas Edison, a 
Polaris ballistic missile submarine operating out of Scotland. 
As the primary naval deterrent against the Soviets, each Polaris 
submarine poised beneath the North Atlantic, its 16 nuclear 
missiles helping to keep the peace by the threat of horrific 
retaliation. 
To maximize the sea time of these expensive instruments of 
force, each submarine had two crews, designated Blue and 
Gold. As one crew patrolled the seas for 60 days, the other 
A fleet ballistic missile submarine. 
remained at the homeport, engaged in refresher training and 
spending time with their families; one month was used for 
"turnover” between crews and for leave. My duty aboard 
Thomas Edison cjualified me for the unofficial title of “Blue 
Nose" for having crossed beneath the ice of the Arctic Circle. 
Under the best of circumstances, patrols were medically 
uneventful, the crew being young and healthy. We could usu¬ 
ally count on an outbreak of upper respiratory illness early in the 
patrol, probably attributable to naive exposure to "Scottish vi¬ 
ruses” after three months in the U.S. Under the worst of 
circumstances, an acute illness or .serious injury could Jeopar¬ 
dize the ship's mission by diverting it from its intended course 
to effect a medical evacuation. 
During the earlier 36,()()()-mile submerged circumnavigation 
by the mammoth submarine Triton, a crew member had devel¬ 
oped severe pain from kidney stones about halfway through the 
voyage. The trip was to remain top secret until completion and 
the necessity to evacuate the patient was potentially compro¬ 
mising to the secrecy and to the record of submergence. Capt. 
Edward Beach, Triton's skipper, arranged a secret rendezvous 
with a navy cruiser, broached only the conning tower of the 
submarine, the rest of the vessel remaining submerged, and the 
unfortunate man was transferred to the cruiser off the coast of 
Montevideo. The historic voyage was completed successfully 
with the ship surfacing off the coast of Delaware, where Captain 
Beach was picked up by helicopter and flown to the White 
House lawn to receive the Presidential Unit Citation for the 
ship’s crew from President Dwight D. Eisenhower. 
Fresh from the Colonies 
In the late 1960s, the British pha.sed out the Royal Navy's air 
fleet with a view to enlarging their nuclear submarine fleet and 
sharing patrol responsibilities with the United States; the U.S. 
provided Polaris missiles for these ships. The Royal Navy’s 
enlarged fleet would require medical officers to be trained, 
specifically in medical aspects of operating nuclear submarines 
on lengthy patrols. 
By then the U.S. Navy had substantial experience with radia¬ 
tion dose measurement, nuclear plant coolant analysis, and with 
problems of prolonged submergence, including treatment of 
medical emergencies at .sea. The U.S. agreed to assist in train¬ 
ing Royal Navy doctors for similar duty. 
I was selected as the first of a series of exchange officers who 
would serve with the Royal Navy in an unbroken chain for 25 
years. My wife Jean and .seven-month-old daughter Christina 
accompanied me to HMS Dolphin, the British submarine base in 
Portsmouth harbor on the south coast of England. This compact 
facility, offering a mix of old and modern architecture, housed 
various naval functions including the headquarters of Elag Offi¬ 
cer, Submarines—the admiral who commanded the U.K. sub¬ 
marine fleet. I was assigned to his staff. 
The admiral, a tall man of about 50 with salt and pepper hair 
and steel-blue eyes, was most welcoming and gave me many 
opportunities to go to sea in both diesel-electric boats and 
nuclear vessels. By the end of my first cruise aboard a British 
diesel, 1 was feeling quite at home, having shared the tiny 
wardroom with the other officers and now wearing the white 
wool turtleneck sweater exclusive to the submarine fleet. 
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CHAMBER 
The hyperbaric coaiplex at the Naval Medical Research lastitute. Bethesda. Md.. pictured in the above schematic diagram, is among 
the most teclmiccdly sophisticated diving research facilities in the world. When the “wet pot, " which projects downward from the 
center of the comple.x, is flooded with water, it becomes the work site for Navy divers who use the other parts of the habitat for 
sleeping, eating, e.xercise e.xperiments and recreation. Each chamber has its own .system of pressure vcilves and gauges for 
cotnpression and decotnpression as well as extensive means of monitoring the human subjects. Steel doors between chambers permit 
isolation of a portion of the cotnple.x for treatmettt of a diving medical problem or for “excursions” to different depth levels. The 
institute's chamber cotnple.x can simuhite ocean dives of up to 3,000 feet, but most saturation diving experiments are conducted at the 
1.000-foot level. 
Located at a site adjacent to Bethesda Naval Hospital, sometimes the hyperbaric coniplex is used to treat medical emergencies 
such as carbon monoxide poisoning, bone infections and “the bends. " or decompression sickness in civilian divers. 
riie Royal Navy Medical School, close hy HMS Dolphin. 
was the locus for training physicians in submarine medicine. 
My job was to provide information on LhS. submarine medical 
practice and coordinate research between the navies. Research 
issues at the time focused on long-term health effects of pro¬ 
longed e.xposure to the submarine environment with its artificial 
atmosphere and inevitable atmospheric contaminants. In fact, 
the technology for atmosphere control was remarkably advanced 
in both nax ies, keeping carbon monoxide, carbon dioxide, hy¬ 
drocarbons and freon within permissible limits with relative 
ease. I also shared in teaching radiation monitoring, air purifi- 
valion and other facets of environmental medicine. 
I’crhaps the most memorable aspect of the Royal Navy way 
; : H were the social events. Officer messes in England are 
uwanably housed in impressive surroundings—historic build¬ 
ings complete with splendid maritime paintings and panelled 
mess halls, and the Dolphin mess was no exception. Formal 
dinners were frequent, with black tie uniform mandatory . 
Each dinner was governed by a protocol of toasts, and as an 
American who was a full member of the mess, one of the toasts 
included the President. I only wished that the President might 
ha\'e shared my hangovers, because after the formal proceed¬ 
ings we adjourned to the bar for more drinks and rowdy games. 
Leaving England wasn't easy. I had grown accustomed to 
riding a hor.se and to sailing, to drinking Port and even to 
hearing British English. At least I could look forw'ard to a 
residency in epidemiology at Yale. 
The Navy arranged this residency so that afterwards I could 
woi k at the .Submarine Medical Research Laboratory at Groton. 
I chose Yale knowing that the faculty at the department of 
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epidemiology and public health (EPH) was excellent. More¬ 
over, I hoped to build bridges between EPH and the laboratory 
in Groton. This seemed logical, given the Navy's interest in 
long-term well-being of submarine personnel and EPH's exper¬ 
tise in epidemiological research, both for acute and chronic 
di.seases. 
The Groton lab was responding to the advent of nuclear- 
powered submarines, ships that could function underwater for 
several years—far longer than the human beings who operated 
them. Early research in this field studied human tolerance to 
carbon dioxide and hypoxia, reduced oxygen levels. 
Groton quickly had established a reputation as the leader in 
nuclear submarine environmental and behavioral research. Eor 
example, the lab had determined that prolonged exposure to 1.5 
percent carbon dioxide levels, previously accepted as safe, caused 
undesirable physiological effects such as increased respiratory 
rate and a feeling of breathlessness. So the Navy designed 
carbon dioxide scrubbers capable of maintaining levels below I 
percent. Scientists studying motivation and effects of stress and 
fatigue recommended that patrol length be limited to approxi¬ 
mately 60 days, which became the standard for Polaris patrols. 
Prom the beginning, the Navy recognized that the closed 
space of a submerged submarine threatened its crew with poten¬ 
tial atmospheric contamination. New studies monitored con¬ 
tinuous exposure for prolonged periods and took into account 
the interactions of contaminants—studies which were to have a 
bearing on “sick building syndrome” in the budding age of 
sealed office buildings. The lab undertook vision and hearing 
studies as well, establishing “international orange” as the color 
that offered maximum visibility at sea. 
Finally, the Groton lab had made its mark in diving research. 
Capt. George Bond conducted early experiments in saturation 
diving in which divers can spend extended lengths of time in 
pressurized chambers at depths even beyond the limits of a 
submarine. The,se multi-phased experiments, entitled Project 
Genesis, extended over six years and led to the Sea Lab project 
in which divers lived in a seabed habitat and worked in the sea 
around them, demonstrating the practicality of Bond’s concepts. 
In 1981, using technology pioneered by Captain Bond, three 
divers at Duke University breached the 2,()()()-foot barrier for 50 
days in {\\e AtlcDitis III dive. Although record-breaking dives of 
this type are, in a sense, technological stunts, they also yield 
important .scientific information. Today, Navy divers conduct 
routine work at greater depths and for longer periods than was 
ever thought possible 30 years ago, thanks to Captain Bond’s 
pioneering vision of saturation diving. 
Such was the milieu of applied research I entered after 
completing my courses at EPH. Drs. Alfred Evans and Adrian 
Ostfeld, my EPH mentors, had trained me well for this assign¬ 
ment, and they both served as consultants to the lab on numer¬ 
ous occasions. I soon became involved with a longitudinal 
study of submariners’ health and a seroepidemiological investi¬ 
gation of respiratory illness in submarine crews. 
About one year after my assignment to the lab, I was named 
its commanding officer. While gratified by this appointment, I 
quickly learned that command did not come without its hazards. 
My initiation came by way of a Time magazine reporter, who 
upon interviewing a young medical officer and a psychologist 
from our staff, published a story that infuriated Admiral Rickover. 
Painting the worst possible picture of life aboard submarines, 
the article falsely suggested that crews suffered severe paranoia 
and often reached the limits of endurance on patrol. The article 
predicted similarly dire problems for astronauts in the new 
space program—developments which never occuiTed. In my 
“International orange” became 
the standard color for emergency 
equipment, including the inflat¬ 
able life preserver affectionately 
named for Mae West. In this 
photo, circa 1950, the legendary 
movie star, ever the good sport, 
visited the lab to thank Groton- 
based sailors for their tribute. 
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daily coinersations with members of Rickover's staff, the storm 
subsided. The admiral made it clear, however, that there were to 
be no more interviews with newsmagazines. 
During my second year in Groton. 1973. we began develop¬ 
ing a plan to resume di\ ing experiments, the large hyperbaric 
chamber used by Captain Bond still being fully operational. 
Despite their depth limitation. 350 feet of seawater, the tanks 
could still help the Navy understand some important questions. 
•So our interdisciplinary team of scientists embarked on a 
series of experiments that sought to determine whether plain air 
had utility as a breathing gas in .saturation diving; the success of 
dives at greater depths depending on carefully balanced mixtures 
of oxygen and inert gases. Most diving work is done at shallow 
depths, and our team was able to show that saturation diving 
could be done at those depths using air. The lab has remained in 
the forefront of this research, advancing di\ ing technology for 
shallow depths as well as our understanding of the human re¬ 
sponse tt) the deep-diving environment. 
.V New Challenge 
In 19S3. the Navy .Surgeon General invited me to lead the Naval 
Medical Research Institute at Bethesda. Md., as its commanding 
officer. Bethesda is the Navy’s flagship laboratory for basic and 
applied medical research regarding combat casualty care, hy¬ 
perbaric medicine, infectious diseases. en\ironmental stress, 
transplantation immunology and toxicology. The institute be¬ 
gan the world's first tissue bank. Navy scientists having pio¬ 
neered techniques of harvesting and storage. 
.Moreover, the institute offers a highly sophisticated complex 
of chambers, allowing for experimental saturation dives at much 
greater depth—routinely to 1.000 feet—than the dives con¬ 
ducted in Groton. The basic science program focuses on the 
effects of pressure on mammalian systems, particularly the 
pulmonary and nervous systems. In applied research. Navy 
divers serve as experimental subjects for testing diving gas 
mixtures and decompression schedules, which the Navy con¬ 
tinually seeks to improve. 
Infectious disease research has focused in recent years on 
malaria prevention and treatment, developing rapid diagnostic 
tests for field use. and on AID.S. In 1983. a new detachment of 
Navy scientists in Peru expanded research into a number of 
tropical diseases. 
.As in Groton, my initiation at Bethesda came quickly. After 
only a week in command, animal activists broke into a research 
lacility and stole several dogs which had beeti used in experi¬ 
ments. As the second such incident, the break-in affirmed that 
upgrading security would be my first priority. A sad testatnent 
to the times, we installed elaborate security systems at the 
expense of our research budget, earmarked to protect and save 
human lives. 
Despite this distraction, during this period the institute expe¬ 
rienced rapid growth in the team conducting transplantation 
immunology research, having maintained a strong capability for 
diiiiiu histo-compatibility research over the years. These scien¬ 
tist . v.iiv among the first to isolate the hematopoietic stem 
sell ih. iiri'cursor of white blood cells before they differenti- 
itc into cell tv pcs— ami related growth factors. 
About this time 1 encountered Admiral Rickover again. Hav¬ 
ing learned that he was a patient in Bethesda Naval Hospital, I 
paid a courtesy call. As I entered the room 1 wondered what his 
mood would be. He was in bed, propped up with pillows, 
reading. He looked a bit older, but no less feisty. As he greeted 
me. he actually managed a smile. 
The radiation incident at Three Mile Island had occurred a 
short time before and I opined, “Admiral, if you were in charge 
of civilian nuclear power that accident would never have hap¬ 
pened." With typical modesty he replied without hesitation, 
“You are ab.solutely right, Sphar." 
In our exchange, the admiral took for granted the exacting 
standards demanded by the Navy—particularly the nuclear navy. 
In fact, this vignette illustrates what is common to the naval 
officer who spends months at a time cruising beneath the sea 
and a .scientist who drives to the laboratory every workday. 
Selected for independence, intelligence, objectivity and leader¬ 
ship, submarine personnel display qualities that are vital to the 
research setting. Hence, the discipline I learned from Admiral 
Rickover’s pursuit of excellence served me well in my later 
assignments in medical research. 
After my tour of duty in Bethesda, I served in the Office of 
the Secretary of Defense, where 1 had oversight of medical 
research in all of the military services. This meant participating 
in NATO meetings in Brus.sels, London and Paris, where I 
enjoyed renewing old international friendships. By now, though, 
almost 30 years had passed since I Joined the Navy; I decided it 
was time to put my uniform in mothballs, as they do the ships of 
an earlier day. 
Today, as a civilian, 1 continue my career in military-related 
biomedical science as director. Medical Research Service in the 
Department of Veterans Affairs. The VA has been one of the 
leading biomedical re.search organizations in the world for more 
than 60 years. The current program is addressing important 
clinical problems in the veteran population—aging, AIDS, alco¬ 
hol/drug dependency, heart disease, post-traumatic .stress disor¬ 
der. schizophrenia, spinal cord and brain injury and the health of 
female veterans, to name but a few areas of research. All of 
these represent important challenges, and successful results will 
benefit the general population as well as veterans. The VA has 
a superb team of intramural investigators, three-quarters of 
them physicians, and a highly regarded peer-review system, so I 
am confident that these challenges will be met effectively. 
It has been most gratifying to serve my country and the world 
by improving people’s quality of life through biomedical re¬ 
search. The adventure goes on. YM 
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GALLERY 
Dr. Harvey Cushing and Aviator Grave Marker, 1918 
As a surgeon and professor at Harvard Medical School during 
World War I, Harvey Cushing, M.D., later professor of 
neurosurgery at Yale, organized Base Hospital Unit Number 5, 
one of several units of American medical volunteers that served 
on the front lines. Dr. Cushing led Unit Number 5 from May 
1917 through the Armistice in November 1918. 
During these years, he composed a million-word journal, 
complete with photographs, which is housed today in the Yale 
Medical Historical Library. The photograph on the left serves as 
the frontis piece for an edited version of these writings: From a 
Surgeon's Journal (Boston: Little, Brown, and Co., 1936). The 
second photograph shows an aviator’s grave in a makeshift 
cemetery in France near Belgium, his tombstone fashioned from 
a shattered airplane propeller. 
In the aftermath of the war, January 1919, Dr. Cushing re- 
llected on a former battlefield near the Somme in France: 
Januaiy 2nd. Hotel Bellevue, Lille, 9 p.m. 
One must cross the old .strip of No Man's Land and see for 
himself..the complete annihilation of towns, villages, and the 
lands between. No description could suffice—the thing itself 
beggars it, staggers it,,. 
Sand bags rot and rains wash away their contents, leveling 
the parapets...trenches and shell holes gradually fill in: the 
openings of ahris and dugouts get choked and obliterated: the 
tangles of wire, bent sheets of corrugated iron, the litter of 
abandoned arms and equipment slowly sink in the mud as do 
the crosses which mark where heroes lie: the derelict skeletons 
of man and man-made machines—riddled tanks and fallen 
aeroplanes, demolished gun carriages and upheaved blocks of 
concrete and rails which once were Boche "pill-boxes"—will 
slowly disappear in the winter nnre of Flanders and in another 
season or two will he covered with soil, grass-grown and 
flower-bedecked. 
Thus the corpse of the battlefields disintegrates, leaving its 
rusting and contorted bones of iron and sinews (f wire, and 
even these relics are being eaten away by a swarm of coolies 
and German prisoners and salvage corps people, like beetles 
busy over a carcass. 
There are many front lines and front lines in many places, 
but there can he none more appalling—more beggaring of 
description than...that disconsolate and desolate strip ofcoun- 
tiy which lies between Ypres and the ridge stretching from 
Paschendaele through Gheluveldt and beyond to Messines. 
A riot of demoralization—the fair earth which for centuries 
had been under the harrow, drenched in the blood of hundreds 
of thousands, fi.xed in an agony of despair, abandoned to soli¬ 
tude, torn, beaten, pounded, seared, upheaved, till no man can 
possibly recognize the acre he has once tilled. 
—Gregory R. Hath 































STUDENT RESEARCH DAY 
Eric Rdshhci. M.D. '92. (rii^lilj e.xplains lo third-year student Ed Gunther how cloned T-cells can prevent insulin 
dei>endent diabetes niellitns in experimental ainnials. 
Opening Remarks 
Student research, by all medical students and M.D./Ph.D. stu¬ 
dents. plays a central role in the Yale System of medical educa¬ 
tion and it is the accomplishments of student research that we 
celebrate today. The ret|uirement of an M.D. thesis at Yale is 
unique among American medical schools, and today we cele¬ 
brate the I.S.Td year of that tradition. 
This year the office of student research will fund over 200 
students for short-term re.search and IS students who are receiv¬ 
ing one-year student research fellowships. This expanded pro¬ 
gram requires a growth in our funding, and 1 am very pleased to 
announce today the establishment of the Paul Lavietes .Student 
Research bellowship. given in honor of Dr. Lavietes. a beloved 
clinician and superb diagnostician and teacher in the department 
ol' medicine lor many years. Funds for the Paid Lavietes Fellow¬ 
ship are gi\en to the school by the Lavietes family, specifically 
Mrs. Ruth Ltivietes. Dr. I.avietes' daughter. Syhia Lavietes. 
M S.W .. assistant clinical professor of pediatrics, and his cousin. 
Ra\ m.ind 1 .avietes of Stratford. Conn. 
file pri/e-w inning theses that will be presented today, and 
eii .-I ivsearch prizes awardeil at graduation, are selected by the 
1 hesic \w ards Committee, w Inch reviews all theses recommended 
for honors by the individual departments. These people are 
listed in the accompanying table, and w'e are grateful for their 
work. 
We also want to thank Linda Seigneur. Gail Beamon and 
Virginia Simon from the office of biomedical communica¬ 
tions. who worked .so hard on the posters you've just seen. 
Laura McDonald, who joined us recently as the .senior admin¬ 
istrative assistant in the office of student research, has done a 
remarkable job coordinating the events ot this day. 
Our special thanks this year goes to Dr. Robert Gifford, 
associate dean for education and student affairs. In addition to 
all the other things that he does for students. Dr. Gifford has 
supported the student research program in every possible way, 
in raising special funds, in providing us space, and in coming 
to all of our meetings. 
.John N. Forrest Jr.. M.D. 
I^ro fessor of medicine 
Director, office of student research 
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Abstracts 
A Prospective Study Assessing Patients 
after Anterior Cruciate Ligament Reconstruction 
with Serial Magnetic Resonance Imaging, Genucom, 
KINCOM and Clinical Evaluations 
by Ann M. Smith 
Faculty’ advisor: Peter JokI, M.D. 
Professor of orthopaedics and rehabilitation 
Faculty discussants: J. Kevin Lynch, M.D. 
Associate clinical professor of orthopaedics and rehabilitation 
Chris F. Pope. M.D. 
Department of radiology, Maine Medical Center 
This prospective study was performed to follow changes in 
anterior cruciate ligament (ACL) grafts after reconstruction and 
to judge what role various instrument parameters might have in 
assessing the success of patellar tendon ACL reconstruction. 
Thirteen patients were followed after ACL reconstruction with 
serial testing that included Genucom (ligament laxity testing), 
KINCOM (muscle strength testing), magnetic resonance imag¬ 
ing (MRI) and clinical evaluations. Muscle strength testing was 
performed preoperatively and 6 and 12 months postoperatively. 
Clinical and ligament laxity evaluations were obtained 
preoperatively, and 6, 12 and 24 months postoperatively. MRI 
evaluations were performed preoperatively, and 1.5, 6, 12 and 
24 months postoperatively. Data from these evaluations were 
analyzed with multiple regression analysis of variance (ANOVA) 
and paired T-tests. 
Student Research Day ora! presenters and colleagues: (front row, from left): Ann M. Smith, Dr. 
Lawrence S. Cohen, deputy’ dean, Sydney Brenner, F.R.S., Kelsey Martin. Back row: Dr. Robert H. 
Gifford, associate dean for education and .student affairs. Michael Girardi, Daniel Fitzgerald. John 
Phillips and Dr. John N. Forrest Jr. Dr. Brenner, director, MRC Molecular Genetics Unit, 
Cambridge, England, delivered the fifth annual Lee E. Farr, M.D., Lecture. 
There were a number of significant clinical findings in this 
study. Twenty-four months after ACL reconstruction, all pa¬ 
tients had improved from their preoperative state as measured 
by ability to return to sports (p=().()()()l). One patient developed 
significant ligamentous laxity 24 months after reconstruction. 
Changes in laxity did not correspond with changes in the clini¬ 
cal outcome. KINCOM testing at each of three different speeds, 
showed the involved quadriceps’ strength increased over the 
follow-up period. A statistically significant quadriceps deficit 
persisted even 12 months after reconstruction (p<().05). No 
statistically significant relationship existed between the quadri¬ 
ceps and hamstring strength and the patients’ ability to return to 
athletic activities (p<().05). 
There were also a number of significant radiographic find¬ 
ings. All grafts were identified on MR as intact at 24 months. 
Graft signal intensity was most like normal tendon early after 
reconstructive surgery while little change in the ACL graft 
occurred between 6 and 24 months. The clinical outcome could 
not be predicted either on magnetic resonance signal or overall 
appearance of the graft. Changes in the patellar tendon (the 
harvest site) and menisci were detectable on MR. 
Although parameters from MRI, Genucom, and KINCOM 
devices can be used to detect changes after ACL reconstruction; 
these changes were not predictive of clinical outcome. Further 
work is still needed to determine their exact roles in manage¬ 
ment of patients following ACL reconstruction. 
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Thesis Subcommittee 
(Awards Committee) 
Edward J. Benz Jr., M.D. 
Emile L.Boulpaep, M.D. 
Miehael Caplan. M.D. 
Dennis L. Cooper. M.D. 
John N. Forrest, Jr.. M.D. (Chairman) 
Robert H. Gifford, M.D. 
Robert E. Handsehumaeher, Ph.D. 
James D. Jamieson. Ph.D. 
Barry Kaeinski, M.D. 
M. Stephen Meyn. M.D. 
I. George Miller Jr.. M.D. 
lr\ in M. Modlin. M.D. 
Coralie Shaw. M.D. 
Andrew Stewart. M.D. 
Frederick J. Suchy, M.D. 
r^ichard S. K. Young. M.D. 
.IdIii] /.. Phillips (111(1 his faculty advisor. .Arthur B. Dubois. 
M l)., projcssor oj cpidcuiioloyy and phvsioloitv. 
Tran.sport of Influenza Virus Ribonucleoproteins 
into and out of the Nucleus 
by Kelsey Catherine Martin 
Faculty advisor: Ari H. Helenius. Ph.D. 
Professor of cell biology, biology and iu the Cancer Center 
Faculty discussant: IraS. Mellman. Ph.D. 
Associate professor of cell biology 
Intluenza is an RNA virus which replicates in the nucleus and 
buds from the plasma membrane. As such, its ribonucleopro¬ 
teins (RNPs) must undergo bidirectional transport across the 
nuclear envelope. This thesis examines the transport of incom¬ 
ing intluenza viral RNPs into the nucleus during viral entry and 
the export of newly synthesized viral RNPs out of the nucleus 
towards the end of infection. 
Upon penetration of the intluenza virus nucleocapsid into the 
host cell cytoplasm, the viral RNA and associated proteins are 
transported to the nucleus, where viral transcription and replica¬ 
tion occur. Using quantitative confocal microscopy, I found 
that over half of cell-associated nucleoprotein (NP) entered the 
nucleus with a half-time of 10 minutes after penetration into 
CHO cells. Microinjection and immunoelectron microscopy 
experiments indicated that the NP entered the nucleus through 
the nuclear pore as part of an intaet RNP structure and that its 
transport was an aetive process. Transport of the incoming 
RNPs into the nucleus was not dependent on an intact microfila¬ 
ment, microtubule, or intermediate filament network. Subse¬ 
quent to penetration, the matrix (Ml) protein appeared to disso¬ 
ciate from the RNP structure and to enter the nucleus indepen¬ 
dently of the RNP. I found that 50 percent of penetrated M I 
entered the nucleus with a halftime of 25 minutes after penetra¬ 
tion into CHO cells. Nuclear transport of M1 appeared to occur 
by passive diffusion. While the entry of incoming M1 into the 
nucleus was not a prerequisite for infection, the separation of 
M 1 from the incoming viral RNPs was. Amantadine, an antivi¬ 
ral agent which induces an early block in intluenza infection, 
was found to block the dissociation e\ent. and to thereby pre¬ 
vent import of incoming RNPs into the nucleus. 
In contrast. I found that export of newly synthesized viral 
RNPs depended on association w ith M I. During infection, the 
export of newly synthesized NP from the nucleus coincided 
with the onset of Ml synthesis. In cells in which Ml was not 
expressed, NP remained confined to the nucleus. When the 
transport of new ly synthesized M1 into the nucleus was blocked 
by cytoplasmically microinjected anti-Ml antibodies, NP re¬ 
mained in the nucleus. By double-label immunocytochemistry, 
M I was found associated with new ly assembled viral RNPs in 
the nucleus, at the nuclear pore, and in the cytoplasm. Thus. MI 
appeared to bind to the viral RNPs in the nucleus and to escort 
them through the nuclear pore to their site of budding at the 
plasma membrane. 
Together, the results of this thesis show that Ml modulates 
the directionality of intluenza \ iral RNP transport into and out 
of the nucleus. 
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Third-year student Robert Icninone looks on as fellow students ponder Ins data about a rabbit model for hitman T-cell Ismphotropic 
virus type I (HTLV-1) infection. 
Extracorporeal Photocheniotherapy 
in a Murine Graft-Versus-Host Model 
of Systemic Lupus Erythematosus: 
Testing the Anti-Idiotypic T-Cell Vaccination Hypothesis 
by Michael Girardi 
Faciilt}’ advisor: Robert E. Tigelaar. M.D. 
Professor of dermatology 
Faciiln discussant: Charles A. Janeway Jr., M.D. 
Professor of immunobiology, biology and in the Cancer Center 
Inoculation of'B6D2F| mice with D2 (H-2‘'^"') splenocytes 
results in a chronic stimulatory gral't-versus-host reaction 
(GVHR) with the clinical manifestations of systemic lupus 
erythematosus (SEE). This investigation tested the ability of 8- 
methoxypsoralen (8-MOP) and ultraviolet A light (UVA)-at- 
tenuated D2 cells, primed to contain an expanded population of 
T-cells with idiotypic receptors directed against MHC-II(1-A‘’), 
to treat and/or prevent such SLE-like disease. Vaccination of 
B6D2E| mice with the extracorporeal Iy photochemo-attenuated 
idiotypic cells was postulated to induce an anti-idiotypic T 
suppressor response capable of mediating disease protection. 
Photochemically attenuated calls from B6D2F|-primed D2 do¬ 
nors were inoculated into B6D2F| recipients weekly (x6-l()) 
either before or after GVHR initiation with normal D2 cells. A 
third group of B6D2F| recipients were vaccinated weekly x 6 
before disease initiation using 8-MOP/UVA-attenuated B6D2F|- 
primed D2 cells further stimulated and expanded in vitro in the 
presence of B6D2F| targets and lL-2. Control B6D2F| mice 
were vaccinated with 8-MOP/UVA-treated D2 cells primed in 
vitro and/or in vivo with C3D2F| (H-2''''') cells. 
Only mice vaccinated with 8-MOP/UVA-attenuated D2-anti- 
B6 cells, secondarily stimulated and expanded in vitro exhibited 
differences from controls when measured by the clinical param¬ 
eters of ascites formation (0 percent of experimental, 67 percent 
of control) and mean survival (29.2 ± 1.2 weeks in experimen¬ 
tal, 17.0 ± 2.4 weeks in control; p<().()25). Histologic evidence 
of SLE-like kidney di.sea.se was found only in the control group. 
The groups also differed in mean ANA titer [calculated as 
log,(titer/40) -i- 11 measured 14 weeks after disease initiation 
(2.6 ± 0.4 in experimental, 5.3 ± 1.7 in control; p<0.()5). Fur¬ 
thermore. in mixed lymphocyte reactions cells from experimen¬ 
tal mice suppressed the proliferative response of a CD4-en- 
riched D2-anti-B6 line (idiotypic) to B6 targets by I 1.4 percent 
when compared to the proliferative response of the same re¬ 
sponder/target combination in the presence of cells from control 
mice (p<0.05). These results indicate photochemo-attenuated 
D2-anti-B6 cells primed in vivo and secondarily stimulated and 
expanded in vitro are capable of preventing progression of 
GVHR-initiated SLE-like disease via a mechanism consistent 
with generation of anti-idiotypic T suppressor cells. 
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S(ini E. Dolilis explains her findings about intergenerational patterns of child nuiltreatnient to fellow 1992 classmates Michael 
(iirardi and Nancy Dingotl Girardi. 
HIV I Nufleocapsid Protein: 
Zinc Binding and Functional Assays 
by Daniel VV. Fitzgerald 
l-'acidty advisor: Joseph K. Coleman. M.D.. Ph.D. 
Professor oj niolecniar biophysics and biochemistry 
I'acnltx discnssant: William Konigsberg. Ph.D. 
Professor ofmolecniar biophysics and biochemistiy and genetics 
The luieleoeapsid (NC) protein (pi5) of the human immuno- 
defieieney virus. IIIV. is a small RNA binding protein which 
coats the HIV genome. NC has been cloned and overproduced 
(under the control of a phage T7 promoter) in soluble form in an 
cob host. The soluble NC protein is a fusion protein contain¬ 
ing l.'i AA from the T7 gene 10 and 7AA from the HIV p24 
protein at the N-terminus to make a protein ol I 7 I amino acids, 
i he plasmid containing the fusion gene is tiesignated pl.SDF. 
Based upon the primary sequence of NC. it has been postulated 
that the NC coordinates two /ine ions and is thus a member of 
tlu' ‘Vine fingei" proteins. A homogeneous product has been 
isi dated Irom the indueerl cells, aiul when isolated umler aerobic 
■ i)iKlitions contains ()..T()..‘S gm atoms of Zn/mole protein and 
only 2 titratable .SI I groups. On (he other hand, if the cells 
• -I u alcd in 2 inM CdCI anil purified at pl I .‘s.O. an unoxidi/.ed 
protein containing 2 gm atoms Cd/mole protein is obtained. 
The Cd( 11) ions can be exchanged with Zn(ll), Co(ll) or "’Cd(II). 
The CodH^NC protein shows d-d electronic transitions at 69S 
nm (£=675 M ' cm ' per Cot 11)) and 640 nm (e=825 M ' cm ' per 
Cot 11)) compatible with regular tetrahedral geometry around 
both Co(ll) ions. The Co(ll). and Cd(ll),NC proteins show 
intense charge transfer bands in the near UV. 355 nm (£=-8000 
M ' cm ') for the Co(ll) protein and 255 nm (£=~I0'* M ' cm ') 
for the Cd(ll),NC protein, compatible with -S coordination. 
"^Cd NMR of the "’Cd(ll),NC protein shows two "’Cd NMR 
signals at 659 and 640 ppm respectively, each integrating to 
-one Cd(ll) ion. The downfield chemical shifts suggest coordi¬ 
nation of each "’Cd(ll) ion to 3 sulfur donor atoms. The 
spectroscopic data fully support the prediction that the NC 
protein binds metal ions to each of the tandem repeats of the - 
Cys-X,-Cys-Xj-His-X^-Cy.s- sequence contained in the N-ter- 
minal half of the molecule. While it is known that the NC 
nonspeeifieally coats the HIV genome, a number of other func¬ 
tions have been postulated. Functional assays pre.sented here 
show that NC increases reverse transcriptase acti\ity by 2.5 
fold. Preliminary data also support the hypothesis that NC 
binds specifically to the psi .sequence of HIV and is thus essen¬ 
tial for specific packaging of viral RNA into virions. 
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Regulation of Cytokine Production 
in the Rat Osteoblast 
by Transforming Growth Factor-Beta 
by John L. Phillips 
Facult}' advisor: Mark C. Horowitz, Ph.D. 
Assistant professor of orthopaedics and rehcdtilitation 
and dermatology 
Faculty discussant: Karl L. Insonga, M.D. 
Associate professor of medicine 
Osteoblast activities include bone formation, osteoclast regula¬ 
tion, and the secretion of a class of hormones called cytokines. 
Osteoblast-derived cytokines include Inteiieiikin-6 (IL-6) and 
two colony stimulating factors (CSFs): Granulocyte-Macroph¬ 
age CSF (GM-CSF), and Macrophage-CSF (M-CSF). Osteo¬ 
blasts secrete cytokines after exposure to ,several well-charac¬ 
terized mitogens such as lipopolysaccharide (LPS), 
phytohemafflutinin (PHA), and Interleukin-1. What roles os¬ 
teoblast-derived cytokines play in normal bone remodeling is 
unknown. 
Transforming Growth Factor-Beta (TGF-6) is a ubiquitous 
23-25 kDa homodimeric protein stored in platelets and bone. 
TGF-6 was originally discovered as an inducer of neoplastic 
transformation in normal fibroblasts but has since been impli¬ 
cated in matrix homeostasis, immunomodulation, development 
and hematopoesis. Bone is the body’s largest source of TGF-6 
and the protein becomes activated after osteoclast bone resorp¬ 
tion. No definitive role for TGF-6 in bone remodeling is 
known. 
This thesis pre.sents experiments which tested the effect of 
TGF-6 on osteoblast cytokine production and release. Data 
from in vitro cytokine assays of conditioned media suggest that 
TGF-6 upregulates IL-6 and GM-CSF secretion through a novel 
synergistic interaction with other low concentration molecules 
including LPS, IL-1, and parathyroid hormone (PTH), as a 
group referred to here as synergens. M-CSF secretion was 
unaffected by TGF-6 alone or in combination with any synergen. 
90 percent of the GM-CSF and IL-6 release observed is achieved 
between 2.5 and 6 hours after exposure to TGF-6 and a given 
synergen. Furthermore, the synergy between TGF-6 and a 
given molecule is TGF-6-dependent. The osteoblast response 
was not altered by exposure to indomethacin. RNA analysis 
suggested that the synergy between TGF-6 and IL-1 may in¬ 
volve TGF-6 upregulation of the IL-1 cell surface receptor. 
These observations are the first to implicate TGF-B as a stimula¬ 
tory molecule for cytokine release from osteoblasts and suggest 
new a,spects of bone remodeling as well as a possible role for the 
osteoblast in hematopoesis. 
Dr. Robert Gifford (right) shows his affection for G. Edith Hsiui2g, Ph.D., professor emeritus of lahoixitoiy medicine, for whom a 
student research fellowship is named. At left is Warren A. Andiman, M.D., associate professor of pediatrics, epidemiology and 
lahoraton’ medicine. 
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RESIDENCY PLACEMENTS 1992 
CALIFORNIA 
Kaiser Rermanente, Santa Clara 
Da\ id Lilli, medicine 
St. Mary’s Medical Center, Long Beach 
KcMit Min. medicine 
Stanford Affiliate Hospital 
James Reese, neurosurgery 
Ping Wang, general surgery 
L niversity of California, Los Angeles 
I iowaid Cheng, internal medicine 
Joanna Jen. neurology 
Da\ id Lilli, diagnostic radiology 
University of California, San Francisco 
Jonallian Barash. /(//inVy practice 
Sara Dobbs, pediatrics 
Yuly Kipervarg, medicine 
Samuel Myers, internal medicine 
Lawr Randall, orthopedics 
Steven Simon, internal medicitie 
University of Southern California, Los Angeles 
L.auren Krieger. orthopedics 
Andrew Phillips, ophthalmology 
CONNKCTICUT 
(ireenwich Hospital 
Joseph LaRocca. niedicine 
Santiago Villazon. medicine 
Hospital of St. Raphael, New Haven 
Nahum Goldberg, medicine 
William Sharpe, medicine 
Norwalk Hospital 
h ail Sillier, medicine 
\ ale-New Haven Hospital 
Darrick Alainio. medicine 
Madeleine Blauroek, interna! medicine 
Samuel Colin, medicine 
•Marlene Corujo. general surgery 
Jodi Dashe, obstetrics and gynecology 
Deborah Dillon, pathology 
Nancy Dingott. pediatrics 
•Michael Girardi. medicine 
Robert Johnson, interned medicine 
•Alan Jotkow itz. interned medicine 
l a ic Krakauer, internal meeUcine 
I rancis Lobo. interned medicine 
Daniel Idiilbin. internal tneelicine 
John Phillips. .vn/g('/T. urology 
Mickey Riggs, psye hieitry 
Mar\ Lllen SuMige:, psye hieitry 
Jonathan Sears, medicine, eiphthetlmologx 
i dward Weiss, internal medicine 
DISTRICT OF COLUMBIA 
Georgetown University Hospital 
Ted Lin, surgery, netirostirgen' 
Ann Smith, diagnostic radiology 
(ieorge Washington University Hospital 
Nathan Schmiechen, emergency medicine 
FLORIDA 
University of Miami/Bascom Palmer 
Ivan Suner. ophthalmology 
ILLINOIS 
University of Chicago Hospitals 
Peter Marcus, obstetrics and gynecology 
Elizabeth Roth, medicine 
Mitch Saltzberg, internal medicine 
West Suburban Hospital-Illinois, Oak Park 
Karen Antell, /d/i;//v practice 
INDIANA 
Indiana University Medical Center, Indianapolis 
Gregory Engel, general stirgeiy 
IOWA 
University of Iowa, Iowa City 
Ross Zbar, otoUtniigology 
MARYLAND 
Johns Hopkins Hospital, Baltimore 
James Blaugrund, sttrgery. otolaiyngology 
Marcus Butler, internal medicine 
James Yeh, surgeiy. otoletryngology 
MASSACHUSETTS 
Beth Israel Hospital, Boston 
Kent Min. diagnostic radiology 
Ken Rosenzweig. medicine 
Boston City Hospital 
Kathryn Ryder, internal medicine 
Daniel Solomon, internal medicine 
Boston University 
Santiago Villazon. ophthalmology 
Brigham & Women's Hospital, Boston 
Douglas Dahl, surgery, urology 
Jeiinifer O'Brien, anesthesiology 
Frederick Welt, internal medicine 
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Children's Hospital, Boston 
Elizabeth Mullen, pediatrics 
Anne Wolf, pediatrics 
.Joint Center for Radiation Therapy, Boston 
Ken Rosenzweig, radiation oncology 
I.ahey Clinic Foundation, Burlington 
Mat Massicotte, urology 
Massachusetts (Jeneral Hospital, Boston 
Stacey Berg, pediatrics 
Laura Drabkin, pediatrics 
Dan Fitzgerald, priinaiy care/inedicine 
Nahum Goldberg, diagnostic radiology 
Karen Loechner, pediatrics 
Julie Lund, internal medicine 
Mat Massicotte. siirgeiy 
John Schulz, general siirgeiy 
Claudia Showalter, diagnostic radiology 
John Walsh, anesthesiology 
McLean Hospital, Belmont 
Karen Loechner. psychiatry 
Mt. Auburn Hospital, Cambridge 
Claudia Showalter. medicine 
New England Deaconess Hospital, Boston 
Jennifer O’Brien, medicine 
Robin Perlmutter, general surgery 
Sean Roddy, siirgeiy 
New England Medical Center, Boston 
Evan Fischer, orthopedics 
MICHIGAN 
University of Michigan Hospitals, Ann Arbor 
Andrew Griffith, surgery, otolaiyngology 
MINNESOTA 
University of Minnesota Hospital & Clinics, Minneapolis 
M. Wallen-Friedman, general snrgeiy 
NEW JERSEY 
St. Barnabas Medical Center, Livingston 
Ann Smith, transitional 
NEW MEXICO 
University of New Mexico School of Medicine, 
Albuquerque 
Mark Epstein, emergency medicine 
NEW YORK 
Columbia University 
Barry Birch, neiirosnrgeiy 
Lenox Hill Hospital, New York 
Ross Zbar, siirgeiy 
Manhattan Eye & Ear 
David Eisenman, otolaiyngology 
St. Luke’s/Roosevelt Hospital, New York 
Tobenna Okezie, orthopedics 
Strong Memorial Hospital, Rochester 
Eric Rashba, internal medicine 
The New York Hospital 
David Eisenman, surgery 
Joseph LaRocca, anesthesiology 
NORTH CAROLINA 
Duke University Medical Center, Durham 
William Dwyer, niedicine/pediatrics 
Doris larovici, psychiatry 
University of North Carolina, Chapel Hill 
Ada Cheung, orthopedics 
Teresa Wooten, pediatrics 
OREGON 
Emanuel Hospital/Health Center, Portland 
Andrew Phillips, transitional 
Jivin Tantisira, transitional 
Oregon Health Science University, Portland 
Ahmed Abou-Zamzam, general surgery 
Joanna Jen. medicine 
PENNSYLVANIA 
Altoona Hospital 
Kurt Kubicka, /d/n//v practice 
Thomas Jefferson University, Philadelphia 
Robin Smith, siirgeiy, urology 
University Health Center/Pittsburgh 
Jivin Tantisira, ophthalmology 
Neely Anne Towe Egan, pediatrics 
University of Pennsylvania Hospital, Philadelphia 
Darrick Alaimo. neurology 
Scott Kasner, neurology 
Nabil Rizk. general siirgeiy 
Chloe Thio. internal medicine 
RHODE ISLAND 
Miriam Hospital, Providence 
Helena Kwakwa, internal medicine 
Rhode Island Hospital, Providence 
Kelly McGarry, primary care/niedicine 
VIRGINIA 
University of Virginia, Charlottesville 
Nancy Harthun, general surgery 
WASHINGTON 
University Washington Affiliate Hospitals, Seattle 
Charles Charman, primary care/niedicine 
William Sharpe, diagnostic radiology 
John Walsh, medicine 
Residency placement information is provided by the Yale Uni¬ 
versity School of Medicine Office of Education and Student 
Affairs. 
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COMMENCEMENT 1992 
Medical graduates take the Yale Physician’s Oath. 
All in fun: RolfTowe. .l.D. '64, 
straightens the cap of his daughter. 
Neely Anne Ton e Egan. M.l). '92. 
Robin Perl unit ter invites the photography to begin. 
'ill ■ Wolf (left) and Jennifer O'Brien 
till- class photo. 
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M.P.H. graduate Linda Marc discusses post-coinniencenient plans. 
M.P.H. candidate Carrie McFadden 
receives word that the EPH 
connnenceinent is about to begin. 
Jean Flatley McGuire. M.S.P.H.. a 
Pew Foundation Doctoral Fellow at 
Brandeis University, fonierly with the 
AIDS Action Council. Washington. D.C., 
delivered the 1992 EPH 
connnenceinent address. 
Robert Randall. M.D. '92, celebrates 
with his family. 
M.P.H. graduate Sean Buckley 
promenades with a proud supporter. 































In Vitro Program 
Celebrates 10 Years 
This summer, the School of Medicine 
and Yale-New Haven Hospital 
celebrated the lOth anniversary of the 
In Vitro b'ertilization Program 
through which approximately 220 
babies have been born. 
Parents and children returned to 
New Haven in .lune for anni\'ersary 
festivities complete with picnic fare, 
a clown, balloons, a puppet show, 
Babar the elephant and more. 
"Through this sophisticated 
program, we have been able to assist 
hundreds of couples w ho otherwise 
would have had to consider adoption 
or remain childless," explains Dr. 
I iw in P,. Jones, associate professor of 
obstetrics and gynecology. 
Initiated in 1982. the Yale IVF 
luogram includes a team of obstetri¬ 
cians, endocrinologists, nurses and 
social workers who address the needs 
of participating infertile couples. On 
May 25, 1983. the first IVF baby in 
New England was born at YNHH 
through this program. 
In 1986, Yale became one of the 
first IVF centers to use the 
cryopreservation process, allowing 
couples to save embryos for use in 
subsec|uent cycles. In 1987. Yale 
began a donor egg program to enable 
women without functioning ovaries 
to become pregnant. More recently, 
Yale opened a center for microma¬ 
nipulation, a process that injects 
sperm cells directly under the egg 
covering, offering an e\’en better 
chance for conception to couples 
with male-factor infertility. 
Recently Joining the Yale IVF 
team is Dr. David L. Olive, associate 
professor of obstetrics and gynecol¬ 
ogy and chief of the division of 
reproductive endocrinology. 
Needle Exchange 
Slows HIV Spread 
Yale researchers report new findings 
consistent with earlier reports that a New 
Haven needle exchange-program which 
began two years ago is slow ing the 
spread of HIV among drug users 
participating in the program. 
Robert Heimer. Ph.D.. associate 
research scientist in medicine, presented 
the results in Baltimore at the annual 
joint meeting of the Association of 
American Physicians, the American 
Society for Clinical Investigation and 
the American Federation for Clinical 
Research. 
Edward H. Kaplan, Ph.D., an 
associate professor in the Yale schools 
of organization and management and of 
medicine, led the research team. He 
developed a new needle tracking system 
to evaluate the effects of the program, in 
which IV drug abusers anonymously 
exchange used syringes for sterile 
needles on a one-to-one basis. The 
tracking system uses polymerase chain 
reaction, a .sophisticated molecular 
technology, to analyze returned needles 
for the presence of HIV. 
Other Yale colleagues involved in the 
study include Bini Jariwala of the 
department of internal medicine, and 
Edwin C. Cadman. M.D.. the Ensign 
Professor of Medicine and chairman of 
the department of internal medicine. 
The study not only pro\ ides e\ idence 
that the New Haven needle exchange 
program reduces the spread of HIV. but 
also indicates that offering clean needles 
does not create a new generation of 
addicts. 
Comments Dr. Kaplan, "Introducing 
this system has allowed us to pro\ ide the 
first definitixe link between the opera¬ 
tions of a needle-exchange program and 
the course of the AIDS epidemic among 
IV drug users in a gi\ en locale. This 
had yet to be established using tradi¬ 
tional evaluation approaches." 
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Epilepsy Center Receives 
$3.5 Million NIH Grant 
The National Institute of Neurological 
ConiniLinicative Disorders and Stroke 
(NINCDS) has awarded the School of 
Medicine's department of neurology a 
five-year, $3.5 million grant to support 
research into the causes and treatments 
of epilepsy. 
The award marks the 25th year of 
continuous NINCDS funding for the 
Yale Epilepsy Research Program. 
Twenty-three scientists participate in 
this program to study the factors 
responsible for the occurrence, fre¬ 
quency and effects of epileptic seizures 
and how they can be controlled. 
“Our research enables us to pinpoint 
the exact location in the brain where 
seizures begin," explains Dr. Richard H. 
Matt.son. professor of neurology at Yale 
and director of the program since 1985. 
“This ultimately will allow us to provide 
better treatment and, perhaps, to prevent 
epilepsy." 
The Yale Epilepsy Research Pro¬ 
gram, jointly based at the School of 
Medicine, the Department of Veterans 
Affairs Medical Center in West Haven 
and Yale-New Haven Hospital, is a 
consortium of scientists from more than 
10 departments and sections, including 
neurology, neurosurgery, psychiatry, 
neuroanatomy, pathology, pharmacol¬ 
ogy, medicine and diagnostic imaging. 
The program comprises several 
projects in which scientists use micro¬ 
scopic, biochemical and neurophysi¬ 
ological examinations to study where 
and how basic abnormalities occur in 
epilepsy. 
Medical Van Treats 
New Haven Homeless 
Drs. Michele Barry, associate professor 
of medicine at the School of Medicine 
and Jeanne Marrazzo, chief resident at 
Yale-New Haven Hospital (YNHH), 
have developed a mobile medical 
community outreach program to provide 
free medical care to homeless persons at 
four New Haven soup kitchens. 
“We are taking urgent medical care 
out to disadvantaged people who may 
otherwise not be receiving care. At the 
same time, we are preparing future 
physicians to treat homeless people in 
settings beyond health care centers,” 
says Dr. Barry. 
The program is suppr)rted by a one- 
year, $5(),7()() grant from the W.K. 
Kellogg Foundation of Battle Creek, 
Mich. The APT Foundation of New 
Haven has donated a van which Dr. 
Barry and her team have stocked with 
over-the-counter medications and 
supplies provided free by several 
pharmaceutical companies. 
On the van, an attending physician 
supervises two medical residents, a 
pediatric nurse, a substance abuse 
counselor from the APT Foundation, 
and a Hill Health Center social worker. 
Once a week, the van stops for two 
hours at each soup kitchen. The team 
sees an average of 15 patients, with 
medical problems ranging from nutri¬ 
tional and vitamin deficiencies, to 
tuberculosis, AIDS, and mental health 
problems. 
YNHH medical residents are now 
required to take a four-week rotation 
with the new program as a standard part 
of their training. 
Scientists Seek to Advance 
Social Phobia Treatment 
A new study underway at the School of 
Medicine could help reveal the basis of 
.social phobia and its relationship to 
other anxiety disorders. 
More than 2.4 million Americans 
suffer from social phobia, finding 
themselves involuntarily blushing, 
shaking, and even having heart palpita¬ 
tions in reaction to everyday social 
interactions. The phobia can .severely 
impair people’s work and social lives, 
and leave them feeling ashamed, 
frustrated and overwhelmed. 
In the study, researchers compare the 
effectiveness of a medication versus a 
placebo for people impaired by social 
phobia. The non-addictive drug, 
currently used to treat nausea, previously 
had been tested on laboratory animals to 
gauge changes in social interaction. 
"Administration of this drug to rodents. 
which usually stay in dark concealed 
places, increased their .social interaction 
in open, bright areas," explains Dr. 
Wayne F. Goodman, assistant professor 
of psychiatry and principal investigator 
of the study at the Yale Psychiatric 
Specialty Center. 
Working with Dr. Goodman on this 
study are Andrew W. Goddard. M.D.. 
director of the Yale Anxiety Disorders 
Research Clinic; Diane E. Sholomskas, 
Ph.D., co-director of the clinic; and 
Karen L. Carrieri, R.N., clinical nurse 
coordinator. 
Researchers Develop 
New Bone Cement 
School of Medicine researchers have 
developed a synthetic bone substitute 
cement that can repair and replace facial 
bone defects incurred from surgery, 
trauma or infection. The cement, 
developed in collaboration with re¬ 
searchers at the American Dental 
Association Health Foundation, is 
composed of calcium and phosphate, 
which make up 75 percent of healthy 
bone. 
In September, Yale was the first of 
three centers in the world to begin using 
the cement after the U.S. Food and Drug 
Administration approved it for clinical 
trials. 
Hydroxyapatite cement (HAG) will 
be used in a variety of craniofacial 
procedures, such as reconstruction of 
bone to correct congenital deformities; 
repairing bone loss due to periodontal 
disease, and filling holes made during 
brain surgery. 
“When tumors are removed from the 
skull, there may be leakage of spinal 
fluid which can be fatal," states Dr. 
Craig D. Friedman, assistant professor 
of surgery. “We used to put fat or 
muscle grafts in the gap. but there were 
still severe problems. With the HAG 
mixture there is no leakage at all." 
Dr. Friedman and his colleagues have 
found that the body replaces the artifi¬ 
cial substance with natural bone as part 
of the skeleton's ongoing maintenance 
process. 
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Coiistniction proceeds on ihe new Children's Hospital at Yale-New Haven. 
Children’s Hospital 
Rises at YNHH 
Yalc-Ncvv Haven Ilosiiilal's faeililies 
renewal projeel—a $lf>6 million 
undertaking whieh involves eonstruelion 
ol the ('hikiren's Hospital and renova¬ 
tion ol the Memorial Unit 
(MU)- eontinues on sehedule. 
('onstruetion began on the hospital 
July 20, 1001. w ith the frame and (he 
walls eompleted by May 1002. Seherl- 
ali'd to open in the summer of 100.^. the 
Ulnldren's Hospital w ill eonsoliilate 
ul \ ale-New 1 la\en's peilialrie 
M : r,fs as well as house labor and 
' I ■ '■>' aiul maternity and newborn 
- . nil hiding high-risk maternity 
and the Newborn Special Care Unit. "It 
will be specially designed for ehildren.” 
slates YNHH Senior Vice President 
Mama Borgslrom. “There will be a 
separate entrance, and dedicated 
emergency, diagnostic imaging and 
operating room areas for ehildren. The 
I I-story building will also house .some 
adult units, and will have a helipad on 
the roof. 
Building for Health, a major capital 
campaign directed by I-. Patrick 
Melkulden Jr., president ol the Bank of 
New Haven, is helping to fund the 
faeililies renewal project. Seeking gifts 
from several sectors--hospital employ¬ 
ees. trustees, the merlieal staff, corpora¬ 
tions aiul foundations, and the eomnni- 
nily, the campaign has raised .$6..S 
million—>1 iK'ieent of its goal. 
Yale Heart Book 
Makes its Debut 
Twenty-eight Yale School of Medicine 
and Yale-New Haven Hospital faculty 
and staff members, from more than 10 
departments and sections, have helped 
write the 429-page Yale University 
School of Medicine Heart Book. 
Published by William Morrow Co. of 
New York, the book’s 29 chapters offer 
state-of-the-art information to the public 
on the prevention, diagnosis and 
treatment of heart disease, including 
easy to understand explanations of the 
heart and circulatory systems, and of 
interventional cardiology, including 
coronary angioplasty. Drs. Barry L. 
Zaret, Lawrence S. Cohen and Marvin 
Moser are the book's medical editors. 
Progress Made toward 
Lyme Disease Vaccine 
Yale School of Medicine and Harvard 
School of F^ublie Health researchers 
have genetically engineered a vaccine 
for tick-borne Lyme disease that protects 
mice from being infected. The agent 
also works as a therapeutic drug, ridding 
the tick vector—and the animal host—of 
the disease-causing bacterium. 
These results, which offer hope for a 
vaccine for humans, were published in 
the June 14 Proceedings of the National 
Academy of Science. 
The team discovered that when a tick 
infected with Lyme disease bacterium 
fed on a vaccinated mouse, the mouse 
was protected from infection and that 
the bacteria living inside the tick was 
killed by the mouse's antibodies. This 
finding also provided the researchers 
with new knowdedge of the body's 
infection-protection mechanism. 
The Yale/Harvard team includes 
Richard A. Fdavell. Ph.D., profes.sor and 
chairman of immunobiology and 
investigator at the Howard Hughes 
Medical Institute, director of the Yale 
study; Erol I'ikiig, M.D., Stephen W. 
Barthold, D.V.M., Ph.D., and Fred S. 
Kantor, M.D.. also at Yale, with Sam 
Telford. Se.D., and Andrew Spielman, 
Se.n., at Harvard. 
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Faculty 
News 
Dr. Roberts Awarded 
Postdoctoral Fellowship 
William L. Roberts. M.D., an instructor 
in laboratory medicine at the School of 
Medicine and chief resident at Yale-New 
Haven Hospital, has been presented a 
Merck/Arnerican Federation for Clinical 
Research Foundation (AFCR) M.D.- 
Ph.D. Postdoctoral Fellowship Award. 
Dr. Roberts will receive $50,000 
annually for three years to support his 
research on compounds used to treat 
leishmaniasis, a parasitic disease 
transmitted by the sandfly vector. In 
collaboration with colleagues in the 
department of epidemiology and public 
health, he is also studying the mecha¬ 
nisms of parasite resistance, in hopes of 
developing new treatments. 
Martina Brueckner 
Named Syntex Scholar 
Martina Brueckner, M.D., assistant 
professor of pediatrics (cardiology), has 
been named a scholar in the 1992 Syntex 
Scholars Program. The program, 
sponsored by Syntex Corp., an interna¬ 
tional health-care company based in 
Palo Alto. Calif., recognizes scientists 
who have demonstrated outstanding 
potential for independent contributions 
in cardiovascular research. Her award is 
one of two $ 150,000 awards over three 
years that Syntex Corp. makes to two 
U.S. academic institutions on behalf of 
the scholars. 
Dr. Brueckner is studying the mouse 
mutation inversus viscerum. The 
mutation results in an inherited abnor¬ 
mality of left-right asymmetry associated 
with congenital heart defects. She uses a 
positional cloning approach similar to 
that which led to the recent cloning of 
the cystic fibrosis gene. 
Two Faculty Named 
Endowed Professors 
Peter E. Schwartz, M.D., professor of 
obstetrics and gynecology and in the 
Cancer Center, has been named the John 
Slade Ely Professoi' of Obstetrics and 
Gynecology, and Joan A. Steitz, Ph.D., 
professor of molecular biophysics and 
biochemistry, has been named the Henry 
Ford 11 Professor of Molecular Biophys¬ 
ics and Biochemistry. 
Dr. Schwartz, who joined the faculty 
in 1970, is acting chairman of obstetrics 
and gynecology, and chief of gyneco¬ 
logical oncology at Yale-New Haven 
Hospital. He also serves on the execu¬ 
tive committee of the Yale Comprehen¬ 
sive Cancer Center. In an effort to 
diagnose and treat ovarian cancer at 
earlier stages. Dr. Schwartz founded the 
Yale Ovarian Cancer Early Detection 
Program in 1990. 
Dr. Steitz, also a faculty member since 
1970. leads the molecular genetics 
program in the Boyer Center for Molecu¬ 
lar Medicine, and is an investigator with 
the Howard Hughes Medical Institute. 
She has conducted studies that defined 
the roles of small nuclear ribonucleopro- 
tein particles in RNA processing in 
mammals. Through this process, the 
information in genes (DNA) is expressed 
in protein molecules. 
Paul Sigler Named to 
National Academy 
Paul B. Sigler, M.D., Ph.D., professor of 
molecular biophysics and biochemistry 
and an investigator with the Howard 
Hughes Medical Institute, has been 
elected to the National Academy of 
Sciences, one of the highest honors 
given to an American scientist. 
Dr. Sigler, who joined the faculty in 
1989, is a specialist on the chemical 
interactions of proteins and nucleic 
acids. He u.ses X-ray crystallography to 
determine the three-dimensional 
structure of molecules and how they link 
with one another. His research focuses 
on how genetic code is transcribed 
through selective binding of regulatory 
proteins to target DNA sequences. 
Dr. Richard J. Rohhins testifying before 
the U.S. Senate. 
Faculty Members 
Brief U.S. Senate 
Richard J. Robbins, M.D., as.sociate 
professor of medicine and of obstetrics 
and gynecology, was one of four 
speakers to address 60 U.S. Senate staff 
members at a briefing hosted by the 
Association of American Medical 
Colleges, the Association of American 
Universities, the National Association of 
State Universities and Land Grant 
Colleges, and other members of the 
Coalition for Research Freedom. The 
briefing focused on the ethical and 
scientific issues of fetal tissue transplan¬ 
tation research. 
D. Eugene Redmond Jr., M.D., 
professor of psychiatry and director of 
the Yale Neural Transplant Program, 
and Myron Genel, M.D.. associate dean 
for government and community affairs, 
also outlined aspects of the Yale 
program to key Senate staff before the 
Senate debate on legislation, which 
called for restoring federal funds for 
research in this area. The Senate later 
approved the legislation, 87 to 10. 
The House of Representatives also 
pas.sed the legislation by a wide margin, 
but on a vote taken on June 24. could not 
override a veto issued by President 
George Bush. 
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Culpeper Foundation 
Scholarship Awarded 
To Peter M. Glazer 
Peter M. Glazer, M.D., Ph.D.. assistant 
prol'essor of therapeutic radiology, has 
received a Charles E. Culpeper Founda¬ 
tion Scholarship in Medical Science for 
1992. These .scholarships support young 
physicians of high potential achievement 
who are committed to careers in 
academic medicine. 
Through this award. Dr. Glazer will 
receive $ I ()().()()() a year for up to three 
years to fund his research investigating 
the possible causes of cancer by examin¬ 
ing the damage produced in the heredi¬ 
tary material of mice by exposure to 
potential carcinogens. 
.)ohn C. Baldwin. M.D.. professor 
and chief of cardiothoracic surgery, 
presented a lecture on the future of heart 
surgery at the Annual World Congress 
on Intensive Care held at the Lhiiversity 
of Brussels in March. In April, he was 
inducted into the American .Surgical 
.Associatit)!!. 
Pravin N. Bhatt. M.D.. senior 
research virologist in comparative 
medicine, has been elected as an 
honorary member of the American 
Cidlege of Laboratory Animal Medicine 
for his contributions to laboratory 
animal science. 
.Joseph R. Bove. M.D.. professor and 
vice chairman of laboratory medicine, 
has been appointed to the national board 
of directors of the American Red Cross, 
lie will serve on the biomedical services 
committee which ad\ ises the board on 
issues concerning blood trtinsl'usion and 
tissue transplantation. 
Malihouheh Eghbali. Ph D.. 
tissociatc professor of anesthesiology, 
was the keynote spetiker at the Cardio¬ 
vascular .Sciences Seminar in Canaila in 
April. She also spoke at the interna¬ 
tional sMiiposium; "Myocartlitis— 
Dilated Cardiomyopathy I’athogenesis 
and Clinical Implications" in Germany 
111 .\lav. Both ttilks I'ocused on "Regula- 
M 'li ;>f (icnc f’xprcssion in Cardiac 
Fibroblasts and their Phenotypic 
Modulation.” 
Jack A. Elia.s, M.D.. professor of 
medicine (pulmonary) and section chief 
of pulmonary and critical care medicine, 
has been appointed to the following 
organizations: the American Society for 
Clinical Investigation (honorary), board 
of directors of the American Thoracic 
Society, the editorial hoards of the 
American Journal of Physiology, Lung, 
Cellular and Molecular Physiology, and 
the Journal of Laboratory and Cliidcal 
Medicine. 
Francis P. Gasparro, Ph D.. 
research scientist in dermatology, has 
been elected to a four-year term as a 
councilor for the American Society for 
Photobiology, beginning in July. He 
afso will .serve as the editor of the 
society's newsletter. 
Myron Genel. M.D.. associate dean 
for government and community affairs 
and professor of pediatrics (endocrinol¬ 
ogy), was re-elected to the House of 
Delegates of the New Haven County 
.Medical Association (NHCMA) board 
of governors and will .serve as a 
NHCMA delegate to the Connecticut 
State Medical Society's House of 
Delegates. 
Thomas J. Godar, M.D., associate 
clinical professor of medicine, was 
awarded the Will Ross Medal for 
distinguished volunteer services by the 
American Lung Association in Miami 
Beach. Fla., in May. 
C. Carl Jaffe. M.D.. professor of 
diagnostic radiology and medicine, was 
appointed chairman of the Biomedical 
Library Research Committee of the 
National Library of Medicine. Dr. Jaffe 
was also named (he 1992 Samson 
Feldman Visiting Scholar in ,Ai1 as 
Applied to Medicine by the Johns 
Hopkins University School of Medicine. 
.Michael Kashgarian. M.D. '58, 
professor of pathology, was elected 
secretary of the New Haven County 
.Medical .Association (NHCMA) in 
April, Dr, Kashgarian. a member since 
1967. continues to .serve as a NHCMA 
delegate to the Connecticut State 
Medical Society's House of Delegates 
and as a member of its board of gover¬ 
nors. C'hairman of the membership 
committee since 1983. he has also 
served on the health systems planning 
and long-range planning committees. 
Marc I. Lorher, M.D.. associate 
professor and director of surgery 
(transplantation), was elected to a three- 
year term on the executive council of the 
American Society of Transplant Sur¬ 
geons at the annual meeting in Chicago 
in May. Dr. Lorber also was reap¬ 
pointed to a tw'o-year term on the 
scientific advisory committee of the 
United Network for Organ Sharing, 
which oversees national transplant- 
related activities through a contract with 
U.S. Department of Health and Human 
Services. 
Adrian M. Ostfeld, M.D., the Anna 
M.R. Lauder Professor of Epidemiology 
and Public Health and Medicine, has 
been elected a fellow of the Royal 
Society of Medicine in London. Recog¬ 
nized for distinguished contributions to 
biomedical science. Dr. Ostfeld is one of 
230 professionals in geriatrics and 
gerontology worldwide who is a society 
member. 
Gerald I. Shulman, M.D.. as.sociate 
professor of medicine (endocrinology), 
and lecturer in molecular biophysics and 
biochemistry, w'as selected as a member 
of the Metabolism Study Section, 
Division of Research Grants, Depart¬ 
ment of Health and Human Services of 
the National Institutes of Health, for a 
three-year term. 
Alan P. Siegal, M.D., assistant 
clinical professor of psychiatry, was 
installed as national president of the 
American Association of Geriatric 
Psychiatry in May. He is also president 
of the Alzheimer's Re.source Center of 
Connecticut, scheduled to open in 
October in Southington. 
John I). Thompson. M.S.. professor 
emeritus and lecturer in public health, 
w as aw aided the Baxter Health Services 
Research Prize, the highest honor in 
health-care services research, for 
developing the diagnosis-related group 
(DRG) .system, which dramatically 
changed how the government reimburses 
LfS. hospitals. 
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Thomas P. Duffy, M.D., professor of medicine and in the 
Cancer Center, 1992 Bohmfalk Charitable Trust Award winner 
for outstanding teaching in the clinical sciences, with Michele 
Bariy, M.D., associate professor o f medicine, who won the 
Leah Lowenstein Award for the full-time faculp’ member who 
represents the highest degree of excellence in non-sexist 
education. 
Peter P. Stein, M.D., assistant professor of medicine, and Maiy 
Jane Minkin, M.D., associate clinical professor of obstetrics 
and gynecology, shared the 1992 Francis Gilman Blake Award 
as the most outstanding teachers of the medical sciences, as 
designated by the graduating class. 
Dr. Robert M. Donaldson Jr. presided as acting dean at the 
1992 Yale School of Medicine Commencement. 
Shanta E. Kapadia, M.B.B.S., lecturer in surgeiy (anatojiiy), 
won the Bohmfalk Charitable Trust Award as the outstand¬ 
ing teacher in the basic sciences. 



















Hunter College Honors 
Dr. Helen Langner 
Hunter College, the college alma mater 
ol Helen Parthenay Langner. M.D. '22. 
obser\'ed her centennary year by 
granting her an honorary Doctor of 
.Science degree. Her citation, excerpted 
bektw. said much of the life and times of 
Dr. l.angner: 
■■^'ou came to Hunter College in 1910 
to pursue your interest in the natural 
sciences, a course of study that was not 
open to you. as a woman, in your home 
state of Connecticut. After receiving a 
degree from Hunter in 1914. you taught 
biology in the public schools and then 
entered Yale Medical School. In 1922, 
you were the fourth woman ever to 
receive a medical degree from Yale. 
You went on to a residency in the then- 
new field of psychiatry, and. later, to an 
active practice. 
■'Highlights of your career included 
working with children in community 
clinics, substitution for psychiatrists 
called to military ser\'ice, ser\ ing as a 
school psychiatrist for the New York 
City Department of Education, teaching 
clinical psychiatry at Cornell University 
.Medical School, and serving as resident 
psychiatrist at Vassar College. You also 
enjoyed an active pri\ate practice in 
New York City and filled important 
psychiatric posts in several agencies in 
Milford. Conn. During your long and 
\ aried career, you have gi\'en generously 
of your time and money to help patients 
who could not otherwise afford psychi¬ 
atric care. 
"East month, you celebrated your 
lOOth birthday. 4'he oklest li\ ing 
member of the Hunter College Hall of 
fame, you continue to practice psychiat¬ 
ric medicine, and ser\e as an atteinling 
psychiatrist at .Milford Hospital." 
\l her other alma mater. \'ale. Dr. 
Eaii-.’iu-r annually attends alumni 
Dr. Helen Langner with Merle Wa.xnian. director of the YSM office for women in 
medicine, at the 1992 Alumni Reunion Weekend, held in June. 
reunion weekend at the School of 
Medicine, drawn by the scientific 
symposia and lectures which keep her 
abreast of current issues in medicine. 
In addition to her professional 
acti\ ities. Dr. Eangner maintains her 
lifelong dedication to wildlife and 
environmental preservation. She is 
active in many conservation groups, 
including the Milford Land Conserva¬ 
tion Trust, the Nature Conservancy 
Connecticut chapter, the Milford Marine 
Institute and Nature Center, and Con¬ 
necticut Eund for the En\ ironment. 
When asked about all the attention 
that she is receiving during her lOOth- 
birthday year. Dr. Langner replied. ''It's 
pretty overwhelming. Em just glad that 
1 still have the wit to appreciate every¬ 
thing that's going on." 
Maxwell J. Wolff, M.D., '25 Med., who 
will celebrate his 9.Sth birthday in 
November, is praeticing dermatology 
part-time, in Los Angeles. 
Eugenio .M. de Hostos. M.D. 42, 
was granted an honorary Doctor of 
Medical Sciences degree by the 
Uni\ersidad Eugenio Maria de Hostos in 
Santo Domingo, Dominican Republic. 
In a January 1992 ceremony. Dr. de 
Hostos tleli\’ered the eommencement 
address to 2.^0 graduate and post- 
izraduate students. 
Allan J. Ryan. M.D., '44-'46 HS, 
was program chairman for the second 
annual meeting of the International 
Association for Dance Medicine and 
Science, held in June in Durham. N.C. 
Jerome M. Classman, '50 PHSP. 
'50 Ph.D., who retired in 1988 as 
director of clinical investigations for 
Caiter-Wallace, Inc., is a pharmaceutical 
industry consultant. 
Paul R. Bruch. M.D. '51, a member 
of the Connecticut Right-to-Life Corp. 
since its formation in 1973, has been its 
president since 1988. The educational 
organization's aim is to amend the U.S. 
Constitution to protect all life from 
conception to natural death. 
Robert P. Hatch. M.D. '54, who 
retired in 1984 from his obstetrics and 
gynecology practice, has become active 
in town planning, budget acti\ ities and 
\olunteer work in his hometown of 
Alfred. Me. He is also a weather 
obser\ er for WESH-TV in Portland. 
William H. Hindle. M.D. 56. 
profes.sor of clinical obstetrics and 
gynecology at the University of South¬ 
ern California School of Medicine and 
director of the Breast Diagnostic Center. 
Women's Hospital. Los .Angeles 
County-University of Southern Califor¬ 
nia Medical Center, has been elected 
president of the National Consortium of 
Breast Centers. 
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Robert I. Levy, M.D. '61. '61-'63 
HS. has been appointed president of 
Wyeth-Ayerst Research, a division of 
American Home Products Corp., and is 
responsible for worldwide research and 
development. 
Stephen C. .Joseph, M.D. '63, dean 
of the School of Public Health and 
professor of public health and pediatrics 
at the University of Minnesota, has been 
inducted into the Society of Scholars at 
the Johns Hopkins University. Created 
in 1967, the society honors distinguished 
researchers who were at Johns Hopkins 
as postdoctoral fellows, junior faculty or 
visiting faculty. Dr. Joseph was a 
postdoctoral fellow at Johns Hopkins. 
Dr. Stephen C. Joseph 
Neal L. Maslan, M.P.H. '64. 
managing director for Ward Howell 
International, a national recruiting firm, 
was profiled as one of America’s top 
150 executive recruiters in The Career 
Makers, a book recently released by 
Harper/Collins Publishers. Mr. Maslan 
specializes in medical, health care, 
product and technology, and venture 
capital search assignments. 
David H. Shapiro, M.D., '67- 71 
HS. was elected president of Morton 
Plant Hospital, Clearwater. Fla. He has 
been on the medical staff for 18 years. 
.John J. Kelly .Jr., M.D. '69, '69- 71 
HS, is professor of neurology and 
chairman of the department of neurology 
at the George Washington University 
Medical Center and Medical School in 
Washington. D.C. 
.Fan Wallace, M.D.. '69-’72 HS, was 
appointed vice president of clinical and 
regulatory affairs at Athena Neuro¬ 
sciences Inc. in South San Francisco. 
Frederick L. Greene, M.D., '7()-’76 
HS, professor of surgery at the Univer¬ 
sity of South Carolina School of 
Medicine, has been elected president of 
the Society of American Gastrointestinal 
Endoscopic Surgeons. 
Peter J. Panzarino, M.D. '72, has 
been named chief clinical officer of 
Vista Health Plans, a not-for-profit 
Southern California health maintenance 
organization and employee assistance 
program specializing in mental health 
and substance abuse. He will also serve 
as medical director of Vista Hill 
Foundation, which owns and operates 
Vista Health Plans. 
William T. Choctaw. M.D. 73. '73- 
'75 HS. was elected mayor pro tern for 
the City of Walnut. Calif., and continues 
to practice surgery full-time. 
Francis S. Collins, Ph.D.’74, 
professor of internal medicine at the 
University of Michigan and a Howard 
Hughes Medical Institute investigator, 
received an honorary Doctor of Science 
degree from Yale in May. 
Dr. Francis S. Collins 
.John I). Schrnmpf, M.D. '74. was 
elected president of the San Francisco 
Radiological Society and a fellow of the 
American College of Radiology. Dr. 
Schrumpf, who practices at California 
Pacific Medical Center, is an associate 
clinical professor at the University of 
California, San Francisco. 
Harvey J. Berger, M.D. 77, is 
chairman and chief executive officer of 
Ariad Pharmaceuticals, Inc., a biotech¬ 
nology company in Cambridge. Mass., 
which he established in 1991. 
FYlwarcl C. Halperin, M.D. '79. 
associate professor of radiation oncology 
at Duke University School of Medicine, 
has been named a 1991-1993 fellow of 
the American Council on Education. He 
will concentrate on academic adminis¬ 
tration and policy. 
Mark L. Demhert. M.D., 83 
M.P.H., is a captain in the U.S. Navy 
Medical Corps and a staff psychiatrist at 
the National Naval Medical Center in 
Bethesda, Md. 
Valerie E. Stone, M.D. '84. has been 
named medical director for ambulatory 
care services in the Boston Department 
of Health and Hospitals (DH&H). She 
.serves as the senior administrative 
physician for ambulatory clinical care at 
all DH&H sites, including the Ambula¬ 
tory Care Center (ACC) at Boston City 
Hospital. The ACC's 72 specialty 
clinics average 178.000 patient visits per 
year. 
Harry A. Lebowitz, M.D.. '86- 89 
HS. a Wilmington. Del., ophthalmolo¬ 
gist. and a member of Surgical Eye 
Expeditions Inc., a charitable organiza¬ 
tion. traveled to El Salvador in April. In 
three days, his team of five volunteer 
physicians performed 120 operations, 
mostly on people blind from cataracts. 
Robert C. Urban Jr.. M.D. 87, a 
fellow in glaucoma at the Massachusetts 
Eye and Ear Infiiniary. Harvard Medical 
School, has been named assistant 
professor of ophthalmology at the 
University of South Florida. Tampa. 
Amy V. Kindrick. M.D. 89, a 
fellow in the Harvard Combined 
Infectious Diseases Training Program, 
has completed an internal medicine 
residency at Brigham and Women’s 
Hospital in Boston. 
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)'(ilc University School ol Medicine 
Heart Book, edited by Barry L. Zuret, 
M.I).. the Rirberl W. Berliner Brol'essor 
ol Medieine (eardiology), seelion ehief 
eardiovaseidar medieine; Marvin Moser, 
M.I)., elinieal profes.sor of medieine; 
and laiw renee .S. Cohen, M.I)., the 
libene/er K. Hunt I’rol'essor of Medieine 
(eardiology) and deputy dean. William 
.Morrow & Co. (New York) 092. 
Assessini^ Pediatric Practice: A Critical 
Study, by Raymond .S. Duff, M.I). '52. 
Health Administration Press (Ann 
Arbor. Mieli.) 199 I. 
Pile Balinese People: A Reinvestipa- 
tion oj Character, by Cordon I). Jensen. 
■M l). '49. O.xiord University Press 
(Asia) 1992. 
Criu k: Phe Broken Promise, by David F. 
Allen, leeturer in publie healib, and 
James F. Jekel. M.I).. 'b5 M.P.H.. the 
Charles FkA. Winslow Professor of 
Publie I lealth and direetor of the 
pre\enli\e meilieine resideney program, 
•St, .Martin's Press (New York) 1991. 
Ill relive Care of the Newborn Infant, by 
lolin C. Sinclair and Michael B. 
Bracken. '70 M.P.H., Ph.D,. |irotessor 
and vice chairman, department of 
a|iidcmiology and publie health. Oxford 
I nivcisity Press (New ')'ork aiul 
;)\l->id) Pt92. 
Medical Care of the Cardiac Surgical 
Patient, edited by Stephen C. 'Vlay. 
M.D. '75. Blackwell Scientific Publica¬ 
tions (Boston, Mass.) 1992. 
The Patient: Biological. P.sychological, 
and Social Dimensions of Medical 
Practice. .Jrd edition, by Hoyle Leigh, 
M.I)., leeturer in psychiatry, and Morton 
F, Reiser, M.D.. the Albert E. Kent 
Professor Emeritus of Psychiatry. 
Plenum Publishing (New York) 1992. 
When Home is No Haven: Child 
Placement Issues, by Albert J. Solnit. 
M.D., Sterling Professor Emeritus of 
Pediatrics and Psychiatry; Barbara F. 
Nordhaus. M.S.W., assistant clinical 
professor of social work in the Child 
Study Center; and Ruth D. Lord, M.A.. 
associate research .scientist in the Child 
Study Center. Yale University Press 
(New Haven and London) 1992. 
A Window to Heaven: How Children 
See Life in Death, by Diane M. Komp. 
M.D., profes.sor of pediatrics (hematol- 
ogy/oneology). Zondervan Publishing 
Flousc (Grand Rapids, Mich.) 1992. 
Student 
News 
Third-year students Yamilee 
Bermingham and Karen Rosewater 
were presented Elm-Ivy Awards for 
(heir work as the first medical students 
serving as student volunteer coordinators 
for (he Medical School Council. Kaveh 
Khoshnood. a third-year Ph.D. student 
in the department of epidemiology and 
publie health, was presented an Elm-Ivy 
Award for his work in educational 
outreach programs to curb the spread of 
AIDS. The annual awards are presented 
by the University and the city of New 
Haven to recognize pet)ple who help 
build a positive relationship between 
')’ale and its host ei(y. 
Second-year student Tamer 
Bourslian and Eric Hoffman, a third- 
year student, have been awarded 
predoctoral fellowships from the 
National Science Foundation. 
Marlene Corujo, M.D. '92, is one of 
two recipients of the 1992 James H. 
Robinson, M.D.. Memorial Prize in 
Surgery by the National Medical 
Fellowships. Inc. The prize acknowl¬ 
edges outstanding performance in the 
surgical disciplines coupled with good 
academic performance, leadership and 
social responsibility. 
Belinda J. Chan, a third-year 
student, volunteers her time to the Big 
Brother/Big Sister program. 
Kirk R. Essenmacher. a third-year 
student, established the SMARTS 
program, in which medical students go 
into high school classrooms to talk with 
students about careers and college. 
Second-year students Barbara M. 
Garcia and Walter O. Jackson 
coordinated a weekly lecture series for 
the medical school's 13th annual 
Summer Research Apprenticeship 
Program, which is designed to interest 
minority high .school students in careers 
in medicine and the biomedical sciences. 
Christopher G. Goring, a second- 
year student, .serves as the student 
coordinator of the Minority Undergradu¬ 
ate Summer Training Program, which is 
funded by the National Heart, Lung and 
Blood Institute of the National Institutes 
of Health. 
This Slimmer, second-year students 
(from left) Chris (lilligan, Greg 
Licholai and Armen Khachatryan are 
bicycling the 3.400 miles from Washing¬ 
ton State to New Jersey to raise money 
for the Leukemia Society of America. 
They hope to raise $20,000. 
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ALUMNI REPORT 
Alumni returning for their annual 
reunion weekend on June 5 and 6 
enjoyed the opportunity to renew 
friendships with classmates and to share 
fond memories. 
On Friday. Marie-Louise Johnson, 
M.D. '56, and vice president of the 
Association of Yale Alumni in Medicine, 
greeted attendees with Acting Dean 
Robert M. Donaldson Jr. A seminar 
entitled “Changing the Curriculum 
within the Yale System” was moderated 
by Robert H. Gifford, M.D., associate 
dean for education and student affairs. 
Participants included Emile L. Boulpaep, 
M.D., professor of cellular and molecular 
physiology; Timothy L. Vollmer, M.D., 
assistant professor of neurology; and 
Charles A. Janeway Jr., M.D., professor 
of immunobiology and biology, and 
investigator, fJoward Hughes Medical 
Institute. All panel members serve on 
the CLiiTiculum committee. A reception 
followed. Returning alumni met with 
classmates at dinners, parties and picnics. 
William F. Collins, M.D., chairman of 
surgery, discussed recent advances in 
this field at surgical grand rounds on 
June 6. Concurrent faculty seminars 
included; “How We Construct a 
Representative First-year Class,” 
moderated by Dr. Gifford; “The Who 
and the How—The Care of Your Now 
Dependent Parents” moderated by Leo 
M. Cooney Jr.. M.D.. Humana Founda¬ 
tion Professor of Geriatric Medicine, and 
Ronald Miller. M.D., associate clinical 
professor of medicine (geriatrics); “The 
Second Decade of the AIDS Epidemic,” 
presented by Gerald H. Eriedland, M.D., 
professor of medicine and epidemiology 
and public health, director of the AIDS 
program; and Elizabeth Cooney, M.D.. 
assistant professor of medicine, director 
of HIV care. Veterans Affairs Medical 
Center. West Haven. The medical 
reunion dialogue and tea concluded the 
scientific program. 
Acting Dean Donaldson presented a 
stimulating state of the school address at 
the annual meeting of the Association of 
Yale Alumni in Medicine (AYAM). 
Sherwin B. Nuland, M.D. '55, associate 
clinical professor of surgery, was joined 
by Eerenc Gyorgyey, historical librarian, 
and R. Kenny Eryer. head of the medical 
library reference services, in a presenta¬ 
tion entitled “The Yale Medical Library: 
Yesterday. Today, and Tomorrow.” A 
guided tour of the library followed. 
Muriel Wolf, M.D. '59, will continue 
as AYAM president and Gilbert Hogan, 
M.D. '57. has agreed to serve another 
term as secretary. The 1992 slate 
elected to replace retiring members of 
the executive committee includes: 
Harold D. Bornstein. M.D. '53, Leo M. 
Cooney Jr., M.D. '69, Lycurgus M. 
Davey, M.D. '43. Michael Kashgarian, 
M.D. '58, Gioacchino S. Parrella, M.D. 
'71, and Barbara A. Ross, M.D. '81. 
Elected as representatives to the Asso¬ 
ciation of Yale Alumni (AYA): John N. 
German, M.D. '62, and Robert M. Rosa. 
M.D. '70. 
We at the office of alumni affairs 
thank Dr. Muriel Wolf for her conscien¬ 
tious leadership as president. Congratu¬ 
lations and a warm thank you for a job 
well done are extended to those mem¬ 
bers of the AYAM executive committee 
and representatives to the AYA whose 
terms have expired. 
Distinguished Alumni Service 
Awards were presented to George A. 
Carden Jr., M.D. '35, and Walter J. 
Burdette, M.D. '42, who was celebrating 
his 50th reunion. Both were honored for 
meritorious service to the school. 
Remarks were delivered by Samuel 
Kushlan. M.D. '35, and Nicholas 
Spinelli, M.D. '44. after they presented 
Yale chairs to the honorees. 
Helen Langner. M.D. '22, was 
honored with a citation and a bouquet of 
roses as our oldest alumna; she just 
celebrated her 100th birthday. She 
attends our yearly meeting regularly and 
still counsels psychiatry patients in her 
community. 
The success of this year's reunion 
challenges us to improve on our record. 
Plans are already in progress for the 
spring of 1993. Reunion classes ending 
in 3 and 8 will be hearing from us soon. 
Our office will be contacting the class 
secretaries for a list of people interested 
in helping to plan class .seminars and 
social events. A planning meeting will 
be scheduled for September. The office 
of alumni affairs encourages you to 
communicate with us. We want and 
need you to be in touch so that we can 
best represent your interests. 
Alumni/student interaction was 
enhanced by joint participation in 
phonathons held on March 24, 25 and 
April I. Twenty-six students from all 
classes of the school joined with 10 
alumni and alumni fund staff in solicit¬ 
ing pledges for the annual campaign. 
This wonderful opportunity for students 
to talk to alumni about financial aid and 
to compare “then and now” at the school 
resulted in pledges exceeding $20,000, 
with an equal amount anticipated from 
non-pledged donations. Einancial aid 
for our dedicated students continues to 
be the principal beneficiary of fund 
contributions. If you haven't pledged, 
plea.se do so. It is important to maintain 
our high percentage of contribution. 
The Yale Corporation appointed 
Gerard N. Bunow. M.D. '58. medical 
school dean starting July I. During his 
previous stay in New Haven as a 
medical student, house officer and 
faculty member, he forged a strong 
constituency within this community. 
We welcome back this son of YSM with 
the expectation that our school will 
increase in strength and remain a leader 
in teaching, research and the practice of 
humane medicine responsive to the 
needs of society as a whole. 
Arthur C. Crovcitto. M.D. '53 
Director ofaluutni ajfair.s 
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Obituaries 
John J. Weber 
John J. Weber. M.D.. emeritus professor 
t)f clinical psychiatry at the College of 
Physicians and Surgeons, Columbia 
University, died April 1 1. He suffered a 
heart attack while fishing near his home 
in Deep River, Conn. He was 72. 
Dr. Weber received international 
recognition for his “outcome studies" at 
Columbia from the 195()s through the 
19S()s. in which he followed the 
progress of psychoanalysis patients to 
determine the effectiveness of their 
therapies. 
Dr. Weber recei\ed his certificate of 
psychoanalytic medicine in 1950 from 
the Columbia University Center for 
Psychoanalytic Training and Research in 
1950. 1 le .served as the center's director 
Irom 1976 to 1981. Dr. Weber was a 
director of the Visiting Nurse Service of 
New York and helped create its Mental 
Health .Advisory Cr)mmittee in 1985. 
Dr. Weber, wIk) also was in private 
practice in .Manhattan, taught and 
continued his research at Columbia until 
his death. 
Dr. Weber spent 10 years securing 
the United States publication of 
Johannes Weyer's l)e Pniesti^ils 
Dcicinoiiuiii, a seminal study published 
in I 56.^ of witchcraft and a rejection of 
the superstitions sLirrounding it. 
A Newark native. f)r. Weber gradu¬ 
ated from Duke University and. in 1943, 
from Yale School of Medicine. He was 
a resident in psychiatry at the Paync- 
Whitney Clinic, New York University- 
Cornel I Medical Center. During World 
W ar II. he was a captain in the U.S. 
.Army Medical Corps. 
He is survived by his wife, Helen, 
and two daughters. Vanessa and 
■Melissa. 
Frederic M. Blodgett 
Frederic M. Blodgett 
Frederic M. Blodgett. M.D., died March 
12 at age 71. 
A 1945 graduate of the School of 
Medicine. Dr. Blodgett served his 
internship and pediatric residency at 
Massachusetts General Hospital in 
Boston. 
During the I96()s, Dr. Blodgett spent 
much of his research time identifying 
"lead belts"—areas with a high preva¬ 
lence of lead poisoning—in cities 
throughout the nation. In 1972, he 
helped develop free erythrocyte 
protoporphrin (FEP), the blood screen¬ 
ing test for lead poisoning. 
Before his retirement after 41 years in 
medicine. Dr. Bhulgett spent 19 years at 
the Children's Hospital of Wisconsin in 
Milwaukee. In 1967, he joined the 
Medical College of Wisconsin faculty 
where he was a professor emeritus of 
pediatrics and .served as chairman of the 
department from 1978 to 1983. He was 
honored with the college's Distinguished 
Service Award, the highest honor given 
to its faculty. In 1960, Dr. Blodgett 
receivetl the laancis Gilman Blake 
Award for Outstanding Teaching at Yale 
Uni\ersitv School of Medicine. 
He founded and was past president of 
the Ambulatory Pediatric Association 
and was a long-time fellow of the 
American Association of Pediatrics. He 
was the 1984 recipient of the AAP Job 
Lewis Smith Award for his work in lead 
poisoning. 
Dr. Blodgett is survived by his wife, 
Phyllis, four daughters and a son. 
Donations may be made to: Frederic M. 
Blodgett Memorial Fund. Department of 
Pediatrics. Account Number 3-35138, 
Medical College of Wisconsin, 8701 
Watertown Plank Rd., Wauwatosa, WI 
53226. 
David C. Cavicke 
David C. Cavicke, M.D., died May 26 in 
Lawrence and Memorial Hospital, New 
London, Conn. He was 65. 
A native of Somerville, Mass.. Dr. 
Cavicke .served as chief resident of 
neurosurgery at Yale from 1955 to 1958. 
He then established the neurosurgical 
practice at Lawrence and Memorial 
Hospital, a service which he headed 
until his death. He took a sabbatical in 
1967 to teach neurosurgery in India. 
In 1948, Dr. Cavicke received a 
bachelor's degree from Harvard Llniver- 
sity and in 1952 received his medical 
degree from Tufts University School of 
Medicine. He served in the Navy from 
1944 to 1945. 
Dr. Cavicke was medical staff 
president at Lawrence and Memorial 
Hospital in 1972 and chief of 
neurrrsurgery for many years. He also 
was assistant clinical profes.sor of 
neurosurgery at Yale School of Medi¬ 
cine and a consultant in neurosurgery at 
Westerly Hospital. Norwich State 
Hospital. Day-Kimball Hospital, the 
U.S. Naval Hospital and the U.S. Coast 
Guard Hospital. 
He was past-president of the Con¬ 
necticut Society of Neurosurgery and the 
New England Neurosurgical Society. 
He leaves his wife. Mary Agnes, and 
three sons. David. Dana and Matthew. 
Contributions may be made to the 
D.C. Cavicke M.D. Neurosurgical Fund 
at Law rence and Memorial Hospital. 365 
Montauk Ave., New London, CT 
06320. 
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Robert E. Kaufman 
Robert E. Kaufman. M.S., died March 
21 at the Cabrini Medical Center 
Hospice. He was 83. 
Dr. Kaufman, a 1929 graduate of 
Yale College and a 1933 graduate of the 
School of Medicine, had been in private 
practice and on the staff of Lenox Hill 
Hospital for 58 years. 
During World War II. he served as 
battalion surgeon with the 4th Infantry 
Division for five years. He was awarded 
both the Bronze and Silver stars for 
valor in combat in Normandy on D-Day. 
A member of the New York County 
Robert M. Lowman 
Robert M. Lowman. M.D., died Dec. 4 
at Yale-New Haven Hospital at age 79. 
A native of Baltimore. Dr. Lowman 
received his M.D. degree from the 
University of Maryland in 1936. He 
spent several years as an instructor in 
radiology at the Graduate School of 
Medicine of the University of Pennsyl¬ 
vania and later accepted the position of 
director of the department of radiology 
at Grace Hospital in 1942, commencing 
a 49-year career with Yale. In 1943, he 
was appointed assistant professor at the 
School of Medicine and in 1962, became 
professor of radiology. 
Medical Society, Dr. Kaufman served on 
the public relations board for more than 
20 years and was chairman of the 
society’s Doctor's Emergency Service 
for more than 15 years. 
Dr. Kaufman appeared in the 
Guinness Book of World Records with 
the world's largest cigarette collection. 
He is survived by his wife, Naida; two 
sons, Colin and Chris; and two granddaugh¬ 
ters, Elizabeth and Molly. Donations may 
be sent to Lenox Hill Hospital, 100 East 
77th St., New York, NY. 
He was the author of more than 120 
publications and was active in several 
national, regional and local medical and 
radiological societies. Dr. Lowman was 
a counsellor for the American College of 
Radiology and the Radiological Society 
of North America, and served as 
president of the New Haven Medical 
Society and of the New England 
Roentgen Ray Society. 
Dr. Lowman .served as a consultant in 
radiology at the Veterans Affairs 
Medical Center in West Haven, where 
he continued to teach students and 
residents until his death. 
III Meiiwriam 
Lewis L. Loster 
November 17, 1991 
'32 M.D 
Robert E. Kaufman 
March 19, 1992 
'33 M.D. 
Joseph A. Bliss 
January 1, 1992 
'38 M.D. 
W. Sterry Branning 
June 8, 1991 
'39 M.D. 
Carl I. Cohen 
April 25, 1992 
'39 M.P.H. 
John J. Weber 
April 12, 1992 
'43 M.D. 
Charles L. Mache Jr. 
February 3, 1992 
'47 M.D. 
Goffredo Accetta 
January 15, 1992 
'51 M.D. 
John J. Zugich 
March 24, 1992 
'51 M.P.H. 
Kenneth A. Simon 
Febrnaiy 13, 1992 
'57 M.D. 
Stephen T. Baker 
May 8, 1991 
'72 M.D. 
'73 M.P.H. 
"'Those holding torches will 
pass them on to one another. ” 
Plato, Republic, 328a 
Inscription over the entrance of 
Sterling Hall of Medicine 
Yale University 
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DEVELOPMENT REPORT 
Dr. Carroll Establishes 
Annuity to Mark Reunion 
Robert E. Carroll. '38. M.D. '42. has 
established a eharitable gift annuity to 
benefit the School of Medicine. This 
gift, which marks Dr. Carroll's 5()th 
reunion year, will support student 
scholarship aid and research and training 
in hand surgery in the department of 
orthopaedics and rehabilitation, and will 
pro\ ide Dr. Carroll and his wife with an 
income for life. 
Dr. Carroll, a prominent hand surgeon 
and longtime supporter of Yale College 
and the School of Medicine, was horn in 
f all River. Mass. After graduating from 
YSM. he received training in general 
surgery and orthopaedic surgery at the 
•Massachusetts General Hospital. For a 
brief time he taught at Mar\'ard Medical 
School. 
Following service in World War II in 
the Pacific, he moved to New York City. 
Dr. Carroll established the division of 
hand surgery at the New York 
Orthopaedic Hospital. Columbia- 
Presbyterian Medical Center. He 
remained there as chief until 1986. The 
hand ser\ ice is renowned for its work 
v\ ith congenital hand deformities, as well 
as ttimors and muscle transplantation; 
during his tenure there. Dr. Carroll 
helped de\ elop the use of silicone 
tendons for hand surgery reconstruction. 
.•\t Columbia, he established one of 
the early formal training programs for 
hand surgery in the United States. Dr. 
Carroll is known as a leading teacher of 
hand surgery not only in the United 
States, hut throughout the world, as well. 
He uas honored recently in Paris by 
membership in the Hand Societies of 16 
countries. 
In addition to his military service. 
Dr. Carroll ser\ed his country as a 
'Hisultant to the U.S. Na\y. Air Force. 
Dr. Robert E. Carroll 
the Veterans Administration and the 
Public Health Service. He has been 
president of the Association of Bone 
and Joint Surgeons and was a founder 
and president of the New York Society 
for Surgery of the Hand, as well as a 
vice president of the American Society 
for Surgery of the Hand. 
Today. Dr. Carroll serves as professor 
of clinical orthopaedic surgery emeritus, 
at Columbia University and consultant in 
Hand Surgery (Orthopaedics) at the 
Columbia-Presbyterian Medical Center. 
He and his wife live in New York City. 
In appreciation for Dr. Carroll's gift. 
Acting Dean Robert M. Donaldson Jr. 
wrote: "On behalf of the entire school, 1 
am delighted to send you an e.xpression of 
our gratitude for your loyalty and for your 
\ aluable and important assistance." 
Jay Aiigeletri 
Senior development officer 


































2nd Annual Symposium in Congenital Heart Disease (A) 
Direclor: Michael Dewar, M.D. 
This miilli-disciplinary symposium will focus atlenlion on innovative diagnostic 
and therapeutic technitiues in fetal, neonatal and adolescent cardiology, neonatal 
cardiac surgery and pediatric intensive care. 
Topics in Neuro-Opbthabnology (H) 
Direclor: David Silverstone, M.D. 
Guest Speaker: Neil Miller, M.D. 
8tb National Conference on Perinatal Bereavement (C) 
Fall from the Tree: Perinatal Loss 
Director: Richard ViscareUo 
This symposium will enhance the scope of comprehensive care given by a multi¬ 
disciplinary team for families in crisis, experiencing pregnancy losses from 
infertility, prematurity, anomalies and stillbirth. 
Cardiology Update 1992 (D) 
Director: Lawrence Cohen, M.D. 
This symposium will present the current status of cardiologic frontiers including 
silent ischemia, interventional cardiology techniciues, thrombolysis, sudden death 
and heart disease in women. 
Recent Findings from the Neuroscience Revolution (E) 
Implications for autism, schizophrenia, affective disorders, and more in young 
children and adults. 
Director: Enid Peschel, Ph.D. 
Topics in the Management of Retinal Disease (E) 
Director: David Silverstone, M.D. 
Guest Speaker: Stuart Fine. M.D. 
CIRCLE THE APPROPRIATE LETTER(S) ON THE ATTACHED POSTCARD TO OBTAIN MORE INEORMATION ON 
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